data_1m7t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1m7t _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.487 HG11 ' N ' ' A' ' 3' ' ' LYS . 43.1 t . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.808 0.337 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.487 ' N ' HG11 ' A' ' 2' ' ' VAL . 2.4 ptpt -143.12 120.6 11.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.274 0.559 . . . . 0.0 110.334 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -72.57 125.35 27.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.931 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.402 ' CD1' HD13 ' A' ' 55' ' ' LEU . 1.1 mp -101.02 107.04 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.92 0.391 . . . . 0.0 110.363 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -97.86 20.06 12.75 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.974 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.3 m -156.95 160.13 38.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.838 0.351 . . . . 0.0 111.413 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -72.43 -27.03 62.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.47 -32.13 42.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.383 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.1 -37.0 84.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.18 -45.2 91.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.027 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -65.31 -44.53 87.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.618 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.76 -45.77 91.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.642 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.55 74.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.07 0.462 . . . . 0.0 110.696 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.37 -35.88 76.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.719 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -62.15 -34.61 76.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.789 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.55 -22.72 53.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.927 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.77 73.35 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.036 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.17 -120.8 21.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.305 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -93.42 1.67 56.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -76.45 148.8 37.01 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 tp -76.51 131.51 39.04 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 2.4 t -113.45 109.07 27.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.272 0.558 . . . . 0.0 111.805 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.494 HG12 ' CE1' ' A' ' 54' ' ' PHE . 7.2 p -104.23 119.2 52.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.442 HG12 ' CD2' ' A' ' 55' ' ' LEU . 3.6 m -124.97 167.6 18.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.824 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -135.9 136.56 40.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.923 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -98.67 114.1 26.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.284 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.9 p -131.78 -171.12 2.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.683 0.754 . . . . 0.0 112.767 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.54 162.3 41.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.546 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 m -63.08 -30.63 71.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.92 0.391 . . . . 0.0 110.045 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -93.32 10.81 30.5 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.188 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.8 t -90.89 113.78 26.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.951 0.405 . . . . 0.0 111.176 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.84 -59.9 3.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.024 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.86 -28.75 69.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.342 2.028 . . . . 0.0 112.311 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.4 m -60.07 -39.87 87.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.803 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -69.11 -20.33 64.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.248 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.5 mtt -74.17 -25.19 59.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.369 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.3 mm -89.42 -24.83 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.654 0.264 . . . . 0.0 111.548 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -47.56 -50.17 51.75 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 38.1 Cg_exo -61.9 -44.67 19.57 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.492 2.128 . . . . 0.0 112.826 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -80.55 -29.46 37.09 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.408 ' CE1' HG23 ' A' ' 24' ' ' VAL . 5.0 t80 -66.74 -46.43 75.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.072 0.463 . . . . 0.0 110.205 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -39.83 90.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.696 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.5 p -60.69 -42.87 98.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 111.063 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.3 mt -60.64 -43.09 97.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.19 -29.42 31.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.222 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -89.05 -21.45 23.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.958 0.409 . . . . 0.0 110.355 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -94.98 3.2 55.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.58 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -109.09 -30.49 8.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 111.058 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 t 36.43 34.41 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.079 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -151.1 -41.36 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.995 0.426 . . . . 0.0 110.858 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.9 m -94.03 157.4 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.543 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.44 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 2.8 tp -106.62 117.45 52.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.331 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.494 ' CE1' HG12 ' A' ' 24' ' ' VAL . 5.2 m-85 -100.78 115.61 30.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.308 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.442 ' CD2' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -123.8 165.54 17.14 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.421 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.416 ' N ' HD11 ' A' ' 55' ' ' LEU . 2.6 tt0 -116.94 119.56 35.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.115 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.93 119.97 63.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.598 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -99.2 120.67 39.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.73 -18.39 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.722 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -66.92 -37.94 85.28 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.4 -34.5 10.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.736 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -95.89 43.35 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.847 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.62 -9.59 50.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.963 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.99 -23.3 17.44 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.521 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.401 HG21 ' CB ' ' A' ' 62' ' ' ALA . 2.5 m -78.83 -47.37 23.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.203 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.97 -57.18 13.32 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.489 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 72.6 Cg_exo -50.69 -28.96 24.08 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.555 2.17 . . . . 0.0 112.101 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -77.86 -22.12 50.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.004 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -107.77 -5.56 17.26 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.886 0.374 . . . . 0.0 111.637 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.03 33.66 87.77 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.909 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.96 137.98 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 117.26 0.53 . . . . 0.0 110.593 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -140.94 79.42 1.7 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.96 0.41 . . . . 0.0 111.49 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.42 164.97 10.24 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.015 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.436 HG21 HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -147.76 154.71 44.37 Favored Pre-proline 0 N--CA 1.464 0.251 0 C-N-CA 122.173 0.189 . . . . 0.0 110.9 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -81.9 118.7 5.84 Favored 'Cis proline' 0 C--N 1.35 0.648 0 C-N-CA 124.772 -0.928 . . . . 0.0 112.779 0.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.36 136.87 32.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.866 0.365 . . . . 0.0 111.318 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 tp -107.8 119.03 38.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.409 ' CD2' ' CG2' ' A' ' 88' ' ' THR . 6.0 mt -114.56 135.22 54.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.241 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.428 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.7 mm? -115.58 123.4 48.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.726 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.49 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 45.8 m-85 -114.37 145.88 41.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.933 0.397 . . . . 0.0 111.177 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -146.85 112.72 5.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.045 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.5 m120 61.51 45.78 8.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 110.221 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.33 2.86 50.99 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.655 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -124.55 140.23 53.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.393 0.597 . . . . 0.0 111.39 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.442 HG21 ' CZ ' ' A' ' 80' ' ' PHE . 28.3 t -68.3 116.94 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.728 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.28 11.27 27.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.094 0.474 . . . . 0.0 111.49 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.428 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -175.96 139.62 0.39 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.643 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.409 ' CG2' ' CD2' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -136.02 116.58 13.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.526 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -120.82 140.98 50.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 110.727 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.3 p -117.04 146.65 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.269 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.48 160.15 12.38 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.491 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.43 163.89 24.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 0.0 111.82 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.44 153.81 33.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.462 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.4 m -64.32 178.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.904 0.383 . . . . 0.0 111.133 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -72.28 -31.19 65.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.053 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.4 -31.34 51.56 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.315 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 17.8 mt-30 -76.91 -30.75 56.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.174 0.487 . . . . 0.0 110.627 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.42 -50.87 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -62.39 -44.44 96.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.997 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.1 pp20? -61.78 -42.49 99.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.83 0.348 . . . . 0.0 110.364 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -63.17 -42.96 99.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.33 0.586 . . . . 0.0 110.36 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.6 mt -65.46 -59.79 3.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.119 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -49.22 -32.21 10.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.466 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.54 -21.51 60.35 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.019 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -108.77 -28.25 9.31 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 110.697 179.911 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 3' ' ' LYS . 41.5 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.696 0.284 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.49 ' N ' HG13 ' A' ' 2' ' ' VAL . 1.9 pttp -146.12 121.36 10.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.224 0.535 . . . . 0.0 110.173 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -72.84 131.59 42.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.679 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.17 108.32 24.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.042 0.449 . . . . 0.0 110.474 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.56 20.18 14.39 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.976 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -155.12 161.73 41.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 111.138 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -75.08 -26.94 59.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.605 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -79.85 -32.01 40.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.512 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.41 88.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.433 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.401 ' CE1' HG21 ' A' ' 57' ' ' VAL . 4.6 t80 -57.06 -42.24 80.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.909 0.385 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.05 -42.95 88.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.91 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -58.14 -46.29 85.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.254 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.25 76.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.64 -43.35 89.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.99 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.48 -26.49 67.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.434 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.17 -49.76 73.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.977 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.36 -64.21 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.778 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.38 -83.04 1.63 Allowed Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.98 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -96.79 -18.55 19.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.82 0.31 . . . . 0.0 111.468 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -73.28 155.46 39.46 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.2 tp -78.17 134.87 37.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.894 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 13.8 t -113.74 110.25 31.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.418 0.627 . . . . 0.0 111.52 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.464 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -104.96 117.17 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.428 HG12 ' CD2' ' A' ' 55' ' ' LEU . 5.5 m -126.4 167.42 21.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.012 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -131.34 133.21 45.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.977 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 78' ' ' LEU . 5.6 m-85 -97.78 110.56 23.11 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 m -119.79 -168.34 1.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.388 0.613 . . . . 0.0 112.607 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.05 154.89 36.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.455 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -35.02 70.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.41 0.624 . . . . 0.0 109.498 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 52.7 p-90 -86.84 11.58 12.97 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.652 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 9.6 t -93.36 157.46 16.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.148 0.499 . . . . 0.0 111.705 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.18 -66.57 0.53 Allowed Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.239 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.1 -21.68 72.36 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.568 2.179 . . . . 0.0 112.308 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.23 -42.99 96.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -68.68 -15.66 63.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.495 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 mtp -72.92 -24.66 60.85 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.1 mm -85.46 -22.63 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.654 0.264 . . . . 0.0 111.685 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 28.6 mtpt -50.0 -59.71 6.47 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_endo -49.55 -45.84 29.34 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.535 2.157 . . . . 0.0 112.864 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -79.19 -29.06 42.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -65.55 -45.7 82.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.447 . . . . 0.0 110.375 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -38.06 84.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.867 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -61.79 -43.15 99.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.815 0.341 . . . . 0.0 110.676 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.97 -45.37 92.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.211 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.9 p -53.32 -27.21 22.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.554 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -85.21 -22.29 28.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.389 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -95.36 -17.56 21.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.918 0.389 . . . . 0.0 110.219 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.433 ' CE2' HD11 ' A' ' 102' ' ' LEU . 17.3 m-85 -99.6 92.66 5.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.879 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.2 m -90.22 49.55 1.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.393 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -153.23 -43.21 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.452 HG23 ' CE1' ' A' ' 54' ' ' PHE . 9.1 m -93.68 155.51 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.906 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.442 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 2.9 tp -105.58 114.69 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.918 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 8.0 m-85 -96.7 116.24 28.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.057 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.428 ' CD2' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -130.63 168.8 16.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.34 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.418 ' N ' HD11 ' A' ' 55' ' ' LEU . 6.5 tt0 -121.34 124.16 43.9 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.401 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -117.33 120.44 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.905 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -97.83 119.22 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.39 -19.2 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.71 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.79 -41.03 97.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -98.21 -34.28 10.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.386 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.1 41.11 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.049 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -9.72 50.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.575 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.26 -23.14 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.422 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.8 m -78.12 -47.05 25.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.052 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.512 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.16 -57.97 11.1 Favored Pre-proline 0 N--CA 1.463 0.183 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 76.3 Cg_exo -51.07 -29.39 27.95 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.665 2.244 . . . . 0.0 112.262 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -76.72 -22.65 53.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.668 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -108.49 -3.5 18.07 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.842 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.45 35.35 91.22 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.175 -0.536 . . . . 0.0 114.0 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.403 HD11 ' CD2' ' A' ' 27' ' ' PHE . 76.4 mt -75.66 134.12 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 117.494 0.647 . . . . 0.0 110.689 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -151.58 51.22 0.82 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.909 0.385 . . . . 0.0 111.399 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.77 103.27 0.17 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.377 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.2 pt -103.14 153.21 38.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.465 0.174 . . . . 0.0 111.281 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.6 116.07 4.33 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.954 -1.269 . . . . 0.0 112.123 -0.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.02 138.17 31.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.017 0.436 . . . . 0.0 112.156 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -107.48 123.43 48.4 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.432 HD11 ' CE1' ' A' ' 27' ' ' PHE . 7.6 mt -114.88 133.02 56.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.236 0.541 . . . . 0.0 111.841 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.13 121.99 44.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.921 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.504 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 50.7 m-85 -114.04 148.21 37.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.983 0.421 . . . . 0.0 111.397 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -147.05 111.99 5.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.952 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 m120 60.73 46.74 8.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.882 0.372 . . . . 0.0 110.316 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.35 4.68 52.06 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.659 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -125.34 139.54 53.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.19 0.495 . . . . 0.0 111.611 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.9 t -67.67 116.14 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.833 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.83 11.11 20.82 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . . . -174.16 142.19 0.8 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.44 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -137.35 127.57 26.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 111.079 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.42 138.76 52.48 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.143 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 t -121.47 146.08 27.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.694 0.283 . . . . 0.0 111.642 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.43 161.02 23.9 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.849 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.07 164.36 18.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 111.542 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.8 151.15 19.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.051 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.63 178.91 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -70.9 -30.71 67.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.96 -30.99 50.02 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.007 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -77.28 -32.37 55.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.915 0.388 . . . . 0.0 110.617 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.0 -51.74 23.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.33 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -60.95 -38.24 85.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.356 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.468 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -61.88 -38.23 87.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.872 0.367 . . . . 0.0 110.268 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.468 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 6.3 t80 -61.48 -41.55 97.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.28 0.562 . . . . 0.0 110.09 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.433 HD11 ' CE2' ' A' ' 49' ' ' TYR . 6.6 mt -66.92 -56.88 8.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.9 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -50.8 -35.56 32.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.998 0.428 . . . . 0.0 110.193 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.6 -22.72 63.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.71 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -106.43 -55.42 2.33 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.624 0.25 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.8 tp . . . . . 0 N--CA 1.464 0.253 0 CA-C-O 121.064 0.459 . . . . 0.0 110.852 179.439 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 3' ' ' LYS . 46.5 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.818 0.342 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.519 ' N ' HG12 ' A' ' 2' ' ' VAL . 5.8 ptpp? -146.53 122.93 10.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.073 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -74.75 131.92 41.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.249 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.401 ' CD1' HD12 ' A' ' 55' ' ' LEU . 1.1 mp -104.28 108.36 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.763 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -97.47 18.93 14.21 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 m -155.15 165.4 36.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.03 0.443 . . . . 0.0 111.523 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -76.89 -26.34 54.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.33 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.0 m -79.78 -33.82 40.25 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.171 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.13 -36.49 83.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.365 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -58.85 -43.44 90.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.059 0.457 . . . . 0.0 110.118 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -65.41 -40.51 93.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.715 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -58.93 -50.71 73.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.711 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.2 75.28 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 mt -65.56 -42.92 91.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.891 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.1 -28.28 68.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.545 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.16 -47.31 83.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.11 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.19 -64.27 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.171 -0.611 . . . . 0.0 109.628 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.88 -87.3 1.47 Allowed Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.201 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.34 -15.77 24.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.092 0.446 . . . . 0.0 111.482 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -75.24 155.62 36.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' A' ' 106' ' ' LEU . 8.1 tp -78.63 133.3 37.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.123 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 5.4 t -112.06 109.62 29.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.491 0.662 . . . . 0.0 111.413 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.452 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.1 p -104.15 115.11 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.456 HG11 ' CD2' ' A' ' 55' ' ' LEU . 3.2 m -122.89 163.98 20.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.306 0.574 . . . . 0.0 112.022 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -128.37 130.81 48.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.582 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -97.52 111.06 23.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.9 t -119.53 -168.94 1.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.238 0.542 . . . . 0.0 112.303 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.84 154.6 36.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.864 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -71.95 -37.84 69.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.48 0.657 . . . . 0.0 109.782 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -86.77 11.74 12.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.159 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.8 t -97.29 156.43 16.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.775 0.322 . . . . 0.0 110.926 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.03 -64.29 0.55 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.296 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.02 -24.36 76.63 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.422 2.081 . . . . 0.0 112.042 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -59.71 -45.54 91.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.305 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -64.9 -25.75 68.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 49.6 mmm -66.85 -16.26 64.18 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.7 mm -86.12 -21.57 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.731 0.3 . . . . 0.0 111.092 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.509 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -50.87 -58.78 9.08 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 7.4 Cg_endo -48.13 -47.81 18.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.796 2.331 . . . . 0.0 113.063 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -80.09 -30.41 39.22 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -65.72 -46.23 79.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.066 0.46 . . . . 0.0 109.942 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -39.57 88.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.729 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 t -61.57 -43.48 98.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.331 . . . . 0.0 110.833 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.47 -40.36 86.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.131 0.491 . . . . 0.0 109.897 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.3 t -56.15 -28.42 57.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.367 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -85.95 -20.52 28.83 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -95.75 -20.56 18.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.105 0.478 . . . . 0.0 110.159 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.409 ' CD2' HG22 ' A' ' 52' ' ' VAL . 16.0 m-85 -97.29 95.74 7.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.539 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -93.93 48.45 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.161 0.505 . . . . 0.0 110.019 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.87 -41.0 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.519 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.447 HG23 ' CE1' ' A' ' 54' ' ' PHE . 10.5 m -95.97 154.55 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.979 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 2.8 tp -105.5 113.99 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.833 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 9.3 m-85 -96.28 116.29 28.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.139 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.456 ' CD2' HG11 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -127.67 165.77 19.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.5 178.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.83 119.21 35.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.71 118.32 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.181 0.515 . . . . 0.0 111.369 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -99.68 121.93 41.94 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.1 p -60.43 -18.98 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.784 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -65.71 -39.09 90.85 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -97.94 -36.67 10.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.534 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 65' ' ' VAL . . . -96.24 43.47 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.749 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -70.2 -9.77 56.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.509 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -94.04 -23.57 17.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.273 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.402 ' CG2' ' CB ' ' A' ' 62' ' ' ALA . 2.4 m -79.14 -46.61 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.036 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.491 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.24 -56.9 14.89 Favored Pre-proline 0 N--CA 1.462 0.175 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 81.1 Cg_exo -50.93 -28.82 25.06 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.677 2.251 . . . . 0.0 112.128 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -76.13 -18.75 59.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.964 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -115.9 -7.35 12.01 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.946 0.403 . . . . 0.0 111.658 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.05 39.94 97.69 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.038 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -76.97 79.66 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 117.013 0.406 . . . . 0.0 110.162 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -87.19 77.82 8.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.959 0.409 . . . . 0.0 111.774 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.73 162.52 9.3 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.129 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.2 pt -145.89 156.5 51.57 Favored Pre-proline 0 CA--C 1.529 0.165 0 C-N-CA 122.157 0.183 . . . . 0.0 110.863 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -87.36 116.4 3.51 Favored 'Cis proline' 0 C--N 1.354 0.825 0 C-N-CA 124.578 -1.009 . . . . 0.0 112.481 -0.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.65 138.03 31.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.88 0.371 . . . . 0.0 111.659 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.65 125.79 51.79 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HB2' HG21 ' A' ' 25' ' ' VAL . 6.3 mt -114.58 133.73 55.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.265 0.555 . . . . 0.0 111.686 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 2.8 mm? -114.48 117.03 29.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.968 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.48 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 45.3 m-85 -108.08 148.76 29.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.423 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -148.25 113.62 5.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.229 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.3 46.66 15.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.932 0.396 . . . . 0.0 110.276 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.83 3.45 55.41 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.918 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -126.26 140.51 52.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.252 0.526 . . . . 0.0 111.667 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.24 119.0 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.911 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -117.05 11.46 14.25 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -173.18 140.23 0.85 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.398 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.0 141.15 46.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.049 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -142.48 136.81 29.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.181 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.4 t -120.32 146.3 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.79 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.27 159.57 23.26 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.857 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.63 132.3 47.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.974 0.416 . . . . 0.0 111.324 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.88 -173.5 2.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.365 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 t -110.03 164.89 12.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.9 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -55.63 -38.01 68.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.769 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.05 -31.7 51.9 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.872 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 43.0 mt-30 -76.18 -31.86 58.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.012 0.406 . . . . 0.0 110.507 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.07 -50.13 30.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -61.51 -43.96 97.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.94 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -61.87 -40.09 94.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.256 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.412 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 30.0 t80 -63.09 -42.12 99.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.293 0.568 . . . . 0.0 110.728 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 mt -68.02 -56.15 9.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.318 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.99 -34.69 21.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.916 0.389 . . . . 0.0 110.471 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.31 -19.69 60.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.23 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -107.0 -34.7 7.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.84 0.352 . . . . 0.0 110.943 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.416 ' HB2' HD22 ' A' ' 22' ' ' LEU . 53.2 tp . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.105 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.478 HG11 ' N ' ' A' ' 3' ' ' LYS . 61.6 t . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.755 0.312 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.478 ' N ' HG11 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -145.4 121.97 11.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.117 0.484 . . . . 0.0 110.238 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -74.01 130.05 39.08 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.027 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.0 OUTLIER -102.97 108.55 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.994 0.426 . . . . 0.0 110.337 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -100.59 19.74 16.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.143 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.26 160.16 40.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.935 0.397 . . . . 0.0 111.071 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.18 -28.64 64.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.002 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.49 -30.59 42.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.983 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.6 90.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.683 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -57.63 -43.8 85.1 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.92 0.39 . . . . 0.0 110.098 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.429 ' HA ' ' NE2' ' A' ' 12' ' ' GLN . 9.8 mm100 -65.38 -44.1 88.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.589 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -58.37 -46.13 86.92 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.313 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.83 -32.31 73.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.043 0.449 . . . . 0.0 110.606 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 mt -68.23 -38.58 82.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.99 -35.32 76.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.398 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.5 -22.5 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.685 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.14 -34.59 78.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.007 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.2 -123.43 31.19 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.25 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.32 6.22 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.599 0.237 . . . . 0.0 111.414 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -79.21 149.77 31.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 tp -76.16 133.21 40.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 5.8 t -111.41 111.43 36.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.523 0.678 . . . . 0.0 112.026 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.47 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -105.8 113.92 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.436 HG13 ' CD2' ' A' ' 55' ' ' LEU . 4.6 m -124.21 167.04 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.203 0.525 . . . . 0.0 112.007 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -134.28 134.34 41.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.023 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -96.91 108.8 21.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.331 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 p -115.69 -169.44 1.59 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.366 0.603 . . . . 0.0 112.355 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.09 154.8 36.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.405 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -71.5 -36.91 71.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.563 0.697 . . . . 0.0 109.53 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 p-90 -87.77 11.28 15.8 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.6 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 12.7 t -91.48 156.1 17.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.11 0.481 . . . . 0.0 112.145 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.28 -75.49 1.0 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.67 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.86 -20.84 30.64 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.702 2.268 . . . . 0.0 112.569 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.0 m -58.85 -43.87 90.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 110.757 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -68.45 -20.16 64.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.512 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 19.4 mtt -71.44 -23.71 61.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.398 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.3 mm -86.43 -24.17 6.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.725 0.298 . . . . 0.0 111.503 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -50.55 -52.9 51.44 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.004 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.54 -47.92 24.62 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.498 2.132 . . . . 0.0 113.107 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -80.34 -26.88 38.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.63 -45.49 82.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.047 0.451 . . . . 0.0 110.226 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.7 -41.47 83.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.988 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.1 t -59.82 -45.05 93.57 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.922 0.391 . . . . 0.0 111.065 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.78 -41.08 85.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.151 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 m -55.68 -26.31 44.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.285 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -87.44 -20.83 26.07 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.624 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -95.41 -19.48 19.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 0.0 110.077 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -99.28 92.15 5.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.705 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 t -88.58 49.06 1.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.877 0.37 . . . . 0.0 110.743 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -153.79 -41.17 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.454 HG13 ' CD1' ' A' ' 106' ' ' LEU . 10.9 m -93.24 154.88 3.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.831 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.484 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 5.3 tp -105.46 114.34 44.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.907 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 8.6 m-85 -96.43 115.76 27.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.377 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.436 ' CD2' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -128.77 167.2 17.64 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.343 178.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.423 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.0 tp10 -119.83 122.15 40.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -176.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.81 120.18 64.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.333 0.587 . . . . 0.0 111.133 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -100.23 119.34 38.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.77 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -60.95 -18.02 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.989 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -64.61 -39.37 93.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 109.681 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.59 -33.9 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.526 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.406 ' CB ' ' CG2' ' A' ' 65' ' ' VAL . . . -95.91 43.68 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.66 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -70.44 -9.58 56.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.658 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.98 -23.22 17.48 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.289 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.406 ' CG2' ' CB ' ' A' ' 62' ' ' ALA . 2.0 m -77.67 -47.6 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.546 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.497 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.2 -57.75 11.81 Favored Pre-proline 0 N--CA 1.462 0.137 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.497 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 76.9 Cg_exo -51.58 -28.62 29.46 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.5 2.133 . . . . 0.0 111.903 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -76.04 -20.04 58.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.761 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -111.57 -4.89 14.62 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.852 0.358 . . . . 0.0 111.852 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.0 35.87 91.24 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.556 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.402 ' CD1' HD12 ' A' ' 78' ' ' LEU . 91.5 mt -75.9 135.98 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 117.173 0.486 . . . . 0.0 110.655 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 -146.86 62.63 1.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.04 0.448 . . . . 0.0 111.286 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.404 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 176.71 160.88 24.58 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.588 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.3 pt -146.31 137.4 12.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 O-C-N 122.995 -0.121 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -89.88 122.14 5.1 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 124.749 -0.938 . . . . 0.0 112.092 0.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -86.56 137.01 32.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.117 0.484 . . . . 0.0 112.189 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 tp -108.97 122.74 47.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.411 ' HB2' HG21 ' A' ' 25' ' ' VAL . 7.0 mt -115.01 136.48 53.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.236 0.541 . . . . 0.0 111.689 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.407 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.4 mm? -117.4 123.33 46.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.039 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.541 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 52.0 m-85 -115.27 147.53 40.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.143 0.497 . . . . 0.0 111.503 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -146.41 111.84 5.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.098 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 m120 60.59 46.53 9.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.392 . . . . 0.0 110.321 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.02 0.6 52.79 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.955 -0.641 . . . . 0.0 114.009 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -123.25 138.93 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.626 0.713 . . . . 0.0 111.592 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.435 ' CG2' ' CE2' ' A' ' 80' ' ' PHE . 39.9 t -67.62 117.98 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.451 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.18 8.8 21.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.407 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -172.26 141.82 1.29 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.673 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 t -137.68 127.94 26.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.157 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.04 137.97 50.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.09 146.27 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.577 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.89 165.24 30.99 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.27 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.27 171.78 5.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 111.521 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.14 -170.6 2.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.491 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.58 166.25 11.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.773 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -57.79 -32.81 67.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.958 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.43 -30.72 53.27 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.795 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 42.3 mt-30 -77.34 -31.15 54.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.729 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -51.33 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -63.45 -44.38 94.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.195 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.1 pp20? -60.71 -42.29 96.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.948 0.404 . . . . 0.0 110.102 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -62.42 -40.6 97.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.387 0.613 . . . . 0.0 110.013 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 mt -64.13 -62.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.846 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.12 -32.01 6.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.27 -24.85 62.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.924 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -108.29 -28.96 9.13 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.802 0.334 . . . . 0.0 111.282 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.454 ' CD1' HG13 ' A' ' 52' ' ' VAL . 2.7 tt . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.788 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 3' ' ' LYS . 46.5 t . . . . . 0 C--O 1.233 0.184 0 CA-C-O 120.843 0.354 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.472 ' N ' HG12 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -143.51 119.9 10.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.325 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -73.48 129.57 38.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 mp -101.81 108.33 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.279 0.561 . . . . 0.0 111.106 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -98.86 19.81 14.28 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.861 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -154.44 158.84 40.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.97 0.414 . . . . 0.0 111.308 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -71.45 -29.47 64.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -31.03 38.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.78 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.46 81.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.623 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -59.25 -43.89 92.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.166 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.17 -39.89 94.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.552 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -58.99 -48.88 79.97 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.28 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.35 -33.98 76.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 111.015 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.419 HD22 ' CG ' ' A' ' 80' ' ' PHE . 15.1 mt -66.95 -40.68 87.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.435 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.59 -28.68 67.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.489 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.62 77.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.08 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.02 -64.83 0.78 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.544 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.88 -82.47 1.52 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.322 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -95.49 -18.63 20.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.661 0.267 . . . . 0.0 111.556 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -75.11 154.8 37.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 106' ' ' LEU . 4.1 tp -78.77 136.11 37.29 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 6.0 t -116.58 106.59 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.034 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.453 HG13 ' CE1' ' A' ' 54' ' ' PHE . 10.4 p -102.54 119.12 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.411 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 4.9 m -127.15 167.55 21.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.856 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -133.42 136.0 44.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.772 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -100.89 111.12 23.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 p -121.39 -167.91 1.59 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.439 0.638 . . . . 0.0 112.366 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.54 154.07 34.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.169 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -33.96 68.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.523 0.678 . . . . 0.0 109.826 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.6 p-90 -86.9 10.52 15.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.912 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 12.2 t -95.15 158.05 15.63 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.142 -0.349 . . . . 0.0 111.529 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.1 -65.64 0.59 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.256 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.34 -22.79 66.02 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.406 2.071 . . . . 0.0 112.404 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.7 m -61.8 -44.36 97.02 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.015 0.436 . . . . 0.0 110.595 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -64.51 -28.11 69.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.198 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.4 mtt -67.15 -16.0 64.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.0 mm -86.89 -22.38 7.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.656 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.424 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 33.1 mtpt -50.97 -60.41 5.63 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 1.3 Cg_endo -47.06 -46.54 18.79 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.634 2.222 . . . . 0.0 113.059 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -80.41 -32.35 37.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -67.2 -44.83 78.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.941 0.4 . . . . 0.0 110.177 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -38.18 84.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.593 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.7 t -60.67 -43.32 97.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.927 0.394 . . . . 0.0 110.496 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.2 mt -59.48 -40.06 85.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.332 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.409 ' OG ' ' CD2' ' A' ' 54' ' ' PHE . 1.2 m -54.07 -27.4 32.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.24 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -88.12 -21.75 24.49 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.646 0.26 . . . . 0.0 111.4 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -94.16 -21.63 18.96 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -96.43 97.29 9.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.95 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -96.1 43.98 1.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.736 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -156.26 11.37 0.27 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.403 HG22 ' CE1' ' A' ' 54' ' ' PHE . 19.2 m -144.3 157.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 120.423 0.154 . . . . 0.0 111.142 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 tp -106.34 115.25 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.237 0.541 . . . . 0.0 110.618 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.453 ' CE1' HG13 ' A' ' 24' ' ' VAL . 6.5 m-85 -97.78 115.91 28.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.858 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -127.65 168.01 15.63 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.63 178.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.413 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -119.59 121.48 39.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.92 119.11 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.276 0.56 . . . . 0.0 111.396 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -98.99 120.74 39.93 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.33 -19.42 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.14 -40.2 96.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.263 0.554 . . . . 0.0 110.004 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -98.78 -35.71 10.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.196 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.407 ' CB ' ' CG2' ' A' ' 65' ' ' VAL . . . -95.17 45.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.669 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -71.95 -11.18 60.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.547 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.7 -21.26 19.46 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.419 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.407 ' CG2' ' CB ' ' A' ' 62' ' ' ALA . 2.5 m -80.04 -46.51 22.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.696 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.66 -57.96 11.62 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 53.3 Cg_exo -52.72 -28.64 38.66 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.619 2.213 . . . . 0.0 111.956 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -76.39 -25.59 54.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.126 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -105.94 -2.38 22.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.02 36.11 91.55 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.172 -0.537 . . . . 0.0 114.051 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 79.3 mt -77.55 133.95 29.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.458 0.629 . . . . 0.0 110.443 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -150.72 54.43 0.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.944 0.402 . . . . 0.0 111.383 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 170.09 105.42 0.18 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.922 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 pt -103.04 153.86 38.0 Favored Pre-proline 0 N--CA 1.463 0.198 0 C-N-CA 122.167 0.187 . . . . 0.0 110.829 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.38 114.78 3.47 Favored 'Cis proline' 0 C--N 1.353 0.767 0 C-N-CA 124.198 -1.167 . . . . 0.0 112.757 -0.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.33 136.75 32.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.957 0.408 . . . . 0.0 111.359 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.98 121.02 43.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 mt -112.37 135.51 52.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.513 0.673 . . . . 0.0 111.874 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.37 126.18 52.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.845 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.9 m-85 -117.14 147.12 42.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.196 0.522 . . . . 0.0 111.267 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 tttm -148.26 115.31 6.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.99 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 m120 57.79 44.62 19.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 110.209 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.02 5.68 62.39 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.911 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -126.06 142.6 51.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.379 0.589 . . . . 0.0 111.483 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' CE2' ' A' ' 80' ' ' PHE . 21.8 t -70.05 119.19 15.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.655 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -115.08 12.34 16.62 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.37 138.91 0.43 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.17 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -134.59 133.23 39.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.693 0.282 . . . . 0.0 110.805 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.66 139.55 45.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.82 146.3 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.13 162.43 28.58 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.216 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.58 133.62 47.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.193 0.521 . . . . 0.0 111.548 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.08 -175.46 2.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.431 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.82 162.66 14.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.53 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -52.4 -37.76 57.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.509 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.58 -29.3 55.71 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.437 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -77.2 -33.23 56.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.586 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -50.88 32.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -42.24 90.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.389 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -62.58 -38.17 89.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.772 0.32 . . . . 0.0 110.483 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.414 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 9.7 t80 -63.77 -42.86 97.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.406 0.622 . . . . 0.0 110.103 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.8 -62.48 1.54 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.953 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.86 -34.31 12.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.098 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.19 -20.33 60.91 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -108.99 -38.1 5.66 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 111.598 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.401 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 3.9 tt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.094 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.457 HG11 ' N ' ' A' ' 3' ' ' LYS . 47.4 t . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 120.997 0.427 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.457 ' N ' HG11 ' A' ' 2' ' ' VAL . 6.2 ptpp? -145.02 121.95 11.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.202 0.525 . . . . 0.0 110.162 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -74.4 128.93 36.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.224 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.79 108.74 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 0.0 110.39 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -100.34 19.52 16.48 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.96 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.31 160.48 38.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.958 0.409 . . . . 0.0 111.165 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.67 -26.33 60.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -79.63 -31.56 41.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.229 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.56 -38.69 90.31 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -56.99 -41.48 78.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.068 0.461 . . . . 0.0 110.051 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -66.37 -45.0 81.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.933 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -58.86 -49.03 79.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.63 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.65 -32.46 73.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.933 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 mt -67.71 -36.87 81.4 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.247 0.546 . . . . 0.0 110.274 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.23 -33.53 73.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.17 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.68 -23.1 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.154 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.95 84.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.073 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.63 -121.13 25.62 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.369 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -94.84 2.63 55.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -78.07 147.14 34.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.0 tp -74.27 132.23 41.91 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 5.3 t -110.48 108.87 26.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.547 0.689 . . . . 0.0 112.13 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.432 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.1 p -102.92 114.39 42.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.481 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 3.4 m -121.11 162.16 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.658 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -126.24 131.08 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.24 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -97.29 107.49 20.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.326 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.5 m -132.45 146.93 52.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.034 0.445 . . . . 0.0 111.813 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.29 159.03 15.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.611 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -70.56 -37.55 74.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.634 0.73 . . . . 0.0 109.143 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -86.08 14.66 5.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.937 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.6 t -91.56 157.09 17.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.887 0.375 . . . . 0.0 111.393 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.7 -73.33 0.91 Allowed Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.386 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.45 -24.91 45.98 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.325 2.017 . . . . 0.0 112.491 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.8 m -58.14 -40.85 82.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.9 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -66.75 -22.84 66.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.541 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 40.1 mtt -68.92 -19.97 64.21 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.2 mm -89.0 -25.24 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.75 0.309 . . . . 0.0 111.628 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.39 -53.18 47.79 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.2 -49.93 14.91 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.619 2.213 . . . . 0.0 113.309 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -80.26 -27.33 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -64.85 -44.5 89.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.034 0.445 . . . . 0.0 110.314 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.64 -41.23 79.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.947 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -58.46 -44.44 89.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 110.596 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mt -59.82 -39.5 85.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.471 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.7 p -56.96 -27.35 61.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -87.78 -19.48 27.46 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.683 0.277 . . . . 0.0 111.66 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -95.53 -22.93 17.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.114 0.483 . . . . 0.0 110.012 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -96.34 97.41 9.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.619 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.2 t -93.66 47.26 1.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.285 0.564 . . . . 0.0 109.813 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -150.15 -42.83 0.13 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.934 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.44 HG22 ' CE1' ' A' ' 54' ' ' PHE . 10.3 m -94.83 155.87 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.828 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.418 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 5.9 tp -106.88 112.72 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.24 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.44 ' CE1' HG22 ' A' ' 52' ' ' VAL . 8.7 m-85 -94.4 115.33 27.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.729 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.481 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -128.45 167.57 16.86 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.643 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.426 ' N ' HD11 ' A' ' 55' ' ' LEU . 6.1 tt0 -118.82 119.52 34.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.228 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -116.68 119.27 61.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -99.6 119.38 37.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.737 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 p -59.86 -18.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -64.89 -38.33 90.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.128 0.489 . . . . 0.0 109.87 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -100.15 -35.53 9.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.381 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.402 ' CB ' HG22 ' A' ' 65' ' ' VAL . . . -94.59 44.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.953 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.91 -11.02 60.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.924 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.4 -21.68 18.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.339 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.402 HG22 ' CB ' ' A' ' 62' ' ' ALA . 2.8 m -79.77 -47.53 21.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.101 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.438 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . -50.97 -60.45 5.56 Favored Pre-proline 0 N--CA 1.466 0.336 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 66' ' ' ALA . 6.8 Cg_endo -48.38 -27.95 10.81 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.732 2.288 . . . . 0.0 112.153 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.3 -25.24 57.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.628 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -106.49 -4.21 20.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.806 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.78 36.88 87.99 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.232 -0.508 . . . . 0.0 113.865 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.3 mt -76.37 133.92 30.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 117.18 0.49 . . . . 0.0 110.523 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -141.87 69.85 1.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.01 0.433 . . . . 0.0 111.887 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.03 166.68 15.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.57 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.431 HG22 HD12 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -150.92 149.45 25.28 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -85.69 121.2 6.36 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 124.311 -1.12 . . . . 0.0 112.507 -0.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 136.54 32.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.885 0.374 . . . . 0.0 111.669 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.99 122.43 46.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.7 mt -114.5 135.54 54.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.335 0.588 . . . . 0.0 111.298 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.61 122.48 44.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.404 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.487 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 51.6 m-85 -115.3 147.67 40.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.134 0.492 . . . . 0.0 111.781 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -146.55 113.42 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.378 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 m120 60.24 45.16 11.78 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.86 0.362 . . . . 0.0 110.283 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.5 2.84 56.52 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.708 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -124.34 139.16 54.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.253 0.526 . . . . 0.0 111.591 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 p -69.14 120.59 16.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.88 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.22 10.93 17.35 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.07 137.24 0.4 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.779 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 48.2 m -139.3 122.08 16.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.828 0.347 . . . . 0.0 111.088 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -120.77 145.21 47.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.38 146.82 25.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.465 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.17 162.3 23.19 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.064 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.31 158.21 33.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.501 . . . . 0.0 111.662 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.97 151.43 28.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.399 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 m -68.77 -178.17 1.13 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.989 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -72.69 -29.93 63.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.77 -33.6 41.61 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.269 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.88 -31.84 61.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.065 0.459 . . . . 0.0 110.381 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.38 -50.18 34.72 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -61.41 -41.25 96.84 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.013 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -60.67 -37.91 83.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.948 0.404 . . . . 0.0 110.066 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 6.8 t80 -63.18 -42.56 99.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.429 0.633 . . . . 0.0 110.323 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.428 HD13 ' CZ ' ' A' ' 54' ' ' PHE . 6.3 mt -65.87 -58.31 5.89 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.231 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.52 -36.21 22.6 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.933 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.56 -20.96 61.23 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -108.34 -32.28 7.51 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.899 0.381 . . . . 0.0 111.459 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 tm? . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.19 179.331 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 3' ' ' LYS . 40.3 t . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 120.915 0.388 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.501 ' N ' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -144.0 121.29 11.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.266 0.555 . . . . 0.0 110.332 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -74.8 127.98 34.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.04 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -100.66 106.93 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.067 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -95.87 16.81 16.65 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.108 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 p -155.4 161.95 40.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.776 0.322 . . . . 0.0 111.394 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.85 -24.54 60.9 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.714 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.54 -32.32 42.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.509 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.81 90.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.81 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.27 -42.6 81.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.872 0.368 . . . . 0.0 110.019 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.43 ' HA ' ' NE2' ' A' ' 12' ' ' GLN . 11.2 mm100 -68.39 -45.21 73.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.807 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -57.55 -45.56 84.97 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.048 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -32.1 73.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.667 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.11 -38.43 78.91 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.64 -34.32 74.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.055 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.47 -22.66 54.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.042 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.4 -34.6 77.59 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.188 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.89 -123.13 32.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.27 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -93.41 5.24 52.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.591 0.234 . . . . 0.0 111.327 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -79.33 150.42 31.46 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.8 tp -77.05 131.85 38.62 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 4.2 t -112.12 108.62 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.566 0.698 . . . . 0.0 111.479 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.462 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -103.26 115.56 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.438 HG13 ' CD2' ' A' ' 55' ' ' LEU . 5.0 m -124.65 167.42 18.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.763 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -136.05 136.86 40.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.966 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.407 ' CE2' HD13 ' A' ' 71' ' ' ILE . 9.7 m-85 -99.46 113.59 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.274 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 m -122.82 -166.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.287 0.565 . . . . 0.0 112.199 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.0 154.05 35.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.184 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -72.23 -35.17 68.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.38 0.61 . . . . 0.0 109.716 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -87.14 10.76 15.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.33 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.0 t -96.51 156.83 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 0.0 111.591 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.59 -71.05 0.76 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.286 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.72 -26.52 47.4 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.481 2.121 . . . . 0.0 112.231 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.3 m -58.94 -44.6 91.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.344 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.77 -24.22 66.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.431 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.5 mmt -67.97 -18.62 64.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.1 mm -87.27 -24.59 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.703 0.287 . . . . 0.0 111.115 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -52.91 -53.66 52.51 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.56 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.45 -50.01 13.21 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.703 2.269 . . . . 0.0 113.164 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -80.07 -27.55 39.32 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -66.02 -45.42 81.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.107 0.479 . . . . 0.0 110.239 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -42.3 84.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.786 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.14 -43.76 95.48 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.898 0.38 . . . . 0.0 110.744 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.1 mt -60.09 -39.76 87.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.412 ' HB2' ' CB ' ' A' ' 54' ' ' PHE . 37.8 t -56.45 -27.7 57.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.245 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -87.89 -18.08 30.0 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.717 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.78 -20.58 18.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.966 0.413 . . . . 0.0 110.09 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -99.27 92.83 5.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.476 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.2 p -88.85 50.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.052 0.453 . . . . 0.0 110.489 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -153.3 -41.21 0.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.985 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.409 HG22 ' CE1' ' A' ' 54' ' ' PHE . 10.8 m -94.38 154.92 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.847 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.44 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 3.4 tp -105.44 113.32 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.361 0.601 . . . . 0.0 111.215 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 7.4 m-85 -95.3 115.99 28.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.502 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.438 ' CD2' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -127.38 165.23 20.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.603 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.41 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.3 tp10 -116.39 119.01 34.31 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.1 117.34 55.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.186 0.517 . . . . 0.0 110.82 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -98.81 120.68 39.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.08 -18.02 15.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.127 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -67.18 -37.69 84.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -99.88 -35.31 9.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.498 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.41 ' CB ' HG22 ' A' ' 65' ' ' VAL . . . -96.67 43.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.547 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -68.79 -10.35 56.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.718 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.76 -22.92 17.77 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.424 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.41 HG22 ' CB ' ' A' ' 62' ' ' ALA . 2.4 m -78.83 -47.35 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.31 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.496 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.6 -56.41 16.9 Favored Pre-proline 0 N--CA 1.462 0.145 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 72.1 Cg_exo -51.77 -28.19 29.53 Favored 'Trans proline' 0 N--CA 1.466 -0.122 0 C-N-CA 122.557 2.172 . . . . 0.0 112.102 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -76.98 -15.47 59.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.997 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -118.5 -7.71 10.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.653 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.32 39.49 95.96 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.304 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.407 HD13 ' CE2' ' A' ' 27' ' ' PHE . 56.4 mt -78.21 79.36 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 117.133 0.467 . . . . 0.0 110.892 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 ttt85 -86.31 78.04 9.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.048 0.452 . . . . 0.0 111.62 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.99 166.05 10.73 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.542 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 pt -148.55 154.32 41.07 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 122.309 0.243 . . . . 0.0 110.704 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -87.14 115.78 3.32 Favored 'Cis proline' 0 C--N 1.352 0.756 0 C-N-CA 124.211 -1.162 . . . . 0.0 112.597 0.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.24 137.18 32.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.909 0.385 . . . . 0.0 111.727 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.45 125.02 51.3 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 mt -113.93 134.61 54.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.376 0.607 . . . . 0.0 111.808 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.423 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 2.8 mm? -115.15 119.83 37.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.791 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.5 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 52.3 m-85 -112.98 147.88 36.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.179 0.514 . . . . 0.0 111.827 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -147.37 113.18 5.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.309 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 m120 60.6 45.94 9.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.037 0.446 . . . . 0.0 110.194 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.29 2.46 48.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.669 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -124.61 138.59 54.3 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.257 0.528 . . . . 0.0 111.813 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.16 116.84 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.647 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -113.07 11.47 18.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.97 0.414 . . . . 0.0 111.907 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . . . -173.17 138.16 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.101 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -136.46 125.51 24.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 111.102 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.98 139.32 53.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.281 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.07 146.07 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.628 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.1 164.1 33.54 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.121 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.69 165.62 12.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.053 0.454 . . . . 0.0 111.744 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.02 144.74 10.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.632 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.7 m -64.41 -177.92 0.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -73.18 -30.96 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.429 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.54 -30.08 54.1 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.79 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 34.3 mt-30 -76.45 -33.08 58.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.97 0.414 . . . . 0.0 110.681 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.61 -51.15 30.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.803 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -60.88 -40.75 94.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.214 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -60.98 -39.19 88.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.786 0.327 . . . . 0.0 110.128 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.452 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 6.8 t80 -60.94 -39.85 91.03 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.333 0.587 . . . . 0.0 109.98 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mt -66.92 -58.46 4.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.344 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.01 -36.39 28.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.827 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.08 -23.81 63.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.032 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -105.89 -53.1 2.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.754 0.312 . . . . 0.0 111.372 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.407 ' CD1' HG11 ' A' ' 52' ' ' VAL . 1.5 tt . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.023 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 52.8 t . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 109.573 -0.528 . . . . 1.1399999999999999 109.573 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.571 ' N ' HG11 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -143.42 124.52 14.47 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 118.764 -1.174 . . . . 1.96 111.975 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -76.5 120.21 21.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.953 -1.476 . . . . 2.5 110.427 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.559 HG21 ' N ' ' A' ' 11' ' ' PHE . 3.1 mp -101.55 113.56 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.797 -0.361 . . . . 1.1699999999999999 111.163 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.455 ' HG2' ' OD2' ' A' ' 61' ' ' ASP . 8.4 mt-10 -100.94 15.97 26.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.104 -0.498 . . . . 1.3799999999999999 112.276 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.452 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.4 m -153.5 160.27 42.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.908 0.385 . . . . 1.3700000000000001 111.246 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.517 ' HA ' HG12 ' A' ' 65' ' ' VAL . 3.1 ttpt -75.55 -23.32 56.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.238 -0.437 . . . . 2.29 111.092 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 m -79.42 -29.98 42.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.698 -0.482 . . . . 1.4299999999999999 109.698 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.52 -41.77 79.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.68 -0.691 . . . . 1.04 110.453 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.559 ' N ' HG21 ' A' ' 5' ' ' ILE . 12.8 t80 -56.51 -49.41 74.79 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.031 -0.531 . . . . 1.5700000000000001 110.501 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -61.45 -37.17 82.61 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.691 -0.855 . . . . 1.22 108.691 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -62.18 -44.37 96.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.937 -1.029 . . . . 1.3999999999999999 111.893 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.04 -33.22 67.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.904 0.383 . . . . 1.04 111.367 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 mt -64.57 -40.64 95.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.319 0.581 . . . . 1.1899999999999999 110.587 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.95 -29.53 69.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 1.8400000000000001 110.525 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.17 -23.86 51.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.129 -0.487 . . . . 1.1299999999999999 111.67 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HB1' HG22 ' A' ' 23' ' ' VAL . . . -72.35 -26.72 62.02 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.595 -0.275 . . . . 1.22 111.288 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.96 -117.65 6.32 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 119.63 -1.271 . . . . 1.04 113.277 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.59 10.34 37.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.54 0.209 . . . . 2.3599999999999999 111.207 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -82.53 151.11 26.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.88 -0.415 . . . . 2.3700000000000001 109.88 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.579 HD11 HD12 ' A' ' 79' ' ' LEU . 0.6 OUTLIER -76.21 121.28 22.67 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.612 -0.514 . . . . 1.0700000000000001 109.612 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.564 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 2.6 t -101.63 111.9 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.725 0.774 . . . . 1.05 112.065 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.541 HG13 ' CE1' ' A' ' 54' ' ' PHE . 9.1 p -108.27 122.19 62.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.663 -1.236 . . . . 1.0900000000000001 107.663 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.723 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 11.4 m -133.13 141.97 43.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.523 0.678 . . . . 1.1299999999999999 112.051 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -107.74 131.04 54.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.374 -0.83 . . . . 1.1299999999999999 112.403 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.461 ' HE1' HD13 ' A' ' 78' ' ' LEU . 2.7 m-85 -96.24 110.28 22.61 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.663 -0.866 . . . . 0.34000000000000002 108.663 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.473 ' O ' HG12 ' A' ' 59' ' ' VAL . 3.3 p -121.14 -168.76 1.72 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.706 0.632 . . . . 1.3400000000000001 112.706 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.06 156.1 39.25 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.133 -0.94 . . . . 1.1100000000000001 110.693 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -37.84 74.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.309 0.576 . . . . 1.6299999999999999 110.184 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 28.4 p-90 -86.61 10.77 14.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.99 -1.004 . . . . 1.24 111.499 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 37.3 t -100.24 140.47 34.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.786 0.327 . . . . 0.98999999999999999 110.244 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.48 -65.65 0.9 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.614 -0.803 . . . . 0.35999999999999999 112.481 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.98 -30.98 25.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.554 2.169 . . . . 0.93999999999999995 111.769 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 79.4 m -58.51 -40.21 82.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.735 -0.666 . . . . 0.65000000000000002 110.621 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -70.68 -26.4 63.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.941 -0.572 . . . . 2.73 111.234 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.5 mmt -69.02 -20.64 64.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.479 . . . . 2.0800000000000001 111.292 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.402 HG21 ' O ' ' A' ' 38' ' ' ILE . 2.9 mm -87.8 -18.21 8.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.793 0.33 . . . . 1.21 110.616 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.81 -54.73 40.31 Favored Pre-proline 0 CA--C 1.528 0.132 0 CA-C-N 116.495 -0.32 . . . . 2.7599999999999998 110.726 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.68 -51.62 10.04 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.657 2.238 . . . . 0.84999999999999998 112.766 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -75.21 -36.18 61.4 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.488 -0.323 . . . . 0.71999999999999997 111.466 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.543 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 7.0 t80 -64.81 -46.36 82.33 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.54 -0.464 . . . . 0.44 109.999 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.431 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -67.28 -42.11 84.37 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.542 0.201 . . . . 1.3899999999999999 111.542 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -60.32 -46.87 88.37 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.918 -0.313 . . . . 1.54 110.742 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.7 mt -54.13 -36.44 63.28 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.35 -0.611 . . . . 1.0700000000000001 109.35 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 43' ' ' HIS . 22.7 t -57.87 -26.33 61.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.294 -0.866 . . . . 1.7 111.117 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.3 -17.64 28.54 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.712 0.291 . . . . 2.2999999999999998 111.035 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.431 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 1.6 ttpp -97.05 -15.15 21.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.091 0.472 . . . . 2.0699999999999998 110.48 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.477 ' HB3' HG23 ' A' ' 52' ' ' VAL . 24.1 m-85 -105.8 84.48 2.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.792 -0.64 . . . . 0.97999999999999998 111.334 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -78.62 43.16 0.47 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.542 -0.754 . . . . 1.5900000000000001 111.542 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -154.6 -29.17 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.672 -0.24 . . . . 1.1799999999999999 111.34 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' A' ' 49' ' ' TYR . 5.3 m -99.35 155.85 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.352 0.596 . . . . 1.05 111.692 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.513 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 1.1 tp -104.38 113.33 41.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.13 -0.941 . . . . 1.1399999999999999 110.963 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.697 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.1 m-85 -99.55 116.43 31.66 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 116.042 -0.527 . . . . 0.40000000000000002 110.876 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.723 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -130.95 167.94 18.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 116.064 -0.516 . . . . 1.0900000000000001 110.296 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.437 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.7 tt0 -121.55 125.08 45.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.023 0.379 . . . . 2.1600000000000001 112.023 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -112.12 116.17 51.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.557 0.694 . . . . 1.04 110.951 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -93.79 115.29 27.69 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.236 -0.893 . . . . 2.1200000000000001 110.379 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 28' ' ' SER . 11.2 p -61.2 -22.28 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.175 -0.466 . . . . 1.04 112.083 -178.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -62.32 -37.95 87.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.091 -0.707 . . . . 1.3 109.091 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.455 ' OD2' ' HG2' ' A' ' 6' ' ' GLU . 1.3 m-20 -101.12 -42.43 6.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.128 -0.942 . . . . 1.3100000000000001 112.314 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -87.78 53.63 2.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.13 0.49 . . . . 1.0800000000000001 110.406 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.501 ' O ' ' CD ' ' A' ' 67' ' ' PRO . 5.4 mt-30 -74.9 -11.53 60.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.667 -0.697 . . . . 3.21 111.324 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.05 -31.12 20.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 1.3700000000000001 110.68 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 8' ' ' LYS . 18.2 m -76.77 -46.97 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.913 -0.585 . . . . 1.0700000000000001 111.14 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.511 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.67 -55.31 23.79 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 113.178 0.807 . . . . 1.1599999999999999 113.178 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 51.0 Cg_exo -55.68 -28.29 65.29 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.161 2.574 . . . . 0.91000000000000003 114.073 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -75.62 -26.47 57.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.869 0.322 . . . . 2.0 111.869 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -99.91 -9.43 22.82 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.23 0.538 . . . . 0.70999999999999996 110.663 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.61 39.44 78.33 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.521 -0.763 . . . . 0.58999999999999997 112.785 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.9 mt -76.46 129.02 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.0 -0.741 . . . . 1.3500000000000001 109.0 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.49 64.68 1.33 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.571 -0.452 . . . . 3.9900000000000002 111.76 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.08 120.74 0.78 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.717 -0.754 . . . . 1.1499999999999999 112.455 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.5 pt -109.14 153.39 42.62 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.626 -0.139 . . . . 1.3300000000000001 110.626 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.9 129.94 17.16 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 124.347 -1.105 . . . . 0.76000000000000001 113.718 0.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.94 138.54 38.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 1.0800000000000001 111.45 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.422 HD21 HD13 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -110.16 113.82 26.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.319 -0.993 . . . . 2.4100000000000001 108.319 177.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.461 HD13 ' HE1' ' A' ' 27' ' ' PHE . 3.5 mt -104.92 131.65 52.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.379 0.609 . . . . 1.0800000000000001 111.454 -177.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.658 ' O ' ' N ' ' A' ' 86' ' ' ALA . 2.1 mm? -113.06 117.34 31.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.177 -0.919 . . . . 1.0600000000000001 111.05 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.564 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 60.0 m-85 -111.93 140.9 46.2 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.507 -0.553 . . . . 0.28999999999999998 109.507 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.664 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 1.8 tttm -141.32 105.82 4.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.48 -0.933 . . . . 1.1000000000000001 108.48 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.8 m120 67.04 47.11 1.43 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.373 -0.603 . . . . 1.1299999999999999 109.373 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.34 4.87 18.96 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.371 -0.831 . . . . 0.27000000000000002 113.718 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -118.51 130.23 55.81 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.39 -0.596 . . . . 1.5600000000000001 109.39 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.1 p -55.18 117.41 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.68 -0.859 . . . . 1.8600000000000001 108.68 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . . . -96.97 -7.24 33.6 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 113.051 0.76 . . . . 0.91000000000000003 113.051 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 79' ' ' LEU . . . -177.05 148.94 0.66 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.098 -0.501 . . . . 1.0600000000000001 112.055 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.2 t -126.87 148.61 49.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.852 -0.613 . . . . 2.1899999999999999 109.801 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -149.79 132.07 15.52 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.224 -0.658 . . . . 1.98 109.224 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.04 146.78 19.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.432 -0.349 . . . . 1.1000000000000001 111.399 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.45 161.57 27.6 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.939 -0.648 . . . . 0.26000000000000001 113.113 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.19 169.05 14.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.812 0.339 . . . . 1.1100000000000001 111.361 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.404 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -157.85 176.69 12.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 1.47 111.333 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -91.27 175.54 6.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.622 -0.717 . . . . 1.21 110.174 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -70.73 -30.84 67.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.621 -0.263 . . . . 1.76 111.365 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.03 -31.92 51.18 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.227 -0.987 . . . . 0.23000000000000001 113.122 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 35.8 mt-30 -75.12 -30.6 60.88 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.915 0.388 . . . . 1.5 110.949 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.422 HD13 HD21 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -73.03 -51.19 19.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.193 0.521 . . . . 1.1499999999999999 109.823 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.431 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 17.2 ttpt -60.16 -45.18 93.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.442 -0.799 . . . . 2.1600000000000001 110.529 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -59.83 -39.03 83.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 1.8100000000000001 110.154 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -62.45 -41.83 99.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.651 -0.704 . . . . 0.34999999999999998 111.311 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.0 mt -68.17 -55.95 10.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.76 -0.654 . . . . 1.1699999999999999 110.451 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -46.45 -33.38 3.92 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.67 -0.493 . . . . 1.1899999999999999 109.67 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.04 -23.95 59.47 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.403 -0.817 . . . . 1.03 113.192 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.429 ' O ' ' CE ' ' A' ' 81' ' ' LYS . 1.7 t30 -108.87 -28.65 9.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.009 0.433 . . . . 0.58999999999999997 111.659 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.511 ' CD2' ' O ' ' A' ' 106' ' ' LEU . 9.3 tt . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 123.628 0.771 . . . . 2.0699999999999998 112.312 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.751 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 88.5 t . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.714 -0.106 . . . . 1.24 110.714 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 2.2 ptpt -141.68 126.2 17.8 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 121.8 0.81 . . . . 2.2000000000000002 111.255 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.62 122.03 25.42 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.404 -1.271 . . . . 2.0499999999999998 110.578 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.623 HD12 ' CD1' ' A' ' 55' ' ' LEU . 3.2 mp -104.43 111.59 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.842 0.353 . . . . 1.0700000000000001 111.35 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -99.77 19.46 15.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.11 -0.495 . . . . 1.6299999999999999 112.058 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -154.8 160.2 41.11 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.999 -0.28 . . . . 1.1899999999999999 110.714 -179.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.451 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 7.1 ttpt -77.57 -21.58 52.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.058 0.456 . . . . 1.97 110.707 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -79.41 -31.91 42.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.635 -0.505 . . . . 1.4199999999999999 109.635 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.24 -38.79 82.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.375 -0.83 . . . . 0.97999999999999998 111.019 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.554 ' N ' HG23 ' A' ' 5' ' ' ILE . 13.2 t80 -58.15 -47.99 81.65 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.165 -0.471 . . . . 1.7 110.403 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.02 -37.37 87.18 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.653 -0.499 . . . . 1.47 109.653 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -60.8 -46.97 88.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.703 -0.68 . . . . 1.53 111.846 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.46 76.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 1.0600000000000001 110.65 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.0 mt -65.2 -42.33 93.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.998 -0.546 . . . . 1.21 110.89 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.21 -30.32 71.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.042 0.449 . . . . 1.72 110.074 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.98 -22.34 53.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.638 -0.71 . . . . 1.26 110.77 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.68 -34.01 73.36 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 116.118 -0.492 . . . . 1.49 110.975 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.33 -125.09 36.69 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.083 -1.056 . . . . 1.05 113.155 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -91.21 7.35 41.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 2.3999999999999999 111.585 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 58.2 mttt -82.49 151.88 26.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.53 -0.304 . . . . 2.1400000000000001 110.383 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 106' ' ' LEU . 1.3 tp -77.09 127.36 32.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 1.1000000000000001 109.858 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.598 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 3.3 t -107.62 115.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.353 0.597 . . . . 1.1000000000000001 111.425 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.525 HG12 ' CE1' ' A' ' 54' ' ' PHE . 7.9 p -110.47 116.09 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.066 -1.087 . . . . 1.28 108.066 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.635 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 16.6 m -124.99 142.98 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-O 121.74 0.781 . . . . 1.4299999999999999 111.793 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -108.19 128.01 54.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.328 -1.306 . . . . 1.1899999999999999 111.211 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -95.42 108.22 20.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.147 -0.686 . . . . 0.40999999999999998 109.147 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.1 p -119.06 -170.93 2.01 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.782 0.66 . . . . 1.47 112.782 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB3' ' CD1' ' A' ' 31' ' ' TRP . . . -152.11 156.83 40.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.845 -1.07 . . . . 1.21 110.137 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.2 -35.51 73.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.556 0.693 . . . . 1.45 110.259 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.479 ' CD1' ' HB3' ' A' ' 29' ' ' ALA . 27.8 p-90 -87.42 12.21 12.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.041 -0.981 . . . . 1.4399999999999999 111.213 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.5 t -102.38 131.67 48.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.742 0.306 . . . . 0.93999999999999995 110.9 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.71 -63.18 1.35 Allowed Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.616 -0.802 . . . . 0.37 112.616 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.77 -32.2 45.0 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.564 2.176 . . . . 0.71999999999999997 112.164 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -58.47 -41.36 85.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.886 -0.597 . . . . 0.70999999999999996 110.363 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -71.18 -19.88 62.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.839 -0.619 . . . . 2.7200000000000002 111.098 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.2 mtt -75.04 -24.86 58.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.016 -0.538 . . . . 1.99 111.434 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mm -85.96 -19.06 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.454 -0.339 . . . . 1.1499999999999999 111.36 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 25.6 mtpt -52.58 -54.24 44.93 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.823 0.344 . . . . 3.0499999999999998 111.054 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 63.8 Cg_exo -48.77 -50.02 13.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.715 2.277 . . . . 0.78000000000000003 112.625 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -77.26 -31.37 54.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.532 0.206 . . . . 0.68999999999999995 111.419 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.457 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 5.4 t80 -65.42 -47.21 77.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.664 -0.414 . . . . 0.35999999999999999 110.176 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -41.0 89.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.294 -0.412 . . . . 1.28 111.846 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -60.1 -45.12 94.03 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.933 -0.307 . . . . 1.8600000000000001 110.856 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.8 mt -57.95 -37.14 73.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.154 0.502 . . . . 1.1499999999999999 109.894 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.2 t -55.55 -31.94 62.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.58 -0.736 . . . . 1.78 111.103 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.02 -20.7 30.08 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.746 0.308 . . . . 2.1800000000000002 110.399 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 2.8 ttpp -92.89 -7.76 45.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.192 -0.458 . . . . 2.4900000000000002 110.514 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.437 ' HB3' HG23 ' A' ' 52' ' ' VAL . 17.9 m-85 -116.2 92.5 3.91 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.154 -0.475 . . . . 1.4299999999999999 111.413 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.5 p -86.55 46.64 1.38 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.435 -0.348 . . . . 2.0499999999999998 110.479 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 21.5 t30 -154.93 -29.96 0.11 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.793 0.294 . . . . 1.5900000000000001 111.793 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.469 HG22 ' CD1' ' A' ' 54' ' ' PHE . 10.9 m -101.53 159.98 3.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.226 -0.443 . . . . 1.0900000000000001 111.384 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 1.5 tp -109.91 116.83 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.469 -0.787 . . . . 1.1299999999999999 110.729 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.751 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.5 m-85 -99.89 116.61 32.35 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.354 -0.839 . . . . 0.45000000000000001 111.156 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.635 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -133.45 166.01 23.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 120.493 -0.483 . . . . 1.0800000000000001 112.009 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 3.4 tt0 -119.32 125.01 48.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.977 0.732 . . . . 1.8400000000000001 112.977 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.49 114.66 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.476 -0.784 . . . . 1.0700000000000001 110.673 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -90.76 114.81 27.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.741 . . . . 1.6899999999999999 109.848 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.95 -21.44 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.885 -0.598 . . . . 1.0900000000000001 111.372 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.18 -41.36 97.15 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.738 -0.468 . . . . 1.26 109.738 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -95.5 -42.55 8.4 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.107 -0.497 . . . . 1.23 111.783 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -90.55 47.35 1.42 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.025 0.44 . . . . 1.0600000000000001 111.219 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -75.09 -3.3 31.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.365 -0.379 . . . . 2.1200000000000001 110.864 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.3 -24.25 20.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.159 -0.312 . . . . 1.3799999999999999 110.159 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 62' ' ' ALA . 34.6 m -85.5 -43.89 16.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.101 0.477 . . . . 1.05 111.557 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.473 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.08 -53.09 47.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.927 0.714 . . . . 1.05 112.927 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.473 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 43.8 Cg_exo -57.82 -27.45 78.31 Favored 'Trans proline' 0 N--CA 1.472 0.208 0 C-N-CA 123.16 2.573 . . . . 0.88 113.456 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -77.29 -22.64 51.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.522 -0.308 . . . . 2.1699999999999999 111.696 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -102.83 -10.08 19.4 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.405 0.621 . . . . 0.95999999999999996 110.427 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.49 39.78 79.35 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.265 -0.879 . . . . 0.63 112.151 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.8 mt -77.61 130.45 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.172 -0.677 . . . . 1.3 109.172 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -144.44 67.02 1.26 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.281 0.563 . . . . 4.1399999999999997 111.337 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.58 117.58 0.71 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.517 -0.849 . . . . 1.3300000000000001 113.247 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.6 pt -105.97 153.82 39.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 110.378 -0.23 . . . . 1.73 110.378 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.41 121.42 7.18 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 123.786 -1.339 . . . . 0.94999999999999996 113.155 0.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.0 140.7 29.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 1.1299999999999999 111.589 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.25 117.09 30.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.458 -0.571 . . . . 1.6000000000000001 109.458 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mt -106.65 132.84 52.18 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.411 0.624 . . . . 1.1399999999999999 111.504 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 86' ' ' ALA . 2.5 mm? -112.62 115.12 28.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.994 -1.003 . . . . 1.0700000000000001 109.429 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.598 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 46.5 m-85 -109.1 145.56 35.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.188 0.518 . . . . 0.29999999999999999 110.007 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.702 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 12.1 tttm -143.86 110.58 5.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.268 -0.878 . . . . 1.2 109.905 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.4 m120 60.51 47.2 8.8 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.341 -0.544 . . . . 0.62 109.715 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.04 5.06 45.6 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.828 -0.701 . . . . 0.25 113.425 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -121.65 132.99 54.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.201 0.5 . . . . 1.73 111.269 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.18 121.81 6.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 108.725 -0.843 . . . . 1.73 108.725 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.702 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -103.04 -11.15 18.34 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.298 0.57 . . . . 1.0700000000000001 112.28 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.415 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -172.89 149.26 1.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.07 -0.968 . . . . 1.1000000000000001 111.577 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.17 145.88 51.76 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.52 -0.764 . . . . 2.1800000000000002 109.211 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -143.68 136.35 27.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.899 -0.408 . . . . 2.46 109.899 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.434 HG11 ' N ' ' A' ' 91' ' ' GLY . 14.1 t -116.76 145.2 22.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.905 0.384 . . . . 1.8400000000000001 111.227 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.434 ' N ' HG11 ' A' ' 90' ' ' VAL . . . 81.9 160.39 26.37 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.517 -0.849 . . . . 0.28000000000000003 113.092 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.01 152.02 42.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.853 0.359 . . . . 1.3 111.4 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.9 171.08 14.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.286 -0.415 . . . . 1.2 110.875 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.53 175.0 8.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.742 -0.663 . . . . 1.4299999999999999 110.276 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -67.45 -33.34 74.94 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.043 -0.263 . . . . 1.51 111.635 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.42 -31.13 52.26 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.183 -1.008 . . . . 0.23000000000000001 112.655 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 53.3 mt-30 -74.86 -29.56 61.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.074 0.464 . . . . 1.73 110.598 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.88 -48.67 23.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.929 -0.578 . . . . 1.1299999999999999 109.58 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.479 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 19.4 ttpt -61.82 -46.13 90.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.581 -0.736 . . . . 1.9199999999999999 111.079 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.0 pp20? -58.72 -40.32 83.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.232 0.539 . . . . 1.8300000000000001 109.93 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.415 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 10.8 t80 -61.37 -41.28 96.84 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.671 -0.695 . . . . 0.40000000000000002 110.882 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mt -68.05 -52.67 32.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 1.1299999999999999 109.891 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -51.11 -36.64 41.54 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.96 0.409 . . . . 1.1799999999999999 110.338 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.43 -19.5 60.95 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 112.737 0.643 . . . . 0.94999999999999996 112.737 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.409 ' HB3' HD22 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -106.97 -44.23 4.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.41999999999999998 110.507 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.431 ' HB2' HD23 ' A' ' 22' ' ' LEU . 67.7 tp . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.726 -0.67 . . . . 2.0699999999999998 109.565 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.851 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 58.8 t . . . . . 0 C--O 1.232 0.167 0 N-CA-C 109.597 -0.52 . . . . 1.2 109.597 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 9.1 ptpt -143.29 117.52 9.56 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 119.428 -0.909 . . . . 2.3199999999999998 111.92 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.84 124.21 23.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.94 -1.027 . . . . 1.79 109.778 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.574 HD13 ' CD1' ' A' ' 55' ' ' LEU . 1.4 mp -103.43 111.77 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.852 0.358 . . . . 1.1200000000000001 111.152 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -97.78 14.02 28.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.99 -0.55 . . . . 1.8 112.152 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.424 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 2.6 m -154.18 155.29 35.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.806 0.336 . . . . 1.1200000000000001 111.034 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.558 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -71.49 -21.77 61.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.371 -0.377 . . . . 1.72 110.85 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -78.86 -32.71 46.11 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.408 -0.59 . . . . 1.1100000000000001 109.408 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB1' HG13 ' A' ' 5' ' ' ILE . . . -66.73 -41.52 87.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.461 -0.791 . . . . 1.05 109.797 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -56.34 -41.86 76.77 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.059 -0.518 . . . . 1.6000000000000001 109.888 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -64.82 -41.21 95.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.074 -0.713 . . . . 1.3999999999999999 109.074 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -59.96 -49.37 77.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.099 -0.955 . . . . 1.6200000000000001 111.76 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.89 74.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.747 0.308 . . . . 1.03 111.313 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.4 mt -69.1 -43.69 73.96 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.147 0.499 . . . . 1.1499999999999999 110.65 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -61.94 -32.1 72.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.009 -0.541 . . . . 1.79 110.688 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.47 -26.9 58.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 1.1599999999999999 110.968 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.527 ' HB3' HG22 ' A' ' 53' ' ' ILE . . . -73.93 -20.72 60.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 1.4199999999999999 111.286 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 46.12 -119.85 4.25 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.794 -0.717 . . . . 0.96999999999999997 114.789 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.457 ' HA ' ' ND2' ' A' ' 82' ' ' ASN . 16.7 t0 -88.74 2.33 53.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.548 -0.326 . . . . 2.3399999999999999 111.534 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 32.0 mttt -78.1 151.96 33.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.71 -0.848 . . . . 2.1800000000000002 108.71 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.67 HD22 ' HB3' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -73.73 125.09 27.31 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.569 -0.53 . . . . 1.0800000000000001 109.569 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.643 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 2.3 t -106.26 105.8 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.472 0.653 . . . . 1.0700000000000001 110.917 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.502 HG11 ' CE1' ' A' ' 54' ' ' PHE . 11.4 p -105.55 115.58 47.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 107.294 -1.373 . . . . 1.3300000000000001 107.294 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.725 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 25.0 m -129.13 126.94 65.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.952 -0.567 . . . . 1.04 111.862 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -93.16 135.67 34.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.42 -0.809 . . . . 1.1599999999999999 111.453 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -98.8 116.25 30.61 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.989 -0.745 . . . . 0.29999999999999999 108.989 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -125.01 -168.43 1.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.463 0.649 . . . . 1.5 112.731 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.75 154.03 35.47 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 114.901 -1.045 . . . . 1.04 109.868 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -35.31 72.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.323 0.582 . . . . 1.5700000000000001 109.809 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -86.42 11.52 12.26 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.124 -0.944 . . . . 1.02 111.291 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.9 t -97.08 140.77 31.09 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.815 0.341 . . . . 0.47999999999999998 110.923 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.78 -66.12 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.599 -0.81 . . . . 0.33000000000000002 112.476 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.62 -25.06 24.68 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.533 2.155 . . . . 0.75 112.344 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.0 m -62.98 -41.69 99.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.5 110.696 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -66.59 -21.25 66.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.013 -0.54 . . . . 2.8700000000000001 111.149 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 mmt -73.36 -26.02 60.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 2.1299999999999999 111.828 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -85.88 -22.79 7.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.745 0.307 . . . . 1.0 111.109 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 10.1 tttt -48.35 -57.04 11.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.619 -0.264 . . . . 2.1499999999999999 110.967 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 11.6 Cg_endo -56.68 -43.88 50.69 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.365 2.043 . . . . 0.82999999999999996 112.678 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -73.73 -37.87 64.97 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.521 0.193 . . . . 0.46999999999999997 111.521 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.45 ' O ' ' CE2' ' A' ' 54' ' ' PHE . 9.0 t80 -64.67 -43.52 93.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.951 -0.3 . . . . 0.59999999999999998 111.037 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -37.94 86.2 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.869 -0.332 . . . . 1.4199999999999999 111.102 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.25 -45.82 91.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.707 0.289 . . . . 1.3899999999999999 110.991 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.9 mt -59.25 -39.9 84.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.892 -0.41 . . . . 1.1499999999999999 109.892 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.431 ' HB2' ' CG ' ' A' ' 54' ' ' PHE . 33.6 t -55.17 -29.19 57.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.535 . . . . 1.5800000000000001 111.016 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -87.51 -20.73 26.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.961 0.41 . . . . 2.3900000000000001 110.007 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.438 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 2.1 ttpp -98.88 8.59 44.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.733 -0.667 . . . . 2.3799999999999999 110.698 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.436 ' HB3' HG21 ' A' ' 52' ' ' VAL . 13.9 m-85 -129.63 108.13 9.97 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.268 -0.423 . . . . 0.93999999999999995 109.883 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.7 m -99.41 47.16 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.098 0.407 . . . . 2.0 112.098 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.48 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 13.9 t30 -158.37 -33.78 0.07 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.704 0.287 . . . . 1.6200000000000001 111.39 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 22' ' ' LEU . 5.0 m -92.82 150.89 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.154 0.428 . . . . 1.1200000000000001 112.154 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.527 HG22 ' HB3' ' A' ' 18' ' ' ALA . 1.3 tp -101.02 119.7 49.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.465 . . . . 1.6100000000000001 110.428 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.851 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 3.9 m-85 -101.79 124.58 47.68 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 116.025 -0.534 . . . . 0.53000000000000003 110.966 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.725 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -139.73 167.53 21.9 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.089 -0.644 . . . . 1.1100000000000001 110.607 177.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.454 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 4.5 tt0 -122.29 126.46 48.17 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.328 0.492 . . . . 2.0499999999999998 112.328 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.9 t -115.52 119.29 61.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.714 -0.675 . . . . 1.0900000000000001 111.388 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -94.42 115.52 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.274 -0.639 . . . . 1.79 109.274 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.4 -19.07 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.393 . . . . 1.1000000000000001 111.5 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -38.66 90.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.889 -0.412 . . . . 1.1399999999999999 109.889 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.56 -43.65 6.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 1.29 110.698 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -86.14 46.76 1.37 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.959 -0.564 . . . . 1.01 111.02 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.528 ' O ' ' CD ' ' A' ' 67' ' ' PRO . 16.6 tt0 -74.87 -12.24 60.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.377 -0.374 . . . . 2.2400000000000002 110.778 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.64 -23.47 31.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.764 0.316 . . . . 1.29 110.277 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 62' ' ' ALA . 8.5 m -83.46 -49.12 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.345 -0.389 . . . . 1.04 112.046 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.551 ' N ' HG22 ' A' ' 65' ' ' VAL . . . -49.64 -54.41 31.53 Favored Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 113.524 0.935 . . . . 1.1299999999999999 113.524 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.528 ' CD ' ' O ' ' A' ' 63' ' ' GLN . 50.4 Cg_exo -55.04 -27.36 54.57 Favored 'Trans proline' 0 CA--C 1.521 -0.144 0 C-N-CA 122.959 2.439 . . . . 0.70999999999999996 112.4 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -76.85 -18.81 58.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 2.4900000000000002 111.203 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -109.22 -8.17 15.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.048 0.451 . . . . 0.93000000000000005 110.922 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.16 36.47 91.88 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.639 -0.71 . . . . 0.54000000000000004 112.983 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 79.4 mt -75.91 132.44 33.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.621 -0.511 . . . . 1.3600000000000001 109.621 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -148.14 49.8 1.04 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.666 0.27 . . . . 4.0499999999999998 111.293 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.08 104.24 0.18 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.464 -0.874 . . . . 1.1799999999999999 112.277 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.7 pt -99.48 153.03 37.99 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.57 0.224 . . . . 1.51 110.808 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.76 119.28 6.22 Favored 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.766 -1.348 . . . . 0.78000000000000003 112.373 -0.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.89 137.95 31.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 1.1100000000000001 111.556 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.401 HD21 HD12 ' A' ' 93' ' ' LEU . 1.3 mp -107.08 118.89 37.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.36 -0.978 . . . . 2.2999999999999998 108.36 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.78 128.19 54.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.604 0.716 . . . . 1.0900000000000001 111.231 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 2.8 mm? -111.31 130.85 55.54 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.983 -1.008 . . . . 1.05 108.855 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.643 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 44.9 m-85 -123.8 151.67 43.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.136 0.493 . . . . 0.28999999999999998 110.4 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.706 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -144.15 115.03 7.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.345 -0.843 . . . . 1.2 109.359 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.457 ' ND2' ' HA ' ' A' ' 20' ' ' ASP . 2.2 m120 53.64 49.57 19.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.374 -0.53 . . . . 1.1399999999999999 110.319 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.44 3.28 31.7 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.143 -0.551 . . . . 0.20999999999999999 113.865 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -119.51 141.81 48.86 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 117.148 0.474 . . . . 1.3700000000000001 110.142 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.61 133.05 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.205 -0.598 . . . . 1.9399999999999999 109.541 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.706 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . . . -103.98 -25.51 12.98 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.635 0.731 . . . . 1.1100000000000001 111.656 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . . . -172.96 160.97 4.37 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.396 -1.275 . . . . 1.03 110.876 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.75 134.21 36.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.272 -0.422 . . . . 1.74 110.837 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.41 138.34 43.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 1.8 110.166 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 91' ' ' GLY . 21.5 t -119.45 145.37 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.437 -0.347 . . . . 1.6100000000000001 111.198 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.441 ' N ' HG13 ' A' ' 90' ' ' VAL . . . 81.72 160.13 25.45 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.647 -0.787 . . . . 0.22 113.034 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.07 152.44 45.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.172 0.51 . . . . 1.1299999999999999 111.733 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.401 HD12 HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -146.05 151.32 37.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.718 -0.674 . . . . 1.47 110.441 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -69.16 178.9 2.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.446 -0.343 . . . . 1.28 111.051 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -72.49 -30.64 64.7 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.158 -0.474 . . . . 1.6200000000000001 111.797 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.53 -31.87 52.86 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.018 -1.087 . . . . 0.25 112.512 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 39.6 mt-30 -75.59 -33.14 60.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.803 0.335 . . . . 1.6799999999999999 110.504 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -48.83 63.18 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.172 -0.677 . . . . 1.22 109.172 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.438 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 18.2 ttpt -60.66 -42.39 96.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.859 -0.609 . . . . 2.1099999999999999 110.422 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.537 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -60.49 -39.97 89.65 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.132 -0.485 . . . . 1.6799999999999999 110.091 179.262 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.537 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 6.9 t80 -62.77 -43.44 98.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.757 -0.656 . . . . 0.32000000000000001 111.429 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.2 mt -67.73 -53.0 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.642 -0.708 . . . . 1.24 109.788 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.05 -37.37 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 1.2 111.153 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.43 -21.31 62.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.209 -0.451 . . . . 0.93000000000000005 111.903 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.67 ' HB3' HD22 ' A' ' 22' ' ' LEU . 4.3 t30 -106.52 -46.98 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.068 -0.253 . . . . 0.93000000000000005 111.219 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.6 tp . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.951 0.405 . . . . 1.9299999999999999 110.169 178.89 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 70.2 t . . . . . 0 N--CA 1.462 0.135 0 N-CA-C 110.229 -0.285 . . . . 1.1299999999999999 110.229 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.535 ' O ' HD11 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -141.51 125.78 17.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.045 -0.662 . . . . 2.6499999999999999 111.31 -178.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.82 122.91 27.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.323 -0.853 . . . . 2.3599999999999999 109.432 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -103.67 112.06 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 112.119 0.414 . . . . 1.03 112.119 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.36 14.19 28.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.657 0.614 . . . . 1.4099999999999999 112.657 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 m -156.61 140.8 16.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.705 0.288 . . . . 1.4399999999999999 111.633 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.542 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -58.26 -23.92 57.67 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.443 -0.344 . . . . 1.78 111.62 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 m -78.31 -33.49 49.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.949 -0.76 . . . . 1.1399999999999999 108.949 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.24 -39.35 86.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.583 -0.735 . . . . 1.05 109.913 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.465 ' HB2' HG23 ' A' ' 5' ' ' ILE . 23.8 t80 -57.64 -46.97 83.49 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.076 -0.511 . . . . 0.78000000000000003 110.701 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -63.35 -38.4 91.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.411 -0.588 . . . . 1.3100000000000001 109.411 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -59.6 -50.1 75.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.619 -0.719 . . . . 1.4399999999999999 111.498 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.13 -32.55 74.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.839 0.352 . . . . 1.0600000000000001 111.238 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 18.4 mt -67.79 -42.54 81.49 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.236 0.541 . . . . 1.1200000000000001 110.613 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -60.56 -31.58 70.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 1.6799999999999999 110.161 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.23 -22.21 55.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.95 -0.568 . . . . 1.05 110.44 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -69.12 -29.3 67.33 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.081 -0.509 . . . . 1.1899999999999999 111.03 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.72 -126.44 42.24 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.347 -0.93 . . . . 0.93000000000000005 113.236 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -92.55 9.06 36.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.35 -0.425 . . . . 2.2799999999999998 111.057 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.56 154.1 27.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.947 -0.39 . . . . 1.9299999999999999 109.947 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.482 ' CB ' HD21 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -78.31 126.38 30.7 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.868 -0.419 . . . . 1.04 109.868 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 6.2 t -110.32 109.0 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.314 0.578 . . . . 1.01 111.753 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.519 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.2 p -104.97 116.88 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.547 -1.279 . . . . 1.1499999999999999 107.547 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.527 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 7.3 m -123.61 136.94 58.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.413 0.625 . . . . 1.0800000000000001 111.655 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.99 129.68 46.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.06 -0.973 . . . . 1.29 111.534 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.445 ' CE1' HD11 ' A' ' 78' ' ' LEU . 11.9 m-85 -97.55 107.9 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.14 -0.689 . . . . 0.32000000000000001 109.14 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 p -119.07 -166.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.31 0.576 . . . . 1.25 112.493 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.65 154.25 36.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.324 -0.853 . . . . 1.1599999999999999 110.296 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.32 -38.59 78.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.657 0.742 . . . . 1.8 109.449 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -84.94 14.08 5.28 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.572 -1.195 . . . . 1.3799999999999999 111.54 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 37.8 t -102.96 144.42 31.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.856 0.36 . . . . 0.71999999999999997 111.076 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.29 -68.24 0.92 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.714 -0.755 . . . . 0.34000000000000002 112.386 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -50.9 -28.72 24.61 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.655 2.236 . . . . 0.97999999999999998 112.175 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.2 m -58.37 -44.46 88.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.56999999999999995 110.946 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -68.26 -25.63 65.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.849 -0.614 . . . . 3.1600000000000001 111.336 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.2 mtp -68.37 -21.28 64.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.496 -0.32 . . . . 2.2000000000000002 111.539 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mm -86.73 -20.7 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.746 0.308 . . . . 1.0800000000000001 111.132 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 3.7 tttt -52.23 -53.67 49.94 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.363 -0.38 . . . . 2.5800000000000001 111.129 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 74.0 Cg_exo -49.63 -47.98 20.84 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.534 2.156 . . . . 0.93999999999999995 112.545 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -78.25 -32.06 49.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.513 -0.312 . . . . 0.54000000000000004 111.688 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.441 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 6.0 t80 -67.29 -48.6 67.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.909 0.385 . . . . 0.39000000000000001 110.477 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.13 -38.26 85.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.256 -0.429 . . . . 1.3899999999999999 111.497 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.0 t -61.61 -45.33 94.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 1.5 110.818 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.0 mt -59.79 -38.66 82.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 1.1599999999999999 110.274 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 p -54.97 -26.13 34.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.966 -0.561 . . . . 1.3799999999999999 110.381 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -86.61 -23.32 25.77 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.052 0.454 . . . . 2.23 110.019 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.16 11.18 39.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.61 -0.723 . . . . 2.4199999999999999 110.869 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.572 ' HB3' HG23 ' A' ' 52' ' ' VAL . 15.5 m-85 -131.78 93.12 3.25 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.426 -0.352 . . . . 1.02 110.453 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.86 48.03 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 1.74 111.644 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -156.7 -37.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.875 0.324 . . . . 1.1899999999999999 111.875 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.572 HG23 ' HB3' ' A' ' 49' ' ' TYR . 16.5 m -93.2 150.72 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 1.1200000000000001 111.785 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.453 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 3.0 tp -99.41 120.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.511 . . . . 1.6399999999999999 110.153 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.716 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 3.0 m-85 -102.55 117.24 34.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.918 -0.583 . . . . 0.28000000000000003 110.195 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.535 HD11 ' O ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -132.08 161.8 32.38 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.954 -0.699 . . . . 1.0700000000000001 110.695 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.441 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -118.42 121.8 41.22 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.088 -0.96 . . . . 2.1600000000000001 112.435 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -115.16 118.5 58.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.777 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -92.88 116.9 29.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.203 -0.666 . . . . 1.79 109.203 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.05 -21.2 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.364 . . . . 1.0800000000000001 111.611 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -40.22 96.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.98 0.419 . . . . 0.93999999999999995 110.065 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.96 -41.99 8.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.812 -0.631 . . . . 1.29 111.207 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.561 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -86.32 51.16 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.382 0.61 . . . . 1.0 110.131 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -71.33 -11.85 61.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.71 -0.677 . . . . 2.9399999999999999 111.13 -179.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.01 -23.35 19.55 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 111.734 0.272 . . . . 1.3300000000000001 111.734 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 62' ' ' ALA . 8.6 m -81.51 -50.92 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.188 0.44 . . . . 1.03 112.188 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.491 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.86 -56.89 14.43 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 113.308 0.855 . . . . 1.04 113.308 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 75.5 Cg_exo -50.81 -27.77 21.34 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.813 2.342 . . . . 0.82999999999999996 112.621 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -77.85 -19.16 55.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 2.1299999999999999 111.413 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -106.93 -8.89 16.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.059 0.457 . . . . 0.64000000000000001 110.364 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.54 38.26 90.38 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.516 -0.766 . . . . 0.51000000000000001 113.265 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.6 mt -78.99 132.14 32.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 117.299 0.549 . . . . 1.3300000000000001 109.603 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -142.96 74.15 1.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.194 0.521 . . . . 4.5 111.087 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.496 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 147.2 143.65 3.89 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.56 -0.746 . . . . 1.1599999999999999 112.023 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -129.8 156.77 78.41 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.359 0.123 . . . . 1.8200000000000001 110.799 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.37 121.48 6.96 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.829 -1.321 . . . . 0.77000000000000002 112.869 0.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -89.63 139.88 30.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 1.2 111.973 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.404 HD22 HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -112.09 118.81 36.42 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.538 -0.912 . . . . 1.5 108.538 177.377 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.445 HD11 ' CE1' ' A' ' 27' ' ' PHE . 1.0 OUTLIER -109.75 132.47 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.488 0.661 . . . . 0.98999999999999999 111.428 -178.409 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.431 HD13 ' HB ' ' A' ' 24' ' ' VAL . 3.5 mm? -111.93 135.59 52.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.141 -0.936 . . . . 1.25 109.029 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.616 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 37.0 m-85 -126.38 152.77 45.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.011 0.434 . . . . 0.37 110.612 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.614 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 0.8 OUTLIER -148.49 110.5 4.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.666 -0.697 . . . . 1.6399999999999999 109.664 -179.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 m120 62.07 48.12 5.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.909 0.385 . . . . 1.3300000000000001 110.438 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 7.42 49.0 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.055 -0.593 . . . . 0.29999999999999999 113.132 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -123.03 142.72 50.54 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 122.778 -0.248 . . . . 1.3999999999999999 110.645 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 p -57.52 129.34 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.301 -0.629 . . . . 2.0299999999999998 109.301 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . . . -103.33 -22.49 13.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.457 0.646 . . . . 1.1100000000000001 112.455 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -171.56 158.32 5.09 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.832 -1.076 . . . . 1.0600000000000001 110.941 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.1 t -134.08 136.01 43.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.226 -0.443 . . . . 2.2400000000000002 110.613 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.51 133.09 36.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.389 -0.597 . . . . 2.0299999999999998 109.389 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 t -115.97 145.97 21.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.671 -0.24 . . . . 1.5700000000000001 111.233 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.23 159.08 27.03 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.517 -0.849 . . . . 0.73999999999999999 112.648 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.88 158.33 30.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.113 0.482 . . . . 1.1799999999999999 111.715 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.404 HD13 HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -152.03 153.06 33.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 1.1399999999999999 110.358 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 m -71.54 -178.99 2.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 1.05 110.92 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -73.07 -30.64 63.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 1.4299999999999999 111.46 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.36 -32.23 48.37 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.201 -0.999 . . . . 0.25 112.722 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 100' ' ' GLU . 45.2 mt-30 -73.62 -35.29 65.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 1.6299999999999999 110.401 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -47.73 64.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.555 -0.748 . . . . 1.1699999999999999 109.412 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -60.61 -43.24 97.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 1.6299999999999999 110.533 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.584 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -61.18 -41.32 96.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.221 -0.445 . . . . 1.71 110.438 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.584 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 7.2 t80 -61.03 -41.83 97.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.322 0.582 . . . . 0.28999999999999998 110.741 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.86 -56.67 7.21 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.472 -0.785 . . . . 1.26 110.117 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -50.08 -36.73 30.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.919 0.39 . . . . 1.1799999999999999 111.042 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.21 -19.93 60.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 1.0600000000000001 112.1 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.473 ' HB3' HD23 ' A' ' 22' ' ' LEU . 10.7 t30 -109.05 -37.34 5.84 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.863 0.32 . . . . 0.88 111.863 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.482 HD21 ' CB ' ' A' ' 22' ' ' LEU . 3.5 tm? . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.056 0.455 . . . . 1.97 109.991 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 3' ' ' LYS . 45.7 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.693 0.282 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.49 ' N ' HG13 ' A' ' 2' ' ' VAL . 14.3 ptmt -143.67 120.81 11.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.191 0.52 . . . . 0.0 110.433 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.94 126.05 29.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.512 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 5' ' ' ILE . 1.0 OUTLIER -98.47 107.43 20.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.202 0.525 . . . . 0.0 110.532 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -97.13 18.62 14.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.652 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 m -156.32 161.35 40.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.916 0.388 . . . . 0.0 111.271 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.02 -27.71 61.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.518 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -79.83 -31.58 40.61 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.498 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.83 -38.34 90.65 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.462 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -58.59 -41.72 86.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.939 0.399 . . . . 0.0 110.016 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -67.5 -44.25 78.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.894 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -57.81 -47.25 83.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.243 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.74 73.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.044 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.5 mt -68.72 -37.96 79.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 110.57 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -60.55 -35.84 77.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.164 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.18 -22.46 55.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.006 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.18 77.41 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.088 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.54 -120.33 17.95 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.548 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -95.59 4.97 52.62 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -79.8 149.42 31.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 tp -77.0 133.15 39.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 5.6 t -113.88 109.91 30.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.502 0.668 . . . . 0.0 112.015 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.449 HG12 ' CE1' ' A' ' 54' ' ' PHE . 8.4 p -105.04 115.7 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.417 HG12 ' CD2' ' A' ' 55' ' ' LEU . 3.8 m -123.33 166.96 17.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.908 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -133.56 133.89 42.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.783 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -96.21 108.15 20.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.2 p -115.85 -168.36 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.314 0.578 . . . . 0.0 112.186 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.77 152.99 33.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.02 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -71.26 -37.57 71.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.508 0.671 . . . . 0.0 109.598 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -86.69 12.62 10.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.176 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 17.2 t -94.87 158.21 15.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.049 0.452 . . . . 0.0 111.625 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.96 -66.94 0.61 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.585 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.06 -21.51 72.55 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.58 2.187 . . . . 0.0 112.203 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.5 m -62.98 -42.01 99.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.297 0.57 . . . . 0.0 109.919 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.34 -29.7 70.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.378 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.4 mtt -68.28 -18.17 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.6 mm -88.14 -23.73 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.476 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -52.88 -51.95 69.51 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.03 -49.44 17.04 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.693 2.262 . . . . 0.0 113.416 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -79.79 -30.29 40.59 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.52 -46.01 81.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.087 0.47 . . . . 0.0 110.293 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -39.28 90.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.267 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.5 t -60.38 -43.99 96.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 111.115 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.4 mt -59.71 -38.33 81.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.926 0.393 . . . . 0.0 110.238 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.6 t -56.47 -30.98 63.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.942 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -86.39 -18.1 32.68 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.575 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -96.05 -20.76 18.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.947 0.403 . . . . 0.0 110.175 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -97.92 92.88 6.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.849 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.9 t -88.93 48.39 1.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.113 0.483 . . . . 0.0 110.719 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -152.73 -42.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.667 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.453 HG22 ' CE1' ' A' ' 54' ' ' PHE . 10.2 m -94.43 153.29 3.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.795 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 6.0 tp -104.49 115.4 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.026 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 8.1 m-85 -97.59 115.92 28.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.544 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.417 ' CD2' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -127.2 164.67 21.16 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.537 178.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.401 ' N ' HD11 ' A' ' 55' ' ' LEU . 3.2 tp10 -116.39 119.34 35.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.53 117.75 56.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.184 0.516 . . . . 0.0 110.946 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -98.47 119.41 37.11 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 p -60.88 -18.84 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -64.17 -39.0 93.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -100.11 -32.85 10.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.584 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.49 43.0 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.82 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -69.16 -10.12 56.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.654 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -94.9 -22.38 18.04 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.312 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.33 -47.71 23.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.665 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.498 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.35 -58.75 8.79 Favored Pre-proline 0 CA--C 1.529 0.143 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 75.2 Cg_exo -49.8 -28.89 18.9 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.458 2.106 . . . . 0.0 112.037 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.9 mttp -77.13 -23.99 51.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.959 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -106.66 -3.65 20.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.93 0.395 . . . . 0.0 112.017 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.88 34.92 89.98 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.889 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 79.7 mt -77.15 135.93 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 117.3 0.55 . . . . 0.0 110.657 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttp85 -143.48 71.28 1.33 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.129 0.49 . . . . 0.0 111.475 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.21 163.42 11.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.591 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.3 pt -148.46 149.84 32.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.418 0.109 . . . . 0.0 110.972 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -86.06 120.16 5.7 Favored 'Cis proline' 0 C--N 1.348 0.538 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.649 0.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.94 137.65 32.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.939 0.399 . . . . 0.0 111.809 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.11 121.76 45.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 mt -114.47 134.58 54.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.238 0.542 . . . . 0.0 111.639 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.417 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.4 mm? -114.33 127.36 55.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.781 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.502 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 46.5 m-85 -118.43 146.67 44.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.975 0.417 . . . . 0.0 111.336 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -146.59 115.27 6.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.002 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m120 59.76 45.21 13.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.872 0.368 . . . . 0.0 110.261 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.29 3.79 54.27 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.896 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.4 141.39 52.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.513 0.657 . . . . 0.0 111.467 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.5 t -68.13 118.3 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.443 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.43 10.49 19.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.943 0.401 . . . . 0.0 112.047 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -175.69 137.92 0.37 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.936 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 m -137.79 124.0 20.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 110.942 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -124.22 142.02 51.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.904 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.97 145.94 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.233 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.11 161.79 24.63 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.131 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.33 170.65 3.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.901 0.382 . . . . 0.0 111.277 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.69 147.06 10.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.657 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 t -64.75 179.07 0.69 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.914 0.388 . . . . 0.0 110.806 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -73.09 -30.81 63.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.118 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.2 -31.37 52.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.86 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -76.21 -32.14 58.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.858 0.361 . . . . 0.0 110.582 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.61 -50.95 31.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.099 0.476 . . . . 0.0 109.884 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -61.54 -42.33 98.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.5 -38.83 88.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.949 0.404 . . . . 0.0 110.137 179.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.441 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 11.2 t80 -61.93 -40.65 96.21 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.402 0.62 . . . . 0.0 110.061 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.67 -60.91 2.42 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.157 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -48.55 -33.83 10.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.095 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.6 -23.5 60.95 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -109.77 -30.03 8.04 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.6 tp . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 120.847 0.356 . . . . 0.0 110.716 179.981 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 67.9 t . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 109.68 -0.489 . . . . 1.1899999999999999 109.68 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.456 ' N ' HG13 ' A' ' 2' ' ' VAL . 11.9 ptpt -144.98 121.81 11.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.36 -0.936 . . . . 2.48 111.268 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.12 123.69 25.67 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.458 -1.246 . . . . 2.23 110.174 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 11' ' ' PHE . 2.1 mp -105.3 114.2 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.847 0.356 . . . . 1.1100000000000001 111.323 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -103.77 16.63 25.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.352 0.501 . . . . 1.47 112.352 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.427 ' H ' HG21 ' A' ' 5' ' ' ILE . 3.4 m -155.48 147.25 23.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.742 0.306 . . . . 1.1799999999999999 111.098 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.428 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.5 ttpt -60.82 -24.64 66.01 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.358 -0.383 . . . . 2.1099999999999999 111.764 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -79.14 -32.32 44.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.928 0.394 . . . . 1.0900000000000001 110.238 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.39 85.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.906 -0.588 . . . . 1.0900000000000001 110.349 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.549 ' N ' HG23 ' A' ' 5' ' ' ILE . 15.5 t80 -56.18 -44.53 79.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.858 -0.61 . . . . 1.6000000000000001 110.693 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.52 -39.45 88.63 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.246 -0.65 . . . . 1.3700000000000001 109.246 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -58.06 -48.45 80.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.746 -0.661 . . . . 1.6000000000000001 110.887 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.56 -34.58 78.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.421 . . . . 1.0700000000000001 111.241 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 mt -66.75 -39.6 87.98 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.234 0.54 . . . . 1.1599999999999999 110.537 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -63.57 -31.98 73.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 1.6000000000000001 110.739 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.72 -22.74 56.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 1.1100000000000001 111.014 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.23 -35.81 71.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 1.3100000000000001 111.477 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.53 -119.44 18.61 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.077 -1.059 . . . . 1.1000000000000001 113.662 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.18 2.29 56.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.717 -0.241 . . . . 2.1899999999999999 111.479 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -79.27 148.1 32.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.692 -0.484 . . . . 2.27 109.692 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.411 HD11 HD12 ' A' ' 79' ' ' LEU . 1.6 tp -72.46 126.99 31.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.14 -0.319 . . . . 1.0900000000000001 110.14 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 4.3 t -107.61 108.11 24.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.521 0.676 . . . . 1.1100000000000001 111.523 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.518 HG13 ' CE1' ' A' ' 54' ' ' PHE . 10.2 p -106.08 116.98 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.951 -1.129 . . . . 1.1000000000000001 107.951 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.715 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 4.3 m -123.13 166.97 17.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.218 0.532 . . . . 1.0700000000000001 111.643 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -133.21 133.75 43.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.802 -0.636 . . . . 1.23 111.834 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -97.86 110.76 23.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.927 -0.768 . . . . 0.31 108.927 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.3 m -128.42 158.94 36.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.597 0.713 . . . . 1.54 112.917 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -116.16 156.65 26.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.971 -1.013 . . . . 1.1499999999999999 111.047 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.2 m -70.79 -35.78 72.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.502 0.668 . . . . 1.29 109.615 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 23.4 p-90 -85.76 10.87 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.736 -1.12 . . . . 1.1399999999999999 111.564 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 38.4 t -98.4 148.12 24.01 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.81 0.338 . . . . 0.81999999999999995 111.027 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.33 -67.33 0.75 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.677 -0.773 . . . . 0.37 112.204 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.73 -24.53 18.22 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.411 2.074 . . . . 0.96999999999999997 112.096 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.7 m -62.9 -43.76 97.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.144 -0.48 . . . . 0.48999999999999999 110.781 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -68.78 -23.21 64.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 3.1499999999999999 111.13 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 mmt -69.7 -22.36 63.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 2.3199999999999998 110.739 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.2 mm -85.98 -21.71 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.418 -0.355 . . . . 1.0700000000000001 110.976 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -52.3 -55.05 35.14 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.464 -0.335 . . . . 2.9300000000000002 111.159 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.54 -49.11 15.37 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.563 2.176 . . . . 0.77000000000000002 112.381 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -77.4 -29.19 53.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 0.55000000000000004 111.519 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.437 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 6.3 t80 -67.76 -46.81 71.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.986 0.422 . . . . 0.55000000000000004 110.257 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -42.9 78.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 1.46 111.952 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 m -59.09 -44.52 91.92 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.841 0.353 . . . . 1.4399999999999999 110.379 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.35 -40.3 85.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.543 -0.54 . . . . 1.1299999999999999 109.543 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.4 t -54.5 -27.55 38.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.889 -0.596 . . . . 1.55 111.179 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -88.96 -16.96 30.5 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.731 0.3 . . . . 1.99 111.038 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -94.56 -19.38 20.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.963 0.411 . . . . 2.6699999999999999 109.912 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.451 ' HB3' HG21 ' A' ' 52' ' ' VAL . 22.1 m-85 -102.26 97.47 7.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.917 -0.583 . . . . 1.1000000000000001 111.477 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.63 46.35 1.33 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.399 -0.364 . . . . 1.73 110.767 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -154.44 -34.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.801 0.334 . . . . 1.26 111.322 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 49' ' ' TYR . 5.8 m -97.59 156.06 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.325 -0.398 . . . . 1.1299999999999999 111.585 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.501 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 1.3 tp -106.39 114.64 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.051 -0.522 . . . . 1.0800000000000001 111.143 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.695 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.2 m-85 -96.11 120.19 35.95 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.197 -0.456 . . . . 0.32000000000000001 110.516 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.715 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.5 OUTLIER -133.31 168.5 18.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 120.378 -0.529 . . . . 1.0700000000000001 111.1 179.178 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.53 124.61 44.81 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.674 0.62 . . . . 2.2799999999999998 112.674 -178.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.19 117.78 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.887 -0.597 . . . . 1.04 111.138 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -93.46 113.21 25.3 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.424 -0.584 . . . . 1.9199999999999999 109.424 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 p -58.49 -19.1 13.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.825 0.305 . . . . 1.0700000000000001 111.825 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -37.54 87.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.94 0.4 . . . . 1.22 110.292 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -102.94 -40.61 6.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.89 -0.596 . . . . 1.26 111.157 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' HG21 ' A' ' 65' ' ' VAL . . . -88.32 49.0 1.72 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.213 0.53 . . . . 1.02 110.395 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -75.83 -6.57 51.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.525 -0.762 . . . . 2.8300000000000001 111.083 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.89 -25.1 20.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.769 0.318 . . . . 1.5600000000000001 110.433 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 62' ' ' ALA . 13.5 m -81.31 -48.58 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.197 -0.456 . . . . 1.0900000000000001 111.759 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.39 -55.56 21.28 Favored Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 112.744 0.646 . . . . 1.0600000000000001 112.744 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 78.3 Cg_exo -51.92 -27.54 28.37 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.863 2.375 . . . . 0.77000000000000002 112.997 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -77.09 -21.35 54.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.278 -0.419 . . . . 2.3100000000000001 111.781 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -108.16 -7.12 16.12 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.087 0.47 . . . . 0.87 111.354 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.4 37.07 90.03 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.687 -0.688 . . . . 0.56999999999999995 113.517 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 61.6 mt -74.12 130.16 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 109.624 -0.51 . . . . 1.29 109.624 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.89 60.16 1.47 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.937 0.399 . . . . 4.54 111.521 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.13 118.43 0.52 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.245 -0.979 . . . . 1.2 113.386 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.6 pt -104.99 152.44 39.63 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.408 -0.219 . . . . 1.53 110.408 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.81 120.26 6.38 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.8 -1.333 . . . . 1.0800000000000001 112.708 0.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.48 134.82 34.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.543 -0.299 . . . . 1.05 111.236 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.87 122.82 47.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.401 -0.963 . . . . 1.6499999999999999 108.401 177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mt -113.84 137.61 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.263 0.554 . . . . 1.0700000000000001 111.548 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.411 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -119.01 113.41 20.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.535 -0.757 . . . . 1.1000000000000001 110.562 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.565 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.9 m-85 -105.0 142.37 34.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.979 -0.555 . . . . 0.28999999999999998 110.766 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -142.25 110.34 5.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.579 -0.737 . . . . 1.1100000000000001 109.487 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.0 m120 61.89 47.08 6.25 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.276 -0.639 . . . . 1.1899999999999999 109.276 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.16 3.79 32.58 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.558 -0.746 . . . . 0.26000000000000001 113.797 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -121.25 133.04 55.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.205 0.502 . . . . 1.6000000000000001 110.814 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.461 HG23 ' CE2' ' A' ' 80' ' ' PHE . 89.7 t -62.72 117.35 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 1.8600000000000001 109.848 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.02 4.49 27.12 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.462 0.541 . . . . 1.04 112.462 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.56 146.51 1.72 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.283 -0.417 . . . . 1.0800000000000001 111.823 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.46 134.21 37.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 2.1699999999999999 110.824 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -132.78 138.77 47.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 2.6499999999999999 110.239 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.7 145.53 26.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 1.6000000000000001 111.009 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.87 160.16 23.38 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.501 -0.857 . . . . 0.31 112.878 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.62 151.27 46.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.114 0.483 . . . . 1.0600000000000001 111.575 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.33 147.77 35.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.76 -0.654 . . . . 1.1499999999999999 110.558 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -65.04 -178.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.576 -0.284 . . . . 1.1699999999999999 110.755 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -73.01 -32.67 65.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 1.75 111.497 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.52 -30.58 56.31 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.206 -0.997 . . . . 0.26000000000000001 112.598 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.534 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 40.4 mt-30 -74.99 -31.22 61.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.972 0.415 . . . . 1.73 110.31 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.98 -49.79 27.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.047 -0.524 . . . . 1.1599999999999999 109.908 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -61.71 -45.16 95.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.544 -0.753 . . . . 2.0 110.965 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.8 pp20? -60.64 -41.68 95.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 1.8200000000000001 110.558 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.91 -42.68 97.35 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.26 0.552 . . . . 0.33000000000000002 111.194 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.4 HD13 HG13 ' A' ' 24' ' ' VAL . 1.7 mt -64.85 -57.72 8.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.791 -0.64 . . . . 1.1100000000000001 109.528 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -49.0 -34.19 12.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.502 . . . . 1.24 110.736 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.47 -22.95 62.62 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.046 -0.524 . . . . 1.04 111.717 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -105.55 -31.44 8.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.806 0.336 . . . . 0.52000000000000002 110.746 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.6 tp . . . . . 0 C--N 1.329 -0.312 0 N-CA-C 109.691 -0.485 . . . . 2.0 109.691 178.73 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 3' ' ' LYS . 42.9 t . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.772 0.32 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.491 ' N ' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -142.73 119.62 11.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.253 0.549 . . . . 0.0 110.346 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.7 127.74 33.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.846 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.12 107.53 21.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.298 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -97.9 19.64 13.49 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.125 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.23 159.53 39.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.855 0.36 . . . . 0.0 111.276 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.91 -26.65 62.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 m -79.64 -32.8 41.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.914 0.387 . . . . 0.0 110.814 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.37 90.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.568 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.435 ' CE1' HG22 ' A' ' 57' ' ' VAL . 3.7 t80 -57.66 -42.71 84.04 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -43.97 83.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.13 -45.7 92.14 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.514 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.49 -31.91 73.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.892 0.377 . . . . 0.0 110.673 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -67.78 -37.39 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.527 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -61.42 -33.91 74.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.304 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.44 -22.67 54.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.9 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.65 -35.91 79.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.63 -122.76 31.13 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.14 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.57 4.33 53.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.501 0.191 . . . . 0.0 111.152 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -77.28 149.7 35.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.8 tp -77.02 132.61 39.05 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 6.3 t -112.45 109.67 29.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.397 0.618 . . . . 0.0 112.37 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.461 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.9 p -104.81 116.22 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.475 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 3.1 m -122.67 167.09 16.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.72 -178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -133.45 133.37 42.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.597 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.412 ' CE1' HD13 ' A' ' 78' ' ' LEU . 5.9 m-85 -98.1 111.89 24.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -118.94 -167.79 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.382 0.61 . . . . 0.0 112.219 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.2 154.5 35.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.013 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -35.73 67.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.376 0.607 . . . . 0.0 109.471 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -87.24 10.78 15.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.08 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 11.3 t -91.79 157.21 17.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.052 0.453 . . . . 0.0 111.479 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.41 -64.17 0.54 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.441 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -63.96 -22.29 68.42 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.497 2.132 . . . . 0.0 112.401 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.9 m -58.58 -41.47 85.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -67.04 -15.24 63.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.391 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.6 mmt -71.16 -26.85 63.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.789 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.8 mm -84.47 -23.86 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.685 0.279 . . . . 0.0 111.361 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.453 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 8.4 ttpt -48.96 -59.21 6.72 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 10.3 Cg_endo -51.96 -45.05 41.15 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.342 2.028 . . . . 0.0 112.697 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -80.74 -29.67 36.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -66.43 -45.69 78.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.082 0.467 . . . . 0.0 110.327 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.14 -39.91 86.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.883 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 62.7 m -61.7 -44.02 97.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.877 0.37 . . . . 0.0 110.887 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.3 mt -59.42 -40.23 86.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.914 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 54' ' ' PHE . 1.2 m -54.73 -28.38 47.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.433 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.54 -19.51 27.78 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.686 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -95.0 -20.62 19.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.04 0.447 . . . . 0.0 110.265 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -98.04 96.13 7.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.675 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.76 47.96 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.072 0.463 . . . . 0.0 110.236 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -152.92 -42.44 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.822 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.451 HG22 ' CE1' ' A' ' 54' ' ' PHE . 11.0 m -93.66 153.85 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.597 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.427 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 5.2 tp -105.75 113.99 44.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.748 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 8.4 m-85 -94.62 116.2 28.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.55 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.475 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -129.02 166.7 18.71 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.514 178.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.409 ' N ' HD13 ' A' ' 55' ' ' LEU . 1.4 tp10 -117.43 118.99 33.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.435 HG22 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -115.34 118.35 58.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.249 0.547 . . . . 0.0 110.787 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -99.34 120.42 39.54 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.27 -18.46 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -67.93 -37.53 81.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.087 0.47 . . . . 0.0 109.81 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -98.78 -34.5 10.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.445 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.422 ' CB ' HG22 ' A' ' 65' ' ' VAL . . . -95.75 47.67 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.097 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -68.57 -8.74 44.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.079 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.57 -25.02 15.29 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.448 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.422 HG22 ' CB ' ' A' ' 62' ' ' ALA . 6.7 m -77.15 -48.78 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.965 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.446 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . -50.22 -60.44 5.24 Favored Pre-proline 0 N--CA 1.463 0.203 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 66' ' ' ALA . 6.3 Cg_endo -49.11 -28.04 13.45 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.571 2.181 . . . . 0.0 111.862 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -73.57 -27.84 61.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.929 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -108.79 -6.26 15.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.901 0.381 . . . . 0.0 111.632 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.41 40.24 97.6 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.087 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 61.3 mt -78.0 81.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 117.007 0.403 . . . . 0.0 110.837 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -87.1 78.33 8.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 111.882 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.27 164.22 10.15 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.397 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.5 pt -149.03 155.71 40.33 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 122.161 0.184 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.23 116.93 4.26 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 124.183 -1.174 . . . . 0.0 112.628 -0.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.14 137.08 32.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.909 0.385 . . . . 0.0 111.865 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.65 123.87 49.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.412 HD13 ' CE1' ' A' ' 27' ' ' PHE . 6.0 mt -116.76 134.88 54.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.219 0.533 . . . . 0.0 111.793 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.71 120.68 40.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.696 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 45.2 m-85 -112.08 146.99 36.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 0.0 111.157 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -146.94 110.6 4.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.328 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.3 m120 61.83 46.47 6.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.909 0.385 . . . . 0.0 110.171 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.51 1.24 57.4 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.908 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -125.49 138.79 53.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.484 0.642 . . . . 0.0 111.861 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.25 119.23 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.529 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.22 11.3 20.21 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -173.88 140.85 0.76 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.63 124.2 22.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.681 0.277 . . . . 0.0 111.127 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -126.17 139.68 53.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.272 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.44 146.34 25.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.643 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.36 161.56 27.36 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.158 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.14 147.86 49.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 111.58 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.38 151.76 42.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.612 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.9 t -65.33 179.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.151 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -72.5 -31.98 65.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.46 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.24 -29.89 55.57 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.711 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -76.88 -32.7 57.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.843 0.354 . . . . 0.0 110.532 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.21 -50.56 31.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -61.4 -42.09 98.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.238 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.38 -39.61 91.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.881 0.372 . . . . 0.0 110.328 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.424 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 10.8 t80 -62.1 -42.56 99.35 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.357 0.598 . . . . 0.0 110.679 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.1 mt -67.41 -54.46 20.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.186 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -50.99 -36.77 40.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.63 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.29 -21.0 60.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -108.58 -26.9 10.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.733 0.302 . . . . 0.0 111.705 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 tm? . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.683 -179.798 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 3' ' ' LYS . 50.9 t . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.81 0.338 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.478 ' N ' HG12 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -145.32 121.84 11.05 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.072 0.463 . . . . 0.0 110.23 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.24 127.55 33.26 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.416 ' CD1' HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -100.51 106.83 19.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.978 0.418 . . . . 0.0 109.928 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -98.45 20.08 13.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.778 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.8 159.79 38.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.946 0.403 . . . . 0.0 111.301 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.37 -25.36 61.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.926 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.84 -32.28 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.951 0.405 . . . . 0.0 110.702 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.67 -39.49 91.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.148 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.404 ' CE1' HG22 ' A' ' 57' ' ' VAL . 3.6 t80 -57.76 -44.52 86.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 109.984 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.84 -45.57 85.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.679 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -58.21 -47.79 82.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.34 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.39 -31.5 72.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.34 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 mt -69.79 -37.91 76.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.41 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -61.41 -33.16 73.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.721 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.42 -23.9 53.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.956 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.72 78.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.24 -122.42 29.0 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.004 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -94.96 6.47 48.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.46 0.171 . . . . 0.0 111.303 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -80.19 148.77 30.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.7 tp -76.25 134.63 39.77 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 4.2 t -113.78 109.19 27.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.459 0.647 . . . . 0.0 112.007 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.48 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.6 p -103.75 116.03 46.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.427 HG13 ' CD2' ' A' ' 55' ' ' LEU . 3.6 m -123.91 165.85 19.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.215 0.531 . . . . 0.0 112.126 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -129.57 131.31 46.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.609 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.24 110.13 22.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.9 p -134.32 149.54 50.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.107 0.48 . . . . 0.0 112.029 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.39 158.26 15.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.352 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -68.96 -37.49 78.85 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -85.48 16.19 3.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.058 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.8 t -90.91 156.95 17.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.36 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.14 -73.85 0.89 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.348 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.47 -22.79 22.5 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.451 2.101 . . . . 0.0 112.227 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.0 m -60.72 -38.11 83.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.22 0.533 . . . . 0.0 110.13 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -69.26 -16.26 63.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.553 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 38.4 mtt -74.16 -23.61 59.28 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.419 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.0 mm -87.25 -22.21 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 8.3 mttp -48.66 -60.01 5.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 10.2 Cg_endo -53.32 -44.51 48.36 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.544 2.162 . . . . 0.0 113.43 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -79.86 -31.61 40.45 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -66.18 -44.32 84.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.946 0.403 . . . . 0.0 110.545 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -39.27 83.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.12 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 p -61.74 -43.65 98.44 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.046 0.451 . . . . 0.0 110.879 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 mt -59.49 -37.03 77.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.021 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -57.86 -28.31 64.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.376 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -87.27 -19.61 28.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.599 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -95.27 -19.68 19.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 110.266 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -99.52 93.94 6.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.854 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.2 t -90.93 49.43 1.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.142 0.496 . . . . 0.0 110.845 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -151.75 -43.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.565 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.437 HG21 ' CE1' ' A' ' 54' ' ' PHE . 10.3 m -92.24 153.95 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.945 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.441 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 5.6 tp -105.35 114.72 45.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.596 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.48 ' CE1' ' CG1' ' A' ' 24' ' ' VAL . 7.3 m-85 -95.39 115.75 27.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.744 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.427 ' CD2' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -128.44 165.81 19.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.455 178.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -118.03 119.46 34.85 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.901 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.404 HG22 ' CE1' ' A' ' 11' ' ' PHE . 2.7 t -114.69 117.84 56.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.488 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -97.26 118.02 32.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.681 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.06 -18.98 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.733 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.4 -39.98 95.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -99.73 -34.08 10.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.765 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.419 ' CB ' HG23 ' A' ' 65' ' ' VAL . . . -95.11 45.03 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.708 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -9.44 57.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.168 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.4 -21.89 18.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.432 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.419 HG23 ' CB ' ' A' ' 62' ' ' ALA . 2.3 m -80.38 -47.02 21.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.992 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.493 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.0 -57.81 11.41 Favored Pre-proline 0 N--CA 1.464 0.225 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 74.6 Cg_exo -50.68 -28.34 22.27 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.536 2.157 . . . . 0.0 111.874 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.98 -23.12 58.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -111.01 -5.25 14.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.87 0.367 . . . . 0.0 111.812 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.56 34.94 89.16 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.581 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 75.2 mt -74.81 132.84 32.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 117.396 0.598 . . . . 0.0 110.364 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -150.7 49.21 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.933 0.397 . . . . 0.0 111.219 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.27 99.46 0.14 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.442 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.42 ' HA ' ' N ' ' A' ' 76' ' ' THR . 2.9 pt -100.96 151.6 37.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.51 0.195 . . . . 0.0 111.109 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.49 113.49 2.97 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 124.036 -1.235 . . . . 0.0 112.752 0.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.42 ' N ' ' HA ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -86.65 135.26 33.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.842 0.353 . . . . 0.0 111.571 179.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.38 125.95 51.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.5 mt -116.88 136.51 52.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.199 0.523 . . . . 0.0 111.702 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.427 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.6 mm? -117.45 122.98 45.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.699 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.543 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 49.1 m-85 -113.64 144.82 42.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.031 0.443 . . . . 0.0 111.375 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -145.62 111.59 5.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.336 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 m120 61.88 45.39 7.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.396 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.37 -0.56 59.63 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.957 -0.64 . . . . 0.0 114.242 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -124.07 141.07 52.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.519 0.66 . . . . 0.0 111.865 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.406 HG23 ' CZ ' ' A' ' 80' ' ' PHE . 38.2 t -67.4 119.73 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.401 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.09 8.33 19.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.427 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -173.61 138.68 0.68 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.113 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.2 m -138.63 120.71 15.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.749 0.309 . . . . 0.0 111.086 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.38 145.15 46.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.942 0.401 . . . . 0.0 111.216 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.01 146.19 25.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.399 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.83 159.29 17.69 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.304 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.9 138.27 48.04 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.027 0.441 . . . . 0.0 111.895 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.01 150.96 49.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.534 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.0 m -65.74 -178.03 0.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.771 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -70.57 -33.95 71.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.677 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.67 -30.49 52.64 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.237 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.438 ' HA ' ' HG2' ' A' ' 100' ' ' GLU . 25.6 mt-30 -77.14 -32.35 56.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.014 0.407 . . . . 0.0 110.591 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.32 -50.26 34.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -61.96 -42.23 98.88 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.654 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 97' ' ' GLN . 13.1 pt-20 -61.56 -42.84 99.43 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.764 0.316 . . . . 0.0 110.838 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -61.92 -42.7 99.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.374 0.607 . . . . 0.0 110.528 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.436 ' CD1' ' CZ ' ' A' ' 54' ' ' PHE . 1.6 mt -67.3 -54.44 20.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.768 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -52.82 -36.2 58.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.749 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.92 -19.17 61.96 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.985 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -107.6 -28.03 10.0 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.639 0.257 . . . . 0.0 111.454 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.94 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.524 HG11 ' N ' ' A' ' 3' ' ' LYS . 44.7 t . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.684 0.278 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.524 ' N ' HG11 ' A' ' 2' ' ' VAL . 1.3 ptpt -145.29 119.77 9.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.124 0.488 . . . . 0.0 110.651 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.29 127.65 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.641 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.2 109.55 25.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.064 0.459 . . . . 0.0 110.557 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -101.41 18.79 19.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.951 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.29 161.38 41.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.086 0.47 . . . . 0.0 111.562 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -73.43 -28.21 61.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.776 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.73 -30.9 41.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.765 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.07 -42.45 89.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.875 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -55.16 -41.51 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 110.213 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -67.1 -44.3 80.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.976 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -58.33 -47.82 82.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.447 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.37 -31.57 72.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 110.928 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 mt -68.68 -39.15 80.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.683 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.46 -34.08 73.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.056 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.66 -22.81 53.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.481 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.44 72.23 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.914 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.34 -123.92 29.35 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.144 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -93.59 4.65 53.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.621 0.248 . . . . 0.0 111.223 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -78.82 149.41 32.55 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.8 tp -76.35 134.96 39.54 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 5.3 t -112.79 113.22 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.519 0.676 . . . . 0.0 112.007 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.48 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.2 p -106.18 112.35 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.45 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.479 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 4.7 m -122.24 167.08 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.75 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -134.46 134.49 41.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.683 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -96.13 106.74 18.97 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -115.75 -169.52 1.6 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.449 0.642 . . . . 0.0 112.615 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.76 153.63 34.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.231 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.8 m -71.26 -36.51 71.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.433 0.635 . . . . 0.0 109.588 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -86.45 12.51 10.1 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.737 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.0 t -92.76 157.65 16.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.998 0.428 . . . . 0.0 111.728 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.18 -69.62 0.64 Allowed Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.344 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.5 -23.21 46.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.641 2.227 . . . . 0.0 112.27 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.1 m -59.89 -42.65 94.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -68.49 -18.6 64.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.365 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.9 mmm -74.04 -25.42 59.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.75 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.9 mm -85.97 -22.57 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.724 0.297 . . . . 0.0 111.664 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.41 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -50.75 -52.78 53.65 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.495 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 63.9 Cg_exo -51.15 -49.57 16.67 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.709 2.273 . . . . 0.0 113.045 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -79.87 -28.45 39.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -66.68 -47.23 73.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.099 0.476 . . . . 0.0 110.412 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -40.19 88.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.24 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.6 t -60.34 -44.58 95.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.599 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt -59.65 -41.92 91.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.123 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.404 ' HB2' ' CB ' ' A' ' 54' ' ' PHE . 31.8 t -54.91 -27.59 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.272 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -87.01 -18.77 29.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.727 0.299 . . . . 0.0 111.334 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -95.81 -19.91 19.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 110.08 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -100.18 92.52 5.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.032 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -89.69 48.06 1.55 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.021 0.438 . . . . 0.0 110.494 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -152.27 -40.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.591 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.487 HG23 ' CE1' ' A' ' 54' ' ' PHE . 12.5 m -94.74 155.25 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.422 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 5.3 tp -105.24 115.55 47.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.815 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.487 ' CE1' HG23 ' A' ' 52' ' ' VAL . 8.9 m-85 -97.61 116.17 29.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.938 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.479 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -129.35 167.79 17.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.45 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.443 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -120.24 122.39 40.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.803 -177.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.28 120.07 63.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.352 0.596 . . . . 0.0 110.744 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -99.74 119.24 37.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.897 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.73 -18.27 16.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.043 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -39.77 94.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.95 -33.63 10.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.496 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.431 ' CB ' ' CG2' ' A' ' 65' ' ' VAL . . . -97.24 43.7 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.469 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -8.94 56.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.666 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.98 -24.61 16.3 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.293 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.431 ' CG2' ' CB ' ' A' ' 62' ' ' ALA . 1.7 m -76.53 -47.43 29.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.494 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.498 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.97 -57.76 11.56 Favored Pre-proline 0 N--CA 1.461 0.108 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 74.2 Cg_exo -50.14 -28.5 19.83 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.435 2.09 . . . . 0.0 111.569 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -75.27 -24.35 57.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.956 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -106.98 -4.82 18.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.894 0.378 . . . . 0.0 111.612 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.98 34.65 89.08 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.78 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.9 mt -75.77 135.41 27.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 117.248 0.524 . . . . 0.0 110.446 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -144.81 64.85 1.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.014 0.435 . . . . 0.0 111.167 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.407 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 169.3 162.73 22.07 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.496 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.8 pt -147.51 141.76 16.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 122.9 -0.176 . . . . 0.0 110.963 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -88.89 122.1 5.56 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 124.172 -1.178 . . . . 0.0 112.398 -0.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER -88.28 137.69 32.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 111.674 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -108.79 124.19 50.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.7 mt -116.44 133.92 55.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.283 0.563 . . . . 0.0 111.618 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.426 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.0 mm? -115.27 122.13 45.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.695 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 50.2 m-85 -113.71 147.98 37.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.262 0.553 . . . . 0.0 111.542 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -147.02 111.01 5.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.208 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.9 m120 61.78 46.48 6.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.374 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.28 2.28 58.84 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.765 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.52 139.45 53.6 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.432 0.616 . . . . 0.0 112.192 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.1 p -67.74 116.98 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.454 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.58 9.53 21.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.426 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -170.88 139.3 1.44 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.937 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.65 122.68 20.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.698 0.285 . . . . 0.0 111.171 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -124.08 138.14 54.48 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.39 146.18 24.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.328 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.38 164.62 30.96 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.279 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.23 169.34 8.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.12 0.486 . . . . 0.0 111.576 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.05 -170.32 2.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.25 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 t -111.52 165.73 11.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.814 0.34 . . . . 0.0 110.814 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -55.79 -34.01 64.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.995 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.46 -31.18 51.88 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.914 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 35.5 mt-30 -76.19 -33.5 59.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.903 0.382 . . . . 0.0 110.553 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.51 -49.77 44.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -61.93 -43.92 97.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.096 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -61.3 -39.1 89.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.881 0.372 . . . . 0.0 110.167 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.441 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 9.7 t80 -61.28 -41.38 96.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.35 0.595 . . . . 0.0 110.333 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.429 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 10.7 mt -69.48 -50.75 42.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.763 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -52.43 -38.14 58.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 110.187 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.52 63.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.796 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -104.29 -56.28 2.22 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 110.923 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 102' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.838 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 3' ' ' LYS . 40.0 t . . . . . 0 CA--C 1.523 -0.091 0 CA-C-O 120.738 0.304 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.468 ' N ' HG12 ' A' ' 2' ' ' VAL . 10.7 ptpt -144.35 121.09 11.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.126 0.488 . . . . 0.0 109.941 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -74.66 129.61 38.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.604 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.98 108.15 22.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.418 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -100.0 18.16 19.18 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.905 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.1 m -154.13 158.04 39.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.84 0.352 . . . . 0.0 111.247 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.63 -26.27 62.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.555 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -79.72 -31.25 41.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.065 0.46 . . . . 0.0 110.298 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.87 -36.18 81.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.056 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -59.91 -42.98 95.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.012 0.434 . . . . 0.0 109.848 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -66.91 -44.7 80.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.614 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.23 -46.44 85.91 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.145 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.97 -30.71 70.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.139 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -69.49 -38.98 77.9 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.084 0.469 . . . . 0.0 110.188 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.25 -33.25 73.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.199 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.96 -23.68 52.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.892 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.32 -33.12 74.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.293 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.1 -122.17 28.68 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.154 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -96.04 7.81 45.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.613 0.244 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -79.05 148.07 32.6 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 tp -76.19 134.53 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 4.7 t -116.61 107.35 22.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.43 0.634 . . . . 0.0 112.085 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.459 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.3 p -101.69 115.07 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.434 HG12 ' CD2' ' A' ' 55' ' ' LEU . 5.2 m -122.59 168.15 15.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.364 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -135.14 134.13 39.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.951 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -96.71 110.71 23.11 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.6 p -119.44 -168.45 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.299 0.571 . . . . 0.0 112.062 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.17 155.07 37.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.037 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -71.23 -35.94 71.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 47.5 p-90 -86.25 11.33 12.33 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.404 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 11.1 t -88.76 157.72 18.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.988 0.423 . . . . 0.0 111.436 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.92 -64.66 0.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.004 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -64.01 -21.39 68.37 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.753 2.302 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.7 m -59.02 -39.82 83.09 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.294 0.569 . . . . 0.0 109.983 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -68.69 -16.88 63.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.564 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 69.2 mmm -74.16 -24.64 59.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.537 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.9 mm -86.19 -24.87 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.631 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -51.09 65.93 Favored Pre-proline 0 N--CA 1.468 0.428 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.3 -48.37 18.03 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.151 1.901 . . . . 0.0 112.703 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -80.59 -31.03 36.87 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.416 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 8.2 t80 -66.59 -45.83 77.92 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.875 0.369 . . . . 0.0 110.319 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.67 -39.35 88.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.554 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.5 m -60.75 -42.86 98.24 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.042 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.18 -44.39 95.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.257 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.0 p -53.55 -25.15 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.229 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -86.6 -21.98 26.5 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 120.608 0.242 . . . . 0.0 111.129 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -94.9 -19.16 20.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.08 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -98.95 92.84 5.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 t -90.11 50.58 1.88 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 110.674 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -153.14 -42.73 0.1 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.492 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.401 HG22 ' CE1' ' A' ' 54' ' ' PHE . 5.5 m -93.29 154.31 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.689 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.433 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 5.7 tp -105.9 115.65 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.909 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.459 ' CE1' ' CG1' ' A' ' 24' ' ' VAL . 5.7 m-85 -97.03 115.83 28.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.505 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.434 ' CD2' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -127.48 166.73 17.39 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.491 178.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.403 ' N ' HD12 ' A' ' 55' ' ' LEU . 1.6 tp10 -117.93 118.6 32.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.39 118.07 57.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.548 0.689 . . . . 0.0 110.842 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -99.34 120.16 39.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.558 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 p -61.2 -17.84 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.4 -40.06 96.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.247 0.546 . . . . 0.0 109.527 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -98.25 -36.29 10.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.987 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.411 ' CB ' ' CG2' ' A' ' 65' ' ' VAL . . . -94.66 42.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.752 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -69.8 -11.17 60.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.343 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.96 -21.98 19.47 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.439 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.411 ' CG2' ' CB ' ' A' ' 62' ' ' ALA . 2.2 m -80.47 -46.48 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.152 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.487 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.04 -56.65 16.3 Favored Pre-proline 0 N--CA 1.466 0.331 0 O-C-N 122.284 -0.26 . . . . 0.0 111.552 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 79.2 Cg_exo -51.35 -28.32 26.64 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.543 2.162 . . . . 0.0 111.958 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -74.41 -24.74 59.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.35 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -108.43 -6.65 16.08 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.628 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.31 38.87 94.06 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.706 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.7 mt -76.28 133.09 31.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 110.38 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.6 tpt85 -149.64 49.05 0.94 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.933 0.397 . . . . 0.0 110.913 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.32 102.09 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.713 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.4 ' HA ' ' N ' ' A' ' 76' ' ' THR . 13.0 pt -101.88 150.02 37.02 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.83 114.05 3.22 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 124.29 -1.129 . . . . 0.0 112.385 0.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.4 ' N ' ' HA ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -86.42 135.05 33.64 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 mp -107.81 126.18 52.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.402 ' HB2' HG23 ' A' ' 25' ' ' VAL . 6.0 mt -118.36 134.07 55.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.268 0.556 . . . . 0.0 111.636 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.4 126.0 54.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.688 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.458 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 51.9 m-85 -118.68 146.8 44.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.954 0.407 . . . . 0.0 110.961 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -144.74 110.45 5.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.805 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.0 m120 60.52 46.41 9.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 110.063 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.08 -3.37 38.23 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.005 -0.616 . . . . 0.0 114.141 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.57 134.1 55.24 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 117.299 0.55 . . . . 0.0 111.68 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.04 116.35 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.445 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.81 11.1 24.47 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.45 137.23 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.263 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.3 m -137.52 124.68 21.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.068 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -122.72 145.14 48.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.352 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.81 146.64 24.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.199 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.44 159.26 10.83 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.964 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.44 141.0 52.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 111.481 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.29 150.97 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.239 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.08 179.09 0.74 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.701 0.286 . . . . 0.0 110.624 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -71.28 -32.56 68.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.731 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.06 -31.03 54.43 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.928 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.74 -31.48 57.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -51.26 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.704 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -61.07 -41.78 97.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.078 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.83 -39.09 90.61 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.91 0.386 . . . . 0.0 110.178 179.467 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.407 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 11.3 t80 -63.27 -42.4 99.12 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.515 0.674 . . . . 0.0 110.114 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.426 HD12 ' CZ ' ' A' ' 54' ' ' PHE . 5.0 mt -66.77 -58.45 5.03 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.85 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -48.86 -34.97 13.6 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.732 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.2 -20.57 60.15 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -109.0 -33.42 6.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 tm? . . . . . 0 C--N 1.326 -0.448 0 CA-C-O 120.893 0.378 . . . . 0.0 110.679 -179.993 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.511 HG11 ' N ' ' A' ' 3' ' ' LYS . 48.3 t . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 120.664 0.268 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.511 ' N ' HG11 ' A' ' 2' ' ' VAL . 7.1 ptpp? -146.09 122.07 10.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.159 0.504 . . . . 0.0 110.265 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -74.48 129.64 38.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.053 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 5' ' ' ILE . 1.1 mp -101.97 108.11 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 110.317 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -98.94 19.27 15.34 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.226 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -154.72 159.74 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 0.0 111.127 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.35 -27.1 62.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.083 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -79.97 -31.87 39.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.952 0.406 . . . . 0.0 110.751 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.63 90.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.898 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -56.36 -40.19 74.12 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.75 -45.14 72.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.046 178.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.77 -48.41 79.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.484 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.41 -32.46 74.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.916 0.389 . . . . 0.0 110.928 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 mt -68.14 -34.58 76.6 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.802 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.01 -34.13 76.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.925 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.2 -22.59 55.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.702 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.68 -37.61 85.1 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.297 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.17 -124.37 35.78 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.997 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -94.19 4.89 53.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.543 0.211 . . . . 0.0 111.031 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 mttp -77.42 149.36 35.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 tp -76.77 136.64 39.0 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 10.6 t -117.05 110.83 32.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.261 0.553 . . . . 0.0 112.234 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.467 HG13 ' CE1' ' A' ' 54' ' ' PHE . 7.9 p -106.69 115.87 49.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.42 HG13 ' CD2' ' A' ' 55' ' ' LEU . 3.3 m -123.02 167.48 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.949 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -134.51 135.96 42.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.284 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -99.06 109.88 22.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.545 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -114.97 -168.67 1.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.139 0.495 . . . . 0.0 111.928 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.08 155.17 37.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.743 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -71.96 -37.47 69.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.499 0.666 . . . . 0.0 109.366 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -86.76 12.4 10.92 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.034 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.0 t -94.17 159.83 14.97 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.994 0.426 . . . . 0.0 111.746 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.94 -64.91 0.44 Allowed Glycine 0 C--N 1.331 0.262 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.045 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.4 -24.13 77.97 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.708 2.272 . . . . 0.0 112.047 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.9 m -58.94 -43.69 91.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.238 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.4 -27.53 67.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.599 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 47.9 mtt -67.83 -17.09 64.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.3 mm -86.27 -22.35 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.904 0.383 . . . . 0.0 111.002 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.499 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -51.28 -58.7 9.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.169 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_endo -48.07 -46.65 21.59 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.539 2.16 . . . . 0.0 112.655 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -78.94 -33.79 45.02 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -66.17 -45.82 79.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.916 0.389 . . . . 0.0 110.402 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -40.68 87.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.657 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -43.85 94.83 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.882 0.372 . . . . 0.0 110.893 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.5 mt -59.68 -39.42 84.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.7 t -56.49 -29.57 61.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.614 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.66 -18.19 31.91 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.144 -0.223 . . . . 0.0 111.516 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -95.1 -20.35 19.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 0.0 110.008 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -100.13 90.65 4.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.473 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 m -86.96 51.28 2.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.081 0.467 . . . . 0.0 110.454 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -154.65 -41.57 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.171 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.424 HG23 ' CE1' ' A' ' 54' ' ' PHE . 10.7 m -93.37 154.45 3.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.013 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.444 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 4.0 tp -103.7 114.48 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.256 0.55 . . . . 0.0 111.507 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 7.7 m-85 -97.61 115.6 28.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.178 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.42 ' CD2' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -128.63 167.89 16.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.115 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.68 120.41 36.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.16 118.11 57.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.0 110.406 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -97.97 119.52 36.74 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.08 -18.71 16.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.03 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -65.66 -38.07 88.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.037 0.446 . . . . 0.0 109.802 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.35 -35.13 10.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.28 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.43 46.07 1.14 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.916 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.3 -11.19 60.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.534 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.75 -22.79 19.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.505 0.193 . . . . 0.0 111.174 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 m -79.31 -47.29 22.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.978 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.452 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . -50.52 -60.16 5.9 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 66' ' ' ALA . 10.2 Cg_endo -50.85 -28.63 24.02 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.713 2.276 . . . . 0.0 111.967 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -78.13 -23.41 47.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.902 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -106.4 -2.96 21.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.649 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.67 33.75 86.98 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.629 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 81.2 mt -77.75 133.64 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 117.184 0.492 . . . . 0.0 110.618 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -144.74 64.35 1.29 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.337 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 170.85 162.38 23.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.243 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.3 pt -147.51 139.78 14.21 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.692 0.246 . . . . 0.0 110.987 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -87.95 123.62 6.65 Favored 'Cis proline' 0 C--N 1.35 0.635 0 C-N-CA 124.203 -1.165 . . . . 0.0 112.604 0.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.99 134.29 33.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.813 0.339 . . . . 0.0 111.077 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.27 123.47 48.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.4 mt -115.6 136.12 53.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.222 0.534 . . . . 0.0 111.845 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.3 mm? -116.34 120.81 40.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.594 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.489 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.3 m-85 -112.17 145.61 39.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 0.0 111.202 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 tttm -145.93 110.94 5.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.998 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.9 m120 62.06 46.19 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 110.111 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.66 2.9 57.45 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.745 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -123.78 136.33 54.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.385 0.592 . . . . 0.0 111.651 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.66 117.59 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.128 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.68 11.48 28.4 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -173.52 144.62 1.15 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.96 119.97 17.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -122.13 139.27 53.94 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.855 0.359 . . . . 0.0 110.249 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 t -121.8 145.92 27.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.464 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.54 159.81 24.38 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.602 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.74 143.89 54.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.976 0.417 . . . . 0.0 111.386 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.43 -171.37 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.513 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.0 t -109.21 165.98 11.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 110.822 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -57.4 -37.72 73.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.05 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.54 -30.12 54.04 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.845 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.58 -32.59 58.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.488 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.44 -49.65 39.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -43.76 98.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.876 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -62.21 -38.1 87.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.891 0.377 . . . . 0.0 110.168 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.415 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 5.6 t80 -61.82 -39.99 93.69 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.207 0.527 . . . . 0.0 109.923 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.6 mt -66.12 -59.32 3.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.914 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.49 -34.49 11.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.058 0.456 . . . . 0.0 110.705 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -24.42 62.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.18 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -106.37 -47.68 3.74 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.676 0.274 . . . . 0.0 111.021 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.768 179.618 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 3' ' ' LYS . 56.8 t . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.456 ' N ' HG13 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -146.77 123.42 11.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.022 0.439 . . . . 0.0 109.827 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -75.38 132.39 40.87 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.415 HG13 ' CB ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -100.16 106.74 19.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 110.543 -179.1 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.76 21.31 10.63 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.87 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.26 159.13 38.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.771 0.32 . . . . 0.0 111.192 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.2 tmpt? -73.58 -26.9 61.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.946 0.403 . . . . 0.0 110.42 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -79.8 -32.11 40.76 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.616 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.415 ' CB ' HG13 ' A' ' 5' ' ' ILE . . . -66.57 -36.25 82.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.463 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.417 ' CE1' HG21 ' A' ' 57' ' ' VAL . 6.0 t80 -58.16 -42.51 86.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.107 0.479 . . . . 0.0 110.168 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -66.53 -41.79 88.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.955 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.96 -48.21 82.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.528 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.93 76.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 110.67 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.405 HD23 ' CG ' ' A' ' 80' ' ' PHE . 12.1 mt -64.78 -40.76 95.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -66.9 -27.1 67.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.624 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -49.19 75.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.876 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.79 -64.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.544 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.51 -86.3 1.46 Allowed Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.809 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -94.4 -16.92 23.02 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -74.86 157.73 34.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 tp -79.5 133.96 36.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 15.7 t -114.37 110.37 31.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.403 0.621 . . . . 0.0 111.573 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.47 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.3 p -106.18 115.05 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.46 HG11 ' CD2' ' A' ' 55' ' ' LEU . 3.2 m -123.05 166.74 17.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.759 -178.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -131.75 132.04 43.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.546 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -97.94 111.84 24.0 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.7 t -117.46 -170.51 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.0 112.472 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.12 155.38 37.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.437 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -35.84 68.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.39 0.614 . . . . 0.0 110.199 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -85.31 11.52 9.99 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.081 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.8 t -96.83 158.26 15.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 111.313 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.51 -66.55 0.5 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.009 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.82 -23.36 71.89 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.454 2.103 . . . . 0.0 112.193 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -58.82 -44.54 90.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -65.0 -26.5 68.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.51 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.5 mtt -67.03 -17.44 64.91 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.5 mm -86.1 -21.72 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.091 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 25.6 mttp -51.37 -59.34 8.02 Favored Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 8.2 Cg_endo -50.35 -45.2 35.24 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.437 2.092 . . . . 0.0 112.869 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -78.88 -31.87 45.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -65.9 -45.37 82.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.93 0.395 . . . . 0.0 110.531 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.78 -38.35 86.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.524 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.6 m -59.67 -42.8 93.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 110.746 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt -60.81 -42.89 98.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.418 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.4 p -54.81 -25.84 31.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.394 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -86.64 -23.15 25.78 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.599 0.238 . . . . 0.0 111.321 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -94.18 -19.05 21.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 110.041 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -100.16 88.03 3.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.966 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 p -87.11 50.92 2.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.463 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -153.5 -42.58 0.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.685 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.432 HG22 ' CE1' ' A' ' 54' ' ' PHE . 12.3 m -93.46 154.56 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.556 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.453 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 1.6 tp -103.79 114.17 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.353 0.597 . . . . 0.0 111.038 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.47 ' CE1' ' CG1' ' A' ' 24' ' ' VAL . 7.5 m-85 -96.91 117.31 30.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.806 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.46 ' CD2' HG11 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -130.76 164.8 24.32 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.395 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -112.98 116.02 29.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.417 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.6 t -114.05 116.46 52.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.168 0.508 . . . . 0.0 111.048 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -99.18 120.18 39.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.469 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.96 -20.03 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.098 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -61.76 -40.77 96.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.219 0.533 . . . . 0.0 109.667 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -100.26 -33.53 10.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.353 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.412 ' CB ' ' CG2' ' A' ' 65' ' ' VAL . . . -94.78 43.6 1.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.548 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -71.66 -9.92 58.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.565 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.38 -21.4 18.4 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.243 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.412 ' CG2' ' CB ' ' A' ' 62' ' ' ALA . 1.6 m -79.34 -47.87 21.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.485 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.499 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.89 -58.28 9.87 Favored Pre-proline 0 C--N 1.333 -0.141 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 74.7 Cg_exo -51.2 -28.3 25.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.415 2.077 . . . . 0.0 111.849 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -73.8 -25.68 60.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.487 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -108.39 -6.12 16.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.691 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.73 36.23 90.94 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 116.007 -0.542 . . . . 0.0 114.33 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.9 mt -74.65 136.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 117.312 0.556 . . . . 0.0 110.653 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -151.79 54.89 0.84 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 111.236 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.73 102.22 0.15 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.428 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.418 ' HA ' ' N ' ' A' ' 76' ' ' THR . 11.8 pt -102.87 154.39 37.56 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 122.971 -0.135 . . . . 0.0 110.835 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.74 114.17 3.17 Favored 'Cis proline' 0 C--N 1.348 0.529 0 C-N-CA 123.768 -1.347 . . . . 0.0 113.125 0.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.418 ' N ' ' HA ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -86.26 136.61 33.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 111.221 179.018 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.39 123.61 48.62 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.7 mt -116.03 136.14 53.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.223 0.535 . . . . 0.0 111.867 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.425 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.9 mm? -116.29 123.46 47.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.863 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.535 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.1 m-85 -113.98 144.94 42.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.024 0.44 . . . . 0.0 111.072 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -146.14 111.34 5.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.061 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.5 m120 61.49 45.29 8.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.774 0.321 . . . . 0.0 110.563 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.99 2.76 58.73 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.52 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -124.45 140.35 53.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.297 0.548 . . . . 0.0 111.809 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.9 120.87 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.672 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.72 8.65 16.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.425 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -173.84 136.56 0.55 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.9 m -136.36 125.26 24.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 0.0 110.771 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 145.17 49.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.046 0.451 . . . . 0.0 111.181 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.59 145.93 25.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.172 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.53 160.83 13.7 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.332 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.29 176.38 1.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.045 0.45 . . . . 0.0 111.508 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -170.37 153.3 4.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.692 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 t -66.78 179.01 1.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.028 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -72.97 -28.63 62.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.068 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.46 -31.77 49.63 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.13 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 39.7 mt-30 -76.87 -31.9 57.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.975 0.387 . . . . 0.0 110.558 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.02 -51.13 27.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -63.33 -43.22 98.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.097 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.4 pp20? -62.06 -43.17 99.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.779 0.323 . . . . 0.0 110.469 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -61.9 -39.21 91.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.4 0.619 . . . . 0.0 110.088 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mt -65.52 -60.7 2.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.009 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -48.23 -32.22 6.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.02 -26.23 63.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.791 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -106.36 -26.58 11.42 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.702 0.287 . . . . 0.0 111.524 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 tt . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 110.482 179.787 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.487 HG11 ' N ' ' A' ' 3' ' ' LYS . 52.1 t . . . . . 0 CA--C 1.522 -0.104 0 CA-C-O 120.71 0.29 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.487 ' N ' HG11 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -143.34 120.51 11.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.185 0.517 . . . . 0.0 110.377 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.63 129.27 37.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.118 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.67 107.79 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.353 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.66 20.19 13.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.159 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -155.15 160.36 40.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.824 0.345 . . . . 0.0 111.401 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.96 -27.07 61.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.624 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.3 m -79.76 -30.99 40.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.858 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.78 -39.78 91.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.735 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -56.77 -43.26 80.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.191 0.52 . . . . 0.0 109.661 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -46.2 78.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.875 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -60.74 -44.8 96.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.434 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.74 -34.32 78.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.577 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.03 -35.9 79.03 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.497 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -35.29 76.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.322 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.45 -22.52 54.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.91 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.1 -33.21 74.1 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.227 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.03 -125.07 37.83 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.036 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.22 6.4 46.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.509 0.195 . . . . 0.0 111.139 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -78.74 150.15 32.53 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 tp -78.08 133.76 37.84 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 6.5 t -113.85 110.19 31.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.454 0.645 . . . . 0.0 112.005 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.456 HG13 ' CE1' ' A' ' 54' ' ' PHE . 7.3 p -102.59 113.84 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.47 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 3.1 m -121.27 165.85 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.758 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -134.31 133.31 40.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.854 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -97.34 110.39 22.95 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.4 p -121.41 -166.76 1.41 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.247 0.546 . . . . 0.0 112.228 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.83 152.71 33.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.155 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -70.44 -36.98 74.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.437 0.637 . . . . 0.0 109.408 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -87.23 11.31 14.49 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.826 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 15.4 t -93.04 155.79 17.29 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.482 . . . . 0.0 112.213 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.79 -75.8 1.04 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.209 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.26 -24.52 21.07 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.62 2.214 . . . . 0.0 112.416 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.2 m -60.49 -41.96 95.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.208 0.528 . . . . 0.0 110.373 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -68.93 -15.64 63.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.25 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.9 mmt -72.96 -28.09 62.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.467 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.2 mm -84.56 -23.97 7.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.734 0.302 . . . . 0.0 111.431 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -49.76 -54.13 34.94 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.898 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -51.45 -48.36 21.65 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.514 2.142 . . . . 0.0 113.345 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -80.08 -28.27 39.17 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -65.63 -45.83 81.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.965 0.412 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.04 -37.96 81.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.95 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -43.96 97.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.917 0.389 . . . . 0.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.54 -42.35 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.111 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.7 t -55.38 -26.19 39.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.293 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -88.45 -20.15 25.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.586 0.231 . . . . 0.0 111.526 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -96.23 -20.35 18.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.058 0.456 . . . . 0.0 110.069 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -98.71 92.83 5.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.725 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.7 p -91.31 48.51 1.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.667 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -151.79 -40.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.58 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.448 HG23 ' CE1' ' A' ' 54' ' ' PHE . 12.5 m -95.35 156.16 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.594 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.421 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 4.7 tp -106.67 115.18 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.892 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.456 ' CE1' HG13 ' A' ' 24' ' ' VAL . 7.7 m-85 -96.34 115.65 27.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.244 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.47 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -128.32 166.24 19.02 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.734 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.447 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -117.98 120.05 36.67 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -176.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.75 117.72 56.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.107 0.48 . . . . 0.0 110.713 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -98.62 120.05 38.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.78 -17.67 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -66.91 -37.61 84.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.2 -37.82 9.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.143 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.59 44.11 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.303 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -9.37 48.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.815 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.57 -22.36 17.67 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.467 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 m -79.06 -47.44 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.53 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.501 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.66 -57.69 11.42 Favored Pre-proline 0 N--CA 1.463 0.178 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 75.3 Cg_exo -51.11 -28.5 25.34 Favored 'Trans proline' 0 C--N 1.34 0.09 0 C-N-CA 122.441 2.094 . . . . 0.0 111.595 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -75.93 -21.72 56.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.918 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -112.63 -5.69 13.96 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.49 39.26 96.71 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.451 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 61.4 mt -79.32 79.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.929 0.365 . . . . 0.0 111.06 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -86.5 82.58 7.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.184 0.516 . . . . 0.0 111.836 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.77 163.13 10.07 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.568 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.2 pt -146.2 156.77 50.3 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -83.5 118.25 5.34 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.402 -1.082 . . . . 0.0 113.063 0.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.16 136.55 32.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.372 . . . . 0.0 111.686 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -109.19 123.29 49.0 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mt -115.6 133.11 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.341 0.591 . . . . 0.0 111.411 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.4 mm? -114.17 121.8 44.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.636 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.458 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 41.6 m-85 -113.07 146.87 38.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.261 0.553 . . . . 0.0 111.544 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -146.69 116.73 7.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.011 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m120 57.98 44.97 18.81 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.455 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.1 2.54 53.43 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.9 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -124.91 139.47 53.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.473 0.637 . . . . 0.0 111.705 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.96 117.51 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.905 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -110.91 10.68 22.33 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -175.7 137.14 0.34 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.527 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.9 m -136.7 125.26 23.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.588 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -123.24 143.21 50.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.859 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.5 146.37 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.568 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.95 159.6 22.49 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.892 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.03 37.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 111.696 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.72 150.4 39.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.7 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 m -63.98 179.81 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -72.78 -32.63 65.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.976 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.01 -30.06 56.16 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.618 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 26.3 mt-30 -76.43 -31.86 58.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.441 . . . . 0.0 110.704 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.33 -50.11 29.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -62.22 -44.08 97.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.107 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 17.8 pt-20 -60.05 -44.22 94.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.713 0.292 . . . . 0.0 110.814 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . 0.407 ' CE2' ' HB2' ' A' ' 87' ' ' ALA . 19.4 t80 -61.92 -42.2 98.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.114 0.483 . . . . 0.0 111.11 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mt -66.67 -57.54 6.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.164 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.26 -34.92 16.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.68 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.74 -22.59 60.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.254 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -107.88 -24.14 11.77 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 tm? . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.813 -179.729 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 58.3 t . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 109.709 -0.478 . . . . 1.1299999999999999 109.709 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.548 ' N ' HG13 ' A' ' 2' ' ' VAL . 10.2 ptpt -143.96 122.43 12.42 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.686 -0.805 . . . . 1.9299999999999999 110.917 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.16 123.4 26.37 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.44 -1.254 . . . . 1.77 109.796 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.629 HG23 ' N ' ' A' ' 11' ' ' PHE . 3.5 mp -102.91 110.79 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.985 0.421 . . . . 1.23 110.558 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -98.63 19.02 15.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.012 -0.54 . . . . 1.5700000000000001 111.545 179.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.45 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.7 m -155.16 163.69 39.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.949 0.404 . . . . 1.03 111.89 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.496 ' HA ' HG12 ' A' ' 65' ' ' VAL . 1.9 ttpt -76.79 -25.55 53.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.984 -0.553 . . . . 1.9399999999999999 110.778 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -79.34 -32.43 43.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.004 0.431 . . . . 1.1000000000000001 109.955 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.51 -37.97 86.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.801 -0.636 . . . . 1.04 110.521 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.629 ' N ' HG23 ' A' ' 5' ' ' ILE . 8.7 t80 -57.85 -46.14 85.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.28999999999999998 110.686 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -65.47 -40.58 93.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.853 -0.612 . . . . 1.25 109.736 178.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -58.58 -48.76 79.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.918 -0.583 . . . . 1.3400000000000001 110.94 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.45 -36.29 82.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.991 -0.549 . . . . 1.03 111.247 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.2 mt -64.69 -38.33 90.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 1.1699999999999999 110.166 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.2 -27.66 68.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 1.7 110.476 179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.9 83.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 1.1699999999999999 111.146 -178.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.15 -65.45 0.67 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 119.943 -0.703 . . . . 1.25 109.922 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.83 -93.24 1.86 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.704 -0.68 . . . . 0.65000000000000002 112.808 -179.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -95.63 -9.95 30.75 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.199 0.499 . . . . 2.2599999999999998 111.669 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -75.24 151.08 38.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.613 -0.514 . . . . 1.73 109.613 179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 23' ' ' VAL . 1.9 tp -76.39 127.91 33.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.883 0.373 . . . . 1.04 110.112 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 3.9 t -106.67 110.23 30.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.34 0.59 . . . . 1.03 111.592 -179.362 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.409 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.3 p -106.07 116.06 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.114 -1.069 . . . . 1.0600000000000001 108.114 178.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.728 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 3.9 m -123.37 164.18 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.179 0.514 . . . . 1.0600000000000001 112.371 -178.012 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -127.81 132.9 49.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 1.1200000000000001 112.067 -178.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -99.1 106.52 18.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.06 -0.719 . . . . 0.29999999999999999 109.06 178.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.55 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.9 p -119.92 -174.76 2.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.068 0.766 . . . . 1.46 113.068 -177.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.02 154.77 41.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.459 -1.246 . . . . 1.0800000000000001 110.396 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -38.45 79.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.169 0.509 . . . . 1.4199999999999999 110.176 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -86.54 14.22 7.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.364 -0.834 . . . . 0.72999999999999998 111.412 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 32.2 t -98.42 141.35 31.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.737 0.303 . . . . 0.52000000000000002 110.571 178.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.89 -67.24 0.94 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.592 -0.813 . . . . 0.34000000000000002 112.196 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -51.95 -26.58 25.35 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.585 2.19 . . . . 0.66000000000000003 112.165 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -60.54 -44.06 96.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.35999999999999999 110.534 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -65.94 -28.44 68.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.795 -0.639 . . . . 2.1000000000000001 111.093 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.0 mtt -68.55 -21.01 64.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 1.7 111.549 -179.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.8 mm -87.21 -23.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.746 0.308 . . . . 1.0800000000000001 111.132 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -51.23 -54.77 34.7 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.39 -0.368 . . . . 2.3999999999999999 110.945 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.31 -48.14 17.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.613 2.209 . . . . 0.71999999999999997 112.485 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -78.24 -28.43 47.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.516 -0.311 . . . . 0.33000000000000002 111.508 -178.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 4.4 t80 -68.31 -47.96 66.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.097 0.475 . . . . 0.28999999999999998 110.187 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.89 -41.67 86.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.735 -0.666 . . . . 0.44 111.505 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -59.39 -44.85 92.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.774 0.321 . . . . 1.45 110.82 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.41 -40.4 86.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.808 -0.441 . . . . 1.1000000000000001 109.808 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.433 ' HB2' ' CB ' ' A' ' 54' ' ' PHE . 35.6 t -53.92 -28.26 35.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 1.51 111.11 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -87.93 -17.9 30.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.641 -0.254 . . . . 2.1400000000000001 111.33 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 4.6 ttpp -95.51 -21.47 18.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.018 0.437 . . . . 1.78 109.946 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -99.04 92.21 5.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.627 -0.715 . . . . 0.85999999999999999 110.708 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -84.26 46.41 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 1.52 111.397 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -157.62 -36.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.956 0.354 . . . . 1.05 111.956 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.465 HG11 ' HB3' ' A' ' 22' ' ' LEU . 6.2 m -91.85 157.07 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.682 0.277 . . . . 1.0800000000000001 111.193 -179.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.46 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 1.2 tp -104.92 116.91 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.222 0.534 . . . . 1.1699999999999999 111.109 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.7 m-85 -99.1 117.27 33.23 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.814 -0.63 . . . . 0.32000000000000001 110.242 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.728 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -133.23 169.78 16.4 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.642 -0.423 . . . . 1.1499999999999999 110.849 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -121.57 124.94 45.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.381 0.882 . . . . 1.8200000000000001 113.381 -178.712 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.8 t -112.0 114.59 47.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.654 -0.703 . . . . 1.05 111.027 178.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -94.47 115.68 27.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.1 -0.5 . . . . 1.8999999999999999 109.686 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 28' ' ' SER . 12.4 p -59.75 -21.05 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 1.0700000000000001 111.644 -178.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -64.65 -38.83 92.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.932 -0.395 . . . . 1.1599999999999999 109.932 179.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -99.61 -39.16 8.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 1.3100000000000001 111.263 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -94.17 50.38 1.39 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.055 0.455 . . . . 1.0 111.176 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 7.0 tt0 -77.54 -3.2 39.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.158 -0.474 . . . . 2.2400000000000002 110.958 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.38 -24.84 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.766 0.317 . . . . 1.28 110.176 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 8' ' ' LYS . 8.2 m -81.98 -48.28 18.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.184 -0.462 . . . . 1.0600000000000001 111.399 179.298 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.471 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.52 -55.14 24.26 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 112.933 0.716 . . . . 1.01 112.933 -178.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.471 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 72.6 Cg_exo -52.35 -27.8 32.5 Favored 'Trans proline' 0 C--O 1.23 0.114 0 C-N-CA 122.871 2.381 . . . . 0.59999999999999998 113.059 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -77.27 -20.26 55.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.124 -0.489 . . . . 2.0 111.895 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -107.48 -6.03 17.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.055 0.455 . . . . 0.80000000000000004 111.055 179.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.04 37.43 93.13 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.626 -0.715 . . . . 0.29999999999999999 112.859 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.9 mt -75.05 134.98 28.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.358 -0.608 . . . . 1.03 109.358 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -147.2 59.77 1.17 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.72 0.295 . . . . 3.3999999999999999 110.968 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.435 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 161.13 117.72 0.45 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.478 -0.867 . . . . 0.94999999999999996 113.297 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 pt -108.24 153.54 41.85 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 110.164 -0.31 . . . . 1.49 110.164 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.76 115.94 4.06 Favored 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.854 -1.311 . . . . 0.80000000000000004 112.488 -0.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -88.63 138.2 31.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.878 0.371 . . . . 1.05 111.424 179.377 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.17 124.86 50.9 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.429 -0.952 . . . . 1.1399999999999999 108.429 177.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mt -116.28 135.33 53.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.272 0.558 . . . . 1.0900000000000001 111.625 -178.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.404 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 4.0 mm? -116.74 112.56 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.508 -0.769 . . . . 1.04 110.889 -179.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.542 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 50.5 m-85 -104.26 142.62 34.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.076 -0.511 . . . . 0.25 110.524 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -143.62 112.7 6.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.731 -0.668 . . . . 1.05 109.638 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.8 m120 61.36 45.73 8.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.21 0.529 . . . . 0.72999999999999998 109.729 -178.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.43 3.32 46.93 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.37 -0.832 . . . . 0.19 113.793 178.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -124.67 140.24 53.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.599 0.699 . . . . 1.6499999999999999 112.106 -179.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.5 t -64.68 116.83 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.586 -0.734 . . . . 2.0 110.788 179.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.54 -1.11 19.95 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.517 0.562 . . . . 1.1799999999999999 112.517 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 79' ' ' LEU . . . -172.79 147.31 1.71 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.058 -0.519 . . . . 1.0800000000000001 111.78 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 t -137.73 144.5 41.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 2.0699999999999998 110.912 178.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -138.55 139.69 38.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.026 -0.534 . . . . 2.3799999999999999 110.059 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.419 HG11 ' N ' ' A' ' 91' ' ' GLY . 15.0 t -121.32 143.96 31.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.681 0.277 . . . . 1.3 111.239 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.419 ' N ' HG11 ' A' ' 90' ' ' VAL . . . 82.66 160.19 27.77 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.529 -0.843 . . . . 0.20000000000000001 112.607 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.69 155.54 39.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.143 0.497 . . . . 1.1599999999999999 111.638 -179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.52 151.61 32.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.602 -0.726 . . . . 1.1399999999999999 110.263 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 m -66.92 179.22 1.16 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.428 . . . . 1.1299999999999999 111.294 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -72.64 -30.59 64.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.624 . . . . 1.46 111.478 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.19 -30.59 54.57 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.131 -1.033 . . . . 0.14000000000000001 112.701 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.567 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 51.6 mt-30 -76.17 -28.46 57.34 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.876 -0.33 . . . . 1.5800000000000001 110.632 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -50.72 16.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.067 0.46 . . . . 1.1100000000000001 109.843 178.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.432 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 14.7 ttpt -59.22 -44.25 92.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.736 -0.665 . . . . 1.74 110.908 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.5 pp20? -61.45 -40.31 94.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.86 -0.609 . . . . 1.3799999999999999 110.574 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -62.38 -42.54 99.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.317 0.58 . . . . 0.29999999999999999 110.645 178.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.55 -54.95 18.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.778 -0.646 . . . . 1.1299999999999999 109.656 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -48.96 -34.05 12.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.169 0.509 . . . . 1.1499999999999999 110.219 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.49 -22.57 61.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.735 -0.666 . . . . 1.03 112.288 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -109.06 -33.32 6.93 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.83 -0.348 . . . . 0.38 111.407 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.456 ' HB2' HD21 ' A' ' 22' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 109.99 -0.374 . . . . 2.02 109.99 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptp . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.895 0.378 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.487 HG11 ' N ' ' A' ' 3' ' ' LYS . 43.1 t 63.87 144.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.487 ' N ' HG11 ' A' ' 2' ' ' VAL . 2.4 ptpt -143.12 120.6 11.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.274 0.559 . . . . 0.0 110.334 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -72.57 125.35 27.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.931 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.402 ' CD1' HD13 ' A' ' 55' ' ' LEU . 1.1 mp -101.02 107.04 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.92 0.391 . . . . 0.0 110.363 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -97.86 20.06 12.75 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.974 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.3 m -156.95 160.13 38.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.838 0.351 . . . . 0.0 111.413 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -72.43 -27.03 62.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.969 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.47 -32.13 42.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.383 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.1 -37.0 84.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.18 -45.2 91.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.027 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -65.31 -44.53 87.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.618 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.76 -45.77 91.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.642 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.55 74.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.07 0.462 . . . . 0.0 110.696 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.37 -35.88 76.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.719 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -62.15 -34.61 76.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.789 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.55 -22.72 53.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.927 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.77 73.35 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.036 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.17 -120.8 21.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.305 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -93.42 1.67 56.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -76.45 148.8 37.01 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 tp -76.51 131.51 39.04 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.49 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 2.4 t -113.45 109.07 27.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.272 0.558 . . . . 0.0 111.805 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.494 HG12 ' CE1' ' A' ' 54' ' ' PHE . 7.2 p -104.23 119.2 52.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.442 HG12 ' CD2' ' A' ' 55' ' ' LEU . 3.6 m -124.97 167.6 18.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.824 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -135.9 136.56 40.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.923 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -98.67 114.1 26.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.284 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.9 p -131.78 -171.12 2.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.683 0.754 . . . . 0.0 112.767 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.54 162.3 41.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.546 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 m -63.08 -30.63 71.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.92 0.391 . . . . 0.0 110.045 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -93.32 10.81 30.5 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.188 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.8 t -90.89 113.78 26.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.951 0.405 . . . . 0.0 111.176 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.84 -59.9 3.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.024 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.86 -28.75 69.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.342 2.028 . . . . 0.0 112.311 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.4 m -60.07 -39.87 87.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.803 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -69.11 -20.33 64.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.248 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.5 mtt -74.17 -25.19 59.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.369 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.3 mm -89.42 -24.83 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.654 0.264 . . . . 0.0 111.548 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -47.56 -50.17 51.75 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 38.1 Cg_exo -61.9 -44.67 19.57 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.492 2.128 . . . . 0.0 112.826 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -80.55 -29.46 37.09 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.408 ' CE1' HG23 ' A' ' 24' ' ' VAL . 5.0 t80 -66.74 -46.43 75.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.072 0.463 . . . . 0.0 110.205 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -39.83 90.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.696 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.5 p -60.69 -42.87 98.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 111.063 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.3 mt -60.64 -43.09 97.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.19 -29.42 31.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.222 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -89.05 -21.45 23.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.958 0.409 . . . . 0.0 110.355 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -94.98 3.2 55.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.58 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -109.09 -30.49 8.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 111.058 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 t 36.43 34.41 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.079 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -151.1 -41.36 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.995 0.426 . . . . 0.0 110.858 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 17.9 m -94.03 157.4 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.543 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.44 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 2.8 tp -106.62 117.45 52.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.331 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.494 ' CE1' HG12 ' A' ' 24' ' ' VAL . 5.2 m-85 -100.78 115.61 30.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.308 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.442 ' CD2' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -123.8 165.54 17.14 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.421 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.416 ' N ' HD11 ' A' ' 55' ' ' LEU . 2.6 tt0 -116.94 119.56 35.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.115 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -116.93 119.97 63.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.598 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -99.2 120.67 39.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.73 -18.39 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.722 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -66.92 -37.94 85.28 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.4 -34.5 10.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.736 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' CB ' HG21 ' A' ' 65' ' ' VAL . . . -95.89 43.35 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.847 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.62 -9.59 50.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.963 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.99 -23.3 17.44 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.521 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.401 HG21 ' CB ' ' A' ' 62' ' ' ALA . 2.5 m -78.83 -47.37 23.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.203 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.97 -57.18 13.32 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.489 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 72.6 Cg_exo -50.69 -28.96 24.08 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.555 2.17 . . . . 0.0 112.101 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -77.86 -22.12 50.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.004 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -107.77 -5.56 17.26 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.886 0.374 . . . . 0.0 111.637 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.03 33.66 87.77 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.909 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.6 mt -75.96 137.98 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 117.26 0.53 . . . . 0.0 110.593 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -140.94 79.42 1.7 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.96 0.41 . . . . 0.0 111.49 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.42 164.97 10.24 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.015 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.436 HG21 HD11 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -147.76 154.71 44.37 Favored Pre-proline 0 N--CA 1.464 0.251 0 C-N-CA 122.173 0.189 . . . . 0.0 110.9 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -81.9 118.7 5.84 Favored 'Cis proline' 0 C--N 1.35 0.648 0 C-N-CA 124.772 -0.928 . . . . 0.0 112.779 0.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.36 136.87 32.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.866 0.365 . . . . 0.0 111.318 178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.3 tp -107.8 119.03 38.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.409 ' CD2' ' CG2' ' A' ' 88' ' ' THR . 6.0 mt -114.56 135.22 54.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.241 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.428 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.7 mm? -115.58 123.4 48.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.726 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.49 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 45.8 m-85 -114.37 145.88 41.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.933 0.397 . . . . 0.0 111.177 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -146.85 112.72 5.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.045 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.5 m120 61.51 45.78 8.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 110.221 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.33 2.86 50.99 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.655 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -124.55 140.23 53.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.393 0.597 . . . . 0.0 111.39 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.442 HG21 ' CZ ' ' A' ' 80' ' ' PHE . 28.3 t -68.3 116.94 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.728 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.28 11.27 27.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.094 0.474 . . . . 0.0 111.49 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.428 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -175.96 139.62 0.39 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.643 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.409 ' CG2' ' CD2' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -136.02 116.58 13.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.526 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -120.82 140.98 50.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 110.727 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.3 p -117.04 146.65 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.269 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.48 160.15 12.38 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.491 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.43 163.89 24.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 0.0 111.82 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.44 153.81 33.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.462 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.4 m -64.32 178.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.904 0.383 . . . . 0.0 111.133 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.6 tptm -72.28 -31.19 65.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.053 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.4 -31.34 51.56 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.315 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.444 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 17.8 mt-30 -76.91 -30.75 56.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.174 0.487 . . . . 0.0 110.627 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.42 -50.87 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -62.39 -44.44 96.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.997 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.1 pp20? -61.78 -42.49 99.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.83 0.348 . . . . 0.0 110.364 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.4 t80 -63.17 -42.96 99.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.33 0.586 . . . . 0.0 110.36 178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.6 mt -65.46 -59.79 3.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.119 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -49.22 -32.21 10.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.466 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.54 -21.51 60.35 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.019 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -108.77 -28.25 9.31 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -72.82 113.11 9.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 110.697 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.152 179.925 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.939 0.399 . . . . 0.0 111.317 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 3' ' ' LYS . 41.5 t -86.94 145.93 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.829 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.49 ' N ' HG13 ' A' ' 2' ' ' VAL . 1.9 pttp -146.12 121.36 10.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.224 0.535 . . . . 0.0 110.173 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -72.84 131.59 42.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.679 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -103.17 108.32 24.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.042 0.449 . . . . 0.0 110.474 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.56 20.18 14.39 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.976 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -155.12 161.73 41.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 111.138 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.5 ttpt -75.08 -26.94 59.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.605 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -79.85 -32.01 40.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.512 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.41 88.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.433 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.401 ' CE1' HG21 ' A' ' 57' ' ' VAL . 4.6 t80 -57.06 -42.24 80.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.909 0.385 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.05 -42.95 88.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.91 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -58.14 -46.29 85.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.254 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.25 76.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.64 -43.35 89.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.99 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.48 -26.49 67.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.434 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.17 -49.76 73.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.977 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.36 -64.21 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.778 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.38 -83.04 1.63 Allowed Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.98 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -96.79 -18.55 19.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.82 0.31 . . . . 0.0 111.468 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -73.28 155.46 39.46 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.2 tp -78.17 134.87 37.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.894 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 13.8 t -113.74 110.25 31.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.418 0.627 . . . . 0.0 111.52 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.464 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -104.96 117.17 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.428 HG12 ' CD2' ' A' ' 55' ' ' LEU . 5.5 m -126.4 167.42 21.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.012 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -131.34 133.21 45.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.977 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.432 ' CE1' HD11 ' A' ' 78' ' ' LEU . 5.6 m-85 -97.78 110.56 23.11 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.5 m -119.79 -168.34 1.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.388 0.613 . . . . 0.0 112.607 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.05 154.89 36.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.455 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -35.02 70.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.41 0.624 . . . . 0.0 109.498 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 52.7 p-90 -86.84 11.58 12.97 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.652 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 9.6 t -93.36 157.46 16.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.148 0.499 . . . . 0.0 111.705 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.18 -66.57 0.53 Allowed Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.239 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.1 -21.68 72.36 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.568 2.179 . . . . 0.0 112.308 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.23 -42.99 96.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -68.68 -15.66 63.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.495 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 mtp -72.92 -24.66 60.85 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.1 mm -85.46 -22.63 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.654 0.264 . . . . 0.0 111.685 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 28.6 mtpt -50.0 -59.71 6.47 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_endo -49.55 -45.84 29.34 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.535 2.157 . . . . 0.0 112.864 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -79.19 -29.06 42.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -65.55 -45.7 82.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.447 . . . . 0.0 110.375 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -38.06 84.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.867 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -61.79 -43.15 99.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.815 0.341 . . . . 0.0 110.676 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.97 -45.37 92.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.211 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.9 p -53.32 -27.21 22.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.554 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -85.21 -22.29 28.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.389 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -95.36 -17.56 21.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.918 0.389 . . . . 0.0 110.219 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.433 ' CE2' HD11 ' A' ' 102' ' ' LEU . 17.3 m-85 -99.6 92.66 5.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.879 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.2 m -90.22 49.55 1.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.393 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -153.23 -43.21 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.452 HG23 ' CE1' ' A' ' 54' ' ' PHE . 9.1 m -93.68 155.51 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.906 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.442 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 2.9 tp -105.58 114.69 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.918 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 8.0 m-85 -96.7 116.24 28.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.057 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.428 ' CD2' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -130.63 168.8 16.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.34 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.418 ' N ' HD11 ' A' ' 55' ' ' LEU . 6.5 tt0 -121.34 124.16 43.9 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.401 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -117.33 120.44 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.905 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -97.83 119.22 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.2 p -61.39 -19.2 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.71 -178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.79 -41.03 97.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -98.21 -34.28 10.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.386 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -95.1 41.11 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.049 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -9.72 50.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.575 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.26 -23.14 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.422 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.8 m -78.12 -47.05 25.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.052 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.512 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.16 -57.97 11.1 Favored Pre-proline 0 N--CA 1.463 0.183 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 76.3 Cg_exo -51.07 -29.39 27.95 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.665 2.244 . . . . 0.0 112.262 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -76.72 -22.65 53.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.668 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -108.49 -3.5 18.07 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.842 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.45 35.35 91.22 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.175 -0.536 . . . . 0.0 114.0 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.403 HD11 ' CD2' ' A' ' 27' ' ' PHE . 76.4 mt -75.66 134.12 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 117.494 0.647 . . . . 0.0 110.689 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -151.58 51.22 0.82 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.909 0.385 . . . . 0.0 111.399 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.77 103.27 0.17 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.377 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.2 pt -103.14 153.21 38.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.465 0.174 . . . . 0.0 111.281 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.6 116.07 4.33 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.954 -1.269 . . . . 0.0 112.123 -0.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.02 138.17 31.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.017 0.436 . . . . 0.0 112.156 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -107.48 123.43 48.4 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.432 HD11 ' CE1' ' A' ' 27' ' ' PHE . 7.6 mt -114.88 133.02 56.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.236 0.541 . . . . 0.0 111.841 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.13 121.99 44.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.921 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.504 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 50.7 m-85 -114.04 148.21 37.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.983 0.421 . . . . 0.0 111.397 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -147.05 111.99 5.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.952 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 m120 60.73 46.74 8.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.882 0.372 . . . . 0.0 110.316 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.35 4.68 52.06 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.659 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -125.34 139.54 53.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.19 0.495 . . . . 0.0 111.611 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 27.9 t -67.67 116.14 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.833 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.83 11.11 20.82 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . . . -174.16 142.19 0.8 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.44 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -137.35 127.57 26.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 111.079 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.42 138.76 52.48 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.143 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 t -121.47 146.08 27.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.694 0.283 . . . . 0.0 111.642 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.43 161.02 23.9 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.849 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.07 164.36 18.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 111.542 -179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -159.8 151.15 19.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.051 -179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.63 178.91 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -70.9 -30.71 67.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.96 -30.99 50.02 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.007 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -77.28 -32.37 55.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.915 0.388 . . . . 0.0 110.617 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.0 -51.74 23.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.33 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -60.95 -38.24 85.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.356 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.468 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -61.88 -38.23 87.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.872 0.367 . . . . 0.0 110.268 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.468 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 6.3 t80 -61.48 -41.55 97.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.28 0.562 . . . . 0.0 110.09 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.433 HD11 ' CE2' ' A' ' 49' ' ' TYR . 6.6 mt -66.92 -56.88 8.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.9 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -50.8 -35.56 32.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.998 0.428 . . . . 0.0 110.193 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.6 -22.72 63.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.71 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -106.43 -55.42 2.33 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.624 0.25 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 19.8 tp -51.51 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.064 0.459 . . . . 0.0 110.852 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.07 -179.517 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.708 0.289 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 3' ' ' LYS . 46.5 t 63.69 144.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.023 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.519 ' N ' HG12 ' A' ' 2' ' ' VAL . 5.8 ptpp? -146.53 122.93 10.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.073 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -74.75 131.92 41.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.249 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' CD1' HD12 ' A' ' 55' ' ' LEU . 1.1 mp -104.28 108.36 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.763 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -97.47 18.93 14.21 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 m -155.15 165.4 36.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.03 0.443 . . . . 0.0 111.523 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -76.89 -26.34 54.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.33 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.0 m -79.78 -33.82 40.25 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.171 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.13 -36.49 83.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.365 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -58.85 -43.44 90.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.059 0.457 . . . . 0.0 110.118 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -65.41 -40.51 93.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.715 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -58.93 -50.71 73.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.711 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.2 75.28 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 mt -65.56 -42.92 91.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.891 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.1 -28.28 68.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.545 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.16 -47.31 83.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.11 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.19 -64.27 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.171 -0.611 . . . . 0.0 109.628 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.88 -87.3 1.47 Allowed Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.201 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.34 -15.77 24.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.092 0.446 . . . . 0.0 111.482 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -75.24 155.62 36.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.416 HD22 ' HB2' ' A' ' 106' ' ' LEU . 8.1 tp -78.63 133.3 37.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.123 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.48 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 5.4 t -112.06 109.62 29.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.491 0.662 . . . . 0.0 111.413 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.452 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.1 p -104.15 115.11 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.456 HG11 ' CD2' ' A' ' 55' ' ' LEU . 3.2 m -122.89 163.98 20.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.306 0.574 . . . . 0.0 112.022 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -128.37 130.81 48.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.582 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -97.52 111.06 23.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.9 t -119.53 -168.94 1.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.238 0.542 . . . . 0.0 112.303 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.84 154.6 36.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.864 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -71.95 -37.84 69.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.48 0.657 . . . . 0.0 109.782 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -86.77 11.74 12.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.159 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 13.8 t -97.29 156.43 16.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.775 0.322 . . . . 0.0 110.926 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.03 -64.29 0.55 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.296 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.02 -24.36 76.63 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.422 2.081 . . . . 0.0 112.042 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -59.71 -45.54 91.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.305 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -64.9 -25.75 68.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 49.6 mmm -66.85 -16.26 64.18 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.7 mm -86.12 -21.57 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.731 0.3 . . . . 0.0 111.092 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.509 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -50.87 -58.78 9.08 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 7.4 Cg_endo -48.13 -47.81 18.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.796 2.331 . . . . 0.0 113.063 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -80.09 -30.41 39.22 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -65.72 -46.23 79.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.066 0.46 . . . . 0.0 109.942 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -39.57 88.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.729 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 t -61.57 -43.48 98.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.331 . . . . 0.0 110.833 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.47 -40.36 86.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.131 0.491 . . . . 0.0 109.897 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.3 t -56.15 -28.42 57.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.367 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -85.95 -20.52 28.83 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -95.75 -20.56 18.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.105 0.478 . . . . 0.0 110.159 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.409 ' CD2' HG22 ' A' ' 52' ' ' VAL . 16.0 m-85 -97.29 95.74 7.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.539 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -93.93 48.45 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.161 0.505 . . . . 0.0 110.019 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.87 -41.0 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.519 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.447 HG23 ' CE1' ' A' ' 54' ' ' PHE . 10.5 m -95.97 154.55 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.979 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 2.8 tp -105.5 113.99 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.833 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 9.3 m-85 -96.28 116.29 28.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.139 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.456 ' CD2' HG11 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -127.67 165.77 19.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.5 178.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -115.83 119.21 35.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -176.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.71 118.32 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.181 0.515 . . . . 0.0 111.369 178.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -99.68 121.93 41.94 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.1 p -60.43 -18.98 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.784 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -65.71 -39.09 90.85 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -97.94 -36.67 10.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.534 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 65' ' ' VAL . . . -96.24 43.47 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.749 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -70.2 -9.77 56.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.509 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -94.04 -23.57 17.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.273 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.402 ' CG2' ' CB ' ' A' ' 62' ' ' ALA . 2.4 m -79.14 -46.61 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.036 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.491 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.24 -56.9 14.89 Favored Pre-proline 0 N--CA 1.462 0.175 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 81.1 Cg_exo -50.93 -28.82 25.06 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.677 2.251 . . . . 0.0 112.128 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -76.13 -18.75 59.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.964 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -115.9 -7.35 12.01 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.946 0.403 . . . . 0.0 111.658 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.05 39.94 97.69 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.038 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 62.0 mt -76.97 79.66 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 117.013 0.406 . . . . 0.0 110.162 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -87.19 77.82 8.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.959 0.409 . . . . 0.0 111.774 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.73 162.52 9.3 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.129 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 31.2 pt -145.89 156.5 51.57 Favored Pre-proline 0 CA--C 1.529 0.165 0 C-N-CA 122.157 0.183 . . . . 0.0 110.863 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -87.36 116.4 3.51 Favored 'Cis proline' 0 C--N 1.354 0.825 0 C-N-CA 124.578 -1.009 . . . . 0.0 112.481 -0.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.65 138.03 31.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.88 0.371 . . . . 0.0 111.659 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.65 125.79 51.79 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.401 ' HB2' HG21 ' A' ' 25' ' ' VAL . 6.3 mt -114.58 133.73 55.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.265 0.555 . . . . 0.0 111.686 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 2.8 mm? -114.48 117.03 29.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.968 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.48 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 45.3 m-85 -108.08 148.76 29.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.423 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -148.25 113.62 5.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.229 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.3 46.66 15.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.932 0.396 . . . . 0.0 110.276 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.83 3.45 55.41 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.918 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -126.26 140.51 52.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.252 0.526 . . . . 0.0 111.667 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.1 p -68.24 119.0 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.911 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -117.05 11.46 14.25 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.447 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -173.18 140.23 0.85 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.398 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.0 141.15 46.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.049 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -142.48 136.81 29.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.181 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.4 t -120.32 146.3 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.79 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.27 159.57 23.26 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.857 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.63 132.3 47.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.974 0.416 . . . . 0.0 111.324 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -113.88 -173.5 2.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.365 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 t -110.03 164.89 12.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.9 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -55.63 -38.01 68.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.769 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.05 -31.7 51.9 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.872 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.412 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 43.0 mt-30 -76.18 -31.86 58.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.012 0.406 . . . . 0.0 110.507 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.07 -50.13 30.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -61.51 -43.96 97.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.94 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -61.87 -40.09 94.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.256 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.412 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 30.0 t80 -63.09 -42.12 99.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.293 0.568 . . . . 0.0 110.728 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.0 mt -68.02 -56.15 9.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.318 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.99 -34.69 21.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.916 0.389 . . . . 0.0 110.471 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.31 -19.69 60.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.23 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -107.0 -34.7 7.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.84 0.352 . . . . 0.0 110.943 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.416 ' HB2' HD22 ' A' ' 22' ' ' LEU . 53.2 tp -69.64 99.08 1.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.105 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.821 -179.208 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.889 0.376 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.478 HG11 ' N ' ' A' ' 3' ' ' LYS . 61.6 t -86.79 144.87 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.707 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.478 ' N ' HG11 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -145.4 121.97 11.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.117 0.484 . . . . 0.0 110.238 -179.577 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -74.01 130.05 39.08 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.027 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.0 OUTLIER -102.97 108.55 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.994 0.426 . . . . 0.0 110.337 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -100.59 19.74 16.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.143 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.26 160.16 40.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.935 0.397 . . . . 0.0 111.071 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.18 -28.64 64.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.002 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.49 -30.59 42.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.983 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.6 90.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.683 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -57.63 -43.8 85.1 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.92 0.39 . . . . 0.0 110.098 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.429 ' HA ' ' NE2' ' A' ' 12' ' ' GLN . 9.8 mm100 -65.38 -44.1 88.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.589 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -58.37 -46.13 86.92 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.313 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.83 -32.31 73.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.043 0.449 . . . . 0.0 110.606 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 mt -68.23 -38.58 82.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.99 -35.32 76.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.398 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.5 -22.5 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.685 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.14 -34.59 78.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.007 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.2 -123.43 31.19 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.25 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.32 6.22 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.599 0.237 . . . . 0.0 111.414 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -79.21 149.77 31.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 tp -76.16 133.21 40.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.541 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 5.8 t -111.41 111.43 36.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.523 0.678 . . . . 0.0 112.026 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.47 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -105.8 113.92 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.436 HG13 ' CD2' ' A' ' 55' ' ' LEU . 4.6 m -124.21 167.04 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.203 0.525 . . . . 0.0 112.007 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -134.28 134.34 41.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.023 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -96.91 108.8 21.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.331 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 p -115.69 -169.44 1.59 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.366 0.603 . . . . 0.0 112.355 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.09 154.8 36.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.405 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -71.5 -36.91 71.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.563 0.697 . . . . 0.0 109.53 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 p-90 -87.77 11.28 15.8 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.6 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 12.7 t -91.48 156.1 17.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.11 0.481 . . . . 0.0 112.145 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.28 -75.49 1.0 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.67 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.86 -20.84 30.64 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.702 2.268 . . . . 0.0 112.569 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.0 m -58.85 -43.87 90.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 110.757 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -68.45 -20.16 64.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.512 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 19.4 mtt -71.44 -23.71 61.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.398 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.3 mm -86.43 -24.17 6.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.725 0.298 . . . . 0.0 111.503 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -50.55 -52.9 51.44 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.004 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.54 -47.92 24.62 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.498 2.132 . . . . 0.0 113.107 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -80.34 -26.88 38.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.63 -45.49 82.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.047 0.451 . . . . 0.0 110.226 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.7 -41.47 83.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.988 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.1 t -59.82 -45.05 93.57 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.922 0.391 . . . . 0.0 111.065 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.78 -41.08 85.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.151 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 m -55.68 -26.31 44.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.285 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -87.44 -20.83 26.07 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.624 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -95.41 -19.48 19.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 0.0 110.077 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -99.28 92.15 5.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.705 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 t -88.58 49.06 1.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.877 0.37 . . . . 0.0 110.743 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -153.79 -41.17 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.454 HG13 ' CD1' ' A' ' 106' ' ' LEU . 10.9 m -93.24 154.88 3.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.831 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.484 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 5.3 tp -105.46 114.34 44.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.907 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 8.6 m-85 -96.43 115.76 27.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.377 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.436 ' CD2' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -128.77 167.2 17.64 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.343 178.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.423 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.0 tp10 -119.83 122.15 40.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -176.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.81 120.18 64.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.333 0.587 . . . . 0.0 111.133 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -100.23 119.34 38.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.77 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -60.95 -18.02 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.989 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -64.61 -39.37 93.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 109.681 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.59 -33.9 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.526 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.406 ' CB ' ' CG2' ' A' ' 65' ' ' VAL . . . -95.91 43.68 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.66 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -70.44 -9.58 56.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.658 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.98 -23.22 17.48 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.289 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.406 ' CG2' ' CB ' ' A' ' 62' ' ' ALA . 2.0 m -77.67 -47.6 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.546 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.497 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.2 -57.75 11.81 Favored Pre-proline 0 N--CA 1.462 0.137 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.497 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 76.9 Cg_exo -51.58 -28.62 29.46 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.5 2.133 . . . . 0.0 111.903 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -76.04 -20.04 58.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.761 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -111.57 -4.89 14.62 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.852 0.358 . . . . 0.0 111.852 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.0 35.87 91.24 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.556 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.402 ' CD1' HD12 ' A' ' 78' ' ' LEU . 91.5 mt -75.9 135.98 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 117.173 0.486 . . . . 0.0 110.655 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 -146.86 62.63 1.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.04 0.448 . . . . 0.0 111.286 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 176.71 160.88 24.58 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.588 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.3 pt -146.31 137.4 12.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 O-C-N 122.995 -0.121 . . . . 0.0 110.764 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -89.88 122.14 5.1 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 124.749 -0.938 . . . . 0.0 112.092 0.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -86.56 137.01 32.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.117 0.484 . . . . 0.0 112.189 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 tp -108.97 122.74 47.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.411 ' HB2' HG21 ' A' ' 25' ' ' VAL . 7.0 mt -115.01 136.48 53.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.236 0.541 . . . . 0.0 111.689 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.407 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.4 mm? -117.4 123.33 46.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.039 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.541 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 52.0 m-85 -115.27 147.53 40.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.143 0.497 . . . . 0.0 111.503 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -146.41 111.84 5.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.098 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 m120 60.59 46.53 9.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.392 . . . . 0.0 110.321 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.02 0.6 52.79 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.955 -0.641 . . . . 0.0 114.009 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -123.25 138.93 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.626 0.713 . . . . 0.0 111.592 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.435 ' CG2' ' CE2' ' A' ' 80' ' ' PHE . 39.9 t -67.62 117.98 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.451 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.18 8.8 21.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.407 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -172.26 141.82 1.29 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.673 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 t -137.68 127.94 26.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.157 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.04 137.97 50.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.09 146.27 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.577 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.89 165.24 30.99 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.27 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.27 171.78 5.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 111.521 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -162.14 -170.6 2.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.491 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.58 166.25 11.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.773 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -57.79 -32.81 67.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.958 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.43 -30.72 53.27 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.795 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 42.3 mt-30 -77.34 -31.15 54.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.729 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.73 -51.33 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -63.45 -44.38 94.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.195 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.1 pp20? -60.71 -42.29 96.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.948 0.404 . . . . 0.0 110.102 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -62.42 -40.6 97.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.387 0.613 . . . . 0.0 110.013 178.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.8 mt -64.13 -62.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.846 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.12 -32.01 6.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.27 -24.85 62.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.924 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -108.29 -28.96 9.13 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.802 0.334 . . . . 0.0 111.282 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.454 ' CD1' HG13 ' A' ' 52' ' ' VAL . 2.7 tt -70.26 112.32 6.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.788 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.0 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.213 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.961 0.41 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 3' ' ' LYS . 46.5 t -76.59 146.1 9.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.137 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.472 ' N ' HG12 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -143.51 119.9 10.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.325 -179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -73.48 129.57 38.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.1 mp -101.81 108.33 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.279 0.561 . . . . 0.0 111.106 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -98.86 19.81 14.28 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.861 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -154.44 158.84 40.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.97 0.414 . . . . 0.0 111.308 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -71.45 -29.47 64.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -31.03 38.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.78 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.46 81.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.623 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -59.25 -43.89 92.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.166 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.17 -39.89 94.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.552 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -58.99 -48.88 79.97 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.28 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.35 -33.98 76.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 111.015 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.419 HD22 ' CG ' ' A' ' 80' ' ' PHE . 15.1 mt -66.95 -40.68 87.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.435 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.59 -28.68 67.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.489 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.62 77.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.08 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.02 -64.83 0.78 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.544 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.88 -82.47 1.52 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.322 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -95.49 -18.63 20.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.661 0.267 . . . . 0.0 111.556 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -75.11 154.8 37.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 106' ' ' LEU . 4.1 tp -78.77 136.11 37.29 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.485 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 6.0 t -116.58 106.59 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.034 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.453 HG13 ' CE1' ' A' ' 54' ' ' PHE . 10.4 p -102.54 119.12 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.411 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 4.9 m -127.15 167.55 21.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.856 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -133.42 136.0 44.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.772 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -100.89 111.12 23.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 p -121.39 -167.91 1.59 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.439 0.638 . . . . 0.0 112.366 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.54 154.07 34.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.169 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -33.96 68.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.523 0.678 . . . . 0.0 109.826 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.6 p-90 -86.9 10.52 15.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.912 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 12.2 t -95.15 158.05 15.63 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.142 -0.349 . . . . 0.0 111.529 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.1 -65.64 0.59 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.256 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.34 -22.79 66.02 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.406 2.071 . . . . 0.0 112.404 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.7 m -61.8 -44.36 97.02 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.015 0.436 . . . . 0.0 110.595 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -64.51 -28.11 69.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.198 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.4 mtt -67.15 -16.0 64.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.0 mm -86.89 -22.38 7.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.656 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.424 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 33.1 mtpt -50.97 -60.41 5.63 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.424 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 1.3 Cg_endo -47.06 -46.54 18.79 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.634 2.222 . . . . 0.0 113.059 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -80.41 -32.35 37.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -67.2 -44.83 78.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.941 0.4 . . . . 0.0 110.177 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -38.18 84.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.593 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.7 t -60.67 -43.32 97.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.927 0.394 . . . . 0.0 110.496 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.2 mt -59.48 -40.06 85.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.332 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.409 ' OG ' ' CD2' ' A' ' 54' ' ' PHE . 1.2 m -54.07 -27.4 32.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.24 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -88.12 -21.75 24.49 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.646 0.26 . . . . 0.0 111.4 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -94.16 -21.63 18.96 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.0 m-85 -96.43 97.29 9.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.95 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -96.1 43.98 1.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.736 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -156.26 11.37 0.27 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.403 HG22 ' CE1' ' A' ' 54' ' ' PHE . 19.2 m -144.3 157.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 120.423 0.154 . . . . 0.0 111.142 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.1 tp -106.34 115.25 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.237 0.541 . . . . 0.0 110.618 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.453 ' CE1' HG13 ' A' ' 24' ' ' VAL . 6.5 m-85 -97.78 115.91 28.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.858 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 56' ' ' GLU . 0.1 OUTLIER -127.65 168.01 15.63 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.63 178.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.413 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -119.59 121.48 39.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.92 119.11 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.276 0.56 . . . . 0.0 111.396 178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -98.99 120.74 39.93 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.33 -19.42 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.14 -40.2 96.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.263 0.554 . . . . 0.0 110.004 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -98.78 -35.71 10.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.196 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.407 ' CB ' ' CG2' ' A' ' 65' ' ' VAL . . . -95.17 45.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.669 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -71.95 -11.18 60.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.547 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.7 -21.26 19.46 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.419 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.407 ' CG2' ' CB ' ' A' ' 62' ' ' ALA . 2.5 m -80.04 -46.51 22.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.696 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.66 -57.96 11.62 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 53.3 Cg_exo -52.72 -28.64 38.66 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.619 2.213 . . . . 0.0 111.956 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -76.39 -25.59 54.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.126 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -105.94 -2.38 22.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.02 36.11 91.55 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.172 -0.537 . . . . 0.0 114.051 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 79.3 mt -77.55 133.95 29.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.458 0.629 . . . . 0.0 110.443 179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -150.72 54.43 0.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.944 0.402 . . . . 0.0 111.383 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 170.09 105.42 0.18 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.922 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 pt -103.04 153.86 38.0 Favored Pre-proline 0 N--CA 1.463 0.198 0 C-N-CA 122.167 0.187 . . . . 0.0 110.829 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.38 114.78 3.47 Favored 'Cis proline' 0 C--N 1.353 0.767 0 C-N-CA 124.198 -1.167 . . . . 0.0 112.757 -0.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.33 136.75 32.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.957 0.408 . . . . 0.0 111.359 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.98 121.02 43.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 10.1 mt -112.37 135.51 52.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.513 0.673 . . . . 0.0 111.874 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -117.37 126.18 52.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.845 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.485 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.9 m-85 -117.14 147.12 42.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.196 0.522 . . . . 0.0 111.267 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 tttm -148.26 115.31 6.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.99 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 m120 57.79 44.62 19.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 110.209 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.02 5.68 62.39 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.911 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -126.06 142.6 51.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.379 0.589 . . . . 0.0 111.483 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.426 HG23 ' CE2' ' A' ' 80' ' ' PHE . 21.8 t -70.05 119.19 15.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.655 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -115.08 12.34 16.62 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.37 138.91 0.43 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.17 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -134.59 133.23 39.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.693 0.282 . . . . 0.0 110.805 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.66 139.55 45.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.82 146.3 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.13 162.43 28.58 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.216 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.58 133.62 47.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.193 0.521 . . . . 0.0 111.548 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.08 -175.46 2.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.431 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.82 162.66 14.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.53 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -52.4 -37.76 57.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.509 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.58 -29.3 55.71 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.437 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -77.2 -33.23 56.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.586 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -50.88 32.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -42.24 90.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.389 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -62.58 -38.17 89.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.772 0.32 . . . . 0.0 110.483 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.414 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 9.7 t80 -63.77 -42.86 97.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.406 0.622 . . . . 0.0 110.103 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.8 -62.48 1.54 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.953 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.86 -34.31 12.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.098 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.19 -20.33 60.91 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -108.99 -38.1 5.66 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 111.598 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.401 ' HA ' ' CD2' ' A' ' 22' ' ' LEU . 3.9 tt -60.81 107.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.094 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 16.3 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.339 179.927 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.24 0 CA-C-O 120.835 0.35 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.457 HG11 ' N ' ' A' ' 3' ' ' LYS . 47.4 t 63.75 144.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.846 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.457 ' N ' HG11 ' A' ' 2' ' ' VAL . 6.2 ptpp? -145.02 121.95 11.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.202 0.525 . . . . 0.0 110.162 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -74.4 128.93 36.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.224 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -99.79 108.74 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 0.0 110.39 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -100.34 19.52 16.48 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.96 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.31 160.48 38.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.958 0.409 . . . . 0.0 111.165 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.67 -26.33 60.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -79.63 -31.56 41.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.229 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.56 -38.69 90.31 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -56.99 -41.48 78.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.068 0.461 . . . . 0.0 110.051 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -66.37 -45.0 81.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.933 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -58.86 -49.03 79.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.63 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.65 -32.46 73.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.933 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 mt -67.71 -36.87 81.4 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.247 0.546 . . . . 0.0 110.274 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.23 -33.53 73.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.17 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.68 -23.1 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.154 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.95 84.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.073 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.63 -121.13 25.62 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.369 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -94.84 2.63 55.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -78.07 147.14 34.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.0 tp -74.27 132.23 41.91 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.487 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 5.3 t -110.48 108.87 26.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.547 0.689 . . . . 0.0 112.13 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.432 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.1 p -102.92 114.39 42.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.481 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 3.4 m -121.11 162.16 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.658 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -126.24 131.08 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.24 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -97.29 107.49 20.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.326 178.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.5 m -132.45 146.93 52.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.034 0.445 . . . . 0.0 111.813 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.29 159.03 15.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.611 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -70.56 -37.55 74.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.634 0.73 . . . . 0.0 109.143 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -86.08 14.66 5.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.937 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.6 t -91.56 157.09 17.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.887 0.375 . . . . 0.0 111.393 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.7 -73.33 0.91 Allowed Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.386 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.45 -24.91 45.98 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.325 2.017 . . . . 0.0 112.491 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.8 m -58.14 -40.85 82.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.9 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -66.75 -22.84 66.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.541 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 40.1 mtt -68.92 -19.97 64.21 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.2 mm -89.0 -25.24 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.75 0.309 . . . . 0.0 111.628 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.39 -53.18 47.79 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.2 -49.93 14.91 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.619 2.213 . . . . 0.0 113.309 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -80.26 -27.33 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -64.85 -44.5 89.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.034 0.445 . . . . 0.0 110.314 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.64 -41.23 79.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.947 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -58.46 -44.44 89.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 110.596 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mt -59.82 -39.5 85.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.471 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.7 p -56.96 -27.35 61.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -87.78 -19.48 27.46 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.683 0.277 . . . . 0.0 111.66 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -95.53 -22.93 17.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.114 0.483 . . . . 0.0 110.012 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -96.34 97.41 9.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.619 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.2 t -93.66 47.26 1.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.285 0.564 . . . . 0.0 109.813 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -150.15 -42.83 0.13 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.934 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.44 HG22 ' CE1' ' A' ' 54' ' ' PHE . 10.3 m -94.83 155.87 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.828 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.418 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 5.9 tp -106.88 112.72 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.24 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.44 ' CE1' HG22 ' A' ' 52' ' ' VAL . 8.7 m-85 -94.4 115.33 27.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.729 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.481 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -128.45 167.57 16.86 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.643 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.426 ' N ' HD11 ' A' ' 55' ' ' LEU . 6.1 tt0 -118.82 119.52 34.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.228 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -116.68 119.27 61.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -99.6 119.38 37.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.737 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 p -59.86 -18.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -64.89 -38.33 90.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.128 0.489 . . . . 0.0 109.87 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -100.15 -35.53 9.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.381 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.402 ' CB ' HG22 ' A' ' 65' ' ' VAL . . . -94.59 44.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.953 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.91 -11.02 60.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.924 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.4 -21.68 18.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.339 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.402 HG22 ' CB ' ' A' ' 62' ' ' ALA . 2.8 m -79.77 -47.53 21.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.101 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.438 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . -50.97 -60.45 5.56 Favored Pre-proline 0 N--CA 1.466 0.336 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 66' ' ' ALA . 6.8 Cg_endo -48.38 -27.95 10.81 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.732 2.288 . . . . 0.0 112.153 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.3 -25.24 57.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.628 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -106.49 -4.21 20.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.806 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.78 36.88 87.99 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.232 -0.508 . . . . 0.0 113.865 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 84.3 mt -76.37 133.92 30.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 117.18 0.49 . . . . 0.0 110.523 179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -141.87 69.85 1.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.01 0.433 . . . . 0.0 111.887 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.03 166.68 15.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.57 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.431 HG22 HD12 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -150.92 149.45 25.28 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -85.69 121.2 6.36 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 124.311 -1.12 . . . . 0.0 112.507 -0.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 136.54 32.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.885 0.374 . . . . 0.0 111.669 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.99 122.43 46.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.7 mt -114.5 135.54 54.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.335 0.588 . . . . 0.0 111.298 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.61 122.48 44.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.404 179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.487 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 51.6 m-85 -115.3 147.67 40.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.134 0.492 . . . . 0.0 111.781 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -146.55 113.42 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.378 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 m120 60.24 45.16 11.78 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.86 0.362 . . . . 0.0 110.283 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.5 2.84 56.52 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.708 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -124.34 139.16 54.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.253 0.526 . . . . 0.0 111.591 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 p -69.14 120.59 16.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.88 179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.22 10.93 17.35 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.07 137.24 0.4 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.779 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 48.2 m -139.3 122.08 16.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.828 0.347 . . . . 0.0 111.088 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -120.77 145.21 47.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.38 146.82 25.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.465 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.17 162.3 23.19 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.064 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.31 158.21 33.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.501 . . . . 0.0 111.662 -178.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.97 151.43 28.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.399 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 m -68.77 -178.17 1.13 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.989 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -72.69 -29.93 63.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.77 -33.6 41.61 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.269 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.88 -31.84 61.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.065 0.459 . . . . 0.0 110.381 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.38 -50.18 34.72 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -61.41 -41.25 96.84 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.013 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.4 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.1 OUTLIER -60.67 -37.91 83.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.948 0.404 . . . . 0.0 110.066 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 87' ' ' ALA . 6.8 t80 -63.18 -42.56 99.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.429 0.633 . . . . 0.0 110.323 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.428 HD13 ' CZ ' ' A' ' 54' ' ' PHE . 6.3 mt -65.87 -58.31 5.89 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.231 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.52 -36.21 22.6 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.933 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.56 -20.96 61.23 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -108.34 -32.28 7.51 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.899 0.381 . . . . 0.0 111.459 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -74.69 98.23 3.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.19 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.665 -179.372 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.731 0.301 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.501 HG13 ' N ' ' A' ' 3' ' ' LYS . 40.3 t -65.91 144.81 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.091 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.501 ' N ' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -144.0 121.29 11.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.266 0.555 . . . . 0.0 110.332 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -74.8 127.98 34.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.04 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -100.66 106.93 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.067 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -95.87 16.81 16.65 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.108 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 p -155.4 161.95 40.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.776 0.322 . . . . 0.0 111.394 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.85 -24.54 60.9 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.714 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.54 -32.32 42.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.509 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.81 90.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.81 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -57.27 -42.6 81.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.872 0.368 . . . . 0.0 110.019 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.43 ' HA ' ' NE2' ' A' ' 12' ' ' GLN . 11.2 mm100 -68.39 -45.21 73.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.807 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -57.55 -45.56 84.97 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.048 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -32.1 73.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.667 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.11 -38.43 78.91 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.64 -34.32 74.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.055 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.47 -22.66 54.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.042 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.4 -34.6 77.59 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.188 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.89 -123.13 32.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.27 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -93.41 5.24 52.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.591 0.234 . . . . 0.0 111.327 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -79.33 150.42 31.46 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.8 tp -77.05 131.85 38.62 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.5 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 4.2 t -112.12 108.62 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.566 0.698 . . . . 0.0 111.479 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.462 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -103.26 115.56 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.438 HG13 ' CD2' ' A' ' 55' ' ' LEU . 5.0 m -124.65 167.42 18.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.763 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -136.05 136.86 40.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.966 -179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.407 ' CE2' HD13 ' A' ' 71' ' ' ILE . 9.7 m-85 -99.46 113.59 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.274 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.6 m -122.82 -166.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.287 0.565 . . . . 0.0 112.199 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.0 154.05 35.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.184 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -72.23 -35.17 68.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.38 0.61 . . . . 0.0 109.716 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.6 p-90 -87.14 10.76 15.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.33 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 25.0 t -96.51 156.83 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 0.0 111.591 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.59 -71.05 0.76 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.286 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.72 -26.52 47.4 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.481 2.121 . . . . 0.0 112.231 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.3 m -58.94 -44.6 91.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.344 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.77 -24.22 66.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.431 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.5 mmt -67.97 -18.62 64.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.1 mm -87.27 -24.59 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.703 0.287 . . . . 0.0 111.115 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -52.91 -53.66 52.51 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.56 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.45 -50.01 13.21 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.703 2.269 . . . . 0.0 113.164 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -80.07 -27.55 39.32 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -66.02 -45.42 81.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.107 0.479 . . . . 0.0 110.239 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -42.3 84.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.786 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.14 -43.76 95.48 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.898 0.38 . . . . 0.0 110.744 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.1 mt -60.09 -39.76 87.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.412 ' HB2' ' CB ' ' A' ' 54' ' ' PHE . 37.8 t -56.45 -27.7 57.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.245 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -87.89 -18.08 30.0 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.717 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.78 -20.58 18.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.966 0.413 . . . . 0.0 110.09 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -99.27 92.83 5.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.476 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.2 p -88.85 50.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.052 0.453 . . . . 0.0 110.489 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -153.3 -41.21 0.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.985 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.409 HG22 ' CE1' ' A' ' 54' ' ' PHE . 10.8 m -94.38 154.92 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.847 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.44 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 3.4 tp -105.44 113.32 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.361 0.601 . . . . 0.0 111.215 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.487 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 7.4 m-85 -95.3 115.99 28.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.502 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.438 ' CD2' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -127.38 165.23 20.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.603 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.41 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.3 tp10 -116.39 119.01 34.31 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.1 117.34 55.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.186 0.517 . . . . 0.0 110.82 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -98.81 120.68 39.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.08 -18.02 15.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.127 -178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -67.18 -37.69 84.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -99.88 -35.31 9.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.498 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.41 ' CB ' HG22 ' A' ' 65' ' ' VAL . . . -96.67 43.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.547 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -68.79 -10.35 56.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.718 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.76 -22.92 17.77 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.424 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.41 HG22 ' CB ' ' A' ' 62' ' ' ALA . 2.4 m -78.83 -47.35 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.31 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.496 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.6 -56.41 16.9 Favored Pre-proline 0 N--CA 1.462 0.145 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.496 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 72.1 Cg_exo -51.77 -28.19 29.53 Favored 'Trans proline' 0 N--CA 1.466 -0.122 0 C-N-CA 122.557 2.172 . . . . 0.0 112.102 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -76.98 -15.47 59.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.997 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -118.5 -7.71 10.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.653 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.32 39.49 95.96 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.304 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.407 HD13 ' CE2' ' A' ' 27' ' ' PHE . 56.4 mt -78.21 79.36 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 117.133 0.467 . . . . 0.0 110.892 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 ttt85 -86.31 78.04 9.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.048 0.452 . . . . 0.0 111.62 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.99 166.05 10.73 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.542 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 pt -148.55 154.32 41.07 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 122.309 0.243 . . . . 0.0 110.704 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -87.14 115.78 3.32 Favored 'Cis proline' 0 C--N 1.352 0.756 0 C-N-CA 124.211 -1.162 . . . . 0.0 112.597 0.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.24 137.18 32.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.909 0.385 . . . . 0.0 111.727 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.45 125.02 51.3 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.4 mt -113.93 134.61 54.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.376 0.607 . . . . 0.0 111.808 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.423 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 2.8 mm? -115.15 119.83 37.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.791 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.5 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 52.3 m-85 -112.98 147.88 36.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.179 0.514 . . . . 0.0 111.827 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -147.37 113.18 5.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.309 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 m120 60.6 45.94 9.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.037 0.446 . . . . 0.0 110.194 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.29 2.46 48.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.669 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -124.61 138.59 54.3 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.257 0.528 . . . . 0.0 111.813 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.9 t -67.16 116.84 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.647 179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -113.07 11.47 18.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.97 0.414 . . . . 0.0 111.907 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . . . -173.17 138.16 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.101 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -136.46 125.51 24.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 111.102 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.98 139.32 53.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.281 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.07 146.07 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.628 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.1 164.1 33.54 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.121 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.69 165.62 12.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.053 0.454 . . . . 0.0 111.744 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -163.02 144.74 10.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.632 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.7 m -64.41 -177.92 0.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -73.18 -30.96 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.429 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.54 -30.08 54.1 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.79 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 34.3 mt-30 -76.45 -33.08 58.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.97 0.414 . . . . 0.0 110.681 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.61 -51.15 30.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.803 179.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -60.88 -40.75 94.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.214 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -60.98 -39.19 88.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.786 0.327 . . . . 0.0 110.128 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.452 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 6.8 t80 -60.94 -39.85 91.03 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.333 0.587 . . . . 0.0 109.98 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 7.2 mt -66.92 -58.46 4.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.344 179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.01 -36.39 28.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.827 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.08 -23.81 63.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.032 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -105.89 -53.1 2.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.754 0.312 . . . . 0.0 111.372 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.407 ' CD1' HG11 ' A' ' 52' ' ' VAL . 1.5 tt -47.51 -42.29 22.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.023 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 26.2 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.249 -0.882 . . . . 0.0 112.083 179.527 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtt . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.934 0.397 . . . . 4.3600000000000003 111.534 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.697 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 52.8 t -108.17 150.93 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.709 -0.678 . . . . 1.1399999999999999 109.573 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.571 ' N ' HG11 ' A' ' 2' ' ' VAL . 0.3 OUTLIER -143.42 124.52 14.47 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 118.764 -1.174 . . . . 1.96 111.975 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -76.5 120.21 21.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.953 -1.476 . . . . 2.5 110.427 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.559 HG21 ' N ' ' A' ' 11' ' ' PHE . 3.1 mp -101.55 113.56 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.797 -0.361 . . . . 1.1699999999999999 111.163 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.455 ' HG2' ' OD2' ' A' ' 61' ' ' ASP . 8.4 mt-10 -100.94 15.97 26.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.104 -0.498 . . . . 1.3799999999999999 112.276 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.452 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.4 m -153.5 160.27 42.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.908 0.385 . . . . 1.3700000000000001 111.246 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.517 ' HA ' HG12 ' A' ' 65' ' ' VAL . 3.1 ttpt -75.55 -23.32 56.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.238 -0.437 . . . . 2.29 111.092 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 m -79.42 -29.98 42.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.698 -0.482 . . . . 1.4299999999999999 109.698 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.52 -41.77 79.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.68 -0.691 . . . . 1.04 110.453 179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.559 ' N ' HG21 ' A' ' 5' ' ' ILE . 12.8 t80 -56.51 -49.41 74.79 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.031 -0.531 . . . . 1.5700000000000001 110.501 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -61.45 -37.17 82.61 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.691 -0.855 . . . . 1.22 108.691 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -62.18 -44.37 96.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.937 -1.029 . . . . 1.3999999999999999 111.893 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.04 -33.22 67.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.904 0.383 . . . . 1.04 111.367 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 mt -64.57 -40.64 95.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.319 0.581 . . . . 1.1899999999999999 110.587 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.95 -29.53 69.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 1.8400000000000001 110.525 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.17 -23.86 51.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.129 -0.487 . . . . 1.1299999999999999 111.67 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HB1' HG22 ' A' ' 23' ' ' VAL . . . -72.35 -26.72 62.02 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.595 -0.275 . . . . 1.22 111.288 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.96 -117.65 6.32 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 119.63 -1.271 . . . . 1.04 113.277 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.59 10.34 37.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.54 0.209 . . . . 2.3599999999999999 111.207 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -82.53 151.11 26.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.88 -0.415 . . . . 2.3700000000000001 109.88 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.579 HD11 HD12 ' A' ' 79' ' ' LEU . 0.6 OUTLIER -76.21 121.28 22.67 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.612 -0.514 . . . . 1.0700000000000001 109.612 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.564 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 2.6 t -101.63 111.9 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.725 0.774 . . . . 1.05 112.065 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.541 HG13 ' CE1' ' A' ' 54' ' ' PHE . 9.1 p -108.27 122.19 62.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.663 -1.236 . . . . 1.0900000000000001 107.663 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.723 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 11.4 m -133.13 141.97 43.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.523 0.678 . . . . 1.1299999999999999 112.051 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -107.74 131.04 54.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.374 -0.83 . . . . 1.1299999999999999 112.403 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.461 ' HE1' HD13 ' A' ' 78' ' ' LEU . 2.7 m-85 -96.24 110.28 22.61 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.663 -0.866 . . . . 0.34000000000000002 108.663 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.473 ' O ' HG12 ' A' ' 59' ' ' VAL . 3.3 p -121.14 -168.76 1.72 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.706 0.632 . . . . 1.3400000000000001 112.706 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.06 156.1 39.25 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.133 -0.94 . . . . 1.1100000000000001 110.693 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -37.84 74.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.309 0.576 . . . . 1.6299999999999999 110.184 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 28.4 p-90 -86.61 10.77 14.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.99 -1.004 . . . . 1.24 111.499 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.433 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 37.3 t -100.24 140.47 34.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.786 0.327 . . . . 0.98999999999999999 110.244 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.48 -65.65 0.9 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.614 -0.803 . . . . 0.35999999999999999 112.481 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.98 -30.98 25.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.554 2.169 . . . . 0.93999999999999995 111.769 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 79.4 m -58.51 -40.21 82.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.735 -0.666 . . . . 0.65000000000000002 110.621 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -70.68 -26.4 63.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.941 -0.572 . . . . 2.73 111.234 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.5 mmt -69.02 -20.64 64.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.479 . . . . 2.0800000000000001 111.292 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.402 HG21 ' O ' ' A' ' 38' ' ' ILE . 2.9 mm -87.8 -18.21 8.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.793 0.33 . . . . 1.21 110.616 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.81 -54.73 40.31 Favored Pre-proline 0 CA--C 1.528 0.132 0 CA-C-N 116.495 -0.32 . . . . 2.7599999999999998 110.726 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.68 -51.62 10.04 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.657 2.238 . . . . 0.84999999999999998 112.766 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -75.21 -36.18 61.4 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.488 -0.323 . . . . 0.71999999999999997 111.466 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.543 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 7.0 t80 -64.81 -46.36 82.33 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.54 -0.464 . . . . 0.44 109.999 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.431 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -67.28 -42.11 84.37 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.542 0.201 . . . . 1.3899999999999999 111.542 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -60.32 -46.87 88.37 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.918 -0.313 . . . . 1.54 110.742 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.7 mt -54.13 -36.44 63.28 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.35 -0.611 . . . . 1.0700000000000001 109.35 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 43' ' ' HIS . 22.7 t -57.87 -26.33 61.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.294 -0.866 . . . . 1.7 111.117 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.3 -17.64 28.54 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.712 0.291 . . . . 2.2999999999999998 111.035 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.431 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 1.6 ttpp -97.05 -15.15 21.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.091 0.472 . . . . 2.0699999999999998 110.48 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.477 ' HB3' HG23 ' A' ' 52' ' ' VAL . 24.1 m-85 -105.8 84.48 2.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.792 -0.64 . . . . 0.97999999999999998 111.334 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -78.62 43.16 0.47 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.542 -0.754 . . . . 1.5900000000000001 111.542 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -154.6 -29.17 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.672 -0.24 . . . . 1.1799999999999999 111.34 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.477 HG23 ' HB3' ' A' ' 49' ' ' TYR . 5.3 m -99.35 155.85 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.352 0.596 . . . . 1.05 111.692 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.513 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 1.1 tp -104.38 113.33 41.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.13 -0.941 . . . . 1.1399999999999999 110.963 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.697 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.1 m-85 -99.55 116.43 31.66 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 116.042 -0.527 . . . . 0.40000000000000002 110.876 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.723 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.8 OUTLIER -130.95 167.94 18.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 116.064 -0.516 . . . . 1.0900000000000001 110.296 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.437 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 5.7 tt0 -121.55 125.08 45.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.023 0.379 . . . . 2.1600000000000001 112.023 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 6.7 t -112.12 116.17 51.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.557 0.694 . . . . 1.04 110.951 179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -93.79 115.29 27.69 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.236 -0.893 . . . . 2.1200000000000001 110.379 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 28' ' ' SER . 11.2 p -61.2 -22.28 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.175 -0.466 . . . . 1.04 112.083 -178.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -62.32 -37.95 87.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.091 -0.707 . . . . 1.3 109.091 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.455 ' OD2' ' HG2' ' A' ' 6' ' ' GLU . 1.3 m-20 -101.12 -42.43 6.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.128 -0.942 . . . . 1.3100000000000001 112.314 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -87.78 53.63 2.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.13 0.49 . . . . 1.0800000000000001 110.406 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.501 ' O ' ' CD ' ' A' ' 67' ' ' PRO . 5.4 mt-30 -74.9 -11.53 60.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.667 -0.697 . . . . 3.21 111.324 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.05 -31.12 20.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 1.3700000000000001 110.68 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 8' ' ' LYS . 18.2 m -76.77 -46.97 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.913 -0.585 . . . . 1.0700000000000001 111.14 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.511 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.67 -55.31 23.79 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 113.178 0.807 . . . . 1.1599999999999999 113.178 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.511 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 51.0 Cg_exo -55.68 -28.29 65.29 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.161 2.574 . . . . 0.91000000000000003 114.073 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -75.62 -26.47 57.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.869 0.322 . . . . 2.0 111.869 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -99.91 -9.43 22.82 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.23 0.538 . . . . 0.70999999999999996 110.663 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.61 39.44 78.33 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.521 -0.763 . . . . 0.58999999999999997 112.785 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.9 mt -76.46 129.02 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.0 -0.741 . . . . 1.3500000000000001 109.0 178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.49 64.68 1.33 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.571 -0.452 . . . . 3.9900000000000002 111.76 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.08 120.74 0.78 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.717 -0.754 . . . . 1.1499999999999999 112.455 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.5 pt -109.14 153.39 42.62 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.626 -0.139 . . . . 1.3300000000000001 110.626 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.9 129.94 17.16 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 124.347 -1.105 . . . . 0.76000000000000001 113.718 0.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.94 138.54 38.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 1.0800000000000001 111.45 178.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.422 HD21 HD13 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -110.16 113.82 26.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.319 -0.993 . . . . 2.4100000000000001 108.319 177.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.461 HD13 ' HE1' ' A' ' 27' ' ' PHE . 3.5 mt -104.92 131.65 52.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.379 0.609 . . . . 1.0800000000000001 111.454 -177.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.658 ' O ' ' N ' ' A' ' 86' ' ' ALA . 2.1 mm? -113.06 117.34 31.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.177 -0.919 . . . . 1.0600000000000001 111.05 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.564 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 60.0 m-85 -111.93 140.9 46.2 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.507 -0.553 . . . . 0.28999999999999998 109.507 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.664 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 1.8 tttm -141.32 105.82 4.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.48 -0.933 . . . . 1.1000000000000001 108.48 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.8 m120 67.04 47.11 1.43 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.373 -0.603 . . . . 1.1299999999999999 109.373 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.34 4.87 18.96 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.371 -0.831 . . . . 0.27000000000000002 113.718 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -118.51 130.23 55.81 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.39 -0.596 . . . . 1.5600000000000001 109.39 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.1 p -55.18 117.41 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.68 -0.859 . . . . 1.8600000000000001 108.68 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.664 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . . . -96.97 -7.24 33.6 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 113.051 0.76 . . . . 0.91000000000000003 113.051 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 79' ' ' LEU . . . -177.05 148.94 0.66 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.098 -0.501 . . . . 1.0600000000000001 112.055 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.2 t -126.87 148.61 49.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.852 -0.613 . . . . 2.1899999999999999 109.801 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -149.79 132.07 15.52 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.224 -0.658 . . . . 1.98 109.224 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.04 146.78 19.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.432 -0.349 . . . . 1.1000000000000001 111.399 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.45 161.57 27.6 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.939 -0.648 . . . . 0.26000000000000001 113.113 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.19 169.05 14.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.812 0.339 . . . . 1.1100000000000001 111.361 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.404 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -157.85 176.69 12.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 1.47 111.333 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -91.27 175.54 6.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.622 -0.717 . . . . 1.21 110.174 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -70.73 -30.84 67.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.621 -0.263 . . . . 1.76 111.365 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.03 -31.92 51.18 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.227 -0.987 . . . . 0.23000000000000001 113.122 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.582 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 35.8 mt-30 -75.12 -30.6 60.88 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.915 0.388 . . . . 1.5 110.949 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.422 HD13 HD21 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -73.03 -51.19 19.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.193 0.521 . . . . 1.1499999999999999 109.823 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.431 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 17.2 ttpt -60.16 -45.18 93.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.442 -0.799 . . . . 2.1600000000000001 110.529 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.582 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -59.83 -39.03 83.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 1.8100000000000001 110.154 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -62.45 -41.83 99.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.651 -0.704 . . . . 0.34999999999999998 111.311 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.0 mt -68.17 -55.95 10.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.76 -0.654 . . . . 1.1699999999999999 110.451 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 107' ' ' VAL . 1.4 t70 -46.45 -33.38 3.92 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.67 -0.493 . . . . 1.1899999999999999 109.67 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.04 -23.95 59.47 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.403 -0.817 . . . . 1.03 113.192 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.429 ' O ' ' CE ' ' A' ' 81' ' ' LYS . 1.7 t30 -108.87 -28.65 9.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.009 0.433 . . . . 0.58999999999999997 111.659 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.511 ' CD2' ' O ' ' A' ' 106' ' ' LEU . 9.3 tt -64.61 0.52 1.07 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.628 0.771 . . . . 2.0699999999999998 112.312 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 103' ' ' ASP . 11.6 m . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.426 -0.797 . . . . 2.6899999999999999 112.699 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mtt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.992 0.425 . . . . 4.5300000000000002 111.425 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.751 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 88.5 t -70.59 147.56 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.865 -0.607 . . . . 1.24 110.714 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 2.2 ptpt -141.68 126.2 17.8 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 121.8 0.81 . . . . 2.2000000000000002 111.255 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.62 122.03 25.42 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.404 -1.271 . . . . 2.0499999999999998 110.578 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.623 HD12 ' CD1' ' A' ' 55' ' ' LEU . 3.2 mp -104.43 111.59 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.842 0.353 . . . . 1.0700000000000001 111.35 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -99.77 19.46 15.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.11 -0.495 . . . . 1.6299999999999999 112.058 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -154.8 160.2 41.11 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.999 -0.28 . . . . 1.1899999999999999 110.714 -179.509 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.451 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 7.1 ttpt -77.57 -21.58 52.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.058 0.456 . . . . 1.97 110.707 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -79.41 -31.91 42.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.635 -0.505 . . . . 1.4199999999999999 109.635 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.24 -38.79 82.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.375 -0.83 . . . . 0.97999999999999998 111.019 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.554 ' N ' HG23 ' A' ' 5' ' ' ILE . 13.2 t80 -58.15 -47.99 81.65 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.165 -0.471 . . . . 1.7 110.403 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.02 -37.37 87.18 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.653 -0.499 . . . . 1.47 109.653 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -60.8 -46.97 88.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.703 -0.68 . . . . 1.53 111.846 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.46 76.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 1.0600000000000001 110.65 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.0 mt -65.2 -42.33 93.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.998 -0.546 . . . . 1.21 110.89 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.21 -30.32 71.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.042 0.449 . . . . 1.72 110.074 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.98 -22.34 53.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.638 -0.71 . . . . 1.26 110.77 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.68 -34.01 73.36 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 116.118 -0.492 . . . . 1.49 110.975 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.33 -125.09 36.69 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.083 -1.056 . . . . 1.05 113.155 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -91.21 7.35 41.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 2.3999999999999999 111.585 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 58.2 mttt -82.49 151.88 26.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.53 -0.304 . . . . 2.1400000000000001 110.383 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 106' ' ' LEU . 1.3 tp -77.09 127.36 32.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 1.1000000000000001 109.858 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.598 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 3.3 t -107.62 115.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.353 0.597 . . . . 1.1000000000000001 111.425 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.525 HG12 ' CE1' ' A' ' 54' ' ' PHE . 7.9 p -110.47 116.09 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.066 -1.087 . . . . 1.28 108.066 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.635 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 16.6 m -124.99 142.98 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-O 121.74 0.781 . . . . 1.4299999999999999 111.793 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -108.19 128.01 54.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.328 -1.306 . . . . 1.1899999999999999 111.211 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -95.42 108.22 20.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.147 -0.686 . . . . 0.40999999999999998 109.147 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.1 p -119.06 -170.93 2.01 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.782 0.66 . . . . 1.47 112.782 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB3' ' CD1' ' A' ' 31' ' ' TRP . . . -152.11 156.83 40.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.845 -1.07 . . . . 1.21 110.137 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.2 -35.51 73.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.556 0.693 . . . . 1.45 110.259 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.479 ' CD1' ' HB3' ' A' ' 29' ' ' ALA . 27.8 p-90 -87.42 12.21 12.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.041 -0.981 . . . . 1.4399999999999999 111.213 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 35.5 t -102.38 131.67 48.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.742 0.306 . . . . 0.93999999999999995 110.9 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.71 -63.18 1.35 Allowed Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.616 -0.802 . . . . 0.37 112.616 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.77 -32.2 45.0 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.564 2.176 . . . . 0.71999999999999997 112.164 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -58.47 -41.36 85.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.886 -0.597 . . . . 0.70999999999999996 110.363 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -71.18 -19.88 62.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.839 -0.619 . . . . 2.7200000000000002 111.098 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.2 mtt -75.04 -24.86 58.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.016 -0.538 . . . . 1.99 111.434 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mm -85.96 -19.06 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.454 -0.339 . . . . 1.1499999999999999 111.36 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 25.6 mtpt -52.58 -54.24 44.93 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.823 0.344 . . . . 3.0499999999999998 111.054 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 63.8 Cg_exo -48.77 -50.02 13.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.715 2.277 . . . . 0.78000000000000003 112.625 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -77.26 -31.37 54.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.532 0.206 . . . . 0.68999999999999995 111.419 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.457 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 5.4 t80 -65.42 -47.21 77.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.664 -0.414 . . . . 0.35999999999999999 110.176 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -41.0 89.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.294 -0.412 . . . . 1.28 111.846 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -60.1 -45.12 94.03 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.933 -0.307 . . . . 1.8600000000000001 110.856 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.8 mt -57.95 -37.14 73.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.154 0.502 . . . . 1.1499999999999999 109.894 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.2 t -55.55 -31.94 62.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.58 -0.736 . . . . 1.78 111.103 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.02 -20.7 30.08 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.746 0.308 . . . . 2.1800000000000002 110.399 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 2.8 ttpp -92.89 -7.76 45.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.192 -0.458 . . . . 2.4900000000000002 110.514 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.437 ' HB3' HG23 ' A' ' 52' ' ' VAL . 17.9 m-85 -116.2 92.5 3.91 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.154 -0.475 . . . . 1.4299999999999999 111.413 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.5 p -86.55 46.64 1.38 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.435 -0.348 . . . . 2.0499999999999998 110.479 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 21.5 t30 -154.93 -29.96 0.11 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.793 0.294 . . . . 1.5900000000000001 111.793 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.469 HG22 ' CD1' ' A' ' 54' ' ' PHE . 10.9 m -101.53 159.98 3.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.226 -0.443 . . . . 1.0900000000000001 111.384 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 1.5 tp -109.91 116.83 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.469 -0.787 . . . . 1.1299999999999999 110.729 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.751 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.5 m-85 -99.89 116.61 32.35 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.354 -0.839 . . . . 0.45000000000000001 111.156 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.635 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.4 OUTLIER -133.45 166.01 23.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 120.493 -0.483 . . . . 1.0800000000000001 112.009 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.474 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 3.4 tt0 -119.32 125.01 48.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.977 0.732 . . . . 1.8400000000000001 112.977 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.4 t -114.49 114.66 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.476 -0.784 . . . . 1.0700000000000001 110.673 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -90.76 114.81 27.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.741 . . . . 1.6899999999999999 109.848 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.95 -21.44 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.885 -0.598 . . . . 1.0900000000000001 111.372 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.18 -41.36 97.15 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.738 -0.468 . . . . 1.26 109.738 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -95.5 -42.55 8.4 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.107 -0.497 . . . . 1.23 111.783 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -90.55 47.35 1.42 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.025 0.44 . . . . 1.0600000000000001 111.219 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -75.09 -3.3 31.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.365 -0.379 . . . . 2.1200000000000001 110.864 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.3 -24.25 20.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.159 -0.312 . . . . 1.3799999999999999 110.159 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 62' ' ' ALA . 34.6 m -85.5 -43.89 16.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.101 0.477 . . . . 1.05 111.557 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.473 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.08 -53.09 47.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.927 0.714 . . . . 1.05 112.927 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.473 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 43.8 Cg_exo -57.82 -27.45 78.31 Favored 'Trans proline' 0 N--CA 1.472 0.208 0 C-N-CA 123.16 2.573 . . . . 0.88 113.456 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -77.29 -22.64 51.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.522 -0.308 . . . . 2.1699999999999999 111.696 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -102.83 -10.08 19.4 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.405 0.621 . . . . 0.95999999999999996 110.427 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.49 39.78 79.35 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.265 -0.879 . . . . 0.63 112.151 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 67.8 mt -77.61 130.45 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.172 -0.677 . . . . 1.3 109.172 178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -144.44 67.02 1.26 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.281 0.563 . . . . 4.1399999999999997 111.337 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.58 117.58 0.71 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.517 -0.849 . . . . 1.3300000000000001 113.247 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.6 pt -105.97 153.82 39.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 110.378 -0.23 . . . . 1.73 110.378 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.41 121.42 7.18 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 123.786 -1.339 . . . . 0.94999999999999996 113.155 0.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -93.0 140.7 29.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 1.1299999999999999 111.589 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.25 117.09 30.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.458 -0.571 . . . . 1.6000000000000001 109.458 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 3.2 mt -106.65 132.84 52.18 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.411 0.624 . . . . 1.1399999999999999 111.504 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 86' ' ' ALA . 2.5 mm? -112.62 115.12 28.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.994 -1.003 . . . . 1.0700000000000001 109.429 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.598 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 46.5 m-85 -109.1 145.56 35.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.188 0.518 . . . . 0.29999999999999999 110.007 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.702 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 12.1 tttm -143.86 110.58 5.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.268 -0.878 . . . . 1.2 109.905 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.4 m120 60.51 47.2 8.8 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.341 -0.544 . . . . 0.62 109.715 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.04 5.06 45.6 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.828 -0.701 . . . . 0.25 113.425 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -121.65 132.99 54.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.201 0.5 . . . . 1.73 111.269 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.18 121.81 6.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 108.725 -0.843 . . . . 1.73 108.725 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.702 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -103.04 -11.15 18.34 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.298 0.57 . . . . 1.0700000000000001 112.28 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.415 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -172.89 149.26 1.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.07 -0.968 . . . . 1.1000000000000001 111.577 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.17 145.88 51.76 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.52 -0.764 . . . . 2.1800000000000002 109.211 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -143.68 136.35 27.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.899 -0.408 . . . . 2.46 109.899 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.434 HG11 ' N ' ' A' ' 91' ' ' GLY . 14.1 t -116.76 145.2 22.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.905 0.384 . . . . 1.8400000000000001 111.227 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.434 ' N ' HG11 ' A' ' 90' ' ' VAL . . . 81.9 160.39 26.37 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.517 -0.849 . . . . 0.28000000000000003 113.092 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.01 152.02 42.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.853 0.359 . . . . 1.3 111.4 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.9 171.08 14.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.286 -0.415 . . . . 1.2 110.875 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.53 175.0 8.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.742 -0.663 . . . . 1.4299999999999999 110.276 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -67.45 -33.34 74.94 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.043 -0.263 . . . . 1.51 111.635 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.42 -31.13 52.26 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.183 -1.008 . . . . 0.23000000000000001 112.655 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.477 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 53.3 mt-30 -74.86 -29.56 61.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.074 0.464 . . . . 1.73 110.598 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.88 -48.67 23.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.929 -0.578 . . . . 1.1299999999999999 109.58 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.479 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 19.4 ttpt -61.82 -46.13 90.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.581 -0.736 . . . . 1.9199999999999999 111.079 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.0 pp20? -58.72 -40.32 83.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.232 0.539 . . . . 1.8300000000000001 109.93 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.415 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 10.8 t80 -61.37 -41.28 96.84 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.671 -0.695 . . . . 0.40000000000000002 110.882 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mt -68.05 -52.67 32.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 1.1299999999999999 109.891 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -51.11 -36.64 41.54 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.96 0.409 . . . . 1.1799999999999999 110.338 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.43 -19.5 60.95 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 112.737 0.643 . . . . 0.94999999999999996 112.737 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.409 ' HB3' HD22 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -106.97 -44.23 4.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.41999999999999998 110.507 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.431 ' HB2' HD23 ' A' ' 22' ' ' LEU . 67.7 tp -63.84 112.87 3.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.726 -0.67 . . . . 2.0699999999999998 109.565 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.177 -0.916 . . . . 2.2999999999999998 110.736 -179.65 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.964 0.411 . . . . 3.79 111.422 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.851 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 58.8 t -107.21 149.08 10.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.892 -0.595 . . . . 1.2 109.597 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 55' ' ' LEU . 9.1 ptpt -143.29 117.52 9.56 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 119.428 -0.909 . . . . 2.3199999999999998 111.92 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.84 124.21 23.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.94 -1.027 . . . . 1.79 109.778 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.574 HD13 ' CD1' ' A' ' 55' ' ' LEU . 1.4 mp -103.43 111.77 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.852 0.358 . . . . 1.1200000000000001 111.152 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -97.78 14.02 28.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.99 -0.55 . . . . 1.8 112.152 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.424 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 2.6 m -154.18 155.29 35.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.806 0.336 . . . . 1.1200000000000001 111.034 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.558 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -71.49 -21.77 61.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.371 -0.377 . . . . 1.72 110.85 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -78.86 -32.71 46.11 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.408 -0.59 . . . . 1.1100000000000001 109.408 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB1' HG13 ' A' ' 5' ' ' ILE . . . -66.73 -41.52 87.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.461 -0.791 . . . . 1.05 109.797 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -56.34 -41.86 76.77 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.059 -0.518 . . . . 1.6000000000000001 109.888 178.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -64.82 -41.21 95.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.074 -0.713 . . . . 1.3999999999999999 109.074 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -59.96 -49.37 77.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.099 -0.955 . . . . 1.6200000000000001 111.76 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.89 74.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.747 0.308 . . . . 1.03 111.313 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.4 mt -69.1 -43.69 73.96 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.147 0.499 . . . . 1.1499999999999999 110.65 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -61.94 -32.1 72.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.009 -0.541 . . . . 1.79 110.688 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.47 -26.9 58.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 1.1599999999999999 110.968 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.527 ' HB3' HG22 ' A' ' 53' ' ' ILE . . . -73.93 -20.72 60.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 1.4199999999999999 111.286 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 46.12 -119.85 4.25 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.794 -0.717 . . . . 0.96999999999999997 114.789 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.457 ' HA ' ' ND2' ' A' ' 82' ' ' ASN . 16.7 t0 -88.74 2.33 53.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.548 -0.326 . . . . 2.3399999999999999 111.534 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 32.0 mttt -78.1 151.96 33.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.71 -0.848 . . . . 2.1800000000000002 108.71 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.67 HD22 ' HB3' ' A' ' 105' ' ' ASN . 0.2 OUTLIER -73.73 125.09 27.31 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.569 -0.53 . . . . 1.0800000000000001 109.569 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.643 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 2.3 t -106.26 105.8 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.472 0.653 . . . . 1.0700000000000001 110.917 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.502 HG11 ' CE1' ' A' ' 54' ' ' PHE . 11.4 p -105.55 115.58 47.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 107.294 -1.373 . . . . 1.3300000000000001 107.294 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.725 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 25.0 m -129.13 126.94 65.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.952 -0.567 . . . . 1.04 111.862 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -93.16 135.67 34.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.42 -0.809 . . . . 1.1599999999999999 111.453 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -98.8 116.25 30.61 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.989 -0.745 . . . . 0.29999999999999999 108.989 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 11.2 p -125.01 -168.43 1.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.463 0.649 . . . . 1.5 112.731 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.75 154.03 35.47 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 114.901 -1.045 . . . . 1.04 109.868 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -35.31 72.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.323 0.582 . . . . 1.5700000000000001 109.809 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -86.42 11.52 12.26 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.124 -0.944 . . . . 1.02 111.291 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.9 t -97.08 140.77 31.09 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.815 0.341 . . . . 0.47999999999999998 110.923 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.78 -66.12 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.599 -0.81 . . . . 0.33000000000000002 112.476 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.62 -25.06 24.68 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.533 2.155 . . . . 0.75 112.344 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.0 m -62.98 -41.69 99.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.5 110.696 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -66.59 -21.25 66.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.013 -0.54 . . . . 2.8700000000000001 111.149 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 mmt -73.36 -26.02 60.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 2.1299999999999999 111.828 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 38' ' ' ILE . 1.0 OUTLIER -85.88 -22.79 7.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.745 0.307 . . . . 1.0 111.109 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 10.1 tttt -48.35 -57.04 11.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.619 -0.264 . . . . 2.1499999999999999 110.967 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 11.6 Cg_endo -56.68 -43.88 50.69 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.365 2.043 . . . . 0.82999999999999996 112.678 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -73.73 -37.87 64.97 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.521 0.193 . . . . 0.46999999999999997 111.521 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.45 ' O ' ' CE2' ' A' ' 54' ' ' PHE . 9.0 t80 -64.67 -43.52 93.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.951 -0.3 . . . . 0.59999999999999998 111.037 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -37.94 86.2 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.869 -0.332 . . . . 1.4199999999999999 111.102 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.25 -45.82 91.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.707 0.289 . . . . 1.3899999999999999 110.991 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.9 mt -59.25 -39.9 84.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.892 -0.41 . . . . 1.1499999999999999 109.892 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.431 ' HB2' ' CG ' ' A' ' 54' ' ' PHE . 33.6 t -55.17 -29.19 57.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.535 . . . . 1.5800000000000001 111.016 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -87.51 -20.73 26.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.961 0.41 . . . . 2.3900000000000001 110.007 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.438 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 2.1 ttpp -98.88 8.59 44.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.733 -0.667 . . . . 2.3799999999999999 110.698 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.436 ' HB3' HG21 ' A' ' 52' ' ' VAL . 13.9 m-85 -129.63 108.13 9.97 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.268 -0.423 . . . . 0.93999999999999995 109.883 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.7 m -99.41 47.16 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.098 0.407 . . . . 2.0 112.098 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.48 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 13.9 t30 -158.37 -33.78 0.07 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.704 0.287 . . . . 1.6200000000000001 111.39 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 22' ' ' LEU . 5.0 m -92.82 150.89 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.154 0.428 . . . . 1.1200000000000001 112.154 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.527 HG22 ' HB3' ' A' ' 18' ' ' ALA . 1.3 tp -101.02 119.7 49.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.465 . . . . 1.6100000000000001 110.428 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.851 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 3.9 m-85 -101.79 124.58 47.68 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 116.025 -0.534 . . . . 0.53000000000000003 110.966 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.725 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -139.73 167.53 21.9 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.089 -0.644 . . . . 1.1100000000000001 110.607 177.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.454 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 4.5 tt0 -122.29 126.46 48.17 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.328 0.492 . . . . 2.0499999999999998 112.328 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.9 t -115.52 119.29 61.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.714 -0.675 . . . . 1.0900000000000001 111.388 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -94.42 115.52 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.274 -0.639 . . . . 1.79 109.274 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.7 p -58.4 -19.07 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.393 . . . . 1.1000000000000001 111.5 -178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -38.66 90.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.889 -0.412 . . . . 1.1399999999999999 109.889 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.56 -43.65 6.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 1.29 110.698 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.657 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -86.14 46.76 1.37 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.959 -0.564 . . . . 1.01 111.02 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.528 ' O ' ' CD ' ' A' ' 67' ' ' PRO . 16.6 tt0 -74.87 -12.24 60.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.377 -0.374 . . . . 2.2400000000000002 110.778 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.64 -23.47 31.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.764 0.316 . . . . 1.29 110.277 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 62' ' ' ALA . 8.5 m -83.46 -49.12 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.345 -0.389 . . . . 1.04 112.046 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.551 ' N ' HG22 ' A' ' 65' ' ' VAL . . . -49.64 -54.41 31.53 Favored Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 113.524 0.935 . . . . 1.1299999999999999 113.524 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.528 ' CD ' ' O ' ' A' ' 63' ' ' GLN . 50.4 Cg_exo -55.04 -27.36 54.57 Favored 'Trans proline' 0 CA--C 1.521 -0.144 0 C-N-CA 122.959 2.439 . . . . 0.70999999999999996 112.4 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -76.85 -18.81 58.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 2.4900000000000002 111.203 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -109.22 -8.17 15.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.048 0.451 . . . . 0.93000000000000005 110.922 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.16 36.47 91.88 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.639 -0.71 . . . . 0.54000000000000004 112.983 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 79.4 mt -75.91 132.44 33.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.621 -0.511 . . . . 1.3600000000000001 109.621 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -148.14 49.8 1.04 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.666 0.27 . . . . 4.0499999999999998 111.293 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.08 104.24 0.18 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.464 -0.874 . . . . 1.1799999999999999 112.277 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.7 pt -99.48 153.03 37.99 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.57 0.224 . . . . 1.51 110.808 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.76 119.28 6.22 Favored 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.766 -1.348 . . . . 0.78000000000000003 112.373 -0.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.89 137.95 31.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 1.1100000000000001 111.556 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.401 HD21 HD12 ' A' ' 93' ' ' LEU . 1.3 mp -107.08 118.89 37.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.36 -0.978 . . . . 2.2999999999999998 108.36 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.78 128.19 54.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.604 0.716 . . . . 1.0900000000000001 111.231 -178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.469 ' HB3' ' HB2' ' A' ' 86' ' ' ALA . 2.8 mm? -111.31 130.85 55.54 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.983 -1.008 . . . . 1.05 108.855 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.643 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 44.9 m-85 -123.8 151.67 43.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.136 0.493 . . . . 0.28999999999999998 110.4 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.706 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -144.15 115.03 7.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.345 -0.843 . . . . 1.2 109.359 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.457 ' ND2' ' HA ' ' A' ' 20' ' ' ASP . 2.2 m120 53.64 49.57 19.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.374 -0.53 . . . . 1.1399999999999999 110.319 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.44 3.28 31.7 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.143 -0.551 . . . . 0.20999999999999999 113.865 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -119.51 141.81 48.86 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 117.148 0.474 . . . . 1.3700000000000001 110.142 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.61 133.05 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.205 -0.598 . . . . 1.9399999999999999 109.541 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.706 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . . . -103.98 -25.51 12.98 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.635 0.731 . . . . 1.1100000000000001 111.656 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 101' ' ' PHE . . . -172.96 160.97 4.37 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.396 -1.275 . . . . 1.03 110.876 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.75 134.21 36.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.272 -0.422 . . . . 1.74 110.837 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.41 138.34 43.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 1.8 110.166 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 91' ' ' GLY . 21.5 t -119.45 145.37 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.437 -0.347 . . . . 1.6100000000000001 111.198 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.441 ' N ' HG13 ' A' ' 90' ' ' VAL . . . 81.72 160.13 25.45 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.647 -0.787 . . . . 0.22 113.034 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.07 152.44 45.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.172 0.51 . . . . 1.1299999999999999 111.733 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.401 HD12 HD21 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -146.05 151.32 37.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.718 -0.674 . . . . 1.47 110.441 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -69.16 178.9 2.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.446 -0.343 . . . . 1.28 111.051 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -72.49 -30.64 64.7 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.158 -0.474 . . . . 1.6200000000000001 111.797 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.53 -31.87 52.86 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.018 -1.087 . . . . 0.25 112.512 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.48 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 39.6 mt-30 -75.59 -33.14 60.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.803 0.335 . . . . 1.6799999999999999 110.504 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.58 -48.83 63.18 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.172 -0.677 . . . . 1.22 109.172 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.438 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 18.2 ttpt -60.66 -42.39 96.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.859 -0.609 . . . . 2.1099999999999999 110.422 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.537 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -60.49 -39.97 89.65 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.132 -0.485 . . . . 1.6799999999999999 110.091 179.262 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.537 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 6.9 t80 -62.77 -43.44 98.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.757 -0.656 . . . . 0.32000000000000001 111.429 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.2 mt -67.73 -53.0 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.642 -0.708 . . . . 1.24 109.788 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.05 -37.37 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 1.2 111.153 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.43 -21.31 62.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.209 -0.451 . . . . 0.93000000000000005 111.903 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.67 ' HB3' HD22 ' A' ' 22' ' ' LEU . 4.3 t30 -106.52 -46.98 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.068 -0.253 . . . . 0.93000000000000005 111.219 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 56.6 tp -60.59 90.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.951 0.405 . . . . 1.9299999999999999 110.169 178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.344 -0.836 . . . . 2.4100000000000001 111.03 -179.649 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 mtt . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.767 0.318 . . . . 4.2800000000000002 111.374 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 70.2 t -111.01 149.7 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 1.1299999999999999 110.229 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.535 ' O ' HD11 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -141.51 125.78 17.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.045 -0.662 . . . . 2.6499999999999999 111.31 -178.671 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.82 122.91 27.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.323 -0.853 . . . . 2.3599999999999999 109.432 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.501 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.3 mp -103.67 112.06 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 112.119 0.414 . . . . 1.03 112.119 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.36 14.19 28.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.657 0.614 . . . . 1.4099999999999999 112.657 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 m -156.61 140.8 16.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.705 0.288 . . . . 1.4399999999999999 111.633 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.542 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -58.26 -23.92 57.67 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.443 -0.344 . . . . 1.78 111.62 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 m -78.31 -33.49 49.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.949 -0.76 . . . . 1.1399999999999999 108.949 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.24 -39.35 86.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.583 -0.735 . . . . 1.05 109.913 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.465 ' HB2' HG23 ' A' ' 5' ' ' ILE . 23.8 t80 -57.64 -46.97 83.49 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.076 -0.511 . . . . 0.78000000000000003 110.701 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -63.35 -38.4 91.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.411 -0.588 . . . . 1.3100000000000001 109.411 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -59.6 -50.1 75.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.619 -0.719 . . . . 1.4399999999999999 111.498 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.13 -32.55 74.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.839 0.352 . . . . 1.0600000000000001 111.238 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 18.4 mt -67.79 -42.54 81.49 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.236 0.541 . . . . 1.1200000000000001 110.613 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -60.56 -31.58 70.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 1.6799999999999999 110.161 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.23 -22.21 55.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.95 -0.568 . . . . 1.05 110.44 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 15' ' ' LEU . . . -69.12 -29.3 67.33 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.081 -0.509 . . . . 1.1899999999999999 111.03 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.72 -126.44 42.24 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.347 -0.93 . . . . 0.93000000000000005 113.236 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -92.55 9.06 36.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.35 -0.425 . . . . 2.2799999999999998 111.057 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.56 154.1 27.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.947 -0.39 . . . . 1.9299999999999999 109.947 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.482 ' CB ' HD21 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -78.31 126.38 30.7 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.868 -0.419 . . . . 1.04 109.868 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.616 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 6.2 t -110.32 109.0 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.314 0.578 . . . . 1.01 111.753 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.519 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.2 p -104.97 116.88 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.547 -1.279 . . . . 1.1499999999999999 107.547 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.527 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 7.3 m -123.61 136.94 58.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.413 0.625 . . . . 1.0800000000000001 111.655 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.99 129.68 46.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.06 -0.973 . . . . 1.29 111.534 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.445 ' CE1' HD11 ' A' ' 78' ' ' LEU . 11.9 m-85 -97.55 107.9 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.14 -0.689 . . . . 0.32000000000000001 109.14 178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 p -119.07 -166.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.31 0.576 . . . . 1.25 112.493 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.65 154.25 36.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.324 -0.853 . . . . 1.1599999999999999 110.296 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.32 -38.59 78.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.657 0.742 . . . . 1.8 109.449 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 37.7 p-90 -84.94 14.08 5.28 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.572 -1.195 . . . . 1.3799999999999999 111.54 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 37.8 t -102.96 144.42 31.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.856 0.36 . . . . 0.71999999999999997 111.076 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.29 -68.24 0.92 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.714 -0.755 . . . . 0.34000000000000002 112.386 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -50.9 -28.72 24.61 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.655 2.236 . . . . 0.97999999999999998 112.175 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.2 m -58.37 -44.46 88.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.56999999999999995 110.946 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -68.26 -25.63 65.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.849 -0.614 . . . . 3.1600000000000001 111.336 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.2 mtp -68.37 -21.28 64.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.496 -0.32 . . . . 2.2000000000000002 111.539 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mm -86.73 -20.7 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.746 0.308 . . . . 1.0800000000000001 111.132 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 3.7 tttt -52.23 -53.67 49.94 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.363 -0.38 . . . . 2.5800000000000001 111.129 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 74.0 Cg_exo -49.63 -47.98 20.84 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.534 2.156 . . . . 0.93999999999999995 112.545 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -78.25 -32.06 49.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.513 -0.312 . . . . 0.54000000000000004 111.688 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.441 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 6.0 t80 -67.29 -48.6 67.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.909 0.385 . . . . 0.39000000000000001 110.477 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.13 -38.26 85.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.256 -0.429 . . . . 1.3899999999999999 111.497 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.0 t -61.61 -45.33 94.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 1.5 110.818 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.0 mt -59.79 -38.66 82.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 1.1599999999999999 110.274 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 p -54.97 -26.13 34.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.966 -0.561 . . . . 1.3799999999999999 110.381 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -86.61 -23.32 25.77 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.052 0.454 . . . . 2.23 110.019 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.16 11.18 39.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.61 -0.723 . . . . 2.4199999999999999 110.869 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.572 ' HB3' HG23 ' A' ' 52' ' ' VAL . 15.5 m-85 -131.78 93.12 3.25 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.426 -0.352 . . . . 1.02 110.453 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.86 48.03 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 1.74 111.644 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -156.7 -37.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.875 0.324 . . . . 1.1899999999999999 111.875 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.572 HG23 ' HB3' ' A' ' 49' ' ' TYR . 16.5 m -93.2 150.72 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 1.1200000000000001 111.785 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.453 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 3.0 tp -99.41 120.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.511 . . . . 1.6399999999999999 110.153 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.716 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 3.0 m-85 -102.55 117.24 34.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.918 -0.583 . . . . 0.28000000000000003 110.195 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.535 HD11 ' O ' ' A' ' 3' ' ' LYS . 0.2 OUTLIER -132.08 161.8 32.38 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.954 -0.699 . . . . 1.0700000000000001 110.695 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.441 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -118.42 121.8 41.22 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.088 -0.96 . . . . 2.1600000000000001 112.435 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.0 t -115.16 118.5 58.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.856 -0.611 . . . . 1.0 110.777 178.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -92.88 116.9 29.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.203 -0.666 . . . . 1.79 109.203 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.05 -21.2 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.364 . . . . 1.0800000000000001 111.611 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -40.22 96.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.98 0.419 . . . . 0.93999999999999995 110.065 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.96 -41.99 8.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.812 -0.631 . . . . 1.29 111.207 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.561 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -86.32 51.16 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.382 0.61 . . . . 1.0 110.131 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -71.33 -11.85 61.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.71 -0.677 . . . . 2.9399999999999999 111.13 -179.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.01 -23.35 19.55 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 111.734 0.272 . . . . 1.3300000000000001 111.734 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 62' ' ' ALA . 8.6 m -81.51 -50.92 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.188 0.44 . . . . 1.03 112.188 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.491 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.86 -56.89 14.43 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 113.308 0.855 . . . . 1.04 113.308 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.491 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 75.5 Cg_exo -50.81 -27.77 21.34 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.813 2.342 . . . . 0.82999999999999996 112.621 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -77.85 -19.16 55.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 2.1299999999999999 111.413 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -106.93 -8.89 16.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.059 0.457 . . . . 0.64000000000000001 110.364 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.54 38.26 90.38 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.516 -0.766 . . . . 0.51000000000000001 113.265 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 59.6 mt -78.99 132.14 32.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 117.299 0.549 . . . . 1.3300000000000001 109.603 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -142.96 74.15 1.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.194 0.521 . . . . 4.5 111.087 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.496 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 147.2 143.65 3.89 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.56 -0.746 . . . . 1.1599999999999999 112.023 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -129.8 156.77 78.41 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.359 0.123 . . . . 1.8200000000000001 110.799 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.37 121.48 6.96 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.829 -1.321 . . . . 0.77000000000000002 112.869 0.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.496 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -89.63 139.88 30.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 1.2 111.973 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.404 HD22 HD13 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -112.09 118.81 36.42 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.538 -0.912 . . . . 1.5 108.538 177.377 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.445 HD11 ' CE1' ' A' ' 27' ' ' PHE . 1.0 OUTLIER -109.75 132.47 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.488 0.661 . . . . 0.98999999999999999 111.428 -178.409 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.431 HD13 ' HB ' ' A' ' 24' ' ' VAL . 3.5 mm? -111.93 135.59 52.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.141 -0.936 . . . . 1.25 109.029 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.616 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 37.0 m-85 -126.38 152.77 45.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.011 0.434 . . . . 0.37 110.612 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.614 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . 0.8 OUTLIER -148.49 110.5 4.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.666 -0.697 . . . . 1.6399999999999999 109.664 -179.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 m120 62.07 48.12 5.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.909 0.385 . . . . 1.3300000000000001 110.438 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 7.42 49.0 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.055 -0.593 . . . . 0.29999999999999999 113.132 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -123.03 142.72 50.54 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 122.778 -0.248 . . . . 1.3999999999999999 110.645 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 p -57.52 129.34 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.301 -0.629 . . . . 2.0299999999999998 109.301 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 81' ' ' LYS . . . -103.33 -22.49 13.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.457 0.646 . . . . 1.1100000000000001 112.455 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.448 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -171.56 158.32 5.09 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.832 -1.076 . . . . 1.0600000000000001 110.941 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.1 t -134.08 136.01 43.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.226 -0.443 . . . . 2.2400000000000002 110.613 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.51 133.09 36.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.389 -0.597 . . . . 2.0299999999999998 109.389 178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 t -115.97 145.97 21.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.671 -0.24 . . . . 1.5700000000000001 111.233 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.23 159.08 27.03 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.517 -0.849 . . . . 0.73999999999999999 112.648 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.88 158.33 30.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.113 0.482 . . . . 1.1799999999999999 111.715 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.404 HD13 HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -152.03 153.06 33.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 1.1399999999999999 110.358 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 m -71.54 -178.99 2.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 1.05 110.92 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -73.07 -30.64 63.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 1.4299999999999999 111.46 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.36 -32.23 48.37 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.201 -0.999 . . . . 0.25 112.722 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 100' ' ' GLU . 45.2 mt-30 -73.62 -35.29 65.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 1.6299999999999999 110.401 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -47.73 64.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.555 -0.748 . . . . 1.1699999999999999 109.412 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -60.61 -43.24 97.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 1.6299999999999999 110.533 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.584 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -61.18 -41.32 96.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.221 -0.445 . . . . 1.71 110.438 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.584 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 7.2 t80 -61.03 -41.83 97.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.322 0.582 . . . . 0.28999999999999998 110.741 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.86 -56.67 7.21 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.472 -0.785 . . . . 1.26 110.117 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -50.08 -36.73 30.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.919 0.39 . . . . 1.1799999999999999 111.042 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.21 -19.93 60.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 1.0600000000000001 112.1 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.473 ' HB3' HD23 ' A' ' 22' ' ' LEU . 10.7 t30 -109.05 -37.34 5.84 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.863 0.32 . . . . 0.88 111.863 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.482 HD21 ' CB ' ' A' ' 22' ' ' LEU . 3.5 tm? -71.94 94.44 1.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.056 0.455 . . . . 1.97 109.991 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.144 -0.931 . . . . 2.5299999999999998 111.039 -179.307 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 mtp . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.964 0.412 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.49 HG13 ' N ' ' A' ' 3' ' ' LYS . 45.7 t -102.14 145.05 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.695 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.49 ' N ' HG13 ' A' ' 2' ' ' VAL . 14.3 ptmt -143.67 120.81 11.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.191 0.52 . . . . 0.0 110.433 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.94 126.05 29.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.512 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.426 ' O ' HG22 ' A' ' 5' ' ' ILE . 1.0 OUTLIER -98.47 107.43 20.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.202 0.525 . . . . 0.0 110.532 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -97.13 18.62 14.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.652 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 m -156.32 161.35 40.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.916 0.388 . . . . 0.0 111.271 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -73.02 -27.71 61.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.518 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -79.83 -31.58 40.61 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.498 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.83 -38.34 90.65 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.462 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -58.59 -41.72 86.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.939 0.399 . . . . 0.0 110.016 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -67.5 -44.25 78.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.894 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -57.81 -47.25 83.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.243 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.74 73.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.044 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.5 mt -68.72 -37.96 79.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 110.57 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -60.55 -35.84 77.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.164 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.18 -22.46 55.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.006 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.18 77.41 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.088 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.54 -120.33 17.95 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.548 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -95.59 4.97 52.62 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -79.8 149.42 31.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.9 tp -77.0 133.15 39.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 5.6 t -113.88 109.91 30.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.502 0.668 . . . . 0.0 112.015 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.449 HG12 ' CE1' ' A' ' 54' ' ' PHE . 8.4 p -105.04 115.7 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.417 HG12 ' CD2' ' A' ' 55' ' ' LEU . 3.8 m -123.33 166.96 17.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.908 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -133.56 133.89 42.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.783 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -96.21 108.15 20.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.2 p -115.85 -168.36 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.314 0.578 . . . . 0.0 112.186 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.77 152.99 33.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.02 179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -71.26 -37.57 71.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.508 0.671 . . . . 0.0 109.598 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -86.69 12.62 10.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.176 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 17.2 t -94.87 158.21 15.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.049 0.452 . . . . 0.0 111.625 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.96 -66.94 0.61 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.585 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.06 -21.51 72.55 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.58 2.187 . . . . 0.0 112.203 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.5 m -62.98 -42.01 99.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.297 0.57 . . . . 0.0 109.919 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.34 -29.7 70.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.378 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.4 mtt -68.28 -18.17 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.6 mm -88.14 -23.73 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.476 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -52.88 -51.95 69.51 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.03 -49.44 17.04 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.693 2.262 . . . . 0.0 113.416 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -79.79 -30.29 40.59 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.52 -46.01 81.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.087 0.47 . . . . 0.0 110.293 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -39.28 90.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.267 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.5 t -60.38 -43.99 96.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 111.115 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.4 mt -59.71 -38.33 81.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.926 0.393 . . . . 0.0 110.238 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.6 t -56.47 -30.98 63.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.942 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -86.39 -18.1 32.68 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.575 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -96.05 -20.76 18.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.947 0.403 . . . . 0.0 110.175 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -97.92 92.88 6.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.849 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.9 t -88.93 48.39 1.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.113 0.483 . . . . 0.0 110.719 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -152.73 -42.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.667 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.453 HG22 ' CE1' ' A' ' 54' ' ' PHE . 10.2 m -94.43 153.29 3.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.795 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 6.0 tp -104.49 115.4 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.026 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 8.1 m-85 -97.59 115.92 28.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.544 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.417 ' CD2' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -127.2 164.67 21.16 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.537 178.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.401 ' N ' HD11 ' A' ' 55' ' ' LEU . 3.2 tp10 -116.39 119.34 35.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -115.53 117.75 56.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.184 0.516 . . . . 0.0 110.946 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -98.47 119.41 37.11 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.5 p -60.88 -18.84 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -64.17 -39.0 93.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -100.11 -32.85 10.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.584 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.49 43.0 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.82 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -69.16 -10.12 56.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.654 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -94.9 -22.38 18.04 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.312 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 m -78.33 -47.71 23.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.665 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.498 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.35 -58.75 8.79 Favored Pre-proline 0 CA--C 1.529 0.143 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 75.2 Cg_exo -49.8 -28.89 18.9 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.458 2.106 . . . . 0.0 112.037 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.9 mttp -77.13 -23.99 51.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.959 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -106.66 -3.65 20.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.93 0.395 . . . . 0.0 112.017 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.88 34.92 89.98 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.889 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 79.7 mt -77.15 135.93 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 117.3 0.55 . . . . 0.0 110.657 179.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttp85 -143.48 71.28 1.33 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.129 0.49 . . . . 0.0 111.475 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.21 163.42 11.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.591 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 47.3 pt -148.46 149.84 32.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.418 0.109 . . . . 0.0 110.972 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -86.06 120.16 5.7 Favored 'Cis proline' 0 C--N 1.348 0.538 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.649 0.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.94 137.65 32.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.939 0.399 . . . . 0.0 111.809 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.11 121.76 45.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.6 mt -114.47 134.58 54.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.238 0.542 . . . . 0.0 111.639 -178.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.417 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.4 mm? -114.33 127.36 55.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.781 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.502 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 46.5 m-85 -118.43 146.67 44.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.975 0.417 . . . . 0.0 111.336 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -146.59 115.27 6.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.002 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m120 59.76 45.21 13.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.872 0.368 . . . . 0.0 110.261 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.29 3.79 54.27 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.896 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.4 141.39 52.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.513 0.657 . . . . 0.0 111.467 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 42.5 t -68.13 118.3 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.443 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.43 10.49 19.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.943 0.401 . . . . 0.0 112.047 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.417 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -175.69 137.92 0.37 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.936 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 4.9 m -137.79 124.0 20.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 110.942 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -124.22 142.02 51.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.904 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.97 145.94 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.233 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.11 161.79 24.63 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.131 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.33 170.65 3.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.901 0.382 . . . . 0.0 111.277 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -163.69 147.06 10.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.657 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 t -64.75 179.07 0.69 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.914 0.388 . . . . 0.0 110.806 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -73.09 -30.81 63.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.118 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.2 -31.37 52.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.86 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -76.21 -32.14 58.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.858 0.361 . . . . 0.0 110.582 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.61 -50.95 31.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.099 0.476 . . . . 0.0 109.884 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -61.54 -42.33 98.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.5 -38.83 88.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.949 0.404 . . . . 0.0 110.137 179.583 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.441 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 11.2 t80 -61.93 -40.65 96.21 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.402 0.62 . . . . 0.0 110.061 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.67 -60.91 2.42 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.157 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -48.55 -33.83 10.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.095 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.6 -23.5 60.95 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -109.77 -30.03 8.04 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 36.6 tp -64.06 -55.31 23.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.847 0.356 . . . . 0.0 110.716 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.846 -179.946 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.9 mtt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 121.074 0.464 . . . . 4.0999999999999996 111.544 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.695 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 67.9 t -118.17 151.85 20.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.679 -0.691 . . . . 1.1899999999999999 109.68 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.456 ' N ' HG13 ' A' ' 2' ' ' VAL . 11.9 ptpt -144.98 121.81 11.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.36 -0.936 . . . . 2.48 111.268 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.12 123.69 25.67 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.458 -1.246 . . . . 2.23 110.174 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 11' ' ' PHE . 2.1 mp -105.3 114.2 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.847 0.356 . . . . 1.1100000000000001 111.323 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -103.77 16.63 25.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.352 0.501 . . . . 1.47 112.352 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.427 ' H ' HG21 ' A' ' 5' ' ' ILE . 3.4 m -155.48 147.25 23.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.742 0.306 . . . . 1.1799999999999999 111.098 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.428 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.5 ttpt -60.82 -24.64 66.01 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.358 -0.383 . . . . 2.1099999999999999 111.764 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -79.14 -32.32 44.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.928 0.394 . . . . 1.0900000000000001 110.238 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.24 -41.39 85.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.906 -0.588 . . . . 1.0900000000000001 110.349 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.549 ' N ' HG23 ' A' ' 5' ' ' ILE . 15.5 t80 -56.18 -44.53 79.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.858 -0.61 . . . . 1.6000000000000001 110.693 179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -66.52 -39.45 88.63 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.246 -0.65 . . . . 1.3700000000000001 109.246 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -58.06 -48.45 80.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.746 -0.661 . . . . 1.6000000000000001 110.887 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.56 -34.58 78.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.421 . . . . 1.0700000000000001 111.241 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 mt -66.75 -39.6 87.98 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.234 0.54 . . . . 1.1599999999999999 110.537 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -63.57 -31.98 73.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 1.6000000000000001 110.739 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.72 -22.74 56.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 1.1100000000000001 111.014 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -71.23 -35.81 71.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 1.3100000000000001 111.477 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.53 -119.44 18.61 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.077 -1.059 . . . . 1.1000000000000001 113.662 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.18 2.29 56.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.717 -0.241 . . . . 2.1899999999999999 111.479 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -79.27 148.1 32.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.692 -0.484 . . . . 2.27 109.692 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.411 HD11 HD12 ' A' ' 79' ' ' LEU . 1.6 tp -72.46 126.99 31.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.14 -0.319 . . . . 1.0900000000000001 110.14 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.565 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 4.3 t -107.61 108.11 24.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.521 0.676 . . . . 1.1100000000000001 111.523 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.518 HG13 ' CE1' ' A' ' 54' ' ' PHE . 10.2 p -106.08 116.98 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.951 -1.129 . . . . 1.1000000000000001 107.951 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.715 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 4.3 m -123.13 166.97 17.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.218 0.532 . . . . 1.0700000000000001 111.643 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -133.21 133.75 43.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.802 -0.636 . . . . 1.23 111.834 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -97.86 110.76 23.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.927 -0.768 . . . . 0.31 108.927 178.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.3 m -128.42 158.94 36.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.597 0.713 . . . . 1.54 112.917 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -116.16 156.65 26.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.971 -1.013 . . . . 1.1499999999999999 111.047 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.2 m -70.79 -35.78 72.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.502 0.668 . . . . 1.29 109.615 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 23.4 p-90 -85.76 10.87 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.736 -1.12 . . . . 1.1399999999999999 111.564 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 38.4 t -98.4 148.12 24.01 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.81 0.338 . . . . 0.81999999999999995 111.027 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.33 -67.33 0.75 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.677 -0.773 . . . . 0.37 112.204 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.73 -24.53 18.22 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.411 2.074 . . . . 0.96999999999999997 112.096 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.7 m -62.9 -43.76 97.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.144 -0.48 . . . . 0.48999999999999999 110.781 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -68.78 -23.21 64.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 3.1499999999999999 111.13 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 mmt -69.7 -22.36 63.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 2.3199999999999998 110.739 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.2 mm -85.98 -21.71 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.418 -0.355 . . . . 1.0700000000000001 110.976 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -52.3 -55.05 35.14 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.464 -0.335 . . . . 2.9300000000000002 111.159 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -48.54 -49.11 15.37 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.563 2.176 . . . . 0.77000000000000002 112.381 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -77.4 -29.19 53.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 0.55000000000000004 111.519 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.437 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 6.3 t80 -67.76 -46.81 71.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.986 0.422 . . . . 0.55000000000000004 110.257 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -42.9 78.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 1.46 111.952 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 m -59.09 -44.52 91.92 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.841 0.353 . . . . 1.4399999999999999 110.379 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.35 -40.3 85.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.543 -0.54 . . . . 1.1299999999999999 109.543 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 32.4 t -54.5 -27.55 38.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.889 -0.596 . . . . 1.55 111.179 179.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -88.96 -16.96 30.5 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.731 0.3 . . . . 1.99 111.038 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -94.56 -19.38 20.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.963 0.411 . . . . 2.6699999999999999 109.912 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.451 ' HB3' HG21 ' A' ' 52' ' ' VAL . 22.1 m-85 -102.26 97.47 7.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.917 -0.583 . . . . 1.1000000000000001 111.477 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.63 46.35 1.33 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.399 -0.364 . . . . 1.73 110.767 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -154.44 -34.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.801 0.334 . . . . 1.26 111.322 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 49' ' ' TYR . 5.8 m -97.59 156.06 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.325 -0.398 . . . . 1.1299999999999999 111.585 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.501 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 1.3 tp -106.39 114.64 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.051 -0.522 . . . . 1.0800000000000001 111.143 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.695 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.2 m-85 -96.11 120.19 35.95 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.197 -0.456 . . . . 0.32000000000000001 110.516 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.715 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.5 OUTLIER -133.31 168.5 18.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 120.378 -0.529 . . . . 1.0700000000000001 111.1 179.178 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -121.53 124.61 44.81 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.674 0.62 . . . . 2.2799999999999998 112.674 -178.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 t -113.19 117.78 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.887 -0.597 . . . . 1.04 111.138 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -93.46 113.21 25.3 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.424 -0.584 . . . . 1.9199999999999999 109.424 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 p -58.49 -19.1 13.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.825 0.305 . . . . 1.0700000000000001 111.825 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -37.54 87.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.94 0.4 . . . . 1.22 110.292 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -102.94 -40.61 6.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.89 -0.596 . . . . 1.26 111.157 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.476 ' O ' HG21 ' A' ' 65' ' ' VAL . . . -88.32 49.0 1.72 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.213 0.53 . . . . 1.02 110.395 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.407 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -75.83 -6.57 51.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.525 -0.762 . . . . 2.8300000000000001 111.083 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.89 -25.1 20.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.769 0.318 . . . . 1.5600000000000001 110.433 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 62' ' ' ALA . 13.5 m -81.31 -48.58 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.197 -0.456 . . . . 1.0900000000000001 111.759 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.39 -55.56 21.28 Favored Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 112.744 0.646 . . . . 1.0600000000000001 112.744 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.486 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 78.3 Cg_exo -51.92 -27.54 28.37 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.863 2.375 . . . . 0.77000000000000002 112.997 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -77.09 -21.35 54.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.278 -0.419 . . . . 2.3100000000000001 111.781 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -108.16 -7.12 16.12 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.087 0.47 . . . . 0.87 111.354 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.4 37.07 90.03 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.687 -0.688 . . . . 0.56999999999999995 113.517 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 61.6 mt -74.12 130.16 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 109.624 -0.51 . . . . 1.29 109.624 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.89 60.16 1.47 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.937 0.399 . . . . 4.54 111.521 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.13 118.43 0.52 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.245 -0.979 . . . . 1.2 113.386 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.6 pt -104.99 152.44 39.63 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.408 -0.219 . . . . 1.53 110.408 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.81 120.26 6.38 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.8 -1.333 . . . . 1.0800000000000001 112.708 0.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.48 134.82 34.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.543 -0.299 . . . . 1.05 111.236 179.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.87 122.82 47.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.401 -0.963 . . . . 1.6499999999999999 108.401 177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mt -113.84 137.61 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.263 0.554 . . . . 1.0700000000000001 111.548 -178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.411 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -119.01 113.41 20.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.535 -0.757 . . . . 1.1000000000000001 110.562 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.565 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.9 m-85 -105.0 142.37 34.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.979 -0.555 . . . . 0.28999999999999998 110.766 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -142.25 110.34 5.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.579 -0.737 . . . . 1.1100000000000001 109.487 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.0 m120 61.89 47.08 6.25 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.276 -0.639 . . . . 1.1899999999999999 109.276 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.16 3.79 32.58 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.558 -0.746 . . . . 0.26000000000000001 113.797 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -121.25 133.04 55.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.205 0.502 . . . . 1.6000000000000001 110.814 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.461 HG23 ' CE2' ' A' ' 80' ' ' PHE . 89.7 t -62.72 117.35 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 1.8600000000000001 109.848 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.02 4.49 27.12 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.462 0.541 . . . . 1.04 112.462 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -172.56 146.51 1.72 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.283 -0.417 . . . . 1.0800000000000001 111.823 179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.46 134.21 37.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 2.1699999999999999 110.824 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -132.78 138.77 47.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 2.6499999999999999 110.239 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.7 145.53 26.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 1.6000000000000001 111.009 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.87 160.16 23.38 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.501 -0.857 . . . . 0.31 112.878 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.62 151.27 46.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.114 0.483 . . . . 1.0600000000000001 111.575 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -143.33 147.77 35.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.76 -0.654 . . . . 1.1499999999999999 110.558 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -65.04 -178.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.576 -0.284 . . . . 1.1699999999999999 110.755 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -73.01 -32.67 65.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 1.75 111.497 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.52 -30.58 56.31 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.206 -0.997 . . . . 0.26000000000000001 112.598 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.534 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 40.4 mt-30 -74.99 -31.22 61.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.972 0.415 . . . . 1.73 110.31 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.98 -49.79 27.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.047 -0.524 . . . . 1.1599999999999999 109.908 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -61.71 -45.16 95.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.544 -0.753 . . . . 2.0 110.965 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.534 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.8 pp20? -60.64 -41.68 95.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 1.8200000000000001 110.558 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -63.91 -42.68 97.35 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.26 0.552 . . . . 0.33000000000000002 111.194 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.4 HD13 HG13 ' A' ' 24' ' ' VAL . 1.7 mt -64.85 -57.72 8.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.791 -0.64 . . . . 1.1100000000000001 109.528 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -49.0 -34.19 12.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.502 . . . . 1.24 110.736 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.47 -22.95 62.62 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.046 -0.524 . . . . 1.04 111.717 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -105.55 -31.44 8.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.806 0.336 . . . . 0.52000000000000002 110.746 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 42.6 tp -75.15 95.72 3.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.691 -0.485 . . . . 2.0 109.691 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.255 -0.879 . . . . 2.6000000000000001 111.347 -179.531 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 121.008 0.432 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.491 HG13 ' N ' ' A' ' 3' ' ' LYS . 42.9 t -125.56 145.89 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.604 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.491 ' N ' HG13 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -142.73 119.62 11.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.253 0.549 . . . . 0.0 110.346 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.7 127.74 33.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.846 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.12 107.53 21.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.298 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -97.9 19.64 13.49 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.125 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.23 159.53 39.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.855 0.36 . . . . 0.0 111.276 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -71.91 -26.65 62.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 m -79.64 -32.8 41.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.914 0.387 . . . . 0.0 110.814 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.37 90.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.568 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.435 ' CE1' HG22 ' A' ' 57' ' ' VAL . 3.7 t80 -57.66 -42.71 84.04 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -43.97 83.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.13 -45.7 92.14 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.514 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.49 -31.91 73.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.892 0.377 . . . . 0.0 110.673 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -67.78 -37.39 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.527 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -61.42 -33.91 74.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.304 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.44 -22.67 54.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.9 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.65 -35.91 79.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.63 -122.76 31.13 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.14 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.57 4.33 53.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.501 0.191 . . . . 0.0 111.152 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -77.28 149.7 35.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.8 tp -77.02 132.61 39.05 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.482 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 6.3 t -112.45 109.67 29.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.397 0.618 . . . . 0.0 112.37 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.461 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.9 p -104.81 116.22 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.475 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 3.1 m -122.67 167.09 16.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.72 -178.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -133.45 133.37 42.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.597 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.412 ' CE1' HD13 ' A' ' 78' ' ' LEU . 5.9 m-85 -98.1 111.89 24.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -118.94 -167.79 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.382 0.61 . . . . 0.0 112.219 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.2 154.5 35.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.013 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -35.73 67.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.376 0.607 . . . . 0.0 109.471 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -87.24 10.78 15.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.08 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 11.3 t -91.79 157.21 17.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.052 0.453 . . . . 0.0 111.479 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.41 -64.17 0.54 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.441 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -63.96 -22.29 68.42 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.497 2.132 . . . . 0.0 112.401 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.9 m -58.58 -41.47 85.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -67.04 -15.24 63.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.391 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.6 mmt -71.16 -26.85 63.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.789 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.8 mm -84.47 -23.86 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.685 0.279 . . . . 0.0 111.361 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.453 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 8.4 ttpt -48.96 -59.21 6.72 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 10.3 Cg_endo -51.96 -45.05 41.15 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.342 2.028 . . . . 0.0 112.697 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -80.74 -29.67 36.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -66.43 -45.69 78.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.082 0.467 . . . . 0.0 110.327 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.14 -39.91 86.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.883 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 62.7 m -61.7 -44.02 97.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.877 0.37 . . . . 0.0 110.887 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.3 mt -59.42 -40.23 86.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.914 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 54' ' ' PHE . 1.2 m -54.73 -28.38 47.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.433 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.54 -19.51 27.78 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.686 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -95.0 -20.62 19.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.04 0.447 . . . . 0.0 110.265 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -98.04 96.13 7.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.675 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.76 47.96 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.072 0.463 . . . . 0.0 110.236 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -152.92 -42.44 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.822 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.451 HG22 ' CE1' ' A' ' 54' ' ' PHE . 11.0 m -93.66 153.85 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.597 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.427 ' O ' ' CG2' ' A' ' 53' ' ' ILE . 5.2 tp -105.75 113.99 44.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.748 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.482 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 8.4 m-85 -94.62 116.2 28.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.55 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.475 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -129.02 166.7 18.71 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.514 178.611 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.409 ' N ' HD13 ' A' ' 55' ' ' LEU . 1.4 tp10 -117.43 118.99 33.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.435 HG22 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -115.34 118.35 58.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.249 0.547 . . . . 0.0 110.787 178.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -99.34 120.42 39.54 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.27 -18.46 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -67.93 -37.53 81.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.087 0.47 . . . . 0.0 109.81 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -98.78 -34.5 10.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.445 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.422 ' CB ' HG22 ' A' ' 65' ' ' VAL . . . -95.75 47.67 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.097 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -68.57 -8.74 44.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.079 -179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.57 -25.02 15.29 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.448 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.422 HG22 ' CB ' ' A' ' 62' ' ' ALA . 6.7 m -77.15 -48.78 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.965 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.446 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . -50.22 -60.44 5.24 Favored Pre-proline 0 N--CA 1.463 0.203 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 66' ' ' ALA . 6.3 Cg_endo -49.11 -28.04 13.45 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.571 2.181 . . . . 0.0 111.862 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -73.57 -27.84 61.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.929 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -108.79 -6.26 15.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.901 0.381 . . . . 0.0 111.632 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.41 40.24 97.6 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.087 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 61.3 mt -78.0 81.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 117.007 0.403 . . . . 0.0 110.837 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -87.1 78.33 8.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 111.882 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.27 164.22 10.15 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.397 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.5 pt -149.03 155.71 40.33 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 122.161 0.184 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.23 116.93 4.26 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 124.183 -1.174 . . . . 0.0 112.628 -0.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.14 137.08 32.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.909 0.385 . . . . 0.0 111.865 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.65 123.87 49.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.412 HD13 ' CE1' ' A' ' 27' ' ' PHE . 6.0 mt -116.76 134.88 54.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.219 0.533 . . . . 0.0 111.793 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.71 120.68 40.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.696 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.482 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 45.2 m-85 -112.08 146.99 36.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 0.0 111.157 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -146.94 110.6 4.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.328 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.3 m120 61.83 46.47 6.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.909 0.385 . . . . 0.0 110.171 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.51 1.24 57.4 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.908 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -125.49 138.79 53.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.484 0.642 . . . . 0.0 111.861 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -68.25 119.23 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.529 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.22 11.3 20.21 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -173.88 140.85 0.76 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.63 124.2 22.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.681 0.277 . . . . 0.0 111.127 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -126.17 139.68 53.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.272 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.44 146.34 25.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.643 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.36 161.56 27.36 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.158 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.14 147.86 49.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 111.58 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.38 151.76 42.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.612 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.9 t -65.33 179.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.151 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -72.5 -31.98 65.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.46 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.24 -29.89 55.57 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.711 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -76.88 -32.7 57.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.843 0.354 . . . . 0.0 110.532 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.21 -50.56 31.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -61.4 -42.09 98.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.238 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.38 -39.61 91.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.881 0.372 . . . . 0.0 110.328 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.424 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 10.8 t80 -62.1 -42.56 99.35 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.357 0.598 . . . . 0.0 110.679 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.1 mt -67.41 -54.46 20.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.186 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -50.99 -36.77 40.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.63 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.29 -21.0 60.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -108.58 -26.9 10.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.733 0.302 . . . . 0.0 111.705 -178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -76.66 -77.75 0.13 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.683 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.0 p . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.998 179.477 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.876 0.37 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 3' ' ' LYS . 50.9 t -63.47 145.6 13.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.137 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.478 ' N ' HG12 ' A' ' 2' ' ' VAL . 0.8 OUTLIER -145.32 121.84 11.05 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.072 0.463 . . . . 0.0 110.23 -179.728 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.24 127.55 33.26 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.416 ' CD1' HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -100.51 106.83 19.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.978 0.418 . . . . 0.0 109.928 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -98.45 20.08 13.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.778 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.8 159.79 38.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.946 0.403 . . . . 0.0 111.301 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -72.37 -25.36 61.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.926 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.84 -32.28 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.951 0.405 . . . . 0.0 110.702 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.67 -39.49 91.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.148 -179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.404 ' CE1' HG22 ' A' ' 57' ' ' VAL . 3.6 t80 -57.76 -44.52 86.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 109.984 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.84 -45.57 85.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.679 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -58.21 -47.79 82.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.34 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.39 -31.5 72.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.34 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 mt -69.79 -37.91 76.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.41 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -61.41 -33.16 73.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.721 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.42 -23.9 53.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.956 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.72 78.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.24 -122.42 29.0 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.004 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -94.96 6.47 48.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.46 0.171 . . . . 0.0 111.303 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -80.19 148.77 30.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.7 tp -76.25 134.63 39.77 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.543 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 4.2 t -113.78 109.19 27.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.459 0.647 . . . . 0.0 112.007 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.48 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.6 p -103.75 116.03 46.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.427 HG13 ' CD2' ' A' ' 55' ' ' LEU . 3.6 m -123.91 165.85 19.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.215 0.531 . . . . 0.0 112.126 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -129.57 131.31 46.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.609 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -98.24 110.13 22.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.9 p -134.32 149.54 50.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.107 0.48 . . . . 0.0 112.029 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.39 158.26 15.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.352 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -68.96 -37.49 78.85 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -85.48 16.19 3.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.058 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 36.8 t -90.91 156.95 17.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.36 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.14 -73.85 0.89 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.348 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.47 -22.79 22.5 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.451 2.101 . . . . 0.0 112.227 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.0 m -60.72 -38.11 83.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.22 0.533 . . . . 0.0 110.13 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -69.26 -16.26 63.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.553 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 38.4 mtt -74.16 -23.61 59.28 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.419 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.0 mm -87.25 -22.21 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 8.3 mttp -48.66 -60.01 5.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 10.2 Cg_endo -53.32 -44.51 48.36 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.544 2.162 . . . . 0.0 113.43 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -79.86 -31.61 40.45 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -66.18 -44.32 84.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.946 0.403 . . . . 0.0 110.545 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -39.27 83.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.12 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 p -61.74 -43.65 98.44 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.046 0.451 . . . . 0.0 110.879 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 mt -59.49 -37.03 77.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.021 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -57.86 -28.31 64.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.376 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -87.27 -19.61 28.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.599 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -95.27 -19.68 19.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 110.266 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -99.52 93.94 6.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.854 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.2 t -90.93 49.43 1.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.142 0.496 . . . . 0.0 110.845 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -151.75 -43.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.565 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.437 HG21 ' CE1' ' A' ' 54' ' ' PHE . 10.3 m -92.24 153.95 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.945 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.441 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 5.6 tp -105.35 114.72 45.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.596 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.48 ' CE1' ' CG1' ' A' ' 24' ' ' VAL . 7.3 m-85 -95.39 115.75 27.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.744 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.427 ' CD2' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -128.44 165.81 19.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.455 178.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -118.03 119.46 34.85 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.901 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.404 HG22 ' CE1' ' A' ' 11' ' ' PHE . 2.7 t -114.69 117.84 56.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.488 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -97.26 118.02 32.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.681 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.06 -18.98 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.733 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.4 -39.98 95.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -99.73 -34.08 10.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.765 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.419 ' CB ' HG23 ' A' ' 65' ' ' VAL . . . -95.11 45.03 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.708 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -9.44 57.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.168 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.4 -21.89 18.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.432 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.419 HG23 ' CB ' ' A' ' 62' ' ' ALA . 2.3 m -80.38 -47.02 21.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.992 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.493 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.0 -57.81 11.41 Favored Pre-proline 0 N--CA 1.464 0.225 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.493 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 74.6 Cg_exo -50.68 -28.34 22.27 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.536 2.157 . . . . 0.0 111.874 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.98 -23.12 58.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -111.01 -5.25 14.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.87 0.367 . . . . 0.0 111.812 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.56 34.94 89.16 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.581 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 75.2 mt -74.81 132.84 32.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 117.396 0.598 . . . . 0.0 110.364 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -150.7 49.21 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.933 0.397 . . . . 0.0 111.219 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.27 99.46 0.14 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.442 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.42 ' HA ' ' N ' ' A' ' 76' ' ' THR . 2.9 pt -100.96 151.6 37.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.51 0.195 . . . . 0.0 111.109 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.49 113.49 2.97 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 124.036 -1.235 . . . . 0.0 112.752 0.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.42 ' N ' ' HA ' ' A' ' 74' ' ' ILE . 0.3 OUTLIER -86.65 135.26 33.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.842 0.353 . . . . 0.0 111.571 179.176 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.38 125.95 51.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.5 mt -116.88 136.51 52.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.199 0.523 . . . . 0.0 111.702 -178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.427 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.6 mm? -117.45 122.98 45.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.699 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.543 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 49.1 m-85 -113.64 144.82 42.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.031 0.443 . . . . 0.0 111.375 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.5 tttm -145.62 111.59 5.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.336 -179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 m120 61.88 45.39 7.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.396 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.37 -0.56 59.63 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.957 -0.64 . . . . 0.0 114.242 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -124.07 141.07 52.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.519 0.66 . . . . 0.0 111.865 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.406 HG23 ' CZ ' ' A' ' 80' ' ' PHE . 38.2 t -67.4 119.73 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.401 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.09 8.33 19.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.427 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -173.61 138.68 0.68 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.113 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 22.2 m -138.63 120.71 15.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.749 0.309 . . . . 0.0 111.086 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.38 145.15 46.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.942 0.401 . . . . 0.0 111.216 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.01 146.19 25.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.399 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.83 159.29 17.69 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.304 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.9 138.27 48.04 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.027 0.441 . . . . 0.0 111.895 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.01 150.96 49.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.534 179.551 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.0 m -65.74 -178.03 0.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.771 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -70.57 -33.95 71.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.677 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.67 -30.49 52.64 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.237 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.438 ' HA ' ' HG2' ' A' ' 100' ' ' GLU . 25.6 mt-30 -77.14 -32.35 56.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.014 0.407 . . . . 0.0 110.591 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.32 -50.26 34.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -61.96 -42.23 98.88 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.654 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.438 ' HG2' ' HA ' ' A' ' 97' ' ' GLN . 13.1 pt-20 -61.56 -42.84 99.43 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.764 0.316 . . . . 0.0 110.838 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -61.92 -42.7 99.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.374 0.607 . . . . 0.0 110.528 178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.436 ' CD1' ' CZ ' ' A' ' 54' ' ' PHE . 1.6 mt -67.3 -54.44 20.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.768 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -52.82 -36.2 58.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.749 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.92 -19.17 61.96 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.985 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -107.6 -28.03 10.0 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.639 0.257 . . . . 0.0 111.454 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -70.82 114.69 9.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.257 -179.981 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 mmt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.961 0.41 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.524 HG11 ' N ' ' A' ' 3' ' ' LYS . 44.7 t -101.25 148.05 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.524 ' N ' HG11 ' A' ' 2' ' ' VAL . 1.3 ptpt -145.29 119.77 9.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.124 0.488 . . . . 0.0 110.651 -179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.29 127.65 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.641 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -101.2 109.55 25.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.064 0.459 . . . . 0.0 110.557 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -101.41 18.79 19.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.951 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.29 161.38 41.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.086 0.47 . . . . 0.0 111.562 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.2 ttpt -73.43 -28.21 61.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.776 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.73 -30.9 41.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.765 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.07 -42.45 89.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.875 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -55.16 -41.51 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 110.213 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -67.1 -44.3 80.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.976 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -58.33 -47.82 82.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.447 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.37 -31.57 72.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 110.928 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 mt -68.68 -39.15 80.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.683 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.46 -34.08 73.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.056 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.66 -22.81 53.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.481 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.44 72.23 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.914 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.34 -123.92 29.35 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.144 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -93.59 4.65 53.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.621 0.248 . . . . 0.0 111.223 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -78.82 149.41 32.55 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.8 tp -76.35 134.96 39.54 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 5.3 t -112.79 113.22 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.519 0.676 . . . . 0.0 112.007 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.48 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.2 p -106.18 112.35 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.45 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.479 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 4.7 m -122.24 167.08 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.75 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -134.46 134.49 41.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.683 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -96.13 106.74 18.97 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -115.75 -169.52 1.6 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.449 0.642 . . . . 0.0 112.615 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.76 153.63 34.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.231 179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.8 m -71.26 -36.51 71.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.433 0.635 . . . . 0.0 109.588 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -86.45 12.51 10.1 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.737 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 21.0 t -92.76 157.65 16.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.998 0.428 . . . . 0.0 111.728 -179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.18 -69.62 0.64 Allowed Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.344 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.5 -23.21 46.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.641 2.227 . . . . 0.0 112.27 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.1 m -59.89 -42.65 94.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -68.49 -18.6 64.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.365 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.9 mmm -74.04 -25.42 59.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.75 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.9 mm -85.97 -22.57 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.724 0.297 . . . . 0.0 111.664 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.41 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -50.75 -52.78 53.65 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.495 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 63.9 Cg_exo -51.15 -49.57 16.67 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.709 2.273 . . . . 0.0 113.045 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -79.87 -28.45 39.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -66.68 -47.23 73.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.099 0.476 . . . . 0.0 110.412 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -40.19 88.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.24 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.6 t -60.34 -44.58 95.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.599 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt -59.65 -41.92 91.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.123 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.404 ' HB2' ' CB ' ' A' ' 54' ' ' PHE . 31.8 t -54.91 -27.59 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.272 179.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -87.01 -18.77 29.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.727 0.299 . . . . 0.0 111.334 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -95.81 -19.91 19.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 110.08 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -100.18 92.52 5.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.032 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -89.69 48.06 1.55 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.021 0.438 . . . . 0.0 110.494 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -152.27 -40.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.591 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.487 HG23 ' CE1' ' A' ' 54' ' ' PHE . 12.5 m -94.74 155.25 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.422 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.442 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 5.3 tp -105.24 115.55 47.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.815 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.487 ' CE1' HG23 ' A' ' 52' ' ' VAL . 8.9 m-85 -97.61 116.17 29.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.938 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.479 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -129.35 167.79 17.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.45 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.443 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -120.24 122.39 40.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.803 -177.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -116.28 120.07 63.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.352 0.596 . . . . 0.0 110.744 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -99.74 119.24 37.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.897 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.73 -18.27 16.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.043 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -39.77 94.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.95 -33.63 10.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.496 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.431 ' CB ' ' CG2' ' A' ' 65' ' ' VAL . . . -97.24 43.7 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.469 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -8.94 56.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.666 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.98 -24.61 16.3 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.293 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.431 ' CG2' ' CB ' ' A' ' 62' ' ' ALA . 1.7 m -76.53 -47.43 29.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.494 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.498 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.97 -57.76 11.56 Favored Pre-proline 0 N--CA 1.461 0.108 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.498 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 74.2 Cg_exo -50.14 -28.5 19.83 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.435 2.09 . . . . 0.0 111.569 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -75.27 -24.35 57.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.956 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -106.98 -4.82 18.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.894 0.378 . . . . 0.0 111.612 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.98 34.65 89.08 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.78 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.9 mt -75.77 135.41 27.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 117.248 0.524 . . . . 0.0 110.446 179.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -144.81 64.85 1.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.014 0.435 . . . . 0.0 111.167 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.407 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 169.3 162.73 22.07 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.496 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.8 pt -147.51 141.76 16.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 122.9 -0.176 . . . . 0.0 110.963 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -88.89 122.1 5.56 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 124.172 -1.178 . . . . 0.0 112.398 -0.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER -88.28 137.69 32.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 111.674 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -108.79 124.19 50.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.7 mt -116.44 133.92 55.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.283 0.563 . . . . 0.0 111.618 -178.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.426 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.0 mm? -115.27 122.13 45.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.695 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.514 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 50.2 m-85 -113.71 147.98 37.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.262 0.553 . . . . 0.0 111.542 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -147.02 111.01 5.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.208 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.9 m120 61.78 46.48 6.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.374 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.28 2.28 58.84 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.765 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.52 139.45 53.6 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.432 0.616 . . . . 0.0 112.192 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.1 p -67.74 116.98 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.454 178.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.58 9.53 21.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.426 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -170.88 139.3 1.44 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.937 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.65 122.68 20.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.698 0.285 . . . . 0.0 111.171 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -124.08 138.14 54.48 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.39 146.18 24.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.328 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.38 164.62 30.96 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.279 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.23 169.34 8.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.12 0.486 . . . . 0.0 111.576 -179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.05 -170.32 2.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.25 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 t -111.52 165.73 11.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.814 0.34 . . . . 0.0 110.814 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -55.79 -34.01 64.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.995 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.46 -31.18 51.88 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.914 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.426 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 35.5 mt-30 -76.19 -33.5 59.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.903 0.382 . . . . 0.0 110.553 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.51 -49.77 44.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -61.93 -43.92 97.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.096 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.6 OUTLIER -61.3 -39.1 89.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.881 0.372 . . . . 0.0 110.167 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.441 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 9.7 t80 -61.28 -41.38 96.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.35 0.595 . . . . 0.0 110.333 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.429 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 10.7 mt -69.48 -50.75 42.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.763 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -52.43 -38.14 58.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 110.187 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.52 63.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.796 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -104.29 -56.28 2.22 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 110.923 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.418 ' N ' ' O ' ' A' ' 102' ' ' LEU . 3.2 tm? -52.87 98.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.838 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.816 -179.738 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.899 0.381 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 3' ' ' LYS . 40.0 t -136.34 146.02 29.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.468 ' N ' HG12 ' A' ' 2' ' ' VAL . 10.7 ptpt -144.35 121.09 11.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.126 0.488 . . . . 0.0 109.941 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -74.66 129.61 38.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.604 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -100.98 108.15 22.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.418 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -100.0 18.16 19.18 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.905 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.1 m -154.13 158.04 39.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.84 0.352 . . . . 0.0 111.247 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -71.63 -26.27 62.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.555 179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -79.72 -31.25 41.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.065 0.46 . . . . 0.0 110.298 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.87 -36.18 81.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.056 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -59.91 -42.98 95.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.012 0.434 . . . . 0.0 109.848 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -66.91 -44.7 80.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.614 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.23 -46.44 85.91 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.145 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.97 -30.71 70.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.139 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.9 mt -69.49 -38.98 77.9 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.084 0.469 . . . . 0.0 110.188 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.25 -33.25 73.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.199 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.96 -23.68 52.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.892 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.32 -33.12 74.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.293 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.1 -122.17 28.68 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.154 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -96.04 7.81 45.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.613 0.244 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -79.05 148.07 32.6 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.1 tp -76.19 134.53 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 4.7 t -116.61 107.35 22.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.43 0.634 . . . . 0.0 112.085 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.459 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.3 p -101.69 115.07 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.434 HG12 ' CD2' ' A' ' 55' ' ' LEU . 5.2 m -122.59 168.15 15.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.364 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -135.14 134.13 39.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.951 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -96.71 110.71 23.11 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 51.6 p -119.44 -168.45 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.299 0.571 . . . . 0.0 112.062 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.17 155.07 37.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.037 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -71.23 -35.94 71.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 47.5 p-90 -86.25 11.33 12.33 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.404 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 11.1 t -88.76 157.72 18.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.988 0.423 . . . . 0.0 111.436 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.92 -64.66 0.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.004 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -64.01 -21.39 68.37 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.753 2.302 . . . . 0.0 112.499 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.7 m -59.02 -39.82 83.09 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.294 0.569 . . . . 0.0 109.983 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -68.69 -16.88 63.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.564 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 69.2 mmm -74.16 -24.64 59.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.537 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.9 mm -86.19 -24.87 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.631 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -51.09 65.93 Favored Pre-proline 0 N--CA 1.468 0.428 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.3 -48.37 18.03 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.151 1.901 . . . . 0.0 112.703 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -80.59 -31.03 36.87 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.416 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 8.2 t80 -66.59 -45.83 77.92 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.875 0.369 . . . . 0.0 110.319 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.67 -39.35 88.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.554 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.5 m -60.75 -42.86 98.24 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.042 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.18 -44.39 95.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.257 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.0 p -53.55 -25.15 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.229 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -86.6 -21.98 26.5 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 120.608 0.242 . . . . 0.0 111.129 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -94.9 -19.16 20.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.08 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -98.95 92.84 5.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 t -90.11 50.58 1.88 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 110.674 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -153.14 -42.73 0.1 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.492 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.401 HG22 ' CE1' ' A' ' 54' ' ' PHE . 5.5 m -93.29 154.31 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.689 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.433 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 5.7 tp -105.9 115.65 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.909 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.459 ' CE1' ' CG1' ' A' ' 24' ' ' VAL . 5.7 m-85 -97.03 115.83 28.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.505 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.434 ' CD2' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -127.48 166.73 17.39 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.491 178.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' N ' HD12 ' A' ' 55' ' ' LEU . 1.6 tp10 -117.93 118.6 32.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.39 118.07 57.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.548 0.689 . . . . 0.0 110.842 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -99.34 120.16 39.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.558 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.7 p -61.2 -17.84 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.4 -40.06 96.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.247 0.546 . . . . 0.0 109.527 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -98.25 -36.29 10.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.987 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.411 ' CB ' ' CG2' ' A' ' 65' ' ' VAL . . . -94.66 42.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.752 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -69.8 -11.17 60.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.343 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.96 -21.98 19.47 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.439 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.411 ' CG2' ' CB ' ' A' ' 62' ' ' ALA . 2.2 m -80.47 -46.48 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.152 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.487 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -50.04 -56.65 16.3 Favored Pre-proline 0 N--CA 1.466 0.331 0 O-C-N 122.284 -0.26 . . . . 0.0 111.552 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.487 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 79.2 Cg_exo -51.35 -28.32 26.64 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.543 2.162 . . . . 0.0 111.958 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -74.41 -24.74 59.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.35 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -108.43 -6.65 16.08 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.628 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.31 38.87 94.06 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.706 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 76.7 mt -76.28 133.09 31.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 110.38 179.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.6 tpt85 -149.64 49.05 0.94 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.933 0.397 . . . . 0.0 110.913 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.32 102.09 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.713 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.4 ' HA ' ' N ' ' A' ' 76' ' ' THR . 13.0 pt -101.88 150.02 37.02 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.83 114.05 3.22 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 124.29 -1.129 . . . . 0.0 112.385 0.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.4 ' N ' ' HA ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -86.42 135.05 33.64 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 2.0 mp -107.81 126.18 52.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.402 ' HB2' HG23 ' A' ' 25' ' ' VAL . 6.0 mt -118.36 134.07 55.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.268 0.556 . . . . 0.0 111.636 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -113.4 126.0 54.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.688 179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.458 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 51.9 m-85 -118.68 146.8 44.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.954 0.407 . . . . 0.0 110.961 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -144.74 110.45 5.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.805 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.0 m120 60.52 46.41 9.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 110.063 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.08 -3.37 38.23 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.005 -0.616 . . . . 0.0 114.141 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.57 134.1 55.24 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 117.299 0.55 . . . . 0.0 111.68 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.0 p -68.04 116.35 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.445 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.81 11.1 24.47 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.45 137.23 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.263 179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.3 m -137.52 124.68 21.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.068 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -122.72 145.14 48.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.352 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.81 146.64 24.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.199 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.44 159.26 10.83 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.964 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.44 141.0 52.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 111.481 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.29 150.97 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.239 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.08 179.09 0.74 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.701 0.286 . . . . 0.0 110.624 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -71.28 -32.56 68.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.731 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.06 -31.03 54.43 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.928 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.74 -31.48 57.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -51.26 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.704 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -61.07 -41.78 97.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.078 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.407 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.83 -39.09 90.61 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.91 0.386 . . . . 0.0 110.178 179.467 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.407 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 11.3 t80 -63.27 -42.4 99.12 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.515 0.674 . . . . 0.0 110.114 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.426 HD12 ' CZ ' ' A' ' 54' ' ' PHE . 5.0 mt -66.77 -58.45 5.03 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.85 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -48.86 -34.97 13.6 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.732 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.2 -20.57 60.15 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -109.0 -33.42 6.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.24 114.22 7.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.893 0.378 . . . . 0.0 110.679 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 5.1 m . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.197 -179.71 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.947 0.403 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.511 HG11 ' N ' ' A' ' 3' ' ' LYS . 48.3 t 63.45 146.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.642 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.511 ' N ' HG11 ' A' ' 2' ' ' VAL . 7.1 ptpp? -146.09 122.07 10.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.159 0.504 . . . . 0.0 110.265 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -74.48 129.64 38.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.053 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.423 ' N ' HD13 ' A' ' 5' ' ' ILE . 1.1 mp -101.97 108.11 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 110.317 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -98.94 19.27 15.34 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.226 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -154.72 159.74 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 0.0 111.127 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.35 -27.1 62.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.083 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -79.97 -31.87 39.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.952 0.406 . . . . 0.0 110.751 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.63 90.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.898 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -56.36 -40.19 74.12 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.75 -45.14 72.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.046 178.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.77 -48.41 79.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.484 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.41 -32.46 74.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.916 0.389 . . . . 0.0 110.928 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 mt -68.14 -34.58 76.6 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.802 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.01 -34.13 76.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.925 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.2 -22.59 55.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.702 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.68 -37.61 85.1 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.297 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.17 -124.37 35.78 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.997 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -94.19 4.89 53.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.543 0.211 . . . . 0.0 111.031 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 mttp -77.42 149.36 35.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.4 tp -76.77 136.64 39.0 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.489 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 10.6 t -117.05 110.83 32.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.261 0.553 . . . . 0.0 112.234 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.467 HG13 ' CE1' ' A' ' 54' ' ' PHE . 7.9 p -106.69 115.87 49.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.42 HG13 ' CD2' ' A' ' 55' ' ' LEU . 3.3 m -123.02 167.48 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.949 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -134.51 135.96 42.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.284 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -99.06 109.88 22.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.545 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.3 m -114.97 -168.67 1.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.139 0.495 . . . . 0.0 111.928 -178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.08 155.17 37.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.743 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -71.96 -37.47 69.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.499 0.666 . . . . 0.0 109.366 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -86.76 12.4 10.92 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.034 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.0 t -94.17 159.83 14.97 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.994 0.426 . . . . 0.0 111.746 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.94 -64.91 0.44 Allowed Glycine 0 C--N 1.331 0.262 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.045 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.4 -24.13 77.97 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.708 2.272 . . . . 0.0 112.047 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.9 m -58.94 -43.69 91.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.238 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.4 -27.53 67.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.599 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 47.9 mtt -67.83 -17.09 64.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.3 mm -86.27 -22.35 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.904 0.383 . . . . 0.0 111.002 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.499 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -51.28 -58.7 9.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.169 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_endo -48.07 -46.65 21.59 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.539 2.16 . . . . 0.0 112.655 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -78.94 -33.79 45.02 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -66.17 -45.82 79.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.916 0.389 . . . . 0.0 110.402 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -40.68 87.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.657 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -43.85 94.83 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.882 0.372 . . . . 0.0 110.893 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.5 mt -59.68 -39.42 84.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.7 t -56.49 -29.57 61.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.614 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.66 -18.19 31.91 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.144 -0.223 . . . . 0.0 111.516 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -95.1 -20.35 19.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 0.0 110.008 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -100.13 90.65 4.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.473 179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 m -86.96 51.28 2.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.081 0.467 . . . . 0.0 110.454 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -154.65 -41.57 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.171 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.424 HG23 ' CE1' ' A' ' 54' ' ' PHE . 10.7 m -93.37 154.45 3.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.013 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.444 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 4.0 tp -103.7 114.48 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.256 0.55 . . . . 0.0 111.507 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.479 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 7.7 m-85 -97.61 115.6 28.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.178 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.42 ' CD2' HG13 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -128.63 167.89 16.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.115 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.68 120.41 36.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.16 118.11 57.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.0 110.406 178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -97.97 119.52 36.74 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -60.08 -18.71 16.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.03 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -65.66 -38.07 88.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.037 0.446 . . . . 0.0 109.802 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.35 -35.13 10.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.28 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -94.43 46.07 1.14 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.916 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.3 -11.19 60.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.534 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.75 -22.79 19.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.505 0.193 . . . . 0.0 111.174 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.4 m -79.31 -47.29 22.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.978 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.452 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . -50.52 -60.16 5.9 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 66' ' ' ALA . 10.2 Cg_endo -50.85 -28.63 24.02 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.713 2.276 . . . . 0.0 111.967 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -78.13 -23.41 47.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.902 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -106.4 -2.96 21.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.649 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.67 33.75 86.98 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.629 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 81.2 mt -77.75 133.64 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 117.184 0.492 . . . . 0.0 110.618 179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -144.74 64.35 1.29 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.337 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 170.85 162.38 23.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.243 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.3 pt -147.51 139.78 14.21 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.692 0.246 . . . . 0.0 110.987 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -87.95 123.62 6.65 Favored 'Cis proline' 0 C--N 1.35 0.635 0 C-N-CA 124.203 -1.165 . . . . 0.0 112.604 0.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.99 134.29 33.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.813 0.339 . . . . 0.0 111.077 179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.27 123.47 48.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 7.4 mt -115.6 136.12 53.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.222 0.534 . . . . 0.0 111.845 -177.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.3 mm? -116.34 120.81 40.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.594 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.489 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.3 m-85 -112.17 145.61 39.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 0.0 111.202 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 tttm -145.93 110.94 5.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.998 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.9 m120 62.06 46.19 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 110.111 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.66 2.9 57.45 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.745 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -123.78 136.33 54.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.385 0.592 . . . . 0.0 111.651 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.6 p -66.66 117.59 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.128 179.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.68 11.48 28.4 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -173.52 144.62 1.15 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.96 119.97 17.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -122.13 139.27 53.94 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.855 0.359 . . . . 0.0 110.249 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 t -121.8 145.92 27.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.464 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.54 159.81 24.38 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.602 -179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.74 143.89 54.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.976 0.417 . . . . 0.0 111.386 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.43 -171.37 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.513 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.0 t -109.21 165.98 11.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 110.822 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -57.4 -37.72 73.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.05 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.54 -30.12 54.04 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.845 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.58 -32.59 58.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.488 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.44 -49.65 39.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -43.76 98.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.876 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -62.21 -38.1 87.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.891 0.377 . . . . 0.0 110.168 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.415 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 5.6 t80 -61.82 -39.99 93.69 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.207 0.527 . . . . 0.0 109.923 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.6 mt -66.12 -59.32 3.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.914 179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.49 -34.49 11.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.058 0.456 . . . . 0.0 110.705 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -24.42 62.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.18 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -106.37 -47.68 3.74 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.676 0.274 . . . . 0.0 111.021 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.1 tt -53.19 106.46 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.768 179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.066 -179.853 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 mtm . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 121.026 0.441 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.456 HG13 ' N ' ' A' ' 3' ' ' LYS . 56.8 t -64.37 145.08 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.097 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.456 ' N ' HG13 ' A' ' 2' ' ' VAL . 0.5 OUTLIER -146.77 123.42 11.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.022 0.439 . . . . 0.0 109.827 179.98 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -75.38 132.39 40.87 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.415 HG13 ' CB ' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -100.16 106.74 19.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 110.543 -179.1 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.76 21.31 10.63 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.87 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.26 159.13 38.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.771 0.32 . . . . 0.0 111.192 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.2 tmpt? -73.58 -26.9 61.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.946 0.403 . . . . 0.0 110.42 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -79.8 -32.11 40.76 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.616 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' CB ' HG13 ' A' ' 5' ' ' ILE . . . -66.57 -36.25 82.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.463 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.417 ' CE1' HG21 ' A' ' 57' ' ' VAL . 6.0 t80 -58.16 -42.51 86.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.107 0.479 . . . . 0.0 110.168 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -66.53 -41.79 88.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.955 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.96 -48.21 82.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.528 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.93 76.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 110.67 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.405 HD23 ' CG ' ' A' ' 80' ' ' PHE . 12.1 mt -64.78 -40.76 95.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -66.9 -27.1 67.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.624 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -49.19 75.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.876 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.79 -64.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.544 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.51 -86.3 1.46 Allowed Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.809 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -94.4 -16.92 23.02 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -74.86 157.73 34.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.3 tp -79.5 133.96 36.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.535 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 15.7 t -114.37 110.37 31.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.403 0.621 . . . . 0.0 111.573 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.47 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.3 p -106.18 115.05 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.46 HG11 ' CD2' ' A' ' 55' ' ' LEU . 3.2 m -123.05 166.74 17.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.759 -178.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -131.75 132.04 43.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.546 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -97.94 111.84 24.0 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.7 t -117.46 -170.51 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.0 112.472 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.12 155.38 37.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.437 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -35.84 68.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.39 0.614 . . . . 0.0 110.199 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -85.31 11.52 9.99 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.081 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 8.8 t -96.83 158.26 15.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 111.313 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.51 -66.55 0.5 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.009 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.82 -23.36 71.89 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.454 2.103 . . . . 0.0 112.193 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -58.82 -44.54 90.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -65.0 -26.5 68.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.51 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.5 mtt -67.03 -17.44 64.91 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.5 mm -86.1 -21.72 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.091 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.459 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 25.6 mttp -51.37 -59.34 8.02 Favored Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.459 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 8.2 Cg_endo -50.35 -45.2 35.24 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.437 2.092 . . . . 0.0 112.869 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -78.88 -31.87 45.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -65.9 -45.37 82.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.93 0.395 . . . . 0.0 110.531 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.78 -38.35 86.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.524 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.6 m -59.67 -42.8 93.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 110.746 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mt -60.81 -42.89 98.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.418 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.4 p -54.81 -25.84 31.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.394 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -86.64 -23.15 25.78 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.599 0.238 . . . . 0.0 111.321 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -94.18 -19.05 21.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 110.041 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 19.7 m-85 -100.16 88.03 3.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.966 179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 p -87.11 50.92 2.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.463 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -153.5 -42.58 0.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.685 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.432 HG22 ' CE1' ' A' ' 54' ' ' PHE . 12.3 m -93.46 154.56 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.556 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.453 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 1.6 tp -103.79 114.17 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.353 0.597 . . . . 0.0 111.038 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.47 ' CE1' ' CG1' ' A' ' 24' ' ' VAL . 7.5 m-85 -96.91 117.31 30.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.806 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.46 ' CD2' HG11 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -130.76 164.8 24.32 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.395 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -112.98 116.02 29.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.417 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.6 t -114.05 116.46 52.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.168 0.508 . . . . 0.0 111.048 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -99.18 120.18 39.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.469 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.2 p -60.96 -20.03 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.098 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -61.76 -40.77 96.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.219 0.533 . . . . 0.0 109.667 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -100.26 -33.53 10.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.353 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.412 ' CB ' ' CG2' ' A' ' 65' ' ' VAL . . . -94.78 43.6 1.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.548 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -71.66 -9.92 58.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.565 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.38 -21.4 18.4 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.243 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.412 ' CG2' ' CB ' ' A' ' 62' ' ' ALA . 1.6 m -79.34 -47.87 21.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.485 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.499 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.89 -58.28 9.87 Favored Pre-proline 0 C--N 1.333 -0.141 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 74.7 Cg_exo -51.2 -28.3 25.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.415 2.077 . . . . 0.0 111.849 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -73.8 -25.68 60.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.487 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -108.39 -6.12 16.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.691 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.73 36.23 90.94 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 116.007 -0.542 . . . . 0.0 114.33 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 63.9 mt -74.65 136.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 117.312 0.556 . . . . 0.0 110.653 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -151.79 54.89 0.84 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 111.236 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.73 102.22 0.15 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.428 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.418 ' HA ' ' N ' ' A' ' 76' ' ' THR . 11.8 pt -102.87 154.39 37.56 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 122.971 -0.135 . . . . 0.0 110.835 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.74 114.17 3.17 Favored 'Cis proline' 0 C--N 1.348 0.529 0 C-N-CA 123.768 -1.347 . . . . 0.0 113.125 0.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.418 ' N ' ' HA ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -86.26 136.61 33.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 111.221 179.018 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -107.39 123.61 48.62 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.7 mt -116.03 136.14 53.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.223 0.535 . . . . 0.0 111.867 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.425 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.9 mm? -116.29 123.46 47.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.863 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.535 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.1 m-85 -113.98 144.94 42.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.024 0.44 . . . . 0.0 111.072 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -146.14 111.34 5.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.061 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.5 m120 61.49 45.29 8.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.774 0.321 . . . . 0.0 110.563 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.99 2.76 58.73 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.52 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -124.45 140.35 53.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.297 0.548 . . . . 0.0 111.809 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.0 t -69.9 120.87 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.672 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.72 8.65 16.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.425 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -173.84 136.56 0.55 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.9 m -136.36 125.26 24.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 0.0 110.771 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 145.17 49.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.046 0.451 . . . . 0.0 111.181 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.59 145.93 25.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.172 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.53 160.83 13.7 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.332 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.29 176.38 1.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.045 0.45 . . . . 0.0 111.508 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -170.37 153.3 4.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.692 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 t -66.78 179.01 1.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.028 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -72.97 -28.63 62.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.068 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.46 -31.77 49.63 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.13 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.488 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 39.7 mt-30 -76.87 -31.9 57.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.975 0.387 . . . . 0.0 110.558 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.02 -51.13 27.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -63.33 -43.22 98.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.097 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.4 pp20? -62.06 -43.17 99.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.779 0.323 . . . . 0.0 110.469 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -61.9 -39.21 91.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.4 0.619 . . . . 0.0 110.088 178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 4.3 mt -65.52 -60.7 2.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.009 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -48.23 -32.22 6.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.02 -26.23 63.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.791 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -106.36 -26.58 11.42 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.702 0.287 . . . . 0.0 111.524 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 1.8 tt -72.64 -37.35 68.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 110.482 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.292 -0.861 . . . . 0.0 112.223 179.338 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ttm . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.845 0.355 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.487 HG11 ' N ' ' A' ' 3' ' ' LYS . 52.1 t -70.43 145.7 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.625 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.487 ' N ' HG11 ' A' ' 2' ' ' VAL . 0.0 OUTLIER -143.34 120.51 11.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.185 0.517 . . . . 0.0 110.377 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.63 129.27 37.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.118 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.67 107.79 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.353 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.66 20.19 13.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.159 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -155.15 160.36 40.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.824 0.345 . . . . 0.0 111.401 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -72.96 -27.07 61.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.624 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.3 m -79.76 -30.99 40.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.858 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.78 -39.78 91.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.735 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -56.77 -43.26 80.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.191 0.52 . . . . 0.0 109.661 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -46.2 78.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.875 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -60.74 -44.8 96.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.434 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.74 -34.32 78.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.577 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.03 -35.9 79.03 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.497 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -35.29 76.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.322 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.45 -22.52 54.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.91 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.1 -33.21 74.1 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.227 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.03 -125.07 37.83 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.036 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.22 6.4 46.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.509 0.195 . . . . 0.0 111.139 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -78.74 150.15 32.53 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.5 tp -78.08 133.76 37.84 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 6.5 t -113.85 110.19 31.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.454 0.645 . . . . 0.0 112.005 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.456 HG13 ' CE1' ' A' ' 54' ' ' PHE . 7.3 p -102.59 113.84 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.47 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 3.1 m -121.27 165.85 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.758 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -134.31 133.31 40.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.854 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.7 m-85 -97.34 110.39 22.95 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.4 p -121.41 -166.76 1.41 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.247 0.546 . . . . 0.0 112.228 -178.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.83 152.71 33.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.155 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -70.44 -36.98 74.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.437 0.637 . . . . 0.0 109.408 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -87.23 11.31 14.49 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.826 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 15.4 t -93.04 155.79 17.29 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.482 . . . . 0.0 112.213 -179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.79 -75.8 1.04 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.209 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.26 -24.52 21.07 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.62 2.214 . . . . 0.0 112.416 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.2 m -60.49 -41.96 95.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.208 0.528 . . . . 0.0 110.373 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -68.93 -15.64 63.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.25 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.9 mmt -72.96 -28.09 62.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.467 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.2 mm -84.56 -23.97 7.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.734 0.302 . . . . 0.0 111.431 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -49.76 -54.13 34.94 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.898 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -51.45 -48.36 21.65 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.514 2.142 . . . . 0.0 113.345 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -80.08 -28.27 39.17 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -65.63 -45.83 81.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.965 0.412 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.04 -37.96 81.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.95 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -43.96 97.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.917 0.389 . . . . 0.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.54 -42.35 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.111 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.7 t -55.38 -26.19 39.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.293 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -88.45 -20.15 25.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.586 0.231 . . . . 0.0 111.526 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -96.23 -20.35 18.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.058 0.456 . . . . 0.0 110.069 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -98.71 92.83 5.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.725 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.7 p -91.31 48.51 1.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.667 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -151.79 -40.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.58 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.448 HG23 ' CE1' ' A' ' 54' ' ' PHE . 12.5 m -95.35 156.16 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.594 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.421 ' CG2' ' CG1' ' A' ' 23' ' ' VAL . 4.7 tp -106.67 115.18 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.892 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.456 ' CE1' HG13 ' A' ' 24' ' ' VAL . 7.7 m-85 -96.34 115.65 27.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.244 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.47 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -128.32 166.24 19.02 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.734 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.447 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -117.98 120.05 36.67 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -176.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.75 117.72 56.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.107 0.48 . . . . 0.0 110.713 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -98.62 120.05 38.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.78 -17.67 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -66.91 -37.61 84.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.2 -37.82 9.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.143 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -96.59 44.11 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.303 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -9.37 48.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.815 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.57 -22.36 17.67 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.467 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 2.8 m -79.06 -47.44 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.53 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.501 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.66 -57.69 11.42 Favored Pre-proline 0 N--CA 1.463 0.178 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 75.3 Cg_exo -51.11 -28.5 25.34 Favored 'Trans proline' 0 C--N 1.34 0.09 0 C-N-CA 122.441 2.094 . . . . 0.0 111.595 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -75.93 -21.72 56.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.918 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -112.63 -5.69 13.96 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.49 39.26 96.71 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.451 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 61.4 mt -79.32 79.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.929 0.365 . . . . 0.0 111.06 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -86.5 82.58 7.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.184 0.516 . . . . 0.0 111.836 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.77 163.13 10.07 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.568 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.2 pt -146.2 156.77 50.3 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -83.5 118.25 5.34 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.402 -1.082 . . . . 0.0 113.063 0.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.16 136.55 32.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.372 . . . . 0.0 111.686 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -109.19 123.29 49.0 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 6.3 mt -115.6 133.11 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.341 0.591 . . . . 0.0 111.411 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.412 ' HB2' ' CB ' ' A' ' 87' ' ' ALA . 3.4 mm? -114.17 121.8 44.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.636 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.458 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 41.6 m-85 -113.07 146.87 38.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.261 0.553 . . . . 0.0 111.544 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -146.69 116.73 7.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.011 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m120 57.98 44.97 18.81 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.455 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.1 2.54 53.43 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.9 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -124.91 139.47 53.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.473 0.637 . . . . 0.0 111.705 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.4 p -67.96 117.51 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.905 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -110.91 10.68 22.33 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 79' ' ' LEU . . . -175.7 137.14 0.34 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.527 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.9 m -136.7 125.26 23.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.588 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -123.24 143.21 50.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.859 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.5 146.37 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.568 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.95 159.6 22.49 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.892 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.03 37.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 111.696 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.72 150.4 39.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.7 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 m -63.98 179.81 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -72.78 -32.63 65.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.976 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.01 -30.06 56.16 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.618 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.425 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 26.3 mt-30 -76.43 -31.86 58.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.441 . . . . 0.0 110.704 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.33 -50.11 29.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -62.22 -44.08 97.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.107 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 17.8 pt-20 -60.05 -44.22 94.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.713 0.292 . . . . 0.0 110.814 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . 0.407 ' CE2' ' HB2' ' A' ' 87' ' ' ALA . 19.4 t80 -61.92 -42.2 98.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.114 0.483 . . . . 0.0 111.11 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 3.6 mt -66.67 -57.54 6.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.164 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.26 -34.92 16.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.68 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.74 -22.59 60.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.254 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -107.88 -24.14 11.77 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -75.25 -80.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.813 -179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 107' ' ' VAL . 12.5 p . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.133 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mtt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 121.144 0.497 . . . . 3.8999999999999999 111.588 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.633 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 58.3 t -110.8 151.17 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.668 -0.696 . . . . 1.1299999999999999 109.709 179.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.548 ' N ' HG13 ' A' ' 2' ' ' VAL . 10.2 ptpt -143.96 122.43 12.42 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.686 -0.805 . . . . 1.9299999999999999 110.917 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.16 123.4 26.37 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.44 -1.254 . . . . 1.77 109.796 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.629 HG23 ' N ' ' A' ' 11' ' ' PHE . 3.5 mp -102.91 110.79 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.985 0.421 . . . . 1.23 110.558 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -98.63 19.02 15.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.012 -0.54 . . . . 1.5700000000000001 111.545 179.515 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.45 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.7 m -155.16 163.69 39.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.949 0.404 . . . . 1.03 111.89 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.496 ' HA ' HG12 ' A' ' 65' ' ' VAL . 1.9 ttpt -76.79 -25.55 53.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.984 -0.553 . . . . 1.9399999999999999 110.778 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -79.34 -32.43 43.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.004 0.431 . . . . 1.1000000000000001 109.955 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.51 -37.97 86.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.801 -0.636 . . . . 1.04 110.521 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.629 ' N ' HG23 ' A' ' 5' ' ' ILE . 8.7 t80 -57.85 -46.14 85.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.28999999999999998 110.686 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -65.47 -40.58 93.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.853 -0.612 . . . . 1.25 109.736 178.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -58.58 -48.76 79.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.918 -0.583 . . . . 1.3400000000000001 110.94 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.45 -36.29 82.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.991 -0.549 . . . . 1.03 111.247 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.2 mt -64.69 -38.33 90.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 1.1699999999999999 110.166 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.2 -27.66 68.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 1.7 110.476 179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.9 83.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 1.1699999999999999 111.146 -178.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.15 -65.45 0.67 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 119.943 -0.703 . . . . 1.25 109.922 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.83 -93.24 1.86 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.704 -0.68 . . . . 0.65000000000000002 112.808 -179.243 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -95.63 -9.95 30.75 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.199 0.499 . . . . 2.2599999999999998 111.669 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -75.24 151.08 38.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.613 -0.514 . . . . 1.73 109.613 179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.476 HD12 ' N ' ' A' ' 23' ' ' VAL . 1.9 tp -76.39 127.91 33.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.883 0.373 . . . . 1.04 110.112 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 3.9 t -106.67 110.23 30.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.34 0.59 . . . . 1.03 111.592 -179.362 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.409 ' CG1' ' CE1' ' A' ' 54' ' ' PHE . 7.3 p -106.07 116.06 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.114 -1.069 . . . . 1.0600000000000001 108.114 178.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.728 ' CG1' ' HG ' ' A' ' 55' ' ' LEU . 3.9 m -123.37 164.18 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.179 0.514 . . . . 1.0600000000000001 112.371 -178.012 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.0 t0 -127.81 132.9 49.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 1.1200000000000001 112.067 -178.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -99.1 106.52 18.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.06 -0.719 . . . . 0.29999999999999999 109.06 178.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.55 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.9 p -119.92 -174.76 2.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.068 0.766 . . . . 1.46 113.068 -177.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.02 154.77 41.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.459 -1.246 . . . . 1.0800000000000001 110.396 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -38.45 79.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.169 0.509 . . . . 1.4199999999999999 110.176 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -86.54 14.22 7.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.364 -0.834 . . . . 0.72999999999999998 111.412 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 32.2 t -98.42 141.35 31.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.737 0.303 . . . . 0.52000000000000002 110.571 178.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.89 -67.24 0.94 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.592 -0.813 . . . . 0.34000000000000002 112.196 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -51.95 -26.58 25.35 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.585 2.19 . . . . 0.66000000000000003 112.165 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -60.54 -44.06 96.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.35999999999999999 110.534 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -65.94 -28.44 68.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.795 -0.639 . . . . 2.1000000000000001 111.093 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.0 mtt -68.55 -21.01 64.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 1.7 111.549 -179.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.8 mm -87.21 -23.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.746 0.308 . . . . 1.0800000000000001 111.132 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.5 mttt -51.23 -54.77 34.7 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.39 -0.368 . . . . 2.3999999999999999 110.945 179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.31 -48.14 17.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.613 2.209 . . . . 0.71999999999999997 112.485 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -78.24 -28.43 47.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.516 -0.311 . . . . 0.33000000000000002 111.508 -178.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 4.4 t80 -68.31 -47.96 66.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.097 0.475 . . . . 0.28999999999999998 110.187 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.89 -41.67 86.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.735 -0.666 . . . . 0.44 111.505 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -59.39 -44.85 92.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.774 0.321 . . . . 1.45 110.82 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.41 -40.4 86.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.808 -0.441 . . . . 1.1000000000000001 109.808 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.433 ' HB2' ' CB ' ' A' ' 54' ' ' PHE . 35.6 t -53.92 -28.26 35.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 1.51 111.11 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -87.93 -17.9 30.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.641 -0.254 . . . . 2.1400000000000001 111.33 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.432 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 4.6 ttpp -95.51 -21.47 18.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.018 0.437 . . . . 1.78 109.946 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -99.04 92.21 5.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.627 -0.715 . . . . 0.85999999999999999 110.708 179.686 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -84.26 46.41 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 1.52 111.397 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -157.62 -36.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.956 0.354 . . . . 1.05 111.956 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.465 HG11 ' HB3' ' A' ' 22' ' ' LEU . 6.2 m -91.85 157.07 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.682 0.277 . . . . 1.0800000000000001 111.193 -179.318 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.46 ' CG2' ' O ' ' A' ' 53' ' ' ILE . 1.2 tp -104.92 116.91 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.222 0.534 . . . . 1.1699999999999999 111.109 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.633 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.7 m-85 -99.1 117.27 33.23 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.814 -0.63 . . . . 0.32000000000000001 110.242 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.728 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.6 OUTLIER -133.23 169.78 16.4 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.642 -0.423 . . . . 1.1499999999999999 110.849 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.518 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -121.57 124.94 45.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.381 0.882 . . . . 1.8200000000000001 113.381 -178.712 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.8 t -112.0 114.59 47.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.654 -0.703 . . . . 1.05 111.027 178.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -94.47 115.68 27.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.1 -0.5 . . . . 1.8999999999999999 109.686 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 28' ' ' SER . 12.4 p -59.75 -21.05 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 1.0700000000000001 111.644 -178.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -64.65 -38.83 92.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.932 -0.395 . . . . 1.1599999999999999 109.932 179.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -99.61 -39.16 8.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 1.3100000000000001 111.263 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 65' ' ' VAL . . . -94.17 50.38 1.39 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.055 0.455 . . . . 1.0 111.176 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 7.0 tt0 -77.54 -3.2 39.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.158 -0.474 . . . . 2.2400000000000002 110.958 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.38 -24.84 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.766 0.317 . . . . 1.28 110.176 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 8' ' ' LYS . 8.2 m -81.98 -48.28 18.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.184 -0.462 . . . . 1.0600000000000001 111.399 179.298 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.471 ' CB ' ' HD3' ' A' ' 67' ' ' PRO . . . -49.52 -55.14 24.26 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 112.933 0.716 . . . . 1.01 112.933 -178.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.471 ' HD3' ' CB ' ' A' ' 66' ' ' ALA . 72.6 Cg_exo -52.35 -27.8 32.5 Favored 'Trans proline' 0 C--O 1.23 0.114 0 C-N-CA 122.871 2.381 . . . . 0.59999999999999998 113.059 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -77.27 -20.26 55.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.124 -0.489 . . . . 2.0 111.895 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -107.48 -6.03 17.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.055 0.455 . . . . 0.80000000000000004 111.055 179.482 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.04 37.43 93.13 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.626 -0.715 . . . . 0.29999999999999999 112.859 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 70.9 mt -75.05 134.98 28.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.358 -0.608 . . . . 1.03 109.358 179.089 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -147.2 59.77 1.17 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.72 0.295 . . . . 3.3999999999999999 110.968 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.435 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 161.13 117.72 0.45 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.478 -0.867 . . . . 0.94999999999999996 113.297 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 pt -108.24 153.54 41.85 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 110.164 -0.31 . . . . 1.49 110.164 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.76 115.94 4.06 Favored 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.854 -1.311 . . . . 0.80000000000000004 112.488 -0.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -88.63 138.2 31.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.878 0.371 . . . . 1.05 111.424 179.377 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -108.17 124.86 50.9 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.429 -0.952 . . . . 1.1399999999999999 108.429 177.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 5.0 mt -116.28 135.33 53.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.272 0.558 . . . . 1.0900000000000001 111.625 -178.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.404 ' HB2' ' HB1' ' A' ' 87' ' ' ALA . 4.0 mm? -116.74 112.56 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.508 -0.769 . . . . 1.04 110.889 -179.423 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.542 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 50.5 m-85 -104.26 142.62 34.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.076 -0.511 . . . . 0.25 110.524 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -143.62 112.7 6.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.731 -0.668 . . . . 1.05 109.638 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.8 m120 61.36 45.73 8.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.21 0.529 . . . . 0.72999999999999998 109.729 -178.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.43 3.32 46.93 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.37 -0.832 . . . . 0.19 113.793 178.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -124.67 140.24 53.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.599 0.699 . . . . 1.6499999999999999 112.106 -179.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.5 t -64.68 116.83 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.586 -0.734 . . . . 2.0 110.788 179.08 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.54 -1.11 19.95 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.517 0.562 . . . . 1.1799999999999999 112.517 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 79' ' ' LEU . . . -172.79 147.31 1.71 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.058 -0.519 . . . . 1.0800000000000001 111.78 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 t -137.73 144.5 41.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 2.0699999999999998 110.912 178.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -138.55 139.69 38.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.026 -0.534 . . . . 2.3799999999999999 110.059 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.419 HG11 ' N ' ' A' ' 91' ' ' GLY . 15.0 t -121.32 143.96 31.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.681 0.277 . . . . 1.3 111.239 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.419 ' N ' HG11 ' A' ' 90' ' ' VAL . . . 82.66 160.19 27.77 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.529 -0.843 . . . . 0.20000000000000001 112.607 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.69 155.54 39.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.143 0.497 . . . . 1.1599999999999999 111.638 -179.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.52 151.61 32.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.602 -0.726 . . . . 1.1399999999999999 110.263 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 m -66.92 179.22 1.16 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.428 . . . . 1.1299999999999999 111.294 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -72.64 -30.59 64.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.624 . . . . 1.46 111.478 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.19 -30.59 54.57 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.131 -1.033 . . . . 0.14000000000000001 112.701 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.567 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 51.6 mt-30 -76.17 -28.46 57.34 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.876 -0.33 . . . . 1.5800000000000001 110.632 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -50.72 16.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.067 0.46 . . . . 1.1100000000000001 109.843 178.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.432 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 14.7 ttpt -59.22 -44.25 92.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.736 -0.665 . . . . 1.74 110.908 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.567 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.5 pp20? -61.45 -40.31 94.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.86 -0.609 . . . . 1.3799999999999999 110.574 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -62.38 -42.54 99.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.317 0.58 . . . . 0.29999999999999999 110.645 178.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.1 mt -66.55 -54.95 18.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.778 -0.646 . . . . 1.1299999999999999 109.656 179.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -48.96 -34.05 12.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.169 0.509 . . . . 1.1499999999999999 110.219 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.49 -22.57 61.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.735 -0.666 . . . . 1.03 112.288 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -109.06 -33.32 6.93 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.83 -0.348 . . . . 0.38 111.407 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.456 ' HB2' HD21 ' A' ' 22' ' ' LEU . 3.2 tm? -79.13 103.05 8.8 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.99 -0.374 . . . . 2.02 109.99 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.141 -0.933 . . . . 2.4300000000000002 111.385 -179.51 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.723 HG13 ' HA ' ' A' ' 55' ' ' LEU . 43.1 t . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.808 0.337 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -143.12 120.6 11.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.274 0.559 . . . . 0.0 110.334 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -72.57 125.35 27.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.931 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.857 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -101.02 107.04 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.92 0.391 . . . . 0.0 110.363 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -97.86 20.06 12.75 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.974 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.3 m -156.95 160.13 38.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.838 0.351 . . . . 0.0 111.413 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.657 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.7 ttpt -72.43 -27.03 62.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.969 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.47 -32.13 42.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.383 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.402 ' CB ' HG13 ' A' ' 5' ' ' ILE . . . -66.1 -37.0 84.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.18 -45.2 91.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.027 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -65.31 -44.53 87.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.618 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.76 -45.77 91.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.642 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.55 74.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.07 0.462 . . . . 0.0 110.696 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.37 -35.88 76.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.719 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -62.15 -34.61 76.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.789 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.55 -22.72 53.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.927 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.77 73.35 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.036 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.17 -120.8 21.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.305 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -93.42 1.67 56.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -76.45 148.8 37.01 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.867 HD11 HD12 ' A' ' 79' ' ' LEU . 4.2 tp -76.51 131.51 39.04 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 1.013 HG13 HG23 ' A' ' 53' ' ' ILE . 2.4 t -113.45 109.07 27.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.272 0.558 . . . . 0.0 111.805 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.608 HG11 HD11 ' A' ' 102' ' ' LEU . 7.2 p -104.23 119.2 52.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.632 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.6 m -124.97 167.6 18.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.824 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -135.9 136.56 40.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.923 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.575 ' HE1' HD12 ' A' ' 78' ' ' LEU . 13.6 m-85 -98.67 114.1 26.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.284 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.509 ' O ' HG12 ' A' ' 59' ' ' VAL . 28.9 p -131.78 -171.12 2.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.683 0.754 . . . . 0.0 112.767 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.54 162.3 41.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.546 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 m -63.08 -30.63 71.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.92 0.391 . . . . 0.0 110.045 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -93.32 10.81 30.5 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.188 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.8 t -90.89 113.78 26.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.951 0.405 . . . . 0.0 111.176 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.84 -59.9 3.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.024 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.86 -28.75 69.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.342 2.028 . . . . 0.0 112.311 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.4 m -60.07 -39.87 87.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.803 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -69.11 -20.33 64.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.248 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.5 mtt -74.17 -25.19 59.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.369 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.505 HD11 ' HB1' ' A' ' 92' ' ' ALA . 7.3 mm -89.42 -24.83 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.654 0.264 . . . . 0.0 111.548 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -47.56 -50.17 51.75 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 38.1 Cg_exo -61.9 -44.67 19.57 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.492 2.128 . . . . 0.0 112.826 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.424 ' HB3' ' HD2' ' A' ' 95' ' ' LYS . 22.4 m-85 -80.55 -29.46 37.09 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.453 ' HB2' HG22 ' A' ' 38' ' ' ILE . 5.0 t80 -66.74 -46.43 75.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.072 0.463 . . . . 0.0 110.205 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -39.83 90.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.696 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.5 p -60.69 -42.87 98.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 111.063 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.402 HD22 ' HE1' ' A' ' 49' ' ' TYR . 48.3 mt -60.64 -43.09 97.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.19 -29.42 31.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.222 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -89.05 -21.45 23.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.958 0.409 . . . . 0.0 110.355 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -94.98 3.2 55.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.58 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.543 ' HB3' HG22 ' A' ' 52' ' ' VAL . 7.2 m-85 -109.09 -30.49 8.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 111.058 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 t 36.43 34.41 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.079 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -151.1 -41.36 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.995 0.426 . . . . 0.0 110.858 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 22' ' ' LEU . 17.9 m -94.03 157.4 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.543 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 1.013 HG23 HG13 ' A' ' 23' ' ' VAL . 2.8 tp -106.62 117.45 52.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.331 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.643 ' O ' HG22 ' A' ' 2' ' ' VAL . 5.2 m-85 -100.78 115.61 30.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.308 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.857 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -123.8 165.54 17.14 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.421 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.6 tt0 -116.94 119.56 35.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.115 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.452 HG22 HD11 ' A' ' 55' ' ' LEU . 2.3 t -116.93 119.97 63.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.598 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -99.2 120.67 39.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 28' ' ' SER . 13.9 p -60.73 -18.39 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.722 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -66.92 -37.94 85.28 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.4 -34.5 10.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.736 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.901 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.89 43.35 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.847 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.62 -9.59 50.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.963 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.99 -23.3 17.44 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.521 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.901 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.5 m -78.83 -47.37 23.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.203 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.888 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.97 -57.18 13.32 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.888 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 72.6 Cg_exo -50.69 -28.96 24.08 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.555 2.17 . . . . 0.0 112.101 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -77.86 -22.12 50.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.004 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -107.77 -5.56 17.26 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.886 0.374 . . . . 0.0 111.637 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.03 33.66 87.77 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.909 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 78' ' ' LEU . 59.6 mt -75.96 137.98 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 117.26 0.53 . . . . 0.0 110.593 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -140.94 79.42 1.7 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.96 0.41 . . . . 0.0 111.49 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.42 164.97 10.24 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.015 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.647 ' N ' HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -147.76 154.71 44.37 Favored Pre-proline 0 N--CA 1.464 0.251 0 C-N-CA 122.173 0.189 . . . . 0.0 110.9 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -81.9 118.7 5.84 Favored 'Cis proline' 0 C--N 1.35 0.648 0 C-N-CA 124.772 -0.928 . . . . 0.0 112.779 0.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.513 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -87.36 136.87 32.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.866 0.365 . . . . 0.0 111.318 178.912 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 93' ' ' LEU . 1.3 tp -107.8 119.03 38.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.744 ' CD2' HG23 ' A' ' 88' ' ' THR . 6.0 mt -114.56 135.22 54.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.241 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.919 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 3.7 mm? -115.58 123.4 48.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.726 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.618 ' CE2' HG22 ' A' ' 85' ' ' VAL . 45.8 m-85 -114.37 145.88 41.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.933 0.397 . . . . 0.0 111.177 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -146.85 112.72 5.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.045 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.5 m120 61.51 45.78 8.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 110.221 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.33 2.86 50.99 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.655 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -124.55 140.23 53.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.393 0.597 . . . . 0.0 111.39 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.618 HG22 ' CE2' ' A' ' 80' ' ' PHE . 28.3 t -68.3 116.94 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.728 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.28 11.27 27.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.094 0.474 . . . . 0.0 111.49 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.919 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -175.96 139.62 0.39 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.643 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.744 HG23 ' CD2' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -136.02 116.58 13.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.526 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -120.82 140.98 50.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 110.727 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.3 p -117.04 146.65 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.269 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.48 160.15 12.38 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.491 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 38' ' ' ILE . . . -69.43 163.89 24.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 0.0 111.82 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.568 HD11 HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -153.44 153.81 33.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.462 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.4 m -64.32 178.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.904 0.383 . . . . 0.0 111.133 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.424 ' HD2' ' HB3' ' A' ' 41' ' ' PHE . 1.6 tptm -72.28 -31.19 65.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.053 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.4 -31.34 51.56 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.315 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 17.8 mt-30 -76.91 -30.75 56.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.174 0.487 . . . . 0.0 110.627 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.528 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -72.42 -50.87 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -62.39 -44.44 96.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.997 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.1 pp20? -61.78 -42.49 99.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.83 0.348 . . . . 0.0 110.364 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.701 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 29.4 t80 -63.17 -42.96 99.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.33 0.586 . . . . 0.0 110.36 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.608 HD11 HG11 ' A' ' 24' ' ' VAL . 2.6 mt -65.46 -59.79 3.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.119 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -49.22 -32.21 10.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.466 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.54 -21.51 60.35 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.019 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -108.77 -28.25 9.31 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.553 HD13 ' C ' ' A' ' 106' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 110.697 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.718 HG13 ' HA ' ' A' ' 55' ' ' LEU . 41.5 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.696 0.284 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -146.12 121.36 10.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.224 0.535 . . . . 0.0 110.173 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -72.84 131.59 42.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.679 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.851 HD13 HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -103.17 108.32 24.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.042 0.449 . . . . 0.0 110.474 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.56 20.18 14.39 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.976 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -155.12 161.73 41.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 111.138 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HA ' HG13 ' A' ' 65' ' ' VAL . 26.5 ttpt -75.08 -26.94 59.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.605 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -79.85 -32.01 40.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.512 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.41 88.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.433 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.52 ' CE1' HG21 ' A' ' 57' ' ' VAL . 4.6 t80 -57.06 -42.24 80.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.909 0.385 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.05 -42.95 88.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.91 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -58.14 -46.29 85.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.254 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.25 76.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.64 -43.35 89.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.99 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.48 -26.49 67.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.434 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.17 -49.76 73.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.977 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.36 -64.21 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.778 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.38 -83.04 1.63 Allowed Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.98 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -96.79 -18.55 19.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.82 0.31 . . . . 0.0 111.468 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -73.28 155.46 39.46 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.019 HD11 HD12 ' A' ' 79' ' ' LEU . 5.2 tp -78.17 134.87 37.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.894 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.864 HG13 ' CG2' ' A' ' 53' ' ' ILE . 13.8 t -113.74 110.25 31.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.418 0.627 . . . . 0.0 111.52 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.618 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -104.96 117.17 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.547 HG12 ' HG ' ' A' ' 55' ' ' LEU . 5.5 m -126.4 167.42 21.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.012 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -131.34 133.21 45.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.977 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.779 ' CE1' HD12 ' A' ' 78' ' ' LEU . 5.6 m-85 -97.78 110.56 23.11 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.681 ' O ' HG12 ' A' ' 59' ' ' VAL . 4.5 m -119.79 -168.34 1.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.388 0.613 . . . . 0.0 112.607 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.05 154.89 36.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.455 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -35.02 70.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.41 0.624 . . . . 0.0 109.498 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.452 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 52.7 p-90 -86.84 11.58 12.97 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.652 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.736 ' SG ' HD12 ' A' ' 74' ' ' ILE . 9.6 t -93.36 157.46 16.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.148 0.499 . . . . 0.0 111.705 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.18 -66.57 0.53 Allowed Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.239 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.1 -21.68 72.36 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.568 2.179 . . . . 0.0 112.308 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.23 -42.99 96.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -68.68 -15.66 63.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.495 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 mtp -72.92 -24.66 60.85 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.1 mm -85.46 -22.63 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.654 0.264 . . . . 0.0 111.685 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 28.6 mtpt -50.0 -59.71 6.47 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_endo -49.55 -45.84 29.34 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.535 2.157 . . . . 0.0 112.864 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -79.19 -29.06 42.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -65.55 -45.7 82.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.447 . . . . 0.0 110.375 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -38.06 84.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.867 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -61.79 -43.15 99.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.815 0.341 . . . . 0.0 110.676 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.97 -45.37 92.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.211 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 23.9 p -53.32 -27.21 22.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.554 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -85.21 -22.29 28.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.389 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -95.36 -17.56 21.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.918 0.389 . . . . 0.0 110.219 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.829 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.3 m-85 -99.6 92.66 5.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.879 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.2 m -90.22 49.55 1.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.393 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -153.23 -43.21 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.829 HG22 ' HB3' ' A' ' 49' ' ' TYR . 9.1 m -93.68 155.51 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.906 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.864 ' CG2' HG13 ' A' ' 23' ' ' VAL . 2.9 tp -105.58 114.69 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.918 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.618 ' CE1' HG11 ' A' ' 24' ' ' VAL . 8.0 m-85 -96.7 116.24 28.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.057 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.851 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -130.63 168.8 16.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.34 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.423 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.5 tt0 -121.34 124.16 43.9 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.52 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -117.33 120.44 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.905 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -97.83 119.22 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 28' ' ' SER . 11.2 p -61.39 -19.2 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.71 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.79 -41.03 97.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -98.21 -34.28 10.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.386 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.919 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.1 41.11 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.049 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -9.72 50.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.575 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.26 -23.14 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.422 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.919 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 1.8 m -78.12 -47.05 25.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.052 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.935 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.16 -57.97 11.1 Favored Pre-proline 0 N--CA 1.463 0.183 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.935 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 76.3 Cg_exo -51.07 -29.39 27.95 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.665 2.244 . . . . 0.0 112.262 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -76.72 -22.65 53.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.668 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -108.49 -3.5 18.07 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.842 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.45 35.35 91.22 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.175 -0.536 . . . . 0.0 114.0 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.653 HD11 HD11 ' A' ' 78' ' ' LEU . 76.4 mt -75.66 134.12 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 117.494 0.647 . . . . 0.0 110.689 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -151.58 51.22 0.82 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.909 0.385 . . . . 0.0 111.399 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.77 103.27 0.17 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.377 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.736 HD12 ' SG ' ' A' ' 32' ' ' CYS . 5.2 pt -103.14 153.21 38.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.465 0.174 . . . . 0.0 111.281 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.6 116.07 4.33 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.954 -1.269 . . . . 0.0 112.123 -0.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.02 138.17 31.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.017 0.436 . . . . 0.0 112.156 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.403 HD22 HD11 ' A' ' 93' ' ' LEU . 1.1 mp -107.48 123.43 48.4 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.779 HD12 ' CE1' ' A' ' 27' ' ' PHE . 7.6 mt -114.88 133.02 56.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.236 0.541 . . . . 0.0 111.841 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -115.13 121.99 44.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.921 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.651 ' CE2' HG22 ' A' ' 85' ' ' VAL . 50.7 m-85 -114.04 148.21 37.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.983 0.421 . . . . 0.0 111.397 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -147.05 111.99 5.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.952 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 60.73 46.74 8.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.882 0.372 . . . . 0.0 110.316 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.35 4.68 52.06 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.659 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -125.34 139.54 53.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.19 0.495 . . . . 0.0 111.611 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.651 HG22 ' CE2' ' A' ' 80' ' ' PHE . 27.9 t -67.67 116.14 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.833 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.83 11.11 20.82 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.803 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -174.16 142.19 0.8 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.44 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -137.35 127.57 26.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 111.079 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.42 138.76 52.48 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.143 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 t -121.47 146.08 27.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.694 0.283 . . . . 0.0 111.642 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.43 161.02 23.9 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.849 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.703 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -67.07 164.36 18.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 111.542 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.703 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -159.8 151.15 19.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.051 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.63 178.91 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -70.9 -30.71 67.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.96 -30.99 50.02 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.007 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -77.28 -32.37 55.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.915 0.388 . . . . 0.0 110.617 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.482 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -71.0 -51.74 23.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.33 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -60.95 -38.24 85.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.356 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -61.88 -38.23 87.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.872 0.367 . . . . 0.0 110.268 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.655 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 6.3 t80 -61.48 -41.55 97.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.28 0.562 . . . . 0.0 110.09 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.466 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 6.6 mt -66.92 -56.88 8.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.9 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -50.8 -35.56 32.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.998 0.428 . . . . 0.0 110.193 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.6 -22.72 63.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.71 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -106.43 -55.42 2.33 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.624 0.25 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.639 HD13 HG12 ' A' ' 52' ' ' VAL . 19.8 tp . . . . . 0 N--CA 1.464 0.253 0 CA-C-O 121.064 0.459 . . . . 0.0 110.852 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 55' ' ' LEU . 46.5 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.818 0.342 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -146.53 122.93 10.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.073 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -74.75 131.92 41.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.249 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.87 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -104.28 108.36 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.763 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -97.47 18.93 14.21 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 m -155.15 165.4 36.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.03 0.443 . . . . 0.0 111.523 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.624 ' HA ' HG13 ' A' ' 65' ' ' VAL . 22.3 ttpt -76.89 -26.34 54.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.33 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.0 m -79.78 -33.82 40.25 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.171 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.13 -36.49 83.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.365 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.511 ' CE1' HG21 ' A' ' 57' ' ' VAL . 5.4 t80 -58.85 -43.44 90.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.059 0.457 . . . . 0.0 110.118 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -65.41 -40.51 93.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.715 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -58.93 -50.71 73.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.711 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.2 75.28 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 15' ' ' LEU . 15.6 mt -65.56 -42.92 91.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.891 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.1 -28.28 68.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.545 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.16 -47.31 83.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.11 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.19 -64.27 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.171 -0.611 . . . . 0.0 109.628 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.88 -87.3 1.47 Allowed Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.201 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.34 -15.77 24.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.092 0.446 . . . . 0.0 111.482 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -75.24 155.62 36.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.019 HD11 HD12 ' A' ' 79' ' ' LEU . 8.1 tp -78.63 133.3 37.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.123 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.904 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.4 t -112.06 109.62 29.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.491 0.662 . . . . 0.0 111.413 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.686 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.1 p -104.15 115.11 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.633 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.2 m -122.89 163.98 20.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.306 0.574 . . . . 0.0 112.022 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -128.37 130.81 48.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.582 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.618 ' HE1' HD12 ' A' ' 78' ' ' LEU . 3.4 m-85 -97.52 111.06 23.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.585 ' O ' HG12 ' A' ' 59' ' ' VAL . 35.9 t -119.53 -168.94 1.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.238 0.542 . . . . 0.0 112.303 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.634 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.84 154.6 36.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.864 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -71.95 -37.84 69.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.48 0.657 . . . . 0.0 109.782 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -86.77 11.74 12.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.159 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.634 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 13.8 t -97.29 156.43 16.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.775 0.322 . . . . 0.0 110.926 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.03 -64.29 0.55 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.296 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.02 -24.36 76.63 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.422 2.081 . . . . 0.0 112.042 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -59.71 -45.54 91.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.305 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -64.9 -25.75 68.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 49.6 mmm -66.85 -16.26 64.18 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 8.7 mm -86.12 -21.57 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.731 0.3 . . . . 0.0 111.092 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.512 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -50.87 -58.78 9.08 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 7.4 Cg_endo -48.13 -47.81 18.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.796 2.331 . . . . 0.0 113.063 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -80.09 -30.41 39.22 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 6.1 t80 -65.72 -46.23 79.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.066 0.46 . . . . 0.0 109.942 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -39.57 88.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.729 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 t -61.57 -43.48 98.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.331 . . . . 0.0 110.833 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.47 -40.36 86.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.131 0.491 . . . . 0.0 109.897 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.3 t -56.15 -28.42 57.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.367 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -85.95 -20.52 28.83 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -95.75 -20.56 18.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.105 0.478 . . . . 0.0 110.159 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.83 ' HB3' HG22 ' A' ' 52' ' ' VAL . 16.0 m-85 -97.29 95.74 7.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.539 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -93.93 48.45 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.161 0.505 . . . . 0.0 110.019 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.87 -41.0 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.519 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.83 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.5 m -95.97 154.55 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.979 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.904 ' CG2' HG13 ' A' ' 23' ' ' VAL . 2.8 tp -105.5 113.99 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.833 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.686 ' CE1' HG11 ' A' ' 24' ' ' VAL . 9.3 m-85 -96.28 116.29 28.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.139 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.87 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.67 165.77 19.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.5 178.515 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.407 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -115.83 119.21 35.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -176.451 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.511 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -115.71 118.32 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.181 0.515 . . . . 0.0 111.369 178.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -99.68 121.93 41.94 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.585 HG12 ' O ' ' A' ' 28' ' ' SER . 13.1 p -60.43 -18.98 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.784 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -65.71 -39.09 90.85 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -97.94 -36.67 10.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.534 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.901 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.24 43.47 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.749 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -70.2 -9.77 56.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.509 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -94.04 -23.57 17.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.273 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.901 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -79.14 -46.61 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.036 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.884 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.24 -56.9 14.89 Favored Pre-proline 0 N--CA 1.462 0.175 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.884 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 81.1 Cg_exo -50.93 -28.82 25.06 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.677 2.251 . . . . 0.0 112.128 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -76.13 -18.75 59.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.964 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -115.9 -7.35 12.01 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.946 0.403 . . . . 0.0 111.658 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.05 39.94 97.69 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.038 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 78' ' ' LEU . 62.0 mt -76.97 79.66 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 117.013 0.406 . . . . 0.0 110.162 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -87.19 77.82 8.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.959 0.409 . . . . 0.0 111.774 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.73 162.52 9.3 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.129 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 32' ' ' CYS . 31.2 pt -145.89 156.5 51.57 Favored Pre-proline 0 CA--C 1.529 0.165 0 C-N-CA 122.157 0.183 . . . . 0.0 110.863 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -87.36 116.4 3.51 Favored 'Cis proline' 0 C--N 1.354 0.825 0 C-N-CA 124.578 -1.009 . . . . 0.0 112.481 -0.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.517 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -88.65 138.03 31.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.88 0.371 . . . . 0.0 111.659 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -107.65 125.79 51.79 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.618 HD12 ' HE1' ' A' ' 27' ' ' PHE . 6.3 mt -114.58 133.73 55.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.265 0.555 . . . . 0.0 111.686 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 HD11 ' A' ' 22' ' ' LEU . 2.8 mm? -114.48 117.03 29.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.968 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.512 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 45.3 m-85 -108.08 148.76 29.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.423 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -148.25 113.62 5.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.229 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 58.3 46.66 15.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.932 0.396 . . . . 0.0 110.276 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.83 3.45 55.41 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.918 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -126.26 140.51 52.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.252 0.526 . . . . 0.0 111.667 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 85' ' ' VAL . 11.1 p -68.24 119.0 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.911 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -117.05 11.46 14.25 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.866 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.18 140.23 0.85 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.398 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.0 141.15 46.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.049 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -142.48 136.81 29.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.181 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.4 t -120.32 146.3 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.79 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.518 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.27 159.57 23.26 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.857 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.63 132.3 47.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.974 0.416 . . . . 0.0 111.324 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.704 HD11 HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -113.88 -173.5 2.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.365 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 t -110.03 164.89 12.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.9 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -55.63 -38.01 68.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.769 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.05 -31.7 51.9 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.872 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 43.0 mt-30 -76.18 -31.86 58.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.012 0.406 . . . . 0.0 110.507 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.07 -50.13 30.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -61.51 -43.96 97.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.94 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -61.87 -40.09 94.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.256 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.8 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 30.0 t80 -63.09 -42.12 99.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.293 0.568 . . . . 0.0 110.728 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.612 HD11 HG11 ' A' ' 24' ' ' VAL . 3.0 mt -68.02 -56.15 9.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.318 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.99 -34.69 21.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.916 0.389 . . . . 0.0 110.471 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.31 -19.69 60.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.23 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -107.0 -34.7 7.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.84 0.352 . . . . 0.0 110.943 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.75 HD13 HG12 ' A' ' 52' ' ' VAL . 53.2 tp . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.105 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.708 HG13 ' HA ' ' A' ' 55' ' ' LEU . 61.6 t . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.755 0.312 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.4 121.97 11.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.117 0.484 . . . . 0.0 110.238 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -74.01 130.05 39.08 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.027 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.857 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -102.97 108.55 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.994 0.426 . . . . 0.0 110.337 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -100.59 19.74 16.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.143 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.26 160.16 40.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.935 0.397 . . . . 0.0 111.071 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.626 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -71.18 -28.64 64.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.002 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.49 -30.59 42.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.983 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.6 90.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.683 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -57.63 -43.8 85.1 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.92 0.39 . . . . 0.0 110.098 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -65.38 -44.1 88.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.589 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -58.37 -46.13 86.92 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.313 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.83 -32.31 73.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.043 0.449 . . . . 0.0 110.606 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 mt -68.23 -38.58 82.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.99 -35.32 76.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.398 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.5 -22.5 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.685 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.14 -34.59 78.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.007 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.2 -123.43 31.19 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.25 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.32 6.22 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.599 0.237 . . . . 0.0 111.414 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -79.21 149.77 31.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.968 HD11 HD12 ' A' ' 79' ' ' LEU . 6.4 tp -76.16 133.21 40.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.869 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.8 t -111.41 111.43 36.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.523 0.678 . . . . 0.0 112.026 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.68 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -105.8 113.92 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.593 HG12 ' HG ' ' A' ' 55' ' ' LEU . 4.6 m -124.21 167.04 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.203 0.525 . . . . 0.0 112.007 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -134.28 134.34 41.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.023 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.598 ' CE1' HD12 ' A' ' 78' ' ' LEU . 6.7 m-85 -96.91 108.8 21.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.331 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 35' ' ' CYS . 50.9 p -115.69 -169.44 1.59 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.366 0.603 . . . . 0.0 112.355 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.8 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.09 154.8 36.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.405 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -71.5 -36.91 71.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.563 0.697 . . . . 0.0 109.53 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 p-90 -87.77 11.28 15.8 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.6 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.8 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 12.7 t -91.48 156.1 17.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.11 0.481 . . . . 0.0 112.145 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.28 -75.49 1.0 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.67 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.86 -20.84 30.64 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.702 2.268 . . . . 0.0 112.569 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 85.0 m -58.85 -43.87 90.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 110.757 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -68.45 -20.16 64.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.512 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 19.4 mtt -71.44 -23.71 61.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.398 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.3 mm -86.43 -24.17 6.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.725 0.298 . . . . 0.0 111.503 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -50.55 -52.9 51.44 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.004 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.54 -47.92 24.62 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.498 2.132 . . . . 0.0 113.107 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -80.34 -26.88 38.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.63 -45.49 82.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.047 0.451 . . . . 0.0 110.226 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.7 -41.47 83.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.988 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.1 t -59.82 -45.05 93.57 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.922 0.391 . . . . 0.0 111.065 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.78 -41.08 85.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.151 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 m -55.68 -26.31 44.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.285 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -87.44 -20.83 26.07 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.624 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -95.41 -19.48 19.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 0.0 110.077 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.825 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.6 m-85 -99.28 92.15 5.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.705 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 t -88.58 49.06 1.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.877 0.37 . . . . 0.0 110.743 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -153.79 -41.17 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.825 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.9 m -93.24 154.88 3.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.831 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.869 ' CG2' HG13 ' A' ' 23' ' ' VAL . 5.3 tp -105.46 114.34 44.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.907 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.68 ' CE1' HG11 ' A' ' 24' ' ' VAL . 8.6 m-85 -96.43 115.76 27.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.377 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.857 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.77 167.2 17.64 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.343 178.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.0 tp10 -119.83 122.15 40.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -176.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.81 120.18 64.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.333 0.587 . . . . 0.0 111.133 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -100.23 119.34 38.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.77 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -60.95 -18.02 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.989 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -64.61 -39.37 93.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 109.681 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.59 -33.9 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.526 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.92 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.91 43.68 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.66 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -70.44 -9.58 56.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.658 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.98 -23.22 17.48 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.289 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.92 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.0 m -77.67 -47.6 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.546 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.91 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.2 -57.75 11.81 Favored Pre-proline 0 N--CA 1.462 0.137 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.91 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 76.9 Cg_exo -51.58 -28.62 29.46 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.5 2.133 . . . . 0.0 111.903 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -76.04 -20.04 58.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.761 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -111.57 -4.89 14.62 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.852 0.358 . . . . 0.0 111.852 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.0 35.87 91.24 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.556 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.696 HD11 HD11 ' A' ' 78' ' ' LEU . 91.5 mt -75.9 135.98 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 117.173 0.486 . . . . 0.0 110.655 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 -146.86 62.63 1.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.04 0.448 . . . . 0.0 111.286 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.404 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 176.71 160.88 24.58 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.588 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.492 HD12 ' SG ' ' A' ' 32' ' ' CYS . 36.3 pt -146.31 137.4 12.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 O-C-N 122.995 -0.121 . . . . 0.0 110.764 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -89.88 122.14 5.1 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 124.749 -0.938 . . . . 0.0 112.092 0.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -86.56 137.01 32.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.117 0.484 . . . . 0.0 112.189 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.533 HD21 HD21 ' A' ' 98' ' ' LEU . 1.1 tp -108.97 122.74 47.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 177.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 71' ' ' ILE . 7.0 mt -115.01 136.48 53.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.236 0.541 . . . . 0.0 111.689 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.968 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -117.4 123.33 46.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.039 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.667 ' CE2' HG22 ' A' ' 85' ' ' VAL . 52.0 m-85 -115.27 147.53 40.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.143 0.497 . . . . 0.0 111.503 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -146.41 111.84 5.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.098 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 60.59 46.53 9.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.392 . . . . 0.0 110.321 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.02 0.6 52.79 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.955 -0.641 . . . . 0.0 114.009 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -123.25 138.93 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.626 0.713 . . . . 0.0 111.592 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.667 HG22 ' CE2' ' A' ' 80' ' ' PHE . 39.9 t -67.62 117.98 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.451 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.18 8.8 21.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.831 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.26 141.82 1.29 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.673 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 t -137.68 127.94 26.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.157 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.04 137.97 50.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.09 146.27 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.577 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.89 165.24 30.99 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.27 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.631 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -67.27 171.78 5.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 111.521 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.757 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -162.14 -170.6 2.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.491 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.58 166.25 11.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.773 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -57.79 -32.81 67.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.958 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.43 -30.72 53.27 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.795 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 42.3 mt-30 -77.34 -31.15 54.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.729 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.757 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -71.73 -51.33 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -63.45 -44.38 94.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.195 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.1 pp20? -60.71 -42.29 96.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.948 0.404 . . . . 0.0 110.102 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.68 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 22.1 t80 -62.42 -40.6 97.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.387 0.613 . . . . 0.0 110.013 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.555 HD21 ' HB ' ' A' ' 24' ' ' VAL . 3.8 mt -64.13 -62.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.846 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.12 -32.01 6.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.27 -24.85 62.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.924 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -108.29 -28.96 9.13 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.802 0.334 . . . . 0.0 111.282 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 22' ' ' LEU . 2.7 tt . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.788 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.765 HG13 ' HA ' ' A' ' 55' ' ' LEU . 46.5 t . . . . . 0 C--O 1.233 0.184 0 CA-C-O 120.843 0.354 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.51 119.9 10.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -73.48 129.57 38.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.873 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -101.81 108.33 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.279 0.561 . . . . 0.0 111.106 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -98.86 19.81 14.28 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.861 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -154.44 158.84 40.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.97 0.414 . . . . 0.0 111.308 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.66 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.0 ttpt -71.45 -29.47 64.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -31.03 38.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.78 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.46 81.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.623 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.514 ' CE1' HG21 ' A' ' 57' ' ' VAL . 3.9 t80 -59.25 -43.89 92.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.166 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.17 -39.89 94.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.552 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -58.99 -48.88 79.97 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.28 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.35 -33.98 76.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 111.015 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 15' ' ' LEU . 15.1 mt -66.95 -40.68 87.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.435 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.59 -28.68 67.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.489 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.62 77.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.08 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.02 -64.83 0.78 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.544 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.88 -82.47 1.52 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.322 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -95.49 -18.63 20.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.661 0.267 . . . . 0.0 111.556 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -75.11 154.8 37.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.954 HD11 HD12 ' A' ' 79' ' ' LEU . 4.1 tp -78.77 136.11 37.29 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.78 ' N ' HD12 ' A' ' 22' ' ' LEU . 6.0 t -116.58 106.59 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.034 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.659 HG23 HD21 ' A' ' 79' ' ' LEU . 10.4 p -102.54 119.12 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 78' ' ' LEU . 4.9 m -127.15 167.55 21.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.856 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.61 ' OD1' HD12 ' A' ' 77' ' ' LEU . 24.8 t70 -133.42 136.0 44.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.772 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.666 ' CE1' HD12 ' A' ' 78' ' ' LEU . 3.6 m-85 -100.89 111.12 23.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 p -121.39 -167.91 1.59 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.439 0.638 . . . . 0.0 112.366 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.54 154.07 34.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.169 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -33.96 68.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.523 0.678 . . . . 0.0 109.826 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.484 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 51.6 p-90 -86.9 10.52 15.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.912 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 12.2 t -95.15 158.05 15.63 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.142 -0.349 . . . . 0.0 111.529 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.1 -65.64 0.59 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.256 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.34 -22.79 66.02 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.406 2.071 . . . . 0.0 112.404 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.7 m -61.8 -44.36 97.02 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.015 0.436 . . . . 0.0 110.595 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -64.51 -28.11 69.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.198 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.4 mtt -67.15 -16.0 64.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.0 mm -86.89 -22.38 7.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.656 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 33.1 mtpt -50.97 -60.41 5.63 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 1.3 Cg_endo -47.06 -46.54 18.79 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.634 2.222 . . . . 0.0 113.059 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -80.41 -32.35 37.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.471 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 6.4 t80 -67.2 -44.83 78.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.941 0.4 . . . . 0.0 110.177 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -38.18 84.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.593 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.7 t -60.67 -43.32 97.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.927 0.394 . . . . 0.0 110.496 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.2 mt -59.48 -40.06 85.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.332 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 m -54.07 -27.4 32.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.24 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -88.12 -21.75 24.49 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.646 0.26 . . . . 0.0 111.4 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -94.16 -21.63 18.96 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.777 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.0 m-85 -96.43 97.29 9.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.95 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -96.1 43.98 1.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.736 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.26 11.37 0.27 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.777 HG22 ' HB3' ' A' ' 49' ' ' TYR . 19.2 m -144.3 157.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 120.423 0.154 . . . . 0.0 111.142 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.775 ' CG2' HG13 ' A' ' 23' ' ' VAL . 3.1 tp -106.34 115.25 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.237 0.541 . . . . 0.0 110.618 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.686 ' O ' HG22 ' A' ' 2' ' ' VAL . 6.5 m-85 -97.78 115.91 28.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.858 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.873 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.65 168.01 15.63 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.63 178.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.422 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -119.59 121.48 39.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.394 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.514 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.1 t -118.92 119.11 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.276 0.56 . . . . 0.0 111.396 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -98.99 120.74 39.93 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.33 -19.42 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.14 -40.2 96.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.263 0.554 . . . . 0.0 110.004 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -98.78 -35.71 10.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.196 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.919 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.17 45.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.669 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -71.95 -11.18 60.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.547 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.7 -21.26 19.46 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.419 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.919 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.5 m -80.04 -46.51 22.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.696 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.902 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.66 -57.96 11.62 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.902 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 53.3 Cg_exo -52.72 -28.64 38.66 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.619 2.213 . . . . 0.0 111.956 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -76.39 -25.59 54.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.126 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -105.94 -2.38 22.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.02 36.11 91.55 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.172 -0.537 . . . . 0.0 114.051 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.741 HD11 HD11 ' A' ' 78' ' ' LEU . 79.3 mt -77.55 133.95 29.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.458 0.629 . . . . 0.0 110.443 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -150.72 54.43 0.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.944 0.402 . . . . 0.0 111.383 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 170.09 105.42 0.18 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.922 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 pt -103.04 153.86 38.0 Favored Pre-proline 0 N--CA 1.463 0.198 0 C-N-CA 122.167 0.187 . . . . 0.0 110.829 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.38 114.78 3.47 Favored 'Cis proline' 0 C--N 1.353 0.767 0 C-N-CA 124.198 -1.167 . . . . 0.0 112.757 -0.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.428 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -88.33 136.75 32.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.957 0.408 . . . . 0.0 111.359 179.336 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.661 HD13 HD21 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -106.98 121.02 43.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.125 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.741 HD11 HD11 ' A' ' 71' ' ' ILE . 10.1 mt -112.37 135.51 52.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.513 0.673 . . . . 0.0 111.874 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.954 HD12 HD11 ' A' ' 22' ' ' LEU . 3.6 mm? -117.37 126.18 52.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.845 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.558 ' CE2' HG22 ' A' ' 85' ' ' VAL . 47.9 m-85 -117.14 147.12 42.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.196 0.522 . . . . 0.0 111.267 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 tttm -148.26 115.31 6.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.99 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 m120 57.79 44.62 19.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 110.209 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.02 5.68 62.39 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.911 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -126.06 142.6 51.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.379 0.589 . . . . 0.0 111.483 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.558 HG22 ' CE2' ' A' ' 80' ' ' PHE . 21.8 t -70.05 119.19 15.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.655 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -115.08 12.34 16.62 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.91 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.37 138.91 0.43 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.17 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -134.59 133.23 39.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.693 0.282 . . . . 0.0 110.805 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.66 139.55 45.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.82 146.3 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.5 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.13 162.43 28.58 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.216 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.58 133.62 47.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.193 0.521 . . . . 0.0 111.548 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.661 HD21 HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -116.08 -175.46 2.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.431 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.82 162.66 14.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.53 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -52.4 -37.76 57.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.509 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.58 -29.3 55.71 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.437 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -77.2 -33.23 56.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.586 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -50.88 32.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -42.24 90.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.389 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -62.58 -38.17 89.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.772 0.32 . . . . 0.0 110.483 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.91 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 9.7 t80 -63.77 -42.86 97.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.406 0.622 . . . . 0.0 110.103 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.516 HD21 ' HB ' ' A' ' 24' ' ' VAL . 4.4 mt -64.8 -62.48 1.54 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.953 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.86 -34.31 12.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.098 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.19 -20.33 60.91 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -108.99 -38.1 5.66 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 111.598 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.436 ' C ' HD23 ' A' ' 106' ' ' LEU . 3.9 tt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.094 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.714 HG13 ' HA ' ' A' ' 55' ' ' LEU . 47.4 t . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 120.997 0.427 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -145.02 121.95 11.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.202 0.525 . . . . 0.0 110.162 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -74.4 128.93 36.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.224 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.833 HD13 HD13 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -99.79 108.74 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 0.0 110.39 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -100.34 19.52 16.48 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.96 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.31 160.48 38.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.958 0.409 . . . . 0.0 111.165 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -73.67 -26.33 60.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -79.63 -31.56 41.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.229 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.56 -38.69 90.31 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -56.99 -41.48 78.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.068 0.461 . . . . 0.0 110.051 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -66.37 -45.0 81.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.933 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -58.86 -49.03 79.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.63 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.65 -32.46 73.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.933 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 mt -67.71 -36.87 81.4 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.247 0.546 . . . . 0.0 110.274 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.23 -33.53 73.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.17 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.68 -23.1 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.154 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.95 84.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.073 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.63 -121.13 25.62 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.369 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -94.84 2.63 55.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -78.07 147.14 34.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.96 HD11 HD12 ' A' ' 79' ' ' LEU . 8.0 tp -74.27 132.23 41.91 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.947 HG13 HG23 ' A' ' 53' ' ' ILE . 5.3 t -110.48 108.87 26.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.547 0.689 . . . . 0.0 112.13 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.631 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.1 p -102.92 114.39 42.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.695 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.4 m -121.11 162.16 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.658 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -126.24 131.08 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.24 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.49 ' CE1' HD12 ' A' ' 78' ' ' LEU . 3.4 m-85 -97.29 107.49 20.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.326 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.5 m -132.45 146.93 52.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.034 0.445 . . . . 0.0 111.813 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -96.29 159.03 15.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.611 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -70.56 -37.55 74.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.634 0.73 . . . . 0.0 109.143 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -86.08 14.66 5.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.937 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 21.6 t -91.56 157.09 17.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.887 0.375 . . . . 0.0 111.393 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.7 -73.33 0.91 Allowed Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.386 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.45 -24.91 45.98 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.325 2.017 . . . . 0.0 112.491 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.8 m -58.14 -40.85 82.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.9 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -66.75 -22.84 66.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.541 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 40.1 mtt -68.92 -19.97 64.21 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.2 mm -89.0 -25.24 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.75 0.309 . . . . 0.0 111.628 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.39 -53.18 47.79 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.2 -49.93 14.91 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.619 2.213 . . . . 0.0 113.309 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -80.26 -27.33 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -64.85 -44.5 89.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.034 0.445 . . . . 0.0 110.314 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.64 -41.23 79.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.947 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -58.46 -44.44 89.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 110.596 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mt -59.82 -39.5 85.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.471 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 10.7 p -56.96 -27.35 61.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -87.78 -19.48 27.46 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.683 0.277 . . . . 0.0 111.66 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -95.53 -22.93 17.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.114 0.483 . . . . 0.0 110.012 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.808 ' HB3' HG22 ' A' ' 52' ' ' VAL . 16.6 m-85 -96.34 97.41 9.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.619 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.2 t -93.66 47.26 1.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.285 0.564 . . . . 0.0 109.813 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -150.15 -42.83 0.13 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.934 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.808 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.3 m -94.83 155.87 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.828 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.947 HG23 HG13 ' A' ' 23' ' ' VAL . 5.9 tp -106.88 112.72 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.24 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.659 ' O ' HG22 ' A' ' 2' ' ' VAL . 8.7 m-85 -94.4 115.33 27.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.729 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.45 167.57 16.86 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.643 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.434 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.1 tt0 -118.82 119.52 34.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.228 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.439 HG22 HD11 ' A' ' 55' ' ' LEU . 2.8 t -116.68 119.27 61.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -99.6 119.38 37.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.737 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 p -59.86 -18.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -64.89 -38.33 90.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.128 0.489 . . . . 0.0 109.87 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -100.15 -35.53 9.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.381 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.898 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.59 44.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.953 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.91 -11.02 60.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.924 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.4 -21.68 18.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.339 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.898 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.8 m -79.77 -47.53 21.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.101 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.641 ' HB3' ' CD ' ' A' ' 67' ' ' PRO . . . -50.97 -60.45 5.56 Favored Pre-proline 0 N--CA 1.466 0.336 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.641 ' CD ' ' HB3' ' A' ' 66' ' ' ALA . 6.8 Cg_endo -48.38 -27.95 10.81 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.732 2.288 . . . . 0.0 112.153 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.3 -25.24 57.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.628 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -106.49 -4.21 20.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.806 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.78 36.88 87.99 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.232 -0.508 . . . . 0.0 113.865 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.594 HD11 HD11 ' A' ' 78' ' ' LEU . 84.3 mt -76.37 133.92 30.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 117.18 0.49 . . . . 0.0 110.523 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -141.87 69.85 1.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.01 0.433 . . . . 0.0 111.887 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.03 166.68 15.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.57 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.646 ' N ' HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -150.92 149.45 25.28 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -85.69 121.2 6.36 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 124.311 -1.12 . . . . 0.0 112.507 -0.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 136.54 32.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.885 0.374 . . . . 0.0 111.669 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.478 HD21 HD21 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -107.99 122.43 46.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.546 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 71' ' ' ILE . 6.7 mt -114.5 135.54 54.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.335 0.588 . . . . 0.0 111.298 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.96 HD12 HD11 ' A' ' 22' ' ' LEU . 3.2 mm? -116.61 122.48 44.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.404 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.52 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 51.6 m-85 -115.3 147.67 40.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.134 0.492 . . . . 0.0 111.781 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -146.55 113.42 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.378 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 m120 60.24 45.16 11.78 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.86 0.362 . . . . 0.0 110.283 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.5 2.84 56.52 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.708 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -124.34 139.16 54.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.253 0.526 . . . . 0.0 111.591 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 85' ' ' VAL . 11.5 p -69.14 120.59 16.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.88 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.22 10.93 17.35 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.901 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.07 137.24 0.4 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.779 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.524 HG23 ' CD2' ' A' ' 78' ' ' LEU . 48.2 m -139.3 122.08 16.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.828 0.347 . . . . 0.0 111.088 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -120.77 145.21 47.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.38 146.82 25.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.465 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.17 162.3 23.19 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.064 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.491 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -68.31 158.21 33.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.501 . . . . 0.0 111.662 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -154.97 151.43 28.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.399 -179.451 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 m -68.77 -178.17 1.13 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.989 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -72.69 -29.93 63.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.77 -33.6 41.61 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.269 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -74.88 -31.84 61.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.065 0.459 . . . . 0.0 110.381 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.485 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -71.38 -50.18 34.72 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.063 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -61.41 -41.25 96.84 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.013 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -60.67 -37.91 83.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.948 0.404 . . . . 0.0 110.066 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.901 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 6.8 t80 -63.18 -42.56 99.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.429 0.633 . . . . 0.0 110.323 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.555 HD21 ' HB ' ' A' ' 24' ' ' VAL . 6.3 mt -65.87 -58.31 5.89 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.231 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.52 -36.21 22.6 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.933 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.56 -20.96 61.23 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.501 ' HB3' HD21 ' A' ' 22' ' ' LEU . 8.4 t30 -108.34 -32.28 7.51 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.899 0.381 . . . . 0.0 111.459 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 22' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.19 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.72 HG13 ' HA ' ' A' ' 55' ' ' LEU . 40.3 t . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 120.915 0.388 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.404 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -144.0 121.29 11.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.266 0.555 . . . . 0.0 110.332 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -74.8 127.98 34.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.04 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.887 HG23 ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -100.66 106.93 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.067 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -95.87 16.81 16.65 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.108 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 p -155.4 161.95 40.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.776 0.322 . . . . 0.0 111.394 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.606 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -72.85 -24.54 60.9 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.714 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.54 -32.32 42.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.509 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.887 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -65.95 -39.81 90.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.81 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.455 ' HB2' HG21 ' A' ' 5' ' ' ILE . 3.9 t80 -57.27 -42.6 81.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.872 0.368 . . . . 0.0 110.019 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -68.39 -45.21 73.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.807 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -57.55 -45.56 84.97 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.048 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -32.1 73.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.667 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.11 -38.43 78.91 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.64 -34.32 74.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.055 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.47 -22.66 54.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.042 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.4 -34.6 77.59 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.188 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.89 -123.13 32.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.27 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -93.41 5.24 52.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.591 0.234 . . . . 0.0 111.327 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -79.33 150.42 31.46 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.965 HD11 HD12 ' A' ' 79' ' ' LEU . 4.8 tp -77.05 131.85 38.62 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.906 HG13 HG23 ' A' ' 53' ' ' ILE . 4.2 t -112.12 108.62 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.566 0.698 . . . . 0.0 111.479 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.62 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -103.26 115.56 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.617 HG23 ' HB2' ' A' ' 78' ' ' LEU . 5.0 m -124.65 167.42 18.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.763 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.503 ' OD1' HD12 ' A' ' 77' ' ' LEU . 37.5 t0 -136.05 136.86 40.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.966 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.514 ' HE1' HD12 ' A' ' 78' ' ' LEU . 9.7 m-85 -99.46 113.59 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.274 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.573 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.6 m -122.82 -166.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.287 0.565 . . . . 0.0 112.199 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.0 154.05 35.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -72.23 -35.17 68.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.38 0.61 . . . . 0.0 109.716 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.417 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 54.6 p-90 -87.14 10.76 15.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.33 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 25.0 t -96.51 156.83 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 0.0 111.591 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.59 -71.05 0.76 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.286 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.72 -26.52 47.4 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.481 2.121 . . . . 0.0 112.231 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.3 m -58.94 -44.6 91.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.344 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.77 -24.22 66.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.431 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.5 mmt -67.97 -18.62 64.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.1 mm -87.27 -24.59 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.703 0.287 . . . . 0.0 111.115 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -52.91 -53.66 52.51 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.56 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.45 -50.01 13.21 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.703 2.269 . . . . 0.0 113.164 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.411 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 17.5 m-85 -80.07 -27.55 39.32 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.442 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 4.0 t80 -66.02 -45.42 81.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.107 0.479 . . . . 0.0 110.239 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -42.3 84.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.786 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -60.14 -43.76 95.48 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.898 0.38 . . . . 0.0 110.744 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.1 mt -60.09 -39.76 87.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.406 ' HB2' ' CB ' ' A' ' 54' ' ' PHE . 37.8 t -56.45 -27.7 57.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.245 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -87.89 -18.08 30.0 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.717 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.78 -20.58 18.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.966 0.413 . . . . 0.0 110.09 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.798 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.1 m-85 -99.27 92.83 5.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.476 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.2 p -88.85 50.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.052 0.453 . . . . 0.0 110.489 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -153.3 -41.21 0.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.985 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.798 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.8 m -94.38 154.92 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.847 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.906 HG23 HG13 ' A' ' 23' ' ' VAL . 3.4 tp -105.44 113.32 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.361 0.601 . . . . 0.0 111.215 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.62 ' CE1' HG11 ' A' ' 24' ' ' VAL . 7.4 m-85 -95.3 115.99 28.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.502 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.72 ' HA ' HG13 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -127.38 165.23 20.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.603 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.3 tp10 -116.39 119.01 34.31 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.1 117.34 55.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.186 0.517 . . . . 0.0 110.82 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -98.81 120.68 39.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 28' ' ' SER . 14.8 p -60.08 -18.02 15.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.127 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -67.18 -37.69 84.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -99.88 -35.31 9.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.498 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.913 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.67 43.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.547 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -68.79 -10.35 56.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.718 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.76 -22.92 17.77 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.424 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.913 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -78.83 -47.35 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.31 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.881 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.6 -56.41 16.9 Favored Pre-proline 0 N--CA 1.462 0.145 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.881 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 72.1 Cg_exo -51.77 -28.19 29.53 Favored 'Trans proline' 0 N--CA 1.466 -0.122 0 C-N-CA 122.557 2.172 . . . . 0.0 112.102 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -76.98 -15.47 59.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.997 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -118.5 -7.71 10.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.653 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.32 39.49 95.96 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.304 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.614 HG23 HG21 ' A' ' 76' ' ' THR . 56.4 mt -78.21 79.36 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 117.133 0.467 . . . . 0.0 110.892 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 ttt85 -86.31 78.04 9.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.048 0.452 . . . . 0.0 111.62 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.99 166.05 10.73 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.542 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 pt -148.55 154.32 41.07 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 122.309 0.243 . . . . 0.0 110.704 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -87.14 115.78 3.32 Favored 'Cis proline' 0 C--N 1.352 0.756 0 C-N-CA 124.211 -1.162 . . . . 0.0 112.597 0.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.614 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -87.24 137.18 32.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.909 0.385 . . . . 0.0 111.727 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.503 HD12 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -108.45 125.02 51.3 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.949 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.617 ' HB2' HG23 ' A' ' 25' ' ' VAL . 6.4 mt -113.93 134.61 54.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.376 0.607 . . . . 0.0 111.808 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.965 HD12 HD11 ' A' ' 22' ' ' LEU . 2.8 mm? -115.15 119.83 37.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.791 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.59 ' CE2' HG22 ' A' ' 85' ' ' VAL . 52.3 m-85 -112.98 147.88 36.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.179 0.514 . . . . 0.0 111.827 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -147.37 113.18 5.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.309 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 m120 60.6 45.94 9.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.037 0.446 . . . . 0.0 110.194 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.29 2.46 48.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.669 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -124.61 138.59 54.3 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.257 0.528 . . . . 0.0 111.813 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.59 HG22 ' CE2' ' A' ' 80' ' ' PHE . 42.9 t -67.16 116.84 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.647 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -113.07 11.47 18.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.97 0.414 . . . . 0.0 111.907 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.816 ' HB3' ' CB ' ' A' ' 79' ' ' LEU . . . -173.17 138.16 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.101 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -136.46 125.51 24.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 111.102 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.98 139.32 53.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.281 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.07 146.07 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.628 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.1 164.1 33.54 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.121 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.658 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -65.69 165.62 12.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.053 0.454 . . . . 0.0 111.744 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.658 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -163.02 144.74 10.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.632 -179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.7 m -64.41 -177.92 0.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -73.18 -30.96 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.429 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.54 -30.08 54.1 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.79 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 34.3 mt-30 -76.45 -33.08 58.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.97 0.414 . . . . 0.0 110.681 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.555 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -70.61 -51.15 30.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.803 179.226 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -60.88 -40.75 94.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.214 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -60.98 -39.19 88.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.786 0.327 . . . . 0.0 110.128 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.768 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 6.8 t80 -60.94 -39.85 91.03 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.333 0.587 . . . . 0.0 109.98 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.507 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 7.2 mt -66.92 -58.46 4.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.344 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.01 -36.39 28.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.827 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.08 -23.81 63.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.032 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -105.89 -53.1 2.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.754 0.312 . . . . 0.0 111.372 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.525 ' O ' HD23 ' A' ' 106' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.023 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.738 HG13 ' HA ' ' A' ' 55' ' ' LEU . 52.8 t . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 109.573 -0.528 . . . . 0.42 109.573 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.524 ' O ' HD12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -143.42 124.52 14.47 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 118.764 -1.174 . . . . 1.43 111.975 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -76.5 120.21 21.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.953 -1.476 . . . . 2.28 110.427 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.112 HG23 ' HB3' ' A' ' 10' ' ' ALA . 3.1 mp -101.55 113.56 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.797 -0.361 . . . . 0.36 111.163 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HG2' ' OD2' ' A' ' 61' ' ' ASP . 8.4 mt-10 -100.94 15.97 26.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.104 -0.498 . . . . 1.38 112.276 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.452 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.4 m -153.5 160.27 42.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.908 0.385 . . . . 0.98 111.246 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.477 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.1 ttpt -75.55 -23.32 56.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.238 -0.437 . . . . 1.65 111.092 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 m -79.42 -29.98 42.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.698 -0.482 . . . . 0.8 109.698 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 1.112 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -68.52 -41.77 79.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.68 -0.691 . . . . 0.24 110.453 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -56.51 -49.41 74.79 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.031 -0.531 . . . . 1.13 110.501 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -61.45 -37.17 82.61 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.691 -0.855 . . . . 0.94 108.691 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -62.18 -44.37 96.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.937 -1.029 . . . . 1.4 111.893 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.04 -33.22 67.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.904 0.383 . . . . 0.28 111.367 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 mt -64.57 -40.64 95.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.319 0.581 . . . . 0.4 110.587 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.95 -29.53 69.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 1.84 110.525 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.17 -23.86 51.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.43 111.67 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.446 ' HB1' HG22 ' A' ' 23' ' ' VAL . . . -72.35 -26.72 62.02 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.66 111.288 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.96 -117.65 6.32 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 119.63 -1.271 . . . . 1.04 113.277 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.59 10.34 37.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.54 0.209 . . . . 2.36 111.207 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -82.53 151.11 26.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.88 -0.415 . . . . 1.82 109.88 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.885 HD11 ' CD1' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -76.21 121.28 22.67 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.612 -0.514 . . . . 0.28 109.612 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.875 HG13 ' CG2' ' A' ' 53' ' ' ILE . 2.6 t -101.63 111.9 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.725 0.774 . . . . 0.22 112.065 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.673 HG11 ' CE1' ' A' ' 54' ' ' PHE . 9.1 p -108.27 122.19 62.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.663 -1.236 . . . . 0.36 107.663 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.037 HG12 ' HG ' ' A' ' 55' ' ' LEU . 11.4 m -133.13 141.97 43.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.523 0.678 . . . . 0.67 112.051 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -107.74 131.04 54.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.374 -0.83 . . . . 1.13 112.403 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.405 ' HE1' HD12 ' A' ' 78' ' ' LEU . 2.7 m-85 -96.24 110.28 22.61 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.663 -0.866 . . . . 0.28 108.663 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 59' ' ' VAL . 3.3 p -121.14 -168.76 1.72 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.706 0.632 . . . . 1.03 112.706 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.06 156.1 39.25 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.133 -0.94 . . . . 0.37 110.693 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -37.84 74.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.309 0.576 . . . . 1.14 110.184 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 28.4 p-90 -86.61 10.77 14.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.99 -1.004 . . . . 0.99 111.499 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 37.3 t -100.24 140.47 34.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.786 0.327 . . . . 0.99 110.244 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.48 -65.65 0.9 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.614 -0.803 . . . . 0.36 112.481 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.98 -30.98 25.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.554 2.169 . . . . 0.68 111.769 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 79.4 m -58.51 -40.21 82.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.735 -0.666 . . . . 0.65 110.621 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -70.68 -26.4 63.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.941 -0.572 . . . . 2.15 111.234 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.5 mmt -69.02 -20.64 64.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.479 . . . . 1.48 111.292 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.9 mm -87.8 -18.21 8.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.793 0.33 . . . . 0.61 110.616 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.81 -54.73 40.31 Favored Pre-proline 0 CA--C 1.528 0.132 0 CA-C-N 116.495 -0.32 . . . . 2.12 110.726 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.68 -51.62 10.04 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.657 2.238 . . . . 0.47 112.766 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -75.21 -36.18 61.4 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.488 -0.323 . . . . 0.56 111.466 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.543 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 7.0 t80 -64.81 -46.36 82.33 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.54 -0.464 . . . . 0.38 109.999 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -67.28 -42.11 84.37 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.542 0.201 . . . . 0.98 111.542 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -60.32 -46.87 88.37 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.918 -0.313 . . . . 1.19 110.742 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.7 mt -54.13 -36.44 63.28 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.35 -0.611 . . . . 0.32 109.35 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 43' ' ' HIS . 22.7 t -57.87 -26.33 61.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.294 -0.866 . . . . 1.3 111.117 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.3 -17.64 28.54 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.712 0.291 . . . . 2.3 111.035 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 1.6 ttpp -97.05 -15.15 21.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.091 0.472 . . . . 1.48 110.48 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.901 ' HB3' HG22 ' A' ' 52' ' ' VAL . 24.1 m-85 -105.8 84.48 2.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.792 -0.64 . . . . 0.98 111.334 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -78.62 43.16 0.47 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.542 -0.754 . . . . 1.25 111.542 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -154.6 -29.17 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.672 -0.24 . . . . 1.03 111.34 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.901 HG22 ' HB3' ' A' ' 49' ' ' TYR . 5.3 m -99.35 155.85 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.352 0.596 . . . . 0.29 111.692 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.875 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.1 tp -104.38 113.33 41.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.13 -0.941 . . . . 0.29 110.963 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.716 ' O ' HG22 ' A' ' 2' ' ' VAL . 6.1 m-85 -99.55 116.43 31.66 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 116.042 -0.527 . . . . 0.32 110.876 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.059 HD13 HD13 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -130.95 167.94 18.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 116.064 -0.516 . . . . 0.24 110.296 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.869 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.7 tt0 -121.55 125.08 45.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.023 0.379 . . . . 2.16 112.023 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.571 ' CG2' HD11 ' A' ' 55' ' ' LEU . 6.7 t -112.12 116.17 51.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.557 0.694 . . . . 0.17 110.951 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -93.79 115.29 27.69 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.236 -0.893 . . . . 2.12 110.379 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 28' ' ' SER . 11.2 p -61.2 -22.28 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.22 112.083 -178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -62.32 -37.95 87.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.091 -0.707 . . . . 1.3 109.091 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.458 ' OD2' ' HG2' ' A' ' 6' ' ' GLU . 1.3 m-20 -101.12 -42.43 6.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.128 -0.942 . . . . 1.31 112.314 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.775 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -87.78 53.63 2.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.13 0.49 . . . . 0.26 110.406 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.501 ' O ' ' CD ' ' A' ' 67' ' ' PRO . 5.4 mt-30 -74.9 -11.53 60.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.667 -0.697 . . . . 2.58 111.324 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -87.05 -31.12 20.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 1.37 110.68 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.775 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 18.2 m -76.77 -46.97 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.913 -0.585 . . . . 0.21 111.14 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.882 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.67 -55.31 23.79 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 113.178 0.807 . . . . 0.29 113.178 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.882 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 51.0 Cg_exo -55.68 -28.29 65.29 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.161 2.574 . . . . 0.49 114.073 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -75.62 -26.47 57.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.869 0.322 . . . . 1.47 111.869 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -99.91 -9.43 22.82 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.23 0.538 . . . . 0.46 110.663 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.61 39.44 78.33 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.521 -0.763 . . . . 0.55 112.785 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.626 HD11 HD11 ' A' ' 78' ' ' LEU . 63.9 mt -76.46 129.02 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.0 -0.741 . . . . 1.35 109.0 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.49 64.68 1.33 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.571 -0.452 . . . . 3.47 111.76 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.08 120.74 0.78 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.717 -0.754 . . . . 1.15 112.455 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 32' ' ' CYS . 13.5 pt -109.14 153.39 42.62 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.626 -0.139 . . . . 0.65 110.626 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.9 129.94 17.16 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 124.347 -1.105 . . . . 0.4 113.718 0.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.538 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -101.94 138.54 38.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.45 111.45 178.404 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.16 113.82 26.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.319 -0.993 . . . . 1.81 108.319 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.652 ' HB2' HG23 ' A' ' 25' ' ' VAL . 3.5 mt -104.92 131.65 52.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.379 0.609 . . . . 0.26 111.454 -177.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.885 ' CD1' HD11 ' A' ' 22' ' ' LEU . 2.1 mm? -113.06 117.34 31.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.177 -0.919 . . . . 0.29 111.05 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.602 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 60.0 m-85 -111.93 140.9 46.2 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.507 -0.553 . . . . 0.26 109.507 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.786 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 1.8 tttm -141.32 105.82 4.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.48 -0.933 . . . . 0.46 108.48 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.8 m120 67.04 47.11 1.43 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.373 -0.603 . . . . 1.13 109.373 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.34 4.87 18.96 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.371 -0.831 . . . . 0.24 113.718 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -118.51 130.23 55.81 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.39 -0.596 . . . . 1.56 109.39 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.1 p -55.18 117.41 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.68 -0.859 . . . . 1.21 108.68 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -96.97 -7.24 33.6 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 113.051 0.76 . . . . 0.23 113.051 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -177.05 148.94 0.66 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.098 -0.501 . . . . 0.25 112.055 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.2 t -126.87 148.61 49.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.852 -0.613 . . . . 1.54 109.801 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -149.79 132.07 15.52 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.224 -0.658 . . . . 1.39 109.224 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.04 146.78 19.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.432 -0.349 . . . . 0.3 111.399 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.45 161.57 27.6 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.939 -0.648 . . . . 0.24 113.113 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.65 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -70.19 169.05 14.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.812 0.339 . . . . 0.44 111.361 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.65 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -157.85 176.69 12.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.86 111.333 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -91.27 175.54 6.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.622 -0.717 . . . . 0.98 110.174 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -70.73 -30.84 67.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.621 -0.263 . . . . 1.17 111.365 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.03 -31.92 51.18 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.227 -0.987 . . . . 0.22 113.122 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.602 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 35.8 mt-30 -75.12 -30.6 60.88 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.915 0.388 . . . . 1.0 110.949 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.465 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -73.03 -51.19 19.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.193 0.521 . . . . 0.42 109.823 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.447 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 17.2 ttpt -60.16 -45.18 93.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.442 -0.799 . . . . 1.64 110.529 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.602 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -59.83 -39.03 83.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 1.81 110.154 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.423 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 8.5 t80 -62.45 -41.83 99.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.651 -0.704 . . . . 0.28 111.311 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.482 HD21 ' HB ' ' A' ' 24' ' ' VAL . 8.0 mt -68.17 -55.95 10.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.76 -0.654 . . . . 0.31 110.451 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -46.45 -33.38 3.92 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.67 -0.493 . . . . 1.19 109.67 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.04 -23.95 59.47 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.403 -0.817 . . . . 0.23 113.192 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.429 ' O ' ' CE ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -108.87 -28.65 9.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.009 0.433 . . . . 0.59 111.659 -178.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.951 ' O ' HD23 ' A' ' 106' ' ' LEU . 9.3 tt . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 123.628 0.771 . . . . 1.35 112.312 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 55' ' ' LEU . 88.5 t . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.714 -0.106 . . . . 0.49 110.714 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.498 ' O ' HD12 ' A' ' 5' ' ' ILE . 2.2 ptpt -141.68 126.2 17.8 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 121.8 0.81 . . . . 1.64 111.255 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.62 122.03 25.42 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.404 -1.271 . . . . 2.05 110.578 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.096 HD13 HD13 ' A' ' 55' ' ' LEU . 3.2 mp -104.43 111.59 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.842 0.353 . . . . 0.19 111.35 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -99.77 19.46 15.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.11 -0.495 . . . . 1.63 112.058 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -154.8 160.2 41.11 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.999 -0.28 . . . . 0.96 110.714 -179.509 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.47 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 7.1 ttpt -77.57 -21.58 52.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.058 0.456 . . . . 1.48 110.707 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -79.41 -31.91 42.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.635 -0.505 . . . . 0.79 109.635 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 1.013 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -68.24 -38.79 82.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.375 -0.83 . . . . 0.26 111.019 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -58.15 -47.99 81.65 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.165 -0.471 . . . . 1.25 110.403 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -64.02 -37.37 87.18 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.653 -0.499 . . . . 1.21 109.653 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -60.8 -46.97 88.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.703 -0.68 . . . . 1.53 111.846 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.46 76.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.32 110.65 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.0 mt -65.2 -42.33 93.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.998 -0.546 . . . . 0.44 110.89 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.21 -30.32 71.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.042 0.449 . . . . 1.72 110.074 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.98 -22.34 53.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.638 -0.71 . . . . 0.48 110.77 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.68 -34.01 73.36 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 116.118 -0.492 . . . . 0.73 110.975 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.33 -125.09 36.69 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.083 -1.056 . . . . 1.05 113.155 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -91.21 7.35 41.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 2.4 111.585 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 58.2 mttt -82.49 151.88 26.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.53 -0.304 . . . . 1.54 110.383 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.932 HD11 HD12 ' A' ' 79' ' ' LEU . 1.3 tp -77.09 127.36 32.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.31 109.858 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.874 HG13 ' CG2' ' A' ' 53' ' ' ILE . 3.3 t -107.62 115.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.353 0.597 . . . . 0.33 111.425 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.537 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.9 p -110.47 116.09 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.066 -1.087 . . . . 0.63 108.066 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.997 HG12 ' HG ' ' A' ' 55' ' ' LEU . 16.6 m -124.99 142.98 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-O 121.74 0.781 . . . . 0.84 111.793 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -108.19 128.01 54.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.328 -1.306 . . . . 1.19 111.211 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -95.42 108.22 20.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.147 -0.686 . . . . 0.35 109.147 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.1 p -119.06 -170.93 2.01 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.782 0.66 . . . . 1.03 112.782 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.11 156.83 40.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.845 -1.07 . . . . 0.4 110.137 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.2 -35.51 73.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.556 0.693 . . . . 0.93 110.259 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.437 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 27.8 p-90 -87.42 12.21 12.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.041 -0.981 . . . . 1.12 111.213 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 35.5 t -102.38 131.67 48.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.742 0.306 . . . . 0.94 110.9 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.71 -63.18 1.35 Allowed Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.616 -0.802 . . . . 0.36 112.616 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.77 -32.2 45.0 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.564 2.176 . . . . 0.63 112.164 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -58.47 -41.36 85.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.886 -0.597 . . . . 0.71 110.363 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -71.18 -19.88 62.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.839 -0.619 . . . . 2.24 111.098 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.2 mtt -75.04 -24.86 58.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.016 -0.538 . . . . 1.45 111.434 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mm -85.96 -19.06 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.454 -0.339 . . . . 0.65 111.36 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 25.6 mtpt -52.58 -54.24 44.93 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.823 0.344 . . . . 2.51 111.054 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 63.8 Cg_exo -48.77 -50.02 13.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.715 2.277 . . . . 0.44 112.625 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -77.26 -31.37 54.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.532 0.206 . . . . 0.53 111.419 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.457 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 5.4 t80 -65.42 -47.21 77.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.664 -0.414 . . . . 0.3 110.176 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -41.0 89.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.294 -0.412 . . . . 0.88 111.846 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -60.1 -45.12 94.03 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.933 -0.307 . . . . 1.3 110.856 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.8 mt -57.95 -37.14 73.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.154 0.502 . . . . 0.42 109.894 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.2 t -55.55 -31.94 62.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.58 -0.736 . . . . 1.25 111.103 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.02 -20.7 30.08 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.746 0.308 . . . . 2.18 110.399 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 2.8 ttpp -92.89 -7.76 45.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.192 -0.458 . . . . 2.05 110.514 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.845 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.9 m-85 -116.2 92.5 3.91 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.154 -0.475 . . . . 1.43 111.413 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.5 p -86.55 46.64 1.38 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.435 -0.348 . . . . 1.7 110.479 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 21.5 t30 -154.93 -29.96 0.11 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.793 0.294 . . . . 1.38 111.793 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.845 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.9 m -101.53 159.98 3.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.226 -0.443 . . . . 0.36 111.384 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.874 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.5 tp -109.91 116.83 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.469 -0.787 . . . . 0.38 110.729 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.755 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.5 m-85 -99.89 116.61 32.35 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.354 -0.839 . . . . 0.33 111.156 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.096 HD13 HD13 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -133.45 166.01 23.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 120.493 -0.483 . . . . 0.23 112.009 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.927 ' N ' HD12 ' A' ' 55' ' ' LEU . 3.4 tt0 -119.32 125.01 48.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.977 0.732 . . . . 1.84 112.977 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.663 HG22 HD11 ' A' ' 55' ' ' LEU . 3.4 t -114.49 114.66 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.476 -0.784 . . . . 0.2 110.673 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -90.76 114.81 27.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.741 . . . . 1.69 109.848 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.95 -21.44 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.885 -0.598 . . . . 0.25 111.372 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.18 -41.36 97.15 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.738 -0.468 . . . . 1.26 109.738 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -95.5 -42.55 8.4 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.107 -0.497 . . . . 1.23 111.783 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -90.55 47.35 1.42 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.025 0.44 . . . . 0.23 111.219 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -75.09 -3.3 31.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.365 -0.379 . . . . 2.0 110.864 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.3 -24.25 20.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.159 -0.312 . . . . 1.38 110.159 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 62' ' ' ALA . 34.6 m -85.5 -43.89 16.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.101 0.477 . . . . 0.2 111.557 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.836 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.08 -53.09 47.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.927 0.714 . . . . 0.27 112.927 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.836 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 43.8 Cg_exo -57.82 -27.45 78.31 Favored 'Trans proline' 0 N--CA 1.472 0.208 0 C-N-CA 123.16 2.573 . . . . 0.46 113.456 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -77.29 -22.64 51.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.522 -0.308 . . . . 1.58 111.696 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -102.83 -10.08 19.4 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.405 0.621 . . . . 0.49 110.427 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.49 39.78 79.35 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.265 -0.879 . . . . 0.61 112.151 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.671 HD11 HD11 ' A' ' 78' ' ' LEU . 67.8 mt -77.61 130.45 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.172 -0.677 . . . . 1.3 109.172 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -144.44 67.02 1.26 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.281 0.563 . . . . 3.59 111.337 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.58 117.58 0.71 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.517 -0.849 . . . . 1.15 113.247 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 32' ' ' CYS . 16.6 pt -105.97 153.82 39.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 110.378 -0.23 . . . . 1.11 110.378 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.41 121.42 7.18 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 123.786 -1.339 . . . . 0.95 113.155 0.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.609 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -93.0 140.7 29.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.4 111.589 179.014 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.25 117.09 30.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.458 -0.571 . . . . 0.99 109.458 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.747 ' HB2' HG23 ' A' ' 25' ' ' VAL . 3.2 mt -106.65 132.84 52.18 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.411 0.624 . . . . 0.4 111.504 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.932 HD12 HD11 ' A' ' 22' ' ' LEU . 2.5 mm? -112.62 115.12 28.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.994 -1.003 . . . . 0.27 109.429 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.64 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 46.5 m-85 -109.1 145.56 35.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.188 0.518 . . . . 0.25 110.007 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.669 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 12.1 tttm -143.86 110.58 5.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.268 -0.878 . . . . 0.4 109.905 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.4 m120 60.51 47.2 8.8 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.341 -0.544 . . . . 0.62 109.715 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.04 5.06 45.6 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.828 -0.701 . . . . 0.25 113.425 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -121.65 132.99 54.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.201 0.5 . . . . 1.73 111.269 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.18 121.81 6.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 108.725 -0.843 . . . . 1.08 108.725 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.669 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -103.04 -11.15 18.34 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.298 0.57 . . . . 0.22 112.28 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.596 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.89 149.26 1.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.07 -0.968 . . . . 0.21 111.577 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.17 145.88 51.76 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.52 -0.764 . . . . 1.5 109.211 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -143.68 136.35 27.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.899 -0.408 . . . . 1.93 109.899 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.1 t -116.76 145.2 22.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.905 0.384 . . . . 1.09 111.227 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.9 160.39 26.37 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.517 -0.849 . . . . 0.27 113.092 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.01 152.02 42.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.853 0.359 . . . . 0.56 111.4 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.535 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -138.9 171.08 14.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.286 -0.415 . . . . 0.64 110.875 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.53 175.0 8.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.742 -0.663 . . . . 0.92 110.276 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -67.45 -33.34 74.94 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.043 -0.263 . . . . 0.95 111.635 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.42 -31.13 52.26 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.183 -1.008 . . . . 0.22 112.655 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.497 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 53.3 mt-30 -74.86 -29.56 61.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.074 0.464 . . . . 1.37 110.598 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.535 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -74.88 -48.67 23.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.929 -0.578 . . . . 0.39 109.58 179.012 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.509 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 19.4 ttpt -61.82 -46.13 90.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.581 -0.736 . . . . 1.27 111.079 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.0 pp20? -58.72 -40.32 83.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.232 0.539 . . . . 1.83 109.93 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.53 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 10.8 t80 -61.37 -41.28 96.84 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.671 -0.695 . . . . 0.33 110.882 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mt -68.05 -52.67 32.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.42 109.891 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -51.11 -36.64 41.54 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.96 0.409 . . . . 1.18 110.338 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.43 -19.5 60.95 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 112.737 0.643 . . . . 0.22 112.737 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.537 ' HB3' HD21 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -106.97 -44.23 4.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.42 110.507 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.449 ' HB2' HD23 ' A' ' 22' ' ' LEU . 67.7 tp . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.726 -0.67 . . . . 1.37 109.565 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.872 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 58.8 t . . . . . 0 C--O 1.232 0.167 0 N-CA-C 109.597 -0.52 . . . . 0.42 109.597 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.587 ' O ' HD12 ' A' ' 5' ' ' ILE . 9.1 ptpt -143.29 117.52 9.56 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 119.428 -0.909 . . . . 1.77 111.92 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.84 124.21 23.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.94 -1.027 . . . . 1.79 109.778 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.872 HD13 HD13 ' A' ' 55' ' ' LEU . 1.4 mp -103.43 111.77 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.852 0.358 . . . . 0.23 111.152 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -97.78 14.02 28.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.99 -0.55 . . . . 1.8 112.152 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.424 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 2.6 m -154.18 155.29 35.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.72 111.034 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.576 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -71.49 -21.77 61.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.371 -0.377 . . . . 1.16 110.85 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -78.86 -32.71 46.11 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.408 -0.59 . . . . 0.32 109.408 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.746 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -66.73 -41.52 87.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.461 -0.791 . . . . 0.23 109.797 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.453 ' HB2' HG21 ' A' ' 5' ' ' ILE . 18.2 t80 -56.34 -41.86 76.77 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.059 -0.518 . . . . 1.16 109.888 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -64.82 -41.21 95.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.074 -0.713 . . . . 1.27 109.074 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -59.96 -49.37 77.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.099 -0.955 . . . . 1.62 111.76 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.89 74.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.747 0.308 . . . . 0.3 111.313 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.505 HD23 HG11 ' A' ' 23' ' ' VAL . 24.4 mt -69.1 -43.69 73.96 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.147 0.499 . . . . 0.42 110.65 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -61.94 -32.1 72.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.009 -0.541 . . . . 1.79 110.688 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.47 -26.9 58.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.48 110.968 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.569 ' HB1' HG22 ' A' ' 23' ' ' VAL . . . -73.93 -20.72 60.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.73 111.286 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 46.12 -119.85 4.25 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.794 -0.717 . . . . 0.97 114.789 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -88.74 2.33 53.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.548 -0.326 . . . . 2.34 111.534 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 32.0 mttt -78.1 151.96 33.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.71 -0.848 . . . . 1.64 108.71 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.808 ' HB3' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -73.73 125.09 27.31 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.569 -0.53 . . . . 0.32 109.569 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.967 HG13 ' CG2' ' A' ' 53' ' ' ILE . 2.3 t -106.26 105.8 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.472 0.653 . . . . 0.23 110.917 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.55 HG23 ' CD2' ' A' ' 79' ' ' LEU . 11.4 p -105.55 115.58 47.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 107.294 -1.373 . . . . 0.69 107.294 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.983 HG12 ' HG ' ' A' ' 55' ' ' LEU . 25.0 m -129.13 126.94 65.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.952 -0.567 . . . . 0.83 111.862 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -93.16 135.67 34.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.42 -0.809 . . . . 1.16 111.453 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -98.8 116.25 30.61 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.989 -0.745 . . . . 0.24 108.989 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 59' ' ' VAL . 11.2 p -125.01 -168.43 1.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.463 0.649 . . . . 1.25 112.731 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.75 154.03 35.47 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 114.901 -1.045 . . . . 0.39 109.868 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -35.31 72.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.323 0.582 . . . . 0.92 109.809 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -86.42 11.52 12.26 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.124 -0.944 . . . . 0.81 111.291 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.549 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 36.9 t -97.08 140.77 31.09 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.815 0.341 . . . . 0.48 110.923 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.78 -66.12 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.599 -0.81 . . . . 0.3 112.476 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.62 -25.06 24.68 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.533 2.155 . . . . 0.52 112.344 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.0 m -62.98 -41.69 99.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.5 110.696 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -66.59 -21.25 66.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.013 -0.54 . . . . 2.37 111.149 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 mmt -73.36 -26.02 60.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 1.53 111.828 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.88 -22.79 7.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.745 0.307 . . . . 0.26 111.109 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 10.1 tttt -48.35 -57.04 11.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.619 -0.264 . . . . 1.69 110.967 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 11.6 Cg_endo -56.68 -43.88 50.69 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.365 2.043 . . . . 0.45 112.678 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -73.73 -37.87 64.97 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.521 0.193 . . . . 0.38 111.521 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.45 ' O ' ' CE2' ' A' ' 54' ' ' PHE . 9.0 t80 -64.67 -43.52 93.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.951 -0.3 . . . . 0.48 111.037 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -37.94 86.2 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.869 -0.332 . . . . 1.02 111.102 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.25 -45.82 91.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.707 0.289 . . . . 1.1 110.991 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.53 HD13 HD22 ' A' ' 98' ' ' LEU . 19.9 mt -59.25 -39.9 84.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.892 -0.41 . . . . 0.45 109.892 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.421 ' HB2' ' CG ' ' A' ' 54' ' ' PHE . 33.6 t -55.17 -29.19 57.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.535 . . . . 1.3 111.016 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -87.51 -20.73 26.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.961 0.41 . . . . 2.39 110.007 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 2.1 ttpp -98.88 8.59 44.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.733 -0.667 . . . . 1.92 110.698 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.717 ' HB3' HG22 ' A' ' 52' ' ' VAL . 13.9 m-85 -129.63 108.13 9.97 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.268 -0.423 . . . . 0.88 109.883 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.7 m -99.41 47.16 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.098 0.407 . . . . 1.52 112.098 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.475 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 13.9 t30 -158.37 -33.78 0.07 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.704 0.287 . . . . 1.3 111.39 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.808 HG12 ' HB3' ' A' ' 22' ' ' LEU . 5.0 m -92.82 150.89 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.154 0.428 . . . . 0.34 112.154 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.967 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.3 tp -101.02 119.7 49.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.428 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.872 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 3.9 m-85 -101.79 124.58 47.68 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 116.025 -0.534 . . . . 0.37 110.966 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.983 ' HG ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -139.73 167.53 21.9 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.089 -0.644 . . . . 0.3 110.607 177.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.879 ' N ' HD12 ' A' ' 55' ' ' LEU . 4.5 tt0 -122.29 126.46 48.17 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.328 0.492 . . . . 2.05 112.328 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.673 HG22 HD11 ' A' ' 55' ' ' LEU . 3.9 t -115.52 119.29 61.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.714 -0.675 . . . . 0.2 111.388 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -94.42 115.52 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.274 -0.639 . . . . 1.79 109.274 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 28' ' ' SER . 10.7 p -58.4 -19.07 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.393 . . . . 0.27 111.5 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -38.66 90.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.889 -0.412 . . . . 1.14 109.889 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.56 -43.65 6.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 1.29 110.698 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.746 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -86.14 46.76 1.37 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.959 -0.564 . . . . 0.24 111.02 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.528 ' O ' ' CD ' ' A' ' 67' ' ' PRO . 16.6 tt0 -74.87 -12.24 60.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.377 -0.374 . . . . 2.03 110.778 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.64 -23.47 31.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.764 0.316 . . . . 1.29 110.277 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 62' ' ' ALA . 8.5 m -83.46 -49.12 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.345 -0.389 . . . . 0.21 112.046 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.866 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.64 -54.41 31.53 Favored Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 113.524 0.935 . . . . 0.28 113.524 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.866 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 50.4 Cg_exo -55.04 -27.36 54.57 Favored 'Trans proline' 0 CA--C 1.521 -0.144 0 C-N-CA 122.959 2.439 . . . . 0.41 112.4 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -76.85 -18.81 58.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 1.93 111.203 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -109.22 -8.17 15.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.048 0.451 . . . . 0.43 110.922 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.16 36.47 91.88 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.639 -0.71 . . . . 0.51 112.983 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 78' ' ' LEU . 79.4 mt -75.91 132.44 33.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.621 -0.511 . . . . 1.36 109.621 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -148.14 49.8 1.04 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.666 0.27 . . . . 3.23 111.293 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.08 104.24 0.18 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.464 -0.874 . . . . 1.07 112.277 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.7 pt -99.48 153.03 37.99 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.57 0.224 . . . . 0.88 110.808 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.76 119.28 6.22 Favored 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.766 -1.348 . . . . 0.44 112.373 -0.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.472 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -89.89 137.95 31.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.49 111.556 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.55 HD22 HD21 ' A' ' 93' ' ' LEU . 1.3 mp -107.08 118.89 37.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.36 -0.978 . . . . 1.7 108.36 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.566 ' HB2' HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -106.78 128.19 54.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.604 0.716 . . . . 0.23 111.231 -178.407 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.782 HD12 HD11 ' A' ' 22' ' ' LEU . 2.8 mm? -111.31 130.85 55.54 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.983 -1.008 . . . . 0.3 108.855 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.696 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 44.9 m-85 -123.8 151.67 43.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.136 0.493 . . . . 0.25 110.4 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.931 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -144.15 115.03 7.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.345 -0.843 . . . . 0.54 109.359 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 53.64 49.57 19.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.374 -0.53 . . . . 1.14 110.319 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.44 3.28 31.7 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.143 -0.551 . . . . 0.19 113.865 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -119.51 141.81 48.86 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 117.148 0.474 . . . . 1.37 110.142 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.61 133.05 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.205 -0.598 . . . . 1.27 109.541 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.931 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -103.98 -25.51 12.98 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.635 0.731 . . . . 0.24 111.656 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.96 160.97 4.37 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.396 -1.275 . . . . 0.19 110.876 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.75 134.21 36.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.272 -0.422 . . . . 1.13 110.837 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.41 138.34 43.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 1.34 110.166 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.45 145.37 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.437 -0.347 . . . . 0.98 111.198 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.72 160.13 25.45 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.647 -0.787 . . . . 0.2 113.034 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.07 152.44 45.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.172 0.51 . . . . 0.44 111.733 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.55 HD21 HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -146.05 151.32 37.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.718 -0.674 . . . . 0.79 110.441 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -69.16 178.9 2.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.446 -0.343 . . . . 0.98 111.051 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -72.49 -30.64 64.7 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.158 -0.474 . . . . 0.95 111.797 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.53 -31.87 52.86 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.018 -1.087 . . . . 0.24 112.512 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.502 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 39.6 mt-30 -75.59 -33.14 60.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.803 0.335 . . . . 1.3 110.504 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.53 HD22 HD13 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -68.58 -48.83 63.18 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.172 -0.677 . . . . 0.4 109.172 179.213 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 18.2 ttpt -60.66 -42.39 96.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.859 -0.609 . . . . 1.45 110.422 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -60.49 -39.97 89.65 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.132 -0.485 . . . . 1.68 110.091 179.262 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.536 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 6.9 t80 -62.77 -43.44 98.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.757 -0.656 . . . . 0.26 111.429 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.2 mt -67.73 -53.0 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.642 -0.708 . . . . 0.51 109.788 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.05 -37.37 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 1.2 111.153 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.43 -21.31 62.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.209 -0.451 . . . . 0.29 111.903 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.71 ' HB3' HD21 ' A' ' 22' ' ' LEU . 4.3 t30 -106.52 -46.98 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.068 -0.253 . . . . 0.72 111.219 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.629 HD13 HG12 ' A' ' 52' ' ' VAL . 56.6 tp . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.951 0.405 . . . . 1.32 110.169 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 70.2 t . . . . . 0 N--CA 1.462 0.135 0 N-CA-C 110.229 -0.285 . . . . 0.26 110.229 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.51 125.78 17.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.045 -0.662 . . . . 2.08 111.31 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.82 122.91 27.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.323 -0.853 . . . . 2.36 109.432 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.033 HD13 HD13 ' A' ' 55' ' ' LEU . 1.3 mp -103.67 112.06 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 112.119 0.414 . . . . 0.18 112.119 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.36 14.19 28.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.657 0.614 . . . . 1.41 112.657 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 m -156.61 140.8 16.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.705 0.288 . . . . 0.93 111.633 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -58.26 -23.92 57.67 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.443 -0.344 . . . . 1.2 111.62 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 m -78.31 -33.49 49.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.949 -0.76 . . . . 0.32 108.949 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -67.24 -39.35 86.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.583 -0.735 . . . . 0.21 109.913 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.539 ' HB2' HG21 ' A' ' 5' ' ' ILE . 23.8 t80 -57.64 -46.97 83.49 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.076 -0.511 . . . . 0.63 110.701 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -63.35 -38.4 91.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.411 -0.588 . . . . 1.08 109.411 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -59.6 -50.1 75.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.619 -0.719 . . . . 1.44 111.498 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.13 -32.55 74.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.839 0.352 . . . . 0.31 111.238 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 mt -67.79 -42.54 81.49 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.236 0.541 . . . . 0.41 110.613 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -60.56 -31.58 70.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 1.68 110.161 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.23 -22.21 55.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.95 -0.568 . . . . 0.45 110.44 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.12 -29.3 67.33 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.72 111.03 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.72 -126.44 42.24 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.347 -0.93 . . . . 0.93 113.236 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -92.55 9.06 36.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.35 -0.425 . . . . 2.28 111.057 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.56 154.1 27.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.947 -0.39 . . . . 1.35 109.947 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.903 HD11 HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -78.31 126.38 30.7 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.868 -0.419 . . . . 0.26 109.868 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.912 HG13 ' CG2' ' A' ' 53' ' ' ILE . 6.2 t -110.32 109.0 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.314 0.578 . . . . 0.22 111.753 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 24' ' ' VAL . 7.2 p -104.97 116.88 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.547 -1.279 . . . . 0.31 107.547 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.733 HG12 ' HG ' ' A' ' 55' ' ' LEU . 7.3 m -123.61 136.94 58.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.413 0.625 . . . . 0.81 111.655 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.99 129.68 46.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.06 -0.973 . . . . 1.29 111.534 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -97.55 107.9 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.14 -0.689 . . . . 0.28 109.14 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 p -119.07 -166.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.31 0.576 . . . . 0.91 112.493 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.65 154.25 36.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.324 -0.853 . . . . 0.36 110.296 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.32 -38.59 78.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.657 0.742 . . . . 1.41 109.449 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.433 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 37.7 p-90 -84.94 14.08 5.28 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.572 -1.195 . . . . 1.11 111.54 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 37.8 t -102.96 144.42 31.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.856 0.36 . . . . 0.72 111.076 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.29 -68.24 0.92 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.714 -0.755 . . . . 0.3 112.386 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -50.9 -28.72 24.61 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.655 2.236 . . . . 0.68 112.175 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.2 m -58.37 -44.46 88.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.57 110.946 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -68.26 -25.63 65.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.849 -0.614 . . . . 2.57 111.336 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.2 mtp -68.37 -21.28 64.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.496 -0.32 . . . . 1.63 111.539 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mm -86.73 -20.7 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.746 0.308 . . . . 0.25 111.132 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 3.7 tttt -52.23 -53.67 49.94 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.363 -0.38 . . . . 2.04 111.129 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 74.0 Cg_exo -49.63 -47.98 20.84 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.534 2.156 . . . . 0.57 112.545 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -78.25 -32.06 49.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.513 -0.312 . . . . 0.44 111.688 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.441 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 6.0 t80 -67.29 -48.6 67.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.909 0.385 . . . . 0.33 110.477 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.13 -38.26 85.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.256 -0.429 . . . . 0.96 111.497 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.0 t -61.61 -45.33 94.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 1.16 110.818 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.0 mt -59.79 -38.66 82.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 0.37 110.274 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 p -54.97 -26.13 34.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.966 -0.561 . . . . 1.05 110.381 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -86.61 -23.32 25.77 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.052 0.454 . . . . 2.23 110.019 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.16 11.18 39.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.61 -0.723 . . . . 1.9 110.869 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.812 ' HB3' HG22 ' A' ' 52' ' ' VAL . 15.5 m-85 -131.78 93.12 3.25 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.426 -0.352 . . . . 1.02 110.453 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.86 48.03 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 1.47 111.644 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -156.7 -37.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.875 0.324 . . . . 1.19 111.875 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.812 HG22 ' HB3' ' A' ' 49' ' ' TYR . 16.5 m -93.2 150.72 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.28 111.785 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.912 ' CG2' HG13 ' A' ' 23' ' ' VAL . 3.0 tp -99.41 120.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.511 . . . . 1.1 110.153 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.729 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 3.0 m-85 -102.55 117.24 34.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.918 -0.583 . . . . 0.2 110.195 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.033 HD13 HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -132.08 161.8 32.38 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.954 -0.699 . . . . 0.17 110.695 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -118.42 121.8 41.22 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.088 -0.96 . . . . 2.16 112.435 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.62 HG22 HD11 ' A' ' 55' ' ' LEU . 2.0 t -115.16 118.5 58.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.856 -0.611 . . . . 0.15 110.777 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -92.88 116.9 29.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.203 -0.666 . . . . 1.79 109.203 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.05 -21.2 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.364 . . . . 0.19 111.611 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -40.22 96.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.98 0.419 . . . . 0.94 110.065 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.96 -41.99 8.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.812 -0.631 . . . . 1.29 111.207 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.556 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -86.32 51.16 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.382 0.61 . . . . 0.21 110.131 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -71.33 -11.85 61.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.71 -0.677 . . . . 2.51 111.13 -179.464 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.01 -23.35 19.55 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 111.734 0.272 . . . . 1.33 111.734 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 62' ' ' ALA . 8.6 m -81.51 -50.92 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.188 0.44 . . . . 0.18 112.188 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.889 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.86 -56.89 14.43 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 113.308 0.855 . . . . 0.27 113.308 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.889 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 75.5 Cg_exo -50.81 -27.77 21.34 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.813 2.342 . . . . 0.46 112.621 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -77.85 -19.16 55.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 1.53 111.413 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -106.93 -8.89 16.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.059 0.457 . . . . 0.38 110.364 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.54 38.26 90.38 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.516 -0.766 . . . . 0.46 113.265 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.504 HG23 HG21 ' A' ' 76' ' ' THR . 59.6 mt -78.99 132.14 32.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 117.299 0.549 . . . . 1.33 109.603 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -142.96 74.15 1.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.194 0.521 . . . . 3.91 111.087 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.494 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 147.2 143.65 3.89 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.56 -0.746 . . . . 1.03 112.023 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -129.8 156.77 78.41 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.359 0.123 . . . . 1.17 110.799 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.37 121.48 6.96 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.829 -1.321 . . . . 0.67 112.869 0.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -89.63 139.88 30.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 0.49 111.973 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.433 HD13 HD21 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -112.09 118.81 36.42 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.538 -0.912 . . . . 0.97 108.538 177.377 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.564 ' HB2' HG23 ' A' ' 25' ' ' VAL . 1.0 OUTLIER -109.75 132.47 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.488 0.661 . . . . 0.19 111.428 -178.409 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.903 HD12 HD11 ' A' ' 22' ' ' LEU . 3.5 mm? -111.93 135.59 52.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.141 -0.936 . . . . 0.65 109.029 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.672 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 37.0 m-85 -126.38 152.77 45.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.011 0.434 . . . . 0.31 110.612 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 1.024 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 0.8 OUTLIER -148.49 110.5 4.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.666 -0.697 . . . . 0.93 109.664 -179.181 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 62.07 48.12 5.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.909 0.385 . . . . 1.33 110.438 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 7.42 49.0 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.055 -0.593 . . . . 0.27 113.132 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -123.03 142.72 50.54 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 122.778 -0.248 . . . . 1.4 110.645 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 p -57.52 129.34 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.301 -0.629 . . . . 1.31 109.301 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 1.024 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -103.33 -22.49 13.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.457 0.646 . . . . 0.33 112.455 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -171.56 158.32 5.09 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.832 -1.076 . . . . 0.28 110.941 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.1 t -134.08 136.01 43.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.226 -0.443 . . . . 1.62 110.613 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.445 ' HD2' HD22 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -136.51 133.09 36.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.389 -0.597 . . . . 1.47 109.389 178.839 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 t -115.97 145.97 21.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.671 -0.24 . . . . 0.95 111.233 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.23 159.08 27.03 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.517 -0.849 . . . . 0.74 112.648 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.88 158.33 30.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.113 0.482 . . . . 0.51 111.715 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.584 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -152.03 153.06 33.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.64 110.358 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 m -71.54 -178.99 2.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.92 110.92 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -73.07 -30.64 63.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.82 111.46 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.36 -32.23 48.37 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.201 -0.999 . . . . 0.23 112.722 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.484 ' HA ' ' HG2' ' A' ' 100' ' ' GLU . 45.2 mt-30 -73.62 -35.29 65.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 1.29 110.401 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.584 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -69.08 -47.73 64.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.555 -0.748 . . . . 0.37 109.412 178.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -60.61 -43.24 97.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 1.04 110.533 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.601 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -61.18 -41.32 96.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.221 -0.445 . . . . 1.71 110.438 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.601 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 7.2 t80 -61.03 -41.83 97.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.322 0.582 . . . . 0.24 110.741 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.86 -56.67 7.21 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.472 -0.785 . . . . 0.46 110.117 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -50.08 -36.73 30.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.919 0.39 . . . . 1.18 111.042 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.21 -19.93 60.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.19 112.1 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.654 ' HB3' HD21 ' A' ' 22' ' ' LEU . 10.7 t30 -109.05 -37.34 5.84 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.863 0.32 . . . . 0.84 111.863 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.604 HD23 HG12 ' A' ' 52' ' ' VAL . 3.5 tm? . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.056 0.455 . . . . 1.33 109.991 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.708 HG13 ' HA ' ' A' ' 55' ' ' LEU . 45.7 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.693 0.282 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.635 ' HE2' ' HB2' ' A' ' 14' ' ' ALA . 14.3 ptmt -143.67 120.81 11.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.191 0.52 . . . . 0.0 110.433 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.94 126.05 29.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.512 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.845 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -98.47 107.43 20.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.202 0.525 . . . . 0.0 110.532 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -97.13 18.62 14.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.652 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 m -156.32 161.35 40.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.916 0.388 . . . . 0.0 111.271 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.702 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -73.02 -27.71 61.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.518 179.439 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -79.83 -31.58 40.61 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.498 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.83 -38.34 90.65 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.462 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -58.59 -41.72 86.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.939 0.399 . . . . 0.0 110.016 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -67.5 -44.25 78.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.894 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -57.81 -47.25 83.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.243 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.635 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . . . -65.02 -31.74 73.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.044 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.5 mt -68.72 -37.96 79.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 110.57 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -60.55 -35.84 77.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.164 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.18 -22.46 55.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.006 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.18 77.41 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.088 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.54 -120.33 17.95 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.548 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -95.59 4.97 52.62 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -79.8 149.42 31.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.981 HD11 HD12 ' A' ' 79' ' ' LEU . 4.9 tp -77.0 133.15 39.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.864 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.6 t -113.88 109.91 30.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.502 0.668 . . . . 0.0 112.015 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.571 HG23 HD21 ' A' ' 79' ' ' LEU . 8.4 p -105.04 115.7 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.554 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.8 m -123.33 166.96 17.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.908 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -133.56 133.89 42.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.783 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.573 ' HE1' HD12 ' A' ' 78' ' ' LEU . 4.2 m-85 -96.21 108.15 20.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.5 ' O ' HG12 ' A' ' 59' ' ' VAL . 31.2 p -115.85 -168.36 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.314 0.578 . . . . 0.0 112.186 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.77 152.99 33.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.02 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -71.26 -37.57 71.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.508 0.671 . . . . 0.0 109.598 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -86.69 12.62 10.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.176 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.713 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 17.2 t -94.87 158.21 15.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.049 0.452 . . . . 0.0 111.625 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.96 -66.94 0.61 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.585 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.06 -21.51 72.55 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.58 2.187 . . . . 0.0 112.203 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.5 m -62.98 -42.01 99.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.297 0.57 . . . . 0.0 109.919 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.34 -29.7 70.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.378 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.4 mtt -68.28 -18.17 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 11.6 mm -88.14 -23.73 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.476 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -52.88 -51.95 69.51 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.03 -49.44 17.04 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.693 2.262 . . . . 0.0 113.416 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -79.79 -30.29 40.59 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 4.9 t80 -65.52 -46.01 81.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.087 0.47 . . . . 0.0 110.293 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -39.28 90.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.267 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.5 t -60.38 -43.99 96.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 111.115 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.4 mt -59.71 -38.33 81.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.926 0.393 . . . . 0.0 110.238 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.6 t -56.47 -30.98 63.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.942 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -86.39 -18.1 32.68 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.575 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -96.05 -20.76 18.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.947 0.403 . . . . 0.0 110.175 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.85 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.1 m-85 -97.92 92.88 6.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.849 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.9 t -88.93 48.39 1.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.113 0.483 . . . . 0.0 110.719 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -152.73 -42.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.667 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.85 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.2 m -94.43 153.29 3.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.795 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.864 ' CG2' HG13 ' A' ' 23' ' ' VAL . 6.0 tp -104.49 115.4 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.026 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.611 ' O ' HG22 ' A' ' 2' ' ' VAL . 8.1 m-85 -97.59 115.92 28.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.544 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.845 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.2 164.67 21.16 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.537 178.696 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.415 ' N ' HD12 ' A' ' 55' ' ' LEU . 3.2 tp10 -116.39 119.34 35.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.447 HG22 HD11 ' A' ' 55' ' ' LEU . 2.1 t -115.53 117.75 56.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.184 0.516 . . . . 0.0 110.946 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -98.47 119.41 37.11 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 28' ' ' SER . 13.5 p -60.88 -18.84 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -64.17 -39.0 93.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -100.11 -32.85 10.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.584 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.892 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.49 43.0 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.82 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 31.0 tt0 -69.16 -10.12 56.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.654 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -94.9 -22.38 18.04 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.312 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.892 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -78.33 -47.71 23.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.665 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.935 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.35 -58.75 8.79 Favored Pre-proline 0 CA--C 1.529 0.143 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.935 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 75.2 Cg_exo -49.8 -28.89 18.9 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.458 2.106 . . . . 0.0 112.037 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.9 mttp -77.13 -23.99 51.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.959 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -106.66 -3.65 20.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.93 0.395 . . . . 0.0 112.017 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.88 34.92 89.98 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.889 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.625 HD11 HD11 ' A' ' 78' ' ' LEU . 79.7 mt -77.15 135.93 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 117.3 0.55 . . . . 0.0 110.657 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttp85 -143.48 71.28 1.33 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.129 0.49 . . . . 0.0 111.475 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.21 163.42 11.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.591 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.608 HD12 ' SG ' ' A' ' 32' ' ' CYS . 47.3 pt -148.46 149.84 32.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.418 0.109 . . . . 0.0 110.972 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -86.06 120.16 5.7 Favored 'Cis proline' 0 C--N 1.348 0.538 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.649 0.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.94 137.65 32.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.939 0.399 . . . . 0.0 111.809 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.675 HD22 HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -109.11 121.76 45.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.574 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.81 ' CD2' HG23 ' A' ' 88' ' ' THR . 6.6 mt -114.47 134.58 54.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.238 0.542 . . . . 0.0 111.639 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.981 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -114.33 127.36 55.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.781 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.593 ' CE2' HG22 ' A' ' 85' ' ' VAL . 46.5 m-85 -118.43 146.67 44.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.975 0.417 . . . . 0.0 111.336 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.474 ' HD2' HD13 ' A' ' 22' ' ' LEU . 1.2 tttm -146.59 115.27 6.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.002 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m120 59.76 45.21 13.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.872 0.368 . . . . 0.0 110.261 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.29 3.79 54.27 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.896 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.4 141.39 52.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.513 0.657 . . . . 0.0 111.467 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.593 HG22 ' CE2' ' A' ' 80' ' ' PHE . 42.5 t -68.13 118.3 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.443 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.43 10.49 19.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.943 0.401 . . . . 0.0 112.047 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -175.69 137.92 0.37 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.936 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.81 HG23 ' CD2' ' A' ' 78' ' ' LEU . 4.9 m -137.79 124.0 20.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 110.942 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -124.22 142.02 51.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.904 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.97 145.94 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.233 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.439 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 80.11 161.79 24.63 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.131 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.61 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -64.33 170.65 3.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.901 0.382 . . . . 0.0 111.277 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.675 HD11 HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -163.69 147.06 10.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.657 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 t -64.75 179.07 0.69 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.914 0.388 . . . . 0.0 110.806 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -73.09 -30.81 63.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.118 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.2 -31.37 52.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.86 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -76.21 -32.14 58.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.858 0.361 . . . . 0.0 110.582 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -70.61 -50.95 31.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.099 0.476 . . . . 0.0 109.884 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -61.54 -42.33 98.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.5 -38.83 88.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.949 0.404 . . . . 0.0 110.137 179.583 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.739 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 11.2 t80 -61.93 -40.65 96.21 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.402 0.62 . . . . 0.0 110.061 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 4.5 mt -65.67 -60.91 2.42 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.157 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -48.55 -33.83 10.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.095 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.6 -23.5 60.95 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -109.77 -30.03 8.04 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.711 HD13 HG12 ' A' ' 52' ' ' VAL . 36.6 tp . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 120.847 0.356 . . . . 0.0 110.716 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.755 HG13 ' HA ' ' A' ' 55' ' ' LEU . 67.9 t . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 109.68 -0.489 . . . . 0.42 109.68 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.46 ' O ' HD12 ' A' ' 5' ' ' ILE . 11.9 ptpt -144.98 121.81 11.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.36 -0.936 . . . . 1.98 111.268 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.12 123.69 25.67 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.458 -1.246 . . . . 2.23 110.174 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.942 HG23 ' HB3' ' A' ' 10' ' ' ALA . 2.1 mp -105.3 114.2 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.847 0.356 . . . . 0.26 111.323 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -103.77 16.63 25.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.352 0.501 . . . . 1.47 112.352 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -155.48 147.25 23.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.742 0.306 . . . . 0.95 111.098 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.503 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.5 ttpt -60.82 -24.64 66.01 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.358 -0.383 . . . . 1.5 111.764 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -79.14 -32.32 44.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.928 0.394 . . . . 0.32 110.238 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.942 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -67.24 -41.39 85.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.906 -0.588 . . . . 0.3 110.349 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -56.18 -44.53 79.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.858 -0.61 . . . . 1.15 110.693 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -66.52 -39.45 88.63 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.246 -0.65 . . . . 1.17 109.246 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -58.06 -48.45 80.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.746 -0.661 . . . . 1.6 110.887 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.56 -34.58 78.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.421 . . . . 0.32 111.241 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 15' ' ' LEU . 18.2 mt -66.75 -39.6 87.98 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.234 0.54 . . . . 0.41 110.537 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -63.57 -31.98 73.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 1.6 110.739 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.72 -22.74 56.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.47 111.014 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.447 ' HB1' HG22 ' A' ' 23' ' ' VAL . . . -71.23 -35.81 71.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.72 111.477 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.53 -119.44 18.61 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.077 -1.059 . . . . 1.1 113.662 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.18 2.29 56.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.717 -0.241 . . . . 2.19 111.479 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -79.27 148.1 32.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.692 -0.484 . . . . 1.74 109.692 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.979 HD11 HD12 ' A' ' 79' ' ' LEU . 1.6 tp -72.46 126.99 31.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.14 -0.319 . . . . 0.31 110.14 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.772 HG13 HG22 ' A' ' 53' ' ' ILE . 4.3 t -107.61 108.11 24.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.521 0.676 . . . . 0.24 111.523 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.619 HG23 ' CD2' ' A' ' 79' ' ' LEU . 10.2 p -106.08 116.98 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.951 -1.129 . . . . 0.31 107.951 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.071 HG12 ' HG ' ' A' ' 55' ' ' LEU . 4.3 m -123.13 166.97 17.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.218 0.532 . . . . 0.78 111.643 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.443 ' OD1' HD12 ' A' ' 77' ' ' LEU . 37.4 t0 -133.21 133.75 43.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.802 -0.636 . . . . 1.23 111.834 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HE1' HD12 ' A' ' 78' ' ' LEU . 8.8 m-85 -97.86 110.76 23.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.927 -0.768 . . . . 0.27 108.927 178.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.3 m -128.42 158.94 36.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.597 0.713 . . . . 1.19 112.917 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.587 ' HB1' ' CD1' ' A' ' 31' ' ' TRP . . . -116.16 156.65 26.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.971 -1.013 . . . . 0.37 111.047 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.2 m -70.79 -35.78 72.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.502 0.668 . . . . 0.75 109.615 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.587 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 23.4 p-90 -85.76 10.87 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.736 -1.12 . . . . 0.89 111.564 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.476 ' SG ' HD12 ' A' ' 74' ' ' ILE . 38.4 t -98.4 148.12 24.01 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.81 0.338 . . . . 0.82 111.027 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.33 -67.33 0.75 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.677 -0.773 . . . . 0.37 112.204 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.73 -24.53 18.22 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.411 2.074 . . . . 0.61 112.096 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.7 m -62.9 -43.76 97.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.144 -0.48 . . . . 0.49 110.781 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -68.78 -23.21 64.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 2.56 111.13 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 mmt -69.7 -22.36 63.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 1.8 110.739 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.2 mm -85.98 -21.71 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.418 -0.355 . . . . 0.25 110.976 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 2.0 tttt -52.3 -55.05 35.14 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.464 -0.335 . . . . 2.47 111.159 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 39' ' ' LYS . 72.7 Cg_exo -48.54 -49.11 15.37 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.563 2.176 . . . . 0.41 112.381 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -77.4 -29.19 53.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 0.44 111.519 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.437 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 6.3 t80 -67.76 -46.81 71.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.986 0.422 . . . . 0.46 110.257 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -42.9 78.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 1.03 111.952 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 m -59.09 -44.52 91.92 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.841 0.353 . . . . 0.91 110.379 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.35 -40.3 85.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.543 -0.54 . . . . 0.35 109.543 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 32.4 t -54.5 -27.55 38.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.889 -0.596 . . . . 1.22 111.179 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -88.96 -16.96 30.5 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.731 0.3 . . . . 1.99 111.038 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -94.56 -19.38 20.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.963 0.411 . . . . 2.16 109.912 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.847 ' HB3' HG22 ' A' ' 52' ' ' VAL . 22.1 m-85 -102.26 97.47 7.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.917 -0.583 . . . . 1.1 111.477 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.63 46.35 1.33 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.399 -0.364 . . . . 1.39 110.767 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -154.44 -34.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.801 0.334 . . . . 1.08 111.322 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 49' ' ' TYR . 5.8 m -97.59 156.06 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.325 -0.398 . . . . 0.32 111.585 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.772 HG22 HG13 ' A' ' 23' ' ' VAL . 1.3 tp -106.39 114.64 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.051 -0.522 . . . . 0.29 111.143 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.712 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.2 m-85 -96.11 120.19 35.95 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.197 -0.456 . . . . 0.24 110.516 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.071 ' HG ' HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -133.31 168.5 18.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 120.378 -0.529 . . . . 0.22 111.1 179.178 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.789 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -121.53 124.61 44.81 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.674 0.62 . . . . 2.28 112.674 -178.344 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.612 HG22 HD11 ' A' ' 55' ' ' LEU . 2.7 t -113.19 117.78 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.887 -0.597 . . . . 0.19 111.138 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -93.46 113.21 25.3 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.424 -0.584 . . . . 1.92 109.424 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 p -58.49 -19.1 13.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.825 0.305 . . . . 0.28 111.825 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -37.54 87.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.94 0.4 . . . . 1.22 110.292 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -102.94 -40.61 6.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.89 -0.596 . . . . 1.26 111.157 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -88.32 49.0 1.72 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.213 0.53 . . . . 0.28 110.395 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -75.83 -6.57 51.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.525 -0.762 . . . . 2.55 111.083 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.89 -25.1 20.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.769 0.318 . . . . 1.56 110.433 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.642 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 13.5 m -81.31 -48.58 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.197 -0.456 . . . . 0.26 111.759 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.876 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.39 -55.56 21.28 Favored Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 112.744 0.646 . . . . 0.29 112.744 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.876 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 78.3 Cg_exo -51.92 -27.54 28.37 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.863 2.375 . . . . 0.46 112.997 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -77.09 -21.35 54.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.278 -0.419 . . . . 1.77 111.781 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -108.16 -7.12 16.12 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.087 0.47 . . . . 0.42 111.354 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.4 37.07 90.03 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.687 -0.688 . . . . 0.49 113.517 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.659 HG23 HG21 ' A' ' 76' ' ' THR . 61.6 mt -74.12 130.16 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 109.624 -0.51 . . . . 1.29 109.624 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.89 60.16 1.47 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.937 0.399 . . . . 3.89 111.521 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.13 118.43 0.52 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.245 -0.979 . . . . 1.12 113.386 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.476 HD12 ' SG ' ' A' ' 32' ' ' CYS . 17.6 pt -104.99 152.44 39.63 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.408 -0.219 . . . . 0.89 110.408 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.81 120.26 6.38 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.8 -1.333 . . . . 1.08 112.708 0.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.659 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -91.48 134.82 34.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.543 -0.299 . . . . 0.33 111.236 179.176 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.443 HD12 ' OD1' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -107.87 122.82 47.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.401 -0.963 . . . . 1.08 108.401 177.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.506 ' HB2' HG23 ' A' ' 25' ' ' VAL . 5.0 mt -113.84 137.61 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.263 0.554 . . . . 0.22 111.548 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.979 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -119.01 113.41 20.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.535 -0.757 . . . . 0.22 110.562 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.61 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.9 m-85 -105.0 142.37 34.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.979 -0.555 . . . . 0.25 110.766 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -142.25 110.34 5.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.579 -0.737 . . . . 0.43 109.487 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 61.89 47.08 6.25 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.276 -0.639 . . . . 1.19 109.276 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.16 3.79 32.58 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.558 -0.746 . . . . 0.23 113.797 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -121.25 133.04 55.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.205 0.502 . . . . 1.6 110.814 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.72 117.35 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 1.26 109.848 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.02 4.49 27.12 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.462 0.541 . . . . 0.23 112.462 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.807 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.56 146.51 1.72 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.283 -0.417 . . . . 0.2 111.823 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.46 134.21 37.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 1.53 110.824 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -132.78 138.77 47.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 2.17 110.239 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.7 145.53 26.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.87 111.009 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.87 160.16 23.38 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.501 -0.857 . . . . 0.25 112.878 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.62 151.27 46.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.114 0.483 . . . . 0.55 111.575 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.606 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -143.33 147.77 35.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.76 -0.654 . . . . 0.55 110.558 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -65.04 -178.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.576 -0.284 . . . . 1.02 110.755 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -73.01 -32.67 65.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 1.09 111.497 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.52 -30.58 56.31 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.206 -0.997 . . . . 0.25 112.598 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.553 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 40.4 mt-30 -74.99 -31.22 61.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.972 0.415 . . . . 1.26 110.31 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.606 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -72.98 -49.79 27.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.047 -0.524 . . . . 0.43 109.908 179.221 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -61.71 -45.16 95.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.544 -0.753 . . . . 1.43 110.965 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.8 pp20? -60.64 -41.68 95.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 1.82 110.558 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.66 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 47.0 t80 -63.91 -42.68 97.35 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.26 0.552 . . . . 0.27 111.194 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.618 HD11 HG11 ' A' ' 24' ' ' VAL . 1.7 mt -64.85 -57.72 8.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.791 -0.64 . . . . 0.43 109.528 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -49.0 -34.19 12.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.502 . . . . 1.24 110.736 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.47 -22.95 62.62 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.046 -0.524 . . . . 0.23 111.717 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.425 ' HB3' HD21 ' A' ' 22' ' ' LEU . 6.8 t30 -105.55 -31.44 8.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.806 0.336 . . . . 0.52 110.746 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.527 ' HB2' HD23 ' A' ' 22' ' ' LEU . 42.6 tp . . . . . 0 C--N 1.329 -0.312 0 N-CA-C 109.691 -0.485 . . . . 1.35 109.691 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.72 HG13 ' HA ' ' A' ' 55' ' ' LEU . 42.9 t . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.772 0.32 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.73 119.62 11.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.253 0.549 . . . . 0.0 110.346 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.7 127.74 33.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.846 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.798 HD13 HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -101.12 107.53 21.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.298 -179.601 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -97.9 19.64 13.49 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.125 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.23 159.53 39.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.855 0.36 . . . . 0.0 111.276 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.608 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -71.91 -26.65 62.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 m -79.64 -32.8 41.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.914 0.387 . . . . 0.0 110.814 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.37 90.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.568 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -57.66 -42.71 84.04 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -43.97 83.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.13 -45.7 92.14 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.514 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.49 -31.91 73.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.892 0.377 . . . . 0.0 110.673 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -67.78 -37.39 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.527 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -61.42 -33.91 74.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.304 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.44 -22.67 54.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.9 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.65 -35.91 79.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.63 -122.76 31.13 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.14 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.57 4.33 53.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.501 0.191 . . . . 0.0 111.152 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -77.28 149.7 35.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.917 HD11 HD12 ' A' ' 79' ' ' LEU . 9.8 tp -77.02 132.61 39.05 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.879 HG13 ' CG2' ' A' ' 53' ' ' ILE . 6.3 t -112.45 109.67 29.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.397 0.618 . . . . 0.0 112.37 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.758 HG11 HD11 ' A' ' 102' ' ' LEU . 7.9 p -104.81 116.22 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.657 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.1 m -122.67 167.09 16.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.72 -178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -133.45 133.37 42.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.597 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -98.1 111.89 24.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -118.94 -167.79 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.382 0.61 . . . . 0.0 112.219 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.2 154.5 35.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.013 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -35.73 67.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.376 0.607 . . . . 0.0 109.471 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -87.24 10.78 15.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.08 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.713 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 11.3 t -91.79 157.21 17.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.052 0.453 . . . . 0.0 111.479 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.41 -64.17 0.54 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.441 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 22.9 Cg_exo -63.96 -22.29 68.42 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.497 2.132 . . . . 0.0 112.401 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.9 m -58.58 -41.47 85.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -67.04 -15.24 63.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.391 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.462 ' HG2' ' HA ' ' A' ' 34' ' ' PRO . 4.6 mmt -71.16 -26.85 63.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.789 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.8 mm -84.47 -23.86 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.685 0.279 . . . . 0.0 111.361 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 8.4 ttpt -48.96 -59.21 6.72 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 10.3 Cg_endo -51.96 -45.05 41.15 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.342 2.028 . . . . 0.0 112.697 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -80.74 -29.67 36.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -66.43 -45.69 78.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.082 0.467 . . . . 0.0 110.327 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.14 -39.91 86.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.883 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 62.7 m -61.7 -44.02 97.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.877 0.37 . . . . 0.0 110.887 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.3 mt -59.42 -40.23 86.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.914 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 m -54.73 -28.38 47.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.433 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.54 -19.51 27.78 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.686 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -95.0 -20.62 19.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.04 0.447 . . . . 0.0 110.265 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.856 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.5 m-85 -98.04 96.13 7.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.675 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.76 47.96 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.072 0.463 . . . . 0.0 110.236 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -152.92 -42.44 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.822 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.856 HG22 ' HB3' ' A' ' 49' ' ' TYR . 11.0 m -93.66 153.85 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.597 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.879 ' CG2' HG13 ' A' ' 23' ' ' VAL . 5.2 tp -105.75 113.99 44.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.748 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.561 ' O ' HG13 ' A' ' 2' ' ' VAL . 8.4 m-85 -94.62 116.2 28.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.55 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.798 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -129.02 166.7 18.71 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.514 178.611 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.432 ' N ' HD12 ' A' ' 55' ' ' LEU . 1.4 tp10 -117.43 118.99 33.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.34 118.35 58.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.249 0.547 . . . . 0.0 110.787 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -99.34 120.42 39.54 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.27 -18.46 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -67.93 -37.53 81.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.087 0.47 . . . . 0.0 109.81 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -98.78 -34.5 10.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.445 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.856 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.75 47.67 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.097 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 67' ' ' PRO . 39.6 tp60 -68.57 -8.74 44.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.079 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.57 -25.02 15.29 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.448 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.856 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 6.7 m -77.15 -48.78 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.965 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.627 ' HB3' ' CD ' ' A' ' 67' ' ' PRO . . . -50.22 -60.44 5.24 Favored Pre-proline 0 N--CA 1.463 0.203 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 66' ' ' ALA . 6.3 Cg_endo -49.11 -28.04 13.45 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.571 2.181 . . . . 0.0 111.862 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -73.57 -27.84 61.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.929 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -108.79 -6.26 15.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.901 0.381 . . . . 0.0 111.632 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.41 40.24 97.6 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.087 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.721 HG23 HG21 ' A' ' 76' ' ' THR . 61.3 mt -78.0 81.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 117.007 0.403 . . . . 0.0 110.837 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -87.1 78.33 8.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 111.882 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.27 164.22 10.15 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.397 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.5 pt -149.03 155.71 40.33 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 122.161 0.184 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.23 116.93 4.26 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 124.183 -1.174 . . . . 0.0 112.628 -0.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.721 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -87.14 137.08 32.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.909 0.385 . . . . 0.0 111.865 179.498 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.465 HD21 HD21 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -107.65 123.87 49.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.901 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.625 HD11 HD11 ' A' ' 71' ' ' ILE . 6.0 mt -116.76 134.88 54.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.219 0.533 . . . . 0.0 111.793 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.917 HD12 HD11 ' A' ' 22' ' ' LEU . 3.5 mm? -114.71 120.68 40.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.696 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.519 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 45.2 m-85 -112.08 146.99 36.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 0.0 111.157 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -146.94 110.6 4.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.328 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 61.83 46.47 6.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.909 0.385 . . . . 0.0 110.171 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.51 1.24 57.4 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.908 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -125.49 138.79 53.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.484 0.642 . . . . 0.0 111.861 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 85' ' ' VAL . 7.2 p -68.25 119.23 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.529 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.22 11.3 20.21 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.842 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.88 140.85 0.76 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.63 124.2 22.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.681 0.277 . . . . 0.0 111.127 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.442 ' HD2' HD22 ' A' ' 93' ' ' LEU . 5.4 tmtt? -126.17 139.68 53.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.272 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.44 146.34 25.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.643 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.404 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.36 161.56 27.36 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.158 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.14 147.86 49.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 111.58 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.653 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -142.38 151.76 42.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.612 179.757 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.9 t -65.33 179.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.151 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -72.5 -31.98 65.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.46 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.24 -29.89 55.57 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.711 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 54.8 mt-30 -76.88 -32.7 57.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.843 0.354 . . . . 0.0 110.532 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.653 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -71.21 -50.56 31.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.781 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -61.4 -42.09 98.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.238 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.38 -39.61 91.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.881 0.372 . . . . 0.0 110.328 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.808 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 10.8 t80 -62.1 -42.56 99.35 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.357 0.598 . . . . 0.0 110.679 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.758 HD11 HG11 ' A' ' 24' ' ' VAL . 6.1 mt -67.41 -54.46 20.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.186 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -50.99 -36.77 40.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.63 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.29 -21.0 60.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.403 ' HB3' HD21 ' A' ' 22' ' ' LEU . 9.1 t30 -108.58 -26.9 10.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.733 0.302 . . . . 0.0 111.705 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.519 HD23 HG12 ' A' ' 52' ' ' VAL . 3.3 tm? . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.683 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 54' ' ' PHE . 50.9 t . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.81 0.338 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.32 121.84 11.05 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.072 0.463 . . . . 0.0 110.23 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.24 127.55 33.26 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.71 HD13 HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -100.51 106.83 19.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.978 0.418 . . . . 0.0 109.928 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -98.45 20.08 13.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.778 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.8 159.79 38.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.946 0.403 . . . . 0.0 111.301 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.582 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -72.37 -25.36 61.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.926 179.476 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.84 -32.28 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.951 0.405 . . . . 0.0 110.702 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -65.67 -39.49 91.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.148 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.401 ' CE1' HG21 ' A' ' 57' ' ' VAL . 3.6 t80 -57.76 -44.52 86.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 109.984 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.84 -45.57 85.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.679 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -58.21 -47.79 82.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.34 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.39 -31.5 72.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.34 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 mt -69.79 -37.91 76.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.41 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -61.41 -33.16 73.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.721 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.42 -23.9 53.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.956 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.72 78.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.24 -122.42 29.0 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.004 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -94.96 6.47 48.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.46 0.171 . . . . 0.0 111.303 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -80.19 148.77 30.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.919 HD11 HD12 ' A' ' 79' ' ' LEU . 8.7 tp -76.25 134.63 39.77 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.92 HG13 HG23 ' A' ' 53' ' ' ILE . 4.2 t -113.78 109.19 27.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.459 0.647 . . . . 0.0 112.007 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.007 HG11 HD11 ' A' ' 102' ' ' LEU . 7.6 p -103.75 116.03 46.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.562 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.6 m -123.91 165.85 19.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.215 0.531 . . . . 0.0 112.126 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -129.57 131.31 46.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.609 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.564 ' CE1' HD12 ' A' ' 78' ' ' LEU . 4.6 m-85 -98.24 110.13 22.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.9 p -134.32 149.54 50.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.107 0.48 . . . . 0.0 112.029 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.39 158.26 15.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.352 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -68.96 -37.49 78.85 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -85.48 16.19 3.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.058 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.586 ' SG ' HD12 ' A' ' 74' ' ' ILE . 36.8 t -90.91 156.95 17.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.36 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.14 -73.85 0.89 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.348 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.47 -22.79 22.5 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.451 2.101 . . . . 0.0 112.227 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.0 m -60.72 -38.11 83.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.22 0.533 . . . . 0.0 110.13 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -69.26 -16.26 63.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.553 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 38.4 mtt -74.16 -23.61 59.28 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.419 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.417 HG22 ' HB2' ' A' ' 42' ' ' PHE . 10.0 mm -87.25 -22.21 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 8.3 mttp -48.66 -60.01 5.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 10.2 Cg_endo -53.32 -44.51 48.36 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.544 2.162 . . . . 0.0 113.43 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.412 ' O ' HD12 ' A' ' 45' ' ' LEU . 14.4 m-85 -79.86 -31.61 40.45 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.43 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 4.9 t80 -66.18 -44.32 84.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.946 0.403 . . . . 0.0 110.545 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -39.27 83.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.12 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 p -61.74 -43.65 98.44 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.046 0.451 . . . . 0.0 110.879 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 41' ' ' PHE . 7.6 mt -59.49 -37.03 77.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.021 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -57.86 -28.31 64.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.376 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -87.27 -19.61 28.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.599 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -95.27 -19.68 19.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 110.266 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.829 ' HB3' HG22 ' A' ' 52' ' ' VAL . 19.0 m-85 -99.52 93.94 6.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.854 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.2 t -90.93 49.43 1.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.142 0.496 . . . . 0.0 110.845 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -151.75 -43.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.565 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.847 HG12 ' HB3' ' A' ' 22' ' ' LEU . 10.3 m -92.24 153.95 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.945 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.92 HG23 HG13 ' A' ' 23' ' ' VAL . 5.6 tp -105.35 114.72 45.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.596 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.662 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.3 m-85 -95.39 115.75 27.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.744 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.71 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.44 165.81 19.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.455 178.593 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -118.03 119.46 34.85 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.901 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.401 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.7 t -114.69 117.84 56.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.488 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -97.26 118.02 32.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.681 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.06 -18.98 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.733 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.4 -39.98 95.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -99.73 -34.08 10.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.765 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.91 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.11 45.03 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.708 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -9.44 57.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.168 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.4 -21.89 18.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.432 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.91 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.3 m -80.38 -47.02 21.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.992 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.908 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.0 -57.81 11.41 Favored Pre-proline 0 N--CA 1.464 0.225 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.908 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 74.6 Cg_exo -50.68 -28.34 22.27 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.536 2.157 . . . . 0.0 111.874 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.98 -23.12 58.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -111.01 -5.25 14.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.87 0.367 . . . . 0.0 111.812 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.56 34.94 89.16 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.581 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.639 HD11 HD11 ' A' ' 78' ' ' LEU . 75.2 mt -74.81 132.84 32.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 117.396 0.598 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -150.7 49.21 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.933 0.397 . . . . 0.0 111.219 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.27 99.46 0.14 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.442 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.586 HD12 ' SG ' ' A' ' 32' ' ' CYS . 2.9 pt -100.96 151.6 37.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.51 0.195 . . . . 0.0 111.109 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.49 113.49 2.97 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 124.036 -1.235 . . . . 0.0 112.752 0.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.47 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -86.65 135.26 33.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.842 0.353 . . . . 0.0 111.571 179.176 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -107.38 125.95 51.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.639 HD11 HD11 ' A' ' 71' ' ' ILE . 7.5 mt -116.88 136.51 52.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.199 0.523 . . . . 0.0 111.702 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.919 HD12 HD11 ' A' ' 22' ' ' LEU . 3.6 mm? -117.45 122.98 45.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.699 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.582 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 49.1 m-85 -113.64 144.82 42.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.031 0.443 . . . . 0.0 111.375 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HD2' HD13 ' A' ' 22' ' ' LEU . 3.5 tttm -145.62 111.59 5.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.336 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 m120 61.88 45.39 7.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.396 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.37 -0.56 59.63 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.957 -0.64 . . . . 0.0 114.242 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -124.07 141.07 52.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.519 0.66 . . . . 0.0 111.865 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.554 HG22 ' CE2' ' A' ' 80' ' ' PHE . 38.2 t -67.4 119.73 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.401 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.09 8.33 19.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.884 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -173.61 138.68 0.68 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.113 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.595 HG23 ' CD2' ' A' ' 78' ' ' LEU . 22.2 m -138.63 120.71 15.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.749 0.309 . . . . 0.0 111.086 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.38 145.15 46.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.942 0.401 . . . . 0.0 111.216 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.01 146.19 25.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.399 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.602 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 79.83 159.29 17.69 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.304 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.9 138.27 48.04 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.027 0.441 . . . . 0.0 111.895 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -128.01 150.96 49.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.534 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.0 m -65.74 -178.03 0.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.771 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -70.57 -33.95 71.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.677 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.67 -30.49 52.64 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.237 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 100' ' ' GLU . 25.6 mt-30 -77.14 -32.35 56.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.014 0.407 . . . . 0.0 110.591 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -71.32 -50.26 34.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -61.96 -42.23 98.88 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.654 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 97' ' ' GLN . 13.1 pt-20 -61.56 -42.84 99.43 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.764 0.316 . . . . 0.0 110.838 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.884 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 38.5 t80 -61.92 -42.7 99.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.374 0.607 . . . . 0.0 110.528 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 1.007 HD11 HG11 ' A' ' 24' ' ' VAL . 1.6 mt -67.3 -54.44 20.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.768 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -52.82 -36.2 58.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.749 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.92 -19.17 61.96 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.985 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -107.6 -28.03 10.0 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.639 0.257 . . . . 0.0 111.454 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.683 HD23 HG12 ' A' ' 52' ' ' VAL . 3.1 tm? . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.756 HG13 ' HA ' ' A' ' 55' ' ' LEU . 44.7 t . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.684 0.278 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -145.29 119.77 9.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.124 0.488 . . . . 0.0 110.651 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.29 127.65 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.641 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.781 HD13 HD13 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -101.2 109.55 25.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.064 0.459 . . . . 0.0 110.557 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -101.41 18.79 19.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.951 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.29 161.38 41.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.086 0.47 . . . . 0.0 111.562 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.644 ' HA ' HG13 ' A' ' 65' ' ' VAL . 5.2 ttpt -73.43 -28.21 61.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.776 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.73 -30.9 41.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.765 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.07 -42.45 89.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.875 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -55.16 -41.51 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 110.213 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -67.1 -44.3 80.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.976 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -58.33 -47.82 82.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.447 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.37 -31.57 72.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 110.928 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 mt -68.68 -39.15 80.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.683 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.46 -34.08 73.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.056 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.66 -22.81 53.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.481 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.44 72.23 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.914 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.34 -123.92 29.35 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.144 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -93.59 4.65 53.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.621 0.248 . . . . 0.0 111.223 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -78.82 149.41 32.55 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.98 HD11 HD12 ' A' ' 79' ' ' LEU . 6.8 tp -76.35 134.96 39.54 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.885 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.3 t -112.79 113.22 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.519 0.676 . . . . 0.0 112.007 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.649 ' HB ' HD21 ' A' ' 102' ' ' LEU . 7.2 p -106.18 112.35 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.45 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.695 HG12 ' HG ' ' A' ' 55' ' ' LEU . 4.7 m -122.24 167.08 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.75 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -134.46 134.49 41.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.683 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.605 ' HE1' HD12 ' A' ' 78' ' ' LEU . 6.4 m-85 -96.13 106.74 18.97 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -115.75 -169.52 1.6 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.449 0.642 . . . . 0.0 112.615 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.689 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.76 153.63 34.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.231 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.8 m -71.26 -36.51 71.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.433 0.635 . . . . 0.0 109.588 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -86.45 12.51 10.1 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.737 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.689 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 21.0 t -92.76 157.65 16.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.998 0.428 . . . . 0.0 111.728 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.18 -69.62 0.64 Allowed Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.344 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.5 -23.21 46.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.641 2.227 . . . . 0.0 112.27 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.1 m -59.89 -42.65 94.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -68.49 -18.6 64.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.365 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.9 mmm -74.04 -25.42 59.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.75 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.9 mm -85.97 -22.57 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.724 0.297 . . . . 0.0 111.664 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.41 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -50.75 -52.78 53.65 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.495 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 63.9 Cg_exo -51.15 -49.57 16.67 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.709 2.273 . . . . 0.0 113.045 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -79.87 -28.45 39.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -66.68 -47.23 73.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.099 0.476 . . . . 0.0 110.412 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -40.19 88.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.24 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.6 t -60.34 -44.58 95.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.599 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt -59.65 -41.92 91.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.123 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.8 t -54.91 -27.59 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.272 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -87.01 -18.77 29.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.727 0.299 . . . . 0.0 111.334 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -95.81 -19.91 19.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 110.08 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.875 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.3 m-85 -100.18 92.52 5.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.032 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -89.69 48.06 1.55 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.021 0.438 . . . . 0.0 110.494 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -152.27 -40.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.591 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' A' ' 49' ' ' TYR . 12.5 m -94.74 155.25 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.422 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.885 ' CG2' HG13 ' A' ' 23' ' ' VAL . 5.3 tp -105.24 115.55 47.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.815 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.64 ' CE1' HG11 ' A' ' 24' ' ' VAL . 8.9 m-85 -97.61 116.17 29.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.938 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.781 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -129.35 167.79 17.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.45 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.453 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -120.24 122.39 40.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.803 -177.517 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.428 HG22 HD11 ' A' ' 55' ' ' LEU . 2.5 t -116.28 120.07 63.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.352 0.596 . . . . 0.0 110.744 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -99.74 119.24 37.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.897 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.73 -18.27 16.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.043 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -39.77 94.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.95 -33.63 10.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.496 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.938 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -97.24 43.7 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.469 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -8.94 56.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.666 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.98 -24.61 16.3 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.293 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.938 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 1.7 m -76.53 -47.43 29.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.494 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.924 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.97 -57.76 11.56 Favored Pre-proline 0 N--CA 1.461 0.108 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.924 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 74.2 Cg_exo -50.14 -28.5 19.83 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.435 2.09 . . . . 0.0 111.569 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -75.27 -24.35 57.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.956 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -106.98 -4.82 18.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.894 0.378 . . . . 0.0 111.612 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.98 34.65 89.08 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.78 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.652 HD11 HD11 ' A' ' 78' ' ' LEU . 70.9 mt -75.77 135.41 27.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 117.248 0.524 . . . . 0.0 110.446 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -144.81 64.85 1.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.014 0.435 . . . . 0.0 111.167 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.407 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 169.3 162.73 22.07 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.496 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.8 pt -147.51 141.76 16.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 122.9 -0.176 . . . . 0.0 110.963 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -88.89 122.1 5.56 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 124.172 -1.178 . . . . 0.0 112.398 -0.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER -88.28 137.69 32.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 111.674 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -108.79 124.19 50.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 71' ' ' ILE . 6.7 mt -116.44 133.92 55.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.283 0.563 . . . . 0.0 111.618 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.98 HD12 HD11 ' A' ' 22' ' ' LEU . 3.0 mm? -115.27 122.13 45.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.695 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 50.2 m-85 -113.71 147.98 37.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.262 0.553 . . . . 0.0 111.542 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -147.02 111.01 5.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.208 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.9 m120 61.78 46.48 6.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.374 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.28 2.28 58.84 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.765 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.52 139.45 53.6 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.432 0.616 . . . . 0.0 112.192 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 85' ' ' VAL . 11.1 p -67.74 116.98 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.454 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.58 9.53 21.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.871 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -170.88 139.3 1.44 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.937 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.65 122.68 20.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.698 0.285 . . . . 0.0 111.171 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -124.08 138.14 54.48 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.39 146.18 24.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.328 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.38 164.62 30.96 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.279 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.594 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -67.23 169.34 8.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.12 0.486 . . . . 0.0 111.576 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.756 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -159.05 -170.32 2.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.25 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 t -111.52 165.73 11.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.814 0.34 . . . . 0.0 110.814 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -55.79 -34.01 64.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.995 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.46 -31.18 51.88 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.914 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 35.5 mt-30 -76.19 -33.5 59.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.903 0.382 . . . . 0.0 110.553 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.756 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -70.51 -49.77 44.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.736 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -61.93 -43.92 97.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.096 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.6 OUTLIER -61.3 -39.1 89.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.881 0.372 . . . . 0.0 110.167 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.793 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 9.7 t80 -61.28 -41.38 96.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.35 0.595 . . . . 0.0 110.333 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.649 HD21 ' HB ' ' A' ' 24' ' ' VAL . 10.7 mt -69.48 -50.75 42.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.763 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -52.43 -38.14 58.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 110.187 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.52 63.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.796 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -104.29 -56.28 2.22 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 110.923 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 22' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.838 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 55' ' ' LEU . 40.0 t . . . . . 0 CA--C 1.523 -0.091 0 CA-C-O 120.738 0.304 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -144.35 121.09 11.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.126 0.488 . . . . 0.0 109.941 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -74.66 129.61 38.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.604 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.854 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -100.98 108.15 22.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.418 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -100.0 18.16 19.18 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.905 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.1 m -154.13 158.04 39.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.84 0.352 . . . . 0.0 111.247 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.564 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -71.63 -26.27 62.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.555 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -79.72 -31.25 41.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.065 0.46 . . . . 0.0 110.298 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.87 -36.18 81.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.056 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -59.91 -42.98 95.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.012 0.434 . . . . 0.0 109.848 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -66.91 -44.7 80.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.614 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.23 -46.44 85.91 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.145 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.97 -30.71 70.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.139 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 15' ' ' LEU . 15.9 mt -69.49 -38.98 77.9 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.084 0.469 . . . . 0.0 110.188 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.25 -33.25 73.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.199 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.96 -23.68 52.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.892 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.32 -33.12 74.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.293 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.1 -122.17 28.68 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.154 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -96.04 7.81 45.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.613 0.244 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -79.05 148.07 32.6 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.916 HD11 HD12 ' A' ' 79' ' ' LEU . 6.1 tp -76.19 134.53 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.952 HG13 HG23 ' A' ' 53' ' ' ILE . 4.7 t -116.61 107.35 22.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.43 0.634 . . . . 0.0 112.085 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.563 HG23 ' CD2' ' A' ' 79' ' ' LEU . 7.3 p -101.69 115.07 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.556 HG12 ' HG ' ' A' ' 55' ' ' LEU . 5.2 m -122.59 168.15 15.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.364 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -135.14 134.13 39.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.951 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.484 ' HE1' HD12 ' A' ' 78' ' ' LEU . 7.1 m-85 -96.71 110.71 23.11 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' HG12 ' A' ' 59' ' ' VAL . 51.6 p -119.44 -168.45 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.299 0.571 . . . . 0.0 112.062 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.17 155.07 37.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.037 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -71.23 -35.94 71.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.462 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 47.5 p-90 -86.25 11.33 12.33 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.404 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 11.1 t -88.76 157.72 18.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.988 0.423 . . . . 0.0 111.436 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.92 -64.66 0.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.004 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 30.3 Cg_exo -64.01 -21.39 68.37 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.753 2.302 . . . . 0.0 112.499 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.7 m -59.02 -39.82 83.09 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.294 0.569 . . . . 0.0 109.983 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -68.69 -16.88 63.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.564 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.408 ' HG2' ' HA ' ' A' ' 34' ' ' PRO . 69.2 mmm -74.16 -24.64 59.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.537 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.539 HG22 ' HB2' ' A' ' 42' ' ' PHE . 6.9 mm -86.19 -24.87 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.631 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -51.09 65.93 Favored Pre-proline 0 N--CA 1.468 0.428 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.3 -48.37 18.03 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.151 1.901 . . . . 0.0 112.703 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -80.59 -31.03 36.87 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 8.2 t80 -66.59 -45.83 77.92 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.875 0.369 . . . . 0.0 110.319 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.67 -39.35 88.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.554 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.5 m -60.75 -42.86 98.24 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.042 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.18 -44.39 95.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.257 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 25.0 p -53.55 -25.15 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.229 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -86.6 -21.98 26.5 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 120.608 0.242 . . . . 0.0 111.129 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -94.9 -19.16 20.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.08 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.766 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.4 m-85 -98.95 92.84 5.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 t -90.11 50.58 1.88 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 110.674 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -153.14 -42.73 0.1 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.492 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' A' ' 49' ' ' TYR . 5.5 m -93.29 154.31 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.689 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.952 HG23 HG13 ' A' ' 23' ' ' VAL . 5.7 tp -105.9 115.65 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.909 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.613 ' O ' HG13 ' A' ' 2' ' ' VAL . 5.7 m-85 -97.03 115.83 28.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.505 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.854 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.48 166.73 17.39 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.491 178.931 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.412 ' N ' HD12 ' A' ' 55' ' ' LEU . 1.6 tp10 -117.93 118.6 32.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.462 HG22 HD11 ' A' ' 55' ' ' LEU . 2.4 t -116.39 118.07 57.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.548 0.689 . . . . 0.0 110.842 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -99.34 120.16 39.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.558 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 28' ' ' SER . 13.7 p -61.2 -17.84 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.4 -40.06 96.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.247 0.546 . . . . 0.0 109.527 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -98.25 -36.29 10.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.987 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.93 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.66 42.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.752 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -69.8 -11.17 60.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.343 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.96 -21.98 19.47 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.439 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.93 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.2 m -80.47 -46.48 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.152 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.877 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.04 -56.65 16.3 Favored Pre-proline 0 N--CA 1.466 0.331 0 O-C-N 122.284 -0.26 . . . . 0.0 111.552 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 79.2 Cg_exo -51.35 -28.32 26.64 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.543 2.162 . . . . 0.0 111.958 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -74.41 -24.74 59.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.35 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -108.43 -6.65 16.08 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.628 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.31 38.87 94.06 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.706 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.617 HG23 HG21 ' A' ' 76' ' ' THR . 76.7 mt -76.28 133.09 31.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 110.38 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.6 tpt85 -149.64 49.05 0.94 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.933 0.397 . . . . 0.0 110.913 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.32 102.09 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.713 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.407 ' HA ' ' N ' ' A' ' 76' ' ' THR . 13.0 pt -101.88 150.02 37.02 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.83 114.05 3.22 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 124.29 -1.129 . . . . 0.0 112.385 0.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.617 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -86.42 135.05 33.64 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.603 HD22 HD21 ' A' ' 93' ' ' LEU . 2.0 mp -107.81 126.18 52.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.55 HD11 HD11 ' A' ' 71' ' ' ILE . 6.0 mt -118.36 134.07 55.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.268 0.556 . . . . 0.0 111.636 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.916 HD12 HD11 ' A' ' 22' ' ' LEU . 3.1 mm? -113.4 126.0 54.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.688 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.494 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 51.9 m-85 -118.68 146.8 44.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.954 0.407 . . . . 0.0 110.961 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -144.74 110.45 5.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.805 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.0 m120 60.52 46.41 9.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 110.063 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.08 -3.37 38.23 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.005 -0.616 . . . . 0.0 114.141 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.57 134.1 55.24 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 117.299 0.55 . . . . 0.0 111.68 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 85' ' ' VAL . 10.0 p -68.04 116.35 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.445 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.81 11.1 24.47 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.89 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.45 137.23 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.263 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.531 HG23 ' CD2' ' A' ' 78' ' ' LEU . 51.3 m -137.52 124.68 21.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -122.72 145.14 48.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.352 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.81 146.64 24.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.199 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.44 159.26 10.83 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.964 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.44 141.0 52.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 111.481 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.603 HD21 HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -129.29 150.97 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.239 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.08 179.09 0.74 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.701 0.286 . . . . 0.0 110.624 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -71.28 -32.56 68.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.731 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.06 -31.03 54.43 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.928 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.74 -31.48 57.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.535 HD11 HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -71.78 -51.26 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.704 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -61.07 -41.78 97.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.078 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.83 -39.09 90.61 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.91 0.386 . . . . 0.0 110.178 179.467 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.89 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 11.3 t80 -63.27 -42.4 99.12 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.515 0.674 . . . . 0.0 110.114 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.51 HD11 HG11 ' A' ' 24' ' ' VAL . 5.0 mt -66.77 -58.45 5.03 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.85 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -48.86 -34.97 13.6 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.732 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.2 -20.57 60.15 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -109.0 -33.42 6.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.678 HD23 HG12 ' A' ' 52' ' ' VAL . 3.4 tm? . . . . . 0 C--N 1.326 -0.448 0 CA-C-O 120.893 0.378 . . . . 0.0 110.679 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.718 HG13 ' HA ' ' A' ' 55' ' ' LEU . 48.3 t . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 120.664 0.268 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -146.09 122.07 10.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.159 0.504 . . . . 0.0 110.265 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -74.48 129.64 38.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.053 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.872 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -101.97 108.11 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 110.317 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -98.94 19.27 15.34 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.226 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -154.72 159.74 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 0.0 111.127 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.614 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -72.35 -27.1 62.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.083 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -79.97 -31.87 39.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.952 0.406 . . . . 0.0 110.751 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.63 90.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.898 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.492 ' CE1' HG21 ' A' ' 57' ' ' VAL . 3.8 t80 -56.36 -40.19 74.12 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.75 -45.14 72.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.046 178.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.77 -48.41 79.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.484 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.41 -32.46 74.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.916 0.389 . . . . 0.0 110.928 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 mt -68.14 -34.58 76.6 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.802 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.01 -34.13 76.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.925 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.2 -22.59 55.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.702 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.68 -37.61 85.1 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.297 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.17 -124.37 35.78 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.997 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -94.19 4.89 53.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.543 0.211 . . . . 0.0 111.031 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 mttp -77.42 149.36 35.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.801 HD12 ' N ' ' A' ' 23' ' ' VAL . 4.4 tp -76.77 136.64 39.0 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.865 HG13 HG23 ' A' ' 53' ' ' ILE . 10.6 t -117.05 110.83 32.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.261 0.553 . . . . 0.0 112.234 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.524 HG11 ' CZ ' ' A' ' 54' ' ' PHE . 7.9 p -106.69 115.87 49.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.53 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.3 m -123.02 167.48 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.949 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -134.51 135.96 42.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.284 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.598 ' HE1' HD12 ' A' ' 78' ' ' LEU . 7.8 m-85 -99.06 109.88 22.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.545 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.3 m -114.97 -168.67 1.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.139 0.495 . . . . 0.0 111.928 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.722 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.08 155.17 37.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.743 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -71.96 -37.47 69.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.499 0.666 . . . . 0.0 109.366 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -86.76 12.4 10.92 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.034 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.722 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 8.0 t -94.17 159.83 14.97 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.994 0.426 . . . . 0.0 111.746 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.94 -64.91 0.44 Allowed Glycine 0 C--N 1.331 0.262 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.045 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.4 -24.13 77.97 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.708 2.272 . . . . 0.0 112.047 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.9 m -58.94 -43.69 91.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.238 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.4 -27.53 67.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.599 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 47.9 mtt -67.83 -17.09 64.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.3 mm -86.27 -22.35 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.904 0.383 . . . . 0.0 111.002 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -51.28 -58.7 9.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.169 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_endo -48.07 -46.65 21.59 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.539 2.16 . . . . 0.0 112.655 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -78.94 -33.79 45.02 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -66.17 -45.82 79.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.916 0.389 . . . . 0.0 110.402 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -40.68 87.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.657 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -43.85 94.83 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.882 0.372 . . . . 0.0 110.893 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.466 HD22 ' HG3' ' A' ' 99' ' ' LYS . 21.5 mt -59.68 -39.42 84.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.7 t -56.49 -29.57 61.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.614 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.66 -18.19 31.91 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.144 -0.223 . . . . 0.0 111.516 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -95.1 -20.35 19.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 0.0 110.008 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.794 ' HB3' HG22 ' A' ' 52' ' ' VAL . 21.8 m-85 -100.13 90.65 4.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.473 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 m -86.96 51.28 2.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.081 0.467 . . . . 0.0 110.454 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -154.65 -41.57 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.171 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.7 m -93.37 154.45 3.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.013 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.865 HG23 HG13 ' A' ' 23' ' ' VAL . 4.0 tp -103.7 114.48 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.256 0.55 . . . . 0.0 111.507 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.622 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.7 m-85 -97.61 115.6 28.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.178 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.872 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.63 167.89 16.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.115 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.68 120.41 36.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.492 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -115.16 118.11 57.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.0 110.406 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -97.97 119.52 36.74 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 28' ' ' SER . 13.9 p -60.08 -18.71 16.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.03 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -65.66 -38.07 88.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.037 0.446 . . . . 0.0 109.802 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.35 -35.13 10.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.28 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.903 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.43 46.07 1.14 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.916 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.3 -11.19 60.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.534 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.75 -22.79 19.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.505 0.193 . . . . 0.0 111.174 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.903 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -79.31 -47.29 22.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.978 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.634 ' HB3' ' CD ' ' A' ' 67' ' ' PRO . . . -50.52 -60.16 5.9 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.634 ' CD ' ' HB3' ' A' ' 66' ' ' ALA . 10.2 Cg_endo -50.85 -28.63 24.02 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.713 2.276 . . . . 0.0 111.967 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -78.13 -23.41 47.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.902 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -106.4 -2.96 21.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.649 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.67 33.75 86.98 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.629 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.639 HD11 HD11 ' A' ' 78' ' ' LEU . 81.2 mt -77.75 133.64 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 117.184 0.492 . . . . 0.0 110.618 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -144.74 64.35 1.29 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.337 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 170.85 162.38 23.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.243 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.3 pt -147.51 139.78 14.21 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.692 0.246 . . . . 0.0 110.987 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -87.95 123.62 6.65 Favored 'Cis proline' 0 C--N 1.35 0.635 0 C-N-CA 124.203 -1.165 . . . . 0.0 112.604 0.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.498 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -86.99 134.29 33.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.813 0.339 . . . . 0.0 111.077 179.199 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.863 HD22 HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -106.27 123.47 48.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.639 HD11 HD11 ' A' ' 71' ' ' ILE . 7.4 mt -115.6 136.12 53.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.222 0.534 . . . . 0.0 111.845 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.931 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 3.3 mm? -116.34 120.81 40.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.594 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.529 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.3 m-85 -112.17 145.61 39.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 0.0 111.202 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 tttm -145.93 110.94 5.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.998 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.9 m120 62.06 46.19 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 110.111 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.66 2.9 57.45 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.745 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -123.78 136.33 54.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.385 0.592 . . . . 0.0 111.651 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 85' ' ' VAL . 7.6 p -66.66 117.59 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.128 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.68 11.48 28.4 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.931 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.52 144.62 1.15 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.96 119.97 17.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -122.13 139.27 53.94 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.855 0.359 . . . . 0.0 110.249 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 t -121.8 145.92 27.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.464 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.6 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.54 159.81 24.38 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.602 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.74 143.89 54.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.976 0.417 . . . . 0.0 111.386 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.863 HD11 HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -125.43 -171.37 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.513 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.0 t -109.21 165.98 11.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 110.822 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -57.4 -37.72 73.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.05 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.54 -30.12 54.04 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.845 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.58 -32.59 58.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.488 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.44 -49.65 39.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.466 ' HG3' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -61.01 -43.76 98.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.876 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -62.21 -38.1 87.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.891 0.377 . . . . 0.0 110.168 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.678 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 5.6 t80 -61.82 -39.99 93.69 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.207 0.527 . . . . 0.0 109.923 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.435 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 6.6 mt -66.12 -59.32 3.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.914 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.49 -34.49 11.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.058 0.456 . . . . 0.0 110.705 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -24.42 62.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.18 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -106.37 -47.68 3.74 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.676 0.274 . . . . 0.0 111.021 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.495 ' C ' HD23 ' A' ' 106' ' ' LEU . 6.1 tt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.768 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.731 HG13 ' HA ' ' A' ' 55' ' ' LEU . 56.8 t . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.77 123.42 11.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.022 0.439 . . . . 0.0 109.827 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -75.38 132.39 40.87 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.91 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -100.16 106.74 19.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 110.543 -179.1 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.76 21.31 10.63 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.87 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.26 159.13 38.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.771 0.32 . . . . 0.0 111.192 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.701 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.2 tmpt? -73.58 -26.9 61.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.946 0.403 . . . . 0.0 110.42 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -79.8 -32.11 40.76 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.616 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.421 ' CB ' HG13 ' A' ' 5' ' ' ILE . . . -66.57 -36.25 82.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.463 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.586 ' CE1' HG21 ' A' ' 57' ' ' VAL . 6.0 t80 -58.16 -42.51 86.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.107 0.479 . . . . 0.0 110.168 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -66.53 -41.79 88.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.955 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.96 -48.21 82.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.528 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.93 76.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 110.67 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 15' ' ' LEU . 12.1 mt -64.78 -40.76 95.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -66.9 -27.1 67.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.624 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -49.19 75.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.876 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.79 -64.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.544 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.51 -86.3 1.46 Allowed Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.809 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -94.4 -16.92 23.02 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -74.86 157.73 34.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.054 HD11 HD12 ' A' ' 79' ' ' LEU . 5.3 tp -79.5 133.96 36.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.863 HG13 ' CG2' ' A' ' 53' ' ' ILE . 15.7 t -114.37 110.37 31.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.403 0.621 . . . . 0.0 111.573 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.668 ' HB ' HD21 ' A' ' 102' ' ' LEU . 7.3 p -106.18 115.05 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.572 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.2 m -123.05 166.74 17.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.759 -178.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -131.75 132.04 43.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.546 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.692 ' HE1' HD12 ' A' ' 78' ' ' LEU . 4.7 m-85 -97.94 111.84 24.0 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.686 ' O ' HG12 ' A' ' 59' ' ' VAL . 22.7 t -117.46 -170.51 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.0 112.472 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.12 155.38 37.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.437 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -35.84 68.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.39 0.614 . . . . 0.0 110.199 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -85.31 11.52 9.99 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.081 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 8.8 t -96.83 158.26 15.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 111.313 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.51 -66.55 0.5 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.009 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.82 -23.36 71.89 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.454 2.103 . . . . 0.0 112.193 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -58.82 -44.54 90.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -65.0 -26.5 68.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.51 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.5 mtt -67.03 -17.44 64.91 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.544 HD11 ' HB1' ' A' ' 92' ' ' ALA . 14.5 mm -86.1 -21.72 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.091 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 25.6 mttp -51.37 -59.34 8.02 Favored Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 8.2 Cg_endo -50.35 -45.2 35.24 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.437 2.092 . . . . 0.0 112.869 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -78.88 -31.87 45.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.419 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 4.5 t80 -65.9 -45.37 82.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.93 0.395 . . . . 0.0 110.531 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.78 -38.35 86.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.524 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.6 m -59.67 -42.8 93.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 110.746 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 54' ' ' PHE . 10.5 mt -60.81 -42.89 98.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.418 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.4 p -54.81 -25.84 31.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.394 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -86.64 -23.15 25.78 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.599 0.238 . . . . 0.0 111.321 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -94.18 -19.05 21.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 110.041 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.832 ' HB3' HG22 ' A' ' 52' ' ' VAL . 19.7 m-85 -100.16 88.03 3.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.966 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 p -87.11 50.92 2.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.463 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -153.5 -42.58 0.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.685 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.832 HG22 ' HB3' ' A' ' 49' ' ' TYR . 12.3 m -93.46 154.56 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.556 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.863 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.6 tp -103.79 114.17 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.353 0.597 . . . . 0.0 111.038 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.646 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.5 m-85 -96.91 117.31 30.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.806 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.91 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -130.76 164.8 24.32 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.395 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -112.98 116.02 29.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.586 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.6 t -114.05 116.46 52.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.168 0.508 . . . . 0.0 111.048 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -99.18 120.18 39.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.469 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 28' ' ' SER . 10.2 p -60.96 -20.03 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.098 -178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -61.76 -40.77 96.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.219 0.533 . . . . 0.0 109.667 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -100.26 -33.53 10.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.353 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.914 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.78 43.6 1.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.548 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -71.66 -9.92 58.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.565 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.38 -21.4 18.4 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.243 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.914 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 1.6 m -79.34 -47.87 21.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.485 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.919 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.89 -58.28 9.87 Favored Pre-proline 0 C--N 1.333 -0.141 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.919 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 74.7 Cg_exo -51.2 -28.3 25.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.415 2.077 . . . . 0.0 111.849 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -73.8 -25.68 60.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.487 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -108.39 -6.12 16.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.691 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.73 36.23 90.94 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 116.007 -0.542 . . . . 0.0 114.33 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.627 HD11 HD11 ' A' ' 78' ' ' LEU . 63.9 mt -74.65 136.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 117.312 0.556 . . . . 0.0 110.653 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -151.79 54.89 0.84 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 111.236 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.73 102.22 0.15 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.428 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.428 ' HA ' ' N ' ' A' ' 76' ' ' THR . 11.8 pt -102.87 154.39 37.56 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 122.971 -0.135 . . . . 0.0 110.835 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.74 114.17 3.17 Favored 'Cis proline' 0 C--N 1.348 0.529 0 C-N-CA 123.768 -1.347 . . . . 0.0 113.125 0.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.484 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -86.26 136.61 33.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 111.221 179.018 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -107.39 123.61 48.62 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.692 HD12 ' HE1' ' A' ' 27' ' ' PHE . 6.7 mt -116.03 136.14 53.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.223 0.535 . . . . 0.0 111.867 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.054 HD12 HD11 ' A' ' 22' ' ' LEU . 3.9 mm? -116.29 123.46 47.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.863 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.639 ' CE2' HG22 ' A' ' 85' ' ' VAL . 47.1 m-85 -113.98 144.94 42.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.024 0.44 . . . . 0.0 111.072 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -146.14 111.34 5.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.061 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 61.49 45.29 8.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.774 0.321 . . . . 0.0 110.563 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.99 2.76 58.73 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.52 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -124.45 140.35 53.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.297 0.548 . . . . 0.0 111.809 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.639 HG22 ' CE2' ' A' ' 80' ' ' PHE . 33.0 t -69.9 120.87 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.672 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.72 8.65 16.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.904 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.84 136.56 0.55 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.9 m -136.36 125.26 24.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 0.0 110.771 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 145.17 49.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.046 0.451 . . . . 0.0 111.181 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.59 145.93 25.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.172 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.409 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 77.53 160.83 13.7 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.332 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.666 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -65.29 176.38 1.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.045 0.45 . . . . 0.0 111.508 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -170.37 153.3 4.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.692 -179.552 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 t -66.78 179.01 1.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.028 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -72.97 -28.63 62.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.068 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.46 -31.77 49.63 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.13 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 39.7 mt-30 -76.87 -31.9 57.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.975 0.387 . . . . 0.0 110.558 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.611 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -71.02 -51.13 27.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.047 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -63.33 -43.22 98.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.097 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.4 pp20? -62.06 -43.17 99.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.779 0.323 . . . . 0.0 110.469 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.748 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 29.8 t80 -61.9 -39.21 91.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.4 0.619 . . . . 0.0 110.088 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.668 HD21 ' HB ' ' A' ' 24' ' ' VAL . 4.3 mt -65.52 -60.7 2.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.009 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -48.23 -32.22 6.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.02 -26.23 63.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.791 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -106.36 -26.58 11.42 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.702 0.287 . . . . 0.0 111.524 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.629 ' O ' HD23 ' A' ' 106' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 110.482 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.696 HG13 ' HA ' ' A' ' 55' ' ' LEU . 52.1 t . . . . . 0 CA--C 1.522 -0.104 0 CA-C-O 120.71 0.29 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -143.34 120.51 11.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.185 0.517 . . . . 0.0 110.377 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.63 129.27 37.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.118 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.796 HD13 HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -101.67 107.79 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.353 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.66 20.19 13.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.159 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -155.15 160.36 40.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.824 0.345 . . . . 0.0 111.401 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.648 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -72.96 -27.07 61.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.624 179.474 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.438 HG22 ' OE2' ' A' ' 13' ' ' GLU . 6.3 m -79.76 -30.99 40.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.858 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.428 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -65.78 -39.78 91.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.735 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 57' ' ' VAL . 4.8 t80 -56.77 -43.26 80.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.191 0.52 . . . . 0.0 109.661 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -66.12 -46.2 78.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.875 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.438 ' OE2' HG22 ' A' ' 9' ' ' THR . 14.0 mt-10 -60.74 -44.8 96.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.434 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.74 -34.32 78.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.577 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.03 -35.9 79.03 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.497 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -35.29 76.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.322 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.45 -22.52 54.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.91 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.1 -33.21 74.1 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.227 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.03 -125.07 37.83 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.036 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.22 6.4 46.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.509 0.195 . . . . 0.0 111.139 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -78.74 150.15 32.53 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.951 HD11 HD12 ' A' ' 79' ' ' LEU . 6.5 tp -78.08 133.76 37.84 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.884 HG13 HG23 ' A' ' 53' ' ' ILE . 6.5 t -113.85 110.19 31.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.454 0.645 . . . . 0.0 112.005 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.684 HG11 HD11 ' A' ' 102' ' ' LEU . 7.3 p -102.59 113.84 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.709 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.1 m -121.27 165.85 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.758 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -134.31 133.31 40.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.854 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.459 ' HE1' HD12 ' A' ' 78' ' ' LEU . 10.7 m-85 -97.34 110.39 22.95 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 35' ' ' CYS . 54.4 p -121.41 -166.76 1.41 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.247 0.546 . . . . 0.0 112.228 -178.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.83 152.71 33.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.155 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -70.44 -36.98 74.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.437 0.637 . . . . 0.0 109.408 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -87.23 11.31 14.49 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.826 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.769 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 15.4 t -93.04 155.79 17.29 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.482 . . . . 0.0 112.213 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.79 -75.8 1.04 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.209 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HA ' ' CG ' ' A' ' 37' ' ' MET . 9.3 Cg_endo -52.26 -24.52 21.07 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.62 2.214 . . . . 0.0 112.416 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 81.2 m -60.49 -41.96 95.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.208 0.528 . . . . 0.0 110.373 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -68.93 -15.64 63.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.25 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.402 ' CG ' ' HA ' ' A' ' 34' ' ' PRO . 3.9 mmt -72.96 -28.09 62.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.467 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.2 mm -84.56 -23.97 7.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.734 0.302 . . . . 0.0 111.431 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -49.76 -54.13 34.94 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.898 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -51.45 -48.36 21.65 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.514 2.142 . . . . 0.0 113.345 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -80.08 -28.27 39.17 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -65.63 -45.83 81.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.965 0.412 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.04 -37.96 81.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.95 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -43.96 97.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.917 0.389 . . . . 0.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.54 -42.35 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.111 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.7 t -55.38 -26.19 39.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.293 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -88.45 -20.15 25.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.586 0.231 . . . . 0.0 111.526 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -96.23 -20.35 18.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.058 0.456 . . . . 0.0 110.069 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.828 ' HB3' HG22 ' A' ' 52' ' ' VAL . 20.0 m-85 -98.71 92.83 5.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.725 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.7 p -91.31 48.51 1.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.667 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -151.79 -40.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.58 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.828 HG22 ' HB3' ' A' ' 49' ' ' TYR . 12.5 m -95.35 156.16 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.594 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.884 HG23 HG13 ' A' ' 23' ' ' VAL . 4.7 tp -106.67 115.18 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.892 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.622 ' CE1' HG11 ' A' ' 24' ' ' VAL . 7.7 m-85 -96.34 115.65 27.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.244 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.796 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.32 166.24 19.02 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.734 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.458 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -117.98 120.05 36.67 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -176.793 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -114.75 117.72 56.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.107 0.48 . . . . 0.0 110.713 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -98.62 120.05 38.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.78 -17.67 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -66.91 -37.61 84.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.2 -37.82 9.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.143 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.855 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.59 44.11 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.303 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -9.37 48.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.815 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.57 -22.36 17.67 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.467 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.855 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.8 m -79.06 -47.44 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.53 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.926 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.66 -57.69 11.42 Favored Pre-proline 0 N--CA 1.463 0.178 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.926 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 75.3 Cg_exo -51.11 -28.5 25.34 Favored 'Trans proline' 0 C--N 1.34 0.09 0 C-N-CA 122.441 2.094 . . . . 0.0 111.595 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -75.93 -21.72 56.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.918 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -112.63 -5.69 13.96 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.49 39.26 96.71 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.451 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.873 HG23 HG21 ' A' ' 76' ' ' THR . 61.4 mt -79.32 79.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.929 0.365 . . . . 0.0 111.06 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -86.5 82.58 7.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.184 0.516 . . . . 0.0 111.836 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.77 163.13 10.07 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.568 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.2 pt -146.2 156.77 50.3 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -83.5 118.25 5.34 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.402 -1.082 . . . . 0.0 113.063 0.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.873 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -89.16 136.55 32.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.372 . . . . 0.0 111.686 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.622 HD22 HD21 ' A' ' 93' ' ' LEU . 1.1 mp -109.19 123.29 49.0 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.707 ' CD2' HG23 ' A' ' 88' ' ' THR . 6.3 mt -115.6 133.11 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.341 0.591 . . . . 0.0 111.411 -178.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.951 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -114.17 121.8 44.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.636 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.497 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 41.6 m-85 -113.07 146.87 38.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.261 0.553 . . . . 0.0 111.544 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -146.69 116.73 7.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.011 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 57.98 44.97 18.81 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.455 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.1 2.54 53.43 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.9 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -124.91 139.47 53.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.473 0.637 . . . . 0.0 111.705 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 85' ' ' VAL . 10.4 p -67.96 117.51 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.905 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -110.91 10.68 22.33 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.857 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.7 137.14 0.34 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.527 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.707 HG23 ' CD2' ' A' ' 78' ' ' LEU . 10.9 m -136.7 125.26 23.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.588 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -123.24 143.21 50.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.859 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.5 146.37 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.568 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.449 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 80.95 159.6 22.49 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.892 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.03 37.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 111.696 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.622 HD21 HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -118.72 150.4 39.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.7 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 m -63.98 179.81 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -72.78 -32.63 65.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.976 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.01 -30.06 56.16 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.618 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 26.3 mt-30 -76.43 -31.86 58.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.441 . . . . 0.0 110.704 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.589 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -72.33 -50.11 29.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -62.22 -44.08 97.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.107 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 17.8 pt-20 -60.05 -44.22 94.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.713 0.292 . . . . 0.0 110.814 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.857 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 19.4 t80 -61.92 -42.2 98.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.114 0.483 . . . . 0.0 111.11 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.684 HD11 HG11 ' A' ' 24' ' ' VAL . 3.6 mt -66.67 -57.54 6.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.164 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.26 -34.92 16.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.68 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.74 -22.59 60.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.254 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -107.88 -24.14 11.77 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.504 HD23 HG12 ' A' ' 52' ' ' VAL . 2.2 tm? . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.813 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.917 HG13 ' HA ' ' A' ' 55' ' ' LEU . 58.3 t . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 109.709 -0.478 . . . . 0.25 109.709 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.506 ' O ' HD12 ' A' ' 5' ' ' ILE . 10.2 ptpt -143.96 122.43 12.42 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.686 -0.805 . . . . 1.47 110.917 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.16 123.4 26.37 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.44 -1.254 . . . . 1.77 109.796 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 1.048 ' CD1' HD13 ' A' ' 55' ' ' LEU . 3.5 mp -102.91 110.79 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.985 0.421 . . . . 0.49 110.558 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -98.63 19.02 15.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.012 -0.54 . . . . 1.57 111.545 179.515 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.45 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.7 m -155.16 163.69 39.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.949 0.404 . . . . 0.76 111.89 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.9 ttpt -76.79 -25.55 53.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.984 -0.553 . . . . 1.36 110.778 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -79.34 -32.43 43.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.004 0.431 . . . . 0.28 109.955 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 1.041 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -66.51 -37.97 86.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.801 -0.636 . . . . 0.17 110.521 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -57.85 -46.14 85.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.24 110.686 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -65.47 -40.58 93.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.853 -0.612 . . . . 1.01 109.736 178.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -58.58 -48.76 79.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.918 -0.583 . . . . 1.34 110.94 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.45 -36.29 82.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.991 -0.549 . . . . 0.21 111.247 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.2 mt -64.69 -38.33 90.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.3 110.166 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.2 -27.66 68.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 1.7 110.476 179.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.9 83.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.31 111.146 -178.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.15 -65.45 0.67 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 119.943 -0.703 . . . . 0.63 109.922 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.83 -93.24 1.86 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.704 -0.68 . . . . 0.43 112.808 -179.243 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -95.63 -9.95 30.75 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.199 0.499 . . . . 2.26 111.669 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -75.24 151.08 38.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.613 -0.514 . . . . 1.14 109.613 179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.998 HD11 HD12 ' A' ' 79' ' ' LEU . 1.9 tp -76.39 127.91 33.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.883 0.373 . . . . 0.2 110.112 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.827 HG13 ' CG2' ' A' ' 53' ' ' ILE . 3.9 t -106.67 110.23 30.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.34 0.59 . . . . 0.18 111.592 -179.362 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.548 ' HB ' HD21 ' A' ' 102' ' ' LEU . 7.3 p -106.07 116.06 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.114 -1.069 . . . . 0.26 108.114 178.352 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.067 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.9 m -123.37 164.18 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.179 0.514 . . . . 0.46 112.371 -178.012 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.477 ' OD1' HD12 ' A' ' 77' ' ' LEU . 31.0 t0 -127.81 132.9 49.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 1.12 112.067 -178.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -99.1 106.52 18.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.06 -0.719 . . . . 0.24 109.06 178.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.525 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.9 p -119.92 -174.76 2.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.068 0.766 . . . . 1.22 113.068 -177.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -147.02 154.77 41.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.459 -1.246 . . . . 0.28 110.396 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -38.45 79.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.82 110.176 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -86.54 14.22 7.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.364 -0.834 . . . . 0.58 111.412 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 32.2 t -98.42 141.35 31.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.737 0.303 . . . . 0.52 110.571 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.89 -67.24 0.94 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.592 -0.813 . . . . 0.29 112.196 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -51.95 -26.58 25.35 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.585 2.19 . . . . 0.41 112.165 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -60.54 -44.06 96.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.36 110.534 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -65.94 -28.44 68.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.795 -0.639 . . . . 1.57 111.093 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.0 mtt -68.55 -21.01 64.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 1.22 111.549 -179.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.8 mm -87.21 -23.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.746 0.308 . . . . 0.29 111.132 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 31.5 mttt -51.23 -54.77 34.7 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.39 -0.368 . . . . 1.87 110.945 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 39' ' ' LYS . 71.5 Cg_exo -48.31 -48.14 17.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.613 2.209 . . . . 0.32 112.485 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -78.24 -28.43 47.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.516 -0.311 . . . . 0.29 111.508 -178.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 4.4 t80 -68.31 -47.96 66.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.097 0.475 . . . . 0.25 110.187 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.89 -41.67 86.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.735 -0.666 . . . . 0.3 111.505 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -59.39 -44.85 92.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.774 0.321 . . . . 1.12 110.82 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.41 -40.4 86.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.808 -0.441 . . . . 0.2 109.808 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.426 ' HB2' ' CB ' ' A' ' 54' ' ' PHE . 35.6 t -53.92 -28.26 35.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 1.24 111.11 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -87.93 -17.9 30.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.641 -0.254 . . . . 2.14 111.33 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.446 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 4.6 ttpp -95.51 -21.47 18.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.018 0.437 . . . . 1.27 109.946 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.79 ' HB3' HG22 ' A' ' 52' ' ' VAL . 16.9 m-85 -99.04 92.21 5.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.627 -0.715 . . . . 0.71 110.708 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -84.26 46.41 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 1.16 111.397 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -157.62 -36.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.956 0.354 . . . . 1.05 111.956 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.79 HG22 ' HB3' ' A' ' 49' ' ' TYR . 6.2 m -91.85 157.07 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.682 0.277 . . . . 0.2 111.193 -179.318 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.827 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.2 tp -104.92 116.91 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.222 0.534 . . . . 0.34 111.109 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.7 m-85 -99.1 117.27 33.23 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.814 -0.63 . . . . 0.24 110.242 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.067 ' HG ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -133.23 169.78 16.4 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.642 -0.423 . . . . 0.35 110.849 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.968 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -121.57 124.94 45.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.381 0.882 . . . . 1.82 113.381 -178.712 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.507 HG22 HD11 ' A' ' 55' ' ' LEU . 7.8 t -112.0 114.59 47.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.654 -0.703 . . . . 0.15 111.027 178.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -94.47 115.68 27.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.1 -0.5 . . . . 1.9 109.686 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 28' ' ' SER . 12.4 p -59.75 -21.05 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.19 111.644 -178.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -64.65 -38.83 92.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.932 -0.395 . . . . 1.16 109.932 179.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -99.61 -39.16 8.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 1.31 111.263 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.702 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.17 50.38 1.39 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.055 0.455 . . . . 0.16 111.176 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 7.0 tt0 -77.54 -3.2 39.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.158 -0.474 . . . . 2.0 110.958 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.38 -24.84 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.766 0.317 . . . . 1.28 110.176 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.702 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 8.2 m -81.98 -48.28 18.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.184 -0.462 . . . . 0.22 111.399 179.298 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.864 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.52 -55.14 24.26 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 112.933 0.716 . . . . 0.18 112.933 -178.299 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 72.6 Cg_exo -52.35 -27.8 32.5 Favored 'Trans proline' 0 C--O 1.23 0.114 0 C-N-CA 122.871 2.381 . . . . 0.3 113.059 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -77.27 -20.26 55.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.124 -0.489 . . . . 1.36 111.895 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -107.48 -6.03 17.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.055 0.455 . . . . 0.24 111.055 179.482 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.04 37.43 93.13 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.626 -0.715 . . . . 0.26 112.859 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 78' ' ' LEU . 70.9 mt -75.05 134.98 28.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.358 -0.608 . . . . 0.66 109.358 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -147.2 59.77 1.17 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.72 0.295 . . . . 2.76 110.968 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.13 117.72 0.45 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.478 -0.867 . . . . 0.95 113.297 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 pt -108.24 153.54 41.85 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 110.164 -0.31 . . . . 0.82 110.164 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.76 115.94 4.06 Favored 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.854 -1.311 . . . . 0.44 112.488 -0.011 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.63 138.2 31.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.878 0.371 . . . . 0.2 111.424 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.477 HD12 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -108.17 124.86 50.9 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.429 -0.952 . . . . 0.35 108.429 177.57 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.522 HD11 HD11 ' A' ' 71' ' ' ILE . 5.0 mt -116.28 135.33 53.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.272 0.558 . . . . 0.23 111.625 -178.047 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.998 HD12 HD11 ' A' ' 22' ' ' LEU . 4.0 mm? -116.74 112.56 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.508 -0.769 . . . . 0.24 110.889 -179.423 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.584 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 50.5 m-85 -104.26 142.62 34.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.076 -0.511 . . . . 0.19 110.524 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -143.62 112.7 6.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.731 -0.668 . . . . 0.35 109.638 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 61.36 45.73 8.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.21 0.529 . . . . 0.73 109.729 -178.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.43 3.32 46.93 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.37 -0.832 . . . . 0.17 113.793 178.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -124.67 140.24 53.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.599 0.699 . . . . 1.65 112.106 -179.051 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.5 t -64.68 116.83 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.586 -0.734 . . . . 1.26 110.788 179.08 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.54 -1.11 19.95 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.517 0.562 . . . . 0.58 112.517 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.625 ' HB1' ' HZ ' ' A' ' 101' ' ' PHE . . . -172.79 147.31 1.71 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.058 -0.519 . . . . 0.22 111.78 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 t -137.73 144.5 41.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 1.42 110.912 178.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -138.55 139.69 38.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.026 -0.534 . . . . 1.79 110.059 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.0 t -121.32 143.96 31.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.681 0.277 . . . . 0.59 111.239 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.407 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 82.66 160.19 27.77 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.529 -0.843 . . . . 0.18 112.607 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.69 155.54 39.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.143 0.497 . . . . 0.44 111.638 -179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -150.52 151.61 32.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.602 -0.726 . . . . 0.57 110.263 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 m -66.92 179.22 1.16 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.428 . . . . 0.91 111.294 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -72.64 -30.59 64.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.624 . . . . 0.81 111.478 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.19 -30.59 54.57 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.131 -1.033 . . . . 0.14 112.701 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.587 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 51.6 mt-30 -76.17 -28.46 57.34 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.876 -0.33 . . . . 1.18 110.632 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -50.72 16.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.067 0.46 . . . . 0.29 109.843 178.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.446 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 14.7 ttpt -59.22 -44.25 92.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.736 -0.665 . . . . 1.16 110.908 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.5 pp20? -61.45 -40.31 94.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.86 -0.609 . . . . 1.38 110.574 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' PHE . . . . . 0.625 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 11.9 t80 -62.38 -42.54 99.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.317 0.58 . . . . 0.26 110.645 178.846 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.548 HD21 ' HB ' ' A' ' 24' ' ' VAL . 8.1 mt -66.55 -54.95 18.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.778 -0.646 . . . . 0.36 109.656 179.48 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -48.96 -34.05 12.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.169 0.509 . . . . 1.15 110.219 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.49 -22.57 61.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.735 -0.666 . . . . 0.22 112.288 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -109.06 -33.32 6.93 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.83 -0.348 . . . . 0.38 111.407 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' A' ' 22' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 109.99 -0.374 . . . . 1.37 109.99 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptp . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.895 0.378 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.723 HG13 ' HA ' ' A' ' 55' ' ' LEU . 43.1 t 63.87 144.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -143.12 120.6 11.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.274 0.559 . . . . 0.0 110.334 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -72.57 125.35 27.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.931 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.857 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -101.02 107.04 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.92 0.391 . . . . 0.0 110.363 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -97.86 20.06 12.75 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.974 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.3 m -156.95 160.13 38.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.838 0.351 . . . . 0.0 111.413 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.657 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.7 ttpt -72.43 -27.03 62.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.969 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.47 -32.13 42.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.383 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.402 ' CB ' HG13 ' A' ' 5' ' ' ILE . . . -66.1 -37.0 84.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.18 -45.2 91.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.027 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -65.31 -44.53 87.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.618 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.76 -45.77 91.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.642 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.55 74.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.07 0.462 . . . . 0.0 110.696 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.37 -35.88 76.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.719 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -62.15 -34.61 76.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.789 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.55 -22.72 53.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.927 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.77 73.35 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.036 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.17 -120.8 21.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.305 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -93.42 1.67 56.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -76.45 148.8 37.01 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.867 HD11 HD12 ' A' ' 79' ' ' LEU . 4.2 tp -76.51 131.51 39.04 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 1.013 HG13 HG23 ' A' ' 53' ' ' ILE . 2.4 t -113.45 109.07 27.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.272 0.558 . . . . 0.0 111.805 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.608 HG11 HD11 ' A' ' 102' ' ' LEU . 7.2 p -104.23 119.2 52.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.632 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.6 m -124.97 167.6 18.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.824 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -135.9 136.56 40.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.923 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.575 ' HE1' HD12 ' A' ' 78' ' ' LEU . 13.6 m-85 -98.67 114.1 26.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.284 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.509 ' O ' HG12 ' A' ' 59' ' ' VAL . 28.9 p -131.78 -171.12 2.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.683 0.754 . . . . 0.0 112.767 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.54 162.3 41.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.546 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 m -63.08 -30.63 71.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.92 0.391 . . . . 0.0 110.045 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -93.32 10.81 30.5 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.188 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.8 t -90.89 113.78 26.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.951 0.405 . . . . 0.0 111.176 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.84 -59.9 3.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.024 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.86 -28.75 69.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.342 2.028 . . . . 0.0 112.311 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.4 m -60.07 -39.87 87.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.803 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -69.11 -20.33 64.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.248 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.5 mtt -74.17 -25.19 59.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.369 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.505 HD11 ' HB1' ' A' ' 92' ' ' ALA . 7.3 mm -89.42 -24.83 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.654 0.264 . . . . 0.0 111.548 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -47.56 -50.17 51.75 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 38.1 Cg_exo -61.9 -44.67 19.57 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.492 2.128 . . . . 0.0 112.826 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.424 ' HB3' ' HD2' ' A' ' 95' ' ' LYS . 22.4 m-85 -80.55 -29.46 37.09 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.453 ' HB2' HG22 ' A' ' 38' ' ' ILE . 5.0 t80 -66.74 -46.43 75.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.072 0.463 . . . . 0.0 110.205 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -39.83 90.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.696 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.5 p -60.69 -42.87 98.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 111.063 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.402 HD22 ' HE1' ' A' ' 49' ' ' TYR . 48.3 mt -60.64 -43.09 97.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.19 -29.42 31.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.222 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -89.05 -21.45 23.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.958 0.409 . . . . 0.0 110.355 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -94.98 3.2 55.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.58 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.543 ' HB3' HG22 ' A' ' 52' ' ' VAL . 7.2 m-85 -109.09 -30.49 8.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 111.058 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 t 36.43 34.41 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.079 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -151.1 -41.36 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.995 0.426 . . . . 0.0 110.858 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 22' ' ' LEU . 17.9 m -94.03 157.4 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.543 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 1.013 HG23 HG13 ' A' ' 23' ' ' VAL . 2.8 tp -106.62 117.45 52.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.331 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.643 ' O ' HG22 ' A' ' 2' ' ' VAL . 5.2 m-85 -100.78 115.61 30.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.308 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.857 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -123.8 165.54 17.14 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.421 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.6 tt0 -116.94 119.56 35.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.115 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.452 HG22 HD11 ' A' ' 55' ' ' LEU . 2.3 t -116.93 119.97 63.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.598 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -99.2 120.67 39.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 28' ' ' SER . 13.9 p -60.73 -18.39 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.722 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -66.92 -37.94 85.28 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.4 -34.5 10.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.736 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.901 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.89 43.35 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.847 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.62 -9.59 50.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.963 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.99 -23.3 17.44 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.521 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.901 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.5 m -78.83 -47.37 23.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.203 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.888 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.97 -57.18 13.32 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.888 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 72.6 Cg_exo -50.69 -28.96 24.08 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.555 2.17 . . . . 0.0 112.101 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -77.86 -22.12 50.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.004 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -107.77 -5.56 17.26 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.886 0.374 . . . . 0.0 111.637 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.03 33.66 87.77 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.909 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 78' ' ' LEU . 59.6 mt -75.96 137.98 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 117.26 0.53 . . . . 0.0 110.593 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -140.94 79.42 1.7 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.96 0.41 . . . . 0.0 111.49 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.42 164.97 10.24 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.015 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.647 ' N ' HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -147.76 154.71 44.37 Favored Pre-proline 0 N--CA 1.464 0.251 0 C-N-CA 122.173 0.189 . . . . 0.0 110.9 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -81.9 118.7 5.84 Favored 'Cis proline' 0 C--N 1.35 0.648 0 C-N-CA 124.772 -0.928 . . . . 0.0 112.779 0.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.513 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -87.36 136.87 32.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.866 0.365 . . . . 0.0 111.318 178.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 93' ' ' LEU . 1.3 tp -107.8 119.03 38.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.744 ' CD2' HG23 ' A' ' 88' ' ' THR . 6.0 mt -114.56 135.22 54.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.241 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.919 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 3.7 mm? -115.58 123.4 48.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.726 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.618 ' CE2' HG22 ' A' ' 85' ' ' VAL . 45.8 m-85 -114.37 145.88 41.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.933 0.397 . . . . 0.0 111.177 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -146.85 112.72 5.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.045 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.5 m120 61.51 45.78 8.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 110.221 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.33 2.86 50.99 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.655 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -124.55 140.23 53.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.393 0.597 . . . . 0.0 111.39 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.618 HG22 ' CE2' ' A' ' 80' ' ' PHE . 28.3 t -68.3 116.94 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.728 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.28 11.27 27.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.094 0.474 . . . . 0.0 111.49 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.919 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -175.96 139.62 0.39 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.643 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.744 HG23 ' CD2' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -136.02 116.58 13.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.526 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -120.82 140.98 50.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 110.727 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.3 p -117.04 146.65 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.269 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.48 160.15 12.38 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.491 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 38' ' ' ILE . . . -69.43 163.89 24.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 0.0 111.82 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.568 HD11 HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -153.44 153.81 33.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.462 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.4 m -64.32 178.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.904 0.383 . . . . 0.0 111.133 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.424 ' HD2' ' HB3' ' A' ' 41' ' ' PHE . 1.6 tptm -72.28 -31.19 65.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.053 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.4 -31.34 51.56 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.315 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 17.8 mt-30 -76.91 -30.75 56.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.174 0.487 . . . . 0.0 110.627 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.528 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -72.42 -50.87 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -62.39 -44.44 96.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.997 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.1 pp20? -61.78 -42.49 99.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.83 0.348 . . . . 0.0 110.364 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.701 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 29.4 t80 -63.17 -42.96 99.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.33 0.586 . . . . 0.0 110.36 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.608 HD11 HG11 ' A' ' 24' ' ' VAL . 2.6 mt -65.46 -59.79 3.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.119 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -49.22 -32.21 10.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.466 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.54 -21.51 60.35 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.019 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -108.77 -28.25 9.31 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.553 HD13 ' C ' ' A' ' 106' ' ' LEU . 3.2 tm? -72.82 113.11 9.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 110.697 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 106' ' ' LEU . 6.6 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.152 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.939 0.399 . . . . 0.0 111.317 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.718 HG13 ' HA ' ' A' ' 55' ' ' LEU . 41.5 t -86.94 145.93 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.829 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -146.12 121.36 10.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.224 0.535 . . . . 0.0 110.173 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -72.84 131.59 42.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.679 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.851 HD13 HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -103.17 108.32 24.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.042 0.449 . . . . 0.0 110.474 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.56 20.18 14.39 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.976 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -155.12 161.73 41.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 111.138 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HA ' HG13 ' A' ' 65' ' ' VAL . 26.5 ttpt -75.08 -26.94 59.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.605 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -79.85 -32.01 40.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.512 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.41 88.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.433 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.52 ' CE1' HG21 ' A' ' 57' ' ' VAL . 4.6 t80 -57.06 -42.24 80.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.909 0.385 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.05 -42.95 88.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.91 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -58.14 -46.29 85.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.254 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.25 76.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.64 -43.35 89.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.99 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.48 -26.49 67.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.434 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.17 -49.76 73.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.977 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.36 -64.21 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.778 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.38 -83.04 1.63 Allowed Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.98 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -96.79 -18.55 19.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.82 0.31 . . . . 0.0 111.468 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -73.28 155.46 39.46 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.019 HD11 HD12 ' A' ' 79' ' ' LEU . 5.2 tp -78.17 134.87 37.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.894 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.864 HG13 ' CG2' ' A' ' 53' ' ' ILE . 13.8 t -113.74 110.25 31.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.418 0.627 . . . . 0.0 111.52 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.618 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -104.96 117.17 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.547 HG12 ' HG ' ' A' ' 55' ' ' LEU . 5.5 m -126.4 167.42 21.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.012 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -131.34 133.21 45.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.977 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.779 ' CE1' HD12 ' A' ' 78' ' ' LEU . 5.6 m-85 -97.78 110.56 23.11 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.681 ' O ' HG12 ' A' ' 59' ' ' VAL . 4.5 m -119.79 -168.34 1.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.388 0.613 . . . . 0.0 112.607 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.05 154.89 36.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.455 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -35.02 70.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.41 0.624 . . . . 0.0 109.498 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.452 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 52.7 p-90 -86.84 11.58 12.97 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.652 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.736 ' SG ' HD12 ' A' ' 74' ' ' ILE . 9.6 t -93.36 157.46 16.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.148 0.499 . . . . 0.0 111.705 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.18 -66.57 0.53 Allowed Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.239 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.1 -21.68 72.36 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.568 2.179 . . . . 0.0 112.308 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.23 -42.99 96.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -68.68 -15.66 63.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.495 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 mtp -72.92 -24.66 60.85 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.1 mm -85.46 -22.63 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.654 0.264 . . . . 0.0 111.685 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 28.6 mtpt -50.0 -59.71 6.47 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_endo -49.55 -45.84 29.34 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.535 2.157 . . . . 0.0 112.864 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -79.19 -29.06 42.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -65.55 -45.7 82.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.447 . . . . 0.0 110.375 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -38.06 84.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.867 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -61.79 -43.15 99.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.815 0.341 . . . . 0.0 110.676 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.97 -45.37 92.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.211 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 23.9 p -53.32 -27.21 22.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.554 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -85.21 -22.29 28.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.389 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -95.36 -17.56 21.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.918 0.389 . . . . 0.0 110.219 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.829 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.3 m-85 -99.6 92.66 5.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.879 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.2 m -90.22 49.55 1.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.393 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -153.23 -43.21 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.829 HG22 ' HB3' ' A' ' 49' ' ' TYR . 9.1 m -93.68 155.51 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.906 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.864 ' CG2' HG13 ' A' ' 23' ' ' VAL . 2.9 tp -105.58 114.69 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.918 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.618 ' CE1' HG11 ' A' ' 24' ' ' VAL . 8.0 m-85 -96.7 116.24 28.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.057 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.851 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -130.63 168.8 16.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.34 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.423 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.5 tt0 -121.34 124.16 43.9 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.52 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -117.33 120.44 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.905 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -97.83 119.22 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 28' ' ' SER . 11.2 p -61.39 -19.2 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.71 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.79 -41.03 97.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -98.21 -34.28 10.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.386 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.919 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.1 41.11 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.049 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -9.72 50.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.575 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.26 -23.14 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.422 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.919 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 1.8 m -78.12 -47.05 25.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.052 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.935 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.16 -57.97 11.1 Favored Pre-proline 0 N--CA 1.463 0.183 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.935 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 76.3 Cg_exo -51.07 -29.39 27.95 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.665 2.244 . . . . 0.0 112.262 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -76.72 -22.65 53.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.668 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -108.49 -3.5 18.07 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.842 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.45 35.35 91.22 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.175 -0.536 . . . . 0.0 114.0 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.653 HD11 HD11 ' A' ' 78' ' ' LEU . 76.4 mt -75.66 134.12 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 117.494 0.647 . . . . 0.0 110.689 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -151.58 51.22 0.82 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.909 0.385 . . . . 0.0 111.399 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.77 103.27 0.17 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.377 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.736 HD12 ' SG ' ' A' ' 32' ' ' CYS . 5.2 pt -103.14 153.21 38.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.465 0.174 . . . . 0.0 111.281 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.6 116.07 4.33 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.954 -1.269 . . . . 0.0 112.123 -0.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.02 138.17 31.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.017 0.436 . . . . 0.0 112.156 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.403 HD22 HD11 ' A' ' 93' ' ' LEU . 1.1 mp -107.48 123.43 48.4 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.779 HD12 ' CE1' ' A' ' 27' ' ' PHE . 7.6 mt -114.88 133.02 56.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.236 0.541 . . . . 0.0 111.841 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -115.13 121.99 44.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.921 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.651 ' CE2' HG22 ' A' ' 85' ' ' VAL . 50.7 m-85 -114.04 148.21 37.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.983 0.421 . . . . 0.0 111.397 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -147.05 111.99 5.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.952 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 12.9 m-20 60.73 46.74 8.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.882 0.372 . . . . 0.0 110.316 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.35 4.68 52.06 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.659 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -125.34 139.54 53.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.19 0.495 . . . . 0.0 111.611 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.651 HG22 ' CE2' ' A' ' 80' ' ' PHE . 27.9 t -67.67 116.14 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.833 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.83 11.11 20.82 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.803 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -174.16 142.19 0.8 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.44 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -137.35 127.57 26.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 111.079 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.42 138.76 52.48 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.143 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 t -121.47 146.08 27.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.694 0.283 . . . . 0.0 111.642 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.43 161.02 23.9 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.849 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.703 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -67.07 164.36 18.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 111.542 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.703 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -159.8 151.15 19.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.051 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.63 178.91 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -70.9 -30.71 67.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.96 -30.99 50.02 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.007 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -77.28 -32.37 55.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.915 0.388 . . . . 0.0 110.617 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.482 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -71.0 -51.74 23.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.33 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -60.95 -38.24 85.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.356 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -61.88 -38.23 87.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.872 0.367 . . . . 0.0 110.268 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.655 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 6.3 t80 -61.48 -41.55 97.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.28 0.562 . . . . 0.0 110.09 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.466 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 6.6 mt -66.92 -56.88 8.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.9 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -50.8 -35.56 32.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.998 0.428 . . . . 0.0 110.193 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.6 -22.72 63.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.71 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.656 ' O ' HG12 ' A' ' 107' ' ' VAL . 2.6 t30 -106.43 -55.42 2.33 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.624 0.25 . . . . 0.0 110.894 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.639 HD13 HG12 ' A' ' 52' ' ' VAL . 19.8 tp -51.51 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.064 0.459 . . . . 0.0 110.852 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 105' ' ' ASN . 5.1 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.07 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.708 0.289 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 55' ' ' LEU . 46.5 t 63.69 144.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.023 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -146.53 122.93 10.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.073 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -74.75 131.92 41.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.249 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.87 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -104.28 108.36 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.763 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -97.47 18.93 14.21 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 m -155.15 165.4 36.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.03 0.443 . . . . 0.0 111.523 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.624 ' HA ' HG13 ' A' ' 65' ' ' VAL . 22.3 ttpt -76.89 -26.34 54.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.33 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.0 m -79.78 -33.82 40.25 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.171 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.13 -36.49 83.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.365 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.511 ' CE1' HG21 ' A' ' 57' ' ' VAL . 5.4 t80 -58.85 -43.44 90.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.059 0.457 . . . . 0.0 110.118 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -65.41 -40.51 93.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.715 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -58.93 -50.71 73.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.711 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.2 75.28 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 15' ' ' LEU . 15.6 mt -65.56 -42.92 91.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.891 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.1 -28.28 68.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.545 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.16 -47.31 83.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.11 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.19 -64.27 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.171 -0.611 . . . . 0.0 109.628 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.88 -87.3 1.47 Allowed Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.201 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.34 -15.77 24.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.092 0.446 . . . . 0.0 111.482 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -75.24 155.62 36.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.019 HD11 HD12 ' A' ' 79' ' ' LEU . 8.1 tp -78.63 133.3 37.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.123 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.904 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.4 t -112.06 109.62 29.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.491 0.662 . . . . 0.0 111.413 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.686 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.1 p -104.15 115.11 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.633 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.2 m -122.89 163.98 20.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.306 0.574 . . . . 0.0 112.022 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -128.37 130.81 48.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.582 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.618 ' HE1' HD12 ' A' ' 78' ' ' LEU . 3.4 m-85 -97.52 111.06 23.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.585 ' O ' HG12 ' A' ' 59' ' ' VAL . 35.9 t -119.53 -168.94 1.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.238 0.542 . . . . 0.0 112.303 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.634 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.84 154.6 36.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.864 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -71.95 -37.84 69.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.48 0.657 . . . . 0.0 109.782 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -86.77 11.74 12.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.159 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.634 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 13.8 t -97.29 156.43 16.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.775 0.322 . . . . 0.0 110.926 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.03 -64.29 0.55 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.296 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.02 -24.36 76.63 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.422 2.081 . . . . 0.0 112.042 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -59.71 -45.54 91.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.305 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -64.9 -25.75 68.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 49.6 mmm -66.85 -16.26 64.18 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 8.7 mm -86.12 -21.57 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.731 0.3 . . . . 0.0 111.092 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.512 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -50.87 -58.78 9.08 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 7.4 Cg_endo -48.13 -47.81 18.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.796 2.331 . . . . 0.0 113.063 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -80.09 -30.41 39.22 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 6.1 t80 -65.72 -46.23 79.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.066 0.46 . . . . 0.0 109.942 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -39.57 88.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.729 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 t -61.57 -43.48 98.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.331 . . . . 0.0 110.833 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.47 -40.36 86.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.131 0.491 . . . . 0.0 109.897 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.3 t -56.15 -28.42 57.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.367 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -85.95 -20.52 28.83 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -95.75 -20.56 18.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.105 0.478 . . . . 0.0 110.159 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.83 ' HB3' HG22 ' A' ' 52' ' ' VAL . 16.0 m-85 -97.29 95.74 7.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.539 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -93.93 48.45 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.161 0.505 . . . . 0.0 110.019 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.87 -41.0 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.519 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.83 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.5 m -95.97 154.55 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.979 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.904 ' CG2' HG13 ' A' ' 23' ' ' VAL . 2.8 tp -105.5 113.99 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.833 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.686 ' CE1' HG11 ' A' ' 24' ' ' VAL . 9.3 m-85 -96.28 116.29 28.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.139 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.87 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.67 165.77 19.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.5 178.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.407 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -115.83 119.21 35.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -176.451 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.511 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -115.71 118.32 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.181 0.515 . . . . 0.0 111.369 178.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -99.68 121.93 41.94 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.585 HG12 ' O ' ' A' ' 28' ' ' SER . 13.1 p -60.43 -18.98 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.784 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -65.71 -39.09 90.85 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -97.94 -36.67 10.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.534 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.901 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.24 43.47 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.749 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -70.2 -9.77 56.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.509 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -94.04 -23.57 17.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.273 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.901 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -79.14 -46.61 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.036 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.884 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.24 -56.9 14.89 Favored Pre-proline 0 N--CA 1.462 0.175 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.884 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 81.1 Cg_exo -50.93 -28.82 25.06 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.677 2.251 . . . . 0.0 112.128 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -76.13 -18.75 59.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.964 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -115.9 -7.35 12.01 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.946 0.403 . . . . 0.0 111.658 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.05 39.94 97.69 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.038 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 78' ' ' LEU . 62.0 mt -76.97 79.66 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 117.013 0.406 . . . . 0.0 110.162 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -87.19 77.82 8.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.959 0.409 . . . . 0.0 111.774 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.73 162.52 9.3 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.129 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 32' ' ' CYS . 31.2 pt -145.89 156.5 51.57 Favored Pre-proline 0 CA--C 1.529 0.165 0 C-N-CA 122.157 0.183 . . . . 0.0 110.863 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -87.36 116.4 3.51 Favored 'Cis proline' 0 C--N 1.354 0.825 0 C-N-CA 124.578 -1.009 . . . . 0.0 112.481 -0.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.517 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -88.65 138.03 31.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.88 0.371 . . . . 0.0 111.659 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -107.65 125.79 51.79 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.618 HD12 ' HE1' ' A' ' 27' ' ' PHE . 6.3 mt -114.58 133.73 55.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.265 0.555 . . . . 0.0 111.686 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 HD11 ' A' ' 22' ' ' LEU . 2.8 mm? -114.48 117.03 29.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.968 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.512 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 45.3 m-85 -108.08 148.76 29.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.423 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -148.25 113.62 5.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.229 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 58.3 46.66 15.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.932 0.396 . . . . 0.0 110.276 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.83 3.45 55.41 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.918 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -126.26 140.51 52.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.252 0.526 . . . . 0.0 111.667 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 85' ' ' VAL . 11.1 p -68.24 119.0 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.911 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -117.05 11.46 14.25 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.866 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.18 140.23 0.85 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.398 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.0 141.15 46.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.049 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -142.48 136.81 29.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.181 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.4 t -120.32 146.3 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.79 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.518 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.27 159.57 23.26 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.857 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.63 132.3 47.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.974 0.416 . . . . 0.0 111.324 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.704 HD11 HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -113.88 -173.5 2.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.365 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 t -110.03 164.89 12.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.9 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -55.63 -38.01 68.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.769 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.05 -31.7 51.9 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.872 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 43.0 mt-30 -76.18 -31.86 58.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.012 0.406 . . . . 0.0 110.507 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.07 -50.13 30.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -61.51 -43.96 97.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.94 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -61.87 -40.09 94.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.256 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.8 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 30.0 t80 -63.09 -42.12 99.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.293 0.568 . . . . 0.0 110.728 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.612 HD11 HG11 ' A' ' 24' ' ' VAL . 3.0 mt -68.02 -56.15 9.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.318 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.99 -34.69 21.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.916 0.389 . . . . 0.0 110.471 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.31 -19.69 60.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.23 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -107.0 -34.7 7.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.84 0.352 . . . . 0.0 110.943 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.75 HD13 HG12 ' A' ' 52' ' ' VAL . 53.2 tp -69.64 99.08 1.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.105 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.821 -179.208 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.889 0.376 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.708 HG13 ' HA ' ' A' ' 55' ' ' LEU . 61.6 t -86.79 144.87 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.707 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.4 121.97 11.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.117 0.484 . . . . 0.0 110.238 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -74.01 130.05 39.08 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.027 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.857 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -102.97 108.55 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.994 0.426 . . . . 0.0 110.337 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -100.59 19.74 16.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.143 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.26 160.16 40.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.935 0.397 . . . . 0.0 111.071 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.626 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -71.18 -28.64 64.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.002 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.49 -30.59 42.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.983 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.6 90.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.683 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -57.63 -43.8 85.1 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.92 0.39 . . . . 0.0 110.098 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 -65.38 -44.1 88.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.589 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -58.37 -46.13 86.92 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.313 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.83 -32.31 73.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.043 0.449 . . . . 0.0 110.606 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 mt -68.23 -38.58 82.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.99 -35.32 76.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.398 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.5 -22.5 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.685 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.14 -34.59 78.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.007 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.2 -123.43 31.19 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.25 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.32 6.22 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.599 0.237 . . . . 0.0 111.414 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -79.21 149.77 31.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.968 HD11 HD12 ' A' ' 79' ' ' LEU . 6.4 tp -76.16 133.21 40.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.869 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.8 t -111.41 111.43 36.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.523 0.678 . . . . 0.0 112.026 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.68 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -105.8 113.92 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.593 HG12 ' HG ' ' A' ' 55' ' ' LEU . 4.6 m -124.21 167.04 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.203 0.525 . . . . 0.0 112.007 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -134.28 134.34 41.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.023 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.598 ' CE1' HD12 ' A' ' 78' ' ' LEU . 6.7 m-85 -96.91 108.8 21.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.331 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 35' ' ' CYS . 50.9 p -115.69 -169.44 1.59 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.366 0.603 . . . . 0.0 112.355 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.8 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.09 154.8 36.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.405 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -71.5 -36.91 71.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.563 0.697 . . . . 0.0 109.53 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 p-90 -87.77 11.28 15.8 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.6 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.8 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 12.7 t -91.48 156.1 17.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.11 0.481 . . . . 0.0 112.145 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.28 -75.49 1.0 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.67 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.86 -20.84 30.64 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.702 2.268 . . . . 0.0 112.569 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 85.0 m -58.85 -43.87 90.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 110.757 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -68.45 -20.16 64.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.512 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 19.4 mtt -71.44 -23.71 61.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.398 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.3 mm -86.43 -24.17 6.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.725 0.298 . . . . 0.0 111.503 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -50.55 -52.9 51.44 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.004 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.54 -47.92 24.62 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.498 2.132 . . . . 0.0 113.107 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -80.34 -26.88 38.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.63 -45.49 82.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.047 0.451 . . . . 0.0 110.226 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.7 -41.47 83.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.988 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.1 t -59.82 -45.05 93.57 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.922 0.391 . . . . 0.0 111.065 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.78 -41.08 85.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.151 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 m -55.68 -26.31 44.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.285 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -87.44 -20.83 26.07 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.624 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -95.41 -19.48 19.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 0.0 110.077 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.825 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.6 m-85 -99.28 92.15 5.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.705 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 t -88.58 49.06 1.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.877 0.37 . . . . 0.0 110.743 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -153.79 -41.17 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.825 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.9 m -93.24 154.88 3.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.831 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.869 ' CG2' HG13 ' A' ' 23' ' ' VAL . 5.3 tp -105.46 114.34 44.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.907 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.68 ' CE1' HG11 ' A' ' 24' ' ' VAL . 8.6 m-85 -96.43 115.76 27.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.377 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.857 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.77 167.2 17.64 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.343 178.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.0 tp10 -119.83 122.15 40.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -176.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.81 120.18 64.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.333 0.587 . . . . 0.0 111.133 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -100.23 119.34 38.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.77 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -60.95 -18.02 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.989 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -64.61 -39.37 93.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 109.681 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.59 -33.9 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.526 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.92 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.91 43.68 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.66 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -70.44 -9.58 56.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.658 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.98 -23.22 17.48 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.289 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.92 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.0 m -77.67 -47.6 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.546 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.91 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.2 -57.75 11.81 Favored Pre-proline 0 N--CA 1.462 0.137 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.91 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 76.9 Cg_exo -51.58 -28.62 29.46 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.5 2.133 . . . . 0.0 111.903 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -76.04 -20.04 58.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.761 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -111.57 -4.89 14.62 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.852 0.358 . . . . 0.0 111.852 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.0 35.87 91.24 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.556 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.696 HD11 HD11 ' A' ' 78' ' ' LEU . 91.5 mt -75.9 135.98 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 117.173 0.486 . . . . 0.0 110.655 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 -146.86 62.63 1.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.04 0.448 . . . . 0.0 111.286 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 176.71 160.88 24.58 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.588 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.492 HD12 ' SG ' ' A' ' 32' ' ' CYS . 36.3 pt -146.31 137.4 12.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 O-C-N 122.995 -0.121 . . . . 0.0 110.764 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -89.88 122.14 5.1 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 124.749 -0.938 . . . . 0.0 112.092 0.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -86.56 137.01 32.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.117 0.484 . . . . 0.0 112.189 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.533 HD21 HD21 ' A' ' 98' ' ' LEU . 1.1 tp -108.97 122.74 47.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 177.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 71' ' ' ILE . 7.0 mt -115.01 136.48 53.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.236 0.541 . . . . 0.0 111.689 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.968 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -117.4 123.33 46.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.039 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.667 ' CE2' HG22 ' A' ' 85' ' ' VAL . 52.0 m-85 -115.27 147.53 40.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.143 0.497 . . . . 0.0 111.503 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -146.41 111.84 5.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.098 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 60.59 46.53 9.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.392 . . . . 0.0 110.321 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.02 0.6 52.79 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.955 -0.641 . . . . 0.0 114.009 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -123.25 138.93 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.626 0.713 . . . . 0.0 111.592 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.667 HG22 ' CE2' ' A' ' 80' ' ' PHE . 39.9 t -67.62 117.98 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.451 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.18 8.8 21.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.831 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.26 141.82 1.29 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.673 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 t -137.68 127.94 26.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.157 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.04 137.97 50.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.09 146.27 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.577 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.89 165.24 30.99 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.27 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.631 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -67.27 171.78 5.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 111.521 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.757 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -162.14 -170.6 2.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.491 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.58 166.25 11.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.773 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -57.79 -32.81 67.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.958 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.43 -30.72 53.27 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.795 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 42.3 mt-30 -77.34 -31.15 54.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.729 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.757 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -71.73 -51.33 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -63.45 -44.38 94.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.195 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.1 pp20? -60.71 -42.29 96.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.948 0.404 . . . . 0.0 110.102 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.68 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 22.1 t80 -62.42 -40.6 97.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.387 0.613 . . . . 0.0 110.013 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.555 HD21 ' HB ' ' A' ' 24' ' ' VAL . 3.8 mt -64.13 -62.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.846 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.12 -32.01 6.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.27 -24.85 62.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.924 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -108.29 -28.96 9.13 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.802 0.334 . . . . 0.0 111.282 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.516 ' O ' HG13 ' A' ' 107' ' ' VAL . 2.7 tt -70.26 112.32 6.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.788 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 106' ' ' LEU . 5.0 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.213 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.961 0.41 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.765 HG13 ' HA ' ' A' ' 55' ' ' LEU . 46.5 t -76.59 146.1 9.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.137 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.51 119.9 10.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -73.48 129.57 38.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.873 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -101.81 108.33 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.279 0.561 . . . . 0.0 111.106 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -98.86 19.81 14.28 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.861 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -154.44 158.84 40.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.97 0.414 . . . . 0.0 111.308 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.66 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.0 ttpt -71.45 -29.47 64.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -31.03 38.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.78 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.46 81.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.623 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.514 ' CE1' HG21 ' A' ' 57' ' ' VAL . 3.9 t80 -59.25 -43.89 92.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.166 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.17 -39.89 94.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.552 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -58.99 -48.88 79.97 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.28 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.35 -33.98 76.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 111.015 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 15' ' ' LEU . 15.1 mt -66.95 -40.68 87.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.435 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.59 -28.68 67.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.489 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.62 77.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.08 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.02 -64.83 0.78 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.544 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.88 -82.47 1.52 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.322 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -95.49 -18.63 20.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.661 0.267 . . . . 0.0 111.556 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -75.11 154.8 37.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.954 HD11 HD12 ' A' ' 79' ' ' LEU . 4.1 tp -78.77 136.11 37.29 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.78 ' N ' HD12 ' A' ' 22' ' ' LEU . 6.0 t -116.58 106.59 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.034 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.659 HG23 HD21 ' A' ' 79' ' ' LEU . 10.4 p -102.54 119.12 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 78' ' ' LEU . 4.9 m -127.15 167.55 21.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.856 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.61 ' OD1' HD12 ' A' ' 77' ' ' LEU . 24.8 t70 -133.42 136.0 44.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.772 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.666 ' CE1' HD12 ' A' ' 78' ' ' LEU . 3.6 m-85 -100.89 111.12 23.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 p -121.39 -167.91 1.59 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.439 0.638 . . . . 0.0 112.366 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.54 154.07 34.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.169 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -33.96 68.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.523 0.678 . . . . 0.0 109.826 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.484 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 51.6 p-90 -86.9 10.52 15.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.912 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 12.2 t -95.15 158.05 15.63 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.142 -0.349 . . . . 0.0 111.529 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.1 -65.64 0.59 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.256 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.34 -22.79 66.02 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.406 2.071 . . . . 0.0 112.404 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.7 m -61.8 -44.36 97.02 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.015 0.436 . . . . 0.0 110.595 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -64.51 -28.11 69.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.198 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.4 mtt -67.15 -16.0 64.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.0 mm -86.89 -22.38 7.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.656 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 33.1 mtpt -50.97 -60.41 5.63 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 1.3 Cg_endo -47.06 -46.54 18.79 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.634 2.222 . . . . 0.0 113.059 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -80.41 -32.35 37.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.471 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 6.4 t80 -67.2 -44.83 78.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.941 0.4 . . . . 0.0 110.177 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -38.18 84.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.593 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.7 t -60.67 -43.32 97.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.927 0.394 . . . . 0.0 110.496 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.2 mt -59.48 -40.06 85.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.332 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 m -54.07 -27.4 32.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.24 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -88.12 -21.75 24.49 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.646 0.26 . . . . 0.0 111.4 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -94.16 -21.63 18.96 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.777 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.0 m-85 -96.43 97.29 9.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.95 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -96.1 43.98 1.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.736 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -156.26 11.37 0.27 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.777 HG22 ' HB3' ' A' ' 49' ' ' TYR . 19.2 m -144.3 157.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 120.423 0.154 . . . . 0.0 111.142 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.775 ' CG2' HG13 ' A' ' 23' ' ' VAL . 3.1 tp -106.34 115.25 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.237 0.541 . . . . 0.0 110.618 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.686 ' O ' HG22 ' A' ' 2' ' ' VAL . 6.5 m-85 -97.78 115.91 28.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.858 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.873 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.65 168.01 15.63 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.63 178.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.422 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -119.59 121.48 39.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.394 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.514 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.1 t -118.92 119.11 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.276 0.56 . . . . 0.0 111.396 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -98.99 120.74 39.93 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.33 -19.42 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.14 -40.2 96.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.263 0.554 . . . . 0.0 110.004 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -98.78 -35.71 10.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.196 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.919 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.17 45.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.669 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -71.95 -11.18 60.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.547 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.7 -21.26 19.46 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.419 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.919 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.5 m -80.04 -46.51 22.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.696 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.902 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.66 -57.96 11.62 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.902 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 53.3 Cg_exo -52.72 -28.64 38.66 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.619 2.213 . . . . 0.0 111.956 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -76.39 -25.59 54.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.126 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -105.94 -2.38 22.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.02 36.11 91.55 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.172 -0.537 . . . . 0.0 114.051 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.741 HD11 HD11 ' A' ' 78' ' ' LEU . 79.3 mt -77.55 133.95 29.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.458 0.629 . . . . 0.0 110.443 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -150.72 54.43 0.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.944 0.402 . . . . 0.0 111.383 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 170.09 105.42 0.18 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.922 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 pt -103.04 153.86 38.0 Favored Pre-proline 0 N--CA 1.463 0.198 0 C-N-CA 122.167 0.187 . . . . 0.0 110.829 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.38 114.78 3.47 Favored 'Cis proline' 0 C--N 1.353 0.767 0 C-N-CA 124.198 -1.167 . . . . 0.0 112.757 -0.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.428 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -88.33 136.75 32.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.957 0.408 . . . . 0.0 111.359 179.336 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.661 HD13 HD21 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -106.98 121.02 43.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.125 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.741 HD11 HD11 ' A' ' 71' ' ' ILE . 10.1 mt -112.37 135.51 52.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.513 0.673 . . . . 0.0 111.874 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.954 HD12 HD11 ' A' ' 22' ' ' LEU . 3.6 mm? -117.37 126.18 52.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.845 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.558 ' CE2' HG22 ' A' ' 85' ' ' VAL . 47.9 m-85 -117.14 147.12 42.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.196 0.522 . . . . 0.0 111.267 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 tttm -148.26 115.31 6.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.99 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 m120 57.79 44.62 19.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 110.209 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.02 5.68 62.39 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.911 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -126.06 142.6 51.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.379 0.589 . . . . 0.0 111.483 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.558 HG22 ' CE2' ' A' ' 80' ' ' PHE . 21.8 t -70.05 119.19 15.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.655 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -115.08 12.34 16.62 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.91 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.37 138.91 0.43 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.17 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -134.59 133.23 39.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.693 0.282 . . . . 0.0 110.805 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.66 139.55 45.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.82 146.3 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.5 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.13 162.43 28.58 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.216 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.58 133.62 47.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.193 0.521 . . . . 0.0 111.548 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.661 HD21 HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -116.08 -175.46 2.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.431 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.82 162.66 14.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.53 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -52.4 -37.76 57.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.509 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.58 -29.3 55.71 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.437 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -77.2 -33.23 56.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.586 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -50.88 32.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -42.24 90.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.389 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -62.58 -38.17 89.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.772 0.32 . . . . 0.0 110.483 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.91 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 9.7 t80 -63.77 -42.86 97.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.406 0.622 . . . . 0.0 110.103 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.516 HD21 ' HB ' ' A' ' 24' ' ' VAL . 4.4 mt -64.8 -62.48 1.54 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.953 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.86 -34.31 12.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.098 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.19 -20.33 60.91 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.501 ' O ' HG22 ' A' ' 107' ' ' VAL . 8.5 t30 -108.99 -38.1 5.66 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 111.598 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.472 ' O ' HG13 ' A' ' 107' ' ' VAL . 3.9 tt -60.81 107.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.094 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 105' ' ' ASN . 16.3 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.339 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.24 0 CA-C-O 120.835 0.35 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.714 HG13 ' HA ' ' A' ' 55' ' ' LEU . 47.4 t 63.75 144.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.846 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -145.02 121.95 11.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.202 0.525 . . . . 0.0 110.162 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -74.4 128.93 36.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.224 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.833 HD13 HD13 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -99.79 108.74 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 0.0 110.39 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -100.34 19.52 16.48 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.96 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.31 160.48 38.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.958 0.409 . . . . 0.0 111.165 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -73.67 -26.33 60.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -79.63 -31.56 41.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.229 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.56 -38.69 90.31 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -56.99 -41.48 78.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.068 0.461 . . . . 0.0 110.051 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -66.37 -45.0 81.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.933 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -58.86 -49.03 79.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.63 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.65 -32.46 73.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.933 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 mt -67.71 -36.87 81.4 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.247 0.546 . . . . 0.0 110.274 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.23 -33.53 73.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.17 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.68 -23.1 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.154 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.95 84.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.073 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.63 -121.13 25.62 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.369 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -94.84 2.63 55.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -78.07 147.14 34.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.96 HD11 HD12 ' A' ' 79' ' ' LEU . 8.0 tp -74.27 132.23 41.91 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.947 HG13 HG23 ' A' ' 53' ' ' ILE . 5.3 t -110.48 108.87 26.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.547 0.689 . . . . 0.0 112.13 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.631 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.1 p -102.92 114.39 42.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.695 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.4 m -121.11 162.16 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.658 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -126.24 131.08 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.24 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.49 ' CE1' HD12 ' A' ' 78' ' ' LEU . 3.4 m-85 -97.29 107.49 20.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.326 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.5 m -132.45 146.93 52.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.034 0.445 . . . . 0.0 111.813 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -96.29 159.03 15.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.611 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -70.56 -37.55 74.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.634 0.73 . . . . 0.0 109.143 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -86.08 14.66 5.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.937 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 21.6 t -91.56 157.09 17.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.887 0.375 . . . . 0.0 111.393 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.7 -73.33 0.91 Allowed Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.386 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.45 -24.91 45.98 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.325 2.017 . . . . 0.0 112.491 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.8 m -58.14 -40.85 82.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.9 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -66.75 -22.84 66.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.541 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 40.1 mtt -68.92 -19.97 64.21 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.2 mm -89.0 -25.24 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.75 0.309 . . . . 0.0 111.628 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.39 -53.18 47.79 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.2 -49.93 14.91 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.619 2.213 . . . . 0.0 113.309 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -80.26 -27.33 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -64.85 -44.5 89.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.034 0.445 . . . . 0.0 110.314 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.64 -41.23 79.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.947 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -58.46 -44.44 89.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 110.596 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mt -59.82 -39.5 85.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.471 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 10.7 p -56.96 -27.35 61.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -87.78 -19.48 27.46 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.683 0.277 . . . . 0.0 111.66 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -95.53 -22.93 17.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.114 0.483 . . . . 0.0 110.012 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.808 ' HB3' HG22 ' A' ' 52' ' ' VAL . 16.6 m-85 -96.34 97.41 9.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.619 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.2 t -93.66 47.26 1.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.285 0.564 . . . . 0.0 109.813 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -150.15 -42.83 0.13 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.934 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.808 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.3 m -94.83 155.87 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.828 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.947 HG23 HG13 ' A' ' 23' ' ' VAL . 5.9 tp -106.88 112.72 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.24 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.659 ' O ' HG22 ' A' ' 2' ' ' VAL . 8.7 m-85 -94.4 115.33 27.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.729 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.45 167.57 16.86 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.643 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.434 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.1 tt0 -118.82 119.52 34.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.228 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.439 HG22 HD11 ' A' ' 55' ' ' LEU . 2.8 t -116.68 119.27 61.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -99.6 119.38 37.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.737 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 p -59.86 -18.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -64.89 -38.33 90.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.128 0.489 . . . . 0.0 109.87 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -100.15 -35.53 9.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.381 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.898 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.59 44.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.953 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.91 -11.02 60.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.924 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.4 -21.68 18.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.339 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.898 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.8 m -79.77 -47.53 21.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.101 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.641 ' HB3' ' CD ' ' A' ' 67' ' ' PRO . . . -50.97 -60.45 5.56 Favored Pre-proline 0 N--CA 1.466 0.336 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.641 ' CD ' ' HB3' ' A' ' 66' ' ' ALA . 6.8 Cg_endo -48.38 -27.95 10.81 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.732 2.288 . . . . 0.0 112.153 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.3 -25.24 57.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.628 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -106.49 -4.21 20.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.806 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.78 36.88 87.99 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.232 -0.508 . . . . 0.0 113.865 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.594 HD11 HD11 ' A' ' 78' ' ' LEU . 84.3 mt -76.37 133.92 30.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 117.18 0.49 . . . . 0.0 110.523 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -141.87 69.85 1.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.01 0.433 . . . . 0.0 111.887 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.03 166.68 15.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.57 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.646 ' N ' HD13 ' A' ' 74' ' ' ILE . 0.2 OUTLIER -150.92 149.45 25.28 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -85.69 121.2 6.36 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 124.311 -1.12 . . . . 0.0 112.507 -0.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 136.54 32.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.885 0.374 . . . . 0.0 111.669 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.478 HD21 HD21 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -107.99 122.43 46.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.546 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 71' ' ' ILE . 6.7 mt -114.5 135.54 54.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.335 0.588 . . . . 0.0 111.298 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.96 HD12 HD11 ' A' ' 22' ' ' LEU . 3.2 mm? -116.61 122.48 44.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.404 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.52 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 51.6 m-85 -115.3 147.67 40.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.134 0.492 . . . . 0.0 111.781 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -146.55 113.42 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.378 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 m120 60.24 45.16 11.78 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.86 0.362 . . . . 0.0 110.283 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.5 2.84 56.52 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.708 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -124.34 139.16 54.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.253 0.526 . . . . 0.0 111.591 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 85' ' ' VAL . 11.5 p -69.14 120.59 16.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.88 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.22 10.93 17.35 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.901 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.07 137.24 0.4 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.779 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.524 HG23 ' CD2' ' A' ' 78' ' ' LEU . 48.2 m -139.3 122.08 16.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.828 0.347 . . . . 0.0 111.088 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -120.77 145.21 47.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.38 146.82 25.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.465 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.17 162.3 23.19 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.064 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.491 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -68.31 158.21 33.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.501 . . . . 0.0 111.662 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -154.97 151.43 28.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.399 -179.451 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 m -68.77 -178.17 1.13 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.989 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -72.69 -29.93 63.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.77 -33.6 41.61 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.269 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -74.88 -31.84 61.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.065 0.459 . . . . 0.0 110.381 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.485 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -71.38 -50.18 34.72 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.063 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -61.41 -41.25 96.84 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.013 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -60.67 -37.91 83.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.948 0.404 . . . . 0.0 110.066 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.901 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 6.8 t80 -63.18 -42.56 99.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.429 0.633 . . . . 0.0 110.323 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.555 HD21 ' HB ' ' A' ' 24' ' ' VAL . 6.3 mt -65.87 -58.31 5.89 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.231 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.52 -36.21 22.6 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.933 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.56 -20.96 61.23 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.501 ' HB3' HD21 ' A' ' 22' ' ' LEU . 8.4 t30 -108.34 -32.28 7.51 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.899 0.381 . . . . 0.0 111.459 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 22' ' ' LEU . 3.2 tm? -74.69 98.23 3.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.19 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.665 -179.372 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.731 0.301 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.72 HG13 ' HA ' ' A' ' 55' ' ' LEU . 40.3 t -65.91 144.81 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.091 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.404 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -144.0 121.29 11.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.266 0.555 . . . . 0.0 110.332 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -74.8 127.98 34.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.04 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.887 HG23 ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -100.66 106.93 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.067 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -95.87 16.81 16.65 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.108 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 p -155.4 161.95 40.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.776 0.322 . . . . 0.0 111.394 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.606 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -72.85 -24.54 60.9 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.714 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.54 -32.32 42.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.509 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.887 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -65.95 -39.81 90.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.81 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.455 ' HB2' HG21 ' A' ' 5' ' ' ILE . 3.9 t80 -57.27 -42.6 81.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.872 0.368 . . . . 0.0 110.019 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.7 mm-40 -68.39 -45.21 73.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.807 178.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -57.55 -45.56 84.97 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.048 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -32.1 73.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.667 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.11 -38.43 78.91 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.64 -34.32 74.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.055 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.47 -22.66 54.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.042 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.4 -34.6 77.59 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.188 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.89 -123.13 32.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.27 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -93.41 5.24 52.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.591 0.234 . . . . 0.0 111.327 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -79.33 150.42 31.46 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.965 HD11 HD12 ' A' ' 79' ' ' LEU . 4.8 tp -77.05 131.85 38.62 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.906 HG13 HG23 ' A' ' 53' ' ' ILE . 4.2 t -112.12 108.62 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.566 0.698 . . . . 0.0 111.479 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.62 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -103.26 115.56 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.617 HG23 ' HB2' ' A' ' 78' ' ' LEU . 5.0 m -124.65 167.42 18.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.763 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.503 ' OD1' HD12 ' A' ' 77' ' ' LEU . 37.5 t0 -136.05 136.86 40.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.966 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.514 ' HE1' HD12 ' A' ' 78' ' ' LEU . 9.7 m-85 -99.46 113.59 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.274 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.573 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.6 m -122.82 -166.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.287 0.565 . . . . 0.0 112.199 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.0 154.05 35.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -72.23 -35.17 68.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.38 0.61 . . . . 0.0 109.716 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.417 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 54.6 p-90 -87.14 10.76 15.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.33 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 25.0 t -96.51 156.83 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 0.0 111.591 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.59 -71.05 0.76 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.286 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.72 -26.52 47.4 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.481 2.121 . . . . 0.0 112.231 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.3 m -58.94 -44.6 91.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.344 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.77 -24.22 66.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.431 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.5 mmt -67.97 -18.62 64.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.1 mm -87.27 -24.59 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.703 0.287 . . . . 0.0 111.115 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -52.91 -53.66 52.51 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.56 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.45 -50.01 13.21 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.703 2.269 . . . . 0.0 113.164 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.411 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 17.5 m-85 -80.07 -27.55 39.32 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.442 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 4.0 t80 -66.02 -45.42 81.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.107 0.479 . . . . 0.0 110.239 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -42.3 84.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.786 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -60.14 -43.76 95.48 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.898 0.38 . . . . 0.0 110.744 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.1 mt -60.09 -39.76 87.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.406 ' HB2' ' CB ' ' A' ' 54' ' ' PHE . 37.8 t -56.45 -27.7 57.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.245 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -87.89 -18.08 30.0 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.717 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.78 -20.58 18.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.966 0.413 . . . . 0.0 110.09 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.798 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.1 m-85 -99.27 92.83 5.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.476 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.2 p -88.85 50.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.052 0.453 . . . . 0.0 110.489 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -153.3 -41.21 0.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.985 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.798 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.8 m -94.38 154.92 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.847 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.906 HG23 HG13 ' A' ' 23' ' ' VAL . 3.4 tp -105.44 113.32 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.361 0.601 . . . . 0.0 111.215 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.62 ' CE1' HG11 ' A' ' 24' ' ' VAL . 7.4 m-85 -95.3 115.99 28.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.502 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.72 ' HA ' HG13 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -127.38 165.23 20.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.603 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.3 tp10 -116.39 119.01 34.31 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.1 117.34 55.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.186 0.517 . . . . 0.0 110.82 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -98.81 120.68 39.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 28' ' ' SER . 14.8 p -60.08 -18.02 15.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.127 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -67.18 -37.69 84.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -99.88 -35.31 9.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.498 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.913 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.67 43.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.547 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -68.79 -10.35 56.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.718 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.76 -22.92 17.77 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.424 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.913 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -78.83 -47.35 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.31 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.881 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.6 -56.41 16.9 Favored Pre-proline 0 N--CA 1.462 0.145 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.881 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 72.1 Cg_exo -51.77 -28.19 29.53 Favored 'Trans proline' 0 N--CA 1.466 -0.122 0 C-N-CA 122.557 2.172 . . . . 0.0 112.102 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -76.98 -15.47 59.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.997 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -118.5 -7.71 10.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.653 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.32 39.49 95.96 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.304 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.614 HG23 HG21 ' A' ' 76' ' ' THR . 56.4 mt -78.21 79.36 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 117.133 0.467 . . . . 0.0 110.892 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 ttt85 -86.31 78.04 9.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.048 0.452 . . . . 0.0 111.62 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.99 166.05 10.73 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.542 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 pt -148.55 154.32 41.07 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 122.309 0.243 . . . . 0.0 110.704 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -87.14 115.78 3.32 Favored 'Cis proline' 0 C--N 1.352 0.756 0 C-N-CA 124.211 -1.162 . . . . 0.0 112.597 0.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.614 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -87.24 137.18 32.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.909 0.385 . . . . 0.0 111.727 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.503 HD12 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -108.45 125.02 51.3 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.949 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.617 ' HB2' HG23 ' A' ' 25' ' ' VAL . 6.4 mt -113.93 134.61 54.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.376 0.607 . . . . 0.0 111.808 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.965 HD12 HD11 ' A' ' 22' ' ' LEU . 2.8 mm? -115.15 119.83 37.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.791 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.59 ' CE2' HG22 ' A' ' 85' ' ' VAL . 52.3 m-85 -112.98 147.88 36.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.179 0.514 . . . . 0.0 111.827 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -147.37 113.18 5.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.309 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 m120 60.6 45.94 9.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.037 0.446 . . . . 0.0 110.194 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.29 2.46 48.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.669 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -124.61 138.59 54.3 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.257 0.528 . . . . 0.0 111.813 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.59 HG22 ' CE2' ' A' ' 80' ' ' PHE . 42.9 t -67.16 116.84 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.647 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -113.07 11.47 18.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.97 0.414 . . . . 0.0 111.907 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.816 ' HB3' ' CB ' ' A' ' 79' ' ' LEU . . . -173.17 138.16 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.101 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -136.46 125.51 24.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 111.102 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.98 139.32 53.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.281 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.07 146.07 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.628 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.1 164.1 33.54 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.121 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.658 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -65.69 165.62 12.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.053 0.454 . . . . 0.0 111.744 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.658 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -163.02 144.74 10.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.632 -179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.7 m -64.41 -177.92 0.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -73.18 -30.96 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.429 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.54 -30.08 54.1 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.79 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 34.3 mt-30 -76.45 -33.08 58.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.97 0.414 . . . . 0.0 110.681 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.555 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -70.61 -51.15 30.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.803 179.226 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -60.88 -40.75 94.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.214 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -60.98 -39.19 88.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.786 0.327 . . . . 0.0 110.128 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.768 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 6.8 t80 -60.94 -39.85 91.03 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.333 0.587 . . . . 0.0 109.98 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.507 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 7.2 mt -66.92 -58.46 4.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.344 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.01 -36.39 28.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.827 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.08 -23.81 63.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.032 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -105.89 -53.1 2.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.754 0.312 . . . . 0.0 111.372 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.525 ' O ' HD23 ' A' ' 106' ' ' LEU . 1.5 tt -47.51 -42.29 22.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.023 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 106' ' ' LEU . 26.2 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.249 -0.882 . . . . 0.0 112.083 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtt . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.934 0.397 . . . . 3.87 111.534 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.738 HG13 ' HA ' ' A' ' 55' ' ' LEU . 52.8 t -108.17 150.93 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.709 -0.678 . . . . 0.42 109.573 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.524 ' O ' HD12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -143.42 124.52 14.47 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 118.764 -1.174 . . . . 1.43 111.975 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -76.5 120.21 21.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.953 -1.476 . . . . 2.28 110.427 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.112 HG23 ' HB3' ' A' ' 10' ' ' ALA . 3.1 mp -101.55 113.56 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.797 -0.361 . . . . 0.36 111.163 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HG2' ' OD2' ' A' ' 61' ' ' ASP . 8.4 mt-10 -100.94 15.97 26.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.104 -0.498 . . . . 1.38 112.276 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.452 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.4 m -153.5 160.27 42.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.908 0.385 . . . . 0.98 111.246 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.477 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.1 ttpt -75.55 -23.32 56.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.238 -0.437 . . . . 1.65 111.092 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 m -79.42 -29.98 42.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.698 -0.482 . . . . 0.8 109.698 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 1.112 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -68.52 -41.77 79.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.68 -0.691 . . . . 0.24 110.453 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -56.51 -49.41 74.79 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.031 -0.531 . . . . 1.13 110.501 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -61.45 -37.17 82.61 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.691 -0.855 . . . . 0.94 108.691 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -62.18 -44.37 96.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.937 -1.029 . . . . 1.4 111.893 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.04 -33.22 67.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.904 0.383 . . . . 0.28 111.367 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 mt -64.57 -40.64 95.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.319 0.581 . . . . 0.4 110.587 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.95 -29.53 69.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 1.84 110.525 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.17 -23.86 51.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.43 111.67 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.446 ' HB1' HG22 ' A' ' 23' ' ' VAL . . . -72.35 -26.72 62.02 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.66 111.288 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.96 -117.65 6.32 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 119.63 -1.271 . . . . 1.04 113.277 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.59 10.34 37.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.54 0.209 . . . . 2.36 111.207 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -82.53 151.11 26.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.88 -0.415 . . . . 1.82 109.88 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.885 HD11 ' CD1' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -76.21 121.28 22.67 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.612 -0.514 . . . . 0.28 109.612 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.875 HG13 ' CG2' ' A' ' 53' ' ' ILE . 2.6 t -101.63 111.9 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.725 0.774 . . . . 0.22 112.065 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.673 HG11 ' CE1' ' A' ' 54' ' ' PHE . 9.1 p -108.27 122.19 62.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.663 -1.236 . . . . 0.36 107.663 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.037 HG12 ' HG ' ' A' ' 55' ' ' LEU . 11.4 m -133.13 141.97 43.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.523 0.678 . . . . 0.67 112.051 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -107.74 131.04 54.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.374 -0.83 . . . . 1.13 112.403 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.405 ' HE1' HD12 ' A' ' 78' ' ' LEU . 2.7 m-85 -96.24 110.28 22.61 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.663 -0.866 . . . . 0.28 108.663 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 59' ' ' VAL . 3.3 p -121.14 -168.76 1.72 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.706 0.632 . . . . 1.03 112.706 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.06 156.1 39.25 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.133 -0.94 . . . . 0.37 110.693 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -37.84 74.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.309 0.576 . . . . 1.14 110.184 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 28.4 p-90 -86.61 10.77 14.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.99 -1.004 . . . . 0.99 111.499 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 37.3 t -100.24 140.47 34.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.786 0.327 . . . . 0.99 110.244 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.48 -65.65 0.9 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.614 -0.803 . . . . 0.36 112.481 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.98 -30.98 25.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.554 2.169 . . . . 0.68 111.769 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 79.4 m -58.51 -40.21 82.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.735 -0.666 . . . . 0.65 110.621 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -70.68 -26.4 63.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.941 -0.572 . . . . 2.15 111.234 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.5 mmt -69.02 -20.64 64.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.479 . . . . 1.48 111.292 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.9 mm -87.8 -18.21 8.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.793 0.33 . . . . 0.61 110.616 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.81 -54.73 40.31 Favored Pre-proline 0 CA--C 1.528 0.132 0 CA-C-N 116.495 -0.32 . . . . 2.12 110.726 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.68 -51.62 10.04 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.657 2.238 . . . . 0.47 112.766 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -75.21 -36.18 61.4 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.488 -0.323 . . . . 0.56 111.466 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.543 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 7.0 t80 -64.81 -46.36 82.33 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.54 -0.464 . . . . 0.38 109.999 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -67.28 -42.11 84.37 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.542 0.201 . . . . 0.98 111.542 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -60.32 -46.87 88.37 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.918 -0.313 . . . . 1.19 110.742 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.7 mt -54.13 -36.44 63.28 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.35 -0.611 . . . . 0.32 109.35 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 43' ' ' HIS . 22.7 t -57.87 -26.33 61.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.294 -0.866 . . . . 1.3 111.117 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.3 -17.64 28.54 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.712 0.291 . . . . 2.3 111.035 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 1.6 ttpp -97.05 -15.15 21.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.091 0.472 . . . . 1.48 110.48 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.901 ' HB3' HG22 ' A' ' 52' ' ' VAL . 24.1 m-85 -105.8 84.48 2.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.792 -0.64 . . . . 0.98 111.334 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -78.62 43.16 0.47 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.542 -0.754 . . . . 1.25 111.542 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -154.6 -29.17 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.672 -0.24 . . . . 1.03 111.34 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.901 HG22 ' HB3' ' A' ' 49' ' ' TYR . 5.3 m -99.35 155.85 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.352 0.596 . . . . 0.29 111.692 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.875 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.1 tp -104.38 113.33 41.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.13 -0.941 . . . . 0.29 110.963 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.716 ' O ' HG22 ' A' ' 2' ' ' VAL . 6.1 m-85 -99.55 116.43 31.66 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 116.042 -0.527 . . . . 0.32 110.876 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.059 HD13 HD13 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -130.95 167.94 18.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 116.064 -0.516 . . . . 0.24 110.296 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.869 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.7 tt0 -121.55 125.08 45.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.023 0.379 . . . . 2.16 112.023 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.571 ' CG2' HD11 ' A' ' 55' ' ' LEU . 6.7 t -112.12 116.17 51.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.557 0.694 . . . . 0.17 110.951 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -93.79 115.29 27.69 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.236 -0.893 . . . . 2.12 110.379 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 28' ' ' SER . 11.2 p -61.2 -22.28 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.22 112.083 -178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -62.32 -37.95 87.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.091 -0.707 . . . . 1.3 109.091 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.458 ' OD2' ' HG2' ' A' ' 6' ' ' GLU . 1.3 m-20 -101.12 -42.43 6.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.128 -0.942 . . . . 1.31 112.314 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.775 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -87.78 53.63 2.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.13 0.49 . . . . 0.26 110.406 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.501 ' O ' ' CD ' ' A' ' 67' ' ' PRO . 5.4 mt-30 -74.9 -11.53 60.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.667 -0.697 . . . . 2.58 111.324 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -87.05 -31.12 20.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 1.37 110.68 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.775 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 18.2 m -76.77 -46.97 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.913 -0.585 . . . . 0.21 111.14 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.882 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.67 -55.31 23.79 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 113.178 0.807 . . . . 0.29 113.178 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.882 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 51.0 Cg_exo -55.68 -28.29 65.29 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.161 2.574 . . . . 0.49 114.073 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -75.62 -26.47 57.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.869 0.322 . . . . 1.47 111.869 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -99.91 -9.43 22.82 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.23 0.538 . . . . 0.46 110.663 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.61 39.44 78.33 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.521 -0.763 . . . . 0.55 112.785 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.626 HD11 HD11 ' A' ' 78' ' ' LEU . 63.9 mt -76.46 129.02 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.0 -0.741 . . . . 1.35 109.0 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.49 64.68 1.33 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.571 -0.452 . . . . 3.47 111.76 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.08 120.74 0.78 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.717 -0.754 . . . . 1.15 112.455 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 32' ' ' CYS . 13.5 pt -109.14 153.39 42.62 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.626 -0.139 . . . . 0.65 110.626 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.9 129.94 17.16 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 124.347 -1.105 . . . . 0.4 113.718 0.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.538 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -101.94 138.54 38.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.45 111.45 178.404 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.16 113.82 26.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.319 -0.993 . . . . 1.81 108.319 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.652 ' HB2' HG23 ' A' ' 25' ' ' VAL . 3.5 mt -104.92 131.65 52.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.379 0.609 . . . . 0.26 111.454 -177.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.885 ' CD1' HD11 ' A' ' 22' ' ' LEU . 2.1 mm? -113.06 117.34 31.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.177 -0.919 . . . . 0.29 111.05 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.602 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 60.0 m-85 -111.93 140.9 46.2 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.507 -0.553 . . . . 0.26 109.507 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.786 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 1.8 tttm -141.32 105.82 4.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.48 -0.933 . . . . 0.46 108.48 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.8 m120 67.04 47.11 1.43 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.373 -0.603 . . . . 1.13 109.373 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.34 4.87 18.96 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.371 -0.831 . . . . 0.24 113.718 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -118.51 130.23 55.81 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.39 -0.596 . . . . 1.56 109.39 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.1 p -55.18 117.41 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.68 -0.859 . . . . 1.21 108.68 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -96.97 -7.24 33.6 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 113.051 0.76 . . . . 0.23 113.051 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -177.05 148.94 0.66 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.098 -0.501 . . . . 0.25 112.055 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.2 t -126.87 148.61 49.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.852 -0.613 . . . . 1.54 109.801 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -149.79 132.07 15.52 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.224 -0.658 . . . . 1.39 109.224 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.04 146.78 19.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.432 -0.349 . . . . 0.3 111.399 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.45 161.57 27.6 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.939 -0.648 . . . . 0.24 113.113 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.65 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -70.19 169.05 14.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.812 0.339 . . . . 0.44 111.361 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.65 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -157.85 176.69 12.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.86 111.333 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -91.27 175.54 6.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.622 -0.717 . . . . 0.98 110.174 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -70.73 -30.84 67.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.621 -0.263 . . . . 1.17 111.365 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.03 -31.92 51.18 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.227 -0.987 . . . . 0.22 113.122 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.602 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 35.8 mt-30 -75.12 -30.6 60.88 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.915 0.388 . . . . 1.0 110.949 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.465 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -73.03 -51.19 19.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.193 0.521 . . . . 0.42 109.823 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.447 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 17.2 ttpt -60.16 -45.18 93.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.442 -0.799 . . . . 1.64 110.529 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.602 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -59.83 -39.03 83.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 1.81 110.154 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.423 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 8.5 t80 -62.45 -41.83 99.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.651 -0.704 . . . . 0.28 111.311 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.482 HD21 ' HB ' ' A' ' 24' ' ' VAL . 8.0 mt -68.17 -55.95 10.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.76 -0.654 . . . . 0.31 110.451 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.447 ' O ' HG13 ' A' ' 107' ' ' VAL . 1.4 t70 -46.45 -33.38 3.92 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.67 -0.493 . . . . 1.19 109.67 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.04 -23.95 59.47 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.403 -0.817 . . . . 0.23 113.192 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.429 ' O ' ' CE ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -108.87 -28.65 9.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.009 0.433 . . . . 0.59 111.659 -178.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.951 ' O ' HD23 ' A' ' 106' ' ' LEU . 9.3 tt -64.61 0.52 1.07 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.628 0.771 . . . . 1.35 112.312 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 103' ' ' ASP . 11.6 m . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.426 -0.797 . . . . 2.69 112.699 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mtt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.992 0.425 . . . . 4.04 111.425 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 55' ' ' LEU . 88.5 t -70.59 147.56 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.865 -0.607 . . . . 0.49 110.714 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.498 ' O ' HD12 ' A' ' 5' ' ' ILE . 2.2 ptpt -141.68 126.2 17.8 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 121.8 0.81 . . . . 1.64 111.255 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.62 122.03 25.42 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.404 -1.271 . . . . 2.05 110.578 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.096 HD13 HD13 ' A' ' 55' ' ' LEU . 3.2 mp -104.43 111.59 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.842 0.353 . . . . 0.19 111.35 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -99.77 19.46 15.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.11 -0.495 . . . . 1.63 112.058 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -154.8 160.2 41.11 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.999 -0.28 . . . . 0.96 110.714 -179.509 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.47 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 7.1 ttpt -77.57 -21.58 52.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.058 0.456 . . . . 1.48 110.707 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -79.41 -31.91 42.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.635 -0.505 . . . . 0.79 109.635 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 1.013 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -68.24 -38.79 82.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.375 -0.83 . . . . 0.26 111.019 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -58.15 -47.99 81.65 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.165 -0.471 . . . . 1.25 110.403 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.6 mm-40 -64.02 -37.37 87.18 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.653 -0.499 . . . . 1.21 109.653 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -60.8 -46.97 88.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.703 -0.68 . . . . 1.53 111.846 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.46 76.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.32 110.65 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.0 mt -65.2 -42.33 93.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.998 -0.546 . . . . 0.44 110.89 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.21 -30.32 71.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.042 0.449 . . . . 1.72 110.074 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.98 -22.34 53.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.638 -0.71 . . . . 0.48 110.77 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.68 -34.01 73.36 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 116.118 -0.492 . . . . 0.73 110.975 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.33 -125.09 36.69 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.083 -1.056 . . . . 1.05 113.155 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -91.21 7.35 41.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 2.4 111.585 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 58.2 mttt -82.49 151.88 26.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.53 -0.304 . . . . 1.54 110.383 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.932 HD11 HD12 ' A' ' 79' ' ' LEU . 1.3 tp -77.09 127.36 32.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.31 109.858 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.874 HG13 ' CG2' ' A' ' 53' ' ' ILE . 3.3 t -107.62 115.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.353 0.597 . . . . 0.33 111.425 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.537 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.9 p -110.47 116.09 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.066 -1.087 . . . . 0.63 108.066 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.997 HG12 ' HG ' ' A' ' 55' ' ' LEU . 16.6 m -124.99 142.98 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-O 121.74 0.781 . . . . 0.84 111.793 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -108.19 128.01 54.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.328 -1.306 . . . . 1.19 111.211 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -95.42 108.22 20.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.147 -0.686 . . . . 0.35 109.147 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.1 p -119.06 -170.93 2.01 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.782 0.66 . . . . 1.03 112.782 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.11 156.83 40.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.845 -1.07 . . . . 0.4 110.137 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.2 -35.51 73.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.556 0.693 . . . . 0.93 110.259 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.437 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 27.8 p-90 -87.42 12.21 12.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.041 -0.981 . . . . 1.12 111.213 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 35.5 t -102.38 131.67 48.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.742 0.306 . . . . 0.94 110.9 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.71 -63.18 1.35 Allowed Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.616 -0.802 . . . . 0.36 112.616 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.77 -32.2 45.0 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.564 2.176 . . . . 0.63 112.164 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -58.47 -41.36 85.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.886 -0.597 . . . . 0.71 110.363 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -71.18 -19.88 62.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.839 -0.619 . . . . 2.24 111.098 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.2 mtt -75.04 -24.86 58.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.016 -0.538 . . . . 1.45 111.434 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mm -85.96 -19.06 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.454 -0.339 . . . . 0.65 111.36 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 25.6 mtpt -52.58 -54.24 44.93 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.823 0.344 . . . . 2.51 111.054 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 63.8 Cg_exo -48.77 -50.02 13.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.715 2.277 . . . . 0.44 112.625 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -77.26 -31.37 54.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.532 0.206 . . . . 0.53 111.419 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.457 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 5.4 t80 -65.42 -47.21 77.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.664 -0.414 . . . . 0.3 110.176 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -41.0 89.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.294 -0.412 . . . . 0.88 111.846 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -60.1 -45.12 94.03 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.933 -0.307 . . . . 1.3 110.856 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.8 mt -57.95 -37.14 73.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.154 0.502 . . . . 0.42 109.894 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.2 t -55.55 -31.94 62.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.58 -0.736 . . . . 1.25 111.103 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.02 -20.7 30.08 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.746 0.308 . . . . 2.18 110.399 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 2.8 ttpp -92.89 -7.76 45.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.192 -0.458 . . . . 2.05 110.514 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.845 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.9 m-85 -116.2 92.5 3.91 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.154 -0.475 . . . . 1.43 111.413 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.5 p -86.55 46.64 1.38 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.435 -0.348 . . . . 1.7 110.479 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 21.5 t30 -154.93 -29.96 0.11 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.793 0.294 . . . . 1.38 111.793 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.845 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.9 m -101.53 159.98 3.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.226 -0.443 . . . . 0.36 111.384 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.874 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.5 tp -109.91 116.83 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.469 -0.787 . . . . 0.38 110.729 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.755 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.5 m-85 -99.89 116.61 32.35 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.354 -0.839 . . . . 0.33 111.156 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.096 HD13 HD13 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -133.45 166.01 23.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 120.493 -0.483 . . . . 0.23 112.009 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.927 ' N ' HD12 ' A' ' 55' ' ' LEU . 3.4 tt0 -119.32 125.01 48.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.977 0.732 . . . . 1.84 112.977 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.663 HG22 HD11 ' A' ' 55' ' ' LEU . 3.4 t -114.49 114.66 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.476 -0.784 . . . . 0.2 110.673 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -90.76 114.81 27.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.741 . . . . 1.69 109.848 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.95 -21.44 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.885 -0.598 . . . . 0.25 111.372 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.18 -41.36 97.15 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.738 -0.468 . . . . 1.26 109.738 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -95.5 -42.55 8.4 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.107 -0.497 . . . . 1.23 111.783 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -90.55 47.35 1.42 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.025 0.44 . . . . 0.23 111.219 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -75.09 -3.3 31.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.365 -0.379 . . . . 2.0 110.864 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.3 -24.25 20.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.159 -0.312 . . . . 1.38 110.159 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 62' ' ' ALA . 34.6 m -85.5 -43.89 16.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.101 0.477 . . . . 0.2 111.557 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.836 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.08 -53.09 47.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.927 0.714 . . . . 0.27 112.927 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.836 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 43.8 Cg_exo -57.82 -27.45 78.31 Favored 'Trans proline' 0 N--CA 1.472 0.208 0 C-N-CA 123.16 2.573 . . . . 0.46 113.456 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -77.29 -22.64 51.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.522 -0.308 . . . . 1.58 111.696 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -102.83 -10.08 19.4 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.405 0.621 . . . . 0.49 110.427 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.49 39.78 79.35 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.265 -0.879 . . . . 0.61 112.151 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.671 HD11 HD11 ' A' ' 78' ' ' LEU . 67.8 mt -77.61 130.45 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.172 -0.677 . . . . 1.3 109.172 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -144.44 67.02 1.26 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.281 0.563 . . . . 3.59 111.337 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.58 117.58 0.71 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.517 -0.849 . . . . 1.15 113.247 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 32' ' ' CYS . 16.6 pt -105.97 153.82 39.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 110.378 -0.23 . . . . 1.11 110.378 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.41 121.42 7.18 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 123.786 -1.339 . . . . 0.95 113.155 0.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.609 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -93.0 140.7 29.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.4 111.589 179.014 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.25 117.09 30.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.458 -0.571 . . . . 0.99 109.458 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.747 ' HB2' HG23 ' A' ' 25' ' ' VAL . 3.2 mt -106.65 132.84 52.18 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.411 0.624 . . . . 0.4 111.504 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.932 HD12 HD11 ' A' ' 22' ' ' LEU . 2.5 mm? -112.62 115.12 28.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.994 -1.003 . . . . 0.27 109.429 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.64 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 46.5 m-85 -109.1 145.56 35.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.188 0.518 . . . . 0.25 110.007 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.669 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 12.1 tttm -143.86 110.58 5.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.268 -0.878 . . . . 0.4 109.905 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.4 m120 60.51 47.2 8.8 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.341 -0.544 . . . . 0.62 109.715 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.04 5.06 45.6 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.828 -0.701 . . . . 0.25 113.425 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -121.65 132.99 54.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.201 0.5 . . . . 1.73 111.269 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.18 121.81 6.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 108.725 -0.843 . . . . 1.08 108.725 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.669 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -103.04 -11.15 18.34 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.298 0.57 . . . . 0.22 112.28 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.596 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.89 149.26 1.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.07 -0.968 . . . . 0.21 111.577 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.17 145.88 51.76 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.52 -0.764 . . . . 1.5 109.211 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -143.68 136.35 27.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.899 -0.408 . . . . 1.93 109.899 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.1 t -116.76 145.2 22.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.905 0.384 . . . . 1.09 111.227 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.9 160.39 26.37 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.517 -0.849 . . . . 0.27 113.092 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.01 152.02 42.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.853 0.359 . . . . 0.56 111.4 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.535 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -138.9 171.08 14.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.286 -0.415 . . . . 0.64 110.875 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.53 175.0 8.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.742 -0.663 . . . . 0.92 110.276 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -67.45 -33.34 74.94 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.043 -0.263 . . . . 0.95 111.635 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.42 -31.13 52.26 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.183 -1.008 . . . . 0.22 112.655 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.497 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 53.3 mt-30 -74.86 -29.56 61.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.074 0.464 . . . . 1.37 110.598 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.535 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -74.88 -48.67 23.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.929 -0.578 . . . . 0.39 109.58 179.012 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.509 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 19.4 ttpt -61.82 -46.13 90.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.581 -0.736 . . . . 1.27 111.079 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.0 pp20? -58.72 -40.32 83.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.232 0.539 . . . . 1.83 109.93 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.53 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 10.8 t80 -61.37 -41.28 96.84 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.671 -0.695 . . . . 0.33 110.882 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mt -68.05 -52.67 32.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.42 109.891 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -51.11 -36.64 41.54 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.96 0.409 . . . . 1.18 110.338 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.43 -19.5 60.95 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 112.737 0.643 . . . . 0.22 112.737 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.537 ' HB3' HD21 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -106.97 -44.23 4.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.42 110.507 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.449 ' HB2' HD23 ' A' ' 22' ' ' LEU . 67.7 tp -63.84 112.87 3.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.726 -0.67 . . . . 1.37 109.565 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.177 -0.916 . . . . 1.67 110.736 -179.65 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.964 0.411 . . . . 3.2 111.422 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.872 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 58.8 t -107.21 149.08 10.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.892 -0.595 . . . . 0.42 109.597 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.587 ' O ' HD12 ' A' ' 5' ' ' ILE . 9.1 ptpt -143.29 117.52 9.56 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 119.428 -0.909 . . . . 1.77 111.92 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.84 124.21 23.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.94 -1.027 . . . . 1.79 109.778 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.872 HD13 HD13 ' A' ' 55' ' ' LEU . 1.4 mp -103.43 111.77 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.852 0.358 . . . . 0.23 111.152 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -97.78 14.02 28.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.99 -0.55 . . . . 1.8 112.152 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.424 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 2.6 m -154.18 155.29 35.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.72 111.034 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.576 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -71.49 -21.77 61.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.371 -0.377 . . . . 1.16 110.85 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -78.86 -32.71 46.11 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.408 -0.59 . . . . 0.32 109.408 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.746 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -66.73 -41.52 87.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.461 -0.791 . . . . 0.23 109.797 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.453 ' HB2' HG21 ' A' ' 5' ' ' ILE . 18.2 t80 -56.34 -41.86 76.77 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.059 -0.518 . . . . 1.16 109.888 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -64.82 -41.21 95.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.074 -0.713 . . . . 1.27 109.074 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -59.96 -49.37 77.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.099 -0.955 . . . . 1.62 111.76 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.89 74.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.747 0.308 . . . . 0.3 111.313 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.505 HD23 HG11 ' A' ' 23' ' ' VAL . 24.4 mt -69.1 -43.69 73.96 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.147 0.499 . . . . 0.42 110.65 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -61.94 -32.1 72.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.009 -0.541 . . . . 1.79 110.688 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.47 -26.9 58.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.48 110.968 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.569 ' HB1' HG22 ' A' ' 23' ' ' VAL . . . -73.93 -20.72 60.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.73 111.286 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 46.12 -119.85 4.25 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.794 -0.717 . . . . 0.97 114.789 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -88.74 2.33 53.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.548 -0.326 . . . . 2.34 111.534 -178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 32.0 mttt -78.1 151.96 33.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.71 -0.848 . . . . 1.64 108.71 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.808 ' HB3' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -73.73 125.09 27.31 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.569 -0.53 . . . . 0.32 109.569 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.967 HG13 ' CG2' ' A' ' 53' ' ' ILE . 2.3 t -106.26 105.8 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.472 0.653 . . . . 0.23 110.917 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.55 HG23 ' CD2' ' A' ' 79' ' ' LEU . 11.4 p -105.55 115.58 47.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 107.294 -1.373 . . . . 0.69 107.294 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.983 HG12 ' HG ' ' A' ' 55' ' ' LEU . 25.0 m -129.13 126.94 65.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.952 -0.567 . . . . 0.83 111.862 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -93.16 135.67 34.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.42 -0.809 . . . . 1.16 111.453 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -98.8 116.25 30.61 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.989 -0.745 . . . . 0.24 108.989 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 59' ' ' VAL . 11.2 p -125.01 -168.43 1.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.463 0.649 . . . . 1.25 112.731 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.75 154.03 35.47 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 114.901 -1.045 . . . . 0.39 109.868 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -35.31 72.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.323 0.582 . . . . 0.92 109.809 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -86.42 11.52 12.26 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.124 -0.944 . . . . 0.81 111.291 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.549 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 36.9 t -97.08 140.77 31.09 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.815 0.341 . . . . 0.48 110.923 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.78 -66.12 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.599 -0.81 . . . . 0.3 112.476 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.62 -25.06 24.68 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.533 2.155 . . . . 0.52 112.344 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.0 m -62.98 -41.69 99.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.5 110.696 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -66.59 -21.25 66.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.013 -0.54 . . . . 2.37 111.149 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 mmt -73.36 -26.02 60.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 1.53 111.828 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.88 -22.79 7.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.745 0.307 . . . . 0.26 111.109 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 10.1 tttt -48.35 -57.04 11.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.619 -0.264 . . . . 1.69 110.967 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 11.6 Cg_endo -56.68 -43.88 50.69 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.365 2.043 . . . . 0.45 112.678 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -73.73 -37.87 64.97 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.521 0.193 . . . . 0.38 111.521 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.45 ' O ' ' CE2' ' A' ' 54' ' ' PHE . 9.0 t80 -64.67 -43.52 93.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.951 -0.3 . . . . 0.48 111.037 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -37.94 86.2 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.869 -0.332 . . . . 1.02 111.102 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.25 -45.82 91.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.707 0.289 . . . . 1.1 110.991 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.53 HD13 HD22 ' A' ' 98' ' ' LEU . 19.9 mt -59.25 -39.9 84.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.892 -0.41 . . . . 0.45 109.892 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.421 ' HB2' ' CG ' ' A' ' 54' ' ' PHE . 33.6 t -55.17 -29.19 57.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.535 . . . . 1.3 111.016 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -87.51 -20.73 26.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.961 0.41 . . . . 2.39 110.007 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 2.1 ttpp -98.88 8.59 44.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.733 -0.667 . . . . 1.92 110.698 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.717 ' HB3' HG22 ' A' ' 52' ' ' VAL . 13.9 m-85 -129.63 108.13 9.97 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.268 -0.423 . . . . 0.88 109.883 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.7 m -99.41 47.16 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.098 0.407 . . . . 1.52 112.098 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.475 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 13.9 t30 -158.37 -33.78 0.07 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.704 0.287 . . . . 1.3 111.39 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.808 HG12 ' HB3' ' A' ' 22' ' ' LEU . 5.0 m -92.82 150.89 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.154 0.428 . . . . 0.34 112.154 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.967 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.3 tp -101.02 119.7 49.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.428 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.872 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 3.9 m-85 -101.79 124.58 47.68 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 116.025 -0.534 . . . . 0.37 110.966 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.983 ' HG ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -139.73 167.53 21.9 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.089 -0.644 . . . . 0.3 110.607 177.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.879 ' N ' HD12 ' A' ' 55' ' ' LEU . 4.5 tt0 -122.29 126.46 48.17 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.328 0.492 . . . . 2.05 112.328 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.673 HG22 HD11 ' A' ' 55' ' ' LEU . 3.9 t -115.52 119.29 61.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.714 -0.675 . . . . 0.2 111.388 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -94.42 115.52 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.274 -0.639 . . . . 1.79 109.274 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 28' ' ' SER . 10.7 p -58.4 -19.07 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.393 . . . . 0.27 111.5 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -38.66 90.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.889 -0.412 . . . . 1.14 109.889 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.56 -43.65 6.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 1.29 110.698 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.746 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -86.14 46.76 1.37 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.959 -0.564 . . . . 0.24 111.02 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.528 ' O ' ' CD ' ' A' ' 67' ' ' PRO . 16.6 tt0 -74.87 -12.24 60.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.377 -0.374 . . . . 2.03 110.778 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.64 -23.47 31.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.764 0.316 . . . . 1.29 110.277 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 62' ' ' ALA . 8.5 m -83.46 -49.12 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.345 -0.389 . . . . 0.21 112.046 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.866 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.64 -54.41 31.53 Favored Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 113.524 0.935 . . . . 0.28 113.524 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.866 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 50.4 Cg_exo -55.04 -27.36 54.57 Favored 'Trans proline' 0 CA--C 1.521 -0.144 0 C-N-CA 122.959 2.439 . . . . 0.41 112.4 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -76.85 -18.81 58.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 1.93 111.203 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -109.22 -8.17 15.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.048 0.451 . . . . 0.43 110.922 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.16 36.47 91.88 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.639 -0.71 . . . . 0.51 112.983 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 78' ' ' LEU . 79.4 mt -75.91 132.44 33.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.621 -0.511 . . . . 1.36 109.621 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -148.14 49.8 1.04 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.666 0.27 . . . . 3.23 111.293 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.08 104.24 0.18 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.464 -0.874 . . . . 1.07 112.277 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.7 pt -99.48 153.03 37.99 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.57 0.224 . . . . 0.88 110.808 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.76 119.28 6.22 Favored 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.766 -1.348 . . . . 0.44 112.373 -0.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.472 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -89.89 137.95 31.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.49 111.556 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.55 HD22 HD21 ' A' ' 93' ' ' LEU . 1.3 mp -107.08 118.89 37.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.36 -0.978 . . . . 1.7 108.36 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.566 ' HB2' HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -106.78 128.19 54.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.604 0.716 . . . . 0.23 111.231 -178.407 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.782 HD12 HD11 ' A' ' 22' ' ' LEU . 2.8 mm? -111.31 130.85 55.54 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.983 -1.008 . . . . 0.3 108.855 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.696 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 44.9 m-85 -123.8 151.67 43.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.136 0.493 . . . . 0.25 110.4 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.931 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -144.15 115.03 7.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.345 -0.843 . . . . 0.54 109.359 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 33.4 m-20 53.64 49.57 19.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.374 -0.53 . . . . 1.14 110.319 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.44 3.28 31.7 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.143 -0.551 . . . . 0.19 113.865 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -119.51 141.81 48.86 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 117.148 0.474 . . . . 1.37 110.142 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.61 133.05 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.205 -0.598 . . . . 1.27 109.541 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.931 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -103.98 -25.51 12.98 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.635 0.731 . . . . 0.24 111.656 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.96 160.97 4.37 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.396 -1.275 . . . . 0.19 110.876 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.75 134.21 36.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.272 -0.422 . . . . 1.13 110.837 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.41 138.34 43.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 1.34 110.166 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.45 145.37 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.437 -0.347 . . . . 0.98 111.198 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.72 160.13 25.45 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.647 -0.787 . . . . 0.2 113.034 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.07 152.44 45.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.172 0.51 . . . . 0.44 111.733 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.55 HD21 HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -146.05 151.32 37.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.718 -0.674 . . . . 0.79 110.441 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -69.16 178.9 2.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.446 -0.343 . . . . 0.98 111.051 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -72.49 -30.64 64.7 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.158 -0.474 . . . . 0.95 111.797 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.53 -31.87 52.86 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.018 -1.087 . . . . 0.24 112.512 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.502 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 39.6 mt-30 -75.59 -33.14 60.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.803 0.335 . . . . 1.3 110.504 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.53 HD22 HD13 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -68.58 -48.83 63.18 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.172 -0.677 . . . . 0.4 109.172 179.213 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 18.2 ttpt -60.66 -42.39 96.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.859 -0.609 . . . . 1.45 110.422 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -60.49 -39.97 89.65 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.132 -0.485 . . . . 1.68 110.091 179.262 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.536 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 6.9 t80 -62.77 -43.44 98.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.757 -0.656 . . . . 0.26 111.429 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.2 mt -67.73 -53.0 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.642 -0.708 . . . . 0.51 109.788 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.05 -37.37 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 1.2 111.153 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.43 -21.31 62.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.209 -0.451 . . . . 0.29 111.903 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.71 ' HB3' HD21 ' A' ' 22' ' ' LEU . 4.3 t30 -106.52 -46.98 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.068 -0.253 . . . . 0.72 111.219 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.629 HD13 HG12 ' A' ' 52' ' ' VAL . 56.6 tp -60.59 90.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.951 0.405 . . . . 1.32 110.169 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.344 -0.836 . . . . 2.41 111.03 -179.649 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 mtt . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.767 0.318 . . . . 3.85 111.374 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 70.2 t -111.01 149.7 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.26 110.229 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.51 125.78 17.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.045 -0.662 . . . . 2.08 111.31 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.82 122.91 27.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.323 -0.853 . . . . 2.36 109.432 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.033 HD13 HD13 ' A' ' 55' ' ' LEU . 1.3 mp -103.67 112.06 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 112.119 0.414 . . . . 0.18 112.119 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.36 14.19 28.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.657 0.614 . . . . 1.41 112.657 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 m -156.61 140.8 16.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.705 0.288 . . . . 0.93 111.633 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -58.26 -23.92 57.67 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.443 -0.344 . . . . 1.2 111.62 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 m -78.31 -33.49 49.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.949 -0.76 . . . . 0.32 108.949 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -67.24 -39.35 86.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.583 -0.735 . . . . 0.21 109.913 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.539 ' HB2' HG21 ' A' ' 5' ' ' ILE . 23.8 t80 -57.64 -46.97 83.49 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.076 -0.511 . . . . 0.63 110.701 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -63.35 -38.4 91.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.411 -0.588 . . . . 1.08 109.411 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -59.6 -50.1 75.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.619 -0.719 . . . . 1.44 111.498 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.13 -32.55 74.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.839 0.352 . . . . 0.31 111.238 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 mt -67.79 -42.54 81.49 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.236 0.541 . . . . 0.41 110.613 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -60.56 -31.58 70.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 1.68 110.161 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.23 -22.21 55.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.95 -0.568 . . . . 0.45 110.44 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.12 -29.3 67.33 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.72 111.03 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.72 -126.44 42.24 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.347 -0.93 . . . . 0.93 113.236 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -92.55 9.06 36.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.35 -0.425 . . . . 2.28 111.057 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.56 154.1 27.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.947 -0.39 . . . . 1.35 109.947 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.903 HD11 HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -78.31 126.38 30.7 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.868 -0.419 . . . . 0.26 109.868 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.912 HG13 ' CG2' ' A' ' 53' ' ' ILE . 6.2 t -110.32 109.0 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.314 0.578 . . . . 0.22 111.753 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 24' ' ' VAL . 7.2 p -104.97 116.88 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.547 -1.279 . . . . 0.31 107.547 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.733 HG12 ' HG ' ' A' ' 55' ' ' LEU . 7.3 m -123.61 136.94 58.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.413 0.625 . . . . 0.81 111.655 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.99 129.68 46.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.06 -0.973 . . . . 1.29 111.534 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -97.55 107.9 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.14 -0.689 . . . . 0.28 109.14 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 p -119.07 -166.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.31 0.576 . . . . 0.91 112.493 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.65 154.25 36.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.324 -0.853 . . . . 0.36 110.296 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.32 -38.59 78.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.657 0.742 . . . . 1.41 109.449 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.433 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 37.7 p-90 -84.94 14.08 5.28 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.572 -1.195 . . . . 1.11 111.54 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 37.8 t -102.96 144.42 31.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.856 0.36 . . . . 0.72 111.076 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.29 -68.24 0.92 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.714 -0.755 . . . . 0.3 112.386 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -50.9 -28.72 24.61 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.655 2.236 . . . . 0.68 112.175 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.2 m -58.37 -44.46 88.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.57 110.946 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -68.26 -25.63 65.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.849 -0.614 . . . . 2.57 111.336 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.2 mtp -68.37 -21.28 64.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.496 -0.32 . . . . 1.63 111.539 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mm -86.73 -20.7 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.746 0.308 . . . . 0.25 111.132 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 3.7 tttt -52.23 -53.67 49.94 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.363 -0.38 . . . . 2.04 111.129 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 74.0 Cg_exo -49.63 -47.98 20.84 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.534 2.156 . . . . 0.57 112.545 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -78.25 -32.06 49.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.513 -0.312 . . . . 0.44 111.688 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.441 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 6.0 t80 -67.29 -48.6 67.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.909 0.385 . . . . 0.33 110.477 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.13 -38.26 85.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.256 -0.429 . . . . 0.96 111.497 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.0 t -61.61 -45.33 94.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 1.16 110.818 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.0 mt -59.79 -38.66 82.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 0.37 110.274 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 p -54.97 -26.13 34.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.966 -0.561 . . . . 1.05 110.381 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -86.61 -23.32 25.77 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.052 0.454 . . . . 2.23 110.019 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.16 11.18 39.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.61 -0.723 . . . . 1.9 110.869 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.812 ' HB3' HG22 ' A' ' 52' ' ' VAL . 15.5 m-85 -131.78 93.12 3.25 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.426 -0.352 . . . . 1.02 110.453 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.86 48.03 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 1.47 111.644 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -156.7 -37.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.875 0.324 . . . . 1.19 111.875 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.812 HG22 ' HB3' ' A' ' 49' ' ' TYR . 16.5 m -93.2 150.72 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.28 111.785 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.912 ' CG2' HG13 ' A' ' 23' ' ' VAL . 3.0 tp -99.41 120.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.511 . . . . 1.1 110.153 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.729 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 3.0 m-85 -102.55 117.24 34.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.918 -0.583 . . . . 0.2 110.195 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.033 HD13 HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -132.08 161.8 32.38 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.954 -0.699 . . . . 0.17 110.695 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -118.42 121.8 41.22 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.088 -0.96 . . . . 2.16 112.435 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.62 HG22 HD11 ' A' ' 55' ' ' LEU . 2.0 t -115.16 118.5 58.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.856 -0.611 . . . . 0.15 110.777 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -92.88 116.9 29.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.203 -0.666 . . . . 1.79 109.203 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.05 -21.2 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.364 . . . . 0.19 111.611 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -40.22 96.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.98 0.419 . . . . 0.94 110.065 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.96 -41.99 8.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.812 -0.631 . . . . 1.29 111.207 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.556 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -86.32 51.16 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.382 0.61 . . . . 0.21 110.131 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -71.33 -11.85 61.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.71 -0.677 . . . . 2.51 111.13 -179.464 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.01 -23.35 19.55 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 111.734 0.272 . . . . 1.33 111.734 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 62' ' ' ALA . 8.6 m -81.51 -50.92 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.188 0.44 . . . . 0.18 112.188 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.889 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.86 -56.89 14.43 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 113.308 0.855 . . . . 0.27 113.308 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.889 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 75.5 Cg_exo -50.81 -27.77 21.34 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.813 2.342 . . . . 0.46 112.621 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -77.85 -19.16 55.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 1.53 111.413 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -106.93 -8.89 16.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.059 0.457 . . . . 0.38 110.364 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.54 38.26 90.38 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.516 -0.766 . . . . 0.46 113.265 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.504 HG23 HG21 ' A' ' 76' ' ' THR . 59.6 mt -78.99 132.14 32.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 117.299 0.549 . . . . 1.33 109.603 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -142.96 74.15 1.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.194 0.521 . . . . 3.91 111.087 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.494 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 147.2 143.65 3.89 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.56 -0.746 . . . . 1.03 112.023 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -129.8 156.77 78.41 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.359 0.123 . . . . 1.17 110.799 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.37 121.48 6.96 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.829 -1.321 . . . . 0.67 112.869 0.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -89.63 139.88 30.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 0.49 111.973 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.433 HD13 HD21 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -112.09 118.81 36.42 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.538 -0.912 . . . . 0.97 108.538 177.377 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.564 ' HB2' HG23 ' A' ' 25' ' ' VAL . 1.0 OUTLIER -109.75 132.47 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.488 0.661 . . . . 0.19 111.428 -178.409 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.903 HD12 HD11 ' A' ' 22' ' ' LEU . 3.5 mm? -111.93 135.59 52.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.141 -0.936 . . . . 0.65 109.029 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.672 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 37.0 m-85 -126.38 152.77 45.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.011 0.434 . . . . 0.31 110.612 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 1.024 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 0.8 OUTLIER -148.49 110.5 4.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.666 -0.697 . . . . 0.93 109.664 -179.181 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.7 m-20 62.07 48.12 5.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.909 0.385 . . . . 1.33 110.438 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 7.42 49.0 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.055 -0.593 . . . . 0.27 113.132 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -123.03 142.72 50.54 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 122.778 -0.248 . . . . 1.4 110.645 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 p -57.52 129.34 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.301 -0.629 . . . . 1.31 109.301 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 1.024 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -103.33 -22.49 13.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.457 0.646 . . . . 0.33 112.455 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -171.56 158.32 5.09 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.832 -1.076 . . . . 0.28 110.941 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.1 t -134.08 136.01 43.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.226 -0.443 . . . . 1.62 110.613 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.445 ' HD2' HD22 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -136.51 133.09 36.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.389 -0.597 . . . . 1.47 109.389 178.839 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 t -115.97 145.97 21.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.671 -0.24 . . . . 0.95 111.233 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.23 159.08 27.03 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.517 -0.849 . . . . 0.74 112.648 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.88 158.33 30.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.113 0.482 . . . . 0.51 111.715 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.584 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -152.03 153.06 33.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.64 110.358 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 m -71.54 -178.99 2.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.92 110.92 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -73.07 -30.64 63.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.82 111.46 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.36 -32.23 48.37 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.201 -0.999 . . . . 0.23 112.722 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.484 ' HA ' ' HG2' ' A' ' 100' ' ' GLU . 45.2 mt-30 -73.62 -35.29 65.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 1.29 110.401 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.584 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -69.08 -47.73 64.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.555 -0.748 . . . . 0.37 109.412 178.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -60.61 -43.24 97.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 1.04 110.533 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.601 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -61.18 -41.32 96.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.221 -0.445 . . . . 1.71 110.438 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.601 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 7.2 t80 -61.03 -41.83 97.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.322 0.582 . . . . 0.24 110.741 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.86 -56.67 7.21 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.472 -0.785 . . . . 0.46 110.117 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -50.08 -36.73 30.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.919 0.39 . . . . 1.18 111.042 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.21 -19.93 60.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.19 112.1 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.654 ' HB3' HD21 ' A' ' 22' ' ' LEU . 10.7 t30 -109.05 -37.34 5.84 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.863 0.32 . . . . 0.84 111.863 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.604 HD23 HG12 ' A' ' 52' ' ' VAL . 3.5 tm? -71.94 94.44 1.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.056 0.455 . . . . 1.33 109.991 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.144 -0.931 . . . . 2.01 111.039 -179.307 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 mtp . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.964 0.412 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.708 HG13 ' HA ' ' A' ' 55' ' ' LEU . 45.7 t -102.14 145.05 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.695 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.635 ' HE2' ' HB2' ' A' ' 14' ' ' ALA . 14.3 ptmt -143.67 120.81 11.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.191 0.52 . . . . 0.0 110.433 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.94 126.05 29.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.512 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.845 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -98.47 107.43 20.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.202 0.525 . . . . 0.0 110.532 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -97.13 18.62 14.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.652 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 m -156.32 161.35 40.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.916 0.388 . . . . 0.0 111.271 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.702 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -73.02 -27.71 61.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.518 179.439 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -79.83 -31.58 40.61 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.498 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.83 -38.34 90.65 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.462 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -58.59 -41.72 86.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.939 0.399 . . . . 0.0 110.016 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -67.5 -44.25 78.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.894 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -57.81 -47.25 83.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.243 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.635 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . . . -65.02 -31.74 73.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.044 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.5 mt -68.72 -37.96 79.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 110.57 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -60.55 -35.84 77.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.164 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.18 -22.46 55.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.006 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.18 77.41 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.088 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.54 -120.33 17.95 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.548 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -95.59 4.97 52.62 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -79.8 149.42 31.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.981 HD11 HD12 ' A' ' 79' ' ' LEU . 4.9 tp -77.0 133.15 39.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.864 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.6 t -113.88 109.91 30.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.502 0.668 . . . . 0.0 112.015 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.571 HG23 HD21 ' A' ' 79' ' ' LEU . 8.4 p -105.04 115.7 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.554 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.8 m -123.33 166.96 17.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.908 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -133.56 133.89 42.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.783 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.573 ' HE1' HD12 ' A' ' 78' ' ' LEU . 4.2 m-85 -96.21 108.15 20.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.5 ' O ' HG12 ' A' ' 59' ' ' VAL . 31.2 p -115.85 -168.36 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.314 0.578 . . . . 0.0 112.186 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.77 152.99 33.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.02 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -71.26 -37.57 71.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.508 0.671 . . . . 0.0 109.598 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -86.69 12.62 10.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.176 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.713 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 17.2 t -94.87 158.21 15.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.049 0.452 . . . . 0.0 111.625 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.96 -66.94 0.61 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.585 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.06 -21.51 72.55 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.58 2.187 . . . . 0.0 112.203 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.5 m -62.98 -42.01 99.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.297 0.57 . . . . 0.0 109.919 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.34 -29.7 70.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.378 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.4 mtt -68.28 -18.17 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 11.6 mm -88.14 -23.73 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.476 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -52.88 -51.95 69.51 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.03 -49.44 17.04 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.693 2.262 . . . . 0.0 113.416 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -79.79 -30.29 40.59 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 4.9 t80 -65.52 -46.01 81.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.087 0.47 . . . . 0.0 110.293 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -39.28 90.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.267 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.5 t -60.38 -43.99 96.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 111.115 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.4 mt -59.71 -38.33 81.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.926 0.393 . . . . 0.0 110.238 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.6 t -56.47 -30.98 63.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.942 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -86.39 -18.1 32.68 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.575 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -96.05 -20.76 18.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.947 0.403 . . . . 0.0 110.175 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.85 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.1 m-85 -97.92 92.88 6.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.849 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.9 t -88.93 48.39 1.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.113 0.483 . . . . 0.0 110.719 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -152.73 -42.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.667 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.85 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.2 m -94.43 153.29 3.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.795 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.864 ' CG2' HG13 ' A' ' 23' ' ' VAL . 6.0 tp -104.49 115.4 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.026 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.611 ' O ' HG22 ' A' ' 2' ' ' VAL . 8.1 m-85 -97.59 115.92 28.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.544 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.845 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.2 164.67 21.16 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.537 178.696 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.415 ' N ' HD12 ' A' ' 55' ' ' LEU . 3.2 tp10 -116.39 119.34 35.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.447 HG22 HD11 ' A' ' 55' ' ' LEU . 2.1 t -115.53 117.75 56.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.184 0.516 . . . . 0.0 110.946 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -98.47 119.41 37.11 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 28' ' ' SER . 13.5 p -60.88 -18.84 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -64.17 -39.0 93.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -100.11 -32.85 10.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.584 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.892 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.49 43.0 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.82 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 31.0 tt0 -69.16 -10.12 56.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.654 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -94.9 -22.38 18.04 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.312 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.892 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -78.33 -47.71 23.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.665 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.935 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.35 -58.75 8.79 Favored Pre-proline 0 CA--C 1.529 0.143 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.935 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 75.2 Cg_exo -49.8 -28.89 18.9 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.458 2.106 . . . . 0.0 112.037 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.9 mttp -77.13 -23.99 51.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.959 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -106.66 -3.65 20.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.93 0.395 . . . . 0.0 112.017 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.88 34.92 89.98 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.889 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.625 HD11 HD11 ' A' ' 78' ' ' LEU . 79.7 mt -77.15 135.93 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 117.3 0.55 . . . . 0.0 110.657 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttp85 -143.48 71.28 1.33 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.129 0.49 . . . . 0.0 111.475 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.21 163.42 11.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.591 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.608 HD12 ' SG ' ' A' ' 32' ' ' CYS . 47.3 pt -148.46 149.84 32.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.418 0.109 . . . . 0.0 110.972 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -86.06 120.16 5.7 Favored 'Cis proline' 0 C--N 1.348 0.538 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.649 0.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.94 137.65 32.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.939 0.399 . . . . 0.0 111.809 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.675 HD22 HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -109.11 121.76 45.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.574 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.81 ' CD2' HG23 ' A' ' 88' ' ' THR . 6.6 mt -114.47 134.58 54.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.238 0.542 . . . . 0.0 111.639 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.981 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -114.33 127.36 55.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.781 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.593 ' CE2' HG22 ' A' ' 85' ' ' VAL . 46.5 m-85 -118.43 146.67 44.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.975 0.417 . . . . 0.0 111.336 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.474 ' HD2' HD13 ' A' ' 22' ' ' LEU . 1.2 tttm -146.59 115.27 6.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.002 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m120 59.76 45.21 13.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.872 0.368 . . . . 0.0 110.261 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.29 3.79 54.27 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.896 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.4 141.39 52.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.513 0.657 . . . . 0.0 111.467 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.593 HG22 ' CE2' ' A' ' 80' ' ' PHE . 42.5 t -68.13 118.3 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.443 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.43 10.49 19.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.943 0.401 . . . . 0.0 112.047 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -175.69 137.92 0.37 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.936 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.81 HG23 ' CD2' ' A' ' 78' ' ' LEU . 4.9 m -137.79 124.0 20.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 110.942 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -124.22 142.02 51.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.904 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.97 145.94 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.233 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.439 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 80.11 161.79 24.63 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.131 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.61 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -64.33 170.65 3.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.901 0.382 . . . . 0.0 111.277 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.675 HD11 HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -163.69 147.06 10.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.657 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 t -64.75 179.07 0.69 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.914 0.388 . . . . 0.0 110.806 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -73.09 -30.81 63.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.118 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.2 -31.37 52.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.86 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -76.21 -32.14 58.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.858 0.361 . . . . 0.0 110.582 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -70.61 -50.95 31.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.099 0.476 . . . . 0.0 109.884 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -61.54 -42.33 98.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.5 -38.83 88.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.949 0.404 . . . . 0.0 110.137 179.583 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.739 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 11.2 t80 -61.93 -40.65 96.21 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.402 0.62 . . . . 0.0 110.061 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 4.5 mt -65.67 -60.91 2.42 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.157 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -48.55 -33.83 10.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.095 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.6 -23.5 60.95 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -109.77 -30.03 8.04 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.711 HD13 HG12 ' A' ' 52' ' ' VAL . 36.6 tp -64.06 -55.31 23.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.847 0.356 . . . . 0.0 110.716 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 106' ' ' LEU . 14.1 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.846 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.9 mtt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 121.074 0.464 . . . . 3.72 111.544 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.755 HG13 ' HA ' ' A' ' 55' ' ' LEU . 67.9 t -118.17 151.85 20.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.679 -0.691 . . . . 0.42 109.68 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.46 ' O ' HD12 ' A' ' 5' ' ' ILE . 11.9 ptpt -144.98 121.81 11.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.36 -0.936 . . . . 1.98 111.268 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.12 123.69 25.67 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.458 -1.246 . . . . 2.23 110.174 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.942 HG23 ' HB3' ' A' ' 10' ' ' ALA . 2.1 mp -105.3 114.2 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.847 0.356 . . . . 0.26 111.323 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -103.77 16.63 25.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.352 0.501 . . . . 1.47 112.352 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -155.48 147.25 23.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.742 0.306 . . . . 0.95 111.098 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.503 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.5 ttpt -60.82 -24.64 66.01 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.358 -0.383 . . . . 1.5 111.764 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -79.14 -32.32 44.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.928 0.394 . . . . 0.32 110.238 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.942 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -67.24 -41.39 85.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.906 -0.588 . . . . 0.3 110.349 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -56.18 -44.53 79.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.858 -0.61 . . . . 1.15 110.693 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -66.52 -39.45 88.63 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.246 -0.65 . . . . 1.17 109.246 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -58.06 -48.45 80.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.746 -0.661 . . . . 1.6 110.887 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.56 -34.58 78.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.421 . . . . 0.32 111.241 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.412 ' HA ' HD23 ' A' ' 15' ' ' LEU . 18.2 mt -66.75 -39.6 87.98 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.234 0.54 . . . . 0.41 110.537 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -63.57 -31.98 73.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 1.6 110.739 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.72 -22.74 56.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.47 111.014 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.447 ' HB1' HG22 ' A' ' 23' ' ' VAL . . . -71.23 -35.81 71.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.72 111.477 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.53 -119.44 18.61 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.077 -1.059 . . . . 1.1 113.662 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.18 2.29 56.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.717 -0.241 . . . . 2.19 111.479 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -79.27 148.1 32.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.692 -0.484 . . . . 1.74 109.692 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.979 HD11 HD12 ' A' ' 79' ' ' LEU . 1.6 tp -72.46 126.99 31.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.14 -0.319 . . . . 0.31 110.14 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.772 HG13 HG22 ' A' ' 53' ' ' ILE . 4.3 t -107.61 108.11 24.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.521 0.676 . . . . 0.24 111.523 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.619 HG23 ' CD2' ' A' ' 79' ' ' LEU . 10.2 p -106.08 116.98 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.951 -1.129 . . . . 0.31 107.951 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.071 HG12 ' HG ' ' A' ' 55' ' ' LEU . 4.3 m -123.13 166.97 17.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.218 0.532 . . . . 0.78 111.643 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.443 ' OD1' HD12 ' A' ' 77' ' ' LEU . 37.4 t0 -133.21 133.75 43.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.802 -0.636 . . . . 1.23 111.834 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HE1' HD12 ' A' ' 78' ' ' LEU . 8.8 m-85 -97.86 110.76 23.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.927 -0.768 . . . . 0.27 108.927 178.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.3 m -128.42 158.94 36.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.597 0.713 . . . . 1.19 112.917 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.587 ' HB1' ' CD1' ' A' ' 31' ' ' TRP . . . -116.16 156.65 26.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.971 -1.013 . . . . 0.37 111.047 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.2 m -70.79 -35.78 72.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.502 0.668 . . . . 0.75 109.615 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.587 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 23.4 p-90 -85.76 10.87 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.736 -1.12 . . . . 0.89 111.564 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.476 ' SG ' HD12 ' A' ' 74' ' ' ILE . 38.4 t -98.4 148.12 24.01 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.81 0.338 . . . . 0.82 111.027 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.33 -67.33 0.75 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.677 -0.773 . . . . 0.37 112.204 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.73 -24.53 18.22 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.411 2.074 . . . . 0.61 112.096 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.7 m -62.9 -43.76 97.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.144 -0.48 . . . . 0.49 110.781 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -68.78 -23.21 64.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 2.56 111.13 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 mmt -69.7 -22.36 63.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 1.8 110.739 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.2 mm -85.98 -21.71 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.418 -0.355 . . . . 0.25 110.976 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 2.0 tttt -52.3 -55.05 35.14 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.464 -0.335 . . . . 2.47 111.159 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 39' ' ' LYS . 72.7 Cg_exo -48.54 -49.11 15.37 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.563 2.176 . . . . 0.41 112.381 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -77.4 -29.19 53.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 0.44 111.519 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.437 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 6.3 t80 -67.76 -46.81 71.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.986 0.422 . . . . 0.46 110.257 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -42.9 78.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 1.03 111.952 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 m -59.09 -44.52 91.92 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.841 0.353 . . . . 0.91 110.379 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.35 -40.3 85.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.543 -0.54 . . . . 0.35 109.543 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 32.4 t -54.5 -27.55 38.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.889 -0.596 . . . . 1.22 111.179 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -88.96 -16.96 30.5 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.731 0.3 . . . . 1.99 111.038 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -94.56 -19.38 20.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.963 0.411 . . . . 2.16 109.912 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.847 ' HB3' HG22 ' A' ' 52' ' ' VAL . 22.1 m-85 -102.26 97.47 7.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.917 -0.583 . . . . 1.1 111.477 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.63 46.35 1.33 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.399 -0.364 . . . . 1.39 110.767 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -154.44 -34.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.801 0.334 . . . . 1.08 111.322 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 49' ' ' TYR . 5.8 m -97.59 156.06 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.325 -0.398 . . . . 0.32 111.585 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.772 HG22 HG13 ' A' ' 23' ' ' VAL . 1.3 tp -106.39 114.64 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.051 -0.522 . . . . 0.29 111.143 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.712 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.2 m-85 -96.11 120.19 35.95 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.197 -0.456 . . . . 0.24 110.516 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.071 ' HG ' HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -133.31 168.5 18.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 120.378 -0.529 . . . . 0.22 111.1 179.178 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.789 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -121.53 124.61 44.81 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.674 0.62 . . . . 2.28 112.674 -178.344 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.612 HG22 HD11 ' A' ' 55' ' ' LEU . 2.7 t -113.19 117.78 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.887 -0.597 . . . . 0.19 111.138 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -93.46 113.21 25.3 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.424 -0.584 . . . . 1.92 109.424 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 p -58.49 -19.1 13.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.825 0.305 . . . . 0.28 111.825 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -37.54 87.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.94 0.4 . . . . 1.22 110.292 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -102.94 -40.61 6.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.89 -0.596 . . . . 1.26 111.157 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -88.32 49.0 1.72 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.213 0.53 . . . . 0.28 110.395 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -75.83 -6.57 51.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.525 -0.762 . . . . 2.55 111.083 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.89 -25.1 20.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.769 0.318 . . . . 1.56 110.433 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.642 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 13.5 m -81.31 -48.58 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.197 -0.456 . . . . 0.26 111.759 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.876 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.39 -55.56 21.28 Favored Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 112.744 0.646 . . . . 0.29 112.744 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.876 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 78.3 Cg_exo -51.92 -27.54 28.37 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.863 2.375 . . . . 0.46 112.997 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -77.09 -21.35 54.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.278 -0.419 . . . . 1.77 111.781 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -108.16 -7.12 16.12 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.087 0.47 . . . . 0.42 111.354 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.4 37.07 90.03 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.687 -0.688 . . . . 0.49 113.517 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.659 HG23 HG21 ' A' ' 76' ' ' THR . 61.6 mt -74.12 130.16 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 109.624 -0.51 . . . . 1.29 109.624 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.89 60.16 1.47 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.937 0.399 . . . . 3.89 111.521 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.13 118.43 0.52 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.245 -0.979 . . . . 1.12 113.386 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.476 HD12 ' SG ' ' A' ' 32' ' ' CYS . 17.6 pt -104.99 152.44 39.63 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.408 -0.219 . . . . 0.89 110.408 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.81 120.26 6.38 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.8 -1.333 . . . . 1.08 112.708 0.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.659 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -91.48 134.82 34.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.543 -0.299 . . . . 0.33 111.236 179.176 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.443 HD12 ' OD1' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -107.87 122.82 47.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.401 -0.963 . . . . 1.08 108.401 177.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.506 ' HB2' HG23 ' A' ' 25' ' ' VAL . 5.0 mt -113.84 137.61 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.263 0.554 . . . . 0.22 111.548 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.979 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -119.01 113.41 20.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.535 -0.757 . . . . 0.22 110.562 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.61 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.9 m-85 -105.0 142.37 34.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.979 -0.555 . . . . 0.25 110.766 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -142.25 110.34 5.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.579 -0.737 . . . . 0.43 109.487 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 26.3 m-20 61.89 47.08 6.25 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.276 -0.639 . . . . 1.19 109.276 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.16 3.79 32.58 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.558 -0.746 . . . . 0.23 113.797 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -121.25 133.04 55.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.205 0.502 . . . . 1.6 110.814 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.72 117.35 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 1.26 109.848 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.02 4.49 27.12 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.462 0.541 . . . . 0.23 112.462 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.807 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.56 146.51 1.72 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.283 -0.417 . . . . 0.2 111.823 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.46 134.21 37.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 1.53 110.824 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -132.78 138.77 47.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 2.17 110.239 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.7 145.53 26.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.87 111.009 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.87 160.16 23.38 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.501 -0.857 . . . . 0.25 112.878 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.62 151.27 46.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.114 0.483 . . . . 0.55 111.575 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.606 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -143.33 147.77 35.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.76 -0.654 . . . . 0.55 110.558 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -65.04 -178.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.576 -0.284 . . . . 1.02 110.755 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -73.01 -32.67 65.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 1.09 111.497 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.52 -30.58 56.31 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.206 -0.997 . . . . 0.25 112.598 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.553 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 40.4 mt-30 -74.99 -31.22 61.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.972 0.415 . . . . 1.26 110.31 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.606 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -72.98 -49.79 27.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.047 -0.524 . . . . 0.43 109.908 179.221 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -61.71 -45.16 95.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.544 -0.753 . . . . 1.43 110.965 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.8 pp20? -60.64 -41.68 95.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 1.82 110.558 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.66 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 47.0 t80 -63.91 -42.68 97.35 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.26 0.552 . . . . 0.27 111.194 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.618 HD11 HG11 ' A' ' 24' ' ' VAL . 1.7 mt -64.85 -57.72 8.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.791 -0.64 . . . . 0.43 109.528 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -49.0 -34.19 12.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.502 . . . . 1.24 110.736 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.47 -22.95 62.62 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.046 -0.524 . . . . 0.23 111.717 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.425 ' HB3' HD21 ' A' ' 22' ' ' LEU . 6.8 t30 -105.55 -31.44 8.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.806 0.336 . . . . 0.52 110.746 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.527 ' HB2' HD23 ' A' ' 22' ' ' LEU . 42.6 tp -75.15 95.72 3.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.691 -0.485 . . . . 1.35 109.691 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.255 -0.879 . . . . 2.47 111.347 -179.531 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 121.008 0.432 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.72 HG13 ' HA ' ' A' ' 55' ' ' LEU . 42.9 t -125.56 145.89 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.604 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.73 119.62 11.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.253 0.549 . . . . 0.0 110.346 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.7 127.74 33.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.846 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.798 HD13 HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -101.12 107.53 21.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.298 -179.601 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -97.9 19.64 13.49 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.125 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.23 159.53 39.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.855 0.36 . . . . 0.0 111.276 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.608 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -71.91 -26.65 62.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 m -79.64 -32.8 41.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.914 0.387 . . . . 0.0 110.814 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.37 90.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.568 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -57.66 -42.71 84.04 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -43.97 83.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.13 -45.7 92.14 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.514 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.49 -31.91 73.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.892 0.377 . . . . 0.0 110.673 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -67.78 -37.39 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.527 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -61.42 -33.91 74.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.304 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.44 -22.67 54.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.9 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.65 -35.91 79.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.63 -122.76 31.13 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.14 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.57 4.33 53.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.501 0.191 . . . . 0.0 111.152 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -77.28 149.7 35.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.917 HD11 HD12 ' A' ' 79' ' ' LEU . 9.8 tp -77.02 132.61 39.05 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.879 HG13 ' CG2' ' A' ' 53' ' ' ILE . 6.3 t -112.45 109.67 29.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.397 0.618 . . . . 0.0 112.37 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.758 HG11 HD11 ' A' ' 102' ' ' LEU . 7.9 p -104.81 116.22 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.657 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.1 m -122.67 167.09 16.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.72 -178.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -133.45 133.37 42.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.597 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -98.1 111.89 24.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -118.94 -167.79 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.382 0.61 . . . . 0.0 112.219 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.2 154.5 35.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.013 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -35.73 67.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.376 0.607 . . . . 0.0 109.471 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -87.24 10.78 15.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.08 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.713 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 11.3 t -91.79 157.21 17.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.052 0.453 . . . . 0.0 111.479 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.41 -64.17 0.54 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.441 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 22.9 Cg_exo -63.96 -22.29 68.42 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.497 2.132 . . . . 0.0 112.401 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.9 m -58.58 -41.47 85.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -67.04 -15.24 63.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.391 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.462 ' HG2' ' HA ' ' A' ' 34' ' ' PRO . 4.6 mmt -71.16 -26.85 63.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.789 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.8 mm -84.47 -23.86 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.685 0.279 . . . . 0.0 111.361 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 8.4 ttpt -48.96 -59.21 6.72 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 10.3 Cg_endo -51.96 -45.05 41.15 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.342 2.028 . . . . 0.0 112.697 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -80.74 -29.67 36.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -66.43 -45.69 78.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.082 0.467 . . . . 0.0 110.327 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.14 -39.91 86.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.883 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 62.7 m -61.7 -44.02 97.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.877 0.37 . . . . 0.0 110.887 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.3 mt -59.42 -40.23 86.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.914 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 m -54.73 -28.38 47.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.433 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.54 -19.51 27.78 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.686 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -95.0 -20.62 19.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.04 0.447 . . . . 0.0 110.265 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.856 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.5 m-85 -98.04 96.13 7.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.675 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.76 47.96 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.072 0.463 . . . . 0.0 110.236 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -152.92 -42.44 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.822 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.856 HG22 ' HB3' ' A' ' 49' ' ' TYR . 11.0 m -93.66 153.85 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.597 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.879 ' CG2' HG13 ' A' ' 23' ' ' VAL . 5.2 tp -105.75 113.99 44.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.748 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.561 ' O ' HG13 ' A' ' 2' ' ' VAL . 8.4 m-85 -94.62 116.2 28.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.55 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.798 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -129.02 166.7 18.71 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.514 178.611 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.432 ' N ' HD12 ' A' ' 55' ' ' LEU . 1.4 tp10 -117.43 118.99 33.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.34 118.35 58.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.249 0.547 . . . . 0.0 110.787 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -99.34 120.42 39.54 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.27 -18.46 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -67.93 -37.53 81.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.087 0.47 . . . . 0.0 109.81 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -98.78 -34.5 10.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.445 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.856 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.75 47.67 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.097 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 67' ' ' PRO . 39.6 tp60 -68.57 -8.74 44.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.079 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.57 -25.02 15.29 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.448 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.856 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 6.7 m -77.15 -48.78 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.965 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.627 ' HB3' ' CD ' ' A' ' 67' ' ' PRO . . . -50.22 -60.44 5.24 Favored Pre-proline 0 N--CA 1.463 0.203 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 66' ' ' ALA . 6.3 Cg_endo -49.11 -28.04 13.45 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.571 2.181 . . . . 0.0 111.862 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -73.57 -27.84 61.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.929 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -108.79 -6.26 15.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.901 0.381 . . . . 0.0 111.632 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.41 40.24 97.6 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.087 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.721 HG23 HG21 ' A' ' 76' ' ' THR . 61.3 mt -78.0 81.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 117.007 0.403 . . . . 0.0 110.837 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -87.1 78.33 8.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 111.882 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.27 164.22 10.15 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.397 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.5 pt -149.03 155.71 40.33 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 122.161 0.184 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.23 116.93 4.26 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 124.183 -1.174 . . . . 0.0 112.628 -0.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.721 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -87.14 137.08 32.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.909 0.385 . . . . 0.0 111.865 179.498 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.465 HD21 HD21 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -107.65 123.87 49.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.901 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.625 HD11 HD11 ' A' ' 71' ' ' ILE . 6.0 mt -116.76 134.88 54.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.219 0.533 . . . . 0.0 111.793 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.917 HD12 HD11 ' A' ' 22' ' ' LEU . 3.5 mm? -114.71 120.68 40.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.696 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.519 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 45.2 m-85 -112.08 146.99 36.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 0.0 111.157 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -146.94 110.6 4.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.328 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 61.83 46.47 6.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.909 0.385 . . . . 0.0 110.171 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.51 1.24 57.4 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.908 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -125.49 138.79 53.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.484 0.642 . . . . 0.0 111.861 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 85' ' ' VAL . 7.2 p -68.25 119.23 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.529 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.22 11.3 20.21 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.842 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.88 140.85 0.76 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.63 124.2 22.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.681 0.277 . . . . 0.0 111.127 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.442 ' HD2' HD22 ' A' ' 93' ' ' LEU . 5.4 tmtt? -126.17 139.68 53.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.272 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.44 146.34 25.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.643 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.404 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.36 161.56 27.36 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.158 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.14 147.86 49.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 111.58 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.653 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -142.38 151.76 42.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.612 179.757 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.9 t -65.33 179.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.151 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -72.5 -31.98 65.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.46 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.24 -29.89 55.57 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.711 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 54.8 mt-30 -76.88 -32.7 57.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.843 0.354 . . . . 0.0 110.532 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.653 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -71.21 -50.56 31.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -61.4 -42.09 98.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.238 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.38 -39.61 91.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.881 0.372 . . . . 0.0 110.328 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.808 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 10.8 t80 -62.1 -42.56 99.35 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.357 0.598 . . . . 0.0 110.679 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.758 HD11 HG11 ' A' ' 24' ' ' VAL . 6.1 mt -67.41 -54.46 20.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.186 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -50.99 -36.77 40.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.63 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.29 -21.0 60.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.403 ' HB3' HD21 ' A' ' 22' ' ' LEU . 9.1 t30 -108.58 -26.9 10.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.733 0.302 . . . . 0.0 111.705 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.549 HD13 ' N ' ' A' ' 107' ' ' VAL . 3.3 tm? -76.66 -77.75 0.13 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.683 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.549 ' N ' HD13 ' A' ' 106' ' ' LEU . 5.0 p . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.998 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.876 0.37 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 54' ' ' PHE . 50.9 t -63.47 145.6 13.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.137 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.32 121.84 11.05 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.072 0.463 . . . . 0.0 110.23 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.24 127.55 33.26 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.71 HD13 HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -100.51 106.83 19.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.978 0.418 . . . . 0.0 109.928 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -98.45 20.08 13.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.778 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.8 159.79 38.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.946 0.403 . . . . 0.0 111.301 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.582 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -72.37 -25.36 61.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.926 179.476 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.84 -32.28 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.951 0.405 . . . . 0.0 110.702 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -65.67 -39.49 91.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.148 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.401 ' CE1' HG21 ' A' ' 57' ' ' VAL . 3.6 t80 -57.76 -44.52 86.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 109.984 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.84 -45.57 85.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.679 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -58.21 -47.79 82.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.34 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.39 -31.5 72.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.34 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 mt -69.79 -37.91 76.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.41 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -61.41 -33.16 73.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.721 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.42 -23.9 53.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.956 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.72 78.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.24 -122.42 29.0 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.004 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -94.96 6.47 48.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.46 0.171 . . . . 0.0 111.303 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -80.19 148.77 30.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.919 HD11 HD12 ' A' ' 79' ' ' LEU . 8.7 tp -76.25 134.63 39.77 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.92 HG13 HG23 ' A' ' 53' ' ' ILE . 4.2 t -113.78 109.19 27.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.459 0.647 . . . . 0.0 112.007 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.007 HG11 HD11 ' A' ' 102' ' ' LEU . 7.6 p -103.75 116.03 46.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.562 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.6 m -123.91 165.85 19.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.215 0.531 . . . . 0.0 112.126 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -129.57 131.31 46.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.609 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.564 ' CE1' HD12 ' A' ' 78' ' ' LEU . 4.6 m-85 -98.24 110.13 22.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.9 p -134.32 149.54 50.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.107 0.48 . . . . 0.0 112.029 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.39 158.26 15.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.352 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -68.96 -37.49 78.85 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -85.48 16.19 3.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.058 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.586 ' SG ' HD12 ' A' ' 74' ' ' ILE . 36.8 t -90.91 156.95 17.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.36 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.14 -73.85 0.89 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.348 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.47 -22.79 22.5 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.451 2.101 . . . . 0.0 112.227 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.0 m -60.72 -38.11 83.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.22 0.533 . . . . 0.0 110.13 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -69.26 -16.26 63.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.553 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 38.4 mtt -74.16 -23.61 59.28 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.419 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.417 HG22 ' HB2' ' A' ' 42' ' ' PHE . 10.0 mm -87.25 -22.21 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 8.3 mttp -48.66 -60.01 5.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 10.2 Cg_endo -53.32 -44.51 48.36 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.544 2.162 . . . . 0.0 113.43 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.412 ' O ' HD12 ' A' ' 45' ' ' LEU . 14.4 m-85 -79.86 -31.61 40.45 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.43 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 4.9 t80 -66.18 -44.32 84.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.946 0.403 . . . . 0.0 110.545 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -39.27 83.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.12 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 p -61.74 -43.65 98.44 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.046 0.451 . . . . 0.0 110.879 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 41' ' ' PHE . 7.6 mt -59.49 -37.03 77.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.021 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -57.86 -28.31 64.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.376 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -87.27 -19.61 28.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.599 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -95.27 -19.68 19.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 110.266 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.829 ' HB3' HG22 ' A' ' 52' ' ' VAL . 19.0 m-85 -99.52 93.94 6.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.854 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.2 t -90.93 49.43 1.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.142 0.496 . . . . 0.0 110.845 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -151.75 -43.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.565 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.847 HG12 ' HB3' ' A' ' 22' ' ' LEU . 10.3 m -92.24 153.95 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.945 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.92 HG23 HG13 ' A' ' 23' ' ' VAL . 5.6 tp -105.35 114.72 45.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.596 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.662 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.3 m-85 -95.39 115.75 27.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.744 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.71 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.44 165.81 19.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.455 178.593 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -118.03 119.46 34.85 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.901 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.401 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.7 t -114.69 117.84 56.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.488 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -97.26 118.02 32.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.681 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.06 -18.98 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.733 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.4 -39.98 95.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -99.73 -34.08 10.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.765 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.91 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.11 45.03 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.708 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -9.44 57.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.168 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.4 -21.89 18.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.432 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.91 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.3 m -80.38 -47.02 21.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.992 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.908 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.0 -57.81 11.41 Favored Pre-proline 0 N--CA 1.464 0.225 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.908 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 74.6 Cg_exo -50.68 -28.34 22.27 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.536 2.157 . . . . 0.0 111.874 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.98 -23.12 58.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -111.01 -5.25 14.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.87 0.367 . . . . 0.0 111.812 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.56 34.94 89.16 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.581 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.639 HD11 HD11 ' A' ' 78' ' ' LEU . 75.2 mt -74.81 132.84 32.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 117.396 0.598 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -150.7 49.21 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.933 0.397 . . . . 0.0 111.219 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.27 99.46 0.14 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.442 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.586 HD12 ' SG ' ' A' ' 32' ' ' CYS . 2.9 pt -100.96 151.6 37.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.51 0.195 . . . . 0.0 111.109 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.49 113.49 2.97 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 124.036 -1.235 . . . . 0.0 112.752 0.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.47 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -86.65 135.26 33.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.842 0.353 . . . . 0.0 111.571 179.176 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -107.38 125.95 51.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.639 HD11 HD11 ' A' ' 71' ' ' ILE . 7.5 mt -116.88 136.51 52.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.199 0.523 . . . . 0.0 111.702 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.919 HD12 HD11 ' A' ' 22' ' ' LEU . 3.6 mm? -117.45 122.98 45.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.699 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.582 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 49.1 m-85 -113.64 144.82 42.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.031 0.443 . . . . 0.0 111.375 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HD2' HD13 ' A' ' 22' ' ' LEU . 3.5 tttm -145.62 111.59 5.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.336 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 m120 61.88 45.39 7.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.396 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.37 -0.56 59.63 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.957 -0.64 . . . . 0.0 114.242 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -124.07 141.07 52.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.519 0.66 . . . . 0.0 111.865 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.554 HG22 ' CE2' ' A' ' 80' ' ' PHE . 38.2 t -67.4 119.73 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.401 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.09 8.33 19.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.884 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -173.61 138.68 0.68 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.113 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.595 HG23 ' CD2' ' A' ' 78' ' ' LEU . 22.2 m -138.63 120.71 15.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.749 0.309 . . . . 0.0 111.086 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.38 145.15 46.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.942 0.401 . . . . 0.0 111.216 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.01 146.19 25.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.399 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.602 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 79.83 159.29 17.69 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.304 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.9 138.27 48.04 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.027 0.441 . . . . 0.0 111.895 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -128.01 150.96 49.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.534 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.0 m -65.74 -178.03 0.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.771 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -70.57 -33.95 71.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.677 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.67 -30.49 52.64 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.237 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 100' ' ' GLU . 25.6 mt-30 -77.14 -32.35 56.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.014 0.407 . . . . 0.0 110.591 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -71.32 -50.26 34.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -61.96 -42.23 98.88 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.654 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 97' ' ' GLN . 13.1 pt-20 -61.56 -42.84 99.43 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.764 0.316 . . . . 0.0 110.838 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.884 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 38.5 t80 -61.92 -42.7 99.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.374 0.607 . . . . 0.0 110.528 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 1.007 HD11 HG11 ' A' ' 24' ' ' VAL . 1.6 mt -67.3 -54.44 20.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.768 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -52.82 -36.2 58.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.749 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.92 -19.17 61.96 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.985 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -107.6 -28.03 10.0 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.639 0.257 . . . . 0.0 111.454 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.683 HD23 HG12 ' A' ' 52' ' ' VAL . 3.1 tm? -70.82 114.69 9.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 106' ' ' LEU . 4.0 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.257 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 mmt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.961 0.41 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.756 HG13 ' HA ' ' A' ' 55' ' ' LEU . 44.7 t -101.25 148.05 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -145.29 119.77 9.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.124 0.488 . . . . 0.0 110.651 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.29 127.65 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.641 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.781 HD13 HD13 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -101.2 109.55 25.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.064 0.459 . . . . 0.0 110.557 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -101.41 18.79 19.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.951 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.29 161.38 41.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.086 0.47 . . . . 0.0 111.562 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.644 ' HA ' HG13 ' A' ' 65' ' ' VAL . 5.2 ttpt -73.43 -28.21 61.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.776 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.73 -30.9 41.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.765 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.07 -42.45 89.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.875 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -55.16 -41.51 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 110.213 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -67.1 -44.3 80.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.976 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -58.33 -47.82 82.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.447 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.37 -31.57 72.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 110.928 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 mt -68.68 -39.15 80.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.683 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.46 -34.08 73.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.056 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.66 -22.81 53.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.481 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.44 72.23 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.914 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.34 -123.92 29.35 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.144 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -93.59 4.65 53.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.621 0.248 . . . . 0.0 111.223 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -78.82 149.41 32.55 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.98 HD11 HD12 ' A' ' 79' ' ' LEU . 6.8 tp -76.35 134.96 39.54 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.885 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.3 t -112.79 113.22 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.519 0.676 . . . . 0.0 112.007 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.649 ' HB ' HD21 ' A' ' 102' ' ' LEU . 7.2 p -106.18 112.35 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.45 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.695 HG12 ' HG ' ' A' ' 55' ' ' LEU . 4.7 m -122.24 167.08 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.75 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -134.46 134.49 41.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.683 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.605 ' HE1' HD12 ' A' ' 78' ' ' LEU . 6.4 m-85 -96.13 106.74 18.97 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -115.75 -169.52 1.6 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.449 0.642 . . . . 0.0 112.615 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.689 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.76 153.63 34.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.231 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.8 m -71.26 -36.51 71.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.433 0.635 . . . . 0.0 109.588 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -86.45 12.51 10.1 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.737 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.689 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 21.0 t -92.76 157.65 16.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.998 0.428 . . . . 0.0 111.728 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.18 -69.62 0.64 Allowed Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.344 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.5 -23.21 46.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.641 2.227 . . . . 0.0 112.27 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.1 m -59.89 -42.65 94.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -68.49 -18.6 64.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.365 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.9 mmm -74.04 -25.42 59.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.75 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.9 mm -85.97 -22.57 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.724 0.297 . . . . 0.0 111.664 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.41 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -50.75 -52.78 53.65 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.495 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 63.9 Cg_exo -51.15 -49.57 16.67 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.709 2.273 . . . . 0.0 113.045 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -79.87 -28.45 39.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -66.68 -47.23 73.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.099 0.476 . . . . 0.0 110.412 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -40.19 88.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.24 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.6 t -60.34 -44.58 95.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.599 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt -59.65 -41.92 91.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.123 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.8 t -54.91 -27.59 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.272 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -87.01 -18.77 29.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.727 0.299 . . . . 0.0 111.334 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -95.81 -19.91 19.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 110.08 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.875 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.3 m-85 -100.18 92.52 5.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.032 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -89.69 48.06 1.55 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.021 0.438 . . . . 0.0 110.494 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -152.27 -40.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.591 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' A' ' 49' ' ' TYR . 12.5 m -94.74 155.25 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.422 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.885 ' CG2' HG13 ' A' ' 23' ' ' VAL . 5.3 tp -105.24 115.55 47.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.815 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.64 ' CE1' HG11 ' A' ' 24' ' ' VAL . 8.9 m-85 -97.61 116.17 29.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.938 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.781 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -129.35 167.79 17.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.45 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.453 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -120.24 122.39 40.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.803 -177.517 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.428 HG22 HD11 ' A' ' 55' ' ' LEU . 2.5 t -116.28 120.07 63.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.352 0.596 . . . . 0.0 110.744 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -99.74 119.24 37.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.897 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.73 -18.27 16.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.043 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -39.77 94.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.95 -33.63 10.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.496 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.938 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -97.24 43.7 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.469 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -8.94 56.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.666 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.98 -24.61 16.3 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.293 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.938 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 1.7 m -76.53 -47.43 29.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.494 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.924 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.97 -57.76 11.56 Favored Pre-proline 0 N--CA 1.461 0.108 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.924 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 74.2 Cg_exo -50.14 -28.5 19.83 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.435 2.09 . . . . 0.0 111.569 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -75.27 -24.35 57.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.956 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -106.98 -4.82 18.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.894 0.378 . . . . 0.0 111.612 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.98 34.65 89.08 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.78 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.652 HD11 HD11 ' A' ' 78' ' ' LEU . 70.9 mt -75.77 135.41 27.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 117.248 0.524 . . . . 0.0 110.446 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -144.81 64.85 1.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.014 0.435 . . . . 0.0 111.167 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.407 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 169.3 162.73 22.07 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.496 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.8 pt -147.51 141.76 16.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 122.9 -0.176 . . . . 0.0 110.963 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -88.89 122.1 5.56 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 124.172 -1.178 . . . . 0.0 112.398 -0.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER -88.28 137.69 32.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 111.674 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -108.79 124.19 50.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 71' ' ' ILE . 6.7 mt -116.44 133.92 55.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.283 0.563 . . . . 0.0 111.618 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.98 HD12 HD11 ' A' ' 22' ' ' LEU . 3.0 mm? -115.27 122.13 45.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.695 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 50.2 m-85 -113.71 147.98 37.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.262 0.553 . . . . 0.0 111.542 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -147.02 111.01 5.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.208 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.9 m120 61.78 46.48 6.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.374 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.28 2.28 58.84 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.765 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.52 139.45 53.6 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.432 0.616 . . . . 0.0 112.192 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.551 HG13 ' O ' ' A' ' 85' ' ' VAL . 11.1 p -67.74 116.98 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.454 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.58 9.53 21.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.871 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -170.88 139.3 1.44 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.937 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.65 122.68 20.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.698 0.285 . . . . 0.0 111.171 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -124.08 138.14 54.48 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.39 146.18 24.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.328 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.38 164.62 30.96 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.279 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.594 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -67.23 169.34 8.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.12 0.486 . . . . 0.0 111.576 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.756 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -159.05 -170.32 2.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.25 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 t -111.52 165.73 11.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.814 0.34 . . . . 0.0 110.814 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -55.79 -34.01 64.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.995 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.46 -31.18 51.88 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.914 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 35.5 mt-30 -76.19 -33.5 59.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.903 0.382 . . . . 0.0 110.553 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.756 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -70.51 -49.77 44.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.736 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -61.93 -43.92 97.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.096 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.6 OUTLIER -61.3 -39.1 89.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.881 0.372 . . . . 0.0 110.167 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.793 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 9.7 t80 -61.28 -41.38 96.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.35 0.595 . . . . 0.0 110.333 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.649 HD21 ' HB ' ' A' ' 24' ' ' VAL . 10.7 mt -69.48 -50.75 42.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.763 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -52.43 -38.14 58.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 110.187 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.52 63.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.796 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.626 ' O ' HG12 ' A' ' 107' ' ' VAL . 4.3 t30 -104.29 -56.28 2.22 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 110.923 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 22' ' ' LEU . 3.2 tm? -52.87 98.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.838 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 105' ' ' ASN . 4.9 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.816 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.899 0.381 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 55' ' ' LEU . 40.0 t -136.34 146.02 29.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -144.35 121.09 11.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.126 0.488 . . . . 0.0 109.941 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -74.66 129.61 38.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.604 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.854 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -100.98 108.15 22.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.418 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -100.0 18.16 19.18 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.905 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.1 m -154.13 158.04 39.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.84 0.352 . . . . 0.0 111.247 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.564 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -71.63 -26.27 62.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.555 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -79.72 -31.25 41.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.065 0.46 . . . . 0.0 110.298 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.87 -36.18 81.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.056 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -59.91 -42.98 95.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.012 0.434 . . . . 0.0 109.848 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -66.91 -44.7 80.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.614 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.23 -46.44 85.91 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.145 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.97 -30.71 70.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.139 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 15' ' ' LEU . 15.9 mt -69.49 -38.98 77.9 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.084 0.469 . . . . 0.0 110.188 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.25 -33.25 73.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.199 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.96 -23.68 52.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.892 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.32 -33.12 74.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.293 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.1 -122.17 28.68 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.154 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -96.04 7.81 45.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.613 0.244 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -79.05 148.07 32.6 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.916 HD11 HD12 ' A' ' 79' ' ' LEU . 6.1 tp -76.19 134.53 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.952 HG13 HG23 ' A' ' 53' ' ' ILE . 4.7 t -116.61 107.35 22.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.43 0.634 . . . . 0.0 112.085 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.563 HG23 ' CD2' ' A' ' 79' ' ' LEU . 7.3 p -101.69 115.07 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.556 HG12 ' HG ' ' A' ' 55' ' ' LEU . 5.2 m -122.59 168.15 15.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.364 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -135.14 134.13 39.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.951 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.484 ' HE1' HD12 ' A' ' 78' ' ' LEU . 7.1 m-85 -96.71 110.71 23.11 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' HG12 ' A' ' 59' ' ' VAL . 51.6 p -119.44 -168.45 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.299 0.571 . . . . 0.0 112.062 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.17 155.07 37.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.037 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -71.23 -35.94 71.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.462 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 47.5 p-90 -86.25 11.33 12.33 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.404 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 11.1 t -88.76 157.72 18.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.988 0.423 . . . . 0.0 111.436 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.92 -64.66 0.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.004 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 30.3 Cg_exo -64.01 -21.39 68.37 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.753 2.302 . . . . 0.0 112.499 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.7 m -59.02 -39.82 83.09 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.294 0.569 . . . . 0.0 109.983 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -68.69 -16.88 63.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.564 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.408 ' HG2' ' HA ' ' A' ' 34' ' ' PRO . 69.2 mmm -74.16 -24.64 59.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.537 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.539 HG22 ' HB2' ' A' ' 42' ' ' PHE . 6.9 mm -86.19 -24.87 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.631 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -51.09 65.93 Favored Pre-proline 0 N--CA 1.468 0.428 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.3 -48.37 18.03 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.151 1.901 . . . . 0.0 112.703 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -80.59 -31.03 36.87 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 8.2 t80 -66.59 -45.83 77.92 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.875 0.369 . . . . 0.0 110.319 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.67 -39.35 88.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.554 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.5 m -60.75 -42.86 98.24 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.042 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.18 -44.39 95.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.257 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 25.0 p -53.55 -25.15 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.229 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -86.6 -21.98 26.5 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 120.608 0.242 . . . . 0.0 111.129 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -94.9 -19.16 20.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.08 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.766 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.4 m-85 -98.95 92.84 5.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 t -90.11 50.58 1.88 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 110.674 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -153.14 -42.73 0.1 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.492 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' A' ' 49' ' ' TYR . 5.5 m -93.29 154.31 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.689 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.952 HG23 HG13 ' A' ' 23' ' ' VAL . 5.7 tp -105.9 115.65 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.909 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.613 ' O ' HG13 ' A' ' 2' ' ' VAL . 5.7 m-85 -97.03 115.83 28.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.505 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.854 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.48 166.73 17.39 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.491 178.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.412 ' N ' HD12 ' A' ' 55' ' ' LEU . 1.6 tp10 -117.93 118.6 32.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.462 HG22 HD11 ' A' ' 55' ' ' LEU . 2.4 t -116.39 118.07 57.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.548 0.689 . . . . 0.0 110.842 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -99.34 120.16 39.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.558 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 28' ' ' SER . 13.7 p -61.2 -17.84 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.4 -40.06 96.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.247 0.546 . . . . 0.0 109.527 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -98.25 -36.29 10.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.987 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.93 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.66 42.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.752 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -69.8 -11.17 60.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.343 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.96 -21.98 19.47 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.439 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.93 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.2 m -80.47 -46.48 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.152 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.877 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.04 -56.65 16.3 Favored Pre-proline 0 N--CA 1.466 0.331 0 O-C-N 122.284 -0.26 . . . . 0.0 111.552 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 79.2 Cg_exo -51.35 -28.32 26.64 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.543 2.162 . . . . 0.0 111.958 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -74.41 -24.74 59.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.35 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -108.43 -6.65 16.08 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.628 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.31 38.87 94.06 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.706 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.617 HG23 HG21 ' A' ' 76' ' ' THR . 76.7 mt -76.28 133.09 31.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 110.38 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.6 tpt85 -149.64 49.05 0.94 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.933 0.397 . . . . 0.0 110.913 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.32 102.09 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.713 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.407 ' HA ' ' N ' ' A' ' 76' ' ' THR . 13.0 pt -101.88 150.02 37.02 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.83 114.05 3.22 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 124.29 -1.129 . . . . 0.0 112.385 0.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.617 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -86.42 135.05 33.64 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.603 HD22 HD21 ' A' ' 93' ' ' LEU . 2.0 mp -107.81 126.18 52.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.55 HD11 HD11 ' A' ' 71' ' ' ILE . 6.0 mt -118.36 134.07 55.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.268 0.556 . . . . 0.0 111.636 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.916 HD12 HD11 ' A' ' 22' ' ' LEU . 3.1 mm? -113.4 126.0 54.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.688 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.494 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 51.9 m-85 -118.68 146.8 44.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.954 0.407 . . . . 0.0 110.961 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -144.74 110.45 5.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.805 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.0 m120 60.52 46.41 9.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 110.063 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.08 -3.37 38.23 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.005 -0.616 . . . . 0.0 114.141 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.57 134.1 55.24 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 117.299 0.55 . . . . 0.0 111.68 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 85' ' ' VAL . 10.0 p -68.04 116.35 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.445 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.81 11.1 24.47 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.89 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.45 137.23 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.263 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.531 HG23 ' CD2' ' A' ' 78' ' ' LEU . 51.3 m -137.52 124.68 21.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -122.72 145.14 48.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.352 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.81 146.64 24.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.199 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.44 159.26 10.83 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.964 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.44 141.0 52.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 111.481 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.603 HD21 HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -129.29 150.97 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.239 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.08 179.09 0.74 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.701 0.286 . . . . 0.0 110.624 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -71.28 -32.56 68.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.731 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.06 -31.03 54.43 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.928 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.74 -31.48 57.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.535 HD11 HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -71.78 -51.26 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.704 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -61.07 -41.78 97.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.078 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.83 -39.09 90.61 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.91 0.386 . . . . 0.0 110.178 179.467 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.89 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 11.3 t80 -63.27 -42.4 99.12 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.515 0.674 . . . . 0.0 110.114 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.51 HD11 HG11 ' A' ' 24' ' ' VAL . 5.0 mt -66.77 -58.45 5.03 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.85 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -48.86 -34.97 13.6 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.732 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.2 -20.57 60.15 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -109.0 -33.42 6.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.678 HD23 HG12 ' A' ' 52' ' ' VAL . 3.4 tm? -69.24 114.22 7.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.893 0.378 . . . . 0.0 110.679 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 106' ' ' LEU . 5.1 m . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.197 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.947 0.403 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.718 HG13 ' HA ' ' A' ' 55' ' ' LEU . 48.3 t 63.45 146.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.642 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -146.09 122.07 10.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.159 0.504 . . . . 0.0 110.265 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -74.48 129.64 38.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.053 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.872 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -101.97 108.11 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 110.317 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -98.94 19.27 15.34 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.226 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -154.72 159.74 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 0.0 111.127 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.614 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -72.35 -27.1 62.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.083 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -79.97 -31.87 39.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.952 0.406 . . . . 0.0 110.751 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.63 90.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.898 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.492 ' CE1' HG21 ' A' ' 57' ' ' VAL . 3.8 t80 -56.36 -40.19 74.12 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.75 -45.14 72.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.046 178.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.77 -48.41 79.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.484 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.41 -32.46 74.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.916 0.389 . . . . 0.0 110.928 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 mt -68.14 -34.58 76.6 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.802 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.01 -34.13 76.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.925 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.2 -22.59 55.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.702 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.68 -37.61 85.1 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.297 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.17 -124.37 35.78 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.997 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -94.19 4.89 53.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.543 0.211 . . . . 0.0 111.031 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 mttp -77.42 149.36 35.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.801 HD12 ' N ' ' A' ' 23' ' ' VAL . 4.4 tp -76.77 136.64 39.0 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.865 HG13 HG23 ' A' ' 53' ' ' ILE . 10.6 t -117.05 110.83 32.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.261 0.553 . . . . 0.0 112.234 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.524 HG11 ' CZ ' ' A' ' 54' ' ' PHE . 7.9 p -106.69 115.87 49.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.53 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.3 m -123.02 167.48 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.949 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -134.51 135.96 42.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.284 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.598 ' HE1' HD12 ' A' ' 78' ' ' LEU . 7.8 m-85 -99.06 109.88 22.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.545 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.3 m -114.97 -168.67 1.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.139 0.495 . . . . 0.0 111.928 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.722 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.08 155.17 37.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.743 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -71.96 -37.47 69.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.499 0.666 . . . . 0.0 109.366 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -86.76 12.4 10.92 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.034 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.722 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 8.0 t -94.17 159.83 14.97 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.994 0.426 . . . . 0.0 111.746 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.94 -64.91 0.44 Allowed Glycine 0 C--N 1.331 0.262 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.045 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.4 -24.13 77.97 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.708 2.272 . . . . 0.0 112.047 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.9 m -58.94 -43.69 91.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.238 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.4 -27.53 67.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.599 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 47.9 mtt -67.83 -17.09 64.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.3 mm -86.27 -22.35 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.904 0.383 . . . . 0.0 111.002 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -51.28 -58.7 9.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.169 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_endo -48.07 -46.65 21.59 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.539 2.16 . . . . 0.0 112.655 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -78.94 -33.79 45.02 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -66.17 -45.82 79.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.916 0.389 . . . . 0.0 110.402 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -40.68 87.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.657 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -43.85 94.83 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.882 0.372 . . . . 0.0 110.893 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.466 HD22 ' HG3' ' A' ' 99' ' ' LYS . 21.5 mt -59.68 -39.42 84.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.7 t -56.49 -29.57 61.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.614 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.66 -18.19 31.91 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.144 -0.223 . . . . 0.0 111.516 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -95.1 -20.35 19.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 0.0 110.008 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.794 ' HB3' HG22 ' A' ' 52' ' ' VAL . 21.8 m-85 -100.13 90.65 4.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.473 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 m -86.96 51.28 2.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.081 0.467 . . . . 0.0 110.454 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -154.65 -41.57 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.171 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.7 m -93.37 154.45 3.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.013 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.865 HG23 HG13 ' A' ' 23' ' ' VAL . 4.0 tp -103.7 114.48 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.256 0.55 . . . . 0.0 111.507 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.622 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.7 m-85 -97.61 115.6 28.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.178 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.872 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.63 167.89 16.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.115 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.68 120.41 36.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.492 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -115.16 118.11 57.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.0 110.406 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -97.97 119.52 36.74 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 28' ' ' SER . 13.9 p -60.08 -18.71 16.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.03 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -65.66 -38.07 88.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.037 0.446 . . . . 0.0 109.802 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.35 -35.13 10.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.28 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.903 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.43 46.07 1.14 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.916 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.3 -11.19 60.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.534 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.75 -22.79 19.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.505 0.193 . . . . 0.0 111.174 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.903 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -79.31 -47.29 22.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.978 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.634 ' HB3' ' CD ' ' A' ' 67' ' ' PRO . . . -50.52 -60.16 5.9 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.634 ' CD ' ' HB3' ' A' ' 66' ' ' ALA . 10.2 Cg_endo -50.85 -28.63 24.02 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.713 2.276 . . . . 0.0 111.967 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -78.13 -23.41 47.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.902 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -106.4 -2.96 21.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.649 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.67 33.75 86.98 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.629 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.639 HD11 HD11 ' A' ' 78' ' ' LEU . 81.2 mt -77.75 133.64 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 117.184 0.492 . . . . 0.0 110.618 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -144.74 64.35 1.29 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.337 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 170.85 162.38 23.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.243 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.3 pt -147.51 139.78 14.21 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.692 0.246 . . . . 0.0 110.987 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -87.95 123.62 6.65 Favored 'Cis proline' 0 C--N 1.35 0.635 0 C-N-CA 124.203 -1.165 . . . . 0.0 112.604 0.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.498 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -86.99 134.29 33.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.813 0.339 . . . . 0.0 111.077 179.199 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.863 HD22 HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -106.27 123.47 48.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.639 HD11 HD11 ' A' ' 71' ' ' ILE . 7.4 mt -115.6 136.12 53.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.222 0.534 . . . . 0.0 111.845 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.931 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 3.3 mm? -116.34 120.81 40.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.594 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.529 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.3 m-85 -112.17 145.61 39.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 0.0 111.202 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 tttm -145.93 110.94 5.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.998 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.9 m120 62.06 46.19 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 110.111 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.66 2.9 57.45 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.745 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -123.78 136.33 54.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.385 0.592 . . . . 0.0 111.651 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 85' ' ' VAL . 7.6 p -66.66 117.59 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.128 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.68 11.48 28.4 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.931 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.52 144.62 1.15 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.96 119.97 17.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -122.13 139.27 53.94 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.855 0.359 . . . . 0.0 110.249 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 t -121.8 145.92 27.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.464 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.6 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.54 159.81 24.38 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.602 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.74 143.89 54.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.976 0.417 . . . . 0.0 111.386 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.863 HD11 HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -125.43 -171.37 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.513 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.0 t -109.21 165.98 11.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 110.822 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -57.4 -37.72 73.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.05 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.54 -30.12 54.04 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.845 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.58 -32.59 58.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.488 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.44 -49.65 39.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.466 ' HG3' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -61.01 -43.76 98.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.876 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -62.21 -38.1 87.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.891 0.377 . . . . 0.0 110.168 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.678 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 5.6 t80 -61.82 -39.99 93.69 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.207 0.527 . . . . 0.0 109.923 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.435 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 6.6 mt -66.12 -59.32 3.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.914 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.49 -34.49 11.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.058 0.456 . . . . 0.0 110.705 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -24.42 62.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.18 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.66 ' O ' HG22 ' A' ' 107' ' ' VAL . 1.9 t30 -106.37 -47.68 3.74 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.676 0.274 . . . . 0.0 111.021 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.495 ' C ' HD23 ' A' ' 106' ' ' LEU . 6.1 tt -53.19 106.46 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.768 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 105' ' ' ASN . 17.7 m . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.066 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 mtm . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 121.026 0.441 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.731 HG13 ' HA ' ' A' ' 55' ' ' LEU . 56.8 t -64.37 145.08 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.097 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.77 123.42 11.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.022 0.439 . . . . 0.0 109.827 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -75.38 132.39 40.87 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.91 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -100.16 106.74 19.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 110.543 -179.1 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.76 21.31 10.63 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.87 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.26 159.13 38.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.771 0.32 . . . . 0.0 111.192 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.701 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.2 tmpt? -73.58 -26.9 61.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.946 0.403 . . . . 0.0 110.42 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -79.8 -32.11 40.76 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.616 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' CB ' HG13 ' A' ' 5' ' ' ILE . . . -66.57 -36.25 82.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.463 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.586 ' CE1' HG21 ' A' ' 57' ' ' VAL . 6.0 t80 -58.16 -42.51 86.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.107 0.479 . . . . 0.0 110.168 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -66.53 -41.79 88.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.955 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.96 -48.21 82.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.528 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.93 76.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 110.67 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 15' ' ' LEU . 12.1 mt -64.78 -40.76 95.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -66.9 -27.1 67.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.624 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -49.19 75.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.876 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.79 -64.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.544 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.51 -86.3 1.46 Allowed Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.809 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -94.4 -16.92 23.02 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -74.86 157.73 34.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.054 HD11 HD12 ' A' ' 79' ' ' LEU . 5.3 tp -79.5 133.96 36.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.863 HG13 ' CG2' ' A' ' 53' ' ' ILE . 15.7 t -114.37 110.37 31.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.403 0.621 . . . . 0.0 111.573 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.668 ' HB ' HD21 ' A' ' 102' ' ' LEU . 7.3 p -106.18 115.05 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.572 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.2 m -123.05 166.74 17.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.759 -178.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -131.75 132.04 43.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.546 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.692 ' HE1' HD12 ' A' ' 78' ' ' LEU . 4.7 m-85 -97.94 111.84 24.0 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.686 ' O ' HG12 ' A' ' 59' ' ' VAL . 22.7 t -117.46 -170.51 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.0 112.472 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.12 155.38 37.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.437 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -35.84 68.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.39 0.614 . . . . 0.0 110.199 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -85.31 11.52 9.99 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.081 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 8.8 t -96.83 158.26 15.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 111.313 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.51 -66.55 0.5 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.009 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.82 -23.36 71.89 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.454 2.103 . . . . 0.0 112.193 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -58.82 -44.54 90.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -65.0 -26.5 68.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.51 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.5 mtt -67.03 -17.44 64.91 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.544 HD11 ' HB1' ' A' ' 92' ' ' ALA . 14.5 mm -86.1 -21.72 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.091 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 25.6 mttp -51.37 -59.34 8.02 Favored Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 8.2 Cg_endo -50.35 -45.2 35.24 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.437 2.092 . . . . 0.0 112.869 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -78.88 -31.87 45.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.419 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 4.5 t80 -65.9 -45.37 82.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.93 0.395 . . . . 0.0 110.531 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.78 -38.35 86.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.524 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.6 m -59.67 -42.8 93.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 110.746 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 54' ' ' PHE . 10.5 mt -60.81 -42.89 98.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.418 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.4 p -54.81 -25.84 31.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.394 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -86.64 -23.15 25.78 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.599 0.238 . . . . 0.0 111.321 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -94.18 -19.05 21.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 110.041 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.832 ' HB3' HG22 ' A' ' 52' ' ' VAL . 19.7 m-85 -100.16 88.03 3.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.966 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 p -87.11 50.92 2.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.463 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -153.5 -42.58 0.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.685 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.832 HG22 ' HB3' ' A' ' 49' ' ' TYR . 12.3 m -93.46 154.56 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.556 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.863 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.6 tp -103.79 114.17 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.353 0.597 . . . . 0.0 111.038 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.646 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.5 m-85 -96.91 117.31 30.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.806 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.91 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -130.76 164.8 24.32 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.395 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -112.98 116.02 29.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.586 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.6 t -114.05 116.46 52.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.168 0.508 . . . . 0.0 111.048 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -99.18 120.18 39.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.469 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 28' ' ' SER . 10.2 p -60.96 -20.03 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.098 -178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -61.76 -40.77 96.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.219 0.533 . . . . 0.0 109.667 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -100.26 -33.53 10.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.353 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.914 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.78 43.6 1.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.548 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -71.66 -9.92 58.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.565 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.38 -21.4 18.4 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.243 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.914 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 1.6 m -79.34 -47.87 21.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.485 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.919 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.89 -58.28 9.87 Favored Pre-proline 0 C--N 1.333 -0.141 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.919 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 74.7 Cg_exo -51.2 -28.3 25.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.415 2.077 . . . . 0.0 111.849 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -73.8 -25.68 60.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.487 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -108.39 -6.12 16.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.691 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.73 36.23 90.94 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 116.007 -0.542 . . . . 0.0 114.33 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.627 HD11 HD11 ' A' ' 78' ' ' LEU . 63.9 mt -74.65 136.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 117.312 0.556 . . . . 0.0 110.653 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -151.79 54.89 0.84 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 111.236 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.73 102.22 0.15 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.428 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.428 ' HA ' ' N ' ' A' ' 76' ' ' THR . 11.8 pt -102.87 154.39 37.56 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 122.971 -0.135 . . . . 0.0 110.835 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.74 114.17 3.17 Favored 'Cis proline' 0 C--N 1.348 0.529 0 C-N-CA 123.768 -1.347 . . . . 0.0 113.125 0.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.484 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -86.26 136.61 33.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 111.221 179.018 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -107.39 123.61 48.62 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.692 HD12 ' HE1' ' A' ' 27' ' ' PHE . 6.7 mt -116.03 136.14 53.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.223 0.535 . . . . 0.0 111.867 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.054 HD12 HD11 ' A' ' 22' ' ' LEU . 3.9 mm? -116.29 123.46 47.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.863 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.639 ' CE2' HG22 ' A' ' 85' ' ' VAL . 47.1 m-85 -113.98 144.94 42.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.024 0.44 . . . . 0.0 111.072 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -146.14 111.34 5.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.061 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 61.49 45.29 8.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.774 0.321 . . . . 0.0 110.563 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.99 2.76 58.73 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.52 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -124.45 140.35 53.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.297 0.548 . . . . 0.0 111.809 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.639 HG22 ' CE2' ' A' ' 80' ' ' PHE . 33.0 t -69.9 120.87 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.672 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.72 8.65 16.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.904 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.84 136.56 0.55 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.9 m -136.36 125.26 24.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 0.0 110.771 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 145.17 49.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.046 0.451 . . . . 0.0 111.181 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.59 145.93 25.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.172 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.409 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 77.53 160.83 13.7 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.332 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.666 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -65.29 176.38 1.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.045 0.45 . . . . 0.0 111.508 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -170.37 153.3 4.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.692 -179.552 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 t -66.78 179.01 1.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.028 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -72.97 -28.63 62.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.068 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.46 -31.77 49.63 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.13 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 39.7 mt-30 -76.87 -31.9 57.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.975 0.387 . . . . 0.0 110.558 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.611 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -71.02 -51.13 27.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.047 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -63.33 -43.22 98.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.097 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.4 pp20? -62.06 -43.17 99.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.779 0.323 . . . . 0.0 110.469 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.748 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 29.8 t80 -61.9 -39.21 91.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.4 0.619 . . . . 0.0 110.088 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.668 HD21 ' HB ' ' A' ' 24' ' ' VAL . 4.3 mt -65.52 -60.7 2.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.009 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -48.23 -32.22 6.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.02 -26.23 63.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.791 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -106.36 -26.58 11.42 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.702 0.287 . . . . 0.0 111.524 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.629 ' O ' HD23 ' A' ' 106' ' ' LEU . 1.8 tt -72.64 -37.35 68.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 110.482 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 106' ' ' LEU . 22.6 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.292 -0.861 . . . . 0.0 112.223 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ttm . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.845 0.355 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.696 HG13 ' HA ' ' A' ' 55' ' ' LEU . 52.1 t -70.43 145.7 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.625 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -143.34 120.51 11.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.185 0.517 . . . . 0.0 110.377 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.63 129.27 37.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.118 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.796 HD13 HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -101.67 107.79 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.353 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.66 20.19 13.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.159 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -155.15 160.36 40.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.824 0.345 . . . . 0.0 111.401 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.648 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -72.96 -27.07 61.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.624 179.474 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.438 HG22 ' OE2' ' A' ' 13' ' ' GLU . 6.3 m -79.76 -30.99 40.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.858 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.428 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -65.78 -39.78 91.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.735 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 57' ' ' VAL . 4.8 t80 -56.77 -43.26 80.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.191 0.52 . . . . 0.0 109.661 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -66.12 -46.2 78.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.875 178.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.438 ' OE2' HG22 ' A' ' 9' ' ' THR . 14.0 mt-10 -60.74 -44.8 96.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.434 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.74 -34.32 78.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.577 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.03 -35.9 79.03 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.497 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -35.29 76.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.322 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.45 -22.52 54.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.91 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.1 -33.21 74.1 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.227 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.03 -125.07 37.83 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.036 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.22 6.4 46.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.509 0.195 . . . . 0.0 111.139 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -78.74 150.15 32.53 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.951 HD11 HD12 ' A' ' 79' ' ' LEU . 6.5 tp -78.08 133.76 37.84 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.884 HG13 HG23 ' A' ' 53' ' ' ILE . 6.5 t -113.85 110.19 31.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.454 0.645 . . . . 0.0 112.005 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.684 HG11 HD11 ' A' ' 102' ' ' LEU . 7.3 p -102.59 113.84 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.709 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.1 m -121.27 165.85 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.758 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -134.31 133.31 40.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.854 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.459 ' HE1' HD12 ' A' ' 78' ' ' LEU . 10.7 m-85 -97.34 110.39 22.95 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 35' ' ' CYS . 54.4 p -121.41 -166.76 1.41 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.247 0.546 . . . . 0.0 112.228 -178.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.83 152.71 33.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.155 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -70.44 -36.98 74.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.437 0.637 . . . . 0.0 109.408 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -87.23 11.31 14.49 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.826 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.769 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 15.4 t -93.04 155.79 17.29 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.482 . . . . 0.0 112.213 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.79 -75.8 1.04 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.209 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HA ' ' CG ' ' A' ' 37' ' ' MET . 9.3 Cg_endo -52.26 -24.52 21.07 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.62 2.214 . . . . 0.0 112.416 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 81.2 m -60.49 -41.96 95.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.208 0.528 . . . . 0.0 110.373 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -68.93 -15.64 63.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.25 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.402 ' CG ' ' HA ' ' A' ' 34' ' ' PRO . 3.9 mmt -72.96 -28.09 62.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.467 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.2 mm -84.56 -23.97 7.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.734 0.302 . . . . 0.0 111.431 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -49.76 -54.13 34.94 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.898 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -51.45 -48.36 21.65 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.514 2.142 . . . . 0.0 113.345 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -80.08 -28.27 39.17 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -65.63 -45.83 81.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.965 0.412 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.04 -37.96 81.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.95 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -43.96 97.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.917 0.389 . . . . 0.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.54 -42.35 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.111 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.7 t -55.38 -26.19 39.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.293 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -88.45 -20.15 25.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.586 0.231 . . . . 0.0 111.526 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -96.23 -20.35 18.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.058 0.456 . . . . 0.0 110.069 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.828 ' HB3' HG22 ' A' ' 52' ' ' VAL . 20.0 m-85 -98.71 92.83 5.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.725 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.7 p -91.31 48.51 1.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.667 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -151.79 -40.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.58 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.828 HG22 ' HB3' ' A' ' 49' ' ' TYR . 12.5 m -95.35 156.16 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.594 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.884 HG23 HG13 ' A' ' 23' ' ' VAL . 4.7 tp -106.67 115.18 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.892 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.622 ' CE1' HG11 ' A' ' 24' ' ' VAL . 7.7 m-85 -96.34 115.65 27.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.244 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.796 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.32 166.24 19.02 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.734 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.458 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -117.98 120.05 36.67 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -176.793 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -114.75 117.72 56.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.107 0.48 . . . . 0.0 110.713 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -98.62 120.05 38.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.78 -17.67 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -66.91 -37.61 84.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.2 -37.82 9.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.143 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.855 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.59 44.11 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.303 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -9.37 48.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.815 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.57 -22.36 17.67 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.467 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.855 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.8 m -79.06 -47.44 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.53 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.926 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.66 -57.69 11.42 Favored Pre-proline 0 N--CA 1.463 0.178 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.926 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 75.3 Cg_exo -51.11 -28.5 25.34 Favored 'Trans proline' 0 C--N 1.34 0.09 0 C-N-CA 122.441 2.094 . . . . 0.0 111.595 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -75.93 -21.72 56.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.918 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -112.63 -5.69 13.96 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.49 39.26 96.71 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.451 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.873 HG23 HG21 ' A' ' 76' ' ' THR . 61.4 mt -79.32 79.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.929 0.365 . . . . 0.0 111.06 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -86.5 82.58 7.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.184 0.516 . . . . 0.0 111.836 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.77 163.13 10.07 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.568 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.2 pt -146.2 156.77 50.3 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -83.5 118.25 5.34 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.402 -1.082 . . . . 0.0 113.063 0.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.873 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -89.16 136.55 32.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.372 . . . . 0.0 111.686 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.622 HD22 HD21 ' A' ' 93' ' ' LEU . 1.1 mp -109.19 123.29 49.0 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.707 ' CD2' HG23 ' A' ' 88' ' ' THR . 6.3 mt -115.6 133.11 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.341 0.591 . . . . 0.0 111.411 -178.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.951 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -114.17 121.8 44.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.636 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.497 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 41.6 m-85 -113.07 146.87 38.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.261 0.553 . . . . 0.0 111.544 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -146.69 116.73 7.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.011 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 20.5 m-20 57.98 44.97 18.81 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.455 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.1 2.54 53.43 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.9 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -124.91 139.47 53.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.473 0.637 . . . . 0.0 111.705 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.472 HG13 ' O ' ' A' ' 85' ' ' VAL . 10.4 p -67.96 117.51 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.905 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -110.91 10.68 22.33 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.857 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.7 137.14 0.34 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.527 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.707 HG23 ' CD2' ' A' ' 78' ' ' LEU . 10.9 m -136.7 125.26 23.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.588 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -123.24 143.21 50.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.859 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.5 146.37 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.568 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.449 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 80.95 159.6 22.49 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.892 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.03 37.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 111.696 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.622 HD21 HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -118.72 150.4 39.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.7 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 m -63.98 179.81 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -72.78 -32.63 65.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.976 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.01 -30.06 56.16 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.618 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 26.3 mt-30 -76.43 -31.86 58.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.441 . . . . 0.0 110.704 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.589 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -72.33 -50.11 29.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -62.22 -44.08 97.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.107 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 17.8 pt-20 -60.05 -44.22 94.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.713 0.292 . . . . 0.0 110.814 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.857 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 19.4 t80 -61.92 -42.2 98.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.114 0.483 . . . . 0.0 111.11 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.684 HD11 HG11 ' A' ' 24' ' ' VAL . 3.6 mt -66.67 -57.54 6.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.164 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.26 -34.92 16.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.68 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.74 -22.59 60.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.254 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -107.88 -24.14 11.77 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.685 HD13 ' N ' ' A' ' 107' ' ' VAL . 2.2 tm? -75.25 -80.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.813 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.685 ' N ' HD13 ' A' ' 106' ' ' LEU . 12.5 p . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.133 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mtt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 121.144 0.497 . . . . 3.48 111.588 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.917 HG13 ' HA ' ' A' ' 55' ' ' LEU . 58.3 t -110.8 151.17 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.668 -0.696 . . . . 0.25 109.709 179.407 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.506 ' O ' HD12 ' A' ' 5' ' ' ILE . 10.2 ptpt -143.96 122.43 12.42 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.686 -0.805 . . . . 1.47 110.917 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.16 123.4 26.37 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.44 -1.254 . . . . 1.77 109.796 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 1.048 ' CD1' HD13 ' A' ' 55' ' ' LEU . 3.5 mp -102.91 110.79 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.985 0.421 . . . . 0.49 110.558 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -98.63 19.02 15.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.012 -0.54 . . . . 1.57 111.545 179.515 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.45 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.7 m -155.16 163.69 39.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.949 0.404 . . . . 0.76 111.89 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.9 ttpt -76.79 -25.55 53.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.984 -0.553 . . . . 1.36 110.778 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -79.34 -32.43 43.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.004 0.431 . . . . 0.28 109.955 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 1.041 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -66.51 -37.97 86.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.801 -0.636 . . . . 0.17 110.521 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -57.85 -46.14 85.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.24 110.686 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -65.47 -40.58 93.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.853 -0.612 . . . . 1.01 109.736 178.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -58.58 -48.76 79.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.918 -0.583 . . . . 1.34 110.94 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.45 -36.29 82.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.991 -0.549 . . . . 0.21 111.247 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.2 mt -64.69 -38.33 90.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.3 110.166 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.2 -27.66 68.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 1.7 110.476 179.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.9 83.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.31 111.146 -178.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.15 -65.45 0.67 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 119.943 -0.703 . . . . 0.63 109.922 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.83 -93.24 1.86 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.704 -0.68 . . . . 0.43 112.808 -179.243 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -95.63 -9.95 30.75 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.199 0.499 . . . . 2.26 111.669 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -75.24 151.08 38.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.613 -0.514 . . . . 1.14 109.613 179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.998 HD11 HD12 ' A' ' 79' ' ' LEU . 1.9 tp -76.39 127.91 33.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.883 0.373 . . . . 0.2 110.112 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.827 HG13 ' CG2' ' A' ' 53' ' ' ILE . 3.9 t -106.67 110.23 30.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.34 0.59 . . . . 0.18 111.592 -179.362 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.548 ' HB ' HD21 ' A' ' 102' ' ' LEU . 7.3 p -106.07 116.06 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.114 -1.069 . . . . 0.26 108.114 178.352 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.067 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.9 m -123.37 164.18 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.179 0.514 . . . . 0.46 112.371 -178.012 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.477 ' OD1' HD12 ' A' ' 77' ' ' LEU . 31.0 t0 -127.81 132.9 49.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 1.12 112.067 -178.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -99.1 106.52 18.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.06 -0.719 . . . . 0.24 109.06 178.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.525 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.9 p -119.92 -174.76 2.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.068 0.766 . . . . 1.22 113.068 -177.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -147.02 154.77 41.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.459 -1.246 . . . . 0.28 110.396 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -38.45 79.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.82 110.176 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -86.54 14.22 7.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.364 -0.834 . . . . 0.58 111.412 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 32.2 t -98.42 141.35 31.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.737 0.303 . . . . 0.52 110.571 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.89 -67.24 0.94 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.592 -0.813 . . . . 0.29 112.196 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -51.95 -26.58 25.35 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.585 2.19 . . . . 0.41 112.165 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -60.54 -44.06 96.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.36 110.534 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -65.94 -28.44 68.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.795 -0.639 . . . . 1.57 111.093 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.0 mtt -68.55 -21.01 64.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 1.22 111.549 -179.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.8 mm -87.21 -23.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.746 0.308 . . . . 0.29 111.132 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 31.5 mttt -51.23 -54.77 34.7 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.39 -0.368 . . . . 1.87 110.945 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 39' ' ' LYS . 71.5 Cg_exo -48.31 -48.14 17.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.613 2.209 . . . . 0.32 112.485 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -78.24 -28.43 47.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.516 -0.311 . . . . 0.29 111.508 -178.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 4.4 t80 -68.31 -47.96 66.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.097 0.475 . . . . 0.25 110.187 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.89 -41.67 86.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.735 -0.666 . . . . 0.3 111.505 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -59.39 -44.85 92.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.774 0.321 . . . . 1.12 110.82 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.41 -40.4 86.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.808 -0.441 . . . . 0.2 109.808 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.426 ' HB2' ' CB ' ' A' ' 54' ' ' PHE . 35.6 t -53.92 -28.26 35.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 1.24 111.11 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -87.93 -17.9 30.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.641 -0.254 . . . . 2.14 111.33 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.446 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 4.6 ttpp -95.51 -21.47 18.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.018 0.437 . . . . 1.27 109.946 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.79 ' HB3' HG22 ' A' ' 52' ' ' VAL . 16.9 m-85 -99.04 92.21 5.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.627 -0.715 . . . . 0.71 110.708 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -84.26 46.41 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 1.16 111.397 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -157.62 -36.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.956 0.354 . . . . 1.05 111.956 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.79 HG22 ' HB3' ' A' ' 49' ' ' TYR . 6.2 m -91.85 157.07 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.682 0.277 . . . . 0.2 111.193 -179.318 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.827 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.2 tp -104.92 116.91 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.222 0.534 . . . . 0.34 111.109 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.7 m-85 -99.1 117.27 33.23 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.814 -0.63 . . . . 0.24 110.242 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.067 ' HG ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -133.23 169.78 16.4 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.642 -0.423 . . . . 0.35 110.849 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.968 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -121.57 124.94 45.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.381 0.882 . . . . 1.82 113.381 -178.712 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.507 HG22 HD11 ' A' ' 55' ' ' LEU . 7.8 t -112.0 114.59 47.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.654 -0.703 . . . . 0.15 111.027 178.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -94.47 115.68 27.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.1 -0.5 . . . . 1.9 109.686 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 28' ' ' SER . 12.4 p -59.75 -21.05 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.19 111.644 -178.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -64.65 -38.83 92.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.932 -0.395 . . . . 1.16 109.932 179.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -99.61 -39.16 8.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 1.31 111.263 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.702 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.17 50.38 1.39 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.055 0.455 . . . . 0.16 111.176 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 7.0 tt0 -77.54 -3.2 39.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.158 -0.474 . . . . 2.0 110.958 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.38 -24.84 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.766 0.317 . . . . 1.28 110.176 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.702 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 8.2 m -81.98 -48.28 18.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.184 -0.462 . . . . 0.22 111.399 179.298 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.864 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.52 -55.14 24.26 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 112.933 0.716 . . . . 0.18 112.933 -178.299 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 72.6 Cg_exo -52.35 -27.8 32.5 Favored 'Trans proline' 0 C--O 1.23 0.114 0 C-N-CA 122.871 2.381 . . . . 0.3 113.059 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -77.27 -20.26 55.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.124 -0.489 . . . . 1.36 111.895 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -107.48 -6.03 17.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.055 0.455 . . . . 0.24 111.055 179.482 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.04 37.43 93.13 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.626 -0.715 . . . . 0.26 112.859 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 78' ' ' LEU . 70.9 mt -75.05 134.98 28.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.358 -0.608 . . . . 0.66 109.358 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -147.2 59.77 1.17 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.72 0.295 . . . . 2.76 110.968 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.13 117.72 0.45 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.478 -0.867 . . . . 0.95 113.297 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 pt -108.24 153.54 41.85 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 110.164 -0.31 . . . . 0.82 110.164 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.76 115.94 4.06 Favored 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.854 -1.311 . . . . 0.44 112.488 -0.011 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.63 138.2 31.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.878 0.371 . . . . 0.2 111.424 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.477 HD12 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -108.17 124.86 50.9 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.429 -0.952 . . . . 0.35 108.429 177.57 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.522 HD11 HD11 ' A' ' 71' ' ' ILE . 5.0 mt -116.28 135.33 53.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.272 0.558 . . . . 0.23 111.625 -178.047 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.998 HD12 HD11 ' A' ' 22' ' ' LEU . 4.0 mm? -116.74 112.56 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.508 -0.769 . . . . 0.24 110.889 -179.423 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.584 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 50.5 m-85 -104.26 142.62 34.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.076 -0.511 . . . . 0.19 110.524 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -143.62 112.7 6.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.731 -0.668 . . . . 0.35 109.638 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 61.36 45.73 8.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.21 0.529 . . . . 0.73 109.729 -178.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.43 3.32 46.93 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.37 -0.832 . . . . 0.17 113.793 178.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -124.67 140.24 53.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.599 0.699 . . . . 1.65 112.106 -179.051 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.5 t -64.68 116.83 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.586 -0.734 . . . . 1.26 110.788 179.08 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.54 -1.11 19.95 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.517 0.562 . . . . 0.58 112.517 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.625 ' HB1' ' HZ ' ' A' ' 101' ' ' PHE . . . -172.79 147.31 1.71 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.058 -0.519 . . . . 0.22 111.78 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 t -137.73 144.5 41.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 1.42 110.912 178.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -138.55 139.69 38.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.026 -0.534 . . . . 1.79 110.059 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.0 t -121.32 143.96 31.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.681 0.277 . . . . 0.59 111.239 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.407 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 82.66 160.19 27.77 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.529 -0.843 . . . . 0.18 112.607 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.69 155.54 39.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.143 0.497 . . . . 0.44 111.638 -179.11 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -150.52 151.61 32.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.602 -0.726 . . . . 0.57 110.263 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 m -66.92 179.22 1.16 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.428 . . . . 0.91 111.294 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -72.64 -30.59 64.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.624 . . . . 0.81 111.478 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.19 -30.59 54.57 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.131 -1.033 . . . . 0.14 112.701 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.587 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 51.6 mt-30 -76.17 -28.46 57.34 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.876 -0.33 . . . . 1.18 110.632 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -50.72 16.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.067 0.46 . . . . 0.29 109.843 178.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.446 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 14.7 ttpt -59.22 -44.25 92.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.736 -0.665 . . . . 1.16 110.908 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.5 pp20? -61.45 -40.31 94.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.86 -0.609 . . . . 1.38 110.574 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PHE . . . . . 0.625 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 11.9 t80 -62.38 -42.54 99.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.317 0.58 . . . . 0.26 110.645 178.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.548 HD21 ' HB ' ' A' ' 24' ' ' VAL . 8.1 mt -66.55 -54.95 18.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.778 -0.646 . . . . 0.36 109.656 179.48 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -48.96 -34.05 12.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.169 0.509 . . . . 1.15 110.219 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.49 -22.57 61.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.735 -0.666 . . . . 0.22 112.288 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -109.06 -33.32 6.93 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.83 -0.348 . . . . 0.38 111.407 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' A' ' 22' ' ' LEU . 3.2 tm? -79.13 103.05 8.8 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.99 -0.374 . . . . 1.37 109.99 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.141 -0.933 . . . . 2.1 111.385 -179.51 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.723 HG13 ' HA ' ' A' ' 55' ' ' LEU . 43.1 t . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.808 0.337 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -143.12 120.6 11.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.274 0.559 . . . . 0.0 110.334 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -72.57 125.35 27.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.931 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.857 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -101.02 107.04 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.92 0.391 . . . . 0.0 110.363 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -97.86 20.06 12.75 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.974 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.3 m -156.95 160.13 38.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.838 0.351 . . . . 0.0 111.413 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.657 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.7 ttpt -72.43 -27.03 62.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.969 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.47 -32.13 42.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.383 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.402 ' CB ' HG13 ' A' ' 5' ' ' ILE . . . -66.1 -37.0 84.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.18 -45.2 91.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.027 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -65.31 -44.53 87.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.618 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.76 -45.77 91.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.642 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.55 74.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.07 0.462 . . . . 0.0 110.696 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.37 -35.88 76.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.719 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -62.15 -34.61 76.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.789 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.55 -22.72 53.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.927 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.77 73.35 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.036 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.17 -120.8 21.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.305 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -93.42 1.67 56.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -76.45 148.8 37.01 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.867 HD11 HD12 ' A' ' 79' ' ' LEU . 4.2 tp -76.51 131.51 39.04 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 1.013 HG13 HG23 ' A' ' 53' ' ' ILE . 2.4 t -113.45 109.07 27.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.272 0.558 . . . . 0.0 111.805 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.608 HG11 HD11 ' A' ' 102' ' ' LEU . 7.2 p -104.23 119.2 52.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.632 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.6 m -124.97 167.6 18.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.824 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -135.9 136.56 40.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.923 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.575 ' HE1' HD12 ' A' ' 78' ' ' LEU . 13.6 m-85 -98.67 114.1 26.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.284 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.509 ' O ' HG12 ' A' ' 59' ' ' VAL . 28.9 p -131.78 -171.12 2.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.683 0.754 . . . . 0.0 112.767 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.54 162.3 41.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.546 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 m -63.08 -30.63 71.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.92 0.391 . . . . 0.0 110.045 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -93.32 10.81 30.5 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.188 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.8 t -90.89 113.78 26.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.951 0.405 . . . . 0.0 111.176 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.84 -59.9 3.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.024 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.86 -28.75 69.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.342 2.028 . . . . 0.0 112.311 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.4 m -60.07 -39.87 87.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.803 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -69.11 -20.33 64.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.248 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.5 mtt -74.17 -25.19 59.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.369 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.505 HD11 ' HB1' ' A' ' 92' ' ' ALA . 7.3 mm -89.42 -24.83 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.654 0.264 . . . . 0.0 111.548 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.403 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -47.56 -50.17 51.75 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 38.1 Cg_exo -61.9 -44.67 19.57 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.492 2.128 . . . . 0.0 112.826 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.424 ' HB3' ' HD2' ' A' ' 95' ' ' LYS . 22.4 m-85 -80.55 -29.46 37.09 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.453 ' HB2' HG22 ' A' ' 38' ' ' ILE . 5.0 t80 -66.74 -46.43 75.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.072 0.463 . . . . 0.0 110.205 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -39.83 90.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.696 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.5 p -60.69 -42.87 98.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 111.063 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.402 HD22 ' HE1' ' A' ' 49' ' ' TYR . 48.3 mt -60.64 -43.09 97.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.19 -29.42 31.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.222 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -89.05 -21.45 23.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.958 0.409 . . . . 0.0 110.355 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -94.98 3.2 55.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.58 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.543 ' HB3' HG22 ' A' ' 52' ' ' VAL . 7.2 m-85 -109.09 -30.49 8.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 111.058 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 t 36.43 34.41 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.079 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -151.1 -41.36 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.995 0.426 . . . . 0.0 110.858 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 22' ' ' LEU . 17.9 m -94.03 157.4 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.543 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 1.013 HG23 HG13 ' A' ' 23' ' ' VAL . 2.8 tp -106.62 117.45 52.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.331 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.643 ' O ' HG22 ' A' ' 2' ' ' VAL . 5.2 m-85 -100.78 115.61 30.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.308 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.857 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -123.8 165.54 17.14 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.421 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.6 tt0 -116.94 119.56 35.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.115 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.452 HG22 HD11 ' A' ' 55' ' ' LEU . 2.3 t -116.93 119.97 63.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.598 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -99.2 120.67 39.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 28' ' ' SER . 13.9 p -60.73 -18.39 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.722 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -66.92 -37.94 85.28 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.4 -34.5 10.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.736 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.901 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.89 43.35 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.847 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.62 -9.59 50.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.963 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.99 -23.3 17.44 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.521 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.901 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.5 m -78.83 -47.37 23.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.203 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.888 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.97 -57.18 13.32 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.888 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 72.6 Cg_exo -50.69 -28.96 24.08 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.555 2.17 . . . . 0.0 112.101 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -77.86 -22.12 50.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.004 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -107.77 -5.56 17.26 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.886 0.374 . . . . 0.0 111.637 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.03 33.66 87.77 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.909 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 78' ' ' LEU . 59.6 mt -75.96 137.98 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 117.26 0.53 . . . . 0.0 110.593 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -140.94 79.42 1.7 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.96 0.41 . . . . 0.0 111.49 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.42 164.97 10.24 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.015 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -147.76 154.71 44.37 Favored Pre-proline 0 N--CA 1.464 0.251 0 C-N-CA 122.173 0.189 . . . . 0.0 110.9 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -81.9 118.7 5.84 Favored 'Cis proline' 0 C--N 1.35 0.648 0 C-N-CA 124.772 -0.928 . . . . 0.0 112.779 0.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.513 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -87.36 136.87 32.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.866 0.365 . . . . 0.0 111.318 178.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 93' ' ' LEU . 1.3 tp -107.8 119.03 38.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.744 ' CD2' HG23 ' A' ' 88' ' ' THR . 6.0 mt -114.56 135.22 54.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.241 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.919 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 3.7 mm? -115.58 123.4 48.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.726 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.618 ' CE2' HG22 ' A' ' 85' ' ' VAL . 45.8 m-85 -114.37 145.88 41.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.933 0.397 . . . . 0.0 111.177 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -146.85 112.72 5.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.045 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.5 m120 61.51 45.78 8.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 110.221 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.33 2.86 50.99 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.655 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -124.55 140.23 53.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.393 0.597 . . . . 0.0 111.39 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.618 HG22 ' CE2' ' A' ' 80' ' ' PHE . 28.3 t -68.3 116.94 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.728 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.28 11.27 27.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.094 0.474 . . . . 0.0 111.49 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.919 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -175.96 139.62 0.39 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.643 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.744 HG23 ' CD2' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -136.02 116.58 13.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.526 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -120.82 140.98 50.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 110.727 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.3 p -117.04 146.65 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.269 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.48 160.15 12.38 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.491 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 38' ' ' ILE . . . -69.43 163.89 24.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 0.0 111.82 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.568 HD11 HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -153.44 153.81 33.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.462 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.4 m -64.32 178.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.904 0.383 . . . . 0.0 111.133 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.424 ' HD2' ' HB3' ' A' ' 41' ' ' PHE . 1.6 tptm -72.28 -31.19 65.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.053 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.4 -31.34 51.56 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.315 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 17.8 mt-30 -76.91 -30.75 56.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.174 0.487 . . . . 0.0 110.627 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.528 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -72.42 -50.87 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -62.39 -44.44 96.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.997 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.1 pp20? -61.78 -42.49 99.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.83 0.348 . . . . 0.0 110.364 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.701 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 29.4 t80 -63.17 -42.96 99.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.33 0.586 . . . . 0.0 110.36 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.608 HD11 HG11 ' A' ' 24' ' ' VAL . 2.6 mt -65.46 -59.79 3.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.119 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -49.22 -32.21 10.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.466 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.54 -21.51 60.35 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.019 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -108.77 -28.25 9.31 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.553 ' C ' HD13 ' A' ' 106' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 110.697 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.718 HG13 ' HA ' ' A' ' 55' ' ' LEU . 41.5 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.696 0.284 . . . . 0.0 110.829 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -146.12 121.36 10.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.224 0.535 . . . . 0.0 110.173 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -72.84 131.59 42.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.679 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.851 HD13 HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -103.17 108.32 24.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.042 0.449 . . . . 0.0 110.474 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.56 20.18 14.39 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.976 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -155.12 161.73 41.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 111.138 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HA ' HG13 ' A' ' 65' ' ' VAL . 26.5 ttpt -75.08 -26.94 59.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.605 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -79.85 -32.01 40.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.512 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.41 88.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.433 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.52 ' CE1' HG21 ' A' ' 57' ' ' VAL . 4.6 t80 -57.06 -42.24 80.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.909 0.385 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.05 -42.95 88.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.91 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -58.14 -46.29 85.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.254 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.25 76.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.64 -43.35 89.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.99 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.48 -26.49 67.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.434 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.17 -49.76 73.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.977 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.36 -64.21 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.778 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.38 -83.04 1.63 Allowed Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.98 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -96.79 -18.55 19.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.82 0.31 . . . . 0.0 111.468 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -73.28 155.46 39.46 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.019 HD11 HD12 ' A' ' 79' ' ' LEU . 5.2 tp -78.17 134.87 37.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.894 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.864 HG13 ' CG2' ' A' ' 53' ' ' ILE . 13.8 t -113.74 110.25 31.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.418 0.627 . . . . 0.0 111.52 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.618 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -104.96 117.17 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.547 HG12 ' HG ' ' A' ' 55' ' ' LEU . 5.5 m -126.4 167.42 21.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.012 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -131.34 133.21 45.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.977 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.779 ' CE1' HD12 ' A' ' 78' ' ' LEU . 5.6 m-85 -97.78 110.56 23.11 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.681 ' O ' HG12 ' A' ' 59' ' ' VAL . 4.5 m -119.79 -168.34 1.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.388 0.613 . . . . 0.0 112.607 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.05 154.89 36.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.455 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -35.02 70.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.41 0.624 . . . . 0.0 109.498 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.452 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 52.7 p-90 -86.84 11.58 12.97 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.652 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.736 ' SG ' HD12 ' A' ' 74' ' ' ILE . 9.6 t -93.36 157.46 16.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.148 0.499 . . . . 0.0 111.705 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.18 -66.57 0.53 Allowed Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.239 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.1 -21.68 72.36 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.568 2.179 . . . . 0.0 112.308 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.23 -42.99 96.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -68.68 -15.66 63.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.495 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 mtp -72.92 -24.66 60.85 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.1 mm -85.46 -22.63 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.654 0.264 . . . . 0.0 111.685 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 28.6 mtpt -50.0 -59.71 6.47 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_endo -49.55 -45.84 29.34 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.535 2.157 . . . . 0.0 112.864 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -79.19 -29.06 42.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -65.55 -45.7 82.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.447 . . . . 0.0 110.375 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -38.06 84.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.867 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -61.79 -43.15 99.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.815 0.341 . . . . 0.0 110.676 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.97 -45.37 92.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.211 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 23.9 p -53.32 -27.21 22.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.554 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -85.21 -22.29 28.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.389 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -95.36 -17.56 21.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.918 0.389 . . . . 0.0 110.219 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.829 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.3 m-85 -99.6 92.66 5.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.879 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.2 m -90.22 49.55 1.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.393 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -153.23 -43.21 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.829 HG22 ' HB3' ' A' ' 49' ' ' TYR . 9.1 m -93.68 155.51 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.906 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.864 ' CG2' HG13 ' A' ' 23' ' ' VAL . 2.9 tp -105.58 114.69 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.918 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.618 ' CE1' HG11 ' A' ' 24' ' ' VAL . 8.0 m-85 -96.7 116.24 28.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.057 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.851 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -130.63 168.8 16.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.34 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.423 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.5 tt0 -121.34 124.16 43.9 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.52 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -117.33 120.44 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.905 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -97.83 119.22 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 28' ' ' SER . 11.2 p -61.39 -19.2 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.71 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.79 -41.03 97.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -98.21 -34.28 10.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.386 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.919 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.1 41.11 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.049 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -9.72 50.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.575 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.26 -23.14 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.422 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.919 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 1.8 m -78.12 -47.05 25.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.052 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.935 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.16 -57.97 11.1 Favored Pre-proline 0 N--CA 1.463 0.183 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.935 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 76.3 Cg_exo -51.07 -29.39 27.95 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.665 2.244 . . . . 0.0 112.262 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -76.72 -22.65 53.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.668 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -108.49 -3.5 18.07 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.842 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.45 35.35 91.22 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.175 -0.536 . . . . 0.0 114.0 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.653 HD11 HD11 ' A' ' 78' ' ' LEU . 76.4 mt -75.66 134.12 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 117.494 0.647 . . . . 0.0 110.689 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -151.58 51.22 0.82 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.909 0.385 . . . . 0.0 111.399 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.77 103.27 0.17 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.377 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.736 HD12 ' SG ' ' A' ' 32' ' ' CYS . 5.2 pt -103.14 153.21 38.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.465 0.174 . . . . 0.0 111.281 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.6 116.07 4.33 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.954 -1.269 . . . . 0.0 112.123 -0.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.02 138.17 31.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.017 0.436 . . . . 0.0 112.156 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.403 HD22 HD11 ' A' ' 93' ' ' LEU . 1.1 mp -107.48 123.43 48.4 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.779 HD12 ' CE1' ' A' ' 27' ' ' PHE . 7.6 mt -114.88 133.02 56.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.236 0.541 . . . . 0.0 111.841 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -115.13 121.99 44.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.921 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.651 ' CE2' HG22 ' A' ' 85' ' ' VAL . 50.7 m-85 -114.04 148.21 37.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.983 0.421 . . . . 0.0 111.397 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -147.05 111.99 5.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.952 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 m120 60.73 46.74 8.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.882 0.372 . . . . 0.0 110.316 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.35 4.68 52.06 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.659 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -125.34 139.54 53.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.19 0.495 . . . . 0.0 111.611 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.651 HG22 ' CE2' ' A' ' 80' ' ' PHE . 27.9 t -67.67 116.14 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.833 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.83 11.11 20.82 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.803 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -174.16 142.19 0.8 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.44 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -137.35 127.57 26.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 111.079 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.42 138.76 52.48 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.143 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 t -121.47 146.08 27.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.694 0.283 . . . . 0.0 111.642 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.43 161.02 23.9 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.849 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.703 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -67.07 164.36 18.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 111.542 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.703 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -159.8 151.15 19.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.051 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.63 178.91 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -70.9 -30.71 67.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.96 -30.99 50.02 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.007 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -77.28 -32.37 55.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.915 0.388 . . . . 0.0 110.617 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.482 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -71.0 -51.74 23.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.33 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -60.95 -38.24 85.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.356 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -61.88 -38.23 87.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.872 0.367 . . . . 0.0 110.268 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.655 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 6.3 t80 -61.48 -41.55 97.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.28 0.562 . . . . 0.0 110.09 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.466 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 6.6 mt -66.92 -56.88 8.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.9 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -50.8 -35.56 32.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.998 0.428 . . . . 0.0 110.193 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.6 -22.72 63.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.71 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -106.43 -55.42 2.33 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.624 0.25 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.639 HD13 HG12 ' A' ' 52' ' ' VAL . 19.8 tp . . . . . 0 N--CA 1.464 0.253 0 CA-C-O 121.064 0.459 . . . . 0.0 110.852 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 55' ' ' LEU . 46.5 t . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.818 0.342 . . . . 0.0 111.023 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -146.53 122.93 10.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.073 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -74.75 131.92 41.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.249 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.87 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -104.28 108.36 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.763 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -97.47 18.93 14.21 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 m -155.15 165.4 36.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.03 0.443 . . . . 0.0 111.523 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.624 ' HA ' HG13 ' A' ' 65' ' ' VAL . 22.3 ttpt -76.89 -26.34 54.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.33 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.0 m -79.78 -33.82 40.25 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.171 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.13 -36.49 83.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.365 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.511 ' CE1' HG21 ' A' ' 57' ' ' VAL . 5.4 t80 -58.85 -43.44 90.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.059 0.457 . . . . 0.0 110.118 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -65.41 -40.51 93.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.715 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -58.93 -50.71 73.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.711 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.2 75.28 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 15' ' ' LEU . 15.6 mt -65.56 -42.92 91.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.891 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.1 -28.28 68.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.545 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.16 -47.31 83.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.11 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.19 -64.27 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.171 -0.611 . . . . 0.0 109.628 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.88 -87.3 1.47 Allowed Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.201 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.34 -15.77 24.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.092 0.446 . . . . 0.0 111.482 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -75.24 155.62 36.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.019 HD11 HD12 ' A' ' 79' ' ' LEU . 8.1 tp -78.63 133.3 37.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.123 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.904 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.4 t -112.06 109.62 29.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.491 0.662 . . . . 0.0 111.413 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.686 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.1 p -104.15 115.11 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.633 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.2 m -122.89 163.98 20.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.306 0.574 . . . . 0.0 112.022 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -128.37 130.81 48.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.582 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.618 ' HE1' HD12 ' A' ' 78' ' ' LEU . 3.4 m-85 -97.52 111.06 23.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.585 ' O ' HG12 ' A' ' 59' ' ' VAL . 35.9 t -119.53 -168.94 1.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.238 0.542 . . . . 0.0 112.303 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.634 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.84 154.6 36.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.864 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -71.95 -37.84 69.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.48 0.657 . . . . 0.0 109.782 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -86.77 11.74 12.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.159 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.634 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 13.8 t -97.29 156.43 16.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.775 0.322 . . . . 0.0 110.926 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.03 -64.29 0.55 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.296 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.02 -24.36 76.63 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.422 2.081 . . . . 0.0 112.042 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -59.71 -45.54 91.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.305 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -64.9 -25.75 68.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 49.6 mmm -66.85 -16.26 64.18 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 8.7 mm -86.12 -21.57 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.731 0.3 . . . . 0.0 111.092 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.512 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -50.87 -58.78 9.08 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 7.4 Cg_endo -48.13 -47.81 18.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.796 2.331 . . . . 0.0 113.063 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -80.09 -30.41 39.22 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 6.1 t80 -65.72 -46.23 79.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.066 0.46 . . . . 0.0 109.942 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -39.57 88.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.729 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 t -61.57 -43.48 98.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.331 . . . . 0.0 110.833 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.47 -40.36 86.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.131 0.491 . . . . 0.0 109.897 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.3 t -56.15 -28.42 57.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.367 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -85.95 -20.52 28.83 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -95.75 -20.56 18.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.105 0.478 . . . . 0.0 110.159 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.83 ' HB3' HG22 ' A' ' 52' ' ' VAL . 16.0 m-85 -97.29 95.74 7.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.539 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -93.93 48.45 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.161 0.505 . . . . 0.0 110.019 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.87 -41.0 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.519 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.83 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.5 m -95.97 154.55 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.979 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.904 ' CG2' HG13 ' A' ' 23' ' ' VAL . 2.8 tp -105.5 113.99 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.833 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.686 ' CE1' HG11 ' A' ' 24' ' ' VAL . 9.3 m-85 -96.28 116.29 28.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.139 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.87 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.67 165.77 19.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.5 178.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.407 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -115.83 119.21 35.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -176.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.511 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -115.71 118.32 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.181 0.515 . . . . 0.0 111.369 178.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -99.68 121.93 41.94 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.585 HG12 ' O ' ' A' ' 28' ' ' SER . 13.1 p -60.43 -18.98 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.784 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -65.71 -39.09 90.85 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -97.94 -36.67 10.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.534 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.901 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.24 43.47 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.749 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -70.2 -9.77 56.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.509 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -94.04 -23.57 17.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.273 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.901 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -79.14 -46.61 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.036 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.884 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.24 -56.9 14.89 Favored Pre-proline 0 N--CA 1.462 0.175 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.884 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 81.1 Cg_exo -50.93 -28.82 25.06 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.677 2.251 . . . . 0.0 112.128 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -76.13 -18.75 59.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.964 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -115.9 -7.35 12.01 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.946 0.403 . . . . 0.0 111.658 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.05 39.94 97.69 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.038 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 78' ' ' LEU . 62.0 mt -76.97 79.66 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 117.013 0.406 . . . . 0.0 110.162 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -87.19 77.82 8.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.959 0.409 . . . . 0.0 111.774 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.73 162.52 9.3 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.129 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 32' ' ' CYS . 31.2 pt -145.89 156.5 51.57 Favored Pre-proline 0 CA--C 1.529 0.165 0 C-N-CA 122.157 0.183 . . . . 0.0 110.863 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -87.36 116.4 3.51 Favored 'Cis proline' 0 C--N 1.354 0.825 0 C-N-CA 124.578 -1.009 . . . . 0.0 112.481 -0.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.517 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -88.65 138.03 31.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.88 0.371 . . . . 0.0 111.659 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -107.65 125.79 51.79 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.618 HD12 ' HE1' ' A' ' 27' ' ' PHE . 6.3 mt -114.58 133.73 55.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.265 0.555 . . . . 0.0 111.686 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 HD11 ' A' ' 22' ' ' LEU . 2.8 mm? -114.48 117.03 29.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.968 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.512 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 45.3 m-85 -108.08 148.76 29.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.423 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -148.25 113.62 5.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.229 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.3 46.66 15.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.932 0.396 . . . . 0.0 110.276 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.83 3.45 55.41 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.918 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -126.26 140.51 52.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.252 0.526 . . . . 0.0 111.667 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 85' ' ' VAL . 11.1 p -68.24 119.0 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.911 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -117.05 11.46 14.25 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.866 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.18 140.23 0.85 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.398 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.0 141.15 46.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.049 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -142.48 136.81 29.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.181 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.4 t -120.32 146.3 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.79 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.518 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.27 159.57 23.26 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.857 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.63 132.3 47.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.974 0.416 . . . . 0.0 111.324 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.704 HD11 HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -113.88 -173.5 2.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.365 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 t -110.03 164.89 12.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.9 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -55.63 -38.01 68.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.769 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.05 -31.7 51.9 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.872 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 43.0 mt-30 -76.18 -31.86 58.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.012 0.406 . . . . 0.0 110.507 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.07 -50.13 30.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -61.51 -43.96 97.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.94 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -61.87 -40.09 94.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.256 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.8 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 30.0 t80 -63.09 -42.12 99.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.293 0.568 . . . . 0.0 110.728 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.612 HD11 HG11 ' A' ' 24' ' ' VAL . 3.0 mt -68.02 -56.15 9.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.318 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.99 -34.69 21.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.916 0.389 . . . . 0.0 110.471 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.31 -19.69 60.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.23 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -107.0 -34.7 7.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.84 0.352 . . . . 0.0 110.943 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.75 HD13 HG12 ' A' ' 52' ' ' VAL . 53.2 tp . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.105 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.708 HG13 ' HA ' ' A' ' 55' ' ' LEU . 61.6 t . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.755 0.312 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.4 121.97 11.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.117 0.484 . . . . 0.0 110.238 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -74.01 130.05 39.08 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.027 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.857 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -102.97 108.55 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.994 0.426 . . . . 0.0 110.337 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -100.59 19.74 16.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.143 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.26 160.16 40.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.935 0.397 . . . . 0.0 111.071 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.626 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -71.18 -28.64 64.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.002 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.49 -30.59 42.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.983 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.6 90.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.683 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -57.63 -43.8 85.1 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.92 0.39 . . . . 0.0 110.098 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.451 ' HA ' ' NE2' ' A' ' 12' ' ' GLN . 9.8 mm100 -65.38 -44.1 88.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.589 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -58.37 -46.13 86.92 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.313 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.83 -32.31 73.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.043 0.449 . . . . 0.0 110.606 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 mt -68.23 -38.58 82.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.99 -35.32 76.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.398 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.5 -22.5 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.685 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.14 -34.59 78.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.007 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.2 -123.43 31.19 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.25 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.32 6.22 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.599 0.237 . . . . 0.0 111.414 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -79.21 149.77 31.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.968 HD11 HD12 ' A' ' 79' ' ' LEU . 6.4 tp -76.16 133.21 40.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.869 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.8 t -111.41 111.43 36.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.523 0.678 . . . . 0.0 112.026 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.68 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -105.8 113.92 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.593 HG12 ' HG ' ' A' ' 55' ' ' LEU . 4.6 m -124.21 167.04 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.203 0.525 . . . . 0.0 112.007 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -134.28 134.34 41.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.023 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.598 ' CE1' HD12 ' A' ' 78' ' ' LEU . 6.7 m-85 -96.91 108.8 21.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.331 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 35' ' ' CYS . 50.9 p -115.69 -169.44 1.59 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.366 0.603 . . . . 0.0 112.355 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.8 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.09 154.8 36.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.405 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -71.5 -36.91 71.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.563 0.697 . . . . 0.0 109.53 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 p-90 -87.77 11.28 15.8 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.6 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.8 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 12.7 t -91.48 156.1 17.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.11 0.481 . . . . 0.0 112.145 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.28 -75.49 1.0 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.67 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.86 -20.84 30.64 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.702 2.268 . . . . 0.0 112.569 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 85.0 m -58.85 -43.87 90.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 110.757 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -68.45 -20.16 64.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.512 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 19.4 mtt -71.44 -23.71 61.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.398 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.3 mm -86.43 -24.17 6.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.725 0.298 . . . . 0.0 111.503 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -50.55 -52.9 51.44 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.004 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.54 -47.92 24.62 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.498 2.132 . . . . 0.0 113.107 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -80.34 -26.88 38.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.63 -45.49 82.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.047 0.451 . . . . 0.0 110.226 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.7 -41.47 83.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.988 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.1 t -59.82 -45.05 93.57 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.922 0.391 . . . . 0.0 111.065 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.78 -41.08 85.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.151 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 m -55.68 -26.31 44.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.285 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -87.44 -20.83 26.07 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.624 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -95.41 -19.48 19.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 0.0 110.077 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.825 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.6 m-85 -99.28 92.15 5.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.705 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 t -88.58 49.06 1.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.877 0.37 . . . . 0.0 110.743 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -153.79 -41.17 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.825 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.9 m -93.24 154.88 3.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.831 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.869 ' CG2' HG13 ' A' ' 23' ' ' VAL . 5.3 tp -105.46 114.34 44.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.907 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.68 ' CE1' HG11 ' A' ' 24' ' ' VAL . 8.6 m-85 -96.43 115.76 27.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.377 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.857 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.77 167.2 17.64 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.343 178.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.431 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.0 tp10 -119.83 122.15 40.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -176.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.81 120.18 64.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.333 0.587 . . . . 0.0 111.133 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -100.23 119.34 38.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.77 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -60.95 -18.02 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.989 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -64.61 -39.37 93.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 109.681 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.59 -33.9 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.526 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.92 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.91 43.68 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.66 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -70.44 -9.58 56.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.658 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.98 -23.22 17.48 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.289 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.92 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.0 m -77.67 -47.6 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.546 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.91 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.2 -57.75 11.81 Favored Pre-proline 0 N--CA 1.462 0.137 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.91 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 76.9 Cg_exo -51.58 -28.62 29.46 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.5 2.133 . . . . 0.0 111.903 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -76.04 -20.04 58.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.761 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -111.57 -4.89 14.62 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.852 0.358 . . . . 0.0 111.852 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.0 35.87 91.24 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.556 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.696 HD11 HD11 ' A' ' 78' ' ' LEU . 91.5 mt -75.9 135.98 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 117.173 0.486 . . . . 0.0 110.655 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 -146.86 62.63 1.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.04 0.448 . . . . 0.0 111.286 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.404 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 176.71 160.88 24.58 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.588 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.492 HD12 ' SG ' ' A' ' 32' ' ' CYS . 36.3 pt -146.31 137.4 12.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 O-C-N 122.995 -0.121 . . . . 0.0 110.764 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -89.88 122.14 5.1 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 124.749 -0.938 . . . . 0.0 112.092 0.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -86.56 137.01 32.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.117 0.484 . . . . 0.0 112.189 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.533 HD21 HD21 ' A' ' 98' ' ' LEU . 1.1 tp -108.97 122.74 47.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 177.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 71' ' ' ILE . 7.0 mt -115.01 136.48 53.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.236 0.541 . . . . 0.0 111.689 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.968 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -117.4 123.33 46.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.039 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.667 ' CE2' HG22 ' A' ' 85' ' ' VAL . 52.0 m-85 -115.27 147.53 40.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.143 0.497 . . . . 0.0 111.503 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -146.41 111.84 5.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.098 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 m120 60.59 46.53 9.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.392 . . . . 0.0 110.321 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.02 0.6 52.79 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.955 -0.641 . . . . 0.0 114.009 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -123.25 138.93 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.626 0.713 . . . . 0.0 111.592 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.667 HG22 ' CE2' ' A' ' 80' ' ' PHE . 39.9 t -67.62 117.98 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.451 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.18 8.8 21.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.831 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.26 141.82 1.29 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.673 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 t -137.68 127.94 26.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.157 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.04 137.97 50.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.09 146.27 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.577 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.89 165.24 30.99 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.27 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.631 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -67.27 171.78 5.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 111.521 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.757 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -162.14 -170.6 2.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.491 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.58 166.25 11.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.773 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -57.79 -32.81 67.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.958 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.43 -30.72 53.27 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.795 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 42.3 mt-30 -77.34 -31.15 54.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.729 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.757 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -71.73 -51.33 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -63.45 -44.38 94.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.195 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.1 pp20? -60.71 -42.29 96.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.948 0.404 . . . . 0.0 110.102 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.68 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 22.1 t80 -62.42 -40.6 97.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.387 0.613 . . . . 0.0 110.013 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.555 HD21 ' HB ' ' A' ' 24' ' ' VAL . 3.8 mt -64.13 -62.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.846 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.12 -32.01 6.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.27 -24.85 62.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.924 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -108.29 -28.96 9.13 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.802 0.334 . . . . 0.0 111.282 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 22' ' ' LEU . 2.7 tt . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.788 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.765 HG13 ' HA ' ' A' ' 55' ' ' LEU . 46.5 t . . . . . 0 C--O 1.233 0.184 0 CA-C-O 120.843 0.354 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.51 119.9 10.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -73.48 129.57 38.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.873 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -101.81 108.33 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.279 0.561 . . . . 0.0 111.106 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -98.86 19.81 14.28 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.861 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -154.44 158.84 40.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.97 0.414 . . . . 0.0 111.308 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.66 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.0 ttpt -71.45 -29.47 64.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -31.03 38.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.78 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.46 81.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.623 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.514 ' CE1' HG21 ' A' ' 57' ' ' VAL . 3.9 t80 -59.25 -43.89 92.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.166 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.17 -39.89 94.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.552 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -58.99 -48.88 79.97 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.28 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.35 -33.98 76.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 111.015 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 15' ' ' LEU . 15.1 mt -66.95 -40.68 87.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.435 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.59 -28.68 67.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.489 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.62 77.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.08 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.02 -64.83 0.78 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.544 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.88 -82.47 1.52 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.322 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -95.49 -18.63 20.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.661 0.267 . . . . 0.0 111.556 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -75.11 154.8 37.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.954 HD11 HD12 ' A' ' 79' ' ' LEU . 4.1 tp -78.77 136.11 37.29 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.78 ' N ' HD12 ' A' ' 22' ' ' LEU . 6.0 t -116.58 106.59 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.034 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.659 HG23 HD21 ' A' ' 79' ' ' LEU . 10.4 p -102.54 119.12 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 78' ' ' LEU . 4.9 m -127.15 167.55 21.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.856 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.61 ' OD1' HD12 ' A' ' 77' ' ' LEU . 24.8 t70 -133.42 136.0 44.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.772 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.666 ' CE1' HD12 ' A' ' 78' ' ' LEU . 3.6 m-85 -100.89 111.12 23.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 p -121.39 -167.91 1.59 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.439 0.638 . . . . 0.0 112.366 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.54 154.07 34.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.169 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -33.96 68.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.523 0.678 . . . . 0.0 109.826 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.484 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 51.6 p-90 -86.9 10.52 15.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.912 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 12.2 t -95.15 158.05 15.63 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.142 -0.349 . . . . 0.0 111.529 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.1 -65.64 0.59 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.256 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.34 -22.79 66.02 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.406 2.071 . . . . 0.0 112.404 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.7 m -61.8 -44.36 97.02 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.015 0.436 . . . . 0.0 110.595 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -64.51 -28.11 69.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.198 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.4 mtt -67.15 -16.0 64.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.0 mm -86.89 -22.38 7.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.656 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 33.1 mtpt -50.97 -60.41 5.63 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 1.3 Cg_endo -47.06 -46.54 18.79 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.634 2.222 . . . . 0.0 113.059 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -80.41 -32.35 37.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.471 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 6.4 t80 -67.2 -44.83 78.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.941 0.4 . . . . 0.0 110.177 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -38.18 84.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.593 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.7 t -60.67 -43.32 97.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.927 0.394 . . . . 0.0 110.496 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.2 mt -59.48 -40.06 85.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.332 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 m -54.07 -27.4 32.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.24 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -88.12 -21.75 24.49 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.646 0.26 . . . . 0.0 111.4 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -94.16 -21.63 18.96 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.777 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.0 m-85 -96.43 97.29 9.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.95 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -96.1 43.98 1.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.736 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -156.26 11.37 0.27 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.777 HG22 ' HB3' ' A' ' 49' ' ' TYR . 19.2 m -144.3 157.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 120.423 0.154 . . . . 0.0 111.142 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.775 ' CG2' HG13 ' A' ' 23' ' ' VAL . 3.1 tp -106.34 115.25 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.237 0.541 . . . . 0.0 110.618 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.686 ' O ' HG22 ' A' ' 2' ' ' VAL . 6.5 m-85 -97.78 115.91 28.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.858 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.873 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.65 168.01 15.63 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.63 178.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.422 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -119.59 121.48 39.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.514 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.1 t -118.92 119.11 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.276 0.56 . . . . 0.0 111.396 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -98.99 120.74 39.93 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.33 -19.42 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.14 -40.2 96.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.263 0.554 . . . . 0.0 110.004 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -98.78 -35.71 10.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.196 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.919 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.17 45.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.669 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -71.95 -11.18 60.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.547 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.7 -21.26 19.46 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.419 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.919 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.5 m -80.04 -46.51 22.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.696 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.902 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.66 -57.96 11.62 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.902 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 53.3 Cg_exo -52.72 -28.64 38.66 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.619 2.213 . . . . 0.0 111.956 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -76.39 -25.59 54.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.126 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -105.94 -2.38 22.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.02 36.11 91.55 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.172 -0.537 . . . . 0.0 114.051 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.741 HD11 HD11 ' A' ' 78' ' ' LEU . 79.3 mt -77.55 133.95 29.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.458 0.629 . . . . 0.0 110.443 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -150.72 54.43 0.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.944 0.402 . . . . 0.0 111.383 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 170.09 105.42 0.18 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.922 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 pt -103.04 153.86 38.0 Favored Pre-proline 0 N--CA 1.463 0.198 0 C-N-CA 122.167 0.187 . . . . 0.0 110.829 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.38 114.78 3.47 Favored 'Cis proline' 0 C--N 1.353 0.767 0 C-N-CA 124.198 -1.167 . . . . 0.0 112.757 -0.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.428 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -88.33 136.75 32.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.957 0.408 . . . . 0.0 111.359 179.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.661 HD13 HD21 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -106.98 121.02 43.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.741 HD11 HD11 ' A' ' 71' ' ' ILE . 10.1 mt -112.37 135.51 52.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.513 0.673 . . . . 0.0 111.874 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.954 HD12 HD11 ' A' ' 22' ' ' LEU . 3.6 mm? -117.37 126.18 52.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.845 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.558 ' CE2' HG22 ' A' ' 85' ' ' VAL . 47.9 m-85 -117.14 147.12 42.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.196 0.522 . . . . 0.0 111.267 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 tttm -148.26 115.31 6.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.99 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 m120 57.79 44.62 19.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 110.209 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.02 5.68 62.39 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.911 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -126.06 142.6 51.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.379 0.589 . . . . 0.0 111.483 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.558 HG22 ' CE2' ' A' ' 80' ' ' PHE . 21.8 t -70.05 119.19 15.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.655 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -115.08 12.34 16.62 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.91 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.37 138.91 0.43 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.17 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -134.59 133.23 39.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.693 0.282 . . . . 0.0 110.805 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.66 139.55 45.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.82 146.3 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.5 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.13 162.43 28.58 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.216 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.58 133.62 47.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.193 0.521 . . . . 0.0 111.548 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.661 HD21 HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -116.08 -175.46 2.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.431 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.82 162.66 14.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.53 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -52.4 -37.76 57.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.509 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.58 -29.3 55.71 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.437 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -77.2 -33.23 56.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.586 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -50.88 32.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -42.24 90.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.389 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -62.58 -38.17 89.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.772 0.32 . . . . 0.0 110.483 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.91 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 9.7 t80 -63.77 -42.86 97.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.406 0.622 . . . . 0.0 110.103 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.516 HD11 HG11 ' A' ' 24' ' ' VAL . 4.4 mt -64.8 -62.48 1.54 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.953 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.86 -34.31 12.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.098 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.19 -20.33 60.91 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -108.99 -38.1 5.66 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 111.598 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.436 HD23 ' C ' ' A' ' 106' ' ' LEU . 3.9 tt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.094 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.714 HG13 ' HA ' ' A' ' 55' ' ' LEU . 47.4 t . . . . . 0 N--CA 1.462 0.146 0 CA-C-O 120.997 0.427 . . . . 0.0 110.846 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -145.02 121.95 11.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.202 0.525 . . . . 0.0 110.162 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -74.4 128.93 36.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.224 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.833 HD13 HD13 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -99.79 108.74 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 0.0 110.39 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -100.34 19.52 16.48 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.96 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.31 160.48 38.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.958 0.409 . . . . 0.0 111.165 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -73.67 -26.33 60.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -79.63 -31.56 41.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.229 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.56 -38.69 90.31 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -56.99 -41.48 78.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.068 0.461 . . . . 0.0 110.051 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -66.37 -45.0 81.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.933 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -58.86 -49.03 79.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.63 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.65 -32.46 73.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.933 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 mt -67.71 -36.87 81.4 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.247 0.546 . . . . 0.0 110.274 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.23 -33.53 73.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.17 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.68 -23.1 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.154 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.95 84.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.073 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.63 -121.13 25.62 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.369 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -94.84 2.63 55.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -78.07 147.14 34.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.96 HD11 HD12 ' A' ' 79' ' ' LEU . 8.0 tp -74.27 132.23 41.91 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.947 HG13 HG23 ' A' ' 53' ' ' ILE . 5.3 t -110.48 108.87 26.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.547 0.689 . . . . 0.0 112.13 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.631 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.1 p -102.92 114.39 42.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.695 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.4 m -121.11 162.16 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.658 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -126.24 131.08 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.24 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.49 ' CE1' HD12 ' A' ' 78' ' ' LEU . 3.4 m-85 -97.29 107.49 20.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.326 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.5 m -132.45 146.93 52.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.034 0.445 . . . . 0.0 111.813 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -96.29 159.03 15.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.611 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -70.56 -37.55 74.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.634 0.73 . . . . 0.0 109.143 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -86.08 14.66 5.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.937 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 21.6 t -91.56 157.09 17.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.887 0.375 . . . . 0.0 111.393 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.7 -73.33 0.91 Allowed Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.386 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.45 -24.91 45.98 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.325 2.017 . . . . 0.0 112.491 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.8 m -58.14 -40.85 82.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.9 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -66.75 -22.84 66.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.541 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 40.1 mtt -68.92 -19.97 64.21 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.2 mm -89.0 -25.24 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.75 0.309 . . . . 0.0 111.628 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.39 -53.18 47.79 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.2 -49.93 14.91 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.619 2.213 . . . . 0.0 113.309 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -80.26 -27.33 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -64.85 -44.5 89.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.034 0.445 . . . . 0.0 110.314 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.64 -41.23 79.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.947 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -58.46 -44.44 89.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 110.596 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mt -59.82 -39.5 85.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.471 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 10.7 p -56.96 -27.35 61.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -87.78 -19.48 27.46 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.683 0.277 . . . . 0.0 111.66 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -95.53 -22.93 17.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.114 0.483 . . . . 0.0 110.012 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.808 ' HB3' HG22 ' A' ' 52' ' ' VAL . 16.6 m-85 -96.34 97.41 9.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.619 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.2 t -93.66 47.26 1.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.285 0.564 . . . . 0.0 109.813 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -150.15 -42.83 0.13 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.934 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.808 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.3 m -94.83 155.87 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.828 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.947 HG23 HG13 ' A' ' 23' ' ' VAL . 5.9 tp -106.88 112.72 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.24 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.659 ' O ' HG22 ' A' ' 2' ' ' VAL . 8.7 m-85 -94.4 115.33 27.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.729 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.45 167.57 16.86 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.643 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.434 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.1 tt0 -118.82 119.52 34.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.228 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.439 HG22 HD11 ' A' ' 55' ' ' LEU . 2.8 t -116.68 119.27 61.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -99.6 119.38 37.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.737 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 p -59.86 -18.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -64.89 -38.33 90.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.128 0.489 . . . . 0.0 109.87 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -100.15 -35.53 9.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.381 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.898 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.59 44.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.953 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.91 -11.02 60.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.924 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.4 -21.68 18.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.339 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.898 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.8 m -79.77 -47.53 21.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.101 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.641 ' HB3' ' CD ' ' A' ' 67' ' ' PRO . . . -50.97 -60.45 5.56 Favored Pre-proline 0 N--CA 1.466 0.336 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.641 ' CD ' ' HB3' ' A' ' 66' ' ' ALA . 6.8 Cg_endo -48.38 -27.95 10.81 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.732 2.288 . . . . 0.0 112.153 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.3 -25.24 57.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.628 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -106.49 -4.21 20.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.806 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.78 36.88 87.99 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.232 -0.508 . . . . 0.0 113.865 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.594 HD11 HD11 ' A' ' 78' ' ' LEU . 84.3 mt -76.37 133.92 30.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 117.18 0.49 . . . . 0.0 110.523 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -141.87 69.85 1.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.01 0.433 . . . . 0.0 111.887 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.03 166.68 15.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.57 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.646 HD13 ' N ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -150.92 149.45 25.28 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -85.69 121.2 6.36 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 124.311 -1.12 . . . . 0.0 112.507 -0.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 136.54 32.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.885 0.374 . . . . 0.0 111.669 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.478 HD21 HD21 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -107.99 122.43 46.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 71' ' ' ILE . 6.7 mt -114.5 135.54 54.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.335 0.588 . . . . 0.0 111.298 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.96 HD12 HD11 ' A' ' 22' ' ' LEU . 3.2 mm? -116.61 122.48 44.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.404 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.52 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 51.6 m-85 -115.3 147.67 40.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.134 0.492 . . . . 0.0 111.781 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -146.55 113.42 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.378 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 m120 60.24 45.16 11.78 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.86 0.362 . . . . 0.0 110.283 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.5 2.84 56.52 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.708 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -124.34 139.16 54.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.253 0.526 . . . . 0.0 111.591 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 85' ' ' VAL . 11.5 p -69.14 120.59 16.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.88 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.22 10.93 17.35 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.901 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.07 137.24 0.4 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.779 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.524 HG23 ' CD2' ' A' ' 78' ' ' LEU . 48.2 m -139.3 122.08 16.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.828 0.347 . . . . 0.0 111.088 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -120.77 145.21 47.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.38 146.82 25.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.465 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.17 162.3 23.19 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.064 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.491 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -68.31 158.21 33.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.501 . . . . 0.0 111.662 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -154.97 151.43 28.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.399 -179.451 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 m -68.77 -178.17 1.13 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.989 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -72.69 -29.93 63.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.77 -33.6 41.61 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.269 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -74.88 -31.84 61.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.065 0.459 . . . . 0.0 110.381 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.485 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -71.38 -50.18 34.72 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.063 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -61.41 -41.25 96.84 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.013 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -60.67 -37.91 83.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.948 0.404 . . . . 0.0 110.066 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.901 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 6.8 t80 -63.18 -42.56 99.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.429 0.633 . . . . 0.0 110.323 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.555 HD21 ' HB ' ' A' ' 24' ' ' VAL . 6.3 mt -65.87 -58.31 5.89 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.231 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.52 -36.21 22.6 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.933 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.56 -20.96 61.23 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.501 ' HB3' HD21 ' A' ' 22' ' ' LEU . 8.4 t30 -108.34 -32.28 7.51 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.899 0.381 . . . . 0.0 111.459 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 22' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.327 -0.412 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.19 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.72 HG13 ' HA ' ' A' ' 55' ' ' LEU . 40.3 t . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 120.915 0.388 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.404 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -144.0 121.29 11.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.266 0.555 . . . . 0.0 110.332 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -74.8 127.98 34.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.04 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.887 HG23 ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -100.66 106.93 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.067 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -95.87 16.81 16.65 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.108 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 p -155.4 161.95 40.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.776 0.322 . . . . 0.0 111.394 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.606 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -72.85 -24.54 60.9 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.714 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.54 -32.32 42.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.509 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.887 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -65.95 -39.81 90.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.81 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.455 ' HB2' HG21 ' A' ' 5' ' ' ILE . 3.9 t80 -57.27 -42.6 81.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.872 0.368 . . . . 0.0 110.019 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.452 ' HA ' ' NE2' ' A' ' 12' ' ' GLN . 11.2 mm100 -68.39 -45.21 73.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.807 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -57.55 -45.56 84.97 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.048 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -32.1 73.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.667 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.11 -38.43 78.91 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.64 -34.32 74.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.055 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.47 -22.66 54.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.042 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.4 -34.6 77.59 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.188 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.89 -123.13 32.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.27 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -93.41 5.24 52.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.591 0.234 . . . . 0.0 111.327 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -79.33 150.42 31.46 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.965 HD11 HD12 ' A' ' 79' ' ' LEU . 4.8 tp -77.05 131.85 38.62 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.906 HG13 HG23 ' A' ' 53' ' ' ILE . 4.2 t -112.12 108.62 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.566 0.698 . . . . 0.0 111.479 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.62 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -103.26 115.56 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.617 HG23 ' HB2' ' A' ' 78' ' ' LEU . 5.0 m -124.65 167.42 18.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.763 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.503 ' OD1' HD12 ' A' ' 77' ' ' LEU . 37.5 t0 -136.05 136.86 40.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.966 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.514 ' HE1' HD12 ' A' ' 78' ' ' LEU . 9.7 m-85 -99.46 113.59 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.274 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.573 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.6 m -122.82 -166.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.287 0.565 . . . . 0.0 112.199 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.0 154.05 35.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -72.23 -35.17 68.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.38 0.61 . . . . 0.0 109.716 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.417 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 54.6 p-90 -87.14 10.76 15.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.33 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 25.0 t -96.51 156.83 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 0.0 111.591 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.59 -71.05 0.76 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.286 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.72 -26.52 47.4 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.481 2.121 . . . . 0.0 112.231 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.3 m -58.94 -44.6 91.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.344 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.77 -24.22 66.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.431 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.5 mmt -67.97 -18.62 64.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.1 mm -87.27 -24.59 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.703 0.287 . . . . 0.0 111.115 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -52.91 -53.66 52.51 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.56 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.45 -50.01 13.21 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.703 2.269 . . . . 0.0 113.164 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.411 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 17.5 m-85 -80.07 -27.55 39.32 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.442 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 4.0 t80 -66.02 -45.42 81.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.107 0.479 . . . . 0.0 110.239 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -42.3 84.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.786 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -60.14 -43.76 95.48 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.898 0.38 . . . . 0.0 110.744 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.1 mt -60.09 -39.76 87.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.406 ' HB2' ' CB ' ' A' ' 54' ' ' PHE . 37.8 t -56.45 -27.7 57.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.245 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -87.89 -18.08 30.0 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.717 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.78 -20.58 18.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.966 0.413 . . . . 0.0 110.09 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.798 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.1 m-85 -99.27 92.83 5.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.476 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.2 p -88.85 50.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.052 0.453 . . . . 0.0 110.489 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -153.3 -41.21 0.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.985 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.798 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.8 m -94.38 154.92 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.847 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.906 HG23 HG13 ' A' ' 23' ' ' VAL . 3.4 tp -105.44 113.32 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.361 0.601 . . . . 0.0 111.215 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.62 ' CE1' HG11 ' A' ' 24' ' ' VAL . 7.4 m-85 -95.3 115.99 28.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.502 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.72 ' HA ' HG13 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -127.38 165.23 20.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.603 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.3 tp10 -116.39 119.01 34.31 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.1 117.34 55.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.186 0.517 . . . . 0.0 110.82 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -98.81 120.68 39.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 28' ' ' SER . 14.8 p -60.08 -18.02 15.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.127 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -67.18 -37.69 84.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -99.88 -35.31 9.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.498 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.913 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.67 43.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.547 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -68.79 -10.35 56.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.718 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.76 -22.92 17.77 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.424 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.913 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -78.83 -47.35 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.31 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.881 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.6 -56.41 16.9 Favored Pre-proline 0 N--CA 1.462 0.145 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.881 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 72.1 Cg_exo -51.77 -28.19 29.53 Favored 'Trans proline' 0 N--CA 1.466 -0.122 0 C-N-CA 122.557 2.172 . . . . 0.0 112.102 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -76.98 -15.47 59.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.997 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -118.5 -7.71 10.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.653 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.32 39.49 95.96 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.304 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.614 HG23 HG21 ' A' ' 76' ' ' THR . 56.4 mt -78.21 79.36 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 117.133 0.467 . . . . 0.0 110.892 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 ttt85 -86.31 78.04 9.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.048 0.452 . . . . 0.0 111.62 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.99 166.05 10.73 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.542 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 pt -148.55 154.32 41.07 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 122.309 0.243 . . . . 0.0 110.704 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -87.14 115.78 3.32 Favored 'Cis proline' 0 C--N 1.352 0.756 0 C-N-CA 124.211 -1.162 . . . . 0.0 112.597 0.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.614 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -87.24 137.18 32.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.909 0.385 . . . . 0.0 111.727 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.503 HD12 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -108.45 125.02 51.3 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.617 ' HB2' HG23 ' A' ' 25' ' ' VAL . 6.4 mt -113.93 134.61 54.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.376 0.607 . . . . 0.0 111.808 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.965 HD12 HD11 ' A' ' 22' ' ' LEU . 2.8 mm? -115.15 119.83 37.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.791 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.59 ' CE2' HG22 ' A' ' 85' ' ' VAL . 52.3 m-85 -112.98 147.88 36.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.179 0.514 . . . . 0.0 111.827 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -147.37 113.18 5.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.309 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 m120 60.6 45.94 9.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.037 0.446 . . . . 0.0 110.194 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.29 2.46 48.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.669 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -124.61 138.59 54.3 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.257 0.528 . . . . 0.0 111.813 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.59 HG22 ' CE2' ' A' ' 80' ' ' PHE . 42.9 t -67.16 116.84 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.647 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -113.07 11.47 18.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.97 0.414 . . . . 0.0 111.907 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.816 ' HB3' ' CB ' ' A' ' 79' ' ' LEU . . . -173.17 138.16 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.101 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -136.46 125.51 24.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 111.102 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.98 139.32 53.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.281 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.07 146.07 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.628 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.1 164.1 33.54 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.121 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.658 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -65.69 165.62 12.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.053 0.454 . . . . 0.0 111.744 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.658 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -163.02 144.74 10.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.632 -179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.7 m -64.41 -177.92 0.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -73.18 -30.96 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.429 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.54 -30.08 54.1 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.79 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 34.3 mt-30 -76.45 -33.08 58.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.97 0.414 . . . . 0.0 110.681 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.555 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -70.61 -51.15 30.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.803 179.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -60.88 -40.75 94.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.214 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -60.98 -39.19 88.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.786 0.327 . . . . 0.0 110.128 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.768 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 6.8 t80 -60.94 -39.85 91.03 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.333 0.587 . . . . 0.0 109.98 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.507 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 7.2 mt -66.92 -58.46 4.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.344 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.01 -36.39 28.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.827 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.08 -23.81 63.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.032 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -105.89 -53.1 2.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.754 0.312 . . . . 0.0 111.372 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 106' ' ' LEU . 1.5 tt . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.023 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.738 HG13 ' HA ' ' A' ' 55' ' ' LEU . 52.8 t . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 109.573 -0.528 . . . . 0.41999999999999998 109.573 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.524 ' O ' HD12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -143.42 124.52 14.47 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 118.764 -1.174 . . . . 1.4299999999999999 111.975 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -76.5 120.21 21.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.953 -1.476 . . . . 2.2799999999999998 110.427 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.112 HG23 ' HB3' ' A' ' 10' ' ' ALA . 3.1 mp -101.55 113.56 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.797 -0.361 . . . . 0.35999999999999999 111.163 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HG2' ' OD2' ' A' ' 61' ' ' ASP . 8.4 mt-10 -100.94 15.97 26.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.104 -0.498 . . . . 1.3799999999999999 112.276 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.452 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.4 m -153.5 160.27 42.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.908 0.385 . . . . 0.97999999999999998 111.246 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.477 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.1 ttpt -75.55 -23.32 56.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.238 -0.437 . . . . 1.6499999999999999 111.092 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 m -79.42 -29.98 42.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.698 -0.482 . . . . 0.80000000000000004 109.698 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 1.112 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -68.52 -41.77 79.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.68 -0.691 . . . . 0.23999999999999999 110.453 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -56.51 -49.41 74.79 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.031 -0.531 . . . . 1.1299999999999999 110.501 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -61.45 -37.17 82.61 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.691 -0.855 . . . . 0.93999999999999995 108.691 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -62.18 -44.37 96.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.937 -1.029 . . . . 1.3999999999999999 111.893 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.04 -33.22 67.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.904 0.383 . . . . 0.28000000000000003 111.367 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 mt -64.57 -40.64 95.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.319 0.581 . . . . 0.40000000000000002 110.587 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.95 -29.53 69.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 1.8400000000000001 110.525 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.17 -23.86 51.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.42999999999999999 111.67 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.446 ' HB1' HG22 ' A' ' 23' ' ' VAL . . . -72.35 -26.72 62.02 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.66000000000000003 111.288 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.96 -117.65 6.32 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 119.63 -1.271 . . . . 1.04 113.277 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.59 10.34 37.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.54 0.209 . . . . 2.3599999999999999 111.207 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -82.53 151.11 26.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.88 -0.415 . . . . 1.8200000000000001 109.88 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.885 HD11 ' CD1' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -76.21 121.28 22.67 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.612 -0.514 . . . . 0.28000000000000003 109.612 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.875 HG13 ' CG2' ' A' ' 53' ' ' ILE . 2.6 t -101.63 111.9 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.725 0.774 . . . . 0.22 112.065 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.673 HG11 ' CE1' ' A' ' 54' ' ' PHE . 9.1 p -108.27 122.19 62.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.663 -1.236 . . . . 0.35999999999999999 107.663 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.037 HG12 ' HG ' ' A' ' 55' ' ' LEU . 11.4 m -133.13 141.97 43.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.523 0.678 . . . . 0.67000000000000004 112.051 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -107.74 131.04 54.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.374 -0.83 . . . . 1.1299999999999999 112.403 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.405 ' HE1' HD12 ' A' ' 78' ' ' LEU . 2.7 m-85 -96.24 110.28 22.61 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.663 -0.866 . . . . 0.28000000000000003 108.663 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 59' ' ' VAL . 3.3 p -121.14 -168.76 1.72 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.706 0.632 . . . . 1.03 112.706 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.06 156.1 39.25 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.133 -0.94 . . . . 0.37 110.693 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -37.84 74.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.309 0.576 . . . . 1.1399999999999999 110.184 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 28.4 p-90 -86.61 10.77 14.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.99 -1.004 . . . . 0.98999999999999999 111.499 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 37.3 t -100.24 140.47 34.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.786 0.327 . . . . 0.98999999999999999 110.244 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.48 -65.65 0.9 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.614 -0.803 . . . . 0.35999999999999999 112.481 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.98 -30.98 25.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.554 2.169 . . . . 0.68000000000000005 111.769 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 79.4 m -58.51 -40.21 82.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.735 -0.666 . . . . 0.65000000000000002 110.621 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -70.68 -26.4 63.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.941 -0.572 . . . . 2.1499999999999999 111.234 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.5 mmt -69.02 -20.64 64.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.479 . . . . 1.48 111.292 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.9 mm -87.8 -18.21 8.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.793 0.33 . . . . 0.60999999999999999 110.616 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.81 -54.73 40.31 Favored Pre-proline 0 CA--C 1.528 0.132 0 CA-C-N 116.495 -0.32 . . . . 2.1200000000000001 110.726 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.68 -51.62 10.04 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.657 2.238 . . . . 0.46999999999999997 112.766 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -75.21 -36.18 61.4 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.488 -0.323 . . . . 0.56000000000000005 111.466 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.543 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 7.0 t80 -64.81 -46.36 82.33 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.54 -0.464 . . . . 0.38 109.999 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -67.28 -42.11 84.37 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.542 0.201 . . . . 0.97999999999999998 111.542 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -60.32 -46.87 88.37 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.918 -0.313 . . . . 1.1899999999999999 110.742 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.7 mt -54.13 -36.44 63.28 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.35 -0.611 . . . . 0.32000000000000001 109.35 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 43' ' ' HIS . 22.7 t -57.87 -26.33 61.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.294 -0.866 . . . . 1.3 111.117 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.3 -17.64 28.54 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.712 0.291 . . . . 2.2999999999999998 111.035 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 1.6 ttpp -97.05 -15.15 21.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.091 0.472 . . . . 1.48 110.48 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.901 ' HB3' HG22 ' A' ' 52' ' ' VAL . 24.1 m-85 -105.8 84.48 2.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.792 -0.64 . . . . 0.97999999999999998 111.334 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -78.62 43.16 0.47 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.542 -0.754 . . . . 1.25 111.542 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -154.6 -29.17 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.672 -0.24 . . . . 1.03 111.34 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.901 HG22 ' HB3' ' A' ' 49' ' ' TYR . 5.3 m -99.35 155.85 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.352 0.596 . . . . 0.28999999999999998 111.692 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.875 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.1 tp -104.38 113.33 41.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.13 -0.941 . . . . 0.28999999999999998 110.963 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.716 ' O ' HG22 ' A' ' 2' ' ' VAL . 6.1 m-85 -99.55 116.43 31.66 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 116.042 -0.527 . . . . 0.32000000000000001 110.876 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.059 HD13 HD13 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -130.95 167.94 18.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 116.064 -0.516 . . . . 0.23999999999999999 110.296 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.869 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.7 tt0 -121.55 125.08 45.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.023 0.379 . . . . 2.1600000000000001 112.023 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.571 ' CG2' HD11 ' A' ' 55' ' ' LEU . 6.7 t -112.12 116.17 51.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.557 0.694 . . . . 0.17000000000000001 110.951 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -93.79 115.29 27.69 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.236 -0.893 . . . . 2.1200000000000001 110.379 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 28' ' ' SER . 11.2 p -61.2 -22.28 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.22 112.083 -178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -62.32 -37.95 87.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.091 -0.707 . . . . 1.3 109.091 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.458 ' OD2' ' HG2' ' A' ' 6' ' ' GLU . 1.3 m-20 -101.12 -42.43 6.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.128 -0.942 . . . . 1.3100000000000001 112.314 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.775 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -87.78 53.63 2.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.13 0.49 . . . . 0.26000000000000001 110.406 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.501 ' O ' ' CD ' ' A' ' 67' ' ' PRO . 5.4 mt-30 -74.9 -11.53 60.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.667 -0.697 . . . . 2.5800000000000001 111.324 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -87.05 -31.12 20.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 1.3700000000000001 110.68 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.775 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 18.2 m -76.77 -46.97 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.913 -0.585 . . . . 0.20999999999999999 111.14 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.882 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.67 -55.31 23.79 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 113.178 0.807 . . . . 0.28999999999999998 113.178 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.882 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 51.0 Cg_exo -55.68 -28.29 65.29 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.161 2.574 . . . . 0.48999999999999999 114.073 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -75.62 -26.47 57.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.869 0.322 . . . . 1.47 111.869 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -99.91 -9.43 22.82 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.23 0.538 . . . . 0.46000000000000002 110.663 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.61 39.44 78.33 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.521 -0.763 . . . . 0.55000000000000004 112.785 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.626 HD11 HD11 ' A' ' 78' ' ' LEU . 63.9 mt -76.46 129.02 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.0 -0.741 . . . . 1.3500000000000001 109.0 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.49 64.68 1.33 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.571 -0.452 . . . . 3.4700000000000002 111.76 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.08 120.74 0.78 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.717 -0.754 . . . . 1.1499999999999999 112.455 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 32' ' ' CYS . 13.5 pt -109.14 153.39 42.62 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.626 -0.139 . . . . 0.65000000000000002 110.626 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.9 129.94 17.16 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 124.347 -1.105 . . . . 0.40000000000000002 113.718 0.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.538 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -101.94 138.54 38.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.45000000000000001 111.45 178.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.16 113.82 26.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.319 -0.993 . . . . 1.8100000000000001 108.319 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.652 ' HB2' HG23 ' A' ' 25' ' ' VAL . 3.5 mt -104.92 131.65 52.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.379 0.609 . . . . 0.26000000000000001 111.454 -177.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.885 ' CD1' HD11 ' A' ' 22' ' ' LEU . 2.1 mm? -113.06 117.34 31.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.177 -0.919 . . . . 0.28999999999999998 111.05 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.602 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 60.0 m-85 -111.93 140.9 46.2 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.507 -0.553 . . . . 0.26000000000000001 109.507 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.786 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 1.8 tttm -141.32 105.82 4.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.48 -0.933 . . . . 0.46000000000000002 108.48 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.8 m120 67.04 47.11 1.43 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.373 -0.603 . . . . 1.1299999999999999 109.373 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.34 4.87 18.96 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.371 -0.831 . . . . 0.23999999999999999 113.718 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -118.51 130.23 55.81 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.39 -0.596 . . . . 1.5600000000000001 109.39 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.1 p -55.18 117.41 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.68 -0.859 . . . . 1.21 108.68 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -96.97 -7.24 33.6 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 113.051 0.76 . . . . 0.23000000000000001 113.051 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -177.05 148.94 0.66 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.098 -0.501 . . . . 0.25 112.055 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.2 t -126.87 148.61 49.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.852 -0.613 . . . . 1.54 109.801 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -149.79 132.07 15.52 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.224 -0.658 . . . . 1.3899999999999999 109.224 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.04 146.78 19.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.432 -0.349 . . . . 0.29999999999999999 111.399 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.45 161.57 27.6 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.939 -0.648 . . . . 0.23999999999999999 113.113 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.65 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -70.19 169.05 14.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.812 0.339 . . . . 0.44 111.361 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.65 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -157.85 176.69 12.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.85999999999999999 111.333 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -91.27 175.54 6.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.622 -0.717 . . . . 0.97999999999999998 110.174 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -70.73 -30.84 67.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.621 -0.263 . . . . 1.1699999999999999 111.365 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.03 -31.92 51.18 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.227 -0.987 . . . . 0.22 113.122 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.602 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 35.8 mt-30 -75.12 -30.6 60.88 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.915 0.388 . . . . 1.0 110.949 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.465 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -73.03 -51.19 19.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.193 0.521 . . . . 0.41999999999999998 109.823 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.447 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 17.2 ttpt -60.16 -45.18 93.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.442 -0.799 . . . . 1.6399999999999999 110.529 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.602 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -59.83 -39.03 83.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 1.8100000000000001 110.154 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.423 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 8.5 t80 -62.45 -41.83 99.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.651 -0.704 . . . . 0.28000000000000003 111.311 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.482 HD21 ' HB ' ' A' ' 24' ' ' VAL . 8.0 mt -68.17 -55.95 10.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.76 -0.654 . . . . 0.31 110.451 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -46.45 -33.38 3.92 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.67 -0.493 . . . . 1.1899999999999999 109.67 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.04 -23.95 59.47 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.403 -0.817 . . . . 0.23000000000000001 113.192 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.429 ' O ' ' CE ' ' A' ' 81' ' ' LYS . 1.7 t30 -108.87 -28.65 9.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.009 0.433 . . . . 0.58999999999999997 111.659 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.951 HD23 ' O ' ' A' ' 106' ' ' LEU . 9.3 tt . . . . . 0 CA--C 1.536 0.44 0 C-N-CA 123.628 0.771 . . . . 1.3500000000000001 112.312 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 55' ' ' LEU . 88.5 t . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.714 -0.106 . . . . 0.48999999999999999 110.714 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.498 ' O ' HD12 ' A' ' 5' ' ' ILE . 2.2 ptpt -141.68 126.2 17.8 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 121.8 0.81 . . . . 1.6399999999999999 111.255 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.62 122.03 25.42 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.404 -1.271 . . . . 2.0499999999999998 110.578 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.096 HD13 HD13 ' A' ' 55' ' ' LEU . 3.2 mp -104.43 111.59 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.842 0.353 . . . . 0.19 111.35 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -99.77 19.46 15.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.11 -0.495 . . . . 1.6299999999999999 112.058 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -154.8 160.2 41.11 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.999 -0.28 . . . . 0.95999999999999996 110.714 -179.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.47 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 7.1 ttpt -77.57 -21.58 52.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.058 0.456 . . . . 1.48 110.707 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -79.41 -31.91 42.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.635 -0.505 . . . . 0.79000000000000004 109.635 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 1.013 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -68.24 -38.79 82.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.375 -0.83 . . . . 0.26000000000000001 111.019 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -58.15 -47.99 81.65 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.165 -0.471 . . . . 1.25 110.403 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.02 -37.37 87.18 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.653 -0.499 . . . . 1.21 109.653 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -60.8 -46.97 88.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.703 -0.68 . . . . 1.53 111.846 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.46 76.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.32000000000000001 110.65 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.0 mt -65.2 -42.33 93.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.998 -0.546 . . . . 0.44 110.89 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.21 -30.32 71.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.042 0.449 . . . . 1.72 110.074 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.98 -22.34 53.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.638 -0.71 . . . . 0.47999999999999998 110.77 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.68 -34.01 73.36 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 116.118 -0.492 . . . . 0.72999999999999998 110.975 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.33 -125.09 36.69 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.083 -1.056 . . . . 1.05 113.155 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -91.21 7.35 41.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 2.3999999999999999 111.585 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 58.2 mttt -82.49 151.88 26.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.53 -0.304 . . . . 1.54 110.383 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.932 HD11 HD12 ' A' ' 79' ' ' LEU . 1.3 tp -77.09 127.36 32.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.31 109.858 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.874 HG13 ' CG2' ' A' ' 53' ' ' ILE . 3.3 t -107.62 115.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.353 0.597 . . . . 0.33000000000000002 111.425 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.537 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.9 p -110.47 116.09 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.066 -1.087 . . . . 0.63 108.066 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.997 HG12 ' HG ' ' A' ' 55' ' ' LEU . 16.6 m -124.99 142.98 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-O 121.74 0.781 . . . . 0.83999999999999997 111.793 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -108.19 128.01 54.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.328 -1.306 . . . . 1.1899999999999999 111.211 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -95.42 108.22 20.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.147 -0.686 . . . . 0.34999999999999998 109.147 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.1 p -119.06 -170.93 2.01 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.782 0.66 . . . . 1.03 112.782 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.11 156.83 40.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.845 -1.07 . . . . 0.40000000000000002 110.137 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.2 -35.51 73.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.556 0.693 . . . . 0.93000000000000005 110.259 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.437 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 27.8 p-90 -87.42 12.21 12.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.041 -0.981 . . . . 1.1200000000000001 111.213 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 35.5 t -102.38 131.67 48.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.742 0.306 . . . . 0.93999999999999995 110.9 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.71 -63.18 1.35 Allowed Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.616 -0.802 . . . . 0.35999999999999999 112.616 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.77 -32.2 45.0 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.564 2.176 . . . . 0.63 112.164 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -58.47 -41.36 85.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.886 -0.597 . . . . 0.70999999999999996 110.363 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -71.18 -19.88 62.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.839 -0.619 . . . . 2.2400000000000002 111.098 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.2 mtt -75.04 -24.86 58.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.016 -0.538 . . . . 1.45 111.434 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mm -85.96 -19.06 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.454 -0.339 . . . . 0.65000000000000002 111.36 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.406 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 25.6 mtpt -52.58 -54.24 44.93 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.823 0.344 . . . . 2.5099999999999998 111.054 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 63.8 Cg_exo -48.77 -50.02 13.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.715 2.277 . . . . 0.44 112.625 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -77.26 -31.37 54.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.532 0.206 . . . . 0.53000000000000003 111.419 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.457 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 5.4 t80 -65.42 -47.21 77.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.664 -0.414 . . . . 0.29999999999999999 110.176 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -41.0 89.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.294 -0.412 . . . . 0.88 111.846 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -60.1 -45.12 94.03 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.933 -0.307 . . . . 1.3 110.856 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.8 mt -57.95 -37.14 73.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.154 0.502 . . . . 0.41999999999999998 109.894 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.2 t -55.55 -31.94 62.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.58 -0.736 . . . . 1.25 111.103 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.02 -20.7 30.08 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.746 0.308 . . . . 2.1800000000000002 110.399 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 2.8 ttpp -92.89 -7.76 45.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.192 -0.458 . . . . 2.0499999999999998 110.514 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.845 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.9 m-85 -116.2 92.5 3.91 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.154 -0.475 . . . . 1.4299999999999999 111.413 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.5 p -86.55 46.64 1.38 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.435 -0.348 . . . . 1.7 110.479 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 21.5 t30 -154.93 -29.96 0.11 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.793 0.294 . . . . 1.3799999999999999 111.793 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.845 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.9 m -101.53 159.98 3.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.226 -0.443 . . . . 0.35999999999999999 111.384 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.874 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.5 tp -109.91 116.83 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.469 -0.787 . . . . 0.38 110.729 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.755 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.5 m-85 -99.89 116.61 32.35 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.354 -0.839 . . . . 0.33000000000000002 111.156 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.096 HD13 HD13 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -133.45 166.01 23.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 120.493 -0.483 . . . . 0.23000000000000001 112.009 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.927 ' N ' HD12 ' A' ' 55' ' ' LEU . 3.4 tt0 -119.32 125.01 48.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.977 0.732 . . . . 1.8400000000000001 112.977 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.663 HG22 HD11 ' A' ' 55' ' ' LEU . 3.4 t -114.49 114.66 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.476 -0.784 . . . . 0.20000000000000001 110.673 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -90.76 114.81 27.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.741 . . . . 1.6899999999999999 109.848 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.95 -21.44 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.885 -0.598 . . . . 0.25 111.372 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.18 -41.36 97.15 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.738 -0.468 . . . . 1.26 109.738 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -95.5 -42.55 8.4 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.107 -0.497 . . . . 1.23 111.783 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -90.55 47.35 1.42 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.025 0.44 . . . . 0.23000000000000001 111.219 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -75.09 -3.3 31.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.365 -0.379 . . . . 2.0 110.864 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.3 -24.25 20.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.159 -0.312 . . . . 1.3799999999999999 110.159 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 62' ' ' ALA . 34.6 m -85.5 -43.89 16.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.101 0.477 . . . . 0.20000000000000001 111.557 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.836 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.08 -53.09 47.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.927 0.714 . . . . 0.27000000000000002 112.927 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.836 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 43.8 Cg_exo -57.82 -27.45 78.31 Favored 'Trans proline' 0 N--CA 1.472 0.208 0 C-N-CA 123.16 2.573 . . . . 0.46000000000000002 113.456 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -77.29 -22.64 51.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.522 -0.308 . . . . 1.5800000000000001 111.696 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -102.83 -10.08 19.4 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.405 0.621 . . . . 0.48999999999999999 110.427 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.49 39.78 79.35 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.265 -0.879 . . . . 0.60999999999999999 112.151 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.671 HD11 HD11 ' A' ' 78' ' ' LEU . 67.8 mt -77.61 130.45 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.172 -0.677 . . . . 1.3 109.172 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -144.44 67.02 1.26 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.281 0.563 . . . . 3.5899999999999999 111.337 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.58 117.58 0.71 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.517 -0.849 . . . . 1.1499999999999999 113.247 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 32' ' ' CYS . 16.6 pt -105.97 153.82 39.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 110.378 -0.23 . . . . 1.1100000000000001 110.378 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.41 121.42 7.18 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 123.786 -1.339 . . . . 0.94999999999999996 113.155 0.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.609 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -93.0 140.7 29.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.40000000000000002 111.589 179.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.25 117.09 30.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.458 -0.571 . . . . 0.98999999999999999 109.458 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.747 ' HB2' HG23 ' A' ' 25' ' ' VAL . 3.2 mt -106.65 132.84 52.18 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.411 0.624 . . . . 0.40000000000000002 111.504 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.932 HD12 HD11 ' A' ' 22' ' ' LEU . 2.5 mm? -112.62 115.12 28.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.994 -1.003 . . . . 0.27000000000000002 109.429 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.64 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 46.5 m-85 -109.1 145.56 35.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.188 0.518 . . . . 0.25 110.007 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.669 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 12.1 tttm -143.86 110.58 5.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.268 -0.878 . . . . 0.40000000000000002 109.905 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.4 m120 60.51 47.2 8.8 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.341 -0.544 . . . . 0.62 109.715 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.04 5.06 45.6 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.828 -0.701 . . . . 0.25 113.425 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -121.65 132.99 54.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.201 0.5 . . . . 1.73 111.269 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.18 121.81 6.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 108.725 -0.843 . . . . 1.0800000000000001 108.725 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.669 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -103.04 -11.15 18.34 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.298 0.57 . . . . 0.22 112.28 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.596 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.89 149.26 1.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.07 -0.968 . . . . 0.20999999999999999 111.577 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.17 145.88 51.76 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.52 -0.764 . . . . 1.5 109.211 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -143.68 136.35 27.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.899 -0.408 . . . . 1.9299999999999999 109.899 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.1 t -116.76 145.2 22.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.905 0.384 . . . . 1.0900000000000001 111.227 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.9 160.39 26.37 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.517 -0.849 . . . . 0.27000000000000002 113.092 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.01 152.02 42.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.853 0.359 . . . . 0.56000000000000005 111.4 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.535 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -138.9 171.08 14.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.286 -0.415 . . . . 0.64000000000000001 110.875 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.53 175.0 8.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.742 -0.663 . . . . 0.92000000000000004 110.276 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -67.45 -33.34 74.94 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.043 -0.263 . . . . 0.94999999999999996 111.635 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.42 -31.13 52.26 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.183 -1.008 . . . . 0.22 112.655 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.497 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 53.3 mt-30 -74.86 -29.56 61.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.074 0.464 . . . . 1.3700000000000001 110.598 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.535 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -74.88 -48.67 23.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.929 -0.578 . . . . 0.39000000000000001 109.58 179.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.509 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 19.4 ttpt -61.82 -46.13 90.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.581 -0.736 . . . . 1.27 111.079 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.0 pp20? -58.72 -40.32 83.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.232 0.539 . . . . 1.8300000000000001 109.93 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.53 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 10.8 t80 -61.37 -41.28 96.84 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.671 -0.695 . . . . 0.33000000000000002 110.882 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mt -68.05 -52.67 32.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.41999999999999998 109.891 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -51.11 -36.64 41.54 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.96 0.409 . . . . 1.1799999999999999 110.338 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.43 -19.5 60.95 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 112.737 0.643 . . . . 0.22 112.737 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.537 ' HB3' HD21 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -106.97 -44.23 4.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.41999999999999998 110.507 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.449 ' HB2' HD23 ' A' ' 22' ' ' LEU . 67.7 tp . . . . . 0 C--N 1.323 -0.578 0 CA-C-N 115.726 -0.67 . . . . 1.3700000000000001 109.565 178.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.872 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 58.8 t . . . . . 0 C--O 1.232 0.167 0 N-CA-C 109.597 -0.52 . . . . 0.41999999999999998 109.597 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.587 ' O ' HD12 ' A' ' 5' ' ' ILE . 9.1 ptpt -143.29 117.52 9.56 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 119.428 -0.909 . . . . 1.77 111.92 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.84 124.21 23.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.94 -1.027 . . . . 1.79 109.778 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.872 HD13 HD13 ' A' ' 55' ' ' LEU . 1.4 mp -103.43 111.77 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.852 0.358 . . . . 0.23000000000000001 111.152 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -97.78 14.02 28.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.99 -0.55 . . . . 1.8 112.152 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.424 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 2.6 m -154.18 155.29 35.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.71999999999999997 111.034 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.576 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -71.49 -21.77 61.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.371 -0.377 . . . . 1.1599999999999999 110.85 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -78.86 -32.71 46.11 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.408 -0.59 . . . . 0.32000000000000001 109.408 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.746 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -66.73 -41.52 87.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.461 -0.791 . . . . 0.23000000000000001 109.797 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.453 ' HB2' HG21 ' A' ' 5' ' ' ILE . 18.2 t80 -56.34 -41.86 76.77 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.059 -0.518 . . . . 1.1599999999999999 109.888 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -64.82 -41.21 95.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.074 -0.713 . . . . 1.27 109.074 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -59.96 -49.37 77.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.099 -0.955 . . . . 1.6200000000000001 111.76 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.89 74.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.747 0.308 . . . . 0.29999999999999999 111.313 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.505 HD23 HG11 ' A' ' 23' ' ' VAL . 24.4 mt -69.1 -43.69 73.96 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.147 0.499 . . . . 0.41999999999999998 110.65 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -61.94 -32.1 72.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.009 -0.541 . . . . 1.79 110.688 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.47 -26.9 58.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.47999999999999998 110.968 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.569 ' HB1' HG22 ' A' ' 23' ' ' VAL . . . -73.93 -20.72 60.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.72999999999999998 111.286 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 46.12 -119.85 4.25 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.794 -0.717 . . . . 0.96999999999999997 114.789 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HA ' ' ND2' ' A' ' 82' ' ' ASN . 16.7 t0 -88.74 2.33 53.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.548 -0.326 . . . . 2.3399999999999999 111.534 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 32.0 mttt -78.1 151.96 33.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.71 -0.848 . . . . 1.6399999999999999 108.71 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.808 ' HB3' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -73.73 125.09 27.31 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.569 -0.53 . . . . 0.32000000000000001 109.569 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.967 HG13 ' CG2' ' A' ' 53' ' ' ILE . 2.3 t -106.26 105.8 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.472 0.653 . . . . 0.23000000000000001 110.917 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.55 HG23 ' CD2' ' A' ' 79' ' ' LEU . 11.4 p -105.55 115.58 47.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 107.294 -1.373 . . . . 0.68999999999999995 107.294 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.983 HG12 ' HG ' ' A' ' 55' ' ' LEU . 25.0 m -129.13 126.94 65.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.952 -0.567 . . . . 0.82999999999999996 111.862 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -93.16 135.67 34.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.42 -0.809 . . . . 1.1599999999999999 111.453 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -98.8 116.25 30.61 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.989 -0.745 . . . . 0.23999999999999999 108.989 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 59' ' ' VAL . 11.2 p -125.01 -168.43 1.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.463 0.649 . . . . 1.25 112.731 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.75 154.03 35.47 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 114.901 -1.045 . . . . 0.39000000000000001 109.868 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -35.31 72.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.323 0.582 . . . . 0.92000000000000004 109.809 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -86.42 11.52 12.26 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.124 -0.944 . . . . 0.81000000000000005 111.291 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.549 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 36.9 t -97.08 140.77 31.09 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.815 0.341 . . . . 0.47999999999999998 110.923 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.78 -66.12 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.599 -0.81 . . . . 0.29999999999999999 112.476 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.62 -25.06 24.68 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.533 2.155 . . . . 0.52000000000000002 112.344 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.0 m -62.98 -41.69 99.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.5 110.696 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -66.59 -21.25 66.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.013 -0.54 . . . . 2.3700000000000001 111.149 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 mmt -73.36 -26.02 60.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 1.53 111.828 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.88 -22.79 7.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.745 0.307 . . . . 0.26000000000000001 111.109 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 10.1 tttt -48.35 -57.04 11.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.619 -0.264 . . . . 1.6899999999999999 110.967 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 11.6 Cg_endo -56.68 -43.88 50.69 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.365 2.043 . . . . 0.45000000000000001 112.678 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -73.73 -37.87 64.97 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.521 0.193 . . . . 0.38 111.521 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.45 ' O ' ' CE2' ' A' ' 54' ' ' PHE . 9.0 t80 -64.67 -43.52 93.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.951 -0.3 . . . . 0.47999999999999998 111.037 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -37.94 86.2 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.869 -0.332 . . . . 1.02 111.102 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.25 -45.82 91.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.707 0.289 . . . . 1.1000000000000001 110.991 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.53 HD13 HD22 ' A' ' 98' ' ' LEU . 19.9 mt -59.25 -39.9 84.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.892 -0.41 . . . . 0.45000000000000001 109.892 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.421 ' HB2' ' CG ' ' A' ' 54' ' ' PHE . 33.6 t -55.17 -29.19 57.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.535 . . . . 1.3 111.016 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -87.51 -20.73 26.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.961 0.41 . . . . 2.3900000000000001 110.007 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 2.1 ttpp -98.88 8.59 44.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.733 -0.667 . . . . 1.9199999999999999 110.698 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.717 ' HB3' HG22 ' A' ' 52' ' ' VAL . 13.9 m-85 -129.63 108.13 9.97 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.268 -0.423 . . . . 0.88 109.883 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.7 m -99.41 47.16 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.098 0.407 . . . . 1.52 112.098 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.475 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 13.9 t30 -158.37 -33.78 0.07 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.704 0.287 . . . . 1.3 111.39 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.808 HG12 ' HB3' ' A' ' 22' ' ' LEU . 5.0 m -92.82 150.89 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.154 0.428 . . . . 0.34000000000000002 112.154 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.967 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.3 tp -101.02 119.7 49.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.428 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.872 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 3.9 m-85 -101.79 124.58 47.68 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 116.025 -0.534 . . . . 0.37 110.966 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.983 ' HG ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -139.73 167.53 21.9 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.089 -0.644 . . . . 0.29999999999999999 110.607 177.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.879 ' N ' HD12 ' A' ' 55' ' ' LEU . 4.5 tt0 -122.29 126.46 48.17 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.328 0.492 . . . . 2.0499999999999998 112.328 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.673 HG22 HD11 ' A' ' 55' ' ' LEU . 3.9 t -115.52 119.29 61.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.714 -0.675 . . . . 0.20000000000000001 111.388 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -94.42 115.52 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.274 -0.639 . . . . 1.79 109.274 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 28' ' ' SER . 10.7 p -58.4 -19.07 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.393 . . . . 0.27000000000000002 111.5 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -38.66 90.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.889 -0.412 . . . . 1.1399999999999999 109.889 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.56 -43.65 6.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 1.29 110.698 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.746 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -86.14 46.76 1.37 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.959 -0.564 . . . . 0.23999999999999999 111.02 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.528 ' O ' ' CD ' ' A' ' 67' ' ' PRO . 16.6 tt0 -74.87 -12.24 60.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.377 -0.374 . . . . 2.0299999999999998 110.778 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.64 -23.47 31.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.764 0.316 . . . . 1.29 110.277 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 62' ' ' ALA . 8.5 m -83.46 -49.12 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.345 -0.389 . . . . 0.20999999999999999 112.046 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.866 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.64 -54.41 31.53 Favored Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 113.524 0.935 . . . . 0.28000000000000003 113.524 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.866 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 50.4 Cg_exo -55.04 -27.36 54.57 Favored 'Trans proline' 0 CA--C 1.521 -0.144 0 C-N-CA 122.959 2.439 . . . . 0.40999999999999998 112.4 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -76.85 -18.81 58.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 1.9299999999999999 111.203 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -109.22 -8.17 15.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.048 0.451 . . . . 0.42999999999999999 110.922 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.16 36.47 91.88 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.639 -0.71 . . . . 0.51000000000000001 112.983 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 78' ' ' LEU . 79.4 mt -75.91 132.44 33.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.621 -0.511 . . . . 1.3600000000000001 109.621 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -148.14 49.8 1.04 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.666 0.27 . . . . 3.23 111.293 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.08 104.24 0.18 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.464 -0.874 . . . . 1.0700000000000001 112.277 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.7 pt -99.48 153.03 37.99 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.57 0.224 . . . . 0.88 110.808 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.76 119.28 6.22 Favored 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.766 -1.348 . . . . 0.44 112.373 -0.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.472 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -89.89 137.95 31.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.48999999999999999 111.556 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.55 HD22 HD21 ' A' ' 93' ' ' LEU . 1.3 mp -107.08 118.89 37.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.36 -0.978 . . . . 1.7 108.36 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.566 ' HB2' HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -106.78 128.19 54.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.604 0.716 . . . . 0.23000000000000001 111.231 -178.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.782 HD12 HD11 ' A' ' 22' ' ' LEU . 2.8 mm? -111.31 130.85 55.54 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.983 -1.008 . . . . 0.29999999999999999 108.855 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.696 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 44.9 m-85 -123.8 151.67 43.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.136 0.493 . . . . 0.25 110.4 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.931 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -144.15 115.03 7.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.345 -0.843 . . . . 0.54000000000000004 109.359 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.463 ' ND2' ' HA ' ' A' ' 20' ' ' ASP . 2.2 m120 53.64 49.57 19.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.374 -0.53 . . . . 1.1399999999999999 110.319 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.44 3.28 31.7 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.143 -0.551 . . . . 0.19 113.865 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -119.51 141.81 48.86 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 117.148 0.474 . . . . 1.3700000000000001 110.142 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.61 133.05 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.205 -0.598 . . . . 1.27 109.541 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.931 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -103.98 -25.51 12.98 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.635 0.731 . . . . 0.23999999999999999 111.656 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.96 160.97 4.37 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.396 -1.275 . . . . 0.19 110.876 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.75 134.21 36.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.272 -0.422 . . . . 1.1299999999999999 110.837 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.41 138.34 43.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 1.3400000000000001 110.166 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.45 145.37 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.437 -0.347 . . . . 0.97999999999999998 111.198 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.72 160.13 25.45 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.647 -0.787 . . . . 0.20000000000000001 113.034 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.07 152.44 45.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.172 0.51 . . . . 0.44 111.733 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.55 HD21 HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -146.05 151.32 37.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.718 -0.674 . . . . 0.79000000000000004 110.441 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -69.16 178.9 2.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.446 -0.343 . . . . 0.97999999999999998 111.051 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -72.49 -30.64 64.7 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.158 -0.474 . . . . 0.94999999999999996 111.797 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.53 -31.87 52.86 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.018 -1.087 . . . . 0.23999999999999999 112.512 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.502 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 39.6 mt-30 -75.59 -33.14 60.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.803 0.335 . . . . 1.3 110.504 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.53 HD22 HD13 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -68.58 -48.83 63.18 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.172 -0.677 . . . . 0.40000000000000002 109.172 179.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 18.2 ttpt -60.66 -42.39 96.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.859 -0.609 . . . . 1.45 110.422 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -60.49 -39.97 89.65 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.132 -0.485 . . . . 1.6799999999999999 110.091 179.262 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.536 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 6.9 t80 -62.77 -43.44 98.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.757 -0.656 . . . . 0.26000000000000001 111.429 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.2 mt -67.73 -53.0 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.642 -0.708 . . . . 0.51000000000000001 109.788 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.05 -37.37 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 1.2 111.153 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.43 -21.31 62.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.209 -0.451 . . . . 0.28999999999999998 111.903 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.71 ' HB3' HD21 ' A' ' 22' ' ' LEU . 4.3 t30 -106.52 -46.98 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.068 -0.253 . . . . 0.71999999999999997 111.219 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.629 HD13 HG12 ' A' ' 52' ' ' VAL . 56.6 tp . . . . . 0 C--N 1.327 -0.401 0 CA-C-O 120.951 0.405 . . . . 1.3200000000000001 110.169 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 70.2 t . . . . . 0 N--CA 1.462 0.135 0 N-CA-C 110.229 -0.285 . . . . 0.26000000000000001 110.229 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.51 125.78 17.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.045 -0.662 . . . . 2.0800000000000001 111.31 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.82 122.91 27.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.323 -0.853 . . . . 2.3599999999999999 109.432 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.033 HD13 HD13 ' A' ' 55' ' ' LEU . 1.3 mp -103.67 112.06 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 112.119 0.414 . . . . 0.17999999999999999 112.119 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.36 14.19 28.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.657 0.614 . . . . 1.4099999999999999 112.657 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 m -156.61 140.8 16.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.705 0.288 . . . . 0.93000000000000005 111.633 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -58.26 -23.92 57.67 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.443 -0.344 . . . . 1.2 111.62 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 m -78.31 -33.49 49.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.949 -0.76 . . . . 0.32000000000000001 108.949 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -67.24 -39.35 86.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.583 -0.735 . . . . 0.20999999999999999 109.913 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.539 ' HB2' HG21 ' A' ' 5' ' ' ILE . 23.8 t80 -57.64 -46.97 83.49 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.076 -0.511 . . . . 0.63 110.701 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -63.35 -38.4 91.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.411 -0.588 . . . . 1.0800000000000001 109.411 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -59.6 -50.1 75.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.619 -0.719 . . . . 1.4399999999999999 111.498 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.13 -32.55 74.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.839 0.352 . . . . 0.31 111.238 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 mt -67.79 -42.54 81.49 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.236 0.541 . . . . 0.40999999999999998 110.613 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -60.56 -31.58 70.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 1.6799999999999999 110.161 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.23 -22.21 55.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.95 -0.568 . . . . 0.45000000000000001 110.44 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.12 -29.3 67.33 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.71999999999999997 111.03 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.72 -126.44 42.24 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.347 -0.93 . . . . 0.93000000000000005 113.236 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -92.55 9.06 36.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.35 -0.425 . . . . 2.2799999999999998 111.057 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.56 154.1 27.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.947 -0.39 . . . . 1.3500000000000001 109.947 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.903 HD11 HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -78.31 126.38 30.7 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.868 -0.419 . . . . 0.26000000000000001 109.868 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.912 HG13 ' CG2' ' A' ' 53' ' ' ILE . 6.2 t -110.32 109.0 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.314 0.578 . . . . 0.22 111.753 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 24' ' ' VAL . 7.2 p -104.97 116.88 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.547 -1.279 . . . . 0.31 107.547 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.733 HG12 ' HG ' ' A' ' 55' ' ' LEU . 7.3 m -123.61 136.94 58.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.413 0.625 . . . . 0.81000000000000005 111.655 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.99 129.68 46.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.06 -0.973 . . . . 1.29 111.534 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -97.55 107.9 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.14 -0.689 . . . . 0.28000000000000003 109.14 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 p -119.07 -166.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.31 0.576 . . . . 0.91000000000000003 112.493 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.65 154.25 36.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.324 -0.853 . . . . 0.35999999999999999 110.296 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.32 -38.59 78.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.657 0.742 . . . . 1.4099999999999999 109.449 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.433 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 37.7 p-90 -84.94 14.08 5.28 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.572 -1.195 . . . . 1.1100000000000001 111.54 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 37.8 t -102.96 144.42 31.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.856 0.36 . . . . 0.71999999999999997 111.076 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.29 -68.24 0.92 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.714 -0.755 . . . . 0.29999999999999999 112.386 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -50.9 -28.72 24.61 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.655 2.236 . . . . 0.68000000000000005 112.175 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.2 m -58.37 -44.46 88.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.56999999999999995 110.946 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -68.26 -25.63 65.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.849 -0.614 . . . . 2.5699999999999998 111.336 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.2 mtp -68.37 -21.28 64.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.496 -0.32 . . . . 1.6299999999999999 111.539 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mm -86.73 -20.7 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.746 0.308 . . . . 0.25 111.132 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 3.7 tttt -52.23 -53.67 49.94 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.363 -0.38 . . . . 2.04 111.129 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 74.0 Cg_exo -49.63 -47.98 20.84 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.534 2.156 . . . . 0.56999999999999995 112.545 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -78.25 -32.06 49.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.513 -0.312 . . . . 0.44 111.688 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.441 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 6.0 t80 -67.29 -48.6 67.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.909 0.385 . . . . 0.33000000000000002 110.477 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.13 -38.26 85.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.256 -0.429 . . . . 0.95999999999999996 111.497 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.0 t -61.61 -45.33 94.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 1.1599999999999999 110.818 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.0 mt -59.79 -38.66 82.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 0.37 110.274 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 p -54.97 -26.13 34.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.966 -0.561 . . . . 1.05 110.381 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -86.61 -23.32 25.77 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.052 0.454 . . . . 2.23 110.019 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.16 11.18 39.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.61 -0.723 . . . . 1.8999999999999999 110.869 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.812 ' HB3' HG22 ' A' ' 52' ' ' VAL . 15.5 m-85 -131.78 93.12 3.25 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.426 -0.352 . . . . 1.02 110.453 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.86 48.03 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 1.47 111.644 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -156.7 -37.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.875 0.324 . . . . 1.1899999999999999 111.875 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.812 HG22 ' HB3' ' A' ' 49' ' ' TYR . 16.5 m -93.2 150.72 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.28000000000000003 111.785 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.912 ' CG2' HG13 ' A' ' 23' ' ' VAL . 3.0 tp -99.41 120.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.511 . . . . 1.1000000000000001 110.153 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.729 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 3.0 m-85 -102.55 117.24 34.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.918 -0.583 . . . . 0.20000000000000001 110.195 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.033 HD13 HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -132.08 161.8 32.38 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.954 -0.699 . . . . 0.17000000000000001 110.695 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -118.42 121.8 41.22 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.088 -0.96 . . . . 2.1600000000000001 112.435 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.62 HG22 HD11 ' A' ' 55' ' ' LEU . 2.0 t -115.16 118.5 58.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.856 -0.611 . . . . 0.14999999999999999 110.777 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -92.88 116.9 29.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.203 -0.666 . . . . 1.79 109.203 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.05 -21.2 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.364 . . . . 0.19 111.611 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -40.22 96.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.98 0.419 . . . . 0.93999999999999995 110.065 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.96 -41.99 8.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.812 -0.631 . . . . 1.29 111.207 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.556 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -86.32 51.16 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.382 0.61 . . . . 0.20999999999999999 110.131 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -71.33 -11.85 61.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.71 -0.677 . . . . 2.5099999999999998 111.13 -179.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.01 -23.35 19.55 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 111.734 0.272 . . . . 1.3300000000000001 111.734 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 62' ' ' ALA . 8.6 m -81.51 -50.92 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.188 0.44 . . . . 0.17999999999999999 112.188 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.889 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.86 -56.89 14.43 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 113.308 0.855 . . . . 0.27000000000000002 113.308 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.889 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 75.5 Cg_exo -50.81 -27.77 21.34 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.813 2.342 . . . . 0.46000000000000002 112.621 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -77.85 -19.16 55.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 1.53 111.413 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -106.93 -8.89 16.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.059 0.457 . . . . 0.38 110.364 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.54 38.26 90.38 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.516 -0.766 . . . . 0.46000000000000002 113.265 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.504 HG23 HG21 ' A' ' 76' ' ' THR . 59.6 mt -78.99 132.14 32.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 117.299 0.549 . . . . 1.3300000000000001 109.603 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -142.96 74.15 1.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.194 0.521 . . . . 3.9100000000000001 111.087 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.494 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 147.2 143.65 3.89 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.56 -0.746 . . . . 1.03 112.023 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -129.8 156.77 78.41 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.359 0.123 . . . . 1.1699999999999999 110.799 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.37 121.48 6.96 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.829 -1.321 . . . . 0.67000000000000004 112.869 0.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -89.63 139.88 30.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 0.48999999999999999 111.973 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.433 HD13 HD21 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -112.09 118.81 36.42 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.538 -0.912 . . . . 0.96999999999999997 108.538 177.377 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.564 ' HB2' HG23 ' A' ' 25' ' ' VAL . 1.0 OUTLIER -109.75 132.47 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.488 0.661 . . . . 0.19 111.428 -178.409 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.903 HD12 HD11 ' A' ' 22' ' ' LEU . 3.5 mm? -111.93 135.59 52.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.141 -0.936 . . . . 0.65000000000000002 109.029 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.672 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 37.0 m-85 -126.38 152.77 45.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.011 0.434 . . . . 0.31 110.612 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 1.024 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 0.8 OUTLIER -148.49 110.5 4.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.666 -0.697 . . . . 0.93000000000000005 109.664 -179.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 m120 62.07 48.12 5.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.909 0.385 . . . . 1.3300000000000001 110.438 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 7.42 49.0 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.055 -0.593 . . . . 0.27000000000000002 113.132 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -123.03 142.72 50.54 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 122.778 -0.248 . . . . 1.3999999999999999 110.645 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 p -57.52 129.34 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.301 -0.629 . . . . 1.3100000000000001 109.301 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 1.024 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -103.33 -22.49 13.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.457 0.646 . . . . 0.33000000000000002 112.455 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -171.56 158.32 5.09 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.832 -1.076 . . . . 0.28000000000000003 110.941 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.1 t -134.08 136.01 43.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.226 -0.443 . . . . 1.6200000000000001 110.613 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.445 ' HD2' HD22 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -136.51 133.09 36.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.389 -0.597 . . . . 1.47 109.389 178.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 t -115.97 145.97 21.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.671 -0.24 . . . . 0.94999999999999996 111.233 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.23 159.08 27.03 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.517 -0.849 . . . . 0.73999999999999999 112.648 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.88 158.33 30.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.113 0.482 . . . . 0.51000000000000001 111.715 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.584 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -152.03 153.06 33.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.64000000000000001 110.358 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 m -71.54 -178.99 2.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.92000000000000004 110.92 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -73.07 -30.64 63.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.81999999999999995 111.46 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.36 -32.23 48.37 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.201 -0.999 . . . . 0.23000000000000001 112.722 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.484 ' HA ' ' HG2' ' A' ' 100' ' ' GLU . 45.2 mt-30 -73.62 -35.29 65.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 1.29 110.401 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.584 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -69.08 -47.73 64.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.555 -0.748 . . . . 0.37 109.412 178.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -60.61 -43.24 97.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 1.04 110.533 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.601 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -61.18 -41.32 96.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.221 -0.445 . . . . 1.71 110.438 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.601 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 7.2 t80 -61.03 -41.83 97.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.322 0.582 . . . . 0.23999999999999999 110.741 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.86 -56.67 7.21 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.472 -0.785 . . . . 0.46000000000000002 110.117 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -50.08 -36.73 30.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.919 0.39 . . . . 1.1799999999999999 111.042 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.21 -19.93 60.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.19 112.1 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.654 ' HB3' HD21 ' A' ' 22' ' ' LEU . 10.7 t30 -109.05 -37.34 5.84 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.863 0.32 . . . . 0.83999999999999997 111.863 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.604 HD23 HG12 ' A' ' 52' ' ' VAL . 3.5 tm? . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.056 0.455 . . . . 1.3300000000000001 109.991 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.708 HG13 ' HA ' ' A' ' 55' ' ' LEU . 45.7 t . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.693 0.282 . . . . 0.0 110.695 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.635 ' HE2' ' HB2' ' A' ' 14' ' ' ALA . 14.3 ptmt -143.67 120.81 11.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.191 0.52 . . . . 0.0 110.433 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.94 126.05 29.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.512 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.845 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -98.47 107.43 20.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.202 0.525 . . . . 0.0 110.532 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -97.13 18.62 14.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.652 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 m -156.32 161.35 40.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.916 0.388 . . . . 0.0 111.271 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.702 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -73.02 -27.71 61.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.518 179.439 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -79.83 -31.58 40.61 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.498 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.83 -38.34 90.65 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.462 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -58.59 -41.72 86.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.939 0.399 . . . . 0.0 110.016 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -67.5 -44.25 78.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.894 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -57.81 -47.25 83.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.243 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.635 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . . . -65.02 -31.74 73.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.044 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.5 mt -68.72 -37.96 79.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 110.57 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -60.55 -35.84 77.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.164 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.18 -22.46 55.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.006 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.18 77.41 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.088 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.54 -120.33 17.95 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.548 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -95.59 4.97 52.62 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -79.8 149.42 31.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.981 HD11 HD12 ' A' ' 79' ' ' LEU . 4.9 tp -77.0 133.15 39.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.864 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.6 t -113.88 109.91 30.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.502 0.668 . . . . 0.0 112.015 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.571 HG23 HD21 ' A' ' 79' ' ' LEU . 8.4 p -105.04 115.7 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.554 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.8 m -123.33 166.96 17.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.908 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -133.56 133.89 42.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.783 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.573 ' HE1' HD12 ' A' ' 78' ' ' LEU . 4.2 m-85 -96.21 108.15 20.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.5 ' O ' HG12 ' A' ' 59' ' ' VAL . 31.2 p -115.85 -168.36 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.314 0.578 . . . . 0.0 112.186 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.77 152.99 33.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.02 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -71.26 -37.57 71.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.508 0.671 . . . . 0.0 109.598 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -86.69 12.62 10.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.176 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.713 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 17.2 t -94.87 158.21 15.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.049 0.452 . . . . 0.0 111.625 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.96 -66.94 0.61 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.585 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.06 -21.51 72.55 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.58 2.187 . . . . 0.0 112.203 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.5 m -62.98 -42.01 99.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.297 0.57 . . . . 0.0 109.919 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.34 -29.7 70.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.378 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.4 mtt -68.28 -18.17 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 11.6 mm -88.14 -23.73 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.476 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -52.88 -51.95 69.51 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.03 -49.44 17.04 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.693 2.262 . . . . 0.0 113.416 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -79.79 -30.29 40.59 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 4.9 t80 -65.52 -46.01 81.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.087 0.47 . . . . 0.0 110.293 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -39.28 90.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.267 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.5 t -60.38 -43.99 96.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 111.115 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.4 mt -59.71 -38.33 81.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.926 0.393 . . . . 0.0 110.238 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.6 t -56.47 -30.98 63.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.942 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -86.39 -18.1 32.68 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.575 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -96.05 -20.76 18.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.947 0.403 . . . . 0.0 110.175 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.85 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.1 m-85 -97.92 92.88 6.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.849 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.9 t -88.93 48.39 1.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.113 0.483 . . . . 0.0 110.719 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -152.73 -42.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.667 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.85 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.2 m -94.43 153.29 3.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.795 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.864 ' CG2' HG13 ' A' ' 23' ' ' VAL . 6.0 tp -104.49 115.4 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.026 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.611 ' O ' HG22 ' A' ' 2' ' ' VAL . 8.1 m-85 -97.59 115.92 28.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.544 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.845 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.2 164.67 21.16 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.537 178.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.415 ' N ' HD12 ' A' ' 55' ' ' LEU . 3.2 tp10 -116.39 119.34 35.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.447 HG22 HD11 ' A' ' 55' ' ' LEU . 2.1 t -115.53 117.75 56.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.184 0.516 . . . . 0.0 110.946 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -98.47 119.41 37.11 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 28' ' ' SER . 13.5 p -60.88 -18.84 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -64.17 -39.0 93.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -100.11 -32.85 10.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.584 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.892 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.49 43.0 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.82 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 31.0 tt0 -69.16 -10.12 56.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.654 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -94.9 -22.38 18.04 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.312 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.892 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -78.33 -47.71 23.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.665 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.935 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.35 -58.75 8.79 Favored Pre-proline 0 CA--C 1.529 0.143 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.935 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 75.2 Cg_exo -49.8 -28.89 18.9 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.458 2.106 . . . . 0.0 112.037 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.9 mttp -77.13 -23.99 51.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.959 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -106.66 -3.65 20.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.93 0.395 . . . . 0.0 112.017 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.88 34.92 89.98 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.889 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.625 HD11 HD11 ' A' ' 78' ' ' LEU . 79.7 mt -77.15 135.93 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 117.3 0.55 . . . . 0.0 110.657 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttp85 -143.48 71.28 1.33 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.129 0.49 . . . . 0.0 111.475 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.21 163.42 11.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.591 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.608 HD12 ' SG ' ' A' ' 32' ' ' CYS . 47.3 pt -148.46 149.84 32.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.418 0.109 . . . . 0.0 110.972 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -86.06 120.16 5.7 Favored 'Cis proline' 0 C--N 1.348 0.538 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.649 0.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.94 137.65 32.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.939 0.399 . . . . 0.0 111.809 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.675 HD22 HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -109.11 121.76 45.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.81 ' CD2' HG23 ' A' ' 88' ' ' THR . 6.6 mt -114.47 134.58 54.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.238 0.542 . . . . 0.0 111.639 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.981 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -114.33 127.36 55.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.781 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.593 ' CE2' HG22 ' A' ' 85' ' ' VAL . 46.5 m-85 -118.43 146.67 44.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.975 0.417 . . . . 0.0 111.336 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.474 ' HD2' HD13 ' A' ' 22' ' ' LEU . 1.2 tttm -146.59 115.27 6.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.002 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m120 59.76 45.21 13.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.872 0.368 . . . . 0.0 110.261 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.29 3.79 54.27 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.896 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.4 141.39 52.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.513 0.657 . . . . 0.0 111.467 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.593 HG22 ' CE2' ' A' ' 80' ' ' PHE . 42.5 t -68.13 118.3 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.443 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.43 10.49 19.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.943 0.401 . . . . 0.0 112.047 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -175.69 137.92 0.37 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.936 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.81 HG23 ' CD2' ' A' ' 78' ' ' LEU . 4.9 m -137.79 124.0 20.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 110.942 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -124.22 142.02 51.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.904 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.97 145.94 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.233 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.439 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 80.11 161.79 24.63 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.131 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.61 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -64.33 170.65 3.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.901 0.382 . . . . 0.0 111.277 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.675 HD11 HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -163.69 147.06 10.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.657 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 t -64.75 179.07 0.69 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.914 0.388 . . . . 0.0 110.806 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -73.09 -30.81 63.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.118 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.2 -31.37 52.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.86 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -76.21 -32.14 58.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.858 0.361 . . . . 0.0 110.582 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -70.61 -50.95 31.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.099 0.476 . . . . 0.0 109.884 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -61.54 -42.33 98.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.5 -38.83 88.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.949 0.404 . . . . 0.0 110.137 179.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.739 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 11.2 t80 -61.93 -40.65 96.21 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.402 0.62 . . . . 0.0 110.061 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 4.5 mt -65.67 -60.91 2.42 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.157 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -48.55 -33.83 10.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.095 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.6 -23.5 60.95 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -109.77 -30.03 8.04 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.711 HD13 HG12 ' A' ' 52' ' ' VAL . 36.6 tp . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 120.847 0.356 . . . . 0.0 110.716 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.755 HG13 ' HA ' ' A' ' 55' ' ' LEU . 67.9 t . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 109.68 -0.489 . . . . 0.41999999999999998 109.68 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.46 ' O ' HD12 ' A' ' 5' ' ' ILE . 11.9 ptpt -144.98 121.81 11.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.36 -0.936 . . . . 1.98 111.268 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.12 123.69 25.67 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.458 -1.246 . . . . 2.23 110.174 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.942 HG23 ' HB3' ' A' ' 10' ' ' ALA . 2.1 mp -105.3 114.2 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.847 0.356 . . . . 0.26000000000000001 111.323 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -103.77 16.63 25.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.352 0.501 . . . . 1.47 112.352 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -155.48 147.25 23.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.742 0.306 . . . . 0.94999999999999996 111.098 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.503 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.5 ttpt -60.82 -24.64 66.01 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.358 -0.383 . . . . 1.5 111.764 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -79.14 -32.32 44.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.928 0.394 . . . . 0.32000000000000001 110.238 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.942 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -67.24 -41.39 85.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.906 -0.588 . . . . 0.29999999999999999 110.349 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -56.18 -44.53 79.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.858 -0.61 . . . . 1.1499999999999999 110.693 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -66.52 -39.45 88.63 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.246 -0.65 . . . . 1.1699999999999999 109.246 178.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -58.06 -48.45 80.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.746 -0.661 . . . . 1.6000000000000001 110.887 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.56 -34.58 78.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.421 . . . . 0.32000000000000001 111.241 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 15' ' ' LEU . 18.2 mt -66.75 -39.6 87.98 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.234 0.54 . . . . 0.40999999999999998 110.537 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -63.57 -31.98 73.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 1.6000000000000001 110.739 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.72 -22.74 56.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.46999999999999997 111.014 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.447 ' HB1' HG22 ' A' ' 23' ' ' VAL . . . -71.23 -35.81 71.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.71999999999999997 111.477 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.53 -119.44 18.61 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.077 -1.059 . . . . 1.1000000000000001 113.662 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.18 2.29 56.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.717 -0.241 . . . . 2.1899999999999999 111.479 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -79.27 148.1 32.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.692 -0.484 . . . . 1.74 109.692 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.979 HD11 HD12 ' A' ' 79' ' ' LEU . 1.6 tp -72.46 126.99 31.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.14 -0.319 . . . . 0.31 110.14 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.772 HG13 HG22 ' A' ' 53' ' ' ILE . 4.3 t -107.61 108.11 24.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.521 0.676 . . . . 0.23999999999999999 111.523 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.619 HG23 ' CD2' ' A' ' 79' ' ' LEU . 10.2 p -106.08 116.98 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.951 -1.129 . . . . 0.31 107.951 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.071 HG12 ' HG ' ' A' ' 55' ' ' LEU . 4.3 m -123.13 166.97 17.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.218 0.532 . . . . 0.78000000000000003 111.643 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.443 ' OD1' HD12 ' A' ' 77' ' ' LEU . 37.4 t0 -133.21 133.75 43.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.802 -0.636 . . . . 1.23 111.834 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HE1' HD12 ' A' ' 78' ' ' LEU . 8.8 m-85 -97.86 110.76 23.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.927 -0.768 . . . . 0.27000000000000002 108.927 178.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.3 m -128.42 158.94 36.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.597 0.713 . . . . 1.1899999999999999 112.917 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.587 ' HB1' ' CD1' ' A' ' 31' ' ' TRP . . . -116.16 156.65 26.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.971 -1.013 . . . . 0.37 111.047 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.2 m -70.79 -35.78 72.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.502 0.668 . . . . 0.75 109.615 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.587 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 23.4 p-90 -85.76 10.87 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.736 -1.12 . . . . 0.89000000000000001 111.564 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.476 ' SG ' HD12 ' A' ' 74' ' ' ILE . 38.4 t -98.4 148.12 24.01 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.81 0.338 . . . . 0.81999999999999995 111.027 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.33 -67.33 0.75 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.677 -0.773 . . . . 0.37 112.204 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.73 -24.53 18.22 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.411 2.074 . . . . 0.60999999999999999 112.096 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.7 m -62.9 -43.76 97.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.144 -0.48 . . . . 0.48999999999999999 110.781 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -68.78 -23.21 64.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 2.5600000000000001 111.13 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 mmt -69.7 -22.36 63.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 1.8 110.739 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.2 mm -85.98 -21.71 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.418 -0.355 . . . . 0.25 110.976 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 2.0 tttt -52.3 -55.05 35.14 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.464 -0.335 . . . . 2.4700000000000002 111.159 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 39' ' ' LYS . 72.7 Cg_exo -48.54 -49.11 15.37 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.563 2.176 . . . . 0.40999999999999998 112.381 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -77.4 -29.19 53.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 0.44 111.519 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.437 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 6.3 t80 -67.76 -46.81 71.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.986 0.422 . . . . 0.46000000000000002 110.257 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -42.9 78.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 1.03 111.952 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 m -59.09 -44.52 91.92 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.841 0.353 . . . . 0.91000000000000003 110.379 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.35 -40.3 85.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.543 -0.54 . . . . 0.34999999999999998 109.543 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 32.4 t -54.5 -27.55 38.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.889 -0.596 . . . . 1.22 111.179 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -88.96 -16.96 30.5 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.731 0.3 . . . . 1.99 111.038 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -94.56 -19.38 20.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.963 0.411 . . . . 2.1600000000000001 109.912 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.847 ' HB3' HG22 ' A' ' 52' ' ' VAL . 22.1 m-85 -102.26 97.47 7.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.917 -0.583 . . . . 1.1000000000000001 111.477 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.63 46.35 1.33 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.399 -0.364 . . . . 1.3899999999999999 110.767 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -154.44 -34.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.801 0.334 . . . . 1.0800000000000001 111.322 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 49' ' ' TYR . 5.8 m -97.59 156.06 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.325 -0.398 . . . . 0.32000000000000001 111.585 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.772 HG22 HG13 ' A' ' 23' ' ' VAL . 1.3 tp -106.39 114.64 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.051 -0.522 . . . . 0.28999999999999998 111.143 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.712 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.2 m-85 -96.11 120.19 35.95 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.197 -0.456 . . . . 0.23999999999999999 110.516 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.071 ' HG ' HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -133.31 168.5 18.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 120.378 -0.529 . . . . 0.22 111.1 179.178 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.789 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -121.53 124.61 44.81 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.674 0.62 . . . . 2.2799999999999998 112.674 -178.344 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.612 HG22 HD11 ' A' ' 55' ' ' LEU . 2.7 t -113.19 117.78 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.887 -0.597 . . . . 0.19 111.138 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -93.46 113.21 25.3 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.424 -0.584 . . . . 1.9199999999999999 109.424 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 p -58.49 -19.1 13.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.825 0.305 . . . . 0.28000000000000003 111.825 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -37.54 87.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.94 0.4 . . . . 1.22 110.292 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -102.94 -40.61 6.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.89 -0.596 . . . . 1.26 111.157 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -88.32 49.0 1.72 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.213 0.53 . . . . 0.28000000000000003 110.395 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -75.83 -6.57 51.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.525 -0.762 . . . . 2.5499999999999998 111.083 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.89 -25.1 20.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.769 0.318 . . . . 1.5600000000000001 110.433 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.642 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 13.5 m -81.31 -48.58 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.197 -0.456 . . . . 0.26000000000000001 111.759 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.876 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.39 -55.56 21.28 Favored Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 112.744 0.646 . . . . 0.28999999999999998 112.744 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.876 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 78.3 Cg_exo -51.92 -27.54 28.37 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.863 2.375 . . . . 0.46000000000000002 112.997 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -77.09 -21.35 54.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.278 -0.419 . . . . 1.77 111.781 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -108.16 -7.12 16.12 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.087 0.47 . . . . 0.41999999999999998 111.354 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.4 37.07 90.03 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.687 -0.688 . . . . 0.48999999999999999 113.517 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.659 HG23 HG21 ' A' ' 76' ' ' THR . 61.6 mt -74.12 130.16 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 109.624 -0.51 . . . . 1.29 109.624 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.89 60.16 1.47 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.937 0.399 . . . . 3.8900000000000001 111.521 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.13 118.43 0.52 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.245 -0.979 . . . . 1.1200000000000001 113.386 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.476 HD12 ' SG ' ' A' ' 32' ' ' CYS . 17.6 pt -104.99 152.44 39.63 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.408 -0.219 . . . . 0.89000000000000001 110.408 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.81 120.26 6.38 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.8 -1.333 . . . . 1.0800000000000001 112.708 0.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.659 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -91.48 134.82 34.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.543 -0.299 . . . . 0.33000000000000002 111.236 179.176 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.443 HD12 ' OD1' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -107.87 122.82 47.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.401 -0.963 . . . . 1.0800000000000001 108.401 177.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.506 ' HB2' HG23 ' A' ' 25' ' ' VAL . 5.0 mt -113.84 137.61 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.263 0.554 . . . . 0.22 111.548 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.979 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -119.01 113.41 20.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.535 -0.757 . . . . 0.22 110.562 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.61 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.9 m-85 -105.0 142.37 34.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.979 -0.555 . . . . 0.25 110.766 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -142.25 110.34 5.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.579 -0.737 . . . . 0.42999999999999999 109.487 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.0 m120 61.89 47.08 6.25 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.276 -0.639 . . . . 1.1899999999999999 109.276 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.16 3.79 32.58 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.558 -0.746 . . . . 0.23000000000000001 113.797 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -121.25 133.04 55.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.205 0.502 . . . . 1.6000000000000001 110.814 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.72 117.35 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 1.26 109.848 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.02 4.49 27.12 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.462 0.541 . . . . 0.23000000000000001 112.462 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.807 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.56 146.51 1.72 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.283 -0.417 . . . . 0.20000000000000001 111.823 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.46 134.21 37.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 1.53 110.824 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -132.78 138.77 47.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 2.1699999999999999 110.239 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.7 145.53 26.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.87 111.009 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.87 160.16 23.38 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.501 -0.857 . . . . 0.25 112.878 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.62 151.27 46.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.114 0.483 . . . . 0.55000000000000004 111.575 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.606 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -143.33 147.77 35.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.76 -0.654 . . . . 0.55000000000000004 110.558 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -65.04 -178.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.576 -0.284 . . . . 1.02 110.755 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -73.01 -32.67 65.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 1.0900000000000001 111.497 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.52 -30.58 56.31 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.206 -0.997 . . . . 0.25 112.598 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.553 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 40.4 mt-30 -74.99 -31.22 61.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.972 0.415 . . . . 1.26 110.31 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.606 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -72.98 -49.79 27.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.047 -0.524 . . . . 0.42999999999999999 109.908 179.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -61.71 -45.16 95.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.544 -0.753 . . . . 1.4299999999999999 110.965 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.8 pp20? -60.64 -41.68 95.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 1.8200000000000001 110.558 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.66 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 47.0 t80 -63.91 -42.68 97.35 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.26 0.552 . . . . 0.27000000000000002 111.194 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.618 HD11 HG11 ' A' ' 24' ' ' VAL . 1.7 mt -64.85 -57.72 8.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.791 -0.64 . . . . 0.42999999999999999 109.528 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -49.0 -34.19 12.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.502 . . . . 1.24 110.736 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.47 -22.95 62.62 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.046 -0.524 . . . . 0.23000000000000001 111.717 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.425 ' HB3' HD21 ' A' ' 22' ' ' LEU . 6.8 t30 -105.55 -31.44 8.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.806 0.336 . . . . 0.52000000000000002 110.746 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.527 ' HB2' HD23 ' A' ' 22' ' ' LEU . 42.6 tp . . . . . 0 C--N 1.329 -0.312 0 N-CA-C 109.691 -0.485 . . . . 1.3500000000000001 109.691 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.72 HG13 ' HA ' ' A' ' 55' ' ' LEU . 42.9 t . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.772 0.32 . . . . 0.0 110.604 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.73 119.62 11.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.253 0.549 . . . . 0.0 110.346 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.7 127.74 33.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.846 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.798 HD13 HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -101.12 107.53 21.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.298 -179.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -97.9 19.64 13.49 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.125 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.23 159.53 39.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.855 0.36 . . . . 0.0 111.276 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.608 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -71.91 -26.65 62.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 m -79.64 -32.8 41.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.914 0.387 . . . . 0.0 110.814 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.37 90.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.568 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -57.66 -42.71 84.04 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -43.97 83.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.13 -45.7 92.14 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.514 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.49 -31.91 73.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.892 0.377 . . . . 0.0 110.673 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -67.78 -37.39 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.527 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -61.42 -33.91 74.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.304 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.44 -22.67 54.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.9 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.65 -35.91 79.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.63 -122.76 31.13 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.14 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.57 4.33 53.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.501 0.191 . . . . 0.0 111.152 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -77.28 149.7 35.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.917 HD11 HD12 ' A' ' 79' ' ' LEU . 9.8 tp -77.02 132.61 39.05 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.879 HG13 ' CG2' ' A' ' 53' ' ' ILE . 6.3 t -112.45 109.67 29.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.397 0.618 . . . . 0.0 112.37 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.758 HG11 HD11 ' A' ' 102' ' ' LEU . 7.9 p -104.81 116.22 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.657 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.1 m -122.67 167.09 16.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.72 -178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -133.45 133.37 42.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.597 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -98.1 111.89 24.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -118.94 -167.79 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.382 0.61 . . . . 0.0 112.219 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.2 154.5 35.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.013 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -35.73 67.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.376 0.607 . . . . 0.0 109.471 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -87.24 10.78 15.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.08 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.713 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 11.3 t -91.79 157.21 17.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.052 0.453 . . . . 0.0 111.479 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.41 -64.17 0.54 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.441 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 22.9 Cg_exo -63.96 -22.29 68.42 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.497 2.132 . . . . 0.0 112.401 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.9 m -58.58 -41.47 85.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -67.04 -15.24 63.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.391 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.462 ' HG2' ' HA ' ' A' ' 34' ' ' PRO . 4.6 mmt -71.16 -26.85 63.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.789 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.8 mm -84.47 -23.86 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.685 0.279 . . . . 0.0 111.361 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 8.4 ttpt -48.96 -59.21 6.72 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 10.3 Cg_endo -51.96 -45.05 41.15 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.342 2.028 . . . . 0.0 112.697 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -80.74 -29.67 36.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -66.43 -45.69 78.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.082 0.467 . . . . 0.0 110.327 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.14 -39.91 86.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.883 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 62.7 m -61.7 -44.02 97.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.877 0.37 . . . . 0.0 110.887 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.3 mt -59.42 -40.23 86.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.914 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 m -54.73 -28.38 47.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.433 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.54 -19.51 27.78 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.686 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -95.0 -20.62 19.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.04 0.447 . . . . 0.0 110.265 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.856 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.5 m-85 -98.04 96.13 7.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.675 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.76 47.96 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.072 0.463 . . . . 0.0 110.236 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -152.92 -42.44 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.822 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.856 HG22 ' HB3' ' A' ' 49' ' ' TYR . 11.0 m -93.66 153.85 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.597 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.879 ' CG2' HG13 ' A' ' 23' ' ' VAL . 5.2 tp -105.75 113.99 44.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.748 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.561 ' O ' HG13 ' A' ' 2' ' ' VAL . 8.4 m-85 -94.62 116.2 28.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.55 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.798 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -129.02 166.7 18.71 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.514 178.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.432 ' N ' HD12 ' A' ' 55' ' ' LEU . 1.4 tp10 -117.43 118.99 33.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.34 118.35 58.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.249 0.547 . . . . 0.0 110.787 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -99.34 120.42 39.54 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.27 -18.46 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -67.93 -37.53 81.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.087 0.47 . . . . 0.0 109.81 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -98.78 -34.5 10.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.445 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.856 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.75 47.67 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.097 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 67' ' ' PRO . 8.7 tp-100 -68.57 -8.74 44.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.079 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.57 -25.02 15.29 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.448 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.856 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 6.7 m -77.15 -48.78 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.965 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.627 ' HB3' ' CD ' ' A' ' 67' ' ' PRO . . . -50.22 -60.44 5.24 Favored Pre-proline 0 N--CA 1.463 0.203 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 66' ' ' ALA . 6.3 Cg_endo -49.11 -28.04 13.45 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.571 2.181 . . . . 0.0 111.862 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -73.57 -27.84 61.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.929 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -108.79 -6.26 15.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.901 0.381 . . . . 0.0 111.632 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.41 40.24 97.6 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.087 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.721 HG23 HG21 ' A' ' 76' ' ' THR . 61.3 mt -78.0 81.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 117.007 0.403 . . . . 0.0 110.837 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -87.1 78.33 8.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 111.882 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.27 164.22 10.15 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.397 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.5 pt -149.03 155.71 40.33 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 122.161 0.184 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.23 116.93 4.26 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 124.183 -1.174 . . . . 0.0 112.628 -0.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.721 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -87.14 137.08 32.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.909 0.385 . . . . 0.0 111.865 179.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.465 HD21 HD21 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -107.65 123.87 49.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.625 HD11 HD11 ' A' ' 71' ' ' ILE . 6.0 mt -116.76 134.88 54.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.219 0.533 . . . . 0.0 111.793 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.917 HD12 HD11 ' A' ' 22' ' ' LEU . 3.5 mm? -114.71 120.68 40.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.696 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.519 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 45.2 m-85 -112.08 146.99 36.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 0.0 111.157 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -146.94 110.6 4.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.328 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.3 m120 61.83 46.47 6.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.909 0.385 . . . . 0.0 110.171 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.51 1.24 57.4 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.908 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -125.49 138.79 53.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.484 0.642 . . . . 0.0 111.861 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 85' ' ' VAL . 7.2 p -68.25 119.23 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.529 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.22 11.3 20.21 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.842 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.88 140.85 0.76 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.63 124.2 22.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.681 0.277 . . . . 0.0 111.127 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.442 ' HD2' HD22 ' A' ' 93' ' ' LEU . 5.4 tmtt? -126.17 139.68 53.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.272 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.44 146.34 25.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.643 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.404 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.36 161.56 27.36 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.158 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.14 147.86 49.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 111.58 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.653 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -142.38 151.76 42.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.612 179.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.9 t -65.33 179.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.151 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -72.5 -31.98 65.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.46 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.24 -29.89 55.57 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.711 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 54.8 mt-30 -76.88 -32.7 57.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.843 0.354 . . . . 0.0 110.532 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.653 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -71.21 -50.56 31.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -61.4 -42.09 98.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.238 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.38 -39.61 91.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.881 0.372 . . . . 0.0 110.328 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.808 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 10.8 t80 -62.1 -42.56 99.35 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.357 0.598 . . . . 0.0 110.679 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.758 HD11 HG11 ' A' ' 24' ' ' VAL . 6.1 mt -67.41 -54.46 20.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.186 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -50.99 -36.77 40.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.63 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.29 -21.0 60.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.403 ' HB3' HD21 ' A' ' 22' ' ' LEU . 9.1 t30 -108.58 -26.9 10.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.733 0.302 . . . . 0.0 111.705 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.519 HD23 HG12 ' A' ' 52' ' ' VAL . 3.3 tm? . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.683 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 54' ' ' PHE . 50.9 t . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.81 0.338 . . . . 0.0 111.137 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.32 121.84 11.05 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.072 0.463 . . . . 0.0 110.23 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.24 127.55 33.26 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.71 HD13 HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -100.51 106.83 19.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.978 0.418 . . . . 0.0 109.928 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -98.45 20.08 13.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.778 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.8 159.79 38.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.946 0.403 . . . . 0.0 111.301 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.582 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -72.37 -25.36 61.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.926 179.476 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.84 -32.28 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.951 0.405 . . . . 0.0 110.702 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -65.67 -39.49 91.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.148 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.401 ' CE1' HG21 ' A' ' 57' ' ' VAL . 3.6 t80 -57.76 -44.52 86.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 109.984 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.84 -45.57 85.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.679 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -58.21 -47.79 82.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.34 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.39 -31.5 72.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.34 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 mt -69.79 -37.91 76.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.41 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -61.41 -33.16 73.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.721 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.42 -23.9 53.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.956 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.72 78.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.24 -122.42 29.0 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.004 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -94.96 6.47 48.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.46 0.171 . . . . 0.0 111.303 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -80.19 148.77 30.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.919 HD11 HD12 ' A' ' 79' ' ' LEU . 8.7 tp -76.25 134.63 39.77 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.92 HG13 HG23 ' A' ' 53' ' ' ILE . 4.2 t -113.78 109.19 27.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.459 0.647 . . . . 0.0 112.007 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.007 HG11 HD11 ' A' ' 102' ' ' LEU . 7.6 p -103.75 116.03 46.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.562 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.6 m -123.91 165.85 19.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.215 0.531 . . . . 0.0 112.126 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -129.57 131.31 46.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.609 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.564 ' CE1' HD12 ' A' ' 78' ' ' LEU . 4.6 m-85 -98.24 110.13 22.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.9 p -134.32 149.54 50.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.107 0.48 . . . . 0.0 112.029 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.39 158.26 15.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.352 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -68.96 -37.49 78.85 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -85.48 16.19 3.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.058 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.586 ' SG ' HD12 ' A' ' 74' ' ' ILE . 36.8 t -90.91 156.95 17.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.36 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.14 -73.85 0.89 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.348 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.47 -22.79 22.5 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.451 2.101 . . . . 0.0 112.227 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.0 m -60.72 -38.11 83.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.22 0.533 . . . . 0.0 110.13 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -69.26 -16.26 63.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.553 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 38.4 mtt -74.16 -23.61 59.28 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.419 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.417 HG22 ' HB2' ' A' ' 42' ' ' PHE . 10.0 mm -87.25 -22.21 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 8.3 mttp -48.66 -60.01 5.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 10.2 Cg_endo -53.32 -44.51 48.36 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.544 2.162 . . . . 0.0 113.43 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.412 ' O ' HD12 ' A' ' 45' ' ' LEU . 14.4 m-85 -79.86 -31.61 40.45 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.43 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 4.9 t80 -66.18 -44.32 84.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.946 0.403 . . . . 0.0 110.545 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -39.27 83.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.12 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 p -61.74 -43.65 98.44 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.046 0.451 . . . . 0.0 110.879 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 41' ' ' PHE . 7.6 mt -59.49 -37.03 77.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.021 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -57.86 -28.31 64.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.376 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -87.27 -19.61 28.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.599 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -95.27 -19.68 19.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 110.266 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.829 ' HB3' HG22 ' A' ' 52' ' ' VAL . 19.0 m-85 -99.52 93.94 6.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.854 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.2 t -90.93 49.43 1.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.142 0.496 . . . . 0.0 110.845 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -151.75 -43.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.565 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.847 HG12 ' HB3' ' A' ' 22' ' ' LEU . 10.3 m -92.24 153.95 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.945 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.92 HG23 HG13 ' A' ' 23' ' ' VAL . 5.6 tp -105.35 114.72 45.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.596 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.662 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.3 m-85 -95.39 115.75 27.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.744 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.71 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.44 165.81 19.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.455 178.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -118.03 119.46 34.85 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.901 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.401 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.7 t -114.69 117.84 56.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.488 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -97.26 118.02 32.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.681 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.06 -18.98 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.733 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.4 -39.98 95.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -99.73 -34.08 10.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.765 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.91 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.11 45.03 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.708 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -9.44 57.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.168 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.4 -21.89 18.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.432 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.91 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.3 m -80.38 -47.02 21.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.992 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.908 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.0 -57.81 11.41 Favored Pre-proline 0 N--CA 1.464 0.225 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.908 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 74.6 Cg_exo -50.68 -28.34 22.27 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.536 2.157 . . . . 0.0 111.874 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.98 -23.12 58.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -111.01 -5.25 14.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.87 0.367 . . . . 0.0 111.812 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.56 34.94 89.16 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.581 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.639 HD11 HD11 ' A' ' 78' ' ' LEU . 75.2 mt -74.81 132.84 32.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 117.396 0.598 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -150.7 49.21 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.933 0.397 . . . . 0.0 111.219 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.27 99.46 0.14 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.442 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.586 HD12 ' SG ' ' A' ' 32' ' ' CYS . 2.9 pt -100.96 151.6 37.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.51 0.195 . . . . 0.0 111.109 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.49 113.49 2.97 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 124.036 -1.235 . . . . 0.0 112.752 0.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.47 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -86.65 135.26 33.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.842 0.353 . . . . 0.0 111.571 179.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -107.38 125.95 51.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.639 HD11 HD11 ' A' ' 71' ' ' ILE . 7.5 mt -116.88 136.51 52.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.199 0.523 . . . . 0.0 111.702 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.919 HD12 HD11 ' A' ' 22' ' ' LEU . 3.6 mm? -117.45 122.98 45.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.699 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.582 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 49.1 m-85 -113.64 144.82 42.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.031 0.443 . . . . 0.0 111.375 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HD2' HD13 ' A' ' 22' ' ' LEU . 3.5 tttm -145.62 111.59 5.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.336 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 m120 61.88 45.39 7.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.396 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.37 -0.56 59.63 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.957 -0.64 . . . . 0.0 114.242 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -124.07 141.07 52.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.519 0.66 . . . . 0.0 111.865 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.554 HG22 ' CE2' ' A' ' 80' ' ' PHE . 38.2 t -67.4 119.73 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.401 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.09 8.33 19.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.884 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -173.61 138.68 0.68 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.113 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.595 HG23 ' CD2' ' A' ' 78' ' ' LEU . 22.2 m -138.63 120.71 15.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.749 0.309 . . . . 0.0 111.086 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.38 145.15 46.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.942 0.401 . . . . 0.0 111.216 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.01 146.19 25.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.399 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.602 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 79.83 159.29 17.69 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.304 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.9 138.27 48.04 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.027 0.441 . . . . 0.0 111.895 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -128.01 150.96 49.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.534 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.0 m -65.74 -178.03 0.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.771 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -70.57 -33.95 71.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.677 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.67 -30.49 52.64 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.237 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 100' ' ' GLU . 25.6 mt-30 -77.14 -32.35 56.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.014 0.407 . . . . 0.0 110.591 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -71.32 -50.26 34.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -61.96 -42.23 98.88 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.654 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 97' ' ' GLN . 13.1 pt-20 -61.56 -42.84 99.43 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.764 0.316 . . . . 0.0 110.838 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.884 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 38.5 t80 -61.92 -42.7 99.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.374 0.607 . . . . 0.0 110.528 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 1.007 HD11 HG11 ' A' ' 24' ' ' VAL . 1.6 mt -67.3 -54.44 20.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.768 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -52.82 -36.2 58.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.749 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.92 -19.17 61.96 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.985 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -107.6 -28.03 10.0 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.639 0.257 . . . . 0.0 111.454 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.683 HD23 HG12 ' A' ' 52' ' ' VAL . 3.1 tm? . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.756 HG13 ' HA ' ' A' ' 55' ' ' LEU . 44.7 t . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.684 0.278 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -145.29 119.77 9.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.124 0.488 . . . . 0.0 110.651 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.29 127.65 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.641 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.781 HD13 HD13 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -101.2 109.55 25.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.064 0.459 . . . . 0.0 110.557 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -101.41 18.79 19.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.951 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.29 161.38 41.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.086 0.47 . . . . 0.0 111.562 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.644 ' HA ' HG13 ' A' ' 65' ' ' VAL . 5.2 ttpt -73.43 -28.21 61.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.776 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.73 -30.9 41.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.765 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.07 -42.45 89.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.875 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -55.16 -41.51 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 110.213 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -67.1 -44.3 80.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.976 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -58.33 -47.82 82.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.447 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.37 -31.57 72.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 110.928 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 mt -68.68 -39.15 80.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.683 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.46 -34.08 73.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.056 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.66 -22.81 53.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.481 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.44 72.23 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.914 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.34 -123.92 29.35 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.144 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -93.59 4.65 53.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.621 0.248 . . . . 0.0 111.223 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -78.82 149.41 32.55 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.98 HD11 HD12 ' A' ' 79' ' ' LEU . 6.8 tp -76.35 134.96 39.54 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.885 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.3 t -112.79 113.22 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.519 0.676 . . . . 0.0 112.007 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.649 ' HB ' HD21 ' A' ' 102' ' ' LEU . 7.2 p -106.18 112.35 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.45 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.695 HG12 ' HG ' ' A' ' 55' ' ' LEU . 4.7 m -122.24 167.08 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.75 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -134.46 134.49 41.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.683 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.605 ' HE1' HD12 ' A' ' 78' ' ' LEU . 6.4 m-85 -96.13 106.74 18.97 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -115.75 -169.52 1.6 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.449 0.642 . . . . 0.0 112.615 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.689 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.76 153.63 34.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.231 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.8 m -71.26 -36.51 71.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.433 0.635 . . . . 0.0 109.588 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -86.45 12.51 10.1 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.737 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.689 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 21.0 t -92.76 157.65 16.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.998 0.428 . . . . 0.0 111.728 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.18 -69.62 0.64 Allowed Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.344 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.5 -23.21 46.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.641 2.227 . . . . 0.0 112.27 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.1 m -59.89 -42.65 94.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -68.49 -18.6 64.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.365 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.9 mmm -74.04 -25.42 59.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.75 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.9 mm -85.97 -22.57 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.724 0.297 . . . . 0.0 111.664 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.41 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -50.75 -52.78 53.65 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.495 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 63.9 Cg_exo -51.15 -49.57 16.67 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.709 2.273 . . . . 0.0 113.045 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -79.87 -28.45 39.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -66.68 -47.23 73.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.099 0.476 . . . . 0.0 110.412 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -40.19 88.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.24 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.6 t -60.34 -44.58 95.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.599 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt -59.65 -41.92 91.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.123 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.8 t -54.91 -27.59 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.272 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -87.01 -18.77 29.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.727 0.299 . . . . 0.0 111.334 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -95.81 -19.91 19.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 110.08 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.875 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.3 m-85 -100.18 92.52 5.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.032 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -89.69 48.06 1.55 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.021 0.438 . . . . 0.0 110.494 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -152.27 -40.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.591 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' A' ' 49' ' ' TYR . 12.5 m -94.74 155.25 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.422 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.885 ' CG2' HG13 ' A' ' 23' ' ' VAL . 5.3 tp -105.24 115.55 47.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.815 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.64 ' CE1' HG11 ' A' ' 24' ' ' VAL . 8.9 m-85 -97.61 116.17 29.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.938 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.781 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -129.35 167.79 17.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.45 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.453 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -120.24 122.39 40.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.803 -177.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.428 HG22 HD11 ' A' ' 55' ' ' LEU . 2.5 t -116.28 120.07 63.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.352 0.596 . . . . 0.0 110.744 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -99.74 119.24 37.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.897 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.73 -18.27 16.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.043 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -39.77 94.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.95 -33.63 10.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.496 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.938 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -97.24 43.7 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.469 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -8.94 56.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.666 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.98 -24.61 16.3 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.293 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.938 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 1.7 m -76.53 -47.43 29.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.494 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.924 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.97 -57.76 11.56 Favored Pre-proline 0 N--CA 1.461 0.108 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.924 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 74.2 Cg_exo -50.14 -28.5 19.83 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.435 2.09 . . . . 0.0 111.569 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -75.27 -24.35 57.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.956 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -106.98 -4.82 18.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.894 0.378 . . . . 0.0 111.612 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.98 34.65 89.08 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.78 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.652 HD11 HD11 ' A' ' 78' ' ' LEU . 70.9 mt -75.77 135.41 27.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 117.248 0.524 . . . . 0.0 110.446 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -144.81 64.85 1.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.014 0.435 . . . . 0.0 111.167 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.407 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 169.3 162.73 22.07 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.496 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.8 pt -147.51 141.76 16.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 122.9 -0.176 . . . . 0.0 110.963 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -88.89 122.1 5.56 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 124.172 -1.178 . . . . 0.0 112.398 -0.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER -88.28 137.69 32.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 111.674 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -108.79 124.19 50.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 71' ' ' ILE . 6.7 mt -116.44 133.92 55.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.283 0.563 . . . . 0.0 111.618 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.98 HD12 HD11 ' A' ' 22' ' ' LEU . 3.0 mm? -115.27 122.13 45.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.695 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 50.2 m-85 -113.71 147.98 37.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.262 0.553 . . . . 0.0 111.542 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -147.02 111.01 5.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.208 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.9 m120 61.78 46.48 6.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.374 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.28 2.28 58.84 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.765 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.52 139.45 53.6 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.432 0.616 . . . . 0.0 112.192 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 85' ' ' VAL . 11.1 p -67.74 116.98 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.454 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.58 9.53 21.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.871 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -170.88 139.3 1.44 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.937 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.65 122.68 20.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.698 0.285 . . . . 0.0 111.171 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -124.08 138.14 54.48 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.39 146.18 24.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.328 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.38 164.62 30.96 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.279 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.594 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -67.23 169.34 8.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.12 0.486 . . . . 0.0 111.576 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.756 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -159.05 -170.32 2.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.25 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 t -111.52 165.73 11.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.814 0.34 . . . . 0.0 110.814 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -55.79 -34.01 64.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.995 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.46 -31.18 51.88 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.914 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 35.5 mt-30 -76.19 -33.5 59.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.903 0.382 . . . . 0.0 110.553 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.756 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -70.51 -49.77 44.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -61.93 -43.92 97.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.096 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.6 OUTLIER -61.3 -39.1 89.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.881 0.372 . . . . 0.0 110.167 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.793 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 9.7 t80 -61.28 -41.38 96.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.35 0.595 . . . . 0.0 110.333 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.649 HD21 ' HB ' ' A' ' 24' ' ' VAL . 10.7 mt -69.48 -50.75 42.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.763 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -52.43 -38.14 58.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 110.187 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.52 63.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.796 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -104.29 -56.28 2.22 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 110.923 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 22' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.838 179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 55' ' ' LEU . 40.0 t . . . . . 0 CA--C 1.523 -0.091 0 CA-C-O 120.738 0.304 . . . . 0.0 110.739 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -144.35 121.09 11.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.126 0.488 . . . . 0.0 109.941 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -74.66 129.61 38.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.604 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.854 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -100.98 108.15 22.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.418 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -100.0 18.16 19.18 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.905 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.1 m -154.13 158.04 39.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.84 0.352 . . . . 0.0 111.247 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.564 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -71.63 -26.27 62.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.555 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -79.72 -31.25 41.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.065 0.46 . . . . 0.0 110.298 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.87 -36.18 81.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.056 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -59.91 -42.98 95.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.012 0.434 . . . . 0.0 109.848 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -66.91 -44.7 80.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.614 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.23 -46.44 85.91 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.145 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.97 -30.71 70.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.139 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 15' ' ' LEU . 15.9 mt -69.49 -38.98 77.9 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.084 0.469 . . . . 0.0 110.188 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.25 -33.25 73.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.199 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.96 -23.68 52.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.892 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.32 -33.12 74.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.293 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.1 -122.17 28.68 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.154 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -96.04 7.81 45.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.613 0.244 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -79.05 148.07 32.6 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.916 HD11 HD12 ' A' ' 79' ' ' LEU . 6.1 tp -76.19 134.53 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.952 HG13 HG23 ' A' ' 53' ' ' ILE . 4.7 t -116.61 107.35 22.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.43 0.634 . . . . 0.0 112.085 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.563 HG23 ' CD2' ' A' ' 79' ' ' LEU . 7.3 p -101.69 115.07 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.556 HG12 ' HG ' ' A' ' 55' ' ' LEU . 5.2 m -122.59 168.15 15.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.364 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -135.14 134.13 39.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.951 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.484 ' HE1' HD12 ' A' ' 78' ' ' LEU . 7.1 m-85 -96.71 110.71 23.11 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' HG12 ' A' ' 59' ' ' VAL . 51.6 p -119.44 -168.45 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.299 0.571 . . . . 0.0 112.062 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.17 155.07 37.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.037 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -71.23 -35.94 71.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.462 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 47.5 p-90 -86.25 11.33 12.33 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.404 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 11.1 t -88.76 157.72 18.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.988 0.423 . . . . 0.0 111.436 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.92 -64.66 0.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.004 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 30.3 Cg_exo -64.01 -21.39 68.37 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.753 2.302 . . . . 0.0 112.499 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.7 m -59.02 -39.82 83.09 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.294 0.569 . . . . 0.0 109.983 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -68.69 -16.88 63.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.564 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.408 ' HG2' ' HA ' ' A' ' 34' ' ' PRO . 69.2 mmm -74.16 -24.64 59.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.537 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.539 HG22 ' HB2' ' A' ' 42' ' ' PHE . 6.9 mm -86.19 -24.87 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.631 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -51.09 65.93 Favored Pre-proline 0 N--CA 1.468 0.428 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.3 -48.37 18.03 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.151 1.901 . . . . 0.0 112.703 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -80.59 -31.03 36.87 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 8.2 t80 -66.59 -45.83 77.92 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.875 0.369 . . . . 0.0 110.319 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.67 -39.35 88.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.554 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.5 m -60.75 -42.86 98.24 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.042 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.18 -44.39 95.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.257 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 25.0 p -53.55 -25.15 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.229 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -86.6 -21.98 26.5 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 120.608 0.242 . . . . 0.0 111.129 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -94.9 -19.16 20.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.08 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.766 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.4 m-85 -98.95 92.84 5.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 t -90.11 50.58 1.88 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 110.674 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -153.14 -42.73 0.1 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.492 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' A' ' 49' ' ' TYR . 5.5 m -93.29 154.31 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.689 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.952 HG23 HG13 ' A' ' 23' ' ' VAL . 5.7 tp -105.9 115.65 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.909 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.613 ' O ' HG13 ' A' ' 2' ' ' VAL . 5.7 m-85 -97.03 115.83 28.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.505 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.854 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.48 166.73 17.39 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.491 178.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.412 ' N ' HD12 ' A' ' 55' ' ' LEU . 1.6 tp10 -117.93 118.6 32.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.462 HG22 HD11 ' A' ' 55' ' ' LEU . 2.4 t -116.39 118.07 57.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.548 0.689 . . . . 0.0 110.842 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -99.34 120.16 39.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.558 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 28' ' ' SER . 13.7 p -61.2 -17.84 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.4 -40.06 96.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.247 0.546 . . . . 0.0 109.527 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -98.25 -36.29 10.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.987 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.93 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.66 42.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.752 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -69.8 -11.17 60.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.343 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.96 -21.98 19.47 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.439 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.93 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.2 m -80.47 -46.48 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.152 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.877 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.04 -56.65 16.3 Favored Pre-proline 0 N--CA 1.466 0.331 0 O-C-N 122.284 -0.26 . . . . 0.0 111.552 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 79.2 Cg_exo -51.35 -28.32 26.64 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.543 2.162 . . . . 0.0 111.958 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -74.41 -24.74 59.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.35 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -108.43 -6.65 16.08 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.628 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.31 38.87 94.06 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.706 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.617 HG23 HG21 ' A' ' 76' ' ' THR . 76.7 mt -76.28 133.09 31.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 110.38 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.6 tpt85 -149.64 49.05 0.94 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.933 0.397 . . . . 0.0 110.913 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.32 102.09 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.713 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.407 ' HA ' ' N ' ' A' ' 76' ' ' THR . 13.0 pt -101.88 150.02 37.02 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.83 114.05 3.22 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 124.29 -1.129 . . . . 0.0 112.385 0.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.617 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -86.42 135.05 33.64 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.603 HD22 HD21 ' A' ' 93' ' ' LEU . 2.0 mp -107.81 126.18 52.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.55 HD11 HD11 ' A' ' 71' ' ' ILE . 6.0 mt -118.36 134.07 55.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.268 0.556 . . . . 0.0 111.636 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.916 HD12 HD11 ' A' ' 22' ' ' LEU . 3.1 mm? -113.4 126.0 54.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.688 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.494 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 51.9 m-85 -118.68 146.8 44.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.954 0.407 . . . . 0.0 110.961 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -144.74 110.45 5.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.805 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.0 m120 60.52 46.41 9.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 110.063 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.08 -3.37 38.23 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.005 -0.616 . . . . 0.0 114.141 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.57 134.1 55.24 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 117.299 0.55 . . . . 0.0 111.68 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 85' ' ' VAL . 10.0 p -68.04 116.35 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.445 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.81 11.1 24.47 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.89 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.45 137.23 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.263 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.531 HG23 ' CD2' ' A' ' 78' ' ' LEU . 51.3 m -137.52 124.68 21.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -122.72 145.14 48.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.352 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.81 146.64 24.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.199 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.44 159.26 10.83 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.964 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.44 141.0 52.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 111.481 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.603 HD21 HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -129.29 150.97 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.239 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.08 179.09 0.74 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.701 0.286 . . . . 0.0 110.624 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -71.28 -32.56 68.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.731 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.06 -31.03 54.43 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.928 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.74 -31.48 57.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.535 HD11 HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -71.78 -51.26 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.704 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -61.07 -41.78 97.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.078 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.83 -39.09 90.61 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.91 0.386 . . . . 0.0 110.178 179.467 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.89 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 11.3 t80 -63.27 -42.4 99.12 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.515 0.674 . . . . 0.0 110.114 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.51 HD11 HG11 ' A' ' 24' ' ' VAL . 5.0 mt -66.77 -58.45 5.03 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.85 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -48.86 -34.97 13.6 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.732 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.2 -20.57 60.15 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -109.0 -33.42 6.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.678 HD23 HG12 ' A' ' 52' ' ' VAL . 3.4 tm? . . . . . 0 C--N 1.326 -0.448 0 CA-C-O 120.893 0.378 . . . . 0.0 110.679 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.718 HG13 ' HA ' ' A' ' 55' ' ' LEU . 48.3 t . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 120.664 0.268 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -146.09 122.07 10.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.159 0.504 . . . . 0.0 110.265 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -74.48 129.64 38.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.053 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.872 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -101.97 108.11 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 110.317 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -98.94 19.27 15.34 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.226 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -154.72 159.74 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 0.0 111.127 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.614 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -72.35 -27.1 62.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.083 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -79.97 -31.87 39.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.952 0.406 . . . . 0.0 110.751 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.63 90.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.898 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.492 ' CE1' HG21 ' A' ' 57' ' ' VAL . 3.8 t80 -56.36 -40.19 74.12 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.75 -45.14 72.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.046 178.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.77 -48.41 79.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.484 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.41 -32.46 74.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.916 0.389 . . . . 0.0 110.928 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 mt -68.14 -34.58 76.6 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.802 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.01 -34.13 76.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.925 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.2 -22.59 55.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.702 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.68 -37.61 85.1 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.297 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.17 -124.37 35.78 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.997 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -94.19 4.89 53.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.543 0.211 . . . . 0.0 111.031 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 mttp -77.42 149.36 35.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.801 HD12 ' N ' ' A' ' 23' ' ' VAL . 4.4 tp -76.77 136.64 39.0 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.865 HG13 HG23 ' A' ' 53' ' ' ILE . 10.6 t -117.05 110.83 32.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.261 0.553 . . . . 0.0 112.234 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.524 HG11 ' CZ ' ' A' ' 54' ' ' PHE . 7.9 p -106.69 115.87 49.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.53 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.3 m -123.02 167.48 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.949 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -134.51 135.96 42.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.284 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.598 ' HE1' HD12 ' A' ' 78' ' ' LEU . 7.8 m-85 -99.06 109.88 22.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.545 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.3 m -114.97 -168.67 1.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.139 0.495 . . . . 0.0 111.928 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.722 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.08 155.17 37.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.743 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -71.96 -37.47 69.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.499 0.666 . . . . 0.0 109.366 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -86.76 12.4 10.92 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.034 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.722 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 8.0 t -94.17 159.83 14.97 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.994 0.426 . . . . 0.0 111.746 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.94 -64.91 0.44 Allowed Glycine 0 C--N 1.331 0.262 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.045 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.4 -24.13 77.97 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.708 2.272 . . . . 0.0 112.047 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.9 m -58.94 -43.69 91.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.238 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.4 -27.53 67.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.599 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 47.9 mtt -67.83 -17.09 64.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.3 mm -86.27 -22.35 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.904 0.383 . . . . 0.0 111.002 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -51.28 -58.7 9.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.169 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_endo -48.07 -46.65 21.59 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.539 2.16 . . . . 0.0 112.655 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -78.94 -33.79 45.02 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -66.17 -45.82 79.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.916 0.389 . . . . 0.0 110.402 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -40.68 87.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.657 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -43.85 94.83 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.882 0.372 . . . . 0.0 110.893 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.466 HD22 ' HG3' ' A' ' 99' ' ' LYS . 21.5 mt -59.68 -39.42 84.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.7 t -56.49 -29.57 61.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.614 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.66 -18.19 31.91 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.144 -0.223 . . . . 0.0 111.516 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -95.1 -20.35 19.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 0.0 110.008 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.794 ' HB3' HG22 ' A' ' 52' ' ' VAL . 21.8 m-85 -100.13 90.65 4.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.473 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 m -86.96 51.28 2.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.081 0.467 . . . . 0.0 110.454 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -154.65 -41.57 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.171 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.7 m -93.37 154.45 3.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.013 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.865 HG23 HG13 ' A' ' 23' ' ' VAL . 4.0 tp -103.7 114.48 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.256 0.55 . . . . 0.0 111.507 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.622 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.7 m-85 -97.61 115.6 28.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.178 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.872 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.63 167.89 16.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.115 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.68 120.41 36.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.492 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -115.16 118.11 57.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.0 110.406 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -97.97 119.52 36.74 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 28' ' ' SER . 13.9 p -60.08 -18.71 16.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.03 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -65.66 -38.07 88.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.037 0.446 . . . . 0.0 109.802 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.35 -35.13 10.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.28 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.903 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.43 46.07 1.14 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.916 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.3 -11.19 60.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.534 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.75 -22.79 19.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.505 0.193 . . . . 0.0 111.174 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.903 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -79.31 -47.29 22.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.978 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.634 ' HB3' ' CD ' ' A' ' 67' ' ' PRO . . . -50.52 -60.16 5.9 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.634 ' CD ' ' HB3' ' A' ' 66' ' ' ALA . 10.2 Cg_endo -50.85 -28.63 24.02 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.713 2.276 . . . . 0.0 111.967 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -78.13 -23.41 47.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.902 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -106.4 -2.96 21.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.649 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.67 33.75 86.98 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.629 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.639 HD11 HD11 ' A' ' 78' ' ' LEU . 81.2 mt -77.75 133.64 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 117.184 0.492 . . . . 0.0 110.618 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -144.74 64.35 1.29 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.337 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 170.85 162.38 23.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.243 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.3 pt -147.51 139.78 14.21 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.692 0.246 . . . . 0.0 110.987 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -87.95 123.62 6.65 Favored 'Cis proline' 0 C--N 1.35 0.635 0 C-N-CA 124.203 -1.165 . . . . 0.0 112.604 0.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.498 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -86.99 134.29 33.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.813 0.339 . . . . 0.0 111.077 179.199 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.863 HD22 HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -106.27 123.47 48.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.639 HD11 HD11 ' A' ' 71' ' ' ILE . 7.4 mt -115.6 136.12 53.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.222 0.534 . . . . 0.0 111.845 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.931 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 3.3 mm? -116.34 120.81 40.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.594 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.529 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.3 m-85 -112.17 145.61 39.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 0.0 111.202 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 tttm -145.93 110.94 5.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.998 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.9 m120 62.06 46.19 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 110.111 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.66 2.9 57.45 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.745 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -123.78 136.33 54.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.385 0.592 . . . . 0.0 111.651 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 85' ' ' VAL . 7.6 p -66.66 117.59 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.128 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.68 11.48 28.4 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.931 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.52 144.62 1.15 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.96 119.97 17.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -122.13 139.27 53.94 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.855 0.359 . . . . 0.0 110.249 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 t -121.8 145.92 27.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.464 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.6 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.54 159.81 24.38 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.602 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.74 143.89 54.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.976 0.417 . . . . 0.0 111.386 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.863 HD11 HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -125.43 -171.37 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.513 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.0 t -109.21 165.98 11.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 110.822 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -57.4 -37.72 73.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.05 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.54 -30.12 54.04 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.845 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.58 -32.59 58.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.488 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.44 -49.65 39.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.466 ' HG3' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -61.01 -43.76 98.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.876 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -62.21 -38.1 87.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.891 0.377 . . . . 0.0 110.168 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.678 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 5.6 t80 -61.82 -39.99 93.69 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.207 0.527 . . . . 0.0 109.923 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.435 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 6.6 mt -66.12 -59.32 3.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.914 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.49 -34.49 11.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.058 0.456 . . . . 0.0 110.705 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -24.42 62.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.18 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -106.37 -47.68 3.74 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.676 0.274 . . . . 0.0 111.021 -179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 106' ' ' LEU . 6.1 tt . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.768 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.731 HG13 ' HA ' ' A' ' 55' ' ' LEU . 56.8 t . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.856 0.36 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.77 123.42 11.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.022 0.439 . . . . 0.0 109.827 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -75.38 132.39 40.87 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.91 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -100.16 106.74 19.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 110.543 -179.1 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.76 21.31 10.63 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.87 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.26 159.13 38.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.771 0.32 . . . . 0.0 111.192 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.701 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.2 tmpt? -73.58 -26.9 61.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.946 0.403 . . . . 0.0 110.42 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -79.8 -32.11 40.76 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.616 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.421 ' CB ' HG13 ' A' ' 5' ' ' ILE . . . -66.57 -36.25 82.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.463 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.586 ' CE1' HG21 ' A' ' 57' ' ' VAL . 6.0 t80 -58.16 -42.51 86.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.107 0.479 . . . . 0.0 110.168 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -66.53 -41.79 88.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.955 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.96 -48.21 82.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.528 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.93 76.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 110.67 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 15' ' ' LEU . 12.1 mt -64.78 -40.76 95.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -66.9 -27.1 67.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.624 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -49.19 75.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.876 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.79 -64.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.544 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.51 -86.3 1.46 Allowed Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.809 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -94.4 -16.92 23.02 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -74.86 157.73 34.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.054 HD11 HD12 ' A' ' 79' ' ' LEU . 5.3 tp -79.5 133.96 36.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.863 HG13 ' CG2' ' A' ' 53' ' ' ILE . 15.7 t -114.37 110.37 31.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.403 0.621 . . . . 0.0 111.573 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.668 ' HB ' HD21 ' A' ' 102' ' ' LEU . 7.3 p -106.18 115.05 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.572 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.2 m -123.05 166.74 17.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.759 -178.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -131.75 132.04 43.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.546 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.692 ' HE1' HD12 ' A' ' 78' ' ' LEU . 4.7 m-85 -97.94 111.84 24.0 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.686 ' O ' HG12 ' A' ' 59' ' ' VAL . 22.7 t -117.46 -170.51 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.0 112.472 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.12 155.38 37.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.437 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -35.84 68.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.39 0.614 . . . . 0.0 110.199 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -85.31 11.52 9.99 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.081 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 8.8 t -96.83 158.26 15.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 111.313 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.51 -66.55 0.5 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.009 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.82 -23.36 71.89 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.454 2.103 . . . . 0.0 112.193 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -58.82 -44.54 90.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -65.0 -26.5 68.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.51 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.5 mtt -67.03 -17.44 64.91 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.544 HD11 ' HB1' ' A' ' 92' ' ' ALA . 14.5 mm -86.1 -21.72 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.091 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 25.6 mttp -51.37 -59.34 8.02 Favored Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 8.2 Cg_endo -50.35 -45.2 35.24 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.437 2.092 . . . . 0.0 112.869 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -78.88 -31.87 45.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.419 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 4.5 t80 -65.9 -45.37 82.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.93 0.395 . . . . 0.0 110.531 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.78 -38.35 86.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.524 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.6 m -59.67 -42.8 93.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 110.746 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 54' ' ' PHE . 10.5 mt -60.81 -42.89 98.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.418 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.4 p -54.81 -25.84 31.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.394 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -86.64 -23.15 25.78 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.599 0.238 . . . . 0.0 111.321 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -94.18 -19.05 21.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 110.041 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.832 ' HB3' HG22 ' A' ' 52' ' ' VAL . 19.7 m-85 -100.16 88.03 3.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.966 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 p -87.11 50.92 2.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.463 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -153.5 -42.58 0.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.685 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.832 HG22 ' HB3' ' A' ' 49' ' ' TYR . 12.3 m -93.46 154.56 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.556 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.863 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.6 tp -103.79 114.17 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.353 0.597 . . . . 0.0 111.038 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.646 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.5 m-85 -96.91 117.31 30.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.806 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.91 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -130.76 164.8 24.32 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.395 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -112.98 116.02 29.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.586 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.6 t -114.05 116.46 52.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.168 0.508 . . . . 0.0 111.048 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -99.18 120.18 39.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.469 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 28' ' ' SER . 10.2 p -60.96 -20.03 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.098 -178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -61.76 -40.77 96.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.219 0.533 . . . . 0.0 109.667 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -100.26 -33.53 10.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.353 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.914 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.78 43.6 1.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.548 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -71.66 -9.92 58.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.565 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.38 -21.4 18.4 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.243 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.914 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 1.6 m -79.34 -47.87 21.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.485 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.919 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.89 -58.28 9.87 Favored Pre-proline 0 C--N 1.333 -0.141 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.919 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 74.7 Cg_exo -51.2 -28.3 25.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.415 2.077 . . . . 0.0 111.849 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -73.8 -25.68 60.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.487 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -108.39 -6.12 16.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.691 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.73 36.23 90.94 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 116.007 -0.542 . . . . 0.0 114.33 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.627 HD11 HD11 ' A' ' 78' ' ' LEU . 63.9 mt -74.65 136.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 117.312 0.556 . . . . 0.0 110.653 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -151.79 54.89 0.84 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 111.236 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.73 102.22 0.15 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.428 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.428 ' HA ' ' N ' ' A' ' 76' ' ' THR . 11.8 pt -102.87 154.39 37.56 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 122.971 -0.135 . . . . 0.0 110.835 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.74 114.17 3.17 Favored 'Cis proline' 0 C--N 1.348 0.529 0 C-N-CA 123.768 -1.347 . . . . 0.0 113.125 0.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.484 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -86.26 136.61 33.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 111.221 179.018 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -107.39 123.61 48.62 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.692 HD12 ' HE1' ' A' ' 27' ' ' PHE . 6.7 mt -116.03 136.14 53.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.223 0.535 . . . . 0.0 111.867 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.054 HD12 HD11 ' A' ' 22' ' ' LEU . 3.9 mm? -116.29 123.46 47.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.863 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.639 ' CE2' HG22 ' A' ' 85' ' ' VAL . 47.1 m-85 -113.98 144.94 42.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.024 0.44 . . . . 0.0 111.072 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -146.14 111.34 5.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.061 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.5 m120 61.49 45.29 8.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.774 0.321 . . . . 0.0 110.563 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.99 2.76 58.73 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.52 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -124.45 140.35 53.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.297 0.548 . . . . 0.0 111.809 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.639 HG22 ' CE2' ' A' ' 80' ' ' PHE . 33.0 t -69.9 120.87 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.672 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.72 8.65 16.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.904 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.84 136.56 0.55 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.9 m -136.36 125.26 24.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 0.0 110.771 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 145.17 49.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.046 0.451 . . . . 0.0 111.181 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.59 145.93 25.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.172 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.409 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 77.53 160.83 13.7 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.332 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.666 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -65.29 176.38 1.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.045 0.45 . . . . 0.0 111.508 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -170.37 153.3 4.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.692 -179.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 t -66.78 179.01 1.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.028 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -72.97 -28.63 62.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.068 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.46 -31.77 49.63 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.13 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 39.7 mt-30 -76.87 -31.9 57.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.975 0.387 . . . . 0.0 110.558 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.611 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -71.02 -51.13 27.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.047 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -63.33 -43.22 98.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.097 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.4 pp20? -62.06 -43.17 99.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.779 0.323 . . . . 0.0 110.469 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.748 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 29.8 t80 -61.9 -39.21 91.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.4 0.619 . . . . 0.0 110.088 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.668 HD21 ' HB ' ' A' ' 24' ' ' VAL . 4.3 mt -65.52 -60.7 2.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.009 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -48.23 -32.22 6.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.02 -26.23 63.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.791 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -106.36 -26.58 11.42 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.702 0.287 . . . . 0.0 111.524 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 106' ' ' LEU . 1.8 tt . . . . . 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 110.482 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.696 HG13 ' HA ' ' A' ' 55' ' ' LEU . 52.1 t . . . . . 0 CA--C 1.522 -0.104 0 CA-C-O 120.71 0.29 . . . . 0.0 110.625 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -143.34 120.51 11.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.185 0.517 . . . . 0.0 110.377 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.63 129.27 37.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.118 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.796 HD13 HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -101.67 107.79 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.353 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.66 20.19 13.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.159 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -155.15 160.36 40.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.824 0.345 . . . . 0.0 111.401 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.648 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -72.96 -27.07 61.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.624 179.474 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.438 HG22 ' OE2' ' A' ' 13' ' ' GLU . 6.3 m -79.76 -30.99 40.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.858 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.428 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -65.78 -39.78 91.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.735 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 57' ' ' VAL . 4.8 t80 -56.77 -43.26 80.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.191 0.52 . . . . 0.0 109.661 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -46.2 78.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.875 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.438 ' OE2' HG22 ' A' ' 9' ' ' THR . 14.0 mt-10 -60.74 -44.8 96.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.434 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.74 -34.32 78.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.577 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.03 -35.9 79.03 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.497 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -35.29 76.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.322 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.45 -22.52 54.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.91 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.1 -33.21 74.1 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.227 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.03 -125.07 37.83 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.036 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.22 6.4 46.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.509 0.195 . . . . 0.0 111.139 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -78.74 150.15 32.53 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.951 HD11 HD12 ' A' ' 79' ' ' LEU . 6.5 tp -78.08 133.76 37.84 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.884 HG13 HG23 ' A' ' 53' ' ' ILE . 6.5 t -113.85 110.19 31.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.454 0.645 . . . . 0.0 112.005 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.684 HG11 HD11 ' A' ' 102' ' ' LEU . 7.3 p -102.59 113.84 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.709 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.1 m -121.27 165.85 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.758 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -134.31 133.31 40.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.854 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.459 ' HE1' HD12 ' A' ' 78' ' ' LEU . 10.7 m-85 -97.34 110.39 22.95 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 35' ' ' CYS . 54.4 p -121.41 -166.76 1.41 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.247 0.546 . . . . 0.0 112.228 -178.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.83 152.71 33.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.155 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -70.44 -36.98 74.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.437 0.637 . . . . 0.0 109.408 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -87.23 11.31 14.49 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.826 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.769 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 15.4 t -93.04 155.79 17.29 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.482 . . . . 0.0 112.213 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.79 -75.8 1.04 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.209 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HA ' ' CG ' ' A' ' 37' ' ' MET . 9.3 Cg_endo -52.26 -24.52 21.07 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.62 2.214 . . . . 0.0 112.416 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 81.2 m -60.49 -41.96 95.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.208 0.528 . . . . 0.0 110.373 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -68.93 -15.64 63.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.25 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.402 ' CG ' ' HA ' ' A' ' 34' ' ' PRO . 3.9 mmt -72.96 -28.09 62.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.467 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.2 mm -84.56 -23.97 7.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.734 0.302 . . . . 0.0 111.431 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -49.76 -54.13 34.94 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.898 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -51.45 -48.36 21.65 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.514 2.142 . . . . 0.0 113.345 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -80.08 -28.27 39.17 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -65.63 -45.83 81.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.965 0.412 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.04 -37.96 81.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.95 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -43.96 97.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.917 0.389 . . . . 0.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.54 -42.35 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.111 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.7 t -55.38 -26.19 39.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.293 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -88.45 -20.15 25.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.586 0.231 . . . . 0.0 111.526 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -96.23 -20.35 18.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.058 0.456 . . . . 0.0 110.069 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.828 ' HB3' HG22 ' A' ' 52' ' ' VAL . 20.0 m-85 -98.71 92.83 5.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.725 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.7 p -91.31 48.51 1.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.667 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -151.79 -40.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.58 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.828 HG22 ' HB3' ' A' ' 49' ' ' TYR . 12.5 m -95.35 156.16 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.594 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.884 HG23 HG13 ' A' ' 23' ' ' VAL . 4.7 tp -106.67 115.18 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.892 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.622 ' CE1' HG11 ' A' ' 24' ' ' VAL . 7.7 m-85 -96.34 115.65 27.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.244 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.796 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.32 166.24 19.02 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.734 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.458 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -117.98 120.05 36.67 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -176.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -114.75 117.72 56.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.107 0.48 . . . . 0.0 110.713 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -98.62 120.05 38.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.78 -17.67 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -66.91 -37.61 84.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.2 -37.82 9.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.143 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.855 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.59 44.11 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.303 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -9.37 48.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.815 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.57 -22.36 17.67 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.467 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.855 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.8 m -79.06 -47.44 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.53 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.926 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.66 -57.69 11.42 Favored Pre-proline 0 N--CA 1.463 0.178 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.926 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 75.3 Cg_exo -51.11 -28.5 25.34 Favored 'Trans proline' 0 C--N 1.34 0.09 0 C-N-CA 122.441 2.094 . . . . 0.0 111.595 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -75.93 -21.72 56.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.918 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -112.63 -5.69 13.96 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.49 39.26 96.71 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.451 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.873 HG23 HG21 ' A' ' 76' ' ' THR . 61.4 mt -79.32 79.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.929 0.365 . . . . 0.0 111.06 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -86.5 82.58 7.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.184 0.516 . . . . 0.0 111.836 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.77 163.13 10.07 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.568 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.2 pt -146.2 156.77 50.3 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -83.5 118.25 5.34 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.402 -1.082 . . . . 0.0 113.063 0.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.873 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -89.16 136.55 32.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.372 . . . . 0.0 111.686 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.622 HD22 HD21 ' A' ' 93' ' ' LEU . 1.1 mp -109.19 123.29 49.0 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.707 ' CD2' HG23 ' A' ' 88' ' ' THR . 6.3 mt -115.6 133.11 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.341 0.591 . . . . 0.0 111.411 -178.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.951 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -114.17 121.8 44.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.636 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.497 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 41.6 m-85 -113.07 146.87 38.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.261 0.553 . . . . 0.0 111.544 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -146.69 116.73 7.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.011 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m120 57.98 44.97 18.81 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.455 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.1 2.54 53.43 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.9 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -124.91 139.47 53.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.473 0.637 . . . . 0.0 111.705 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 85' ' ' VAL . 10.4 p -67.96 117.51 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.905 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -110.91 10.68 22.33 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.857 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.7 137.14 0.34 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.527 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.707 HG23 ' CD2' ' A' ' 78' ' ' LEU . 10.9 m -136.7 125.26 23.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.588 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -123.24 143.21 50.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.859 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.5 146.37 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.568 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.449 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 80.95 159.6 22.49 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.892 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.03 37.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 111.696 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.622 HD21 HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -118.72 150.4 39.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.7 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 m -63.98 179.81 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -72.78 -32.63 65.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.976 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.01 -30.06 56.16 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.618 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 26.3 mt-30 -76.43 -31.86 58.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.441 . . . . 0.0 110.704 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.589 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -72.33 -50.11 29.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -62.22 -44.08 97.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.107 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 17.8 pt-20 -60.05 -44.22 94.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.713 0.292 . . . . 0.0 110.814 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.857 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 19.4 t80 -61.92 -42.2 98.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.114 0.483 . . . . 0.0 111.11 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.684 HD11 HG11 ' A' ' 24' ' ' VAL . 3.6 mt -66.67 -57.54 6.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.164 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.26 -34.92 16.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.68 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.74 -22.59 60.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.254 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -107.88 -24.14 11.77 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.504 HD23 HG12 ' A' ' 52' ' ' VAL . 2.2 tm? . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.813 -179.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.917 HG13 ' HA ' ' A' ' 55' ' ' LEU . 58.3 t . . . . . 0 CA--C 1.52 -0.21 0 N-CA-C 109.709 -0.478 . . . . 0.25 109.709 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.506 ' O ' HD12 ' A' ' 5' ' ' ILE . 10.2 ptpt -143.96 122.43 12.42 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.686 -0.805 . . . . 1.47 110.917 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.16 123.4 26.37 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.44 -1.254 . . . . 1.77 109.796 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 1.048 ' CD1' HD13 ' A' ' 55' ' ' LEU . 3.5 mp -102.91 110.79 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.985 0.421 . . . . 0.48999999999999999 110.558 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -98.63 19.02 15.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.012 -0.54 . . . . 1.5700000000000001 111.545 179.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.45 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.7 m -155.16 163.69 39.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.949 0.404 . . . . 0.76000000000000001 111.89 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.9 ttpt -76.79 -25.55 53.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.984 -0.553 . . . . 1.3600000000000001 110.778 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -79.34 -32.43 43.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.004 0.431 . . . . 0.28000000000000003 109.955 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 1.041 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -66.51 -37.97 86.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.801 -0.636 . . . . 0.17000000000000001 110.521 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -57.85 -46.14 85.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.23999999999999999 110.686 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -65.47 -40.58 93.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.853 -0.612 . . . . 1.01 109.736 178.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -58.58 -48.76 79.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.918 -0.583 . . . . 1.3400000000000001 110.94 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.45 -36.29 82.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.991 -0.549 . . . . 0.20999999999999999 111.247 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.2 mt -64.69 -38.33 90.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.29999999999999999 110.166 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.2 -27.66 68.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 1.7 110.476 179.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.9 83.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.31 111.146 -178.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.15 -65.45 0.67 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 119.943 -0.703 . . . . 0.63 109.922 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.83 -93.24 1.86 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.704 -0.68 . . . . 0.42999999999999999 112.808 -179.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -95.63 -9.95 30.75 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.199 0.499 . . . . 2.2599999999999998 111.669 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -75.24 151.08 38.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.613 -0.514 . . . . 1.1399999999999999 109.613 179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.998 HD11 HD12 ' A' ' 79' ' ' LEU . 1.9 tp -76.39 127.91 33.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.883 0.373 . . . . 0.20000000000000001 110.112 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.827 HG13 ' CG2' ' A' ' 53' ' ' ILE . 3.9 t -106.67 110.23 30.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.34 0.59 . . . . 0.17999999999999999 111.592 -179.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.548 ' HB ' HD21 ' A' ' 102' ' ' LEU . 7.3 p -106.07 116.06 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.114 -1.069 . . . . 0.26000000000000001 108.114 178.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.067 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.9 m -123.37 164.18 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.179 0.514 . . . . 0.46000000000000002 112.371 -178.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.477 ' OD1' HD12 ' A' ' 77' ' ' LEU . 31.0 t0 -127.81 132.9 49.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 1.1200000000000001 112.067 -178.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -99.1 106.52 18.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.06 -0.719 . . . . 0.23999999999999999 109.06 178.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.525 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.9 p -119.92 -174.76 2.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.068 0.766 . . . . 1.22 113.068 -177.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -147.02 154.77 41.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.459 -1.246 . . . . 0.28000000000000003 110.396 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -38.45 79.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.81999999999999995 110.176 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -86.54 14.22 7.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.364 -0.834 . . . . 0.57999999999999996 111.412 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 32.2 t -98.42 141.35 31.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.737 0.303 . . . . 0.52000000000000002 110.571 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.89 -67.24 0.94 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.592 -0.813 . . . . 0.28999999999999998 112.196 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -51.95 -26.58 25.35 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.585 2.19 . . . . 0.40999999999999998 112.165 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -60.54 -44.06 96.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.35999999999999999 110.534 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -65.94 -28.44 68.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.795 -0.639 . . . . 1.5700000000000001 111.093 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.0 mtt -68.55 -21.01 64.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 1.22 111.549 -179.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.8 mm -87.21 -23.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.746 0.308 . . . . 0.28999999999999998 111.132 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.401 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 31.5 mttt -51.23 -54.77 34.7 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.39 -0.368 . . . . 1.8700000000000001 110.945 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 39' ' ' LYS . 71.5 Cg_exo -48.31 -48.14 17.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.613 2.209 . . . . 0.32000000000000001 112.485 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -78.24 -28.43 47.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.516 -0.311 . . . . 0.28999999999999998 111.508 -178.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 4.4 t80 -68.31 -47.96 66.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.097 0.475 . . . . 0.25 110.187 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.89 -41.67 86.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.735 -0.666 . . . . 0.29999999999999999 111.505 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -59.39 -44.85 92.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.774 0.321 . . . . 1.1200000000000001 110.82 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.41 -40.4 86.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.808 -0.441 . . . . 0.20000000000000001 109.808 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.426 ' HB2' ' CB ' ' A' ' 54' ' ' PHE . 35.6 t -53.92 -28.26 35.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 1.24 111.11 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -87.93 -17.9 30.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.641 -0.254 . . . . 2.1400000000000001 111.33 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.446 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 4.6 ttpp -95.51 -21.47 18.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.018 0.437 . . . . 1.27 109.946 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.79 ' HB3' HG22 ' A' ' 52' ' ' VAL . 16.9 m-85 -99.04 92.21 5.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.627 -0.715 . . . . 0.70999999999999996 110.708 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -84.26 46.41 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 1.1599999999999999 111.397 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -157.62 -36.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.956 0.354 . . . . 1.05 111.956 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.79 HG22 ' HB3' ' A' ' 49' ' ' TYR . 6.2 m -91.85 157.07 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.682 0.277 . . . . 0.20000000000000001 111.193 -179.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.827 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.2 tp -104.92 116.91 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.222 0.534 . . . . 0.34000000000000002 111.109 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.7 m-85 -99.1 117.27 33.23 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.814 -0.63 . . . . 0.23999999999999999 110.242 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.067 ' HG ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -133.23 169.78 16.4 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.642 -0.423 . . . . 0.34999999999999998 110.849 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.968 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -121.57 124.94 45.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.381 0.882 . . . . 1.8200000000000001 113.381 -178.712 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.507 HG22 HD11 ' A' ' 55' ' ' LEU . 7.8 t -112.0 114.59 47.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.654 -0.703 . . . . 0.14999999999999999 111.027 178.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -94.47 115.68 27.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.1 -0.5 . . . . 1.8999999999999999 109.686 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 28' ' ' SER . 12.4 p -59.75 -21.05 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.19 111.644 -178.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -64.65 -38.83 92.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.932 -0.395 . . . . 1.1599999999999999 109.932 179.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -99.61 -39.16 8.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 1.3100000000000001 111.263 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.702 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.17 50.38 1.39 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.055 0.455 . . . . 0.16 111.176 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 7.0 tt0 -77.54 -3.2 39.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.158 -0.474 . . . . 2.0 110.958 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.38 -24.84 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.766 0.317 . . . . 1.28 110.176 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.702 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 8.2 m -81.98 -48.28 18.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.184 -0.462 . . . . 0.22 111.399 179.298 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.864 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.52 -55.14 24.26 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 112.933 0.716 . . . . 0.17999999999999999 112.933 -178.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 72.6 Cg_exo -52.35 -27.8 32.5 Favored 'Trans proline' 0 C--O 1.23 0.114 0 C-N-CA 122.871 2.381 . . . . 0.29999999999999999 113.059 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -77.27 -20.26 55.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.124 -0.489 . . . . 1.3600000000000001 111.895 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -107.48 -6.03 17.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.055 0.455 . . . . 0.23999999999999999 111.055 179.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.04 37.43 93.13 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.626 -0.715 . . . . 0.26000000000000001 112.859 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 78' ' ' LEU . 70.9 mt -75.05 134.98 28.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.358 -0.608 . . . . 0.66000000000000003 109.358 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -147.2 59.77 1.17 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.72 0.295 . . . . 2.7599999999999998 110.968 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.13 117.72 0.45 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.478 -0.867 . . . . 0.94999999999999996 113.297 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 pt -108.24 153.54 41.85 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 110.164 -0.31 . . . . 0.81999999999999995 110.164 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.76 115.94 4.06 Favored 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.854 -1.311 . . . . 0.44 112.488 -0.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.63 138.2 31.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.878 0.371 . . . . 0.20000000000000001 111.424 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.477 HD12 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -108.17 124.86 50.9 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.429 -0.952 . . . . 0.34999999999999998 108.429 177.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.522 HD11 HD11 ' A' ' 71' ' ' ILE . 5.0 mt -116.28 135.33 53.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.272 0.558 . . . . 0.23000000000000001 111.625 -178.047 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.998 HD12 HD11 ' A' ' 22' ' ' LEU . 4.0 mm? -116.74 112.56 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.508 -0.769 . . . . 0.23999999999999999 110.889 -179.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.584 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 50.5 m-85 -104.26 142.62 34.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.076 -0.511 . . . . 0.19 110.524 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -143.62 112.7 6.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.731 -0.668 . . . . 0.34999999999999998 109.638 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.8 m120 61.36 45.73 8.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.21 0.529 . . . . 0.72999999999999998 109.729 -178.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.43 3.32 46.93 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.37 -0.832 . . . . 0.17000000000000001 113.793 178.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -124.67 140.24 53.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.599 0.699 . . . . 1.6499999999999999 112.106 -179.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.5 t -64.68 116.83 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.586 -0.734 . . . . 1.26 110.788 179.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.54 -1.11 19.95 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.517 0.562 . . . . 0.57999999999999996 112.517 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.625 ' HB1' ' HZ ' ' A' ' 101' ' ' PHE . . . -172.79 147.31 1.71 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.058 -0.519 . . . . 0.22 111.78 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 t -137.73 144.5 41.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 1.4199999999999999 110.912 178.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -138.55 139.69 38.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.026 -0.534 . . . . 1.79 110.059 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.0 t -121.32 143.96 31.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.681 0.277 . . . . 0.58999999999999997 111.239 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.407 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 82.66 160.19 27.77 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.529 -0.843 . . . . 0.17999999999999999 112.607 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.69 155.54 39.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.143 0.497 . . . . 0.44 111.638 -179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -150.52 151.61 32.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.602 -0.726 . . . . 0.56999999999999995 110.263 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 m -66.92 179.22 1.16 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.428 . . . . 0.91000000000000003 111.294 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -72.64 -30.59 64.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.624 . . . . 0.81000000000000005 111.478 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.19 -30.59 54.57 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.131 -1.033 . . . . 0.14000000000000001 112.701 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.587 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 51.6 mt-30 -76.17 -28.46 57.34 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.876 -0.33 . . . . 1.1799999999999999 110.632 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -50.72 16.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.067 0.46 . . . . 0.28999999999999998 109.843 178.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.446 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 14.7 ttpt -59.22 -44.25 92.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.736 -0.665 . . . . 1.1599999999999999 110.908 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.5 pp20? -61.45 -40.31 94.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.86 -0.609 . . . . 1.3799999999999999 110.574 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' PHE . . . . . 0.625 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 11.9 t80 -62.38 -42.54 99.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.317 0.58 . . . . 0.26000000000000001 110.645 178.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.548 HD21 ' HB ' ' A' ' 24' ' ' VAL . 8.1 mt -66.55 -54.95 18.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.778 -0.646 . . . . 0.35999999999999999 109.656 179.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -48.96 -34.05 12.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.169 0.509 . . . . 1.1499999999999999 110.219 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.49 -22.57 61.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.735 -0.666 . . . . 0.22 112.288 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -109.06 -33.32 6.93 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.83 -0.348 . . . . 0.38 111.407 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' A' ' 22' ' ' LEU . 3.2 tm? . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 109.99 -0.374 . . . . 1.3700000000000001 109.99 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 ptp . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 120.895 0.378 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.723 HG13 ' HA ' ' A' ' 55' ' ' LEU . 43.1 t 63.87 144.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -143.12 120.6 11.69 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.274 0.559 . . . . 0.0 110.334 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -72.57 125.35 27.23 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.931 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.857 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -101.02 107.04 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.92 0.391 . . . . 0.0 110.363 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -97.86 20.06 12.75 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.974 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.3 m -156.95 160.13 38.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.838 0.351 . . . . 0.0 111.413 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.657 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.7 ttpt -72.43 -27.03 62.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.969 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -79.47 -32.13 42.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.383 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.402 ' CB ' HG13 ' A' ' 5' ' ' ILE . . . -66.1 -37.0 84.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.483 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.18 -45.2 91.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.969 0.414 . . . . 0.0 110.027 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 -65.31 -44.53 87.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.618 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -59.76 -45.77 91.23 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.642 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.4 -32.55 74.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.07 0.462 . . . . 0.0 110.696 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.0 mt -69.37 -35.88 76.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.719 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -62.15 -34.61 76.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.789 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.55 -22.72 53.97 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.927 178.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.06 -32.77 73.35 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.036 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.17 -120.8 21.24 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.305 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -93.42 1.67 56.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 111.631 0.234 . . . . 0.0 111.631 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -76.45 148.8 37.01 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.867 HD11 HD12 ' A' ' 79' ' ' LEU . 4.2 tp -76.51 131.51 39.04 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 1.013 HG13 HG23 ' A' ' 53' ' ' ILE . 2.4 t -113.45 109.07 27.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.272 0.558 . . . . 0.0 111.805 -178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.608 HG11 HD11 ' A' ' 102' ' ' LEU . 7.2 p -104.23 119.2 52.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.632 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.6 m -124.97 167.6 18.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.824 -177.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -135.9 136.56 40.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.923 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.575 ' HE1' HD12 ' A' ' 78' ' ' LEU . 13.6 m-85 -98.67 114.1 26.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.284 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.509 ' O ' HG12 ' A' ' 59' ' ' VAL . 28.9 p -131.78 -171.12 2.54 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.683 0.754 . . . . 0.0 112.767 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -152.54 162.3 41.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.546 178.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.6 m -63.08 -30.63 71.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.92 0.391 . . . . 0.0 110.045 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -93.32 10.81 30.5 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.188 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 16.8 t -90.89 113.78 26.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.951 0.405 . . . . 0.0 111.176 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.84 -59.9 3.57 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.024 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -55.86 -28.75 69.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.342 2.028 . . . . 0.0 112.311 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.4 m -60.07 -39.87 87.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.803 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 6.1 mtpm? -69.11 -20.33 64.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.248 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 7.5 mtt -74.17 -25.19 59.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.369 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.505 HD11 ' HB1' ' A' ' 92' ' ' ALA . 7.3 mm -89.42 -24.83 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-O 120.654 0.264 . . . . 0.0 111.548 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.403 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.6 OUTLIER -47.56 -50.17 51.75 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.403 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 38.1 Cg_exo -61.9 -44.67 19.57 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 122.492 2.128 . . . . 0.0 112.826 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.424 ' HB3' ' HD2' ' A' ' 95' ' ' LYS . 22.4 m-85 -80.55 -29.46 37.09 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.453 ' HB2' HG22 ' A' ' 38' ' ' ILE . 5.0 t80 -66.74 -46.43 75.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.072 0.463 . . . . 0.0 110.205 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.08 -39.83 90.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.696 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.5 p -60.69 -42.87 98.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.802 0.334 . . . . 0.0 111.063 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.402 HD22 ' HE1' ' A' ' 49' ' ' TYR . 48.3 mt -60.64 -43.09 97.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.909 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.19 -29.42 31.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.222 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -89.05 -21.45 23.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.958 0.409 . . . . 0.0 110.355 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.8 ttpp -94.98 3.2 55.21 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.58 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.543 ' HB3' HG22 ' A' ' 52' ' ' VAL . 7.2 m-85 -109.09 -30.49 8.03 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.718 0.294 . . . . 0.0 111.058 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.3 t 36.43 34.41 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.197 -0.456 . . . . 0.0 112.079 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -151.1 -41.36 0.12 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.995 0.426 . . . . 0.0 110.858 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 22' ' ' LEU . 17.9 m -94.03 157.4 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.543 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 1.013 HG23 HG13 ' A' ' 23' ' ' VAL . 2.8 tp -106.62 117.45 52.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.331 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.643 ' O ' HG22 ' A' ' 2' ' ' VAL . 5.2 m-85 -100.78 115.61 30.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.308 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.857 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -123.8 165.54 17.14 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 119.826 -0.75 . . . . 0.0 111.421 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.6 tt0 -116.94 119.56 35.71 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.301 -0.863 . . . . 0.0 113.115 -176.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.452 HG22 HD11 ' A' ' 55' ' ' LEU . 2.3 t -116.93 119.97 63.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.598 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.5 t0 -99.2 120.67 39.91 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.509 HG12 ' O ' ' A' ' 28' ' ' SER . 13.9 p -60.73 -18.39 17.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.992 -0.283 . . . . 0.0 111.722 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -66.92 -37.94 85.28 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.4 -34.5 10.26 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.736 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.901 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.89 43.35 1.08 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.847 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -68.62 -9.59 50.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.963 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -94.99 -23.3 17.44 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.521 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.901 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.5 m -78.83 -47.37 23.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.203 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.888 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.97 -57.18 13.32 Favored Pre-proline 0 N--CA 1.463 0.198 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.888 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 72.6 Cg_exo -50.69 -28.96 24.08 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.555 2.17 . . . . 0.0 112.101 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -77.86 -22.12 50.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.004 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -107.77 -5.56 17.26 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.886 0.374 . . . . 0.0 111.637 -179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.03 33.66 87.77 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.999 -0.546 . . . . 0.0 113.909 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.601 HD11 HD11 ' A' ' 78' ' ' LEU . 59.6 mt -75.96 137.98 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 117.26 0.53 . . . . 0.0 110.593 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -140.94 79.42 1.7 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.96 0.41 . . . . 0.0 111.49 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 137.42 164.97 10.24 Favored Glycine 0 CA--C 1.521 0.439 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.015 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -147.76 154.71 44.37 Favored Pre-proline 0 N--CA 1.464 0.251 0 C-N-CA 122.173 0.189 . . . . 0.0 110.9 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -81.9 118.7 5.84 Favored 'Cis proline' 0 C--N 1.35 0.648 0 C-N-CA 124.772 -0.928 . . . . 0.0 112.779 0.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.513 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -87.36 136.87 32.77 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.866 0.365 . . . . 0.0 111.318 178.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.568 HD22 HD11 ' A' ' 93' ' ' LEU . 1.3 tp -107.8 119.03 38.29 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.744 ' CD2' HG23 ' A' ' 88' ' ' THR . 6.0 mt -114.56 135.22 54.36 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.241 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.919 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 3.7 mm? -115.58 123.4 48.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.726 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.618 ' CE2' HG22 ' A' ' 85' ' ' VAL . 45.8 m-85 -114.37 145.88 41.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.933 0.397 . . . . 0.0 111.177 -179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -146.85 112.72 5.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.045 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 11.5 m120 61.51 45.78 8.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.138 0.494 . . . . 0.0 110.221 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.33 2.86 50.99 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 120.835 -0.698 . . . . 0.0 113.655 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -124.55 140.23 53.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.393 0.597 . . . . 0.0 111.39 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.618 HG22 ' CE2' ' A' ' 80' ' ' PHE . 28.3 t -68.3 116.94 9.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.728 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.28 11.27 27.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.094 0.474 . . . . 0.0 111.49 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.919 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -175.96 139.62 0.39 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.643 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.744 HG23 ' CD2' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -136.02 116.58 13.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.526 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -120.82 140.98 50.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.95 0.405 . . . . 0.0 110.727 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.3 p -117.04 146.65 21.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.269 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.48 160.15 12.38 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.491 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.505 ' HB1' HD11 ' A' ' 38' ' ' ILE . . . -69.43 163.89 24.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.081 0.467 . . . . 0.0 111.82 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.568 HD11 HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -153.44 153.81 33.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.462 179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 5.4 m -64.32 178.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.904 0.383 . . . . 0.0 111.133 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.424 ' HD2' ' HB3' ' A' ' 41' ' ' PHE . 1.6 tptm -72.28 -31.19 65.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.053 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.4 -31.34 51.56 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.48 -0.867 . . . . 0.0 113.315 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.458 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 17.8 mt-30 -76.91 -30.75 56.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.174 0.487 . . . . 0.0 110.627 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.528 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -72.42 -50.87 23.2 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -62.39 -44.44 96.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.997 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.1 pp20? -61.78 -42.49 99.07 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.83 0.348 . . . . 0.0 110.364 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.701 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 29.4 t80 -63.17 -42.96 99.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.33 0.586 . . . . 0.0 110.36 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.608 HD11 HG11 ' A' ' 24' ' ' VAL . 2.6 mt -65.46 -59.79 3.62 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.119 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -49.22 -32.21 10.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.466 -0.333 . . . . 0.0 110.466 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.54 -21.51 60.35 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.019 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -108.77 -28.25 9.31 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.553 ' C ' HD13 ' A' ' 106' ' ' LEU . 3.2 tm? -72.82 113.11 9.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.902 0.382 . . . . 0.0 110.697 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 106' ' ' LEU . 6.6 m . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.152 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.939 0.399 . . . . 0.0 111.317 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.718 HG13 ' HA ' ' A' ' 55' ' ' LEU . 41.5 t -86.94 145.93 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.829 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.9 pttp -146.12 121.36 10.2 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.224 0.535 . . . . 0.0 110.173 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -72.84 131.59 42.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.634 -0.712 . . . . 0.0 109.679 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.851 HD13 HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -103.17 108.32 24.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.042 0.449 . . . . 0.0 110.474 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -99.56 20.18 14.39 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.976 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.3 m -155.12 161.73 41.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 111.138 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.415 ' HA ' HG13 ' A' ' 65' ' ' VAL . 26.5 ttpt -75.08 -26.94 59.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.605 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.0 m -79.85 -32.01 40.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.512 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.77 -38.41 88.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.433 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.52 ' CE1' HG21 ' A' ' 57' ' ' VAL . 4.6 t80 -57.06 -42.24 80.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.909 0.385 . . . . 0.0 110.152 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.05 -42.95 88.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.91 178.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -58.14 -46.29 85.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.254 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.79 -34.25 76.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.927 0.394 . . . . 0.0 110.591 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.64 -43.35 89.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.99 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -65.48 -26.49 67.96 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.434 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.17 -49.76 73.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.977 -178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.36 -64.21 0.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.778 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.38 -83.04 1.63 Allowed Glycine 0 CA--C 1.52 0.37 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.98 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -96.79 -18.55 19.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.82 0.31 . . . . 0.0 111.468 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -73.28 155.46 39.46 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.019 HD11 HD12 ' A' ' 79' ' ' LEU . 5.2 tp -78.17 134.87 37.57 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.894 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.864 HG13 ' CG2' ' A' ' 53' ' ' ILE . 13.8 t -113.74 110.25 31.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.418 0.627 . . . . 0.0 111.52 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.618 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -104.96 117.17 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.547 HG12 ' HG ' ' A' ' 55' ' ' LEU . 5.5 m -126.4 167.42 21.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.012 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -131.34 133.21 45.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.977 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.779 ' CE1' HD12 ' A' ' 78' ' ' LEU . 5.6 m-85 -97.78 110.56 23.11 Favored 'General case' 0 N--CA 1.463 0.223 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.681 ' O ' HG12 ' A' ' 59' ' ' VAL . 4.5 m -119.79 -168.34 1.58 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.388 0.613 . . . . 0.0 112.607 -178.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.623 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.05 154.89 36.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.455 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.69 -35.02 70.13 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.41 0.624 . . . . 0.0 109.498 178.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.452 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 52.7 p-90 -86.84 11.58 12.97 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.652 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.736 ' SG ' HD12 ' A' ' 74' ' ' ILE . 9.6 t -93.36 157.46 16.22 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.148 0.499 . . . . 0.0 111.705 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.18 -66.57 0.53 Allowed Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.239 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -61.1 -21.68 72.36 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.568 2.179 . . . . 0.0 112.308 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.8 m -60.23 -42.99 96.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.986 0.422 . . . . 0.0 110.861 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.9 mtpt -68.68 -15.66 63.59 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.495 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 25.0 mtp -72.92 -24.66 60.85 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 111.673 0.249 . . . . 0.0 111.673 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.1 mm -85.46 -22.63 7.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.654 0.264 . . . . 0.0 111.685 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.472 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 28.6 mtpt -50.0 -59.71 6.47 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_endo -49.55 -45.84 29.34 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.535 2.157 . . . . 0.0 112.864 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -79.19 -29.06 42.72 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -65.55 -45.7 82.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.04 0.447 . . . . 0.0 110.375 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -38.06 84.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.867 -179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.6 m -61.79 -43.15 99.42 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.815 0.341 . . . . 0.0 110.676 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 25.1 mt -59.97 -45.37 92.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.211 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.409 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 23.9 p -53.32 -27.21 22.02 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.554 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -85.21 -22.29 28.77 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.389 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 12.7 tttp -95.36 -17.56 21.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.918 0.389 . . . . 0.0 110.219 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.829 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.3 m-85 -99.6 92.66 5.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.879 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 70.2 m -90.22 49.55 1.71 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.059 0.456 . . . . 0.0 110.393 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -153.23 -43.21 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.788 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.829 HG22 ' HB3' ' A' ' 49' ' ' TYR . 9.1 m -93.68 155.51 3.17 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.906 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.864 ' CG2' HG13 ' A' ' 23' ' ' VAL . 2.9 tp -105.58 114.69 45.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.918 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.618 ' CE1' HG11 ' A' ' 24' ' ' VAL . 8.0 m-85 -96.7 116.24 28.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.057 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.851 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -130.63 168.8 16.53 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.052 -0.659 . . . . 0.0 111.34 178.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.423 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.5 tt0 -121.34 124.16 43.9 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.52 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -117.33 120.44 64.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.905 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -97.83 119.22 36.05 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.681 HG12 ' O ' ' A' ' 28' ' ' SER . 11.2 p -61.39 -19.2 20.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.71 -178.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.79 -41.03 97.22 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -98.21 -34.28 10.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.386 179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.919 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.1 41.11 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.049 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.36 -9.72 50.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.575 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -95.26 -23.14 17.37 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.422 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.919 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 1.8 m -78.12 -47.05 25.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.052 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.935 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.16 -57.97 11.1 Favored Pre-proline 0 N--CA 1.463 0.183 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.935 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 76.3 Cg_exo -51.07 -29.39 27.95 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.665 2.244 . . . . 0.0 112.262 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -76.72 -22.65 53.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.668 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -108.49 -3.5 18.07 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.842 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.45 35.35 91.22 Favored Glycine 0 CA--C 1.521 0.467 0 C-N-CA 121.175 -0.536 . . . . 0.0 114.0 179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.653 HD11 HD11 ' A' ' 78' ' ' LEU . 76.4 mt -75.66 134.12 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-N 117.494 0.647 . . . . 0.0 110.689 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -151.58 51.22 0.82 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.909 0.385 . . . . 0.0 111.399 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.77 103.27 0.17 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.377 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.736 HD12 ' SG ' ' A' ' 32' ' ' CYS . 5.2 pt -103.14 153.21 38.52 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.465 0.174 . . . . 0.0 111.281 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -79.6 116.07 4.33 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.954 -1.269 . . . . 0.0 112.123 -0.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.02 138.17 31.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.017 0.436 . . . . 0.0 112.156 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.403 HD22 HD11 ' A' ' 93' ' ' LEU . 1.1 mp -107.48 123.43 48.4 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.779 HD12 ' CE1' ' A' ' 27' ' ' PHE . 7.6 mt -114.88 133.02 56.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.236 0.541 . . . . 0.0 111.841 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -115.13 121.99 44.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.921 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.651 ' CE2' HG22 ' A' ' 85' ' ' VAL . 50.7 m-85 -114.04 148.21 37.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.983 0.421 . . . . 0.0 111.397 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -147.05 111.99 5.4 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.952 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 m120 60.73 46.74 8.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.882 0.372 . . . . 0.0 110.316 -179.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.35 4.68 52.06 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.987 -0.625 . . . . 0.0 113.659 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -125.34 139.54 53.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 117.19 0.495 . . . . 0.0 111.611 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.651 HG22 ' CE2' ' A' ' 80' ' ' PHE . 27.9 t -67.67 116.14 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.833 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.83 11.11 20.82 Favored 'General case' 0 C--O 1.232 0.144 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.803 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -174.16 142.19 0.8 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.44 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -137.35 127.57 26.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.772 0.32 . . . . 0.0 111.079 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.42 138.76 52.48 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.143 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.4 t -121.47 146.08 27.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.694 0.283 . . . . 0.0 111.642 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.43 161.02 23.9 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.849 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.703 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -67.07 164.36 18.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.016 0.436 . . . . 0.0 111.542 -179.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.703 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -159.8 151.15 19.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.051 -179.505 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.63 178.91 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.995 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -70.9 -30.71 67.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.96 -30.99 50.02 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.655 -0.783 . . . . 0.0 113.007 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -77.28 -32.37 55.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.915 0.388 . . . . 0.0 110.617 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.482 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -71.0 -51.74 23.71 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.33 179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.2 ttpt -60.95 -38.24 85.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.356 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.46 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -61.88 -38.23 87.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.872 0.367 . . . . 0.0 110.268 179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.655 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 6.3 t80 -61.48 -41.55 97.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.28 0.562 . . . . 0.0 110.09 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.466 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 6.6 mt -66.92 -56.88 8.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.9 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -50.8 -35.56 32.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.998 0.428 . . . . 0.0 110.193 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.6 -22.72 63.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.71 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.656 ' O ' HG12 ' A' ' 107' ' ' VAL . 2.6 t30 -106.43 -55.42 2.33 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.624 0.25 . . . . 0.0 110.894 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.639 HD13 HG12 ' A' ' 52' ' ' VAL . 19.8 tp -51.51 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 121.064 0.459 . . . . 0.0 110.852 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.656 HG12 ' O ' ' A' ' 105' ' ' ASN . 5.1 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.215 -0.898 . . . . 0.0 111.07 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.708 0.289 . . . . 0.0 111.109 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 55' ' ' LEU . 46.5 t 63.69 144.42 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.023 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -146.53 122.93 10.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.073 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -74.75 131.92 41.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.249 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.87 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -104.28 108.36 24.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.763 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -97.47 18.93 14.21 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 m -155.15 165.4 36.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.03 0.443 . . . . 0.0 111.523 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.624 ' HA ' HG13 ' A' ' 65' ' ' VAL . 22.3 ttpt -76.89 -26.34 54.06 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.33 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.0 m -79.78 -33.82 40.25 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.171 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.13 -36.49 83.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.365 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.511 ' CE1' HG21 ' A' ' 57' ' ' VAL . 5.4 t80 -58.85 -43.44 90.77 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.059 0.457 . . . . 0.0 110.118 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.2 mm-40 -65.41 -40.51 93.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.715 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -58.93 -50.71 73.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.711 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.94 -33.2 75.28 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.802 0.334 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 15' ' ' LEU . 15.6 mt -65.56 -42.92 91.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.891 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.1 -28.28 68.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.545 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.16 -47.31 83.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.11 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.19 -64.27 0.9 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.171 -0.611 . . . . 0.0 109.628 179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.88 -87.3 1.47 Allowed Glycine 0 CA--C 1.521 0.41 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.201 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.34 -15.77 24.1 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 117.092 0.446 . . . . 0.0 111.482 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.4 mttt -75.24 155.62 36.59 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.019 HD11 HD12 ' A' ' 79' ' ' LEU . 8.1 tp -78.63 133.3 37.27 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.123 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.904 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.4 t -112.06 109.62 29.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.491 0.662 . . . . 0.0 111.413 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.686 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.1 p -104.15 115.11 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.633 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.2 m -122.89 163.98 20.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.306 0.574 . . . . 0.0 112.022 -178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.1 t0 -128.37 130.81 48.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.582 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.618 ' HE1' HD12 ' A' ' 78' ' ' LEU . 3.4 m-85 -97.52 111.06 23.48 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.585 ' O ' HG12 ' A' ' 59' ' ' VAL . 35.9 t -119.53 -168.94 1.67 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.238 0.542 . . . . 0.0 112.303 -177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.634 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.84 154.6 36.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.864 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -71.95 -37.84 69.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.48 0.657 . . . . 0.0 109.782 178.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.7 p-90 -86.77 11.74 12.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.854 -1.066 . . . . 0.0 112.159 -178.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.634 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 13.8 t -97.29 156.43 16.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.775 0.322 . . . . 0.0 110.926 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.03 -64.29 0.55 Allowed Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.296 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -62.02 -24.36 76.63 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.422 2.081 . . . . 0.0 112.042 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -59.71 -45.54 91.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.305 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt -64.9 -25.75 68.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.372 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 49.6 mmm -66.85 -16.26 64.18 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 8.7 mm -86.12 -21.57 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.731 0.3 . . . . 0.0 111.092 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.512 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 0.3 OUTLIER -50.87 -58.78 9.08 Favored Pre-proline 0 CA--C 1.532 0.274 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -179.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 7.4 Cg_endo -48.13 -47.81 18.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.796 2.331 . . . . 0.0 113.063 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -80.09 -30.41 39.22 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.401 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 6.1 t80 -65.72 -46.23 79.72 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.066 0.46 . . . . 0.0 109.942 179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -39.57 88.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.729 -179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.9 t -61.57 -43.48 98.78 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.796 0.331 . . . . 0.0 110.833 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.7 mt -59.47 -40.36 86.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.131 0.491 . . . . 0.0 109.897 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.3 t -56.15 -28.42 57.98 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.367 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -85.95 -20.52 28.83 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.585 0.217 . . . . 0.0 111.585 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 ttpp -95.75 -20.56 18.77 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.105 0.478 . . . . 0.0 110.159 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.83 ' HB3' HG22 ' A' ' 52' ' ' VAL . 16.0 m-85 -97.29 95.74 7.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.539 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.9 t -93.93 48.45 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.161 0.505 . . . . 0.0 110.019 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -151.87 -41.0 0.11 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.519 179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.83 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.5 m -95.97 154.55 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.979 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.904 ' CG2' HG13 ' A' ' 23' ' ' VAL . 2.8 tp -105.5 113.99 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.833 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.686 ' CE1' HG11 ' A' ' 24' ' ' VAL . 9.3 m-85 -96.28 116.29 28.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.139 -179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.87 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.67 165.77 19.38 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.5 178.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.407 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -115.83 119.21 35.25 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 113.461 0.912 . . . . 0.0 113.461 -176.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.511 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -115.71 118.32 58.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.181 0.515 . . . . 0.0 111.369 178.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 44.2 t0 -99.68 121.93 41.94 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.585 HG12 ' O ' ' A' ' 28' ' ' SER . 13.1 p -60.43 -18.98 17.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.784 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -65.71 -39.09 90.85 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -97.94 -36.67 10.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.534 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.901 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.24 43.47 1.08 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.749 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -70.2 -9.77 56.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.509 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -94.04 -23.57 17.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.735 -0.211 . . . . 0.0 111.273 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.901 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -79.14 -46.61 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.158 0 C-N-CA 120.826 -0.349 . . . . 0.0 111.036 179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.884 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.24 -56.9 14.89 Favored Pre-proline 0 N--CA 1.462 0.175 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.884 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 81.1 Cg_exo -50.93 -28.82 25.06 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.677 2.251 . . . . 0.0 112.128 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -76.13 -18.75 59.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.964 178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -115.9 -7.35 12.01 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.946 0.403 . . . . 0.0 111.658 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.05 39.94 97.69 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.038 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.557 HD11 HD11 ' A' ' 78' ' ' LEU . 62.0 mt -76.97 79.66 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 CA-C-N 117.013 0.406 . . . . 0.0 110.162 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.1 ttt-85 -87.19 77.82 8.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.959 0.409 . . . . 0.0 111.774 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 142.73 162.52 9.3 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.129 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 32' ' ' CYS . 31.2 pt -145.89 156.5 51.57 Favored Pre-proline 0 CA--C 1.529 0.165 0 C-N-CA 122.157 0.183 . . . . 0.0 110.863 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -87.36 116.4 3.51 Favored 'Cis proline' 0 C--N 1.354 0.825 0 C-N-CA 124.578 -1.009 . . . . 0.0 112.481 -0.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.517 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -88.65 138.03 31.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.88 0.371 . . . . 0.0 111.659 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.704 HD22 HD11 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -107.65 125.79 51.79 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.618 HD12 ' HE1' ' A' ' 27' ' ' PHE . 6.3 mt -114.58 133.73 55.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.265 0.555 . . . . 0.0 111.686 -178.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.019 HD12 HD11 ' A' ' 22' ' ' LEU . 2.8 mm? -114.48 117.03 29.84 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.968 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.512 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 45.3 m-85 -108.08 148.76 29.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.423 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -148.25 113.62 5.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.229 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.5 m120 58.3 46.66 15.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.932 0.396 . . . . 0.0 110.276 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.83 3.45 55.41 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.918 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -126.26 140.51 52.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.252 0.526 . . . . 0.0 111.667 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 85' ' ' VAL . 11.1 p -68.24 119.0 13.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.911 179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -117.05 11.46 14.25 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.866 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.18 140.23 0.85 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.398 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -135.0 141.15 46.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.049 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -142.48 136.81 29.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.181 179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.4 t -120.32 146.3 25.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.79 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.518 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.27 159.57 23.26 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.857 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.63 132.3 47.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.974 0.416 . . . . 0.0 111.324 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.704 HD11 HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -113.88 -173.5 2.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.365 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 t -110.03 164.89 12.18 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.9 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -55.63 -38.01 68.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.769 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.05 -31.7 51.9 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.872 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.43 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 43.0 mt-30 -76.18 -31.86 58.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 117.012 0.406 . . . . 0.0 110.507 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 tt -72.07 -50.13 30.79 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.6 ttpt -61.51 -43.96 97.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.94 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -61.87 -40.09 94.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.256 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.8 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 30.0 t80 -63.09 -42.12 99.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.293 0.568 . . . . 0.0 110.728 178.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.612 HD11 HG11 ' A' ' 24' ' ' VAL . 3.0 mt -68.02 -56.15 9.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.318 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.99 -34.69 21.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.916 0.389 . . . . 0.0 110.471 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.31 -19.69 60.38 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.23 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -107.0 -34.7 7.1 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.84 0.352 . . . . 0.0 110.943 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.75 HD13 HG12 ' A' ' 52' ' ' VAL . 53.2 tp -69.64 99.08 1.25 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.105 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.133 -0.937 . . . . 0.0 110.821 -179.208 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mmt . . . . . 0 N--CA 1.485 1.307 0 CA-C-O 120.889 0.376 . . . . 0.0 111.259 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.708 HG13 ' HA ' ' A' ' 55' ' ' LEU . 61.6 t -86.79 144.87 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.707 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.4 121.97 11.08 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.117 0.484 . . . . 0.0 110.238 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -74.01 130.05 39.08 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.027 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.857 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -102.97 108.55 24.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.994 0.426 . . . . 0.0 110.337 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -100.59 19.74 16.36 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.143 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -155.26 160.16 40.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.935 0.397 . . . . 0.0 111.071 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.626 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -71.18 -28.64 64.38 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.002 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.49 -30.59 42.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.983 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.11 -39.6 90.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.683 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -57.63 -43.8 85.1 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.92 0.39 . . . . 0.0 110.098 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.451 ' HA ' ' NE2' ' A' ' 12' ' ' GLN . 9.8 mm100 -65.38 -44.1 88.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.589 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -58.37 -46.13 86.92 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.313 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.83 -32.31 73.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.043 0.449 . . . . 0.0 110.606 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.4 mt -68.23 -38.58 82.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.692 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -60.99 -35.32 76.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.398 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.5 -22.5 54.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.685 178.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.14 -34.59 78.39 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.007 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.2 -123.43 31.19 Favored Glycine 0 C--N 1.334 0.458 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.25 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -94.32 6.22 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.599 0.237 . . . . 0.0 111.414 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -79.21 149.77 31.82 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.968 HD11 HD12 ' A' ' 79' ' ' LEU . 6.4 tp -76.16 133.21 40.26 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.869 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.8 t -111.41 111.43 36.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.523 0.678 . . . . 0.0 112.026 -178.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.68 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -105.8 113.92 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.593 HG12 ' HG ' ' A' ' 55' ' ' LEU . 4.6 m -124.21 167.04 18.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.203 0.525 . . . . 0.0 112.007 -177.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -134.28 134.34 41.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.023 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.598 ' CE1' HD12 ' A' ' 78' ' ' LEU . 6.7 m-85 -96.91 108.8 21.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.331 178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.405 ' HB2' ' HB3' ' A' ' 35' ' ' CYS . 50.9 p -115.69 -169.44 1.59 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.366 0.603 . . . . 0.0 112.355 -178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.8 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.09 154.8 36.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.133 -0.939 . . . . 0.0 110.405 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.8 m -71.5 -36.91 71.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.563 0.697 . . . . 0.0 109.53 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.4 p-90 -87.77 11.28 15.8 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 114.67 -1.15 . . . . 0.0 111.6 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.8 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 12.7 t -91.48 156.1 17.95 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.11 0.481 . . . . 0.0 112.145 -179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.28 -75.49 1.0 Allowed Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.67 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.86 -20.84 30.64 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.702 2.268 . . . . 0.0 112.569 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.405 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 85.0 m -58.85 -43.87 90.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.997 0.427 . . . . 0.0 110.757 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt -68.45 -20.16 64.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.512 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 19.4 mtt -71.44 -23.71 61.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.398 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.3 mm -86.43 -24.17 6.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.725 0.298 . . . . 0.0 111.503 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -50.55 -52.9 51.44 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.294 -0.412 . . . . 0.0 112.004 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -52.54 -47.92 24.62 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.498 2.132 . . . . 0.0 113.107 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -80.34 -26.88 38.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -65.63 -45.49 82.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.047 0.451 . . . . 0.0 110.226 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.7 -41.47 83.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.988 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.1 t -59.82 -45.05 93.57 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.922 0.391 . . . . 0.0 111.065 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.9 mt -58.78 -41.08 85.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.151 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.1 m -55.68 -26.31 44.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.285 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -87.44 -20.83 26.07 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.624 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.0 tttp -95.41 -19.48 19.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.017 0.437 . . . . 0.0 110.077 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.825 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.6 m-85 -99.28 92.15 5.3 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.705 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 t -88.58 49.06 1.72 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.877 0.37 . . . . 0.0 110.743 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -153.79 -41.17 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.907 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.825 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.9 m -93.24 154.88 3.19 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.831 -179.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.869 ' CG2' HG13 ' A' ' 23' ' ' VAL . 5.3 tp -105.46 114.34 44.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.907 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.68 ' CE1' HG11 ' A' ' 24' ' ' VAL . 8.6 m-85 -96.43 115.76 27.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.377 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.857 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.77 167.2 17.64 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 119.917 -0.713 . . . . 0.0 111.343 178.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.431 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.0 tp10 -119.83 122.15 40.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -176.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -116.81 120.18 64.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.333 0.587 . . . . 0.0 111.133 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -100.23 119.34 38.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.77 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.9 p -60.95 -18.02 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.989 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -64.61 -39.37 93.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 109.681 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -100.59 -33.9 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.526 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.92 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.91 43.68 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.66 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -70.44 -9.58 56.83 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.658 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.98 -23.22 17.48 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.289 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.92 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.0 m -77.67 -47.6 25.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.546 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.91 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.2 -57.75 11.81 Favored Pre-proline 0 N--CA 1.462 0.137 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.91 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 76.9 Cg_exo -51.58 -28.62 29.46 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.5 2.133 . . . . 0.0 111.903 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -76.04 -20.04 58.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.761 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -111.57 -4.89 14.62 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.852 0.358 . . . . 0.0 111.852 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.0 35.87 91.24 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.028 -0.606 . . . . 0.0 113.556 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.696 HD11 HD11 ' A' ' 78' ' ' LEU . 91.5 mt -75.9 135.98 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 117.173 0.486 . . . . 0.0 110.655 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.9 ttt85 -146.86 62.63 1.19 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.04 0.448 . . . . 0.0 111.286 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 176.71 160.88 24.58 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.588 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.492 HD12 ' SG ' ' A' ' 32' ' ' CYS . 36.3 pt -146.31 137.4 12.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 O-C-N 122.995 -0.121 . . . . 0.0 110.764 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -89.88 122.14 5.1 Favored 'Cis proline' 0 C--N 1.351 0.659 0 C-N-CA 124.749 -0.938 . . . . 0.0 112.092 0.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.2 OUTLIER -86.56 137.01 32.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.117 0.484 . . . . 0.0 112.189 179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.533 HD21 HD21 ' A' ' 98' ' ' LEU . 1.1 tp -108.97 122.74 47.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 177.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 71' ' ' ILE . 7.0 mt -115.01 136.48 53.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.236 0.541 . . . . 0.0 111.689 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.968 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -117.4 123.33 46.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.039 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.667 ' CE2' HG22 ' A' ' 85' ' ' VAL . 52.0 m-85 -115.27 147.53 40.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.143 0.497 . . . . 0.0 111.503 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -146.41 111.84 5.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.098 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 m120 60.59 46.53 9.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.392 . . . . 0.0 110.321 -179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.02 0.6 52.79 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.955 -0.641 . . . . 0.0 114.009 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -123.25 138.93 54.52 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.626 0.713 . . . . 0.0 111.592 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.667 HG22 ' CE2' ' A' ' 80' ' ' PHE . 39.9 t -67.62 117.98 10.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.451 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.18 8.8 21.77 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.128 0.418 . . . . 0.0 112.128 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.831 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.26 141.82 1.29 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.673 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.3 t -137.68 127.94 26.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.157 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.04 137.97 50.52 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.09 146.27 23.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.577 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.89 165.24 30.99 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.27 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.631 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -67.27 171.78 5.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.011 0.434 . . . . 0.0 111.521 -179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.757 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -162.14 -170.6 2.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.491 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -109.58 166.25 11.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.737 0.303 . . . . 0.0 110.773 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 6.9 tttm -57.79 -32.81 67.9 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.958 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.43 -30.72 53.27 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.795 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 42.3 mt-30 -77.34 -31.15 54.32 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.729 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.757 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -71.73 -51.33 23.39 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.874 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.8 ttpp -63.45 -44.38 94.65 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.481 -0.782 . . . . 0.0 111.195 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.1 pp20? -60.71 -42.29 96.93 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.948 0.404 . . . . 0.0 110.102 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.68 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 22.1 t80 -62.42 -40.6 97.08 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.387 0.613 . . . . 0.0 110.013 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.555 HD21 ' HB ' ' A' ' 24' ' ' VAL . 3.8 mt -64.13 -62.08 1.85 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.846 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.12 -32.01 6.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.27 -24.85 62.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.924 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -108.29 -28.96 9.13 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.802 0.334 . . . . 0.0 111.282 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.516 ' O ' HG13 ' A' ' 107' ' ' VAL . 2.7 tt -70.26 112.32 6.51 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.788 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.516 HG13 ' O ' ' A' ' 106' ' ' LEU . 5.0 m . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.286 -0.864 . . . . 0.0 111.213 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.961 0.41 . . . . 0.0 111.235 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.765 HG13 ' HA ' ' A' ' 55' ' ' LEU . 46.5 t -76.59 146.1 9.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.137 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.51 119.9 10.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.325 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -73.48 129.57 38.27 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.873 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -101.81 108.33 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.279 0.561 . . . . 0.0 111.106 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -98.86 19.81 14.28 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.861 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.7 m -154.44 158.84 40.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.97 0.414 . . . . 0.0 111.308 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.66 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.0 ttpt -71.45 -29.47 64.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.944 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.29 -31.03 38.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.78 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.1 -35.46 81.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.623 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.514 ' CE1' HG21 ' A' ' 57' ' ' VAL . 3.9 t80 -59.25 -43.89 92.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.166 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.17 -39.89 94.96 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.552 178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -58.99 -48.88 79.97 Favored 'General case' 0 C--O 1.23 0.052 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.28 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.35 -33.98 76.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 0.0 111.015 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 15' ' ' LEU . 15.1 mt -66.95 -40.68 87.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.435 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -67.59 -28.68 67.97 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.489 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.62 77.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.08 -178.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.02 -64.83 0.78 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 120.203 -0.599 . . . . 0.0 109.544 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.88 -82.47 1.52 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.638 -0.71 . . . . 0.0 113.322 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -95.49 -18.63 20.5 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.661 0.267 . . . . 0.0 111.556 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.6 mttt -75.11 154.8 37.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.954 HD11 HD12 ' A' ' 79' ' ' LEU . 4.1 tp -78.77 136.11 37.29 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.78 ' N ' HD12 ' A' ' 22' ' ' LEU . 6.0 t -116.58 106.59 20.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.034 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.659 HG23 HD21 ' A' ' 79' ' ' LEU . 10.4 p -102.54 119.12 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.453 -0.944 . . . . 0.0 108.453 177.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.537 HG23 ' HB2' ' A' ' 78' ' ' LEU . 4.9 m -127.15 167.55 21.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.856 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.61 ' OD1' HD12 ' A' ' 77' ' ' LEU . 24.8 t70 -133.42 136.0 44.95 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.772 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.666 ' CE1' HD12 ' A' ' 78' ' ' LEU . 3.6 m-85 -100.89 111.12 23.26 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.3 p -121.39 -167.91 1.59 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.439 0.638 . . . . 0.0 112.366 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.54 154.07 34.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.169 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -72.11 -33.96 68.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.523 0.678 . . . . 0.0 109.826 178.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.484 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 51.6 p-90 -86.9 10.52 15.94 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.912 -179.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 12.2 t -95.15 158.05 15.63 Favored 'General case' 0 N--CA 1.464 0.256 0 O-C-N 122.142 -0.349 . . . . 0.0 111.529 179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -108.1 -65.64 0.59 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.256 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -64.34 -22.79 66.02 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.406 2.071 . . . . 0.0 112.404 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 61.7 m -61.8 -44.36 97.02 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.015 0.436 . . . . 0.0 110.595 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -64.51 -28.11 69.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.198 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.4 mtt -67.15 -16.0 64.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.0 mm -86.89 -22.38 7.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.927 -0.309 . . . . 0.0 111.656 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 33.1 mtpt -50.97 -60.41 5.63 Favored Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 1.3 Cg_endo -47.06 -46.54 18.79 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.634 2.222 . . . . 0.0 113.059 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -80.41 -32.35 37.48 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.471 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 6.4 t80 -67.2 -44.83 78.61 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.941 0.4 . . . . 0.0 110.177 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.29 -38.18 84.62 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.593 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.7 t -60.67 -43.32 97.82 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.927 0.394 . . . . 0.0 110.496 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 32.2 mt -59.48 -40.06 85.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.332 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 m -54.07 -27.4 32.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.24 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -88.12 -21.75 24.49 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.646 0.26 . . . . 0.0 111.4 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 19.0 ttpp -94.16 -21.63 18.96 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.777 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.0 m-85 -96.43 97.29 9.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.059 -0.518 . . . . 0.0 109.95 178.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.2 t -96.1 43.98 1.08 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.736 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -156.26 11.37 0.27 Allowed 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.601 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.777 HG22 ' HB3' ' A' ' 49' ' ' TYR . 19.2 m -144.3 157.36 15.24 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-O 120.423 0.154 . . . . 0.0 111.142 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.775 ' CG2' HG13 ' A' ' 23' ' ' VAL . 3.1 tp -106.34 115.25 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.237 0.541 . . . . 0.0 110.618 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.686 ' O ' HG22 ' A' ' 2' ' ' VAL . 6.5 m-85 -97.78 115.91 28.96 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.858 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.873 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.65 168.01 15.63 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 119.969 -0.692 . . . . 0.0 111.63 178.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.422 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -119.59 121.48 39.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -176.394 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.514 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.1 t -118.92 119.11 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.276 0.56 . . . . 0.0 111.396 178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -98.99 120.74 39.93 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.33 -19.42 16.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -63.14 -40.2 96.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.263 0.554 . . . . 0.0 110.004 178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -98.78 -35.71 10.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.196 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.919 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.17 45.96 1.11 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.669 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -71.95 -11.18 60.66 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.547 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -93.7 -21.26 19.46 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.419 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.919 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.5 m -80.04 -46.51 22.11 Favored 'Isoleucine or valine' 0 C--O 1.232 0.135 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.696 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.902 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.66 -57.96 11.62 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.902 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 53.3 Cg_exo -52.72 -28.64 38.66 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.619 2.213 . . . . 0.0 111.956 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -76.39 -25.59 54.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.126 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -105.94 -2.38 22.98 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.02 36.11 91.55 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.172 -0.537 . . . . 0.0 114.051 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.741 HD11 HD11 ' A' ' 78' ' ' LEU . 79.3 mt -77.55 133.95 29.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 117.458 0.629 . . . . 0.0 110.443 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.8 tpm_? -150.72 54.43 0.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.944 0.402 . . . . 0.0 111.383 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 170.09 105.42 0.18 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.922 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.8 pt -103.04 153.86 38.0 Favored Pre-proline 0 N--CA 1.463 0.198 0 C-N-CA 122.167 0.187 . . . . 0.0 110.829 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.38 114.78 3.47 Favored 'Cis proline' 0 C--N 1.353 0.767 0 C-N-CA 124.198 -1.167 . . . . 0.0 112.757 -0.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.428 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -88.33 136.75 32.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.957 0.408 . . . . 0.0 111.359 179.336 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.661 HD13 HD21 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -106.98 121.02 43.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.125 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.741 HD11 HD11 ' A' ' 71' ' ' ILE . 10.1 mt -112.37 135.51 52.97 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.513 0.673 . . . . 0.0 111.874 -177.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.954 HD12 HD11 ' A' ' 22' ' ' LEU . 3.6 mm? -117.37 126.18 52.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.845 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.558 ' CE2' HG22 ' A' ' 85' ' ' VAL . 47.9 m-85 -117.14 147.12 42.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.196 0.522 . . . . 0.0 111.267 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 tttm -148.26 115.31 6.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.99 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.7 m120 57.79 44.62 19.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.92 0.391 . . . . 0.0 110.209 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.02 5.68 62.39 Favored Glycine 0 CA--C 1.523 0.561 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.911 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -126.06 142.6 51.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 117.379 0.589 . . . . 0.0 111.483 -179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.558 HG22 ' CE2' ' A' ' 80' ' ' PHE . 21.8 t -70.05 119.19 15.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.655 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -115.08 12.34 16.62 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.91 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.37 138.91 0.43 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.17 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -134.59 133.23 39.98 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.693 0.282 . . . . 0.0 110.805 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.66 139.55 45.35 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 t -122.82 146.3 28.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 111.776 0.288 . . . . 0.0 111.776 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.5 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.13 162.43 28.58 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.216 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.58 133.62 47.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.193 0.521 . . . . 0.0 111.548 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.661 HD21 HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -116.08 -175.46 2.74 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.431 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -109.82 162.66 14.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.622 -0.263 . . . . 0.0 110.53 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -52.4 -37.76 57.36 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.509 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.58 -29.3 55.71 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.338 -0.934 . . . . 0.0 112.437 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -77.2 -33.23 56.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.869 0.366 . . . . 0.0 110.586 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.65 -50.88 32.07 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.31 -42.24 90.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.389 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -62.58 -38.17 89.05 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.772 0.32 . . . . 0.0 110.483 179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.91 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 9.7 t80 -63.77 -42.86 97.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.406 0.622 . . . . 0.0 110.103 178.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.516 HD11 HG11 ' A' ' 24' ' ' VAL . 4.4 mt -64.8 -62.48 1.54 Allowed 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.239 -0.892 . . . . 0.0 109.953 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.86 -34.31 12.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.098 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.19 -20.33 60.91 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.501 ' O ' HG22 ' A' ' 107' ' ' VAL . 8.5 t30 -108.99 -38.1 5.66 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.86 0.362 . . . . 0.0 111.598 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.472 ' O ' HG13 ' A' ' 107' ' ' VAL . 3.9 tt -60.81 107.22 0.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.094 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.501 HG22 ' O ' ' A' ' 105' ' ' ASN . 16.3 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.333 -0.841 . . . . 0.0 111.339 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.24 0 CA-C-O 120.835 0.35 . . . . 0.0 111.055 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.714 HG13 ' HA ' ' A' ' 55' ' ' LEU . 47.4 t 63.75 144.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.846 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.2 ptpp? -145.02 121.95 11.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.202 0.525 . . . . 0.0 110.162 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -74.4 128.93 36.77 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.224 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.833 HD13 HD13 ' A' ' 55' ' ' LEU . 0.8 OUTLIER -99.79 108.74 23.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.228 0.537 . . . . 0.0 110.39 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -100.34 19.52 16.48 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.96 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.31 160.48 38.58 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.958 0.409 . . . . 0.0 111.165 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.512 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.3 OUTLIER -73.67 -26.33 60.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.959 179.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m -79.63 -31.56 41.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.806 0.336 . . . . 0.0 110.229 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.56 -38.69 90.31 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.901 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -56.99 -41.48 78.49 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.068 0.461 . . . . 0.0 110.051 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -66.37 -45.0 81.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.933 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -58.86 -49.03 79.29 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.63 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.65 -32.46 73.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.933 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 mt -67.71 -36.87 81.4 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.247 0.546 . . . . 0.0 110.274 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -61.23 -33.53 73.65 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.17 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.68 -23.1 53.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.154 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.95 84.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.073 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.63 -121.13 25.62 Favored Glycine 0 C--N 1.335 0.492 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.369 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -94.84 2.63 55.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.467 0.173 . . . . 0.0 111.467 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.8 mttt -78.07 147.14 34.85 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.96 HD11 HD12 ' A' ' 79' ' ' LEU . 8.0 tp -74.27 132.23 41.91 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.947 HG13 HG23 ' A' ' 53' ' ' ILE . 5.3 t -110.48 108.87 26.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.547 0.689 . . . . 0.0 112.13 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.631 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.1 p -102.92 114.39 42.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.695 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.4 m -121.11 162.16 20.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.658 -177.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -126.24 131.08 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.24 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.49 ' CE1' HD12 ' A' ' 78' ' ' LEU . 3.4 m-85 -97.29 107.49 20.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.326 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.5 m -132.45 146.93 52.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.034 0.445 . . . . 0.0 111.813 -178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -96.29 159.03 15.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.611 177.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.0 m -70.56 -37.55 74.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.634 0.73 . . . . 0.0 109.143 177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -86.08 14.66 5.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.937 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.444 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 21.6 t -91.56 157.09 17.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.887 0.375 . . . . 0.0 111.393 179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.7 -73.33 0.91 Allowed Glycine 0 CA--C 1.52 0.397 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.386 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.45 -24.91 45.98 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.325 2.017 . . . . 0.0 112.491 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.8 m -58.14 -40.85 82.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.9 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.8 mtpp -66.75 -22.84 66.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.541 179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 40.1 mtt -68.92 -19.97 64.21 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.2 mm -89.0 -25.24 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 CA-C-O 120.75 0.309 . . . . 0.0 111.628 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.39 -53.18 47.79 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -50.2 -49.93 14.91 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.619 2.213 . . . . 0.0 113.309 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -80.26 -27.33 38.65 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -64.85 -44.5 89.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.034 0.445 . . . . 0.0 110.314 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.64 -41.23 79.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.947 -178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.3 m -58.46 -44.44 89.28 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.829 0.347 . . . . 0.0 110.596 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mt -59.82 -39.5 85.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.471 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.4 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 10.7 p -56.96 -27.35 61.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -87.78 -19.48 27.46 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.683 0.277 . . . . 0.0 111.66 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.9 ttmm -95.53 -22.93 17.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.114 0.483 . . . . 0.0 110.012 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.808 ' HB3' HG22 ' A' ' 52' ' ' VAL . 16.6 m-85 -96.34 97.41 9.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.619 179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.2 t -93.66 47.26 1.22 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.285 0.564 . . . . 0.0 109.813 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -150.15 -42.83 0.13 Allowed 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.934 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.808 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.3 m -94.83 155.87 3.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.828 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.947 HG23 HG13 ' A' ' 23' ' ' VAL . 5.9 tp -106.88 112.72 41.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.24 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.659 ' O ' HG22 ' A' ' 2' ' ' VAL . 8.7 m-85 -94.4 115.33 27.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.729 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.833 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.45 167.57 16.86 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.643 179.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.434 ' N ' HD12 ' A' ' 55' ' ' LEU . 6.1 tt0 -118.82 119.52 34.62 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 114.926 -1.034 . . . . 0.0 113.228 -176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.439 HG22 HD11 ' A' ' 55' ' ' LEU . 2.8 t -116.68 119.27 61.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.225 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -99.6 119.38 37.97 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.737 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 p -59.86 -18.96 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -64.89 -38.33 90.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.128 0.489 . . . . 0.0 109.87 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -100.15 -35.53 9.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.381 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.898 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.59 44.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.953 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -69.91 -11.02 60.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.924 -179.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.4 -21.68 18.78 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 121.288 -0.165 . . . . 0.0 111.339 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.898 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.8 m -79.77 -47.53 21.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.101 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.641 ' HB3' ' CD ' ' A' ' 67' ' ' PRO . . . -50.97 -60.45 5.56 Favored Pre-proline 0 N--CA 1.466 0.336 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.641 ' CD ' ' HB3' ' A' ' 66' ' ' ALA . 6.8 Cg_endo -48.38 -27.95 10.81 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.732 2.288 . . . . 0.0 112.153 179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.3 -25.24 57.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.628 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -106.49 -4.21 20.04 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.806 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.78 36.88 87.99 Favored Glycine 0 CA--C 1.521 0.459 0 C-N-CA 121.232 -0.508 . . . . 0.0 113.865 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.594 HD11 HD11 ' A' ' 78' ' ' LEU . 84.3 mt -76.37 133.92 30.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 CA-C-N 117.18 0.49 . . . . 0.0 110.523 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -141.87 69.85 1.33 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.01 0.433 . . . . 0.0 111.887 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.03 166.68 15.17 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.57 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.646 HD13 ' N ' ' A' ' 74' ' ' ILE . 0.2 OUTLIER -150.92 149.45 25.28 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -85.69 121.2 6.36 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 124.311 -1.12 . . . . 0.0 112.507 -0.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.88 136.54 32.96 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.885 0.374 . . . . 0.0 111.669 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.478 HD21 HD21 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -107.99 122.43 46.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 177.546 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.594 HD11 HD11 ' A' ' 71' ' ' ILE . 6.7 mt -114.5 135.54 54.0 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.335 0.588 . . . . 0.0 111.298 -178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.96 HD12 HD11 ' A' ' 22' ' ' LEU . 3.2 mm? -116.61 122.48 44.74 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.404 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.52 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 51.6 m-85 -115.3 147.67 40.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.134 0.492 . . . . 0.0 111.781 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.8 tttm -146.55 113.42 6.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.378 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.5 m120 60.24 45.16 11.78 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 120.86 0.362 . . . . 0.0 110.283 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.5 2.84 56.52 Favored Glycine 0 CA--C 1.524 0.61 0 CA-C-N 116.036 -0.529 . . . . 0.0 113.708 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.3 tm-20 -124.34 139.16 54.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.253 0.526 . . . . 0.0 111.591 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 85' ' ' VAL . 11.5 p -69.14 120.59 16.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.88 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.22 10.93 17.35 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.901 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.07 137.24 0.4 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.779 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.524 HG23 ' CD2' ' A' ' 78' ' ' LEU . 48.2 m -139.3 122.08 16.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.828 0.347 . . . . 0.0 111.088 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 10.7 mmtt -120.77 145.21 47.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.835 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.38 146.82 25.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.465 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.17 162.3 23.19 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.99 -0.624 . . . . 0.0 113.064 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.491 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -68.31 158.21 33.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.153 0.501 . . . . 0.0 111.662 -178.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -154.97 151.43 28.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.399 -179.451 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.7 m -68.77 -178.17 1.13 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.989 -179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 29.9 tttt -72.69 -29.93 63.81 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.272 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.77 -33.6 41.61 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.323 -0.941 . . . . 0.0 113.269 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.417 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 0.6 OUTLIER -74.88 -31.84 61.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.065 0.459 . . . . 0.0 110.381 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.485 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.5 OUTLIER -71.38 -50.18 34.72 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.063 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -61.41 -41.25 96.84 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.013 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.417 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.1 OUTLIER -60.67 -37.91 83.15 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.948 0.404 . . . . 0.0 110.066 179.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.901 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 6.8 t80 -63.18 -42.56 99.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.429 0.633 . . . . 0.0 110.323 178.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.555 HD21 ' HB ' ' A' ' 24' ' ' VAL . 6.3 mt -65.87 -58.31 5.89 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.231 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -49.52 -36.21 22.6 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.933 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.56 -20.96 61.23 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.64 0.608 . . . . 0.0 112.64 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.501 ' HB3' HD21 ' A' ' 22' ' ' LEU . 8.4 t30 -108.34 -32.28 7.51 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 120.899 0.381 . . . . 0.0 111.459 -179.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.551 HD23 ' HB3' ' A' ' 22' ' ' LEU . 3.2 tm? -74.69 98.23 3.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.19 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.665 -179.372 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.731 0.301 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.72 HG13 ' HA ' ' A' ' 55' ' ' LEU . 40.3 t -65.91 144.81 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.091 -179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.404 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -144.0 121.29 11.58 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.266 0.555 . . . . 0.0 110.332 -179.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -74.8 127.98 34.46 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.04 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.887 HG23 ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -100.66 106.93 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.067 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -95.87 16.81 16.65 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.24 -0.436 . . . . 0.0 112.108 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 p -155.4 161.95 40.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.776 0.322 . . . . 0.0 111.394 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.606 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -72.85 -24.54 60.9 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.714 179.499 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -79.54 -32.32 42.18 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.509 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.887 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -65.95 -39.81 90.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.81 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.455 ' HB2' HG21 ' A' ' 5' ' ' ILE . 3.9 t80 -57.27 -42.6 81.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.872 0.368 . . . . 0.0 110.019 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.452 ' HA ' ' NE2' ' A' ' 12' ' ' GLN . 11.2 mm100 -68.39 -45.21 73.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.807 178.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -57.55 -45.56 84.97 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.048 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.32 -32.1 73.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.667 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -69.11 -38.43 78.91 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.738 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.64 -34.32 74.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.055 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.47 -22.66 54.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.042 178.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.4 -34.6 77.59 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.188 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.89 -123.13 32.5 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.27 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -93.41 5.24 52.25 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.591 0.234 . . . . 0.0 111.327 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -79.33 150.42 31.46 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.965 HD11 HD12 ' A' ' 79' ' ' LEU . 4.8 tp -77.05 131.85 38.62 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.906 HG13 HG23 ' A' ' 53' ' ' ILE . 4.2 t -112.12 108.62 25.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.566 0.698 . . . . 0.0 111.479 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.62 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.5 p -103.26 115.56 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.617 HG23 ' HB2' ' A' ' 78' ' ' LEU . 5.0 m -124.65 167.42 18.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.763 -177.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.503 ' OD1' HD12 ' A' ' 77' ' ' LEU . 37.5 t0 -136.05 136.86 40.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.966 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.514 ' HE1' HD12 ' A' ' 78' ' ' LEU . 9.7 m-85 -99.46 113.59 26.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.274 178.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.573 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.6 m -122.82 -166.64 1.46 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.287 0.565 . . . . 0.0 112.199 -178.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.553 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.0 154.05 35.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.184 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 m -72.23 -35.17 68.78 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.38 0.61 . . . . 0.0 109.716 178.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.417 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 54.6 p-90 -87.14 10.76 15.77 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 115.102 -0.954 . . . . 0.0 112.33 -179.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 25.0 t -96.51 156.83 16.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.926 0.393 . . . . 0.0 111.591 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.59 -71.05 0.76 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.286 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.72 -26.52 47.4 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.481 2.121 . . . . 0.0 112.231 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.3 m -58.94 -44.6 91.42 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.344 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.77 -24.22 66.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.431 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.5 mmt -67.97 -18.62 64.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.1 mm -87.27 -24.59 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.703 0.287 . . . . 0.0 111.115 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -52.91 -53.66 52.51 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.56 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -48.45 -50.01 13.21 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.703 2.269 . . . . 0.0 113.164 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.411 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 17.5 m-85 -80.07 -27.55 39.32 Favored 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.442 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 4.0 t80 -66.02 -45.42 81.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.107 0.479 . . . . 0.0 110.239 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.28 -42.3 84.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.786 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 41' ' ' PHE . 0.4 OUTLIER -60.14 -43.76 95.48 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.898 0.38 . . . . 0.0 110.744 -179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.1 mt -60.09 -39.76 87.26 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.406 ' HB2' ' CB ' ' A' ' 54' ' ' PHE . 37.8 t -56.45 -27.7 57.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.245 179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -87.89 -18.08 30.0 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.717 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.78 -20.58 18.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.966 0.413 . . . . 0.0 110.09 179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.798 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.1 m-85 -99.27 92.83 5.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.476 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.2 p -88.85 50.23 1.92 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.052 0.453 . . . . 0.0 110.489 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -153.3 -41.21 0.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.985 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.798 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.8 m -94.38 154.92 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.847 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.906 HG23 HG13 ' A' ' 23' ' ' VAL . 3.4 tp -105.44 113.32 42.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.361 0.601 . . . . 0.0 111.215 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.62 ' CE1' HG11 ' A' ' 24' ' ' VAL . 7.4 m-85 -95.3 115.99 28.17 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.502 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.72 ' HA ' HG13 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -127.38 165.23 20.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.743 -0.783 . . . . 0.0 111.603 178.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 55' ' ' LEU . 2.3 tp10 -116.39 119.01 34.31 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -115.1 117.34 55.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.186 0.517 . . . . 0.0 110.82 178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -98.81 120.68 39.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 28' ' ' SER . 14.8 p -60.08 -18.02 15.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.281 -0.418 . . . . 0.0 112.127 -178.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -67.18 -37.69 84.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -99.88 -35.31 9.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.498 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.913 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.67 43.34 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.547 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.3 tt0 -68.79 -10.35 56.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.718 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -94.76 -22.92 17.77 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.142 -0.223 . . . . 0.0 111.424 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.913 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -78.83 -47.35 23.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 C-N-CA 120.781 -0.368 . . . . 0.0 111.31 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.881 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.6 -56.41 16.9 Favored Pre-proline 0 N--CA 1.462 0.145 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.881 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 72.1 Cg_exo -51.77 -28.19 29.53 Favored 'Trans proline' 0 N--CA 1.466 -0.122 0 C-N-CA 122.557 2.172 . . . . 0.0 112.102 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -76.98 -15.47 59.63 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.997 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -118.5 -7.71 10.58 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.653 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.32 39.49 95.96 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.911 -0.661 . . . . 0.0 113.304 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.614 HG23 HG21 ' A' ' 76' ' ' THR . 56.4 mt -78.21 79.36 0.81 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 117.133 0.467 . . . . 0.0 110.892 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.7 ttt85 -86.31 78.04 9.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.048 0.452 . . . . 0.0 111.62 -179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.99 166.05 10.73 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.824 -0.703 . . . . 0.0 113.542 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.6 pt -148.55 154.32 41.07 Favored Pre-proline 0 CA--C 1.532 0.254 0 C-N-CA 122.309 0.243 . . . . 0.0 110.704 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -87.14 115.78 3.32 Favored 'Cis proline' 0 C--N 1.352 0.756 0 C-N-CA 124.211 -1.162 . . . . 0.0 112.597 0.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.614 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -87.24 137.18 32.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.909 0.385 . . . . 0.0 111.727 179.389 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.503 HD12 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -108.45 125.02 51.3 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.949 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.617 ' HB2' HG23 ' A' ' 25' ' ' VAL . 6.4 mt -113.93 134.61 54.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.376 0.607 . . . . 0.0 111.808 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.965 HD12 HD11 ' A' ' 22' ' ' LEU . 2.8 mm? -115.15 119.83 37.72 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.791 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.59 ' CE2' HG22 ' A' ' 85' ' ' VAL . 52.3 m-85 -112.98 147.88 36.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.179 0.514 . . . . 0.0 111.827 -178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -147.37 113.18 5.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.309 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.2 m120 60.6 45.94 9.9 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.037 0.446 . . . . 0.0 110.194 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.29 2.46 48.55 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.669 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -124.61 138.59 54.3 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 117.257 0.528 . . . . 0.0 111.813 -179.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.59 HG22 ' CE2' ' A' ' 80' ' ' PHE . 42.9 t -67.16 116.84 7.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.647 179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -113.07 11.47 18.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.97 0.414 . . . . 0.0 111.907 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.816 ' HB3' ' CB ' ' A' ' 79' ' ' LEU . . . -173.17 138.16 0.73 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.101 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 1.1 t -136.46 125.51 24.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 111.102 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.98 139.32 53.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.281 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.7 t -121.07 146.07 26.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.628 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.1 164.1 33.54 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.643 -0.789 . . . . 0.0 113.121 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.658 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -65.69 165.62 12.26 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.053 0.454 . . . . 0.0 111.744 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.658 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.3 OUTLIER -163.02 144.74 10.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.632 -179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.7 m -64.41 -177.92 0.34 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.634 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.3 tttt -73.18 -30.96 63.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.429 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.54 -30.08 54.1 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.316 -0.945 . . . . 0.0 112.79 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.432 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 34.3 mt-30 -76.45 -33.08 58.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.97 0.414 . . . . 0.0 110.681 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.555 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -70.61 -51.15 30.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.803 179.226 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.7 ttpt -60.88 -40.75 94.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.214 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -60.98 -39.19 88.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.786 0.327 . . . . 0.0 110.128 179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.768 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 6.8 t80 -60.94 -39.85 91.03 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.333 0.587 . . . . 0.0 109.98 178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.507 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 7.2 mt -66.92 -58.46 4.93 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.344 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.01 -36.39 28.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.827 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.08 -23.81 63.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.032 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -105.89 -53.1 2.7 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.754 0.312 . . . . 0.0 111.372 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.525 HD23 ' O ' ' A' ' 106' ' ' LEU . 1.5 tt -47.51 -42.29 22.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.023 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 106' ' ' LEU . 26.2 m . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.249 -0.882 . . . . 0.0 112.083 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtt . . . . . 0 N--CA 1.484 1.263 0 CA-C-O 120.934 0.397 . . . . 3.8700000000000001 111.534 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.738 HG13 ' HA ' ' A' ' 55' ' ' LEU . 52.8 t -108.17 150.93 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 115.709 -0.678 . . . . 0.41999999999999998 109.573 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.524 ' O ' HD12 ' A' ' 5' ' ' ILE . 0.3 OUTLIER -143.42 124.52 14.47 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 118.764 -1.174 . . . . 1.4299999999999999 111.975 179.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -76.5 120.21 21.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 113.953 -1.476 . . . . 2.2799999999999998 110.427 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.112 HG23 ' HB3' ' A' ' 10' ' ' ALA . 3.1 mp -101.55 113.56 38.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 120.797 -0.361 . . . . 0.35999999999999999 111.163 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HG2' ' OD2' ' A' ' 61' ' ' ASP . 8.4 mt-10 -100.94 15.97 26.81 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.104 -0.498 . . . . 1.3799999999999999 112.276 179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.452 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.4 m -153.5 160.27 42.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.908 0.385 . . . . 0.97999999999999998 111.246 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.477 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.1 ttpt -75.55 -23.32 56.59 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.238 -0.437 . . . . 1.6499999999999999 111.092 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.5 m -79.42 -29.98 42.14 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.698 -0.482 . . . . 0.80000000000000004 109.698 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 1.112 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -68.52 -41.77 79.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.68 -0.691 . . . . 0.23999999999999999 110.453 179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -56.51 -49.41 74.79 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 116.031 -0.531 . . . . 1.1299999999999999 110.501 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -61.45 -37.17 82.61 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.691 -0.855 . . . . 0.93999999999999995 108.691 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -62.18 -44.37 96.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.937 -1.029 . . . . 1.3999999999999999 111.893 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.04 -33.22 67.82 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.904 0.383 . . . . 0.28000000000000003 111.367 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.5 mt -64.57 -40.64 95.91 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.319 0.581 . . . . 0.40000000000000002 110.587 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.95 -29.53 69.7 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 1.8400000000000001 110.525 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.17 -23.86 51.52 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.129 -0.487 . . . . 0.42999999999999999 111.67 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.446 ' HB1' HG22 ' A' ' 23' ' ' VAL . . . -72.35 -26.72 62.02 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-N 116.595 -0.275 . . . . 0.66000000000000003 111.288 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 51.96 -117.65 6.32 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 119.63 -1.271 . . . . 1.04 113.277 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -95.59 10.34 37.03 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.54 0.209 . . . . 2.3599999999999999 111.207 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -82.53 151.11 26.6 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 109.88 -0.415 . . . . 1.8200000000000001 109.88 179.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.885 HD11 ' CD1' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -76.21 121.28 22.67 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 109.612 -0.514 . . . . 0.28000000000000003 109.612 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.875 HG13 ' CG2' ' A' ' 53' ' ' ILE . 2.6 t -101.63 111.9 32.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.725 0.774 . . . . 0.22 112.065 -179.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.673 HG11 ' CE1' ' A' ' 54' ' ' PHE . 9.1 p -108.27 122.19 62.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.663 -1.236 . . . . 0.35999999999999999 107.663 177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.037 HG12 ' HG ' ' A' ' 55' ' ' LEU . 11.4 m -133.13 141.97 43.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.523 0.678 . . . . 0.67000000000000004 112.051 -177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -107.74 131.04 54.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.374 -0.83 . . . . 1.1299999999999999 112.403 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.405 ' HE1' HD12 ' A' ' 78' ' ' LEU . 2.7 m-85 -96.24 110.28 22.61 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.663 -0.866 . . . . 0.28000000000000003 108.663 178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.501 ' O ' HG12 ' A' ' 59' ' ' VAL . 3.3 p -121.14 -168.76 1.72 Allowed 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.706 0.632 . . . . 1.03 112.706 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.06 156.1 39.25 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.133 -0.94 . . . . 0.37 110.693 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.46 -37.84 74.36 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.309 0.576 . . . . 1.1399999999999999 110.184 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 28.4 p-90 -86.61 10.77 14.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.99 -1.004 . . . . 0.98999999999999999 111.499 -179.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 37.3 t -100.24 140.47 34.44 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.786 0.327 . . . . 0.98999999999999999 110.244 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.48 -65.65 0.9 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.614 -0.803 . . . . 0.35999999999999999 112.481 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -49.98 -30.98 25.91 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.554 2.169 . . . . 0.68000000000000005 111.769 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 79.4 m -58.51 -40.21 82.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.735 -0.666 . . . . 0.65000000000000002 110.621 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -70.68 -26.4 63.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.941 -0.572 . . . . 2.1499999999999999 111.234 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.5 mmt -69.02 -20.64 64.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.479 . . . . 1.48 111.292 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.9 mm -87.8 -18.21 8.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.793 0.33 . . . . 0.60999999999999999 110.616 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -52.81 -54.73 40.31 Favored Pre-proline 0 CA--C 1.528 0.132 0 CA-C-N 116.495 -0.32 . . . . 2.1200000000000001 110.726 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -48.68 -51.62 10.04 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.657 2.238 . . . . 0.46999999999999997 112.766 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -75.21 -36.18 61.4 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.488 -0.323 . . . . 0.56000000000000005 111.466 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.543 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 7.0 t80 -64.81 -46.36 82.33 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 120.54 -0.464 . . . . 0.38 109.999 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.454 ' O ' ' HB3' ' A' ' 46' ' ' SER . 0.2 OUTLIER -67.28 -42.11 84.37 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.542 0.201 . . . . 0.97999999999999998 111.542 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 m -60.32 -46.87 88.37 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 120.918 -0.313 . . . . 1.1899999999999999 110.742 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 24.7 mt -54.13 -36.44 63.28 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.35 -0.611 . . . . 0.32000000000000001 109.35 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 43' ' ' HIS . 22.7 t -57.87 -26.33 61.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.294 -0.866 . . . . 1.3 111.117 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -89.3 -17.64 28.54 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.712 0.291 . . . . 2.2999999999999998 111.035 179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 1.6 ttpp -97.05 -15.15 21.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.091 0.472 . . . . 1.48 110.48 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.901 ' HB3' HG22 ' A' ' 52' ' ' VAL . 24.1 m-85 -105.8 84.48 2.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.792 -0.64 . . . . 0.97999999999999998 111.334 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.3 t -78.62 43.16 0.47 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.542 -0.754 . . . . 1.25 111.542 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -154.6 -29.17 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.672 -0.24 . . . . 1.03 111.34 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.901 HG22 ' HB3' ' A' ' 49' ' ' TYR . 5.3 m -99.35 155.85 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.297 0 CA-C-O 121.352 0.596 . . . . 0.28999999999999998 111.692 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.875 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.1 tp -104.38 113.33 41.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.13 -0.941 . . . . 0.28999999999999998 110.963 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.716 ' O ' HG22 ' A' ' 2' ' ' VAL . 6.1 m-85 -99.55 116.43 31.66 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 116.042 -0.527 . . . . 0.32000000000000001 110.876 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.059 HD13 HD13 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -130.95 167.94 18.16 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 116.064 -0.516 . . . . 0.23999999999999999 110.296 178.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.869 ' N ' HD12 ' A' ' 55' ' ' LEU . 5.7 tt0 -121.55 125.08 45.92 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.023 0.379 . . . . 2.1600000000000001 112.023 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.571 ' CG2' HD11 ' A' ' 55' ' ' LEU . 6.7 t -112.12 116.17 51.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.557 0.694 . . . . 0.17000000000000001 110.951 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -93.79 115.29 27.69 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.236 -0.893 . . . . 2.1200000000000001 110.379 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 28' ' ' SER . 11.2 p -61.2 -22.28 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.175 -0.466 . . . . 0.22 112.083 -178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -62.32 -37.95 87.58 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.091 -0.707 . . . . 1.3 109.091 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.458 ' OD2' ' HG2' ' A' ' 6' ' ' GLU . 1.3 m-20 -101.12 -42.43 6.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.128 -0.942 . . . . 1.3100000000000001 112.314 -179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.775 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -87.78 53.63 2.84 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.13 0.49 . . . . 0.26000000000000001 110.406 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.501 ' O ' ' CD ' ' A' ' 67' ' ' PRO . 5.4 mt-30 -74.9 -11.53 60.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.667 -0.697 . . . . 2.5800000000000001 111.324 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 8' ' ' LYS . 0.4 OUTLIER -87.05 -31.12 20.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.891 0.377 . . . . 1.3700000000000001 110.68 -179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.775 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 18.2 m -76.77 -46.97 29.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.913 -0.585 . . . . 0.20999999999999999 111.14 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.882 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.67 -55.31 23.79 Favored Pre-proline 0 CA--C 1.532 0.28 0 N-CA-C 113.178 0.807 . . . . 0.28999999999999998 113.178 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.882 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 51.0 Cg_exo -55.68 -28.29 65.29 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.161 2.574 . . . . 0.48999999999999999 114.073 -178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.6 mttp -75.62 -26.47 57.82 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.869 0.322 . . . . 1.47 111.869 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -99.91 -9.43 22.82 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.23 0.538 . . . . 0.46000000000000002 110.663 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.61 39.44 78.33 Favored Glycine 0 N--CA 1.443 -0.862 0 CA-C-N 115.521 -0.763 . . . . 0.55000000000000004 112.785 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.626 HD11 HD11 ' A' ' 78' ' ' LEU . 63.9 mt -76.46 129.02 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 109.0 -0.741 . . . . 1.3500000000000001 109.0 178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -143.49 64.68 1.33 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.571 -0.452 . . . . 3.4700000000000002 111.76 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.08 120.74 0.78 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.717 -0.754 . . . . 1.1499999999999999 112.455 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.415 HD12 ' HB2' ' A' ' 32' ' ' CYS . 13.5 pt -109.14 153.39 42.62 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 110.626 -0.139 . . . . 0.65000000000000002 110.626 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -81.9 129.94 17.16 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 124.347 -1.105 . . . . 0.40000000000000002 113.718 0.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.538 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -101.94 138.54 38.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.45000000000000001 111.45 178.404 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.16 113.82 26.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.319 -0.993 . . . . 1.8100000000000001 108.319 177.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.652 ' HB2' HG23 ' A' ' 25' ' ' VAL . 3.5 mt -104.92 131.65 52.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.379 0.609 . . . . 0.26000000000000001 111.454 -177.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.885 ' CD1' HD11 ' A' ' 22' ' ' LEU . 2.1 mm? -113.06 117.34 31.74 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.177 -0.919 . . . . 0.28999999999999998 111.05 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.602 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 60.0 m-85 -111.93 140.9 46.2 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.507 -0.553 . . . . 0.26000000000000001 109.507 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.786 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 1.8 tttm -141.32 105.82 4.86 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.48 -0.933 . . . . 0.46000000000000002 108.48 -178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.8 m120 67.04 47.11 1.43 Allowed 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.373 -0.603 . . . . 1.1299999999999999 109.373 -178.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 65.34 4.87 18.96 Favored Glycine 0 C--N 1.336 0.564 0 CA-C-N 115.371 -0.831 . . . . 0.23999999999999999 113.718 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -118.51 130.23 55.81 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.39 -0.596 . . . . 1.5600000000000001 109.39 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.1 p -55.18 117.41 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 108.68 -0.859 . . . . 1.21 108.68 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.786 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -96.97 -7.24 33.6 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 113.051 0.76 . . . . 0.23000000000000001 113.051 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -177.05 148.94 0.66 Allowed 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.098 -0.501 . . . . 0.25 112.055 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.2 t -126.87 148.61 49.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.852 -0.613 . . . . 1.54 109.801 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 tmtt? -149.79 132.07 15.52 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.224 -0.658 . . . . 1.3899999999999999 109.224 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.8 t -115.04 146.78 19.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.432 -0.349 . . . . 0.29999999999999999 111.399 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.45 161.57 27.6 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.939 -0.648 . . . . 0.23999999999999999 113.113 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.65 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -70.19 169.05 14.42 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.812 0.339 . . . . 0.44 111.361 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.65 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -157.85 176.69 12.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.076 -0.511 . . . . 0.85999999999999999 111.333 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 m -91.27 175.54 6.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.622 -0.717 . . . . 0.97999999999999998 110.174 179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.8 tttt -70.73 -30.84 67.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.621 -0.263 . . . . 1.1699999999999999 111.365 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.03 -31.92 51.18 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.227 -0.987 . . . . 0.22 113.122 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.602 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 35.8 mt-30 -75.12 -30.6 60.88 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.915 0.388 . . . . 1.0 110.949 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.465 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -73.03 -51.19 19.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.193 0.521 . . . . 0.41999999999999998 109.823 179.591 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.447 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 17.2 ttpt -60.16 -45.18 93.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.442 -0.799 . . . . 1.6399999999999999 110.529 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.602 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.4 OUTLIER -59.83 -39.03 83.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 1.8100000000000001 110.154 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.423 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 8.5 t80 -62.45 -41.83 99.03 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.651 -0.704 . . . . 0.28000000000000003 111.311 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.482 HD21 ' HB ' ' A' ' 24' ' ' VAL . 8.0 mt -68.17 -55.95 10.49 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.76 -0.654 . . . . 0.31 110.451 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.447 ' O ' HG13 ' A' ' 107' ' ' VAL . 1.4 t70 -46.45 -33.38 3.92 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.67 -0.493 . . . . 1.1899999999999999 109.67 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.04 -23.95 59.47 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.403 -0.817 . . . . 0.23000000000000001 113.192 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.429 ' O ' ' CE ' ' A' ' 81' ' ' LYS . 1.7 t30 -108.87 -28.65 9.04 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.009 0.433 . . . . 0.58999999999999997 111.659 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.951 HD23 ' O ' ' A' ' 106' ' ' LEU . 9.3 tt -64.61 0.52 1.07 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.628 0.771 . . . . 1.3500000000000001 112.312 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.447 HG13 ' O ' ' A' ' 103' ' ' ASP . 11.6 m . . . . . 0 C--O 1.247 0.939 0 CA-C-O 118.426 -0.797 . . . . 2.6899999999999999 112.699 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mtt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.992 0.425 . . . . 4.04 111.425 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.817 HG13 ' HA ' ' A' ' 55' ' ' LEU . 88.5 t -70.59 147.56 11.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.865 -0.607 . . . . 0.48999999999999999 110.714 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.498 ' O ' HD12 ' A' ' 5' ' ' ILE . 2.2 ptpt -141.68 126.2 17.8 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-O 121.8 0.81 . . . . 1.6399999999999999 111.255 -179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.62 122.03 25.42 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.404 -1.271 . . . . 2.0499999999999998 110.578 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.096 HD13 HD13 ' A' ' 55' ' ' LEU . 3.2 mp -104.43 111.59 34.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 CA-C-O 120.842 0.353 . . . . 0.19 111.35 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -99.77 19.46 15.95 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.11 -0.495 . . . . 1.6299999999999999 112.058 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.453 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.0 OUTLIER -154.8 160.2 41.11 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.999 -0.28 . . . . 0.95999999999999996 110.714 -179.509 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.47 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 7.1 ttpt -77.57 -21.58 52.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.058 0.456 . . . . 1.48 110.707 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 33.2 m -79.41 -31.91 42.79 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.635 -0.505 . . . . 0.79000000000000004 109.635 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 1.013 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -68.24 -38.79 82.19 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.375 -0.83 . . . . 0.26000000000000001 111.019 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -58.15 -47.99 81.65 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 116.165 -0.471 . . . . 1.25 110.403 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.02 -37.37 87.18 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.653 -0.499 . . . . 1.21 109.653 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -60.8 -46.97 88.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.703 -0.68 . . . . 1.53 111.846 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -67.89 -34.46 76.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.32000000000000001 110.65 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.0 mt -65.2 -42.33 93.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.998 -0.546 . . . . 0.44 110.89 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.21 -30.32 71.0 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.042 0.449 . . . . 1.72 110.074 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.98 -22.34 53.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.638 -0.71 . . . . 0.47999999999999998 110.77 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.68 -34.01 73.36 Favored 'General case' 0 CA--C 1.511 -0.547 0 CA-C-N 116.118 -0.492 . . . . 0.72999999999999998 110.975 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 61.33 -125.09 36.69 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.083 -1.056 . . . . 1.05 113.155 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -91.21 7.35 41.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.761 0.315 . . . . 2.3999999999999999 111.585 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 58.2 mttt -82.49 151.88 26.31 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.53 -0.304 . . . . 1.54 110.383 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.932 HD11 HD12 ' A' ' 79' ' ' LEU . 1.3 tp -77.09 127.36 32.52 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.31 109.858 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.874 HG13 ' CG2' ' A' ' 53' ' ' ILE . 3.3 t -107.62 115.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.353 0.597 . . . . 0.33000000000000002 111.425 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.537 HG11 ' CE1' ' A' ' 54' ' ' PHE . 7.9 p -110.47 116.09 51.48 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.724 0 N-CA-C 108.066 -1.087 . . . . 0.63 108.066 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.997 HG12 ' HG ' ' A' ' 55' ' ' LEU . 16.6 m -124.99 142.98 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.898 0 CA-C-O 121.74 0.781 . . . . 0.83999999999999997 111.793 -177.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -108.19 128.01 54.33 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.328 -1.306 . . . . 1.1899999999999999 111.211 -178.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -95.42 108.22 20.42 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.147 -0.686 . . . . 0.34999999999999998 109.147 178.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.1 p -119.06 -170.93 2.01 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.782 0.66 . . . . 1.03 112.782 -177.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.11 156.83 40.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.845 -1.07 . . . . 0.40000000000000002 110.137 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -70.2 -35.51 73.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.556 0.693 . . . . 0.93000000000000005 110.259 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.437 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 27.8 p-90 -87.42 12.21 12.71 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.041 -0.981 . . . . 1.1200000000000001 111.213 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.479 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 35.5 t -102.38 131.67 48.87 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.742 0.306 . . . . 0.93999999999999995 110.9 179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.71 -63.18 1.35 Allowed Glycine 0 CA--C 1.521 0.459 0 C-N-CA 120.616 -0.802 . . . . 0.35999999999999999 112.616 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -51.77 -32.2 45.0 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.564 2.176 . . . . 0.63 112.164 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.1 m -58.47 -41.36 85.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.886 -0.597 . . . . 0.70999999999999996 110.363 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -71.18 -19.88 62.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.839 -0.619 . . . . 2.2400000000000002 111.098 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 10.2 mtt -75.04 -24.86 58.34 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.016 -0.538 . . . . 1.45 111.434 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.7 mm -85.96 -19.06 8.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.454 -0.339 . . . . 0.65000000000000002 111.36 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.406 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 25.6 mtpt -52.58 -54.24 44.93 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.823 0.344 . . . . 2.5099999999999998 111.054 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 63.8 Cg_exo -48.77 -50.02 13.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.715 2.277 . . . . 0.44 112.625 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -77.26 -31.37 54.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.532 0.206 . . . . 0.53000000000000003 111.419 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.457 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 5.4 t80 -65.42 -47.21 77.03 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 120.664 -0.414 . . . . 0.29999999999999999 110.176 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -41.0 89.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.294 -0.412 . . . . 0.88 111.846 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t -60.1 -45.12 94.03 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 120.933 -0.307 . . . . 1.3 110.856 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 39.8 mt -57.95 -37.14 73.59 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.154 0.502 . . . . 0.41999999999999998 109.894 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 12.2 t -55.55 -31.94 62.55 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.58 -0.736 . . . . 1.25 111.103 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -85.02 -20.7 30.08 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.746 0.308 . . . . 2.1800000000000002 110.399 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 2.8 ttpp -92.89 -7.76 45.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.192 -0.458 . . . . 2.0499999999999998 110.514 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.845 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.9 m-85 -116.2 92.5 3.91 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.154 -0.475 . . . . 1.4299999999999999 111.413 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 59.5 p -86.55 46.64 1.38 Allowed 'General case' 0 C--O 1.236 0.367 0 CA-C-N 116.435 -0.348 . . . . 1.7 110.479 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 21.5 t30 -154.93 -29.96 0.11 Allowed 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 111.793 0.294 . . . . 1.3799999999999999 111.793 178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.845 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.9 m -101.53 159.98 3.99 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.226 -0.443 . . . . 0.35999999999999999 111.384 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.874 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.5 tp -109.91 116.83 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 CA-C-N 115.469 -0.787 . . . . 0.38 110.729 -178.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.755 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.5 m-85 -99.89 116.61 32.35 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 115.354 -0.839 . . . . 0.33000000000000002 111.156 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.096 HD13 HD13 ' A' ' 5' ' ' ILE . 0.4 OUTLIER -133.45 166.01 23.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 120.493 -0.483 . . . . 0.23000000000000001 112.009 179.431 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.927 ' N ' HD12 ' A' ' 55' ' ' LEU . 3.4 tt0 -119.32 125.01 48.05 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.977 0.732 . . . . 1.8400000000000001 112.977 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.663 HG22 HD11 ' A' ' 55' ' ' LEU . 3.4 t -114.49 114.66 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 CA-C-N 115.476 -0.784 . . . . 0.20000000000000001 110.673 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -90.76 114.81 27.26 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.741 . . . . 1.6899999999999999 109.848 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.8 p -58.95 -21.44 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-N 115.885 -0.598 . . . . 0.25 111.372 -178.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -64.18 -41.36 97.15 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 109.738 -0.468 . . . . 1.26 109.738 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -95.5 -42.55 8.4 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.107 -0.497 . . . . 1.23 111.783 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.595 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -90.55 47.35 1.42 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.025 0.44 . . . . 0.23000000000000001 111.219 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -75.09 -3.3 31.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.365 -0.379 . . . . 2.0 110.864 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.3 -24.25 20.94 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 110.159 -0.312 . . . . 1.3799999999999999 110.159 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 62' ' ' ALA . 34.6 m -85.5 -43.89 16.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 CA-C-O 121.101 0.477 . . . . 0.20000000000000001 111.557 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.836 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.08 -53.09 47.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 112.927 0.714 . . . . 0.27000000000000002 112.927 -177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.836 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 43.8 Cg_exo -57.82 -27.45 78.31 Favored 'Trans proline' 0 N--CA 1.472 0.208 0 C-N-CA 123.16 2.573 . . . . 0.46000000000000002 113.456 -178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -77.29 -22.64 51.71 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.522 -0.308 . . . . 1.5800000000000001 111.696 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -102.83 -10.08 19.4 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.405 0.621 . . . . 0.48999999999999999 110.427 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 69.49 39.78 79.35 Favored Glycine 0 N--CA 1.441 -1.023 0 CA-C-N 115.265 -0.879 . . . . 0.60999999999999999 112.151 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.671 HD11 HD11 ' A' ' 78' ' ' LEU . 67.8 mt -77.61 130.45 36.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.172 -0.677 . . . . 1.3 109.172 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -144.44 67.02 1.26 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.281 0.563 . . . . 3.5899999999999999 111.337 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 152.58 117.58 0.71 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.517 -0.849 . . . . 1.1499999999999999 113.247 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.452 HD12 ' HB2' ' A' ' 32' ' ' CYS . 16.6 pt -105.97 153.82 39.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 110.378 -0.23 . . . . 1.1100000000000001 110.378 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.41 121.42 7.18 Favored 'Cis proline' 0 C--N 1.346 0.428 0 C-N-CA 123.786 -1.339 . . . . 0.94999999999999996 113.155 0.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.609 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -93.0 140.7 29.2 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.037 -0.529 . . . . 0.40000000000000002 111.589 179.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.25 117.09 30.16 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.458 -0.571 . . . . 0.98999999999999999 109.458 177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.747 ' HB2' HG23 ' A' ' 25' ' ' VAL . 3.2 mt -106.65 132.84 52.18 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.411 0.624 . . . . 0.40000000000000002 111.504 -179.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.932 HD12 HD11 ' A' ' 22' ' ' LEU . 2.5 mm? -112.62 115.12 28.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.994 -1.003 . . . . 0.27000000000000002 109.429 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.64 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 46.5 m-85 -109.1 145.56 35.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.188 0.518 . . . . 0.25 110.007 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.669 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 12.1 tttm -143.86 110.58 5.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.268 -0.878 . . . . 0.40000000000000002 109.905 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.4 m120 60.51 47.2 8.8 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.341 -0.544 . . . . 0.62 109.715 -179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.04 5.06 45.6 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 120.828 -0.701 . . . . 0.25 113.425 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -121.65 132.99 54.96 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.201 0.5 . . . . 1.73 111.269 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 93.9 t -58.18 121.81 6.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 N-CA-C 108.725 -0.843 . . . . 1.0800000000000001 108.725 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.669 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -103.04 -11.15 18.34 Favored 'General case' 0 CA--C 1.51 -0.559 0 CA-C-O 121.298 0.57 . . . . 0.22 112.28 -178.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.596 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.89 149.26 1.91 Allowed 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.07 -0.968 . . . . 0.20999999999999999 111.577 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -130.17 145.88 51.76 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.52 -0.764 . . . . 1.5 109.211 178.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -143.68 136.35 27.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.899 -0.408 . . . . 1.9299999999999999 109.899 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.1 t -116.76 145.2 22.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.905 0.384 . . . . 1.0900000000000001 111.227 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.9 160.39 26.37 Favored Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.517 -0.849 . . . . 0.27000000000000002 113.092 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.01 152.02 42.76 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.853 0.359 . . . . 0.56000000000000005 111.4 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.535 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -138.9 171.08 14.86 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.286 -0.415 . . . . 0.64000000000000001 110.875 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -86.53 175.0 8.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.742 -0.663 . . . . 0.92000000000000004 110.276 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -67.45 -33.34 74.94 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.043 -0.263 . . . . 0.94999999999999996 111.635 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.42 -31.13 52.26 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.183 -1.008 . . . . 0.22 112.655 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.497 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 53.3 mt-30 -74.86 -29.56 61.06 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.074 0.464 . . . . 1.3700000000000001 110.598 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.535 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -74.88 -48.67 23.59 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.929 -0.578 . . . . 0.39000000000000001 109.58 179.012 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.509 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 19.4 ttpt -61.82 -46.13 90.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.581 -0.736 . . . . 1.27 111.079 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.497 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.0 pp20? -58.72 -40.32 83.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.232 0.539 . . . . 1.8300000000000001 109.93 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.53 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 10.8 t80 -61.37 -41.28 96.84 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 115.671 -0.695 . . . . 0.33000000000000002 110.882 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.8 mt -68.05 -52.67 32.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.842 -0.617 . . . . 0.41999999999999998 109.891 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -51.11 -36.64 41.54 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.96 0.409 . . . . 1.1799999999999999 110.338 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.43 -19.5 60.95 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 112.737 0.643 . . . . 0.22 112.737 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.537 ' HB3' HD21 ' A' ' 22' ' ' LEU . 1.0 OUTLIER -106.97 -44.23 4.45 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.133 0.492 . . . . 0.41999999999999998 110.507 -179.145 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.449 ' HB2' HD23 ' A' ' 22' ' ' LEU . 67.7 tp -63.84 112.87 3.09 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.726 -0.67 . . . . 1.3700000000000001 109.565 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.177 -0.916 . . . . 1.6699999999999999 110.736 -179.65 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 120.964 0.411 . . . . 3.2000000000000002 111.422 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.872 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 58.8 t -107.21 149.08 10.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.892 -0.595 . . . . 0.41999999999999998 109.597 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.587 ' O ' HD12 ' A' ' 5' ' ' ILE . 9.1 ptpt -143.29 117.52 9.56 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 119.428 -0.909 . . . . 1.77 111.92 -178.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.84 124.21 23.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.94 -1.027 . . . . 1.79 109.778 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.872 HD13 HD13 ' A' ' 55' ' ' LEU . 1.4 mp -103.43 111.77 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.852 0.358 . . . . 0.23000000000000001 111.152 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -97.78 14.02 28.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.99 -0.55 . . . . 1.8 112.152 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.424 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 2.6 m -154.18 155.29 35.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.806 0.336 . . . . 0.71999999999999997 111.034 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.576 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 0.8 OUTLIER -71.49 -21.77 61.89 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.371 -0.377 . . . . 1.1599999999999999 110.85 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.2 m -78.86 -32.71 46.11 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.408 -0.59 . . . . 0.32000000000000001 109.408 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.746 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -66.73 -41.52 87.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.461 -0.791 . . . . 0.23000000000000001 109.797 179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.453 ' HB2' HG21 ' A' ' 5' ' ' ILE . 18.2 t80 -56.34 -41.86 76.77 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.059 -0.518 . . . . 1.1599999999999999 109.888 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -64.82 -41.21 95.94 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.074 -0.713 . . . . 1.27 109.074 178.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -59.96 -49.37 77.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.099 -0.955 . . . . 1.6200000000000001 111.76 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.89 74.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.747 0.308 . . . . 0.29999999999999999 111.313 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.505 HD23 HG11 ' A' ' 23' ' ' VAL . 24.4 mt -69.1 -43.69 73.96 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.147 0.499 . . . . 0.41999999999999998 110.65 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -61.94 -32.1 72.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.009 -0.541 . . . . 1.79 110.688 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.47 -26.9 58.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.47999999999999998 110.968 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.569 ' HB1' HG22 ' A' ' 23' ' ' VAL . . . -73.93 -20.72 60.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.298 -0.41 . . . . 0.72999999999999998 111.286 179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 46.12 -119.85 4.25 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.794 -0.717 . . . . 0.96999999999999997 114.789 178.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' HA ' ' ND2' ' A' ' 82' ' ' ASN . 16.7 t0 -88.74 2.33 53.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.548 -0.326 . . . . 2.3399999999999999 111.534 -178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 51' ' ' ASN . 32.0 mttt -78.1 151.96 33.12 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.71 -0.848 . . . . 1.6399999999999999 108.71 178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.808 ' HB3' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -73.73 125.09 27.31 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.569 -0.53 . . . . 0.32000000000000001 109.569 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.967 HG13 ' CG2' ' A' ' 53' ' ' ILE . 2.3 t -106.26 105.8 19.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.472 0.653 . . . . 0.23000000000000001 110.917 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.55 HG23 ' CD2' ' A' ' 79' ' ' LEU . 11.4 p -105.55 115.58 47.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 107.294 -1.373 . . . . 0.68999999999999995 107.294 178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.983 HG12 ' HG ' ' A' ' 55' ' ' LEU . 25.0 m -129.13 126.94 65.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.952 -0.567 . . . . 0.82999999999999996 111.862 -177.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -93.16 135.67 34.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.42 -0.809 . . . . 1.1599999999999999 111.453 -178.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -98.8 116.25 30.61 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 108.989 -0.745 . . . . 0.23999999999999999 108.989 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 59' ' ' VAL . 11.2 p -125.01 -168.43 1.82 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.463 0.649 . . . . 1.25 112.731 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.549 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.75 154.03 35.47 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-N 114.901 -1.045 . . . . 0.39000000000000001 109.868 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.6 -35.31 72.93 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.323 0.582 . . . . 0.92000000000000004 109.809 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -86.42 11.52 12.26 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.124 -0.944 . . . . 0.81000000000000005 111.291 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.549 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 36.9 t -97.08 140.77 31.09 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.815 0.341 . . . . 0.47999999999999998 110.923 179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.78 -66.12 0.96 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.599 -0.81 . . . . 0.29999999999999999 112.476 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -52.62 -25.06 24.68 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.533 2.155 . . . . 0.52000000000000002 112.344 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.0 m -62.98 -41.69 99.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 0.5 110.696 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -66.59 -21.25 66.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.013 -0.54 . . . . 2.3700000000000001 111.149 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.2 mmt -73.36 -26.02 60.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 1.53 111.828 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.88 -22.79 7.2 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-O 120.745 0.307 . . . . 0.26000000000000001 111.109 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 10.1 tttt -48.35 -57.04 11.7 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.619 -0.264 . . . . 1.6899999999999999 110.967 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 11.6 Cg_endo -56.68 -43.88 50.69 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.365 2.043 . . . . 0.45000000000000001 112.678 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -73.73 -37.87 64.97 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.521 0.193 . . . . 0.38 111.521 -178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.45 ' O ' ' CE2' ' A' ' 54' ' ' PHE . 9.0 t80 -64.67 -43.52 93.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.951 -0.3 . . . . 0.47999999999999998 111.037 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.48 -37.94 86.2 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.869 -0.332 . . . . 1.02 111.102 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.25 -45.82 91.95 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.707 0.289 . . . . 1.1000000000000001 110.991 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.53 HD13 HD22 ' A' ' 98' ' ' LEU . 19.9 mt -59.25 -39.9 84.25 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 109.892 -0.41 . . . . 0.45000000000000001 109.892 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.421 ' HB2' ' CG ' ' A' ' 54' ' ' PHE . 33.6 t -55.17 -29.19 57.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.535 . . . . 1.3 111.016 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -87.51 -20.73 26.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.961 0.41 . . . . 2.3900000000000001 110.007 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 2.1 ttpp -98.88 8.59 44.83 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.733 -0.667 . . . . 1.9199999999999999 110.698 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.717 ' HB3' HG22 ' A' ' 52' ' ' VAL . 13.9 m-85 -129.63 108.13 9.97 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.268 -0.423 . . . . 0.88 109.883 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.7 m -99.41 47.16 0.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.098 0.407 . . . . 1.52 112.098 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.475 ' O ' ' HB3' ' A' ' 21' ' ' LYS . 13.9 t30 -158.37 -33.78 0.07 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.704 0.287 . . . . 1.3 111.39 178.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.808 HG12 ' HB3' ' A' ' 22' ' ' LEU . 5.0 m -92.82 150.89 3.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 112.154 0.428 . . . . 0.34000000000000002 112.154 -178.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.967 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.3 tp -101.02 119.7 49.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.178 -0.465 . . . . 1.0 110.428 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.872 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 3.9 m-85 -101.79 124.58 47.68 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 116.025 -0.534 . . . . 0.37 110.966 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.983 ' HG ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -139.73 167.53 21.9 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.089 -0.644 . . . . 0.29999999999999999 110.607 177.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.879 ' N ' HD12 ' A' ' 55' ' ' LEU . 4.5 tt0 -122.29 126.46 48.17 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 112.328 0.492 . . . . 2.0499999999999998 112.328 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.673 HG22 HD11 ' A' ' 55' ' ' LEU . 3.9 t -115.52 119.29 61.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.714 -0.675 . . . . 0.20000000000000001 111.388 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -94.42 115.52 27.72 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.274 -0.639 . . . . 1.79 109.274 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 28' ' ' SER . 10.7 p -58.4 -19.07 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.334 -0.393 . . . . 0.27000000000000002 111.5 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.27 -38.66 90.96 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.889 -0.412 . . . . 1.1399999999999999 109.889 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -99.56 -43.65 6.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.895 -0.593 . . . . 1.29 110.698 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.746 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -86.14 46.76 1.37 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.959 -0.564 . . . . 0.23999999999999999 111.02 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.528 ' O ' ' CD ' ' A' ' 67' ' ' PRO . 16.6 tt0 -74.87 -12.24 60.33 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.377 -0.374 . . . . 2.0299999999999998 110.778 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -83.64 -23.47 31.8 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.764 0.316 . . . . 1.29 110.277 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.746 HG22 ' O ' ' A' ' 62' ' ' ALA . 8.5 m -83.46 -49.12 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 116.345 -0.389 . . . . 0.20999999999999999 112.046 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.866 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.64 -54.41 31.53 Favored Pre-proline 0 N--CA 1.467 0.389 0 N-CA-C 113.524 0.935 . . . . 0.28000000000000003 113.524 -177.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.866 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 50.4 Cg_exo -55.04 -27.36 54.57 Favored 'Trans proline' 0 CA--C 1.521 -0.144 0 C-N-CA 122.959 2.439 . . . . 0.40999999999999998 112.4 -179.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 16.3 mttm -76.85 -18.81 58.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.947 -0.57 . . . . 1.9299999999999999 111.203 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -109.22 -8.17 15.16 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.048 0.451 . . . . 0.42999999999999999 110.922 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.16 36.47 91.88 Favored Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 115.639 -0.71 . . . . 0.51000000000000001 112.983 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.526 HD11 HD11 ' A' ' 78' ' ' LEU . 79.4 mt -75.91 132.44 33.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 109.621 -0.511 . . . . 1.3600000000000001 109.621 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -148.14 49.8 1.04 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.666 0.27 . . . . 3.23 111.293 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 178.08 104.24 0.18 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.464 -0.874 . . . . 1.0700000000000001 112.277 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.7 pt -99.48 153.03 37.99 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 120.57 0.224 . . . . 0.88 110.808 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -81.76 119.28 6.22 Favored 'Cis proline' 0 C--N 1.345 0.39 0 C-N-CA 123.766 -1.348 . . . . 0.44 112.373 -0.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.472 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -89.89 137.95 31.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.48999999999999999 111.556 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.55 HD22 HD21 ' A' ' 93' ' ' LEU . 1.3 mp -107.08 118.89 37.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.36 -0.978 . . . . 1.7 108.36 177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.566 ' HB2' HG23 ' A' ' 25' ' ' VAL . 0.2 OUTLIER -106.78 128.19 54.03 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.604 0.716 . . . . 0.23000000000000001 111.231 -178.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.782 HD12 HD11 ' A' ' 22' ' ' LEU . 2.8 mm? -111.31 130.85 55.54 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.983 -1.008 . . . . 0.29999999999999999 108.855 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.696 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 44.9 m-85 -123.8 151.67 43.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.136 0.493 . . . . 0.25 110.4 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.931 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 0.2 OUTLIER -144.15 115.03 7.8 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.345 -0.843 . . . . 0.54000000000000004 109.359 -178.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.463 ' ND2' ' HA ' ' A' ' 20' ' ' ASP . 2.2 m120 53.64 49.57 19.08 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 120.374 -0.53 . . . . 1.1399999999999999 110.319 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.44 3.28 31.7 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 121.143 -0.551 . . . . 0.19 113.865 179.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -119.51 141.81 48.86 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 117.148 0.474 . . . . 1.3700000000000001 110.142 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.61 133.05 13.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.205 -0.598 . . . . 1.27 109.541 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.931 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -103.98 -25.51 12.98 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.635 0.731 . . . . 0.23999999999999999 111.656 -178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.96 160.97 4.37 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.396 -1.275 . . . . 0.19 110.876 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.75 134.21 36.87 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.272 -0.422 . . . . 1.1299999999999999 110.837 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.41 138.34 43.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.293 -0.412 . . . . 1.3400000000000001 110.166 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.45 145.37 25.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.437 -0.347 . . . . 0.97999999999999998 111.198 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.72 160.13 25.45 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.647 -0.787 . . . . 0.20000000000000001 113.034 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.07 152.44 45.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.172 0.51 . . . . 0.44 111.733 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.55 HD21 HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -146.05 151.32 37.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.718 -0.674 . . . . 0.79000000000000004 110.441 -179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 m -69.16 178.9 2.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.446 -0.343 . . . . 0.97999999999999998 111.051 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 19.7 tttt -72.49 -30.64 64.7 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.158 -0.474 . . . . 0.94999999999999996 111.797 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.53 -31.87 52.86 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 120.018 -1.087 . . . . 0.23999999999999999 112.512 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.502 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 39.6 mt-30 -75.59 -33.14 60.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.803 0.335 . . . . 1.3 110.504 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.53 HD22 HD13 ' A' ' 45' ' ' LEU . 0.5 OUTLIER -68.58 -48.83 63.18 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.172 -0.677 . . . . 0.40000000000000002 109.172 179.213 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 18.2 ttpt -60.66 -42.39 96.93 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 115.859 -0.609 . . . . 1.45 110.422 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -60.49 -39.97 89.65 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-N 116.132 -0.485 . . . . 1.6799999999999999 110.091 179.262 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.536 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 6.9 t80 -62.77 -43.44 98.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.757 -0.656 . . . . 0.26000000000000001 111.429 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 6.2 mt -67.73 -53.0 30.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.642 -0.708 . . . . 0.51000000000000001 109.788 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.05 -37.37 53.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 1.2 111.153 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.43 -21.31 62.0 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 116.209 -0.451 . . . . 0.28999999999999998 111.903 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.71 ' HB3' HD21 ' A' ' 22' ' ' LEU . 4.3 t30 -106.52 -46.98 3.88 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 121.068 -0.253 . . . . 0.71999999999999997 111.219 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.629 HD13 HG12 ' A' ' 52' ' ' VAL . 56.6 tp -60.59 90.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.951 0.405 . . . . 1.3200000000000001 110.169 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.344 -0.836 . . . . 2.4100000000000001 111.03 -179.649 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.9 mtt . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 120.767 0.318 . . . . 3.8500000000000001 111.374 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 54' ' ' PHE . 70.2 t -111.01 149.7 13.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.311 -0.404 . . . . 0.26000000000000001 110.229 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -141.51 125.78 17.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 120.045 -0.662 . . . . 2.0800000000000001 111.31 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.82 122.91 27.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.323 -0.853 . . . . 2.3599999999999999 109.432 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.033 HD13 HD13 ' A' ' 55' ' ' LEU . 1.3 mp -103.67 112.06 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 112.119 0.414 . . . . 0.17999999999999999 112.119 -178.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -98.36 14.19 28.89 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.657 0.614 . . . . 1.4099999999999999 112.657 179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 m -156.61 140.8 16.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.705 0.288 . . . . 0.93000000000000005 111.633 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.544 ' HA ' ' CG1' ' A' ' 65' ' ' VAL . 0.0 OUTLIER -58.26 -23.92 57.67 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.443 -0.344 . . . . 1.2 111.62 -179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.5 m -78.31 -33.49 49.26 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.949 -0.76 . . . . 0.32000000000000001 108.949 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.627 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -67.24 -39.35 86.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.583 -0.735 . . . . 0.20999999999999999 109.913 178.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.539 ' HB2' HG21 ' A' ' 5' ' ' ILE . 23.8 t80 -57.64 -46.97 83.49 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.076 -0.511 . . . . 0.63 110.701 179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -63.35 -38.4 91.01 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.411 -0.588 . . . . 1.0800000000000001 109.411 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -59.6 -50.1 75.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.619 -0.719 . . . . 1.4399999999999999 111.498 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.13 -32.55 74.3 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.839 0.352 . . . . 0.31 111.238 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.4 mt -67.79 -42.54 81.49 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.236 0.541 . . . . 0.40999999999999998 110.613 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -60.56 -31.58 70.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.223 -0.444 . . . . 1.6799999999999999 110.161 179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.23 -22.21 55.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.95 -0.568 . . . . 0.45000000000000001 110.44 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.12 -29.3 67.33 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.081 -0.509 . . . . 0.71999999999999997 111.03 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.72 -126.44 42.24 Favored Glycine 0 CA--C 1.508 -0.351 0 C-N-CA 120.347 -0.93 . . . . 0.93000000000000005 113.236 179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -92.55 9.06 36.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.35 -0.425 . . . . 2.2799999999999998 111.057 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 27.3 mttt -80.56 154.1 27.68 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.947 -0.39 . . . . 1.3500000000000001 109.947 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.903 HD11 HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -78.31 126.38 30.7 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.868 -0.419 . . . . 0.26000000000000001 109.868 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.912 HG13 ' CG2' ' A' ' 53' ' ' ILE . 6.2 t -110.32 109.0 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.314 0.578 . . . . 0.22 111.753 -179.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.498 ' O ' HG13 ' A' ' 24' ' ' VAL . 7.2 p -104.97 116.88 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 107.547 -1.279 . . . . 0.31 107.547 177.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.733 HG12 ' HG ' ' A' ' 55' ' ' LEU . 7.3 m -123.61 136.94 58.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 CA-C-O 121.413 0.625 . . . . 0.81000000000000005 111.655 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -100.99 129.68 46.87 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.06 -0.973 . . . . 1.29 111.534 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -97.55 107.9 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.14 -0.689 . . . . 0.28000000000000003 109.14 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.1 p -119.07 -166.64 1.28 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.31 0.576 . . . . 0.91000000000000003 112.493 -178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.65 154.25 36.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.324 -0.853 . . . . 0.35999999999999999 110.296 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.32 -38.59 78.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.657 0.742 . . . . 1.4099999999999999 109.449 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.433 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 37.7 p-90 -84.94 14.08 5.28 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 114.572 -1.195 . . . . 1.1100000000000001 111.54 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 37.8 t -102.96 144.42 31.26 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.856 0.36 . . . . 0.71999999999999997 111.076 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -98.29 -68.24 0.92 Allowed Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.714 -0.755 . . . . 0.29999999999999999 112.386 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -50.9 -28.72 24.61 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.655 2.236 . . . . 0.68000000000000005 112.175 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.2 m -58.37 -44.46 88.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.994 -0.548 . . . . 0.56999999999999995 110.946 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt -68.26 -25.63 65.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.849 -0.614 . . . . 2.5699999999999998 111.336 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.2 mtp -68.37 -21.28 64.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.496 -0.32 . . . . 1.6299999999999999 111.539 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mm -86.73 -20.7 7.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.746 0.308 . . . . 0.25 111.132 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 3.7 tttt -52.23 -53.67 49.94 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.363 -0.38 . . . . 2.04 111.129 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 74.0 Cg_exo -49.63 -47.98 20.84 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.534 2.156 . . . . 0.56999999999999995 112.545 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -78.25 -32.06 49.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.513 -0.312 . . . . 0.44 111.688 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.441 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 6.0 t80 -67.29 -48.6 67.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.909 0.385 . . . . 0.33000000000000002 110.477 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.13 -38.26 85.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.256 -0.429 . . . . 0.95999999999999996 111.497 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 24.0 t -61.61 -45.33 94.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 1.1599999999999999 110.818 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.0 mt -59.79 -38.66 82.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.931 0.396 . . . . 0.37 110.274 -179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.9 p -54.97 -26.13 34.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.966 -0.561 . . . . 1.05 110.381 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -86.61 -23.32 25.77 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 121.052 0.454 . . . . 2.23 110.019 178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.16 11.18 39.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.61 -0.723 . . . . 1.8999999999999999 110.869 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.812 ' HB3' HG22 ' A' ' 52' ' ' VAL . 15.5 m-85 -131.78 93.12 3.25 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.426 -0.352 . . . . 1.02 110.453 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.86 48.03 1.59 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 1.47 111.644 -179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -156.7 -37.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.875 0.324 . . . . 1.1899999999999999 111.875 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.812 HG22 ' HB3' ' A' ' 49' ' ' TYR . 16.5 m -93.2 150.72 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.375 -0.375 . . . . 0.28000000000000003 111.785 -178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.912 ' CG2' HG13 ' A' ' 23' ' ' VAL . 3.0 tp -99.41 120.92 49.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.077 -0.511 . . . . 1.1000000000000001 110.153 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.729 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 3.0 m-85 -102.55 117.24 34.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.918 -0.583 . . . . 0.20000000000000001 110.195 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.033 HD13 HD13 ' A' ' 5' ' ' ILE . 0.2 OUTLIER -132.08 161.8 32.38 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 119.954 -0.699 . . . . 0.17000000000000001 110.695 178.233 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -118.42 121.8 41.22 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.088 -0.96 . . . . 2.1600000000000001 112.435 -177.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.62 HG22 HD11 ' A' ' 55' ' ' LEU . 2.0 t -115.16 118.5 58.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.856 -0.611 . . . . 0.14999999999999999 110.777 178.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 34.2 t0 -92.88 116.9 29.46 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.203 -0.666 . . . . 1.79 109.203 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 9.7 p -58.05 -21.2 16.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.398 -0.364 . . . . 0.19 111.611 -178.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -40.22 96.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.98 0.419 . . . . 0.93999999999999995 110.065 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.96 -41.99 8.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.812 -0.631 . . . . 1.29 111.207 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.556 ' O ' HG22 ' A' ' 65' ' ' VAL . . . -86.32 51.16 2.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.382 0.61 . . . . 0.20999999999999999 110.131 179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.441 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -71.33 -11.85 61.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.71 -0.677 . . . . 2.5099999999999998 111.13 -179.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.01 -23.35 19.55 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 111.734 0.272 . . . . 1.3300000000000001 111.734 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 62' ' ' ALA . 8.6 m -81.51 -50.92 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.188 0.44 . . . . 0.17999999999999999 112.188 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.889 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.86 -56.89 14.43 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 113.308 0.855 . . . . 0.27000000000000002 113.308 -178.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.889 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 75.5 Cg_exo -50.81 -27.77 21.34 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.813 2.342 . . . . 0.46000000000000002 112.621 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.7 mttm -77.85 -19.16 55.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.124 -0.489 . . . . 1.53 111.413 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -106.93 -8.89 16.47 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.059 0.457 . . . . 0.38 110.364 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.54 38.26 90.38 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.516 -0.766 . . . . 0.46000000000000002 113.265 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.504 HG23 HG21 ' A' ' 76' ' ' THR . 59.6 mt -78.99 132.14 32.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 117.299 0.549 . . . . 1.3300000000000001 109.603 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -142.96 74.15 1.43 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.194 0.521 . . . . 3.9100000000000001 111.087 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.494 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 147.2 143.65 3.89 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.56 -0.746 . . . . 1.03 112.023 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 pt -129.8 156.77 78.41 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.359 0.123 . . . . 1.1699999999999999 110.799 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -84.37 121.48 6.96 Favored 'Cis proline' 0 C--N 1.348 0.514 0 C-N-CA 123.829 -1.321 . . . . 0.67000000000000004 112.869 0.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -89.63 139.88 30.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.993 0.425 . . . . 0.48999999999999999 111.973 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.433 HD13 HD21 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -112.09 118.81 36.42 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.538 -0.912 . . . . 0.96999999999999997 108.538 177.377 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.564 ' HB2' HG23 ' A' ' 25' ' ' VAL . 1.0 OUTLIER -109.75 132.47 54.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.488 0.661 . . . . 0.19 111.428 -178.409 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.903 HD12 HD11 ' A' ' 22' ' ' LEU . 3.5 mm? -111.93 135.59 52.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.141 -0.936 . . . . 0.65000000000000002 109.029 178.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.672 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 37.0 m-85 -126.38 152.77 45.86 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.011 0.434 . . . . 0.31 110.612 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 1.024 ' HB2' ' HB2' ' A' ' 86' ' ' ALA . 0.8 OUTLIER -148.49 110.5 4.57 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.666 -0.697 . . . . 0.93000000000000005 109.664 -179.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.9 m120 62.07 48.12 5.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.909 0.385 . . . . 1.3300000000000001 110.438 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 67.86 7.42 49.0 Favored Glycine 0 CA--C 1.519 0.297 0 C-N-CA 121.055 -0.593 . . . . 0.27000000000000002 113.132 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -123.03 142.72 50.54 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 122.778 -0.248 . . . . 1.3999999999999999 110.645 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.1 p -57.52 129.34 19.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.301 -0.629 . . . . 1.3100000000000001 109.301 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 1.024 ' HB2' ' HB2' ' A' ' 81' ' ' LYS . . . -103.33 -22.49 13.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.457 0.646 . . . . 0.33000000000000002 112.455 -177.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -171.56 158.32 5.09 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.832 -1.076 . . . . 0.28000000000000003 110.941 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.1 t -134.08 136.01 43.66 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.226 -0.443 . . . . 1.6200000000000001 110.613 179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.445 ' HD2' HD22 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -136.51 133.09 36.13 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.389 -0.597 . . . . 1.47 109.389 178.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.9 t -115.97 145.97 21.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.671 -0.24 . . . . 0.94999999999999996 111.233 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.23 159.08 27.03 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.517 -0.849 . . . . 0.73999999999999999 112.648 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -66.88 158.33 30.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.113 0.482 . . . . 0.51000000000000001 111.715 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.584 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -152.03 153.06 33.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.526 -0.761 . . . . 0.64000000000000001 110.358 -179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.2 m -71.54 -178.99 2.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.349 -0.387 . . . . 0.92000000000000004 110.92 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -73.07 -30.64 63.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.81999999999999995 111.46 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.36 -32.23 48.37 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.201 -0.999 . . . . 0.23000000000000001 112.722 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.484 ' HA ' ' HG2' ' A' ' 100' ' ' GLU . 45.2 mt-30 -73.62 -35.29 65.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.953 0.406 . . . . 1.29 110.401 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.584 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -69.08 -47.73 64.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.555 -0.748 . . . . 0.37 109.412 178.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.0 ttpt -60.61 -43.24 97.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.813 -0.63 . . . . 1.04 110.533 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.601 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.4 OUTLIER -61.18 -41.32 96.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.221 -0.445 . . . . 1.71 110.438 179.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.601 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 7.2 t80 -61.03 -41.83 97.32 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.322 0.582 . . . . 0.23999999999999999 110.741 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 8.2 mt -68.86 -56.67 7.21 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.472 -0.785 . . . . 0.46000000000000002 110.117 179.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -50.08 -36.73 30.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.919 0.39 . . . . 1.1799999999999999 111.042 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.21 -19.93 60.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.994 -0.548 . . . . 0.19 112.1 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.654 ' HB3' HD21 ' A' ' 22' ' ' LEU . 10.7 t30 -109.05 -37.34 5.84 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 111.863 0.32 . . . . 0.83999999999999997 111.863 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.604 HD23 HG12 ' A' ' 52' ' ' VAL . 3.5 tm? -71.94 94.44 1.46 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.056 0.455 . . . . 1.3300000000000001 109.991 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.144 -0.931 . . . . 2.0099999999999998 111.039 -179.307 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.4 mtp . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.964 0.412 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.708 HG13 ' HA ' ' A' ' 55' ' ' LEU . 45.7 t -102.14 145.05 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.695 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.635 ' HE2' ' HB2' ' A' ' 14' ' ' ALA . 14.3 ptmt -143.67 120.81 11.47 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.191 0.52 . . . . 0.0 110.433 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.94 126.05 29.02 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.512 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.845 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -98.47 107.43 20.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.202 0.525 . . . . 0.0 110.532 -179.28 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -97.13 18.62 14.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.809 -0.632 . . . . 0.0 112.652 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.2 m -156.32 161.35 40.19 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.916 0.388 . . . . 0.0 111.271 -179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.702 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.0 OUTLIER -73.02 -27.71 61.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.518 179.439 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -79.83 -31.58 40.61 Favored 'General case' 0 C--O 1.231 0.101 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.498 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.83 -38.34 90.65 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.462 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -58.59 -41.72 86.45 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.939 0.399 . . . . 0.0 110.016 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 11.3 mm-40 -67.5 -44.25 78.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.894 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -57.81 -47.25 83.14 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.243 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.635 ' HB2' ' HE2' ' A' ' 3' ' ' LYS . . . -65.02 -31.74 73.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.044 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.5 mt -68.72 -37.96 79.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.308 0.575 . . . . 0.0 110.57 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -60.55 -35.84 77.0 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.164 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.18 -22.46 55.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.006 178.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.29 -34.18 77.41 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.088 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.54 -120.33 17.95 Favored Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.523 -0.846 . . . . 0.0 113.548 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 p-10 -95.59 4.97 52.62 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.615 0.228 . . . . 0.0 111.615 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -79.8 149.42 31.06 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.981 HD11 HD12 ' A' ' 79' ' ' LEU . 4.9 tp -77.0 133.15 39.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.864 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.6 t -113.88 109.91 30.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.502 0.668 . . . . 0.0 112.015 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.571 HG23 HD21 ' A' ' 79' ' ' LEU . 8.4 p -105.04 115.7 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.554 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.8 m -123.33 166.96 17.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.908 -177.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -133.56 133.89 42.65 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.783 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.573 ' HE1' HD12 ' A' ' 78' ' ' LEU . 4.2 m-85 -96.21 108.15 20.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.5 ' O ' HG12 ' A' ' 59' ' ' VAL . 31.2 p -115.85 -168.36 1.41 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.314 0.578 . . . . 0.0 112.186 -178.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.77 152.99 33.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.02 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.2 p -71.26 -37.57 71.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.508 0.671 . . . . 0.0 109.598 178.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -86.69 12.62 10.29 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.819 -1.082 . . . . 0.0 112.176 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.713 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 17.2 t -94.87 158.21 15.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.049 0.452 . . . . 0.0 111.625 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -107.96 -66.94 0.61 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.585 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_exo -62.06 -21.51 72.55 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.58 2.187 . . . . 0.0 112.203 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 68.5 m -62.98 -42.01 99.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.297 0.57 . . . . 0.0 109.919 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.34 -29.7 70.47 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.378 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 43.4 mtt -68.28 -18.17 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.402 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 11.6 mm -88.14 -23.73 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.476 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -52.88 -51.95 69.51 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -51.03 -49.44 17.04 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.693 2.262 . . . . 0.0 113.416 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -79.79 -30.29 40.59 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -178.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 4.9 t80 -65.52 -46.01 81.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.087 0.47 . . . . 0.0 110.293 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.05 -39.28 90.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.267 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.5 t -60.38 -43.99 96.07 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 111.115 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.4 mt -59.71 -38.33 81.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.926 0.393 . . . . 0.0 110.238 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.6 t -56.47 -30.98 63.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.942 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -86.39 -18.1 32.68 Favored 'General case' 0 C--O 1.231 0.08 0 C-N-CA 120.951 -0.299 . . . . 0.0 111.575 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -96.05 -20.76 18.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.947 0.403 . . . . 0.0 110.175 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.85 ' HB3' HG22 ' A' ' 52' ' ' VAL . 17.1 m-85 -97.92 92.88 6.03 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.849 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.9 t -88.93 48.39 1.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.113 0.483 . . . . 0.0 110.719 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -152.73 -42.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.667 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.85 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.2 m -94.43 153.29 3.47 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.795 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.864 ' CG2' HG13 ' A' ' 23' ' ' VAL . 6.0 tp -104.49 115.4 46.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.026 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.611 ' O ' HG22 ' A' ' 2' ' ' VAL . 8.1 m-85 -97.59 115.92 28.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.544 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.845 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.2 164.67 21.16 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.537 178.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.415 ' N ' HD12 ' A' ' 55' ' ' LEU . 3.2 tp10 -116.39 119.34 35.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -176.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.447 HG22 HD11 ' A' ' 55' ' ' LEU . 2.1 t -115.53 117.75 56.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.184 0.516 . . . . 0.0 110.946 178.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -98.47 119.41 37.11 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.5 HG12 ' O ' ' A' ' 28' ' ' SER . 13.5 p -60.88 -18.84 18.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -64.17 -39.0 93.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.261 0.553 . . . . 0.0 109.563 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -100.11 -32.85 10.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.584 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.892 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.49 43.0 1.08 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.82 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 31.0 tt0 -69.16 -10.12 56.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.654 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -94.9 -22.38 18.04 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.312 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.892 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -78.33 -47.71 23.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 C-N-CA 120.559 -0.457 . . . . 0.0 110.665 179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.935 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.35 -58.75 8.79 Favored Pre-proline 0 CA--C 1.529 0.143 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.935 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 75.2 Cg_exo -49.8 -28.89 18.9 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.458 2.106 . . . . 0.0 112.037 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.9 mttp -77.13 -23.99 51.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.959 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -106.66 -3.65 20.39 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.93 0.395 . . . . 0.0 112.017 -179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.88 34.92 89.98 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.075 -0.583 . . . . 0.0 113.889 179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.625 HD11 HD11 ' A' ' 78' ' ' LEU . 79.7 mt -77.15 135.93 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 117.3 0.55 . . . . 0.0 110.657 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttp85 -143.48 71.28 1.33 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.129 0.49 . . . . 0.0 111.475 -179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 154.21 163.42 11.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.591 179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.608 HD12 ' SG ' ' A' ' 32' ' ' CYS . 47.3 pt -148.46 149.84 32.5 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.418 0.109 . . . . 0.0 110.972 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -86.06 120.16 5.7 Favored 'Cis proline' 0 C--N 1.348 0.538 0 C-N-CA 123.938 -1.276 . . . . 0.0 112.649 0.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.94 137.65 32.19 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.939 0.399 . . . . 0.0 111.809 179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.675 HD22 HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -109.11 121.76 45.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 177.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.81 ' CD2' HG23 ' A' ' 88' ' ' THR . 6.6 mt -114.47 134.58 54.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.238 0.542 . . . . 0.0 111.639 -178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.981 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -114.33 127.36 55.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.781 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.593 ' CE2' HG22 ' A' ' 85' ' ' VAL . 46.5 m-85 -118.43 146.67 44.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.975 0.417 . . . . 0.0 111.336 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.474 ' HD2' HD13 ' A' ' 22' ' ' LEU . 1.2 tttm -146.59 115.27 6.81 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.002 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 9.3 m120 59.76 45.21 13.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.872 0.368 . . . . 0.0 110.261 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 71.29 3.79 54.27 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 121.139 -0.553 . . . . 0.0 113.896 178.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -124.4 141.39 52.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 117.513 0.657 . . . . 0.0 111.467 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.593 HG22 ' CE2' ' A' ' 80' ' ' PHE . 42.5 t -68.13 118.3 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.443 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.43 10.49 19.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.943 0.401 . . . . 0.0 112.047 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -175.69 137.92 0.37 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.936 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.81 HG23 ' CD2' ' A' ' 78' ' ' LEU . 4.9 m -137.79 124.0 20.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.862 0.363 . . . . 0.0 110.942 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -124.22 142.02 51.58 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.904 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.97 145.94 22.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.233 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.439 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 80.11 161.79 24.63 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.131 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.61 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -64.33 170.65 3.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.901 0.382 . . . . 0.0 111.277 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.675 HD11 HD22 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -163.69 147.06 10.08 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.657 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.9 t -64.75 179.07 0.69 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.914 0.388 . . . . 0.0 110.806 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -73.09 -30.81 63.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.118 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.2 -31.37 52.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.86 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -76.21 -32.14 58.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.858 0.361 . . . . 0.0 110.582 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.46 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -70.61 -50.95 31.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.099 0.476 . . . . 0.0 109.884 179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -61.54 -42.33 98.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.146 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.5 -38.83 88.77 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.949 0.404 . . . . 0.0 110.137 179.583 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.739 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 11.2 t80 -61.93 -40.65 96.21 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.402 0.62 . . . . 0.0 110.061 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.454 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 4.5 mt -65.67 -60.91 2.42 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.157 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -48.55 -33.83 10.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.095 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.6 -23.5 60.95 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -109.77 -30.03 8.04 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.711 HD13 HG12 ' A' ' 52' ' ' VAL . 36.6 tp -64.06 -55.31 23.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.847 0.356 . . . . 0.0 110.716 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 106' ' ' LEU . 14.1 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.194 -0.908 . . . . 0.0 111.846 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 29.9 mtt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 121.074 0.464 . . . . 3.7200000000000002 111.544 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.755 HG13 ' HA ' ' A' ' 55' ' ' LEU . 67.9 t -118.17 151.85 20.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.679 -0.691 . . . . 0.41999999999999998 109.68 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.46 ' O ' HD12 ' A' ' 5' ' ' ILE . 11.9 ptpt -144.98 121.81 11.26 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 119.36 -0.936 . . . . 1.98 111.268 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.12 123.69 25.67 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.458 -1.246 . . . . 2.23 110.174 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.942 HG23 ' HB3' ' A' ' 10' ' ' ALA . 2.1 mp -105.3 114.2 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.847 0.356 . . . . 0.26000000000000001 111.323 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -103.77 16.63 25.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.352 0.501 . . . . 1.47 112.352 179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.4 m -155.48 147.25 23.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.742 0.306 . . . . 0.94999999999999996 111.098 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.503 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.5 ttpt -60.82 -24.64 66.01 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.358 -0.383 . . . . 1.5 111.764 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.3 m -79.14 -32.32 44.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.928 0.394 . . . . 0.32000000000000001 110.238 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.942 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -67.24 -41.39 85.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.906 -0.588 . . . . 0.29999999999999999 110.349 179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -56.18 -44.53 79.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.858 -0.61 . . . . 1.1499999999999999 110.693 179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 12' ' ' GLN . 0.8 OUTLIER -66.52 -39.45 88.63 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.246 -0.65 . . . . 1.1699999999999999 109.246 178.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -58.06 -48.45 80.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.746 -0.661 . . . . 1.6000000000000001 110.887 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.56 -34.58 78.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.273 -0.421 . . . . 0.32000000000000001 111.241 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 15' ' ' LEU . 18.2 mt -66.75 -39.6 87.98 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-O 121.234 0.54 . . . . 0.40999999999999998 110.537 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -63.57 -31.98 73.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.975 -0.557 . . . . 1.6000000000000001 110.739 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.72 -22.74 56.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.46999999999999997 111.014 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.447 ' HB1' HG22 ' A' ' 23' ' ' VAL . . . -71.23 -35.81 71.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.322 -0.399 . . . . 0.71999999999999997 111.477 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.53 -119.44 18.61 Favored Glycine 0 C--N 1.336 0.553 0 C-N-CA 120.077 -1.059 . . . . 1.1000000000000001 113.662 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -93.18 2.29 56.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.717 -0.241 . . . . 2.1899999999999999 111.479 -179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -79.27 148.1 32.29 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.692 -0.484 . . . . 1.74 109.692 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.979 HD11 HD12 ' A' ' 79' ' ' LEU . 1.6 tp -72.46 126.99 31.19 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.14 -0.319 . . . . 0.31 110.14 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.772 HG13 HG22 ' A' ' 53' ' ' ILE . 4.3 t -107.61 108.11 24.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.521 0.676 . . . . 0.23999999999999999 111.523 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.619 HG23 ' CD2' ' A' ' 79' ' ' LEU . 10.2 p -106.08 116.98 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 107.951 -1.129 . . . . 0.31 107.951 178.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.071 HG12 ' HG ' ' A' ' 55' ' ' LEU . 4.3 m -123.13 166.97 17.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.218 0.532 . . . . 0.78000000000000003 111.643 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.443 ' OD1' HD12 ' A' ' 77' ' ' LEU . 37.4 t0 -133.21 133.75 43.14 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.802 -0.636 . . . . 1.23 111.834 -178.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.486 ' HE1' HD12 ' A' ' 78' ' ' LEU . 8.8 m-85 -97.86 110.76 23.27 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.927 -0.768 . . . . 0.27000000000000002 108.927 178.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.3 m -128.42 158.94 36.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.597 0.713 . . . . 1.1899999999999999 112.917 -178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.587 ' HB1' ' CD1' ' A' ' 31' ' ' TRP . . . -116.16 156.65 26.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 114.971 -1.013 . . . . 0.37 111.047 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.2 m -70.79 -35.78 72.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.502 0.668 . . . . 0.75 109.615 178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.587 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 23.4 p-90 -85.76 10.87 12.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.736 -1.12 . . . . 0.89000000000000001 111.564 -179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.476 ' SG ' HD12 ' A' ' 74' ' ' ILE . 38.4 t -98.4 148.12 24.01 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.81 0.338 . . . . 0.81999999999999995 111.027 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.33 -67.33 0.75 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.677 -0.773 . . . . 0.37 112.204 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.73 -24.53 18.22 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 122.411 2.074 . . . . 0.60999999999999999 112.096 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 78.7 m -62.9 -43.76 97.92 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.144 -0.48 . . . . 0.48999999999999999 110.781 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -68.78 -23.21 64.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 2.5600000000000001 111.13 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.1 mmt -69.7 -22.36 63.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.329 -0.396 . . . . 1.8 110.739 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.2 mm -85.98 -21.71 7.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.418 -0.355 . . . . 0.25 110.976 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 2.0 tttt -52.3 -55.05 35.14 Favored Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.464 -0.335 . . . . 2.4700000000000002 111.159 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 39' ' ' LYS . 72.7 Cg_exo -48.54 -49.11 15.37 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.563 2.176 . . . . 0.40999999999999998 112.381 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -77.4 -29.19 53.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.385 -0.37 . . . . 0.44 111.519 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.437 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 6.3 t80 -67.76 -46.81 71.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.986 0.422 . . . . 0.46000000000000002 110.257 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.26 -42.9 78.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.938 -0.574 . . . . 1.03 111.952 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 m -59.09 -44.52 91.92 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.841 0.353 . . . . 0.91000000000000003 110.379 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.9 mt -59.35 -40.3 85.99 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.543 -0.54 . . . . 0.34999999999999998 109.543 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 54' ' ' PHE . 32.4 t -54.5 -27.55 38.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.889 -0.596 . . . . 1.22 111.179 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -88.96 -16.96 30.5 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-O 120.731 0.3 . . . . 1.99 111.038 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.9 ttpp -94.56 -19.38 20.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.963 0.411 . . . . 2.1600000000000001 109.912 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.847 ' HB3' HG22 ' A' ' 52' ' ' VAL . 22.1 m-85 -102.26 97.47 7.74 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.917 -0.583 . . . . 1.1000000000000001 111.477 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.63 46.35 1.33 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.399 -0.364 . . . . 1.3899999999999999 110.767 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -154.44 -34.08 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.801 0.334 . . . . 1.0800000000000001 111.322 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 49' ' ' TYR . 5.8 m -97.59 156.06 3.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.325 -0.398 . . . . 0.32000000000000001 111.585 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.772 HG22 HG13 ' A' ' 23' ' ' VAL . 1.3 tp -106.39 114.64 46.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 CA-C-N 116.051 -0.522 . . . . 0.28999999999999998 111.143 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.712 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.2 m-85 -96.11 120.19 35.95 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 116.197 -0.456 . . . . 0.23999999999999999 110.516 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.071 ' HG ' HG12 ' A' ' 25' ' ' VAL . 0.5 OUTLIER -133.31 168.5 18.47 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 120.378 -0.529 . . . . 0.22 111.1 179.178 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.789 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -121.53 124.61 44.81 Favored 'General case' 0 CA--C 1.514 -0.437 0 N-CA-C 112.674 0.62 . . . . 2.2799999999999998 112.674 -178.344 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.612 HG22 HD11 ' A' ' 55' ' ' LEU . 2.7 t -113.19 117.78 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.887 -0.597 . . . . 0.19 111.138 178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -93.46 113.21 25.3 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.424 -0.584 . . . . 1.9199999999999999 109.424 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.6 p -58.49 -19.1 13.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.825 0.305 . . . . 0.28000000000000003 111.825 -178.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.55 -37.54 87.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.94 0.4 . . . . 1.22 110.292 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -102.94 -40.61 6.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.89 -0.596 . . . . 1.26 111.157 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.642 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -88.32 49.0 1.72 Allowed 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.213 0.53 . . . . 0.28000000000000003 110.395 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.416 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -75.83 -6.57 51.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.525 -0.762 . . . . 2.5499999999999998 111.083 -179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -90.89 -25.1 20.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.769 0.318 . . . . 1.5600000000000001 110.433 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.642 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 13.5 m -81.31 -48.58 18.87 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.197 -0.456 . . . . 0.26000000000000001 111.759 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.876 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.39 -55.56 21.28 Favored Pre-proline 0 N--CA 1.465 0.307 0 N-CA-C 112.744 0.646 . . . . 0.28999999999999998 112.744 -178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.876 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 78.3 Cg_exo -51.92 -27.54 28.37 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.863 2.375 . . . . 0.46000000000000002 112.997 -179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -77.09 -21.35 54.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.278 -0.419 . . . . 1.77 111.781 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -108.16 -7.12 16.12 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.087 0.47 . . . . 0.41999999999999998 111.354 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 67.4 37.07 90.03 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.687 -0.688 . . . . 0.48999999999999999 113.517 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.659 HG23 HG21 ' A' ' 76' ' ' THR . 61.6 mt -74.12 130.16 36.09 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 N-CA-C 109.624 -0.51 . . . . 1.29 109.624 178.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -141.89 60.16 1.47 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.937 0.399 . . . . 3.8900000000000001 111.521 -178.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 159.13 118.43 0.52 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.245 -0.979 . . . . 1.1200000000000001 113.386 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.476 HD12 ' SG ' ' A' ' 32' ' ' CYS . 17.6 pt -104.99 152.44 39.63 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 110.408 -0.219 . . . . 0.89000000000000001 110.408 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -83.81 120.26 6.38 Favored 'Cis proline' 0 C--N 1.346 0.408 0 C-N-CA 123.8 -1.333 . . . . 1.0800000000000001 112.708 0.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.659 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -91.48 134.82 34.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.543 -0.299 . . . . 0.33000000000000002 111.236 179.176 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.443 HD12 ' OD1' ' A' ' 26' ' ' ASP . 0.3 OUTLIER -107.87 122.82 47.57 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.401 -0.963 . . . . 1.0800000000000001 108.401 177.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.506 ' HB2' HG23 ' A' ' 25' ' ' VAL . 5.0 mt -113.84 137.61 51.42 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.263 0.554 . . . . 0.22 111.548 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.979 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -119.01 113.41 20.92 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.535 -0.757 . . . . 0.22 110.562 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.61 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.9 m-85 -105.0 142.37 34.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.979 -0.555 . . . . 0.25 110.766 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -142.25 110.34 5.94 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.579 -0.737 . . . . 0.42999999999999999 109.487 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.0 m120 61.89 47.08 6.25 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.276 -0.639 . . . . 1.1899999999999999 109.276 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 68.16 3.79 32.58 Favored Glycine 0 CA--C 1.522 0.47 0 CA-C-N 115.558 -0.746 . . . . 0.23000000000000001 113.797 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -121.25 133.04 55.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.205 0.502 . . . . 1.6000000000000001 110.814 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.72 117.35 3.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.229 -0.441 . . . . 1.26 109.848 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.02 4.49 27.12 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.462 0.541 . . . . 0.23000000000000001 112.462 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.807 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -172.56 146.51 1.72 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.283 -0.417 . . . . 0.20000000000000001 111.823 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.46 134.21 37.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.137 -0.483 . . . . 1.53 110.824 179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -132.78 138.77 47.26 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 2.1699999999999999 110.239 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 18.7 t -120.7 145.53 26.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.144 -0.48 . . . . 0.87 111.009 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.87 160.16 23.38 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.501 -0.857 . . . . 0.25 112.878 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.62 151.27 46.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.114 0.483 . . . . 0.55000000000000004 111.575 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.606 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -143.33 147.77 35.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.76 -0.654 . . . . 0.55000000000000004 110.558 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.6 m -65.04 -178.76 0.48 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.576 -0.284 . . . . 1.02 110.755 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -73.01 -32.67 65.27 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.408 -0.36 . . . . 1.0900000000000001 111.497 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.52 -30.58 56.31 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.206 -0.997 . . . . 0.25 112.598 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.553 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 40.4 mt-30 -74.99 -31.22 61.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.972 0.415 . . . . 1.26 110.31 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.606 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -72.98 -49.79 27.0 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.047 -0.524 . . . . 0.42999999999999999 109.908 179.221 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -61.71 -45.16 95.14 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.544 -0.753 . . . . 1.4299999999999999 110.965 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.553 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.8 pp20? -60.64 -41.68 95.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 1.8200000000000001 110.558 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.66 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 47.0 t80 -63.91 -42.68 97.35 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.26 0.552 . . . . 0.27000000000000002 111.194 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.618 HD11 HG11 ' A' ' 24' ' ' VAL . 1.7 mt -64.85 -57.72 8.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.791 -0.64 . . . . 0.42999999999999999 109.528 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -49.0 -34.19 12.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.097 -0.502 . . . . 1.24 110.736 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.47 -22.95 62.62 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.046 -0.524 . . . . 0.23000000000000001 111.717 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.425 ' HB3' HD21 ' A' ' 22' ' ' LEU . 6.8 t30 -105.55 -31.44 8.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.806 0.336 . . . . 0.52000000000000002 110.746 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.527 ' HB2' HD23 ' A' ' 22' ' ' LEU . 42.6 tp -75.15 95.72 3.15 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.691 -0.485 . . . . 1.3500000000000001 109.691 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.255 -0.879 . . . . 2.4700000000000002 111.347 -179.531 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 121.008 0.432 . . . . 0.0 111.215 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.72 HG13 ' HA ' ' A' ' 55' ' ' LEU . 42.9 t -125.56 145.89 32.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.604 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.73 119.62 11.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.253 0.549 . . . . 0.0 110.346 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -73.7 127.74 33.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.846 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.798 HD13 HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -101.12 107.53 21.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.298 -179.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -97.9 19.64 13.49 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.125 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.23 159.53 39.0 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.855 0.36 . . . . 0.0 111.276 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.608 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -71.91 -26.65 62.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.9 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.1 m -79.64 -32.8 41.71 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.914 0.387 . . . . 0.0 110.814 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.5 -38.37 90.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.568 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -57.66 -42.71 84.04 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.57 -43.97 83.54 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -60.13 -45.7 92.14 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.514 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.49 -31.91 73.23 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.892 0.377 . . . . 0.0 110.673 179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -67.78 -37.39 82.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.527 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -61.42 -33.91 74.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.304 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.44 -22.67 54.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.9 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.65 -35.91 79.77 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.63 -122.76 31.13 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 120.301 -0.952 . . . . 0.0 113.14 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -94.57 4.33 53.98 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.501 0.191 . . . . 0.0 111.152 -179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.2 mttt -77.28 149.7 35.36 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.917 HD11 HD12 ' A' ' 79' ' ' LEU . 9.8 tp -77.02 132.61 39.05 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.879 HG13 ' CG2' ' A' ' 53' ' ' ILE . 6.3 t -112.45 109.67 29.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.397 0.618 . . . . 0.0 112.37 -178.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.758 HG11 HD11 ' A' ' 102' ' ' LEU . 7.9 p -104.81 116.22 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 177.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.657 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.1 m -122.67 167.09 16.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.72 -178.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -133.45 133.37 42.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.597 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -98.1 111.89 24.05 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.3 m -118.94 -167.79 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.382 0.61 . . . . 0.0 112.219 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.2 154.5 35.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.129 -0.941 . . . . 0.0 110.013 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -72.8 -35.73 67.43 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.376 0.607 . . . . 0.0 109.471 178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.0 p-90 -87.24 10.78 15.96 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.912 -1.04 . . . . 0.0 112.08 -179.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.713 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 11.3 t -91.79 157.21 17.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.052 0.453 . . . . 0.0 111.479 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.41 -64.17 0.54 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.441 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 22.9 Cg_exo -63.96 -22.29 68.42 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.497 2.132 . . . . 0.0 112.401 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.9 m -58.58 -41.47 85.8 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.079 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -67.04 -15.24 63.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.391 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.462 ' HG2' ' HA ' ' A' ' 34' ' ' PRO . 4.6 mmt -71.16 -26.85 63.16 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.789 -179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.8 mm -84.47 -23.86 7.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.685 0.279 . . . . 0.0 111.361 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.46 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 8.4 ttpt -48.96 -59.21 6.72 Favored Pre-proline 0 N--CA 1.465 0.28 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 10.3 Cg_endo -51.96 -45.05 41.15 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.342 2.028 . . . . 0.0 112.697 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.7 m-85 -80.74 -29.67 36.28 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -66.43 -45.69 78.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.082 0.467 . . . . 0.0 110.327 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.14 -39.91 86.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.883 -179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 62.7 m -61.7 -44.02 97.73 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.877 0.37 . . . . 0.0 110.887 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.3 mt -59.42 -40.23 86.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.914 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.2 m -54.73 -28.38 47.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.433 179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -87.54 -19.51 27.78 Favored 'General case' 0 N--CA 1.461 0.107 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.686 -179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 ttpp -95.0 -20.62 19.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.04 0.447 . . . . 0.0 110.265 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.856 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.5 m-85 -98.04 96.13 7.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.675 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.76 47.96 1.41 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.072 0.463 . . . . 0.0 110.236 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -152.92 -42.44 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.822 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.856 HG22 ' HB3' ' A' ' 49' ' ' TYR . 11.0 m -93.66 153.85 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.597 -179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.879 ' CG2' HG13 ' A' ' 23' ' ' VAL . 5.2 tp -105.75 113.99 44.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.748 179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.561 ' O ' HG13 ' A' ' 2' ' ' VAL . 8.4 m-85 -94.62 116.2 28.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.55 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.798 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -129.02 166.7 18.71 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 119.879 -0.728 . . . . 0.0 111.514 178.611 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.432 ' N ' HD12 ' A' ' 55' ' ' LEU . 1.4 tp10 -117.43 118.99 33.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -176.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -115.34 118.35 58.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.249 0.547 . . . . 0.0 110.787 178.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -99.34 120.42 39.54 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.9 p -61.27 -18.46 18.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -67.93 -37.53 81.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.087 0.47 . . . . 0.0 109.81 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -98.78 -34.5 10.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.445 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.856 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.75 47.67 1.11 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.097 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 67' ' ' PRO . 8.7 tp-100 -68.57 -8.74 44.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.079 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.57 -25.02 15.29 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.889 -0.324 . . . . 0.0 111.448 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.856 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 6.7 m -77.15 -48.78 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 120.471 -0.492 . . . . 0.0 110.965 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.627 ' HB3' ' CD ' ' A' ' 67' ' ' PRO . . . -50.22 -60.44 5.24 Favored Pre-proline 0 N--CA 1.463 0.203 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.627 ' CD ' ' HB3' ' A' ' 66' ' ' ALA . 6.3 Cg_endo -49.11 -28.04 13.45 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.571 2.181 . . . . 0.0 111.862 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -73.57 -27.84 61.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.929 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -108.79 -6.26 15.93 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.901 0.381 . . . . 0.0 111.632 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.41 40.24 97.6 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 121.036 -0.602 . . . . 0.0 113.087 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.721 HG23 HG21 ' A' ' 76' ' ' THR . 61.3 mt -78.0 81.21 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 117.007 0.403 . . . . 0.0 110.837 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 45.6 ttp180 -87.1 78.33 8.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.919 0.39 . . . . 0.0 111.882 -178.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 143.27 164.22 10.15 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.701 -0.761 . . . . 0.0 113.397 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 22.5 pt -149.03 155.71 40.33 Favored Pre-proline 0 CA--C 1.53 0.209 0 C-N-CA 122.161 0.184 . . . . 0.0 110.829 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -85.23 116.93 4.26 Favored 'Cis proline' 0 C--N 1.351 0.698 0 C-N-CA 124.183 -1.174 . . . . 0.0 112.628 -0.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.721 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -87.14 137.08 32.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.909 0.385 . . . . 0.0 111.865 179.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.465 HD21 HD21 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -107.65 123.87 49.13 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.901 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.625 HD11 HD11 ' A' ' 71' ' ' ILE . 6.0 mt -116.76 134.88 54.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.219 0.533 . . . . 0.0 111.793 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.917 HD12 HD11 ' A' ' 22' ' ' LEU . 3.5 mm? -114.71 120.68 40.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.696 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.519 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 45.2 m-85 -112.08 146.99 36.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 0.0 111.157 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.0 tttm -146.94 110.6 4.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.328 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.3 m120 61.83 46.47 6.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.909 0.385 . . . . 0.0 110.171 -179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.51 1.24 57.4 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.938 -0.649 . . . . 0.0 113.908 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -125.49 138.79 53.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 117.484 0.642 . . . . 0.0 111.861 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 85' ' ' VAL . 7.2 p -68.25 119.23 13.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.529 179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.22 11.3 20.21 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.842 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.88 140.85 0.76 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.146 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.63 124.2 22.25 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.681 0.277 . . . . 0.0 111.127 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.442 ' HD2' HD22 ' A' ' 93' ' ' LEU . 5.4 tmtt? -126.17 139.68 53.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.272 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.4 t -120.44 146.34 25.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.643 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.404 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.36 161.56 27.36 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.663 -0.779 . . . . 0.0 113.158 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.14 147.86 49.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.051 0.453 . . . . 0.0 111.58 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.653 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -142.38 151.76 42.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.612 179.757 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 43.9 t -65.33 179.67 0.73 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.151 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.8 tttt -72.5 -31.98 65.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.46 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.24 -29.89 55.57 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.711 -179.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.41 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 54.8 mt-30 -76.88 -32.7 57.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.843 0.354 . . . . 0.0 110.532 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.653 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.7 OUTLIER -71.21 -50.56 31.74 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.1 ttpt -61.4 -42.09 98.17 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.238 179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.38 -39.61 91.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.881 0.372 . . . . 0.0 110.328 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.808 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 10.8 t80 -62.1 -42.56 99.35 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.357 0.598 . . . . 0.0 110.679 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.758 HD11 HG11 ' A' ' 24' ' ' VAL . 6.1 mt -67.41 -54.46 20.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.186 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -50.99 -36.77 40.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.63 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.29 -21.0 60.69 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.403 ' HB3' HD21 ' A' ' 22' ' ' LEU . 9.1 t30 -108.58 -26.9 10.16 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.733 0.302 . . . . 0.0 111.705 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.549 HD13 ' N ' ' A' ' 107' ' ' VAL . 3.3 tm? -76.66 -77.75 0.13 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.683 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.549 ' N ' HD13 ' A' ' 106' ' ' LEU . 5.0 p . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.179 -0.915 . . . . 0.0 111.998 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.876 0.37 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.662 HG22 ' O ' ' A' ' 54' ' ' PHE . 50.9 t -63.47 145.6 13.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.137 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -145.32 121.84 11.05 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-O 121.072 0.463 . . . . 0.0 110.23 -179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.24 127.55 33.26 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.71 HD13 HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -100.51 106.83 19.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.978 0.418 . . . . 0.0 109.928 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -98.45 20.08 13.35 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.778 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -156.8 159.79 38.59 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.946 0.403 . . . . 0.0 111.301 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.582 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.5 OUTLIER -72.37 -25.36 61.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.926 179.476 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.84 -32.28 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.951 0.405 . . . . 0.0 110.702 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.518 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -65.67 -39.49 91.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.148 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.401 ' CE1' HG21 ' A' ' 57' ' ' VAL . 3.6 t80 -57.76 -44.52 86.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.911 0.386 . . . . 0.0 109.984 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -64.84 -45.57 85.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.679 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -58.21 -47.79 82.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.34 -179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.39 -31.5 72.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.34 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 mt -69.79 -37.91 76.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.41 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -61.41 -33.16 73.23 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.721 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.42 -23.9 53.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.956 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.72 78.08 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.254 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.24 -122.42 29.0 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.004 179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -94.96 6.47 48.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.46 0.171 . . . . 0.0 111.303 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -80.19 148.77 30.73 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.919 HD11 HD12 ' A' ' 79' ' ' LEU . 8.7 tp -76.25 134.63 39.77 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.92 HG13 HG23 ' A' ' 53' ' ' ILE . 4.2 t -113.78 109.19 27.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.459 0.647 . . . . 0.0 112.007 -178.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.007 HG11 HD11 ' A' ' 102' ' ' LEU . 7.6 p -103.75 116.03 46.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.562 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.6 m -123.91 165.85 19.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.215 0.531 . . . . 0.0 112.126 -177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -129.57 131.31 46.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.609 -179.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.564 ' CE1' HD12 ' A' ' 78' ' ' LEU . 4.6 m-85 -98.24 110.13 22.77 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.9 p -134.32 149.54 50.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.107 0.48 . . . . 0.0 112.029 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.39 158.26 15.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.352 177.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.3 m -68.96 -37.49 78.85 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.1 p-90 -85.48 16.19 3.97 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.058 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.586 ' SG ' HD12 ' A' ' 74' ' ' ILE . 36.8 t -90.91 156.95 17.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.009 0.433 . . . . 0.0 111.36 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -106.14 -73.85 0.89 Allowed Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.348 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.47 -22.79 22.5 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.451 2.101 . . . . 0.0 112.227 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.0 m -60.72 -38.11 83.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.22 0.533 . . . . 0.0 110.13 179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -69.26 -16.26 63.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.553 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 38.4 mtt -74.16 -23.61 59.28 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.419 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.417 HG22 ' HB2' ' A' ' 42' ' ' PHE . 10.0 mm -87.25 -22.21 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 8.3 mttp -48.66 -60.01 5.26 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 10.2 Cg_endo -53.32 -44.51 48.36 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.544 2.162 . . . . 0.0 113.43 -179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.412 ' O ' HD12 ' A' ' 45' ' ' LEU . 14.4 m-85 -79.86 -31.61 40.45 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.43 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 4.9 t80 -66.18 -44.32 84.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.946 0.403 . . . . 0.0 110.545 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.02 -39.27 83.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.12 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.9 p -61.74 -43.65 98.44 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.046 0.451 . . . . 0.0 110.879 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 41' ' ' PHE . 7.6 mt -59.49 -37.03 77.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.021 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.3 m -57.86 -28.31 64.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.376 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -87.27 -19.61 28.03 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.599 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 ttpp -95.27 -19.68 19.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 110.266 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.829 ' HB3' HG22 ' A' ' 52' ' ' VAL . 19.0 m-85 -99.52 93.94 6.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.854 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.2 t -90.93 49.43 1.65 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.142 0.496 . . . . 0.0 110.845 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -151.75 -43.81 0.11 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.565 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.847 HG12 ' HB3' ' A' ' 22' ' ' LEU . 10.3 m -92.24 153.95 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.945 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.92 HG23 HG13 ' A' ' 23' ' ' VAL . 5.6 tp -105.35 114.72 45.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.596 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.662 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.3 m-85 -95.39 115.75 27.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.744 -179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.71 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.44 165.81 19.93 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.455 178.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -118.03 119.46 34.85 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.286 -0.87 . . . . 0.0 112.901 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.401 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.7 t -114.69 117.84 56.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.488 178.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -97.26 118.02 32.77 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.681 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.06 -18.98 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.733 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.4 -39.98 95.97 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -99.73 -34.08 10.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.765 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.91 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -95.11 45.03 1.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.708 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -9.44 57.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.168 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.4 -21.89 18.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.432 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.91 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.3 m -80.38 -47.02 21.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.992 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.908 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.0 -57.81 11.41 Favored Pre-proline 0 N--CA 1.464 0.225 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -178.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.908 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 74.6 Cg_exo -50.68 -28.34 22.27 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.536 2.157 . . . . 0.0 111.874 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.98 -23.12 58.22 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.006 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -111.01 -5.25 14.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 120.87 0.367 . . . . 0.0 111.812 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.56 34.94 89.16 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.581 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.639 HD11 HD11 ' A' ' 78' ' ' LEU . 75.2 mt -74.81 132.84 32.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 117.396 0.598 . . . . 0.0 110.364 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -150.7 49.21 0.87 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.933 0.397 . . . . 0.0 111.219 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -175.27 99.46 0.14 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.442 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.586 HD12 ' SG ' ' A' ' 32' ' ' CYS . 2.9 pt -100.96 151.6 37.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-O 120.51 0.195 . . . . 0.0 111.109 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.49 113.49 2.97 Favored 'Cis proline' 0 C--N 1.349 0.572 0 C-N-CA 124.036 -1.235 . . . . 0.0 112.752 0.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.47 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -86.65 135.26 33.47 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.842 0.353 . . . . 0.0 111.571 179.176 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -107.38 125.95 51.86 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 177.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.639 HD11 HD11 ' A' ' 71' ' ' ILE . 7.5 mt -116.88 136.51 52.89 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.199 0.523 . . . . 0.0 111.702 -178.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.919 HD12 HD11 ' A' ' 22' ' ' LEU . 3.6 mm? -117.45 122.98 45.24 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.63 -0.713 . . . . 0.0 109.699 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.582 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 49.1 m-85 -113.64 144.82 42.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.031 0.443 . . . . 0.0 111.375 -178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HD2' HD13 ' A' ' 22' ' ' LEU . 3.5 tttm -145.62 111.59 5.6 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.336 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 m120 61.88 45.39 7.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.396 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.37 -0.56 59.63 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.957 -0.64 . . . . 0.0 114.242 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -124.07 141.07 52.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 117.519 0.66 . . . . 0.0 111.865 -179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.554 HG22 ' CE2' ' A' ' 80' ' ' PHE . 38.2 t -67.4 119.73 13.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.401 179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -112.09 8.33 19.99 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.884 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -173.61 138.68 0.68 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.113 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.595 HG23 ' CD2' ' A' ' 78' ' ' LEU . 22.2 m -138.63 120.71 15.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.749 0.309 . . . . 0.0 111.086 179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -119.38 145.15 46.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.942 0.401 . . . . 0.0 111.216 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.01 146.19 25.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.399 -179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.602 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 79.83 159.29 17.69 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.304 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.9 138.27 48.04 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.027 0.441 . . . . 0.0 111.895 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 91' ' ' GLY . 0.0 OUTLIER -128.01 150.96 49.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.534 179.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.0 m -65.74 -178.03 0.52 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.771 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 9.3 tttt -70.57 -33.95 71.67 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.677 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.67 -30.49 52.64 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.405 -0.902 . . . . 0.0 113.237 -179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 100' ' ' GLU . 25.6 mt-30 -77.14 -32.35 56.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.014 0.407 . . . . 0.0 110.591 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.538 HD21 HD21 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -71.32 -50.26 34.27 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.7 ttpt -61.96 -42.23 98.88 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.654 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.435 ' HG2' ' HA ' ' A' ' 97' ' ' GLN . 13.1 pt-20 -61.56 -42.84 99.43 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-O 120.764 0.316 . . . . 0.0 110.838 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.884 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 38.5 t80 -61.92 -42.7 99.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.374 0.607 . . . . 0.0 110.528 178.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 1.007 HD11 HG11 ' A' ' 24' ' ' VAL . 1.6 mt -67.3 -54.44 20.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.768 179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -52.82 -36.2 58.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.749 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.92 -19.17 61.96 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.985 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -107.6 -28.03 10.0 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.639 0.257 . . . . 0.0 111.454 -179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.683 HD23 HG12 ' A' ' 52' ' ' VAL . 3.1 tm? -70.82 114.69 9.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 106' ' ' LEU . 4.0 m . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.181 -0.914 . . . . 0.0 111.257 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.8 mmt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.961 0.41 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.756 HG13 ' HA ' ' A' ' 55' ' ' LEU . 44.7 t -101.25 148.05 7.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 ptpt -145.29 119.77 9.69 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.124 0.488 . . . . 0.0 110.651 -179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.29 127.65 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.641 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.781 HD13 HD13 ' A' ' 55' ' ' LEU . 0.7 OUTLIER -101.2 109.55 25.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.064 0.459 . . . . 0.0 110.557 -179.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -101.41 18.79 19.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.951 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.29 161.38 41.82 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.086 0.47 . . . . 0.0 111.562 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.644 ' HA ' HG13 ' A' ' 65' ' ' VAL . 5.2 ttpt -73.43 -28.21 61.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.776 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.73 -30.9 41.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.765 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.07 -42.45 89.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.875 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -55.16 -41.51 71.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.348 . . . . 0.0 110.213 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -67.1 -44.3 80.31 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.976 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -58.33 -47.82 82.53 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.447 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.37 -31.57 72.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 110.928 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.4 mt -68.68 -39.15 80.73 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.683 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -60.46 -34.08 73.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.056 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.66 -22.81 53.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.481 178.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.44 72.23 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.914 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 54.34 -123.92 29.35 Favored Glycine 0 C--N 1.335 0.498 0 C-N-CA 120.505 -0.855 . . . . 0.0 113.144 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -93.59 4.65 53.61 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.621 0.248 . . . . 0.0 111.223 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.7 mttp -78.82 149.41 32.55 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.98 HD11 HD12 ' A' ' 79' ' ' LEU . 6.8 tp -76.35 134.96 39.54 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.885 HG13 ' CG2' ' A' ' 53' ' ' ILE . 5.3 t -112.79 113.22 43.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.519 0.676 . . . . 0.0 112.007 -179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.649 ' HB ' HD21 ' A' ' 102' ' ' LEU . 7.2 p -106.18 112.35 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.45 178.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.695 HG12 ' HG ' ' A' ' 55' ' ' LEU . 4.7 m -122.24 167.08 16.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.75 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -134.46 134.49 41.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.683 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.605 ' HE1' HD12 ' A' ' 78' ' ' LEU . 6.4 m-85 -96.13 106.74 18.97 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -115.75 -169.52 1.6 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.449 0.642 . . . . 0.0 112.615 -178.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.689 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.76 153.63 34.69 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.231 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.8 m -71.26 -36.51 71.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.433 0.635 . . . . 0.0 109.588 178.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.9 p-90 -86.45 12.51 10.1 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.737 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.689 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 21.0 t -92.76 157.65 16.31 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.998 0.428 . . . . 0.0 111.728 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -109.18 -69.62 0.64 Allowed Glycine 0 CA--C 1.52 0.369 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.344 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -56.5 -23.21 46.54 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.641 2.227 . . . . 0.0 112.27 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.1 m -59.89 -42.65 94.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -68.49 -18.6 64.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.365 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.9 mmm -74.04 -25.42 59.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.75 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.9 mm -85.97 -22.57 7.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.724 0.297 . . . . 0.0 111.664 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.41 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -50.75 -52.78 53.65 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.495 179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 63.9 Cg_exo -51.15 -49.57 16.67 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 122.709 2.273 . . . . 0.0 113.045 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -79.87 -28.45 39.96 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -178.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -66.68 -47.23 73.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.099 0.476 . . . . 0.0 110.412 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.78 -40.19 88.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.24 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.6 t -60.34 -44.58 95.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.86 0.362 . . . . 0.0 110.599 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt -59.65 -41.92 91.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.123 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.8 t -54.91 -27.59 44.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.272 179.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -87.01 -18.77 29.86 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.727 0.299 . . . . 0.0 111.334 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -95.81 -19.91 19.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.022 0.439 . . . . 0.0 110.08 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.875 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.3 m-85 -100.18 92.52 5.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.032 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -89.69 48.06 1.55 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.021 0.438 . . . . 0.0 110.494 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.2 t30 -152.27 -40.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.591 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' A' ' 49' ' ' TYR . 12.5 m -94.74 155.25 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.248 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.422 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.885 ' CG2' HG13 ' A' ' 23' ' ' VAL . 5.3 tp -105.24 115.55 47.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.815 179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.64 ' CE1' HG11 ' A' ' 24' ' ' VAL . 8.9 m-85 -97.61 116.17 29.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.938 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.781 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -129.35 167.79 17.23 Favored 'General case' 0 CA--C 1.515 -0.385 0 C-N-CA 119.979 -0.688 . . . . 0.0 111.45 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.453 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -120.24 122.39 40.79 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.803 -177.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.428 HG22 HD11 ' A' ' 55' ' ' LEU . 2.5 t -116.28 120.07 63.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.352 0.596 . . . . 0.0 110.744 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -99.74 119.24 37.83 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.897 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.73 -18.27 16.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.043 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.58 -39.77 94.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.95 -33.63 10.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.496 179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.938 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -97.24 43.7 1.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.469 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.97 -8.94 56.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.666 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.98 -24.61 16.3 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.149 -0.22 . . . . 0.0 111.293 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.938 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 1.7 m -76.53 -47.43 29.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.494 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.924 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.97 -57.76 11.56 Favored Pre-proline 0 N--CA 1.461 0.108 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.924 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 74.2 Cg_exo -50.14 -28.5 19.83 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.435 2.09 . . . . 0.0 111.569 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.1 tttp -75.27 -24.35 57.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.956 178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -106.98 -4.82 18.64 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.894 0.378 . . . . 0.0 111.612 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.98 34.65 89.08 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.78 179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.652 HD11 HD11 ' A' ' 78' ' ' LEU . 70.9 mt -75.77 135.41 27.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 117.248 0.524 . . . . 0.0 110.446 179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -144.81 64.85 1.28 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.014 0.435 . . . . 0.0 111.167 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.407 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . 169.3 162.73 22.07 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.496 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.8 pt -147.51 141.76 16.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 O-C-N 122.9 -0.176 . . . . 0.0 110.963 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -88.89 122.1 5.56 Favored 'Cis proline' 0 C--N 1.349 0.565 0 C-N-CA 124.172 -1.178 . . . . 0.0 112.398 -0.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.407 ' OG1' ' O ' ' A' ' 73' ' ' GLY . 0.3 OUTLIER -88.28 137.69 32.1 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 111.674 179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.1 mp -108.79 124.19 50.21 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 178.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 71' ' ' ILE . 6.7 mt -116.44 133.92 55.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.283 0.563 . . . . 0.0 111.618 -178.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.98 HD12 HD11 ' A' ' 22' ' ' LEU . 3.0 mm? -115.27 122.13 45.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.695 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.55 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 50.2 m-85 -113.71 147.98 37.22 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.262 0.553 . . . . 0.0 111.542 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.3 tttm -147.02 111.01 5.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.208 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.9 m120 61.78 46.48 6.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 110.374 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.28 2.28 58.84 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.765 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -125.52 139.45 53.6 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 117.432 0.616 . . . . 0.0 112.192 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.551 ' O ' HG13 ' A' ' 85' ' ' VAL . 11.1 p -67.74 116.98 8.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.454 178.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -111.58 9.53 21.15 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.871 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -170.88 139.3 1.44 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.937 179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.65 122.68 20.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.698 0.285 . . . . 0.0 111.171 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.4 mmtt -124.08 138.14 54.48 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.5 t -119.39 146.18 24.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.328 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.38 164.62 30.96 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.635 -0.793 . . . . 0.0 113.279 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.594 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -67.23 169.34 8.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.12 0.486 . . . . 0.0 111.576 -179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.756 HD11 ' HG ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -159.05 -170.32 2.97 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.25 -179.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.4 t -111.52 165.73 11.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.814 0.34 . . . . 0.0 110.814 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 15.5 tttm -55.79 -34.01 64.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.995 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.46 -31.18 51.88 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.914 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 35.5 mt-30 -76.19 -33.5 59.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.903 0.382 . . . . 0.0 110.553 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.756 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.4 OUTLIER -70.51 -49.77 44.8 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.736 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 20.5 ttpt -61.93 -43.92 97.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.374 -0.83 . . . . 0.0 111.096 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 0.6 OUTLIER -61.3 -39.1 89.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.881 0.372 . . . . 0.0 110.167 179.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.793 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 9.7 t80 -61.28 -41.38 96.85 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.35 0.595 . . . . 0.0 110.333 178.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.649 HD21 ' HB ' ' A' ' 24' ' ' VAL . 10.7 mt -69.48 -50.75 42.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.763 179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -52.43 -38.14 58.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.05 0.452 . . . . 0.0 110.187 178.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.11 -22.52 63.01 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.796 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.626 ' O ' HG12 ' A' ' 107' ' ' VAL . 4.3 t30 -104.29 -56.28 2.22 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 120.786 0.327 . . . . 0.0 110.923 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 22' ' ' LEU . 3.2 tm? -52.87 98.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.838 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 105' ' ' ASN . 4.9 p . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.816 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.899 0.381 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.725 HG13 ' HA ' ' A' ' 55' ' ' LEU . 40.0 t -136.34 146.02 29.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.739 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 10.7 ptpt -144.35 121.09 11.2 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.126 0.488 . . . . 0.0 109.941 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -74.66 129.61 38.03 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.604 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.854 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -100.98 108.15 22.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.418 -179.304 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -100.0 18.16 19.18 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.905 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.1 m -154.13 158.04 39.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.84 0.352 . . . . 0.0 111.247 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.564 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -71.63 -26.27 62.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.555 179.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.2 m -79.72 -31.25 41.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.065 0.46 . . . . 0.0 110.298 179.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.87 -36.18 81.72 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.056 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -59.91 -42.98 95.09 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.012 0.434 . . . . 0.0 109.848 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -66.91 -44.7 80.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.614 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -58.23 -46.44 85.91 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.145 -179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.97 -30.71 70.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.139 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 15' ' ' LEU . 15.9 mt -69.49 -38.98 77.9 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.084 0.469 . . . . 0.0 110.188 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -61.25 -33.25 73.21 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.199 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.96 -23.68 52.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.892 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.32 -33.12 74.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.293 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.1 -122.17 28.68 Favored Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.154 179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -96.04 7.81 45.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.613 0.244 . . . . 0.0 111.17 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -79.05 148.07 32.6 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.916 HD11 HD12 ' A' ' 79' ' ' LEU . 6.1 tp -76.19 134.53 39.87 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.952 HG13 HG23 ' A' ' 53' ' ' ILE . 4.7 t -116.61 107.35 22.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.43 0.634 . . . . 0.0 112.085 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.563 HG23 ' CD2' ' A' ' 79' ' ' LEU . 7.3 p -101.69 115.07 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 177.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.556 HG12 ' HG ' ' A' ' 55' ' ' LEU . 5.2 m -122.59 168.15 15.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.364 -177.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -135.14 134.13 39.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.951 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.484 ' HE1' HD12 ' A' ' 78' ' ' LEU . 7.1 m-85 -96.71 110.71 23.11 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.435 ' O ' HG12 ' A' ' 59' ' ' VAL . 51.6 p -119.44 -168.45 1.58 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.299 0.571 . . . . 0.0 112.062 -178.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.629 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.17 155.07 37.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.037 179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 m -71.23 -35.94 71.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.462 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 47.5 p-90 -86.25 11.33 12.33 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.404 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 11.1 t -88.76 157.72 18.41 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 120.988 0.423 . . . . 0.0 111.436 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.92 -64.66 0.49 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.004 179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 37' ' ' MET . 30.3 Cg_exo -64.01 -21.39 68.37 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.753 2.302 . . . . 0.0 112.499 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 72.7 m -59.02 -39.82 83.09 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.294 0.569 . . . . 0.0 109.983 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -68.69 -16.88 63.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.564 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.408 ' HG2' ' HA ' ' A' ' 34' ' ' PRO . 69.2 mmm -74.16 -24.64 59.43 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.537 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.539 HG22 ' HB2' ' A' ' 42' ' ' PHE . 6.9 mm -86.19 -24.87 6.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.631 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.19 -51.09 65.93 Favored Pre-proline 0 N--CA 1.468 0.428 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -57.3 -48.37 18.03 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.151 1.901 . . . . 0.0 112.703 -179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -80.59 -31.03 36.87 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.373 0.509 . . . . 0.0 112.373 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 8.2 t80 -66.59 -45.83 77.92 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.875 0.369 . . . . 0.0 110.319 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.67 -39.35 88.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.554 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 27.5 m -60.75 -42.86 98.24 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.042 -179.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.18 -44.39 95.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.257 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 54' ' ' PHE . 25.0 p -53.55 -25.15 15.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.229 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -86.6 -21.98 26.5 Favored 'General case' 0 N--CA 1.461 0.095 0 CA-C-O 120.608 0.242 . . . . 0.0 111.129 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 ttpp -94.9 -19.16 20.5 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.883 0.373 . . . . 0.0 110.08 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.766 ' HB3' HG22 ' A' ' 52' ' ' VAL . 18.4 m-85 -98.95 92.84 5.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.196 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.4 t -90.11 50.58 1.88 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.078 0.466 . . . . 0.0 110.674 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -153.14 -42.73 0.1 Allowed 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.492 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' A' ' 49' ' ' TYR . 5.5 m -93.29 154.31 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.689 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.952 HG23 HG13 ' A' ' 23' ' ' VAL . 5.7 tp -105.9 115.65 48.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.909 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.613 ' O ' HG13 ' A' ' 2' ' ' VAL . 5.7 m-85 -97.03 115.83 28.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.505 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.854 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -127.48 166.73 17.39 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.125 -0.63 . . . . 0.0 111.491 178.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.412 ' N ' HD12 ' A' ' 55' ' ' LEU . 1.6 tp10 -117.93 118.6 32.41 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -176.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.462 HG22 HD11 ' A' ' 55' ' ' LEU . 2.4 t -116.39 118.07 57.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.548 0.689 . . . . 0.0 110.842 178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -99.34 120.16 39.12 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.558 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 28' ' ' SER . 13.7 p -61.2 -17.84 17.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -178.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -63.4 -40.06 96.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.247 0.546 . . . . 0.0 109.527 178.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -98.25 -36.29 10.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.987 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.93 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.66 42.07 1.09 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.752 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -69.8 -11.17 60.65 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.343 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -92.96 -21.98 19.47 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.138 -0.225 . . . . 0.0 111.439 -179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.93 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.2 m -80.47 -46.48 21.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.152 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.877 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -50.04 -56.65 16.3 Favored Pre-proline 0 N--CA 1.466 0.331 0 O-C-N 122.284 -0.26 . . . . 0.0 111.552 -179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.877 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 79.2 Cg_exo -51.35 -28.32 26.64 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.543 2.162 . . . . 0.0 111.958 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -74.41 -24.74 59.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.35 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -108.43 -6.65 16.08 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.628 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.31 38.87 94.06 Favored Glycine 0 CA--C 1.521 0.425 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.706 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.617 HG23 HG21 ' A' ' 76' ' ' THR . 76.7 mt -76.28 133.09 31.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.715 0.293 . . . . 0.0 110.38 179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.6 tpt85 -149.64 49.05 0.94 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.933 0.397 . . . . 0.0 110.913 -179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.32 102.09 0.16 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.713 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.407 ' HA ' ' N ' ' A' ' 76' ' ' THR . 13.0 pt -101.88 150.02 37.02 Favored Pre-proline 0 C--N 1.331 -0.218 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.83 114.05 3.22 Favored 'Cis proline' 0 C--N 1.348 0.505 0 C-N-CA 124.29 -1.129 . . . . 0.0 112.385 0.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.617 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -86.42 135.05 33.64 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.603 HD22 HD21 ' A' ' 93' ' ' LEU . 2.0 mp -107.81 126.18 52.33 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.55 HD11 HD11 ' A' ' 71' ' ' ILE . 6.0 mt -118.36 134.07 55.36 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.268 0.556 . . . . 0.0 111.636 -178.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.916 HD12 HD11 ' A' ' 22' ' ' LEU . 3.1 mm? -113.4 126.0 54.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.688 179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.494 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 51.9 m-85 -118.68 146.8 44.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.954 0.407 . . . . 0.0 110.961 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.0 tttm -144.74 110.45 5.34 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.805 -179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.0 m120 60.52 46.41 9.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.908 0.385 . . . . 0.0 110.063 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 74.08 -3.37 38.23 Favored Glycine 0 CA--C 1.523 0.588 0 C-N-CA 121.005 -0.616 . . . . 0.0 114.141 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.57 134.1 55.24 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 117.299 0.55 . . . . 0.0 111.68 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.516 ' O ' HG13 ' A' ' 85' ' ' VAL . 10.0 p -68.04 116.35 7.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.445 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -109.81 11.1 24.47 Favored 'General case' 0 C--N 1.333 -0.133 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.89 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.45 137.23 0.37 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.263 179.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.531 HG23 ' CD2' ' A' ' 78' ' ' LEU . 51.3 m -137.52 124.68 21.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.068 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.7 mmtt -122.72 145.14 48.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.352 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.81 146.64 24.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.199 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 77.44 159.26 10.83 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.964 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -70.44 141.0 52.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.995 0.426 . . . . 0.0 111.481 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.603 HD21 HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -129.29 150.97 50.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.239 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.08 179.09 0.74 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.701 0.286 . . . . 0.0 110.624 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -71.28 -32.56 68.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.731 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.06 -31.03 54.43 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.928 -179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.74 -31.48 57.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.948 0.404 . . . . 0.0 110.577 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.535 HD11 HD21 ' A' ' 77' ' ' LEU . 0.3 OUTLIER -71.78 -51.26 23.54 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.704 179.122 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -61.07 -41.78 97.27 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.078 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.406 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.0 OUTLIER -61.83 -39.09 90.61 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.91 0.386 . . . . 0.0 110.178 179.467 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.89 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 11.3 t80 -63.27 -42.4 99.12 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.515 0.674 . . . . 0.0 110.114 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.51 HD11 HG11 ' A' ' 24' ' ' VAL . 5.0 mt -66.77 -58.45 5.03 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.85 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -48.86 -34.97 13.6 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-O 120.936 0.398 . . . . 0.0 110.732 179.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.2 -20.57 60.15 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -109.0 -33.42 6.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.678 HD23 HG12 ' A' ' 52' ' ' VAL . 3.4 tm? -69.24 114.22 7.29 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.893 0.378 . . . . 0.0 110.679 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.495 HG13 ' O ' ' A' ' 106' ' ' LEU . 5.1 m . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.197 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttt . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.947 0.403 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.718 HG13 ' HA ' ' A' ' 55' ' ' LEU . 48.3 t 63.45 146.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.642 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 7.1 ptpp? -146.09 122.07 10.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.159 0.504 . . . . 0.0 110.265 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -74.48 129.64 38.14 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.053 -179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.872 HD13 HD13 ' A' ' 55' ' ' LEU . 1.1 mp -101.97 108.11 23.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.953 0.406 . . . . 0.0 110.317 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -98.94 19.27 15.34 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.226 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 m -154.72 159.74 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.882 0.372 . . . . 0.0 111.127 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.614 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -72.35 -27.1 62.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.083 180.0 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.2 m -79.97 -31.87 39.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.952 0.406 . . . . 0.0 110.751 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.59 -38.63 90.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.898 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.492 ' CE1' HG21 ' A' ' 57' ' ' VAL . 3.8 t80 -56.36 -40.19 74.12 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -68.75 -45.14 72.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.046 178.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.77 -48.41 79.76 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.484 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.41 -32.46 74.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.916 0.389 . . . . 0.0 110.928 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.0 mt -68.14 -34.58 76.6 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.802 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -63.01 -34.13 76.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.925 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.2 -22.59 55.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.702 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.68 -37.61 85.1 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.297 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.17 -124.37 35.78 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 120.162 -1.018 . . . . 0.0 112.997 179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -94.19 4.89 53.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.543 0.211 . . . . 0.0 111.031 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.6 mttp -77.42 149.36 35.14 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.801 HD12 ' N ' ' A' ' 23' ' ' VAL . 4.4 tp -76.77 136.64 39.0 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.865 HG13 HG23 ' A' ' 53' ' ' ILE . 10.6 t -117.05 110.83 32.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.261 0.553 . . . . 0.0 112.234 -178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.524 HG11 ' CZ ' ' A' ' 54' ' ' PHE . 7.9 p -106.69 115.87 49.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.53 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.3 m -123.02 167.48 16.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.949 -177.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -134.51 135.96 42.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.914 -0.585 . . . . 0.0 112.284 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.598 ' HE1' HD12 ' A' ' 78' ' ' LEU . 7.8 m-85 -99.06 109.88 22.55 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.545 178.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.432 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.3 m -114.97 -168.67 1.42 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.139 0.495 . . . . 0.0 111.928 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.722 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.08 155.17 37.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.743 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.6 m -71.96 -37.47 69.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.499 0.666 . . . . 0.0 109.366 178.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.5 p-90 -86.76 12.4 10.92 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 114.826 -1.079 . . . . 0.0 112.034 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.722 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 8.0 t -94.17 159.83 14.97 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.994 0.426 . . . . 0.0 111.746 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.94 -64.91 0.44 Allowed Glycine 0 C--N 1.331 0.262 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.045 179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -61.4 -24.13 77.97 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.708 2.272 . . . . 0.0 112.047 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.9 m -58.94 -43.69 91.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.238 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.4 -27.53 67.92 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.599 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 47.9 mtt -67.83 -17.09 64.39 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -179.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.3 mm -86.27 -22.35 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.904 0.383 . . . . 0.0 111.002 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.505 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 0.8 OUTLIER -51.28 -58.7 9.71 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.169 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_endo -48.07 -46.65 21.59 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.539 2.16 . . . . 0.0 112.655 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -78.94 -33.79 45.02 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -66.17 -45.82 79.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.916 0.389 . . . . 0.0 110.402 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.95 -40.68 87.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.657 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -43.85 94.83 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.882 0.372 . . . . 0.0 110.893 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.466 HD22 ' HG3' ' A' ' 99' ' ' LYS . 21.5 mt -59.68 -39.42 84.48 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.7 t -56.49 -29.57 61.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.903 -0.589 . . . . 0.0 111.614 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -86.66 -18.19 31.91 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.144 -0.223 . . . . 0.0 111.516 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.3 tttp -95.1 -20.35 19.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.932 0.396 . . . . 0.0 110.008 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.794 ' HB3' HG22 ' A' ' 52' ' ' VAL . 21.8 m-85 -100.13 90.65 4.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.473 179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.1 m -86.96 51.28 2.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.081 0.467 . . . . 0.0 110.454 179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 43.3 t-20 -154.65 -41.57 0.09 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.171 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.794 HG22 ' HB3' ' A' ' 49' ' ' TYR . 10.7 m -93.37 154.45 3.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 115.979 -0.555 . . . . 0.0 112.013 -178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.865 HG23 HG13 ' A' ' 23' ' ' VAL . 4.0 tp -103.7 114.48 43.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.256 0.55 . . . . 0.0 111.507 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.622 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.7 m-85 -97.61 115.6 28.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.178 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.872 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.63 167.89 16.54 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.034 -0.666 . . . . 0.0 111.115 178.818 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -119.68 120.41 36.53 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -176.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.492 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -115.16 118.11 57.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.175 0.512 . . . . 0.0 110.406 178.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -97.97 119.52 36.74 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 28' ' ' SER . 13.9 p -60.08 -18.71 16.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.03 -178.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -65.66 -38.07 88.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.037 0.446 . . . . 0.0 109.802 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -99.35 -35.13 10.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.28 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.903 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.43 46.07 1.14 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.916 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -72.3 -11.19 60.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.534 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -92.75 -22.79 19.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.505 0.193 . . . . 0.0 111.174 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.903 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.4 m -79.31 -47.29 22.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.978 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.634 ' HB3' ' CD ' ' A' ' 67' ' ' PRO . . . -50.52 -60.16 5.9 Favored Pre-proline 0 N--CA 1.464 0.274 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.634 ' CD ' ' HB3' ' A' ' 66' ' ' ALA . 10.2 Cg_endo -50.85 -28.63 24.02 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.713 2.276 . . . . 0.0 111.967 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.7 mtpp -78.13 -23.41 47.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.902 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -106.4 -2.96 21.56 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.649 -179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 65.67 33.75 86.98 Favored Glycine 0 CA--C 1.52 0.357 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.629 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.639 HD11 HD11 ' A' ' 78' ' ' LEU . 81.2 mt -77.75 133.64 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 117.184 0.492 . . . . 0.0 110.618 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.9 ttp85 -144.74 64.35 1.29 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.337 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 170.85 162.38 23.1 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.243 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.3 pt -147.51 139.78 14.21 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.692 0.246 . . . . 0.0 110.987 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -87.95 123.62 6.65 Favored 'Cis proline' 0 C--N 1.35 0.635 0 C-N-CA 124.203 -1.165 . . . . 0.0 112.604 0.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.498 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -86.99 134.29 33.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.813 0.339 . . . . 0.0 111.077 179.199 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.863 HD22 HD11 ' A' ' 93' ' ' LEU . 0.3 OUTLIER -106.27 123.47 48.1 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.639 HD11 HD11 ' A' ' 71' ' ' ILE . 7.4 mt -115.6 136.12 53.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.222 0.534 . . . . 0.0 111.845 -177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.931 ' HB2' ' HB3' ' A' ' 87' ' ' ALA . 3.3 mm? -116.34 120.81 40.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.594 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.529 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 47.3 m-85 -112.17 145.61 39.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.056 0.455 . . . . 0.0 111.202 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.4 tttm -145.93 110.94 5.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.998 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.9 m120 62.06 46.19 6.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 110.111 -179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.66 2.9 57.45 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.639 -0.709 . . . . 0.0 113.745 178.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -123.78 136.33 54.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.385 0.592 . . . . 0.0 111.651 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 85' ' ' VAL . 7.6 p -66.66 117.59 8.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.128 179.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -107.68 11.48 28.4 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.931 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.52 144.62 1.15 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.96 119.97 17.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.69 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 tptt -122.13 139.27 53.94 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.855 0.359 . . . . 0.0 110.249 179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 20.7 t -121.8 145.92 27.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.464 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.6 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 81.54 159.81 24.38 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.602 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -68.74 143.89 54.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.976 0.417 . . . . 0.0 111.386 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.863 HD11 HD22 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -125.43 -171.37 2.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.513 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 26.0 t -109.21 165.98 11.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 110.822 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.6 tptm -57.4 -37.72 73.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.05 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.54 -30.12 54.04 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.845 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.58 -32.59 58.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.851 0.358 . . . . 0.0 110.488 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.44 -49.65 39.48 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.466 ' HG3' HD22 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -61.01 -43.76 98.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.876 179.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 101' ' ' PHE . 0.3 OUTLIER -62.21 -38.1 87.84 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.891 0.377 . . . . 0.0 110.168 179.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.678 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 5.6 t80 -61.82 -39.99 93.69 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.207 0.527 . . . . 0.0 109.923 178.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.435 HD11 ' CZ ' ' A' ' 54' ' ' PHE . 6.6 mt -66.12 -59.32 3.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.914 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -48.49 -34.49 11.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.058 0.456 . . . . 0.0 110.705 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -70.85 -24.42 62.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.18 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.66 ' O ' HG22 ' A' ' 107' ' ' VAL . 1.9 t30 -106.37 -47.68 3.74 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.676 0.274 . . . . 0.0 111.021 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.495 HD23 ' C ' ' A' ' 106' ' ' LEU . 6.1 tt -53.19 106.46 0.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.768 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 105' ' ' ASN . 17.7 m . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.161 -0.923 . . . . 0.0 111.066 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.7 mtm . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 121.026 0.441 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.731 HG13 ' HA ' ' A' ' 55' ' ' LEU . 56.8 t -64.37 145.08 14.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.097 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -146.77 123.42 11.16 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.022 0.439 . . . . 0.0 109.827 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -75.38 132.39 40.87 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.91 HD13 HD13 ' A' ' 55' ' ' LEU . 1.0 OUTLIER -100.16 106.74 19.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.262 0.553 . . . . 0.0 110.543 -179.1 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -97.76 21.31 10.63 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.87 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -156.26 159.13 38.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.771 0.32 . . . . 0.0 111.192 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.701 ' HA ' HG13 ' A' ' 65' ' ' VAL . 3.2 tmpt? -73.58 -26.9 61.03 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.946 0.403 . . . . 0.0 110.42 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.3 m -79.8 -32.11 40.76 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.616 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' CB ' HG13 ' A' ' 5' ' ' ILE . . . -66.57 -36.25 82.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.463 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.586 ' CE1' HG21 ' A' ' 57' ' ' VAL . 6.0 t80 -58.16 -42.51 86.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.107 0.479 . . . . 0.0 110.168 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -66.53 -41.79 88.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.955 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.96 -48.21 82.63 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.528 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.15 -33.93 76.89 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.921 0.391 . . . . 0.0 110.67 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.474 HD23 ' HA ' ' A' ' 15' ' ' LEU . 12.1 mt -64.78 -40.76 95.8 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -66.9 -27.1 67.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.624 178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.23 -49.19 75.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.876 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.79 -64.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.234 -0.586 . . . . 0.0 109.544 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.51 -86.3 1.46 Allowed Glycine 0 CA--C 1.519 0.342 0 CA-C-N 115.33 -0.85 . . . . 0.0 112.809 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.1 t0 -94.4 -16.92 23.02 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -74.86 157.73 34.6 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.054 HD11 HD12 ' A' ' 79' ' ' LEU . 5.3 tp -79.5 133.96 36.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.863 HG13 ' CG2' ' A' ' 53' ' ' ILE . 15.7 t -114.37 110.37 31.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.403 0.621 . . . . 0.0 111.573 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.668 ' HB ' HD21 ' A' ' 102' ' ' LEU . 7.3 p -106.18 115.05 47.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.572 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.2 m -123.05 166.74 17.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.759 -178.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -131.75 132.04 43.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.546 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.692 ' HE1' HD12 ' A' ' 78' ' ' LEU . 4.7 m-85 -97.94 111.84 24.0 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.686 ' O ' HG12 ' A' ' 59' ' ' VAL . 22.7 t -117.46 -170.51 1.87 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.446 0.641 . . . . 0.0 112.472 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.457 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -152.12 155.38 37.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.437 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.52 -35.84 68.18 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.39 0.614 . . . . 0.0 110.199 178.387 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -85.31 11.52 9.99 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.081 -178.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 8.8 t -96.83 158.26 15.51 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.945 0.402 . . . . 0.0 111.313 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.51 -66.55 0.5 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.009 179.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -59.82 -23.36 71.89 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.454 2.103 . . . . 0.0 112.193 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 71.4 m -58.82 -44.54 90.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.837 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.4 mtpt -65.0 -26.5 68.31 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.51 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.5 mtt -67.03 -17.44 64.91 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.544 HD11 ' HB1' ' A' ' 92' ' ' ALA . 14.5 mm -86.1 -21.72 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 120.895 -0.322 . . . . 0.0 111.091 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 40' ' ' PRO . 25.6 mttp -51.37 -59.34 8.02 Favored Pre-proline 0 N--CA 1.465 0.292 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 39' ' ' LYS . 8.2 Cg_endo -50.35 -45.2 35.24 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.437 2.092 . . . . 0.0 112.869 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -78.88 -31.87 45.65 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -178.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.419 ' CZ ' HG22 ' A' ' 24' ' ' VAL . 4.5 t80 -65.9 -45.37 82.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.93 0.395 . . . . 0.0 110.531 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.78 -38.35 86.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.524 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.6 m -59.67 -42.8 93.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 110.746 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.413 ' HB2' ' CE2' ' A' ' 54' ' ' PHE . 10.5 mt -60.81 -42.89 98.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.418 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 24.4 p -54.81 -25.84 31.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.394 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -86.64 -23.15 25.78 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.599 0.238 . . . . 0.0 111.321 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.7 ttpt -94.18 -19.05 21.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.983 0.421 . . . . 0.0 110.041 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.832 ' HB3' HG22 ' A' ' 52' ' ' VAL . 19.7 m-85 -100.16 88.03 3.61 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.966 179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.6 p -87.11 50.92 2.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.008 0.432 . . . . 0.0 110.463 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -153.5 -42.58 0.09 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.685 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.832 HG22 ' HB3' ' A' ' 49' ' ' TYR . 12.3 m -93.46 154.56 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.556 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.863 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.6 tp -103.79 114.17 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.353 0.597 . . . . 0.0 111.038 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.646 ' O ' HG22 ' A' ' 2' ' ' VAL . 7.5 m-85 -96.91 117.31 30.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.806 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.91 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -130.76 164.8 24.32 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.395 179.274 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -112.98 116.02 29.31 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.586 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.6 t -114.05 116.46 52.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.168 0.508 . . . . 0.0 111.048 178.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -99.18 120.18 39.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.469 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.686 HG12 ' O ' ' A' ' 28' ' ' SER . 10.2 p -60.96 -20.03 21.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.098 -178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -61.76 -40.77 96.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.219 0.533 . . . . 0.0 109.667 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -100.26 -33.53 10.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.353 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.914 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.78 43.6 1.1 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.548 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -71.66 -9.92 58.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.565 -179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -95.38 -21.4 18.4 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 121.226 -0.19 . . . . 0.0 111.243 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.914 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 1.6 m -79.34 -47.87 21.82 Favored 'Isoleucine or valine' 0 C--O 1.231 0.117 0 C-N-CA 120.837 -0.345 . . . . 0.0 110.485 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.919 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.89 -58.28 9.87 Favored Pre-proline 0 C--N 1.333 -0.141 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.919 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 74.7 Cg_exo -51.2 -28.3 25.42 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.415 2.077 . . . . 0.0 111.849 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -73.8 -25.68 60.24 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.487 179.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -108.39 -6.12 16.37 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.691 -179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.73 36.23 90.94 Favored Glycine 0 CA--C 1.523 0.551 0 CA-C-N 116.007 -0.542 . . . . 0.0 114.33 178.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.627 HD11 HD11 ' A' ' 78' ' ' LEU . 63.9 mt -74.65 136.65 24.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 117.312 0.556 . . . . 0.0 110.653 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.6 ttt-85 -151.79 54.89 0.84 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.999 0.428 . . . . 0.0 111.236 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.73 102.22 0.15 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.428 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.428 ' HA ' ' N ' ' A' ' 76' ' ' THR . 11.8 pt -102.87 154.39 37.56 Favored Pre-proline 0 C--N 1.328 -0.346 0 O-C-N 122.971 -0.135 . . . . 0.0 110.835 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.74 114.17 3.17 Favored 'Cis proline' 0 C--N 1.348 0.529 0 C-N-CA 123.768 -1.347 . . . . 0.0 113.125 0.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.484 HG21 HG23 ' A' ' 71' ' ' ILE . 0.2 OUTLIER -86.26 136.61 33.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.834 0.35 . . . . 0.0 111.221 179.018 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.421 HD22 HD11 ' A' ' 93' ' ' LEU . 0.9 OUTLIER -107.39 123.61 48.62 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 177.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.692 HD12 ' HE1' ' A' ' 27' ' ' PHE . 6.7 mt -116.03 136.14 53.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.223 0.535 . . . . 0.0 111.867 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.054 HD12 HD11 ' A' ' 22' ' ' LEU . 3.9 mm? -116.29 123.46 47.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.518 -0.765 . . . . 0.0 109.863 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.639 ' CE2' HG22 ' A' ' 85' ' ' VAL . 47.1 m-85 -113.98 144.94 42.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.024 0.44 . . . . 0.0 111.072 -179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -146.14 111.34 5.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.061 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 4.5 m120 61.49 45.29 8.47 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.774 0.321 . . . . 0.0 110.563 -179.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.99 2.76 58.73 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.52 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -124.45 140.35 53.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 117.297 0.548 . . . . 0.0 111.809 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.639 HG22 ' CE2' ' A' ' 80' ' ' PHE . 33.0 t -69.9 120.87 18.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.672 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -114.72 8.65 16.22 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.904 ' HB3' ' HB2' ' A' ' 79' ' ' LEU . . . -173.84 136.56 0.55 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.971 179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 85.9 m -136.36 125.26 24.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.789 0.328 . . . . 0.0 110.771 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.81 145.17 49.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.046 0.451 . . . . 0.0 111.181 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.59 145.93 25.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.172 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.409 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 77.53 160.83 13.7 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.66 -0.781 . . . . 0.0 113.332 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.666 ' C ' HD23 ' A' ' 93' ' ' LEU . . . -65.29 176.38 1.38 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.045 0.45 . . . . 0.0 111.508 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.666 HD23 ' C ' ' A' ' 92' ' ' ALA . 0.2 OUTLIER -170.37 153.3 4.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.692 -179.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.1 t -66.78 179.01 1.16 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.028 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.4 tttt -72.97 -28.63 62.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.068 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.46 -31.77 49.63 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.483 -0.865 . . . . 0.0 113.13 -179.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 39.7 mt-30 -76.87 -31.9 57.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.975 0.387 . . . . 0.0 110.558 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.611 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -71.02 -51.13 27.18 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.047 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -63.33 -43.22 98.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.097 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.5 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.4 pp20? -62.06 -43.17 99.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.779 0.323 . . . . 0.0 110.469 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.748 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 29.8 t80 -61.9 -39.21 91.18 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.4 0.619 . . . . 0.0 110.088 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.668 HD21 ' HB ' ' A' ' 24' ' ' VAL . 4.3 mt -65.52 -60.7 2.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.009 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -48.23 -32.22 6.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -71.02 -26.23 63.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.791 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -106.36 -26.58 11.42 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.702 0.287 . . . . 0.0 111.524 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.629 HD23 ' O ' ' A' ' 106' ' ' LEU . 1.8 tt -72.64 -37.35 68.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.971 0.415 . . . . 0.0 110.482 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 106' ' ' LEU . 22.6 m . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.292 -0.861 . . . . 0.0 112.223 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.9 ttm . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.845 0.355 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.696 HG13 ' HA ' ' A' ' 55' ' ' LEU . 52.1 t -70.43 145.7 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.625 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -143.34 120.51 11.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 121.185 0.517 . . . . 0.0 110.377 -179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.63 129.27 37.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.118 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.796 HD13 HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -101.67 107.79 22.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.353 -179.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.66 20.19 13.38 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.159 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.0 m -155.15 160.36 40.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.824 0.345 . . . . 0.0 111.401 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.648 ' HA ' HG13 ' A' ' 65' ' ' VAL . 0.7 OUTLIER -72.96 -27.07 61.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.624 179.474 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.438 HG22 ' OE2' ' A' ' 13' ' ' GLU . 6.3 m -79.76 -30.99 40.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.858 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.428 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -65.78 -39.78 91.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.735 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 57' ' ' VAL . 4.8 t80 -56.77 -43.26 80.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.191 0.52 . . . . 0.0 109.661 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.12 -46.2 78.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.875 178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.438 ' OE2' HG22 ' A' ' 9' ' ' THR . 14.0 mt-10 -60.74 -44.8 96.22 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.434 -179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.74 -34.32 78.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.942 0.401 . . . . 0.0 110.577 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.6 mt -68.03 -35.9 79.03 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.497 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -61.28 -35.29 76.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.322 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -76.45 -22.52 54.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.91 178.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.1 -33.21 74.1 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.227 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.03 -125.07 37.83 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.355 -0.926 . . . . 0.0 113.036 179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -92.22 6.4 46.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.509 0.195 . . . . 0.0 111.139 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -78.74 150.15 32.53 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.951 HD11 HD12 ' A' ' 79' ' ' LEU . 6.5 tp -78.08 133.76 37.84 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.884 HG13 HG23 ' A' ' 53' ' ' ILE . 6.5 t -113.85 110.19 31.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.454 0.645 . . . . 0.0 112.005 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.684 HG11 HD11 ' A' ' 102' ' ' LEU . 7.3 p -102.59 113.84 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.709 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.1 m -121.27 165.85 16.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.758 -177.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -134.31 133.31 40.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.854 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.459 ' HE1' HD12 ' A' ' 78' ' ' LEU . 10.7 m-85 -97.34 110.39 22.95 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 35' ' ' CYS . 54.4 p -121.41 -166.76 1.41 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.247 0.546 . . . . 0.0 112.228 -178.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.769 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -151.83 152.71 33.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.155 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.7 m -70.44 -36.98 74.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.437 0.637 . . . . 0.0 109.408 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 52.2 p-90 -87.23 11.31 14.49 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.826 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.769 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 15.4 t -93.04 155.79 17.29 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.482 . . . . 0.0 112.213 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.79 -75.8 1.04 Allowed Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.209 179.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.402 ' HA ' ' CG ' ' A' ' 37' ' ' MET . 9.3 Cg_endo -52.26 -24.52 21.07 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.62 2.214 . . . . 0.0 112.416 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' ' HB2' ' A' ' 28' ' ' SER . 81.2 m -60.49 -41.96 95.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.208 0.528 . . . . 0.0 110.373 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 29.7 mtmt -68.93 -15.64 63.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.25 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.402 ' CG ' ' HA ' ' A' ' 34' ' ' PRO . 3.9 mmt -72.96 -28.09 62.2 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.467 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.2 mm -84.56 -23.97 7.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.734 0.302 . . . . 0.0 111.431 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -49.76 -54.13 34.94 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.898 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_exo -51.45 -48.36 21.65 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.514 2.142 . . . . 0.0 113.345 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -80.08 -28.27 39.17 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -65.63 -45.83 81.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.965 0.412 . . . . 0.0 110.178 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.04 -37.96 81.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.95 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -43.96 97.65 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 120.917 0.389 . . . . 0.0 110.603 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.54 -42.35 92.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.111 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.7 t -55.38 -26.19 39.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.293 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -88.45 -20.15 25.57 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.586 0.231 . . . . 0.0 111.526 -179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.5 tttp -96.23 -20.35 18.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.058 0.456 . . . . 0.0 110.069 179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.828 ' HB3' HG22 ' A' ' 52' ' ' VAL . 20.0 m-85 -98.71 92.83 5.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.725 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 78.7 p -91.31 48.51 1.5 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.667 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -151.79 -40.42 0.11 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.58 179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.828 HG22 ' HB3' ' A' ' 49' ' ' TYR . 12.5 m -95.35 156.16 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.594 -179.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.884 HG23 HG13 ' A' ' 23' ' ' VAL . 4.7 tp -106.67 115.18 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.892 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.622 ' CE1' HG11 ' A' ' 24' ' ' VAL . 7.7 m-85 -96.34 115.65 27.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.56 -0.746 . . . . 0.0 109.244 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.796 HD13 HD13 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -128.32 166.24 19.02 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.734 179.138 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.458 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.4 OUTLIER -117.98 120.05 36.67 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 113.63 0.974 . . . . 0.0 113.63 -176.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG21 ' CE1' ' A' ' 11' ' ' PHE . 2.2 t -114.75 117.72 56.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.107 0.48 . . . . 0.0 110.713 178.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -98.62 120.05 38.38 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.78 -17.67 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 -178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -66.91 -37.61 84.68 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 178.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -98.2 -37.82 9.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.143 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.855 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -96.59 44.11 1.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.303 179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -9.37 48.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.815 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -95.57 -22.36 17.67 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 121.236 -0.185 . . . . 0.0 111.467 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.855 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 2.8 m -79.06 -47.44 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.53 179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.926 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.66 -57.69 11.42 Favored Pre-proline 0 N--CA 1.463 0.178 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.926 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 75.3 Cg_exo -51.11 -28.5 25.34 Favored 'Trans proline' 0 C--N 1.34 0.09 0 C-N-CA 122.441 2.094 . . . . 0.0 111.595 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.6 tttm -75.93 -21.72 56.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.918 179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -112.63 -5.69 13.96 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 64.49 39.26 96.71 Favored Glycine 0 CA--C 1.521 0.434 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.451 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.873 HG23 HG21 ' A' ' 76' ' ' THR . 61.4 mt -79.32 79.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.929 0.365 . . . . 0.0 111.06 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.8 ttt180 -86.5 82.58 7.89 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.184 0.516 . . . . 0.0 111.836 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 134.77 163.13 10.07 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.568 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.2 pt -146.2 156.77 50.3 Favored Pre-proline 0 C--N 1.332 -0.193 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -83.5 118.25 5.34 Favored 'Cis proline' 0 C--N 1.349 0.561 0 C-N-CA 124.402 -1.082 . . . . 0.0 113.063 0.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.873 HG21 HG23 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -89.16 136.55 32.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.372 . . . . 0.0 111.686 179.32 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.622 HD22 HD21 ' A' ' 93' ' ' LEU . 1.1 mp -109.19 123.29 49.0 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.707 ' CD2' HG23 ' A' ' 88' ' ' THR . 6.3 mt -115.6 133.11 56.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.341 0.591 . . . . 0.0 111.411 -178.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.951 HD12 HD11 ' A' ' 22' ' ' LEU . 3.4 mm? -114.17 121.8 44.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.636 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.497 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 41.6 m-85 -113.07 146.87 38.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.261 0.553 . . . . 0.0 111.544 -178.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.3 tttm -146.69 116.73 7.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.011 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.6 m120 57.98 44.97 18.81 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.455 -179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.1 2.54 53.43 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.9 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -124.91 139.47 53.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.473 0.637 . . . . 0.0 111.705 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.472 ' O ' HG13 ' A' ' 85' ' ' VAL . 10.4 p -67.96 117.51 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.905 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -110.91 10.68 22.33 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.857 ' HB1' ' CZ ' ' A' ' 101' ' ' PHE . . . -175.7 137.14 0.34 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.527 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.707 HG23 ' CD2' ' A' ' 78' ' ' LEU . 10.9 m -136.7 125.26 23.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.588 179.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -123.24 143.21 50.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.859 -179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.2 t -120.5 146.37 25.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.568 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.449 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 80.95 159.6 22.49 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.892 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.03 37.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.933 0.397 . . . . 0.0 111.696 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.622 HD21 HD22 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -118.72 150.4 39.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.7 179.588 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 m -63.98 179.81 0.49 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -72.78 -32.63 65.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.976 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.01 -30.06 56.16 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.158 -1.02 . . . . 0.0 112.618 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.448 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 26.3 mt-30 -76.43 -31.86 58.14 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.027 0.441 . . . . 0.0 110.704 179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.589 ' HG ' HD11 ' A' ' 93' ' ' LEU . 0.6 OUTLIER -72.33 -50.11 29.29 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -62.22 -44.08 97.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.107 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 97' ' ' GLN . 17.8 pt-20 -60.05 -44.22 94.85 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.713 0.292 . . . . 0.0 110.814 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.857 ' CZ ' ' HB1' ' A' ' 87' ' ' ALA . 19.4 t80 -61.92 -42.2 98.82 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.114 0.483 . . . . 0.0 111.11 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.684 HD11 HG11 ' A' ' 24' ' ' VAL . 3.6 mt -66.67 -57.54 6.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.164 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.26 -34.92 16.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.68 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.74 -22.59 60.84 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.045 -0.525 . . . . 0.0 112.254 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -107.88 -24.14 11.77 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.685 HD13 ' N ' ' A' ' 107' ' ' VAL . 2.2 tm? -75.25 -80.96 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.813 -179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.685 ' N ' HD13 ' A' ' 106' ' ' LEU . 12.5 p . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.133 179.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mtt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 121.144 0.497 . . . . 3.48 111.588 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.917 HG13 ' HA ' ' A' ' 55' ' ' LEU . 58.3 t -110.8 151.17 13.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.668 -0.696 . . . . 0.25 109.709 179.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.506 ' O ' HD12 ' A' ' 5' ' ' ILE . 10.2 ptpt -143.96 122.43 12.42 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 119.686 -0.805 . . . . 1.47 110.917 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.16 123.4 26.37 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.44 -1.254 . . . . 1.77 109.796 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 1.048 ' CD1' HD13 ' A' ' 55' ' ' LEU . 3.5 mp -102.91 110.79 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 120.985 0.421 . . . . 0.48999999999999999 110.558 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -98.63 19.02 15.43 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.012 -0.54 . . . . 1.5700000000000001 111.545 179.515 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.45 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.7 m -155.16 163.69 39.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.949 0.404 . . . . 0.76000000000000001 111.89 -179.683 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.57 ' HA ' HG13 ' A' ' 65' ' ' VAL . 1.9 ttpt -76.79 -25.55 53.46 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 115.984 -0.553 . . . . 1.3600000000000001 110.778 179.842 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -79.34 -32.43 43.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.004 0.431 . . . . 0.28000000000000003 109.955 179.525 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 1.041 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -66.51 -37.97 86.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.801 -0.636 . . . . 0.17000000000000001 110.521 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -57.85 -46.14 85.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.276 -0.42 . . . . 0.23999999999999999 110.686 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -65.47 -40.58 93.32 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.853 -0.612 . . . . 1.01 109.736 178.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -58.58 -48.76 79.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.918 -0.583 . . . . 1.3400000000000001 110.94 179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -66.45 -36.29 82.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.991 -0.549 . . . . 0.20999999999999999 111.247 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.2 mt -64.69 -38.33 90.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.904 0.383 . . . . 0.29999999999999999 110.166 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.2 -27.66 68.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 1.7 110.476 179.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.06 -44.9 83.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.004 -0.544 . . . . 0.31 111.146 -178.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.15 -65.45 0.67 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 119.943 -0.703 . . . . 0.63 109.922 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.83 -93.24 1.86 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-N 115.704 -0.68 . . . . 0.42999999999999999 112.808 -179.243 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -95.63 -9.95 30.75 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 117.199 0.499 . . . . 2.2599999999999998 111.669 -179.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 78.7 mttt -75.24 151.08 38.44 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.613 -0.514 . . . . 1.1399999999999999 109.613 179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.998 HD11 HD12 ' A' ' 79' ' ' LEU . 1.9 tp -76.39 127.91 33.79 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.883 0.373 . . . . 0.20000000000000001 110.112 179.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.827 HG13 ' CG2' ' A' ' 53' ' ' ILE . 3.9 t -106.67 110.23 30.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.34 0.59 . . . . 0.17999999999999999 111.592 -179.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.548 ' HB ' HD21 ' A' ' 102' ' ' LEU . 7.3 p -106.07 116.06 49.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.114 -1.069 . . . . 0.26000000000000001 108.114 178.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.067 HG12 ' HG ' ' A' ' 55' ' ' LEU . 3.9 m -123.37 164.18 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.179 0.514 . . . . 0.46000000000000002 112.371 -178.012 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.477 ' OD1' HD12 ' A' ' 77' ' ' LEU . 31.0 t0 -127.81 132.9 49.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.794 -0.639 . . . . 1.1200000000000001 112.067 -178.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -99.1 106.52 18.74 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.06 -0.719 . . . . 0.23999999999999999 109.06 178.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.525 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.9 p -119.92 -174.76 2.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 113.068 0.766 . . . . 1.22 113.068 -177.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.536 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -147.02 154.77 41.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.459 -1.246 . . . . 0.28000000000000003 110.396 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -38.45 79.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.169 0.509 . . . . 0.81999999999999995 110.176 179.487 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 46.5 p-90 -86.54 14.22 7.19 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.364 -0.834 . . . . 0.57999999999999996 111.412 -179.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 32.2 t -98.42 141.35 31.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.737 0.303 . . . . 0.52000000000000002 110.571 178.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -96.89 -67.24 0.94 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.592 -0.813 . . . . 0.28999999999999998 112.196 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -51.95 -26.58 25.35 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.585 2.19 . . . . 0.40999999999999998 112.165 -179.992 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.7 m -60.54 -44.06 96.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.35999999999999999 110.534 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -65.94 -28.44 68.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.795 -0.639 . . . . 1.5700000000000001 111.093 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.0 mtt -68.55 -21.01 64.57 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 1.22 111.549 -179.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.8 mm -87.21 -23.44 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.746 0.308 . . . . 0.28999999999999998 111.132 179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.401 ' CB ' ' HD3' ' A' ' 40' ' ' PRO . 31.5 mttt -51.23 -54.77 34.7 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.39 -0.368 . . . . 1.8700000000000001 110.945 179.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 39' ' ' LYS . 71.5 Cg_exo -48.31 -48.14 17.81 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.613 2.209 . . . . 0.32000000000000001 112.485 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -78.24 -28.43 47.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.516 -0.311 . . . . 0.28999999999999998 111.508 -178.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.474 ' O ' ' CD2' ' A' ' 54' ' ' PHE . 4.4 t80 -68.31 -47.96 66.19 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.097 0.475 . . . . 0.25 110.187 179.321 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.89 -41.67 86.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.735 -0.666 . . . . 0.29999999999999999 111.505 -179.468 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.5 t -59.39 -44.85 92.72 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.774 0.321 . . . . 1.1200000000000001 110.82 -179.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.41 -40.4 86.52 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.808 -0.441 . . . . 0.20000000000000001 109.808 179.766 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.426 ' HB2' ' CB ' ' A' ' 54' ' ' PHE . 35.6 t -53.92 -28.26 35.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.0 -0.545 . . . . 1.24 111.11 179.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -87.93 -17.9 30.33 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.641 -0.254 . . . . 2.1400000000000001 111.33 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.446 ' HE2' ' HD2' ' A' ' 99' ' ' LYS . 4.6 ttpp -95.51 -21.47 18.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.018 0.437 . . . . 1.27 109.946 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.79 ' HB3' HG22 ' A' ' 52' ' ' VAL . 16.9 m-85 -99.04 92.21 5.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.627 -0.715 . . . . 0.70999999999999996 110.708 179.686 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.1 t -84.26 46.41 1.21 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.118 -0.492 . . . . 1.1599999999999999 111.397 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -157.62 -36.27 0.07 Allowed 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.956 0.354 . . . . 1.05 111.956 178.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.79 HG22 ' HB3' ' A' ' 49' ' ' TYR . 6.2 m -91.85 157.07 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.682 0.277 . . . . 0.20000000000000001 111.193 -179.318 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.827 ' CG2' HG13 ' A' ' 23' ' ' VAL . 1.2 tp -104.92 116.91 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.222 0.534 . . . . 0.34000000000000002 111.109 179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.649 ' O ' ' HA ' ' A' ' 2' ' ' VAL . 6.7 m-85 -99.1 117.27 33.23 Favored 'General case' 0 CA--C 1.51 -0.586 0 CA-C-N 115.814 -0.63 . . . . 0.23999999999999999 110.242 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.067 ' HG ' HG12 ' A' ' 25' ' ' VAL . 0.6 OUTLIER -133.23 169.78 16.4 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.642 -0.423 . . . . 0.34999999999999998 110.849 179.636 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.968 ' N ' HD12 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -121.57 124.94 45.56 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.381 0.882 . . . . 1.8200000000000001 113.381 -178.712 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.507 HG22 HD11 ' A' ' 55' ' ' LEU . 7.8 t -112.0 114.59 47.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.654 -0.703 . . . . 0.14999999999999999 111.027 178.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -94.47 115.68 27.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.1 -0.5 . . . . 1.8999999999999999 109.686 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.525 HG12 ' O ' ' A' ' 28' ' ' SER . 12.4 p -59.75 -21.05 20.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.274 -0.421 . . . . 0.19 111.644 -178.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -64.65 -38.83 92.35 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.932 -0.395 . . . . 1.1599999999999999 109.932 179.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -99.61 -39.16 8.43 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 1.3100000000000001 111.263 179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.702 ' HB1' ' CG2' ' A' ' 65' ' ' VAL . . . -94.17 50.38 1.39 Allowed 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.055 0.455 . . . . 0.16 111.176 179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 67' ' ' PRO . 7.0 tt0 -77.54 -3.2 39.41 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.158 -0.474 . . . . 2.0 110.958 179.509 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -92.38 -24.84 18.76 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.766 0.317 . . . . 1.28 110.176 179.663 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.702 ' CG2' ' HB1' ' A' ' 62' ' ' ALA . 8.2 m -81.98 -48.28 18.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.184 -0.462 . . . . 0.22 111.399 179.298 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.864 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -49.52 -55.14 24.26 Favored Pre-proline 0 N--CA 1.465 0.32 0 N-CA-C 112.933 0.716 . . . . 0.17999999999999999 112.933 -178.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.864 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 72.6 Cg_exo -52.35 -27.8 32.5 Favored 'Trans proline' 0 C--O 1.23 0.114 0 C-N-CA 122.871 2.381 . . . . 0.29999999999999999 113.059 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mttm -77.27 -20.26 55.34 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.124 -0.489 . . . . 1.3600000000000001 111.895 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -107.48 -6.03 17.29 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.055 0.455 . . . . 0.23999999999999999 111.055 179.482 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 66.04 37.43 93.13 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.626 -0.715 . . . . 0.26000000000000001 112.859 179.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.522 HD11 HD11 ' A' ' 78' ' ' LEU . 70.9 mt -75.05 134.98 28.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 109.358 -0.608 . . . . 0.66000000000000003 109.358 179.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 14.9 ttt180 -147.2 59.77 1.17 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.72 0.295 . . . . 2.7599999999999998 110.968 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 161.13 117.72 0.45 Allowed Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.478 -0.867 . . . . 0.94999999999999996 113.297 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 pt -108.24 153.54 41.85 Favored Pre-proline 0 C--N 1.331 -0.212 0 N-CA-C 110.164 -0.31 . . . . 0.81999999999999995 110.164 178.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.76 115.94 4.06 Favored 'Cis proline' 0 C--N 1.347 0.491 0 C-N-CA 123.854 -1.311 . . . . 0.44 112.488 -0.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.63 138.2 31.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.878 0.371 . . . . 0.20000000000000001 111.424 179.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.477 HD12 ' OD1' ' A' ' 26' ' ' ASP . 0.8 OUTLIER -108.17 124.86 50.9 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.429 -0.952 . . . . 0.34999999999999998 108.429 177.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.522 HD11 HD11 ' A' ' 71' ' ' ILE . 5.0 mt -116.28 135.33 53.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.272 0.558 . . . . 0.23000000000000001 111.625 -178.047 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.998 HD12 HD11 ' A' ' 22' ' ' LEU . 4.0 mm? -116.74 112.56 21.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.508 -0.769 . . . . 0.23999999999999999 110.889 -179.423 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.584 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 50.5 m-85 -104.26 142.62 34.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.076 -0.511 . . . . 0.19 110.524 179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 11.8 tttm -143.62 112.7 6.72 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.731 -0.668 . . . . 0.34999999999999998 109.638 -179.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 8.8 m120 61.36 45.73 8.35 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.21 0.529 . . . . 0.72999999999999998 109.729 -178.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.43 3.32 46.93 Favored Glycine 0 CA--C 1.524 0.618 0 CA-C-N 115.37 -0.832 . . . . 0.17000000000000001 113.793 178.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -124.67 140.24 53.12 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 117.599 0.699 . . . . 1.6499999999999999 112.106 -179.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 22.5 t -64.68 116.83 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.586 -0.734 . . . . 1.26 110.788 179.08 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -108.54 -1.11 19.95 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.517 0.562 . . . . 0.57999999999999996 112.517 -179.6 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.625 ' HB1' ' HZ ' ' A' ' 101' ' ' PHE . . . -172.79 147.31 1.71 Allowed 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.058 -0.519 . . . . 0.22 111.78 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 2.3 t -137.73 144.5 41.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 1.4199999999999999 110.912 178.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -138.55 139.69 38.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.026 -0.534 . . . . 1.79 110.059 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.0 t -121.32 143.96 31.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.681 0.277 . . . . 0.58999999999999997 111.239 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.407 ' O ' HD23 ' A' ' 93' ' ' LEU . . . 82.66 160.19 27.77 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.529 -0.843 . . . . 0.17999999999999999 112.607 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -67.69 155.54 39.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.143 0.497 . . . . 0.44 111.638 -179.11 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.407 HD23 ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -150.52 151.61 32.92 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.602 -0.726 . . . . 0.56999999999999995 110.263 -179.962 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.8 m -66.92 179.22 1.16 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.0 0.428 . . . . 0.91000000000000003 111.294 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -72.64 -30.59 64.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.828 -0.624 . . . . 0.81000000000000005 111.478 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -77.19 -30.59 54.57 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.131 -1.033 . . . . 0.14000000000000001 112.701 -179.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.587 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 51.6 mt-30 -76.17 -28.46 57.34 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.876 -0.33 . . . . 1.1799999999999999 110.632 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.75 -50.72 16.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.067 0.46 . . . . 0.28999999999999998 109.843 178.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.446 ' HD2' ' HE2' ' A' ' 48' ' ' LYS . 14.7 ttpt -59.22 -44.25 92.29 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.736 -0.665 . . . . 1.1599999999999999 110.908 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.587 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 2.5 pp20? -61.45 -40.31 94.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.86 -0.609 . . . . 1.3799999999999999 110.574 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PHE . . . . . 0.625 ' HZ ' ' HB1' ' A' ' 87' ' ' ALA . 11.9 t80 -62.38 -42.54 99.49 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.317 0.58 . . . . 0.26000000000000001 110.645 178.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.548 HD21 ' HB ' ' A' ' 24' ' ' VAL . 8.1 mt -66.55 -54.95 18.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.778 -0.646 . . . . 0.35999999999999999 109.656 179.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -48.96 -34.05 12.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.169 0.509 . . . . 1.1499999999999999 110.219 179.029 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.49 -22.57 61.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.735 -0.666 . . . . 0.22 112.288 179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -109.06 -33.32 6.93 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 120.83 -0.348 . . . . 0.38 111.407 -179.451 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.73 HD23 ' HB3' ' A' ' 22' ' ' LEU . 3.2 tm? -79.13 103.05 8.8 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.99 -0.374 . . . . 1.3700000000000001 109.99 179.295 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.141 -0.933 . . . . 2.1000000000000001 111.385 -179.51 . . . . . . . . 0 0 . 1 stop_ save_